data_1d5v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d5v _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' TYR . 1.8 Cg_endo . . . . . 0 N--CA 1.492 1.421 0 CA-C-O 119.984 -0.09 . . . . 1.18 112.194 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.41 -8.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.538 1.492 . . . . 1.18 111.558 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' PRO . 11.6 m-85 -68.76 138.85 55.18 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.863 . . . . 1.92 109.162 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 t -73.82 164.64 26.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.294 -0.878 . . . . 1.92 108.737 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -59.95 -39.13 84.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.138 -0.976 . . . . 2.23 108.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.8 mm -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 1.66 109.081 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.27 87.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 1.1 109.612 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.07 -43.75 95.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 1.14 108.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.03 -41.98 88.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 1.2 108.106 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -65.56 -40.05 92.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.54 -0.725 . . . . 1.17 110.357 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.595 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.6 mtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -0.967 . . . . 1.77 110.311 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.63 -42.61 75.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 1.09 110.034 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.46 -40.29 88.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.795 . . . . 1.1 109.243 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -66.6 -41.79 87.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.53 -0.731 . . . . 2.34 110.69 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 15' ' ' MET . 19.0 p30 -90.77 7.92 37.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.71 110.258 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.2 116.55 61.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 1.24 109.078 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -43.04 -26.76 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.461 1.441 . . . . 1.64 111.012 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -122.92 131.7 53.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.605 -1.258 . . . . 2.63 107.605 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -60.07 -40.0 88.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.842 -1.161 . . . . 2.55 108.718 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.99 117.76 25.04 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.754 -1.202 . . . . 2.13 107.754 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.85 145.68 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.714 . . . . 1.18 109.46 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.438 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 26.4 p -79.55 162.38 25.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.387 -0.82 . . . . 1.4 109.996 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.02 -43.33 95.32 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.15 -1.055 . . . . 1.39 108.15 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.46 -40.04 96.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.55 -0.719 . . . . 2.03 110.141 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.438 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -60.28 -38.46 94.61 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.528 -1.029 . . . . 0.32 110.528 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.96 -40.27 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -1.229 . . . . 1.14 109.752 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.564 ' OH ' ' NE ' ' A' ' 53' ' ' ARG . 24.7 m-85 -60.34 -42.81 96.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.605 -1.309 . . . . 2.3 109.571 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.98 -41.32 91.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 3.11 110.658 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 63.3 t80 -59.99 -49.08 79.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.922 -1.111 . . . . 2.25 110.278 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.01 -40.0 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 1.26 110.566 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.1 mtt -60.82 -44.05 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.859 -1.151 . . . . 1.17 110.1 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.99 -52.08 13.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 1.17 110.721 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -60.06 -46.72 88.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 3.48 109.2 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -122.77 109.52 32.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.561 -0.903 . . . . 2.43 108.561 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.88 -7.55 12.3 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.146 1.897 . . . . 1.69 113.172 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -59.93 -34.33 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.963 -1.086 . . . . 4.68 108.851 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' ASN . 90.4 m-85 -66.2 -26.93 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 1.91 110.658 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -60.04 -38.96 84.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.872 -1.143 . . . . 3.01 109.342 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.04 -39.79 87.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.059 . . . . 2.34 108.721 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.9 m-20 -118.06 105.02 11.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.282 -0.636 . . . . 2.6 109.282 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 93.5 mttt -90.88 -59.86 2.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 2.25 110.689 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -69.65 140.02 53.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.509 -0.745 . . . . 4.59 110.21 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.9 -59.86 0.45 Allowed Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.221 -1.151 . . . . 1.34 110.221 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.455 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 51.0 p-90 -82.32 -28.92 31.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.263 . . . . 0.57 110.671 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -64.88 -41.11 95.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.937 -1.102 . . . . 2.03 110.06 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -39.53 75.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.388 -0.82 . . . . 2.01 111.695 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.711 -1.243 . . . . 1.99 110.183 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -60.02 -40.05 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 1.28 109.715 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.564 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 20.3 mtt180 -67.22 -37.3 83.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.054 . . . . 3.38 109.504 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.0 -44.18 94.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.829 . . . . 3.09 109.587 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -68.79 -38.61 80.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 2.59 109.419 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.59 59.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 1.29 110.241 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -172.55 -55.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.328 -0.99 . . . . 2.04 108.328 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.58 -39.95 84.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.561 -0.903 . . . . 1.92 108.561 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -71.45 123.36 22.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -0.846 . . . . 1.83 108.727 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -90.06 0.01 57.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.447 -0.783 . . . . 2.17 109.526 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.8 -40.05 94.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 1.92 109.769 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -79.05 150.37 31.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 2.22 109.712 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.67 127.32 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.874 -0.787 . . . . 1.48 108.874 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -92.4 125.0 36.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 2.29 108.525 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.07 79.4 73.02 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 108.91 -0.774 . . . . 1.95 108.91 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo . . . . . 0 C--N 1.305 -1.732 0 C-N-CA 122.478 2.119 . . . . 2.11 112.268 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.513 -0.921 . . . . 2.3 108.513 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -126.53 134.81 50.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.55 109.233 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -159.01 164.35 35.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.16 -0.963 . . . . 1.2 109.779 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.189 -0.944 . . . . 1.44 109.423 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 N--CA 1.492 1.402 0 CA-C-O 120.646 0.186 . . . . 1.18 111.848 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.16 1.31 6.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.409 2.072 . . . . 1.18 112.095 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -81.03 133.12 35.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 1.92 109.47 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -69.35 167.2 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.215 -0.928 . . . . 1.92 108.567 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -59.92 -39.98 87.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 2.23 109.041 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 10' ' ' ILE . 87.9 mt -65.83 -41.05 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 1.66 110.226 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.8 94.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 1.1 110.344 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.85 -40.12 87.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 1.14 109.079 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.5 mt -69.9 -40.0 78.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.223 -0.923 . . . . 1.2 109.391 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -64.28 -40.91 96.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 1.17 109.726 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 73.5 mtm -70.02 -36.93 75.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 1.77 109.474 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.85 84.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 1.09 109.35 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.8 mt -60.08 -50.0 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 1.1 108.856 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -61.72 -40.06 93.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.288 0.566 . . . . 2.34 109.995 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -79.99 -10.07 59.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 1.71 110.379 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 131.48 67.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 1.24 109.488 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.06 -38.93 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.411 1.407 . . . . 1.64 110.896 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -120.03 134.63 55.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.149 -1.056 . . . . 2.63 108.149 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.97 -34.41 73.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.04 -1.038 . . . . 2.55 110.034 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.97 113.91 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.78 -1.2 . . . . 2.13 108.297 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.5 tt -130.01 160.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 1.18 109.445 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.9 p -90.37 165.77 13.67 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.9 0.857 . . . . 1.4 110.714 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.1 -50.02 75.37 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.056 0.932 . . . . 1.39 108.64 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.39 -39.97 94.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.286 0.565 . . . . 2.03 110.208 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.05 96.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.433 -1.067 . . . . 0.32 110.433 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -60.09 -42.04 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.029 -1.277 . . . . 1.14 109.64 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.402 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 34.7 m-85 -59.89 -40.85 90.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.746 -1.221 . . . . 2.3 109.959 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.1 -42.24 94.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 3.11 110.135 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.98 -49.01 79.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 2.25 110.718 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.17 -49.98 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 1.26 111.497 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.7 mtm -60.26 -49.98 75.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.664 -1.273 . . . . 1.17 110.269 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -68.91 -39.99 79.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 1.17 109.539 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -66.17 -49.75 66.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 3.48 109.678 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -119.38 120.19 31.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.594 -0.691 . . . . 2.43 109.301 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.39 -7.49 14.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.863 1.709 . . . . 1.69 112.248 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -60.01 -40.93 90.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.4 -0.812 . . . . 4.68 110.234 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.77 -27.76 67.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 1.91 110.722 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -58.23 -26.04 62.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.045 -1.035 . . . . 3.01 109.436 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.78 1.76 54.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.03 -1.043 . . . . 2.34 110.103 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.536 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 53.4 t30 -147.68 102.36 3.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.393 -0.817 . . . . 2.6 109.278 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.16 -64.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 2.25 110.963 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -69.93 144.03 52.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 4.59 110.074 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.44 -58.41 0.4 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.76 -1.336 . . . . 1.34 109.76 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 29.4 p-90 -89.98 -11.66 40.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.25 . . . . 0.57 110.374 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 56.3 tt0 -68.69 -55.96 9.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 2.03 110.498 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -70.05 -31.52 69.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 2.01 110.58 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.1 p -59.83 -40.44 88.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.052 -1.03 . . . . 1.99 110.81 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mm -60.05 -50.94 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.859 -1.151 . . . . 1.28 110.379 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -69.97 -37.92 75.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.074 -1.016 . . . . 3.38 110.182 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -59.93 -40.09 87.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 3.09 110.606 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 26.3 p30 -69.99 -18.33 63.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.943 -1.098 . . . . 2.59 110.567 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.431 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 85.6 mt -66.4 -40.09 89.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.794 -1.191 . . . . 1.29 111.115 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -70.04 -48.43 57.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.898 -1.126 . . . . 2.04 110.756 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.2 -39.98 96.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 1.92 110.658 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 76.1 m-20 -76.02 112.96 13.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 1.83 110.069 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.24 -5.95 55.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 2.17 109.484 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -62.82 -35.05 78.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 1.92 110.199 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -78.72 152.53 31.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 2.22 109.618 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 1.48 109.567 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -81.93 149.64 28.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 2.29 110.098 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.12 128.69 14.31 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.625 -0.88 . . . . 1.95 108.625 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.493 1.454 0 C-N-CA 121.441 1.427 . . . . 2.11 111.675 179.771 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.014 -1.106 . . . . 2.3 108.014 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -120.75 134.38 55.29 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.591 0.71 . . . . 0.55 110.155 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.64 ' HG1' ' H ' ' A' ' 80' ' ' LEU . 8.8 t -153.48 170.75 19.98 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.911 -0.774 . . . . 1.2 108.911 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.64 ' H ' ' HG1' ' A' ' 79' ' ' THR . 51.6 mt . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.062 -1.024 . . . . 1.44 110.203 -179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo . . . . . 0 N--CA 1.494 1.519 0 CA-C-O 120.563 0.151 . . . . 1.18 111.839 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.8 4.22 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.412 2.075 . . . . 1.18 112.635 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -82.0 143.01 31.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.974 -1.079 . . . . 1.92 109.803 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 9' ' ' TYR . 27.5 t -75.05 160.2 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.528 -0.916 . . . . 1.92 108.528 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.531 ' N ' ' HG ' ' A' ' 8' ' ' SER . 89.0 m-85 -60.02 -39.95 87.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 2.23 108.682 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.3 mm -65.2 -40.05 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.741 -0.837 . . . . 1.66 108.741 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.72 89.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.958 . . . . 1.1 109.642 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.04 -43.14 95.53 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.025 -1.047 . . . . 1.14 108.656 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.32 -50.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 1.2 109.452 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -61.39 -40.01 92.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 1.17 110.015 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.498 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 74.9 mtp -69.88 -38.48 76.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.431 -0.793 . . . . 1.77 109.967 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.22 93.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 1.09 110.032 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.31 -49.98 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 1.1 109.588 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.73 -40.02 76.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.722 -0.611 . . . . 2.34 109.959 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 15' ' ' MET . 68.3 m-80 -76.95 -9.92 59.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.85 . . . . 1.71 110.229 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.75 137.67 54.42 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.088 -1.007 . . . . 1.24 109.454 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.81 -65.19 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.867 1.712 . . . . 1.64 110.858 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -99.81 137.84 37.72 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 2.63 107.684 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -62.43 -28.73 70.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.833 -1.167 . . . . 2.55 109.204 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -79.7 98.3 6.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.136 -0.977 . . . . 2.13 108.569 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -119.66 149.68 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.257 -0.646 . . . . 1.18 109.257 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -79.91 161.55 25.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 1.4 110.273 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.9 tp -59.99 -47.25 86.6 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.686 -0.857 . . . . 1.39 108.686 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -59.97 -39.8 86.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.933 -0.766 . . . . 2.03 108.933 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.55 -39.95 95.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.744 -0.942 . . . . 0.32 110.744 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.04 -40.99 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.735 -1.45 . . . . 1.14 109.931 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.445 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 50.8 m-85 -61.59 -40.31 94.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 2.3 110.086 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.93 -40.68 89.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.17 -0.956 . . . . 3.11 109.881 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.49 -0.756 . . . . 2.25 110.744 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.8 -49.97 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.108 -0.995 . . . . 1.26 111.614 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.8 mtm -62.02 -39.98 94.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.1 -1.0 . . . . 1.17 111.398 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 93.1 m-20 -63.76 -51.67 63.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.746 -1.221 . . . . 1.17 112.071 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -74.86 -24.9 58.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.71 -1.244 . . . . 3.48 111.25 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.527 ' C ' ' H ' ' A' ' 40' ' ' PHE . 71.7 m-85 -130.02 77.62 76.24 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.209 -0.932 . . . . 2.43 109.763 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.75 -7.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.735 2.29 . . . . 1.69 111.438 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.527 ' H ' ' C ' ' A' ' 38' ' ' PHE . 11.8 t80 -59.96 -40.44 89.02 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.416 -0.802 . . . . 4.68 109.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -69.92 -24.1 63.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 1.91 110.446 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.412 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 61.1 mtt-85 -60.01 -37.87 81.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 3.01 108.884 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.96 9.15 17.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 2.34 109.285 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.566 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 0.5 OUTLIER -138.5 120.47 15.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.418 -0.801 . . . . 2.6 109.428 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' N ' HD21 ' A' ' 44' ' ' ASN . 67.1 mttm -120.24 13.1 11.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.596 -0.89 . . . . 2.25 108.596 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.554 ' H ' ' ND2' ' A' ' 44' ' ' ASN . 27.1 mt-30 -59.91 -168.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.023 0.916 . . . . 4.59 111.438 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.15 -10.96 0.06 OUTLIER Glycine 0 N--CA 1.493 2.472 0 CA-C-N 115.997 -0.547 . . . . 1.34 112.257 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.566 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 4.7 p-90 -59.98 -38.87 83.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.726 . . . . 0.57 108.212 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.445 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 21.2 tt0 -60.03 -50.04 75.29 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.607 -0.683 . . . . 2.03 110.019 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -76.1 -33.95 59.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 2.01 111.369 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -59.92 -38.37 82.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 1.99 111.375 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.98 -51.48 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 1.28 111.37 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' N ' ' HH ' ' A' ' 31' ' ' TYR . 13.8 ptm180 -79.81 -29.44 40.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.652 -1.28 . . . . 3.38 110.483 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -59.92 -42.0 92.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 3.09 109.161 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -65.47 -39.98 92.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 2.59 109.566 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.15 -45.44 93.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 1.29 110.542 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -63.33 -45.63 90.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.804 -1.185 . . . . 2.04 110.255 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.8 mt -69.95 -40.08 75.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.977 -1.077 . . . . 1.92 109.877 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -72.47 117.45 14.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 1.83 109.297 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -90.19 -2.73 58.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.46 -0.775 . . . . 2.17 109.376 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -60.72 -40.06 90.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 1.92 109.453 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -79.95 152.05 29.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 2.22 109.558 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.1 t -115.39 121.57 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.577 -0.702 . . . . 1.48 109.321 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -85.74 127.16 34.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 2.29 108.6 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.7 111.28 58.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 1.95 109.308 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--N 1.314 -1.267 0 C-N-CA 121.65 1.567 . . . . 2.11 111.931 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.628 -0.508 . . . . 2.3 109.628 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -111.19 137.13 49.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.695 -0.628 . . . . 0.55 109.976 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -145.25 159.75 42.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.859 . . . . 1.2 109.159 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 1.44 109.2 179.784 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 N--CA 1.495 1.6 0 CA-C-O 120.804 0.251 . . . . 1.18 112.309 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.27 28.79 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.862 2.375 . . . . 1.18 113.267 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -109.5 134.01 52.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.019 -1.05 . . . . 1.92 108.819 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 174.59 11.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 1.92 108.97 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -59.96 -35.93 76.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 2.23 109.908 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.67 -40.01 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 1.66 110.339 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.0 77.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.938 -1.101 . . . . 1.1 110.887 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.05 -39.94 87.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.907 -1.12 . . . . 1.14 108.623 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 88.9 mt -67.74 -39.97 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.498 -0.751 . . . . 1.2 109.274 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -66.08 -40.07 90.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 1.17 110.755 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.8 mtm -69.91 -39.96 75.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 1.77 109.771 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.21 80.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.441 -0.787 . . . . 1.09 109.4 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 1.1 108.902 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -60.72 -40.08 90.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.695 -0.628 . . . . 2.34 110.15 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -69.91 -17.51 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 1.71 109.568 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.95 148.3 71.76 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 1.24 109.718 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.97 -51.68 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.87 1.713 . . . . 1.64 109.724 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -99.11 139.93 34.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.276 -1.379 . . . . 2.63 107.276 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -67.51 -27.26 66.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.975 -1.078 . . . . 2.55 109.796 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -78.68 115.85 18.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.023 -1.048 . . . . 2.13 108.932 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.17 154.31 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 1.18 109.397 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.2 p -80.11 153.56 28.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 1.4 109.776 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 tp -60.04 -44.28 94.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 1.39 109.288 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.27 -40.08 89.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 2.03 110.427 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.66 97.5 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.14 -1.029 . . . . 0.32 111.011 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.02 -42.28 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.276 . . . . 1.14 110.243 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -60.15 -41.95 93.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.965 -1.085 . . . . 2.3 110.202 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.31 -40.38 90.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.351 -0.843 . . . . 3.11 110.069 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.09 -44.69 96.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 2.25 110.285 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.93 -50.15 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.203 -0.935 . . . . 1.26 110.663 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -62.94 -39.91 96.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.063 -1.023 . . . . 1.17 109.365 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.87 -39.94 76.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 1.17 109.78 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -72.18 -50.52 27.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 3.48 109.434 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -115.16 114.1 43.48 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.782 -0.822 . . . . 2.43 108.782 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.11 -3.8 13.78 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.862 1.708 . . . . 1.69 112.036 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.618 -0.882 . . . . 4.68 108.618 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -70.0 -21.52 63.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -0.754 . . . . 1.91 111.142 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.9 -40.02 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.48 -1.388 . . . . 3.01 109.317 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -61.0 -43.69 98.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.011 . . . . 2.34 109.492 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' TYR . 54.3 t30 -109.39 109.49 20.36 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.986 -0.746 . . . . 2.6 108.986 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 97.9 mttt -102.7 -37.7 7.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 2.25 110.602 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -89.03 139.16 30.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 4.59 110.344 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.58 -66.79 0.23 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.291 . . . . 1.34 109.871 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.413 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 24.7 p-90 -71.32 -37.95 71.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.57 110.744 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.94 -50.05 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 2.03 111.162 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -74.52 -25.54 59.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.843 -1.16 . . . . 2.01 110.583 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 t -60.02 -41.24 91.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.105 -0.997 . . . . 1.99 110.282 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.1 mt -65.74 -40.82 88.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.255 -0.903 . . . . 1.28 110.544 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -60.02 -44.08 94.85 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.334 -1.479 . . . . 3.38 108.607 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.697 -0.853 . . . . 3.09 108.697 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -68.44 -39.99 81.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 2.59 110.235 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.75 -40.13 91.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.052 -1.03 . . . . 1.29 110.048 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 t -64.76 -49.68 69.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.883 . . . . 2.04 110.512 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.98 -32.06 70.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.92 109.971 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -74.79 112.21 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 1.83 109.724 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.78 0.0 57.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.4 -0.813 . . . . 2.17 109.692 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.3 p -69.98 -21.37 63.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.983 -1.073 . . . . 1.92 109.727 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.22 153.25 21.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 2.22 109.789 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.0 t -114.38 124.79 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 1.48 109.62 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -80.0 159.95 26.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 2.29 108.602 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.19 77.53 24.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.002 -1.061 . . . . 1.95 109.585 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo . . . . . 0 C--N 1.309 -1.507 0 C-N-CA 122.662 2.241 . . . . 2.11 112.241 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.472 -0.936 . . . . 2.3 108.472 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -116.09 137.13 52.4 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.477 -0.764 . . . . 0.55 109.824 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -153.06 160.95 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.912 . . . . 1.2 109.847 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.211 -0.931 . . . . 1.44 110.109 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.2 Cg_exo . . . . . 0 N--CA 1.491 1.376 0 N-CA-C 111.295 -0.31 . . . . 1.18 111.295 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -42.25 -12.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.248 1.966 . . . . 1.18 113.767 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.6 m-85 -68.16 141.94 55.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.72 -1.238 . . . . 1.92 109.712 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 m -74.38 163.07 28.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 1.92 109.362 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -59.99 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.948 . . . . 2.23 109.518 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.44 -40.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.075 -1.016 . . . . 1.66 109.055 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.19 87.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 1.1 109.945 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.41 -40.12 89.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 1.14 109.544 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.68 -40.05 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.42 -0.955 . . . . 1.2 108.42 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -60.92 -39.99 91.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.712 . . . . 1.17 109.78 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.459 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 65.4 mtt -68.94 -39.39 79.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 1.77 110.0 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.12 83.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 1.09 109.88 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.44 -49.97 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 1.1 109.5 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.65 -40.02 84.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.797 -0.564 . . . . 2.34 110.482 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 15' ' ' MET . 4.2 m-80 -70.23 -15.43 62.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 1.71 110.414 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 146.67 69.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 1.24 109.26 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.86 -44.44 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.738 1.625 . . . . 1.64 109.968 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -106.19 126.52 52.32 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.459 -1.312 . . . . 2.63 107.459 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -58.56 -24.57 61.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.989 -1.069 . . . . 2.55 108.748 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -80.08 84.98 5.71 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.289 -1.004 . . . . 2.13 108.289 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.3 tt -107.03 147.66 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.568 -0.708 . . . . 1.18 109.102 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -79.18 154.96 28.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 1.4 110.452 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.04 -47.53 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.594 0.711 . . . . 1.39 109.75 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.54 -39.9 89.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 2.03 110.341 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.07 96.56 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.232 -0.917 . . . . 0.32 111.158 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.14 -39.91 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.832 -1.393 . . . . 1.14 109.434 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.728 ' HH ' ' H ' ' A' ' 53' ' ' ARG . 39.5 m-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 2.3 109.528 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -61.6 -40.02 93.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 3.11 109.702 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.91 -43.7 94.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.581 -0.7 . . . . 2.25 111.32 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 34' ' ' ILE . 90.4 mt -69.98 -40.71 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.798 -1.189 . . . . 1.26 111.519 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.12 -39.94 78.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.89 -1.131 . . . . 1.17 110.301 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 96.2 m-20 -71.31 -46.95 59.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.918 -1.114 . . . . 1.17 109.854 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -69.76 -35.44 74.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 3.48 110.366 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 40' ' ' PHE . 90.9 m-85 -128.7 79.96 73.46 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.345 -0.847 . . . . 2.43 109.854 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.31 -6.07 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.84 2.36 . . . . 1.69 111.718 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.523 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -60.08 -39.5 86.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 4.68 109.459 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.96 -24.1 63.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.565 -0.709 . . . . 1.91 111.125 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.3 mtt-85 -59.55 -40.09 86.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.815 -1.178 . . . . 3.01 109.738 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.93 -19.11 65.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.009 -1.057 . . . . 2.34 109.992 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -133.54 97.56 3.97 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.012 -0.736 . . . . 2.6 109.012 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 62.7 mttp -88.56 -45.71 9.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 2.25 110.717 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.15 144.3 34.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 4.59 110.121 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.91 -58.04 0.4 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.302 -1.119 . . . . 1.34 110.302 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.5 p-90 -89.19 -13.5 38.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.028 -1.278 . . . . 0.57 109.962 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -60.26 -50.0 75.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.14 -0.975 . . . . 2.03 111.487 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -75.88 -36.77 59.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 2.01 111.671 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 94.0 p -57.84 -23.07 51.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.988 -1.07 . . . . 1.99 110.836 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mm -75.74 -68.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.963 -1.086 . . . . 1.28 110.727 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.728 ' H ' ' HH ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -68.49 -27.01 65.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.114 -0.991 . . . . 3.38 110.693 -178.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.01 -42.01 93.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 3.09 108.655 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 57' ' ' SER . 96.5 m-20 -62.52 -40.12 95.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.454 -0.779 . . . . 2.59 109.61 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.29 59.21 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 1.29 109.159 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' ASN . 40.1 t -159.97 -54.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.264 -0.897 . . . . 2.04 109.564 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.6 mp -65.85 -40.1 91.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 1.92 109.772 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -69.43 127.95 34.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.125 -0.984 . . . . 1.83 108.797 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.96 -1.71 58.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.511 -0.743 . . . . 2.17 109.373 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.8 m -64.81 -39.91 94.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 1.92 109.195 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -84.18 134.0 34.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 2.22 109.264 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 129.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.784 . . . . 1.48 109.175 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.0 139.56 57.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 2.29 109.041 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.69 123.42 31.3 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.638 -0.875 . . . . 1.95 108.638 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.491 1.353 0 C-N-CA 121.07 1.18 . . . . 2.11 111.873 -179.318 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 108.485 -0.932 . . . . 2.3 108.485 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -118.73 140.27 50.2 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.663 0.745 . . . . 0.55 110.518 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -148.17 155.5 41.47 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.257 -1.016 . . . . 1.2 108.257 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.49 1.533 0 O-C-N 120.894 -1.129 . . . . 1.44 109.662 -179.51 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.494 1.539 0 CA-C-O 120.723 0.218 . . . . 1.18 111.589 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.67 27.66 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.388 2.059 . . . . 1.18 113.299 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -100.42 133.59 44.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.878 -1.139 . . . . 1.92 108.839 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.62 ' HG ' ' N ' ' A' ' 9' ' ' TYR . 28.3 t -70.31 161.83 29.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 1.92 108.914 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.62 ' N ' ' HG ' ' A' ' 8' ' ' SER . 78.6 m-85 -59.23 -43.05 92.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.98 -1.075 . . . . 2.23 108.307 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.9 mt -65.15 -40.02 87.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.606 -0.887 . . . . 1.66 108.606 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.97 98.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 1.1 109.862 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.01 -40.14 88.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.913 -1.117 . . . . 1.14 108.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.91 -42.14 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.44 -0.787 . . . . 1.2 108.886 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -60.79 -43.21 98.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.722 -0.611 . . . . 1.17 110.553 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.558 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.8 mtm -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.915 -1.116 . . . . 1.77 109.426 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.401 ' HA ' HD22 ' A' ' 19' ' ' ASN . . . -50.37 -52.34 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.538 -0.726 . . . . 1.09 109.898 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.02 -44.29 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 1.1 109.368 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.1 -46.14 90.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.656 . . . . 2.34 111.187 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 15' ' ' MET . 18.9 p30 -90.04 11.05 21.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.991 -1.068 . . . . 1.71 110.474 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.29 120.39 80.94 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 1.24 108.83 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -41.77 -38.22 4.42 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.443 1.429 . . . . 1.64 110.993 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -112.93 137.23 51.63 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.817 -1.179 . . . . 2.63 107.817 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -60.02 -39.97 87.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.967 -1.083 . . . . 2.55 108.502 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -82.15 129.15 34.75 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.163 -1.051 . . . . 2.13 108.163 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.12 146.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.206 -0.934 . . . . 1.18 110.158 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.77 160.0 26.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.519 -0.738 . . . . 1.4 110.278 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.07 -48.41 81.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.636 -0.875 . . . . 1.39 108.636 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.78 -39.91 90.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 2.03 109.89 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.89 95.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.456 -1.058 . . . . 0.32 110.456 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.12 -42.54 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.322 . . . . 1.14 109.74 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -62.1 -40.1 94.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 2.3 110.736 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.4 -40.17 90.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.953 -1.092 . . . . 3.11 109.614 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 65.6 t80 -60.09 -46.85 88.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 2.25 111.168 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 34' ' ' ILE . 83.3 mt -60.04 -49.83 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.046 -1.034 . . . . 1.26 110.826 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtm -61.86 -40.0 93.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.854 -1.153 . . . . 1.17 110.105 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.65 -39.92 93.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 1.17 110.921 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.435 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.1 OUTLIER -79.99 -67.69 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.885 -1.134 . . . . 3.48 110.103 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 23.7 m-85 -92.09 115.69 65.11 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 2.43 109.004 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.72 -7.81 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.176 1.918 . . . . 1.69 113.278 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 1.1 m-85 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.122 . . . . 4.68 109.341 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -67.83 -26.78 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.574 -0.704 . . . . 1.91 110.848 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.02 -40.01 87.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.004 . . . . 3.01 109.477 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -71.41 -9.31 57.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 2.34 109.214 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 57.5 t-20 -141.51 99.53 3.58 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.049 -0.723 . . . . 2.6 109.049 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 65.0 mttm -96.66 -21.48 17.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 2.25 110.911 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -90.66 136.36 33.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.765 -1.209 . . . . 4.59 110.86 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -75.15 0.23 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.594 -1.003 . . . . 1.34 110.594 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.48 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.6 p-90 -62.42 -37.46 85.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.265 -1.138 . . . . 0.57 110.898 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 56.9 tt0 -59.83 -50.33 74.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 2.03 111.661 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.912 -1.118 . . . . 2.01 112.272 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.7 m -59.95 -40.09 87.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.863 -1.148 . . . . 1.99 112.217 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.1 mt -61.89 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.629 -1.294 . . . . 1.28 110.691 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -69.18 -29.26 67.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.401 -1.437 . . . . 3.38 109.199 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -69.59 -37.2 76.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.044 -1.465 . . . . 3.09 107.044 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.59 -36.35 78.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.688 -0.632 . . . . 2.59 109.317 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.99 -42.01 93.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 1.29 110.558 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -60.04 -46.86 88.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 2.04 109.87 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 10.1 mp -69.98 -37.86 75.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 1.92 109.439 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -75.8 111.99 11.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.19 -0.944 . . . . 1.83 109.269 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.03 -9.8 52.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 2.17 109.626 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 62' ' ' PHE . 30.1 p -60.06 -35.9 76.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 1.92 109.412 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.413 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 74.8 m-85 -78.1 147.42 34.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 2.22 108.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.47 130.64 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.466 -0.771 . . . . 1.48 110.826 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -76.25 158.67 31.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 2.29 109.176 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.8 t -134.64 84.26 39.86 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.389 -0.82 . . . . 1.95 108.994 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo . . . . . 0 C--N 1.31 -1.478 0 C-N-CA 122.655 2.237 . . . . 2.11 112.685 -179.311 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 108.954 -0.758 . . . . 2.3 108.954 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -117.96 140.01 50.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.509 -0.744 . . . . 0.55 109.589 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -144.09 159.93 41.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.318 -0.864 . . . . 1.2 109.507 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 1.44 109.302 179.695 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 N--CA 1.491 1.376 0 N-CA-C 112.577 0.183 . . . . 1.18 112.577 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.72 30.22 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.507 2.138 . . . . 1.18 111.981 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.31 133.94 53.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.429 -0.794 . . . . 1.92 108.871 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -65.67 160.79 21.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 1.92 108.279 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.886 -1.134 . . . . 2.23 108.221 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.17 -41.36 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 1.66 109.154 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.72 96.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 1.1 109.579 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.96 -41.4 91.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 1.14 108.403 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.3 mt -70.01 -41.9 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.379 -0.826 . . . . 1.2 109.453 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -60.2 -40.02 88.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 1.17 110.139 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.5 mtm -70.02 -37.48 75.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 1.77 110.028 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.17 90.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 1.09 110.185 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.93 -49.98 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 1.1 109.071 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.79 -38.57 86.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.473 0.654 . . . . 2.34 109.71 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -77.12 1.04 19.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 1.71 109.49 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.35 149.9 76.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.187 -0.946 . . . . 1.24 108.705 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -37.33 -73.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.193 1.929 . . . . 1.64 112.59 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.1 -79.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.032 -1.042 . . . . 2.63 110.187 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -165.5 -34.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 2.55 108.997 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -88.53 138.38 31.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.276 -0.89 . . . . 2.13 109.805 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -140.81 153.8 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.19 -0.944 . . . . 1.18 109.913 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.7 p -86.01 166.08 16.17 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.332 -0.855 . . . . 1.4 110.474 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.15 -51.59 68.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.872 -1.159 . . . . 1.39 107.872 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.85 -40.01 91.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.782 -0.574 . . . . 2.03 110.445 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -40.02 95.39 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.122 -1.037 . . . . 0.32 110.543 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.51 -43.85 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.02 -1.282 . . . . 1.14 110.363 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.636 ' HH ' ' HE ' ' A' ' 53' ' ' ARG . 39.9 m-85 -60.01 -46.64 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.986 . . . . 2.3 111.989 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.93 -39.29 84.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.771 -1.205 . . . . 3.11 110.076 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -60.01 -40.01 87.79 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.309 -0.87 . . . . 2.25 110.427 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.49 -48.54 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.99 -1.068 . . . . 1.26 111.911 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . 0.561 ' SD ' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -60.05 -39.96 87.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.559 -1.338 . . . . 1.17 110.231 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 88.2 m-20 -68.43 -40.06 81.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.935 -1.103 . . . . 1.17 110.429 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -67.69 -40.01 84.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 3.48 110.27 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.38 122.59 21.02 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.347 -0.845 . . . . 2.43 109.011 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.32 -6.07 16.8 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.55 1.5 . . . . 1.69 111.11 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.07 -44.74 94.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.809 -0.557 . . . . 4.68 110.733 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.38 -23.81 64.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.983 -1.073 . . . . 1.91 111.012 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 64.3 mtt-85 -60.07 -40.05 88.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.84 -1.163 . . . . 3.01 109.393 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.15 -40.01 94.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.883 . . . . 2.34 110.6 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -116.33 112.69 21.9 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.118 -0.697 . . . . 2.6 109.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.55 -66.39 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 2.25 110.438 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -65.33 144.25 57.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 4.59 109.946 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.15 -62.72 0.32 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.582 -1.007 . . . . 1.34 110.582 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -80.86 -12.79 59.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.899 -1.353 . . . . 0.57 110.469 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -70.01 -41.47 74.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 2.03 110.848 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -70.08 -38.28 75.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.32 -0.863 . . . . 2.01 111.352 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.8 t -59.97 -41.14 91.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.954 -1.091 . . . . 1.99 110.662 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.8 mm -59.97 -50.05 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.082 -1.011 . . . . 1.28 110.677 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.636 ' HE ' ' HH ' ' A' ' 31' ' ' TYR . 55.9 mtt180 -63.03 -39.32 94.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.975 -1.078 . . . . 3.38 109.616 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -60.04 -39.98 87.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.38 -0.825 . . . . 3.09 108.797 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -66.58 -39.91 88.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 2.59 109.502 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.48 -39.99 89.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.952 . . . . 1.29 110.282 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -71.2 -39.95 71.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.937 -1.102 . . . . 2.04 110.868 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.1 mt -68.73 -39.99 80.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.074 -1.017 . . . . 1.92 112.049 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -62.02 118.4 7.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.691 -1.255 . . . . 1.83 110.432 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -84.22 -31.61 24.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 2.17 109.622 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p -66.24 -9.18 29.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 1.92 108.965 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -89.85 138.46 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 2.22 107.907 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -123.84 129.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.303 -0.873 . . . . 1.48 110.469 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.2 147.66 38.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.834 . . . . 2.29 108.956 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' PRO . 15.5 t -139.98 64.5 27.66 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.059 -1.026 . . . . 1.95 109.556 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 65' ' ' VAL . 54.8 Cg_exo . . . . . 0 C--N 1.307 -1.621 0 C-N-CA 123.013 2.475 . . . . 2.11 113.375 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 108.828 -0.804 . . . . 2.3 108.828 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -141.89 131.43 23.91 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.052 -1.03 . . . . 0.55 110.903 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -155.04 150.94 27.81 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.897 -0.779 . . . . 1.2 108.897 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.97 -1.081 . . . . 1.44 109.332 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.492 1.419 0 CA-C-O 120.644 0.185 . . . . 1.18 111.669 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.4 26.61 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.418 2.079 . . . . 1.18 113.565 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.55 137.92 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.848 -1.157 . . . . 1.92 108.372 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 m -77.57 166.41 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 1.92 108.947 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -59.94 -37.87 80.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.082 . . . . 2.23 108.354 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.13 -46.48 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 1.66 109.338 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.71 95.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 1.1 110.786 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.2 mt -59.93 -40.05 87.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.154 . . . . 1.14 108.599 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.41 -44.84 94.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 1.2 108.336 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -67.44 -40.06 85.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.602 -0.686 . . . . 1.17 110.738 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.423 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.4 mtt -66.7 -39.91 88.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 1.77 109.148 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -50.04 75.27 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.537 -0.727 . . . . 1.09 110.107 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.46 -50.0 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 1.1 109.509 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -40.0 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.664 -0.647 . . . . 2.34 110.576 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 15' ' ' MET . 70.3 m-80 -82.05 1.27 36.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 1.71 109.87 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.42 149.05 74.86 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 1.24 108.634 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 -32.22 91.17 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.614 1.543 . . . . 1.64 109.806 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -124.21 139.99 53.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.797 -1.186 . . . . 2.63 107.797 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -60.07 -38.99 84.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.02 -1.05 . . . . 2.55 108.585 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -77.97 120.18 22.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.926 -1.139 . . . . 2.13 107.926 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.73 148.87 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.248 -0.907 . . . . 1.18 109.971 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.3 p -79.83 160.0 26.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -0.772 . . . . 1.4 110.89 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -66.32 -39.99 89.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.756 -0.831 . . . . 1.39 108.756 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.91 -40.0 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 2.03 109.672 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.72 -38.51 96.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.344 -1.102 . . . . 0.32 110.344 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.99 -42.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 1.14 109.933 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -60.0 -39.11 84.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.959 -1.088 . . . . 2.3 109.588 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.36 91.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.045 -1.035 . . . . 3.11 108.882 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.95 -47.59 85.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 2.25 110.431 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 mp -61.73 -49.66 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 1.26 110.276 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.6 mtm -60.07 -39.91 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.808 -1.183 . . . . 1.17 109.889 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.09 -51.85 19.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 1.17 109.431 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.11 -50.0 75.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 3.48 109.312 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.57 110.66 38.66 Favored Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 108.812 -0.81 . . . . 2.43 108.812 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.51 -7.33 12.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.982 1.788 . . . . 1.69 112.514 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -60.57 -40.0 90.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.915 . . . . 4.68 109.605 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.06 -17.82 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.693 -0.629 . . . . 1.91 110.777 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.63 -43.17 93.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 3.01 108.46 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.17 -43.74 97.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.337 -0.852 . . . . 2.34 109.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -102.58 99.02 8.99 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.175 -0.676 . . . . 2.6 109.175 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -94.51 -42.56 8.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 2.25 109.476 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -81.29 149.5 28.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 4.59 109.494 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -73.34 0.28 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.133 -1.187 . . . . 1.34 110.133 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 20.6 p-90 -69.49 -38.73 77.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.57 110.664 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.04 -42.07 93.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 2.03 110.721 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -70.04 -39.57 75.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 2.01 110.826 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -0.948 . . . . 1.99 111.259 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.7 mm -60.0 -50.01 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.835 -1.166 . . . . 1.28 110.126 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -60.35 -49.62 76.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.082 . . . . 3.38 109.44 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.143 -1.058 . . . . 3.09 108.143 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.572 ' ND2' HD22 ' A' ' 59' ' ' ASN . 23.8 t-20 -62.07 -40.34 95.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.473 -0.767 . . . . 2.59 109.097 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.84 -40.06 94.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 1.29 110.456 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.7 m -69.5 -46.84 65.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.983 -1.073 . . . . 2.04 110.43 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.59 -39.98 88.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 1.92 110.245 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.572 HD22 ' ND2' ' A' ' 55' ' ' ASN . 42.7 m-80 -75.29 117.54 17.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 1.83 109.752 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.59 -2.41 57.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 2.17 109.352 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -60.36 -39.94 88.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 1.92 109.591 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -79.71 152.8 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 2.22 109.351 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.7 t -112.7 127.46 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.473 -0.767 . . . . 1.48 109.393 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -68.98 145.76 53.32 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.28 -1.007 . . . . 2.29 108.28 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 t -137.39 76.97 42.11 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.144 -0.972 . . . . 1.95 109.715 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo . . . . . 0 C--N 1.306 -1.659 0 C-N-CA 122.62 2.214 . . . . 2.11 111.881 179.444 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 108.273 -1.01 . . . . 2.3 108.273 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -119.95 140.03 51.54 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.758 0.79 . . . . 0.55 110.716 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 t -139.62 162.24 35.58 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.769 -0.826 . . . . 1.2 108.769 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.142 -0.974 . . . . 1.44 110.445 -179.38 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 50.2 Cg_endo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.094 -0.044 . . . . 1.18 112.133 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.03 -12.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.555 2.17 . . . . 1.18 114.142 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 14.4 m-85 -62.43 140.07 58.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.534 -1.354 . . . . 1.92 109.519 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -79.63 168.23 19.65 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.833 -1.173 . . . . 1.92 107.833 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -60.39 -39.91 89.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.902 -1.124 . . . . 2.23 109.095 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.467 ' CD1' ' OD1' ' A' ' 55' ' ' ASN . 38.8 mm -62.18 -41.1 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 1.66 109.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.97 85.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 1.1 110.154 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.1 -40.06 88.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 1.14 108.972 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.54 -40.05 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 1.2 109.132 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.31 -39.96 96.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.573 -0.704 . . . . 1.17 110.488 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.436 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.5 mtt -65.35 -39.95 92.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 1.77 110.078 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.65 80.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.352 -0.843 . . . . 1.09 109.591 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.23 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 1.1 109.247 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.01 -40.14 88.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.413 0.625 . . . . 2.34 110.125 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 15' ' ' MET . 69.4 m-80 -81.94 -0.12 42.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 1.71 109.613 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.77 123.5 85.29 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.276 -0.89 . . . . 1.24 108.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -42.27 -48.23 6.71 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.44 1.426 . . . . 1.64 110.674 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -105.29 142.0 35.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.601 -1.259 . . . . 2.63 107.601 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -60.02 -37.85 80.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.952 -1.092 . . . . 2.55 109.485 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.74 127.91 33.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.811 -1.181 . . . . 2.13 107.811 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.99 151.53 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 1.18 109.532 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.2 p -81.38 156.92 25.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.246 -0.909 . . . . 1.4 110.005 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.97 -48.3 82.28 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.745 0.783 . . . . 1.39 110.04 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 2.03 110.2 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.49 91.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.403 -1.079 . . . . 0.32 110.403 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.95 -42.98 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -1.209 . . . . 1.14 110.771 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.851 -1.156 . . . . 2.3 110.564 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.13 -39.26 85.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.153 -0.967 . . . . 3.11 110.379 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -59.85 -49.3 78.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 2.25 110.729 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.04 -49.92 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.0 -1.063 . . . . 1.26 110.733 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.7 mtm -60.03 -40.12 88.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.874 -1.141 . . . . 1.17 110.445 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.39 -45.22 94.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.928 -1.107 . . . . 1.17 110.715 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.0 mtt-85 -68.02 -48.38 65.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.911 -1.118 . . . . 3.48 111.192 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.14 125.28 26.27 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.158 -0.964 . . . . 2.43 110.521 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.22 -5.0 13.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.971 1.781 . . . . 1.69 110.707 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -60.01 -40.1 88.1 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.335 -0.617 . . . . 4.68 109.335 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.05 -31.28 68.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 1.91 109.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -60.06 -39.94 87.75 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.165 -0.959 . . . . 3.01 109.204 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.26 -40.08 96.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 2.34 110.132 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -110.55 101.37 10.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.175 -0.676 . . . . 2.6 109.175 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -88.53 -40.65 13.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.094 -1.004 . . . . 2.25 110.178 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -78.53 141.68 37.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.003 -1.061 . . . . 4.59 110.421 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.18 -60.37 0.33 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.188 -1.165 . . . . 1.34 110.188 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -88.85 -11.93 43.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -1.223 . . . . 0.57 110.239 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -69.85 -56.63 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 2.03 111.4 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.92 -38.75 76.33 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.253 -0.904 . . . . 2.01 112.327 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.5 m -59.99 -39.85 87.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.783 -1.198 . . . . 1.99 111.226 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.06 -68.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.954 -1.091 . . . . 1.28 111.398 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -69.93 -33.13 71.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 3.38 112.375 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -59.98 -40.16 88.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.342 -1.474 . . . . 3.09 107.676 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.738 HD22 HD22 ' A' ' 59' ' ' ASN . 21.8 t-20 -60.09 -40.53 89.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.614 -0.679 . . . . 2.59 109.25 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.27 -40.14 95.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.997 -1.065 . . . . 1.29 109.704 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -64.52 -49.75 70.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 2.04 110.721 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.882 -1.136 . . . . 1.92 110.069 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.738 HD22 HD22 ' A' ' 55' ' ' ASN . 99.5 m-20 -69.28 121.94 17.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 1.83 110.505 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.5 -3.41 57.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.676 -0.861 . . . . 2.17 108.676 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 1.92 109.524 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -77.3 150.04 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.198 -0.939 . . . . 2.22 109.068 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.5 t -111.05 129.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.534 -0.729 . . . . 1.48 109.573 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -90.64 120.45 31.72 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.194 -1.039 . . . . 2.29 108.194 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.79 127.22 31.7 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 120.807 -1.183 . . . . 1.95 109.326 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 N--CA 1.493 1.455 0 C-N-CA 121.855 1.703 . . . . 2.11 112.008 179.419 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 107.473 -1.306 . . . . 2.3 107.473 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -132.89 124.97 28.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.252 -0.905 . . . . 0.55 109.553 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -152.8 152.42 31.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.282 -0.886 . . . . 1.2 109.751 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.816 . . . . 1.44 108.949 179.497 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 120.806 0.252 . . . . 1.18 111.709 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.17 20.93 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.739 2.293 . . . . 1.18 113.773 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -96.01 137.73 34.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.632 -1.292 . . . . 1.92 109.141 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.7 p -73.33 165.61 24.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 1.92 108.667 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 2.23 109.18 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.35 -39.9 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 1.66 109.64 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.03 99.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 1.1 109.519 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.76 -39.96 90.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 1.14 108.584 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.08 -42.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.546 -0.722 . . . . 1.2 109.766 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -65.67 -41.3 92.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 1.17 109.744 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.95 -33.87 72.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 1.77 109.887 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.577 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -60.05 -46.61 88.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 1.09 109.783 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.03 -45.35 98.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.061 -1.024 . . . . 1.1 109.807 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -63.15 -43.23 98.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.803 -0.561 . . . . 2.34 112.178 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -89.98 10.34 24.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.713 -1.242 . . . . 1.71 110.085 -178.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.78 150.46 81.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 1.24 108.901 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.68 -24.89 65.3 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.732 1.622 . . . . 1.64 110.196 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -139.91 146.57 39.39 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.754 -1.202 . . . . 2.63 107.754 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -59.97 -39.59 86.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.087 . . . . 2.55 108.885 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.06 129.35 34.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 2.13 109.273 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.9 tt -147.83 143.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.796 -0.816 . . . . 1.18 108.796 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -80.02 163.18 24.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 1.4 110.053 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.0 tp -59.93 -40.69 89.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.509 -0.744 . . . . 1.39 109.094 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -60.59 -40.25 91.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.431 -0.793 . . . . 2.03 110.141 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.99 96.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.274 -1.131 . . . . 0.32 110.274 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.48 -40.37 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -1.137 . . . . 1.14 110.517 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.718 ' HH ' ' HE ' ' A' ' 53' ' ' ARG . 29.1 m-85 -60.02 -39.98 87.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.101 . . . . 2.3 110.593 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -59.98 -40.0 87.65 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.949 -1.095 . . . . 3.11 109.903 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . 0.542 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 93.8 t80 -60.02 -49.91 75.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 2.25 111.662 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.69 -49.95 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 1.26 112.154 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 45.7 mtm -60.34 -40.04 89.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.706 -1.246 . . . . 1.17 110.994 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -67.17 -48.65 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 1.17 110.914 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -40.0 75.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.289 -0.882 . . . . 3.48 112.189 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -126.55 80.44 69.78 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.088 -1.007 . . . . 2.43 110.2 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.03 -9.85 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.95 2.433 . . . . 1.69 113.643 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.11 -37.51 80.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.633 -1.292 . . . . 4.68 108.996 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -69.15 -28.03 66.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 1.91 110.898 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -58.84 -39.97 82.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.654 -1.279 . . . . 3.01 108.165 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.29 -40.0 86.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 2.34 109.026 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.489 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 94.8 m-20 -99.92 101.02 12.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.226 -0.657 . . . . 2.6 109.226 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 92.0 mttt -90.41 -78.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.06 -1.025 . . . . 2.25 110.388 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.03 140.01 57.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 4.59 110.235 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.11 -58.2 0.54 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.66 -1.376 . . . . 1.34 109.66 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.489 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 33.3 p-90 -89.69 -10.58 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -1.235 . . . . 0.57 110.807 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 77.9 mt-30 -68.64 -54.53 15.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.883 -1.136 . . . . 2.03 110.916 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -65.35 -34.8 79.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 2.01 110.948 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.1 p -59.51 -41.51 90.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.917 -1.114 . . . . 1.99 109.933 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.13 -50.03 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 1.28 109.797 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.718 ' HE ' ' HH ' ' A' ' 31' ' ' TYR . 25.4 mtt180 -72.76 -38.84 67.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 3.38 109.864 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 3.09 108.674 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -65.58 -40.01 92.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.389 -0.819 . . . . 2.59 109.696 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.7 mt -60.53 -46.65 89.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 1.29 111.291 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -64.66 -39.96 94.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.836 -1.165 . . . . 2.04 110.704 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.99 -37.38 84.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.993 -1.067 . . . . 1.92 109.464 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -79.9 110.54 15.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 1.83 109.608 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.91 -8.61 51.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.768 . . . . 2.17 109.194 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.6 m -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.856 -1.165 . . . . 1.92 107.856 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.24 127.63 32.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.845 -1.168 . . . . 2.22 107.845 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 t -102.54 126.94 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.623 -0.88 . . . . 1.48 108.623 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -97.46 117.84 32.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.868 . . . . 2.29 110.031 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.68 149.48 54.22 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.127 -1.064 . . . . 1.95 108.127 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.31 -1.452 0 C-N-CA 122.016 1.811 . . . . 2.11 111.051 179.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.645 -0.502 . . . . 2.3 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -108.86 133.54 52.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.521 -0.737 . . . . 0.55 109.657 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -153.76 163.96 39.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 1.2 110.244 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.24 -1.022 . . . . 1.44 108.24 179.176 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo . . . . . 0 N--CA 1.491 1.375 0 N-CA-C 111.809 -0.112 . . . . 1.18 111.809 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.21 -12.57 32.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.257 1.971 . . . . 1.18 111.809 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -60.5 134.55 57.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.216 -0.927 . . . . 1.92 108.645 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 p -70.42 162.11 29.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.176 -1.046 . . . . 1.92 108.176 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -58.47 -39.99 81.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 2.23 108.101 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.56 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.411 -0.806 . . . . 1.66 109.155 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.13 91.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 1.1 109.828 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.95 -40.01 87.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.053 -1.03 . . . . 1.14 108.59 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.97 -39.9 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 1.2 109.105 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.76 -39.9 95.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 1.17 110.016 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.48 -38.49 87.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.415 -0.803 . . . . 1.77 109.521 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.57 92.55 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.439 -0.788 . . . . 1.09 109.849 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.4 mt -64.9 -52.92 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 1.1 109.115 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -63.87 -40.01 95.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.731 -0.605 . . . . 2.34 109.539 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -69.96 -21.48 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.543 -0.723 . . . . 1.71 109.967 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 147.31 68.42 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 1.24 108.898 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.38 -48.18 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.866 1.711 . . . . 1.64 110.32 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.88 123.15 45.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.722 -1.214 . . . . 2.63 107.722 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -61.1 -28.12 68.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 2.55 110.368 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -78.8 88.29 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.787 -1.196 . . . . 2.13 108.803 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.33 151.61 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.098 -0.704 . . . . 1.18 109.098 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.527 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 73.2 p -79.91 159.54 26.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 1.4 110.213 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.59 -41.84 95.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.839 -0.8 . . . . 1.39 108.839 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.19 -40.06 88.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 2.03 110.194 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.527 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -61.68 -40.02 98.2 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.693 -0.963 . . . . 0.32 110.693 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.77 -39.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.241 . . . . 1.14 110.798 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.488 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 28.0 m-85 -59.97 -43.84 94.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.709 -1.244 . . . . 2.3 110.19 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.0 -39.99 87.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.245 -0.909 . . . . 3.11 109.096 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -59.91 -50.06 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.657 -0.652 . . . . 2.25 110.883 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.66 -48.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.95 -1.093 . . . . 1.26 111.49 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 32.0 mtm -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 1.17 109.938 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 83.1 m-20 -66.39 -47.03 74.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 1.17 110.727 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 3.48 111.06 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 40' ' ' PHE . 65.9 m-85 -126.1 77.22 71.62 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.226 -0.921 . . . . 2.43 109.85 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.76 -7.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.988 2.459 . . . . 1.69 112.808 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' PHE . 24.1 t80 -58.59 -40.03 82.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 4.68 109.091 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 44' ' ' ASN . 96.8 m-85 -69.99 -23.86 63.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.91 111.501 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.0 mtt-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.559 -1.338 . . . . 3.01 108.724 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.2 -37.03 82.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.512 -0.742 . . . . 2.34 110.007 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 33.0 m120 -108.5 119.18 38.77 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.494 0.664 . . . . 2.6 111.002 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -119.11 15.0 13.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.033 -1.099 . . . . 2.25 108.033 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.07 -118.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.619 -0.675 . . . . 4.59 112.818 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.79 -10.06 67.56 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.18 -0.95 . . . . 1.34 112.275 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 12.5 p-90 -60.03 -36.99 78.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.222 -1.752 . . . . 0.57 107.578 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.488 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 20.1 tt0 -59.99 -50.03 75.34 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.629 -0.669 . . . . 2.03 109.926 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 2.01 111.047 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.9 p -56.86 -34.27 67.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.077 -1.014 . . . . 1.99 111.119 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -59.99 -46.03 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.86 -1.15 . . . . 1.28 109.308 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 26.6 mtt180 -72.94 -39.36 66.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 3.38 110.146 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -59.98 -39.97 87.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 3.09 110.253 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 56' ' ' LEU . 30.0 p30 -75.02 -25.0 58.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.901 -1.124 . . . . 2.59 110.615 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.53 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 56.2 mt -64.15 -42.93 96.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.698 -1.251 . . . . 1.29 110.014 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -69.99 -40.56 75.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.996 -1.065 . . . . 2.04 110.04 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -69.49 -40.0 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.083 . . . . 1.92 109.389 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -75.37 118.7 18.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.263 -0.898 . . . . 1.83 108.898 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.77 -5.66 56.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.505 -0.747 . . . . 2.17 109.072 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 89.5 m -60.38 -40.03 89.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 1.92 109.351 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -85.71 147.05 26.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 2.22 108.762 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.96 124.6 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 1.48 109.366 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -79.04 129.98 35.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.501 -0.926 . . . . 2.29 108.501 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.66 100.31 50.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.623 -0.673 . . . . 1.95 109.875 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.563 0 C-N-CA 122.149 1.899 . . . . 2.11 112.158 179.504 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.269 -0.641 . . . . 2.3 109.269 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -119.9 135.5 54.87 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.689 -0.856 . . . . 0.55 108.689 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -150.57 160.38 43.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.119 -0.988 . . . . 1.2 110.025 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.043 -0.725 . . . . 1.44 109.043 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 N--CA 1.494 1.544 0 CA-C-O 120.753 0.231 . . . . 1.18 112.203 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.19 -1.26 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.834 2.356 . . . . 1.18 113.612 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -72.55 143.41 48.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.593 -1.317 . . . . 1.92 109.416 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.1 p -76.31 163.15 27.29 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.538 -0.912 . . . . 1.92 108.538 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -60.09 -39.93 87.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 2.23 108.647 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.53 -40.02 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.37 -0.831 . . . . 1.66 109.062 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.58 92.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 1.1 110.101 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 1.14 109.128 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.81 -44.68 98.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.176 -1.046 . . . . 1.2 108.176 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -60.11 -39.99 88.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.708 -0.62 . . . . 1.17 109.478 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.9 mtt -68.2 -39.65 82.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.77 110.019 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.64 88.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 1.09 110.495 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.77 -50.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.008 -1.058 . . . . 1.1 109.669 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.99 -39.92 75.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 2.34 110.383 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.14 -32.98 74.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 1.71 109.216 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.78 116.94 62.49 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 1.24 109.134 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -46.54 -33.46 13.12 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.218 1.279 . . . . 1.64 110.696 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -100.04 113.72 26.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.071 -1.085 . . . . 2.63 108.071 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -69.66 -28.81 66.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 2.55 110.077 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -78.47 75.17 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.045 -1.034 . . . . 2.13 108.634 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 tt -100.98 147.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.074 -0.713 . . . . 1.18 109.074 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -80.04 164.88 23.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.422 -0.799 . . . . 1.4 109.679 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.99 -47.19 86.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.214 -1.032 . . . . 1.39 108.214 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.81 -40.04 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.751 -0.593 . . . . 2.03 110.139 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.01 96.39 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.82 -0.912 . . . . 0.32 110.82 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 30' ' ' ILE . 96.7 mt -60.01 -43.91 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.941 -1.329 . . . . 1.14 109.594 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.471 ' HH ' ' CG ' ' A' ' 53' ' ' ARG . 37.7 m-85 -60.17 -40.81 91.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 2.3 110.896 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' OE1' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -66.85 -39.97 87.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.917 -1.114 . . . . 3.11 109.821 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.03 -46.62 88.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 2.25 111.014 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.99 -41.11 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 1.26 110.675 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 30.7 mtt -60.12 -39.98 88.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.036 . . . . 1.17 110.36 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' OE1' ' A' ' 32' ' ' GLN . 96.7 m-20 -68.92 -52.86 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 1.17 111.646 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -69.97 -42.89 72.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.873 -1.142 . . . . 3.48 110.07 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.99 101.51 54.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 108.318 -0.993 . . . . 2.43 108.318 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.46 -6.4 13.64 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.958 1.772 . . . . 1.69 112.717 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -60.0 -36.74 77.85 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.883 -1.154 . . . . 4.68 107.883 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -64.5 -25.28 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.844 -0.616 . . . . 1.91 110.402 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.927 -1.108 . . . . 3.01 109.523 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.09 -39.98 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 2.34 109.524 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -103.61 100.8 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.553 -0.906 . . . . 2.6 108.553 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.59 -68.33 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 2.25 110.513 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.03 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.963 -1.085 . . . . 4.59 110.327 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.55 -60.42 0.41 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.611 -0.996 . . . . 1.34 110.611 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -84.85 -27.81 26.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -1.225 . . . . 0.57 110.712 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.45 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 93.1 mt-30 -60.36 -42.56 96.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 2.03 112.027 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -76.92 -33.92 57.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.711 -1.243 . . . . 2.01 111.8 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . 0.401 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 29.1 t -59.89 -40.11 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.858 -1.151 . . . . 1.99 111.406 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.5 mm -62.95 -59.12 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.04 -1.037 . . . . 1.28 111.711 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' CG ' ' HH ' ' A' ' 31' ' ' TYR . 31.9 ptt180 -70.05 -33.53 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.159 . . . . 3.38 110.667 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -59.97 -40.03 87.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 3.09 109.356 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 51' ' ' SER . 94.4 m-20 -70.03 -21.52 63.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 2.59 111.169 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.96 -50.02 75.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.748 -1.22 . . . . 1.29 110.49 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.8 m -60.02 -40.01 87.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 2.04 109.727 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.2 mp -66.28 -39.99 89.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 1.92 109.06 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.59 113.97 15.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.424 -0.797 . . . . 1.83 109.887 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -89.99 -6.21 55.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.619 -0.882 . . . . 2.17 108.619 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -62.68 -37.74 87.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 1.92 109.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -78.37 156.53 29.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 2.22 108.582 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.2 t -120.16 129.96 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 1.48 109.608 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.94 142.92 52.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 2.29 109.501 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 57.8 t -127.11 88.2 54.82 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.487 -0.931 . . . . 1.95 108.487 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 88.0 Cg_exo . . . . . 0 C--N 1.308 -1.571 0 C-N-CA 121.994 1.796 . . . . 2.11 112.032 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.889 -0.782 . . . . 2.3 108.889 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -119.96 140.03 51.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.55 109.904 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -145.04 160.38 41.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 1.2 109.782 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 1.44 108.785 179.059 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.62 0.175 . . . . 1.18 112.551 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 -2.48 12.68 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.63 2.22 . . . . 1.18 113.25 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 143.65 57.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.796 -1.19 . . . . 1.92 109.748 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 t -79.79 165.93 22.25 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.142 -1.058 . . . . 1.92 108.142 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.92 -40.07 87.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.795 -1.19 . . . . 2.23 109.003 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.0 mt -68.12 -40.03 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 1.66 109.957 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.51 92.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.952 -1.092 . . . . 1.1 109.902 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.08 -45.17 93.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.768 -1.208 . . . . 1.14 108.332 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.417 ' CD1' HD22 ' A' ' 55' ' ' ASN . 98.1 mt -63.91 -45.81 95.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.971 -0.751 . . . . 1.2 108.971 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.91 -40.61 98.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 1.17 110.573 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.532 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.5 mtm -70.04 -39.12 75.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.823 -1.173 . . . . 1.77 109.529 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.9 90.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.555 -0.715 . . . . 1.09 110.501 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.54 -49.89 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.979 -1.076 . . . . 1.1 108.656 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -61.48 -39.94 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.366 0.603 . . . . 2.34 109.494 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 15' ' ' MET . 76.2 m-20 -78.32 -6.06 53.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 1.71 110.37 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.34 126.47 83.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 1.24 109.639 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -41.24 -20.71 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.688 1.592 . . . . 1.64 110.931 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 20' ' ' ALA . 13.4 pt-20 -138.5 141.92 39.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 2.63 108.141 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -60.59 -34.66 74.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.98 -1.075 . . . . 2.55 109.111 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.68 118.42 20.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 2.13 109.42 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.69 158.6 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.338 -0.851 . . . . 1.18 109.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.405 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 25.4 p -86.5 161.8 18.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 1.4 111.041 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.1 tp -61.12 -50.26 73.92 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.185 0.993 . . . . 1.39 109.002 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -59.97 -39.84 87.06 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.978 -0.556 . . . . 2.03 110.434 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.405 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -56.94 -39.94 89.79 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.004 -1.094 . . . . 0.32 110.404 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.8 -40.87 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.938 -1.331 . . . . 1.14 110.272 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 25.1 m-85 -60.03 -40.18 88.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.052 . . . . 2.3 111.142 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -63.34 -37.59 87.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.976 -1.077 . . . . 3.11 110.963 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.01 -45.17 93.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 2.25 110.76 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 34' ' ' ILE . 96.8 mt -69.81 -52.87 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.035 -1.041 . . . . 1.26 112.039 -178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.6 mtm -61.45 -39.97 92.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 1.17 111.283 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.34 -50.49 71.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 1.17 110.847 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -69.97 -39.98 75.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 3.48 111.382 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.581 ' C ' ' H ' ' A' ' 40' ' ' PHE . 89.7 m-85 -122.32 83.04 46.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 2.43 110.34 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.11 -3.93 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.248 1.966 . . . . 1.69 110.758 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.581 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -59.98 -39.99 87.59 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.653 -0.869 . . . . 4.68 108.653 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.0 -29.7 66.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.577 -0.702 . . . . 1.91 110.655 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -60.07 -39.9 87.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 3.01 109.714 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.4 -40.34 96.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 2.34 109.847 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -111.19 77.27 1.03 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.397 -0.594 . . . . 2.6 109.397 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -69.77 -40.03 76.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 2.25 110.04 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.67 148.08 37.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 4.59 110.41 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -61.65 0.35 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.323 -1.111 . . . . 1.34 110.323 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -89.98 -10.3 45.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -1.227 . . . . 0.57 110.786 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.465 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 62.8 tt0 -65.58 -56.79 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.931 -1.106 . . . . 2.03 110.754 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -70.11 -31.76 69.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 2.01 110.603 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -58.51 -39.55 80.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 1.99 110.539 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 5.4 mm -60.09 -49.77 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 1.28 110.236 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -70.05 -36.01 74.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.247 . . . . 3.38 110.426 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -59.92 -40.25 88.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 3.09 109.797 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.548 ' ND2' ' N ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -67.77 -39.99 84.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.511 -1.276 . . . . 2.59 108.396 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.548 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 54.2 mt -60.07 -48.66 80.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 1.29 110.353 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.5 p -70.05 -41.3 74.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 2.04 110.45 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -69.09 -40.15 78.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.025 . . . . 1.92 109.541 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -74.14 119.51 18.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -0.905 . . . . 1.83 108.723 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.76 -9.84 57.8 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 2.17 109.651 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.0 m -60.09 -39.96 87.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 1.92 109.413 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.77 140.67 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 2.22 108.824 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.56 130.1 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.498 -0.751 . . . . 1.48 109.762 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -73.64 135.57 43.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 2.29 109.211 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 77' ' ' TYR . 77.2 t -130.18 126.55 22.33 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.882 -0.785 . . . . 1.95 108.882 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.491 1.374 0 C-N-CA 121.693 1.595 . . . . 2.11 112.263 179.698 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.448 ' N ' ' O ' ' A' ' 65' ' ' VAL . 9.5 m-30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.944 -0.762 . . . . 2.3 108.944 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -119.97 141.99 49.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.692 -0.63 . . . . 0.55 109.689 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -143.03 160.04 41.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.21 -0.931 . . . . 1.2 109.37 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.173 -0.954 . . . . 1.44 109.909 -179.534 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo . . . . . 0 N--CA 1.494 1.504 0 N-CA-C 111.384 -0.275 . . . . 1.18 111.384 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.4 -5.61 16.31 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.313 2.009 . . . . 1.18 112.84 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -69.98 142.06 52.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.022 -1.049 . . . . 1.92 109.792 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -70.89 160.58 32.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.774 -0.825 . . . . 1.92 108.774 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.046 . . . . 2.23 108.748 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.48 -39.54 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 1.66 109.036 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.42 94.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.321 -0.862 . . . . 1.1 110.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.05 -39.94 87.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 1.14 108.895 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.68 -39.99 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.488 -0.758 . . . . 1.2 108.98 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -65.28 -40.05 93.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.745 . . . . 1.17 110.499 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.0 mtm -69.96 -37.78 75.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 1.77 109.792 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.18 90.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 1.09 110.048 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.96 -49.58 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 1.1 108.672 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.74 -39.63 84.22 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.916 -0.584 . . . . 2.34 110.731 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.63 -19.46 65.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 1.71 109.844 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.58 150.12 75.77 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 1.24 109.292 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.79 -52.14 4.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.653 1.568 . . . . 1.64 109.578 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -100.95 135.99 41.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.066 -1.457 . . . . 2.63 107.066 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -64.53 -19.16 65.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.784 -1.198 . . . . 2.55 109.538 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.13 126.13 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 2.13 108.9 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.8 tt -150.16 152.17 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.229 -0.919 . . . . 1.18 109.532 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -79.97 158.74 26.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 1.4 109.659 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.08 -42.99 95.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.994 -1.113 . . . . 1.39 107.994 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -62.77 -40.0 95.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.643 -0.66 . . . . 2.03 110.544 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -37.38 91.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.656 -1.378 . . . . 0.32 109.656 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.24 -39.97 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -1.137 . . . . 1.14 110.064 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 27.1 m-85 -64.38 -39.45 93.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.703 -1.248 . . . . 2.3 110.335 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -59.91 -40.54 89.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 3.11 108.972 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.9 -50.05 73.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 2.25 110.875 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.67 -50.16 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.089 -1.007 . . . . 1.26 112.175 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.6 mtm -60.64 -40.09 90.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 1.17 110.514 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.32 -48.49 72.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 1.17 111.38 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -69.75 -43.38 72.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.775 -1.203 . . . . 3.48 109.87 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 111.97 39.72 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.548 -0.908 . . . . 2.43 108.548 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.97 -5.76 14.72 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.873 1.715 . . . . 1.69 112.345 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.01 -38.13 81.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.371 -0.831 . . . . 4.68 109.418 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -69.91 -23.29 63.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.107 -0.996 . . . . 1.91 110.612 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -59.97 -40.37 88.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.897 -1.127 . . . . 3.01 109.543 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -62.5 -41.05 98.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 2.34 110.146 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -115.06 98.54 6.85 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.412 -0.588 . . . . 2.6 109.412 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.439 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 61.4 mttp -85.21 -31.79 23.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.93 . . . . 2.25 109.657 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -90.39 145.01 25.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 4.59 110.733 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.34 -63.92 0.29 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.726 -0.95 . . . . 1.34 110.726 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.439 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 36.7 p-90 -73.08 -34.84 66.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.979 -1.306 . . . . 0.57 111.894 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.61 -40.89 93.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.702 -1.249 . . . . 2.03 110.811 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -64.27 -40.03 95.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.876 -1.14 . . . . 2.01 110.607 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.2 m -60.81 -40.02 91.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 1.99 111.1 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.14 -47.97 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 1.28 110.832 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 13.3 mtp180 -69.84 -37.7 76.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.061 . . . . 3.38 109.875 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.99 -41.88 93.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.368 -0.832 . . . . 3.09 109.675 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -64.18 -40.01 95.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 2.59 109.62 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.01 -40.86 90.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 1.29 110.483 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -69.07 -44.66 72.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.93 -1.106 . . . . 2.04 110.64 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.06 -40.0 75.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 1.92 110.027 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -74.66 116.11 14.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.899 -1.126 . . . . 1.83 108.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.87 -3.52 57.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 2.17 110.351 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -70.1 -17.9 63.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 1.92 110.172 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.29 153.61 31.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 2.22 109.132 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.9 t -110.06 128.19 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.534 -0.913 . . . . 1.48 108.534 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -96.85 115.57 27.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 2.29 108.876 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 118.43 44.92 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 107.485 -1.302 . . . . 1.95 107.485 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.492 1.429 0 C-N-CA 121.714 1.609 . . . . 2.11 113.043 -178.884 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.653 -0.499 . . . . 2.3 109.653 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -121.02 130.7 53.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.599 -0.688 . . . . 0.55 109.437 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 164.28 33.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -0.792 . . . . 1.2 109.193 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.319 -0.863 . . . . 1.44 109.09 179.774 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.1 Cg_endo . . . . . 0 N--CA 1.494 1.503 0 N-CA-C 111.833 -0.103 . . . . 1.18 111.833 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -39.79 -23.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.613 2.209 . . . . 1.18 113.871 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 5' ' ' PRO . 3.6 m-85 -59.96 137.44 58.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 1.92 110.139 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 p -83.1 173.82 11.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.506 -0.746 . . . . 1.92 109.014 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -62.94 -37.94 89.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 2.23 109.113 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -68.22 -41.28 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 1.66 109.741 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.43 86.18 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -0.937 . . . . 1.1 110.533 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.11 -39.86 87.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.238 -1.023 . . . . 1.14 108.238 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.44 -45.36 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.841 . . . . 1.2 109.184 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -42.91 99.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 1.17 111.066 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.9 mtm -70.0 -40.01 75.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 1.77 110.862 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.69 -43.29 72.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -1.0 . . . . 1.09 109.449 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.9 mt -59.93 -45.97 94.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.492 -0.929 . . . . 1.1 108.492 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.0 -45.07 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.193 0.52 . . . . 2.34 110.501 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 15' ' ' MET . 15.6 p30 -91.11 15.44 11.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.866 -1.146 . . . . 1.71 109.874 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.37 129.5 74.64 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 1.24 108.521 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -40.6 -38.05 2.42 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.544 1.496 . . . . 1.64 110.885 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -124.54 154.23 40.91 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.253 -1.388 . . . . 2.63 107.253 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.782 -1.199 . . . . 2.55 108.489 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -90.64 125.84 35.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 2.13 109.031 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.8 tt -132.48 158.16 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.441 -0.787 . . . . 1.18 109.491 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -81.93 158.51 23.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 1.4 110.022 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.5 tp -59.97 -49.0 79.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.488 -0.758 . . . . 1.39 109.005 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -59.95 -39.57 86.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.541 -0.724 . . . . 2.03 109.843 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.58 -40.16 96.0 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.285 -0.96 . . . . 0.32 110.946 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 30' ' ' ILE . 84.3 mt -60.71 -42.45 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.841 -1.388 . . . . 1.14 109.555 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -60.94 -40.93 95.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 2.3 110.94 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.244 -0.91 . . . . 3.11 109.5 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -59.92 -47.79 84.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 2.25 109.771 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.97 -50.07 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.264 -0.897 . . . . 1.26 110.576 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.86 -39.9 95.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.879 -1.138 . . . . 1.17 110.216 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.11 -40.1 90.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.109 -0.994 . . . . 1.17 109.519 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -69.12 -54.05 17.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 3.48 110.351 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -110.71 123.56 35.26 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 2.43 109.912 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.84 -6.34 15.93 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.011 1.807 . . . . 1.69 111.197 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.03 -44.56 94.54 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.505 0.669 . . . . 4.68 109.541 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -70.07 -27.17 64.4 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.495 -0.753 . . . . 1.91 110.649 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -60.03 -39.77 87.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.849 -1.157 . . . . 3.01 108.581 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.32 -2.7 29.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 2.34 109.401 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 21.5 t-20 -144.47 98.54 3.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.548 -0.72 . . . . 2.6 109.104 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 56.3 mtpt -98.04 -32.93 11.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 2.25 110.626 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.84 143.11 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.876 -1.14 . . . . 4.59 110.398 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.61 -72.15 0.27 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.096 -1.201 . . . . 1.34 110.096 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 18.8 p-90 -69.96 -39.35 76.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.208 -1.172 . . . . 0.57 110.874 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.689 HE21 ' NH2' ' A' ' 53' ' ' ARG . 53.5 tt0 -59.99 -50.07 75.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 2.03 110.978 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -73.49 -31.69 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.936 -1.103 . . . . 2.01 110.044 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.8 m -59.93 -40.21 88.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 1.99 110.258 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 mt -69.88 -43.62 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 1.28 109.138 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.689 ' NH2' HE21 ' A' ' 49' ' ' GLN . 67.2 mtt180 -59.99 -47.18 86.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.718 -1.239 . . . . 3.38 108.417 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -60.8 -40.03 91.13 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 3.09 108.467 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.07 -39.94 95.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.861 -0.792 . . . . 2.59 108.861 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.5 mt -59.99 -45.87 91.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 1.29 110.105 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.35 -42.44 99.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.902 -1.124 . . . . 2.04 109.337 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.6 mt -70.02 -37.22 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 1.92 109.775 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -69.18 117.84 11.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 1.83 109.898 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -90.7 -10.96 41.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 2.17 108.962 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.94 -40.04 87.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.425 -0.797 . . . . 1.92 109.673 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.48 146.19 32.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.297 -0.877 . . . . 2.22 109.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.98 125.35 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.175 -1.046 . . . . 1.48 108.175 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' NZ ' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.42 135.57 38.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 2.29 109.903 -178.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.43 139.02 31.48 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.642 -0.873 . . . . 1.95 108.642 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo . . . . . 0 N--CA 1.494 1.547 0 C-N-CA 122.254 1.969 . . . . 2.11 112.36 -179.963 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.509 -0.552 . . . . 2.3 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -132.15 151.53 51.74 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.366 -0.834 . . . . 0.55 109.492 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.5 t -149.99 169.98 19.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.967 -1.083 . . . . 1.2 110.347 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 1.44 110.551 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo . . . . . 0 N--CA 1.495 1.607 0 CA-C-O 120.582 0.159 . . . . 1.18 112.384 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.55 -9.25 18.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.542 2.161 . . . . 1.18 112.878 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -67.34 143.32 56.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.955 -1.091 . . . . 1.92 108.993 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.547 ' HG ' ' N ' ' A' ' 9' ' ' TYR . 29.9 t -69.65 159.98 32.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -0.973 . . . . 1.92 108.573 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.547 ' N ' ' HG ' ' A' ' 8' ' ' SER . 74.9 m-85 -59.9 -39.97 87.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.934 -1.104 . . . . 2.23 108.465 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 10' ' ' ILE . 96.6 mt -66.53 -39.95 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.786 . . . . 1.66 109.395 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.02 95.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 1.1 110.103 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.06 -40.07 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.198 -0.939 . . . . 1.14 108.588 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.66 -41.93 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 1.2 108.91 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -60.49 -40.1 90.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 1.17 109.676 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.43 -39.94 89.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 1.77 109.175 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.65 85.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.629 -0.67 . . . . 1.09 110.474 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.06 -49.86 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.059 -1.026 . . . . 1.1 108.973 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.57 -40.51 92.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.837 -0.539 . . . . 2.34 110.157 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -70.69 -20.61 62.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 1.71 110.372 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.06 119.85 77.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.091 -1.006 . . . . 1.24 109.812 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.99 -29.55 1.58 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.409 1.406 . . . . 1.64 110.719 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -115.09 128.13 56.04 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.612 -1.255 . . . . 2.63 107.612 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -69.93 -27.31 64.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.922 -1.111 . . . . 2.55 110.142 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -78.54 74.28 5.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.951 -1.093 . . . . 2.13 109.354 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -88.57 147.46 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.815 -0.809 . . . . 1.18 108.815 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -79.04 159.56 27.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 1.4 109.851 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.1 tp -60.42 -50.01 75.3 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.63 0.729 . . . . 1.39 109.839 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 2.03 109.744 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -38.62 94.36 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.495 -1.042 . . . . 0.32 110.495 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 30' ' ' ILE . 87.9 mt -60.02 -43.71 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.973 -1.31 . . . . 1.14 109.933 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -59.99 -45.38 92.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.953 -1.092 . . . . 2.3 110.366 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -59.98 -40.12 88.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 3.11 110.265 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.92 -46.55 89.01 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.141 -0.974 . . . . 2.25 109.412 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.0 mt -65.78 -49.94 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 1.26 111.499 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.0 mtm -61.11 -40.0 92.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.935 -1.103 . . . . 1.17 110.98 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -66.67 -39.93 88.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 1.17 110.555 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -76.94 -67.04 0.75 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 3.48 111.129 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -85.96 130.44 50.37 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.731 -1.23 . . . . 2.43 109.907 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.63 -13.26 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.186 1.924 . . . . 1.69 113.204 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.94 -44.37 94.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.998 -1.064 . . . . 4.68 110.288 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -70.2 -29.21 66.0 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 1.91 111.114 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.949 -1.094 . . . . 3.01 110.124 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -93.2 0.05 57.0 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.003 -1.061 . . . . 2.34 110.264 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.548 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 59.1 t30 -124.27 129.05 50.08 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.271 0.557 . . . . 2.6 109.547 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -129.12 17.89 6.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.512 -0.742 . . . . 2.25 109.402 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -70.43 -160.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 4.59 111.871 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.61 -9.21 0.25 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 116.112 -0.494 . . . . 1.34 111.917 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.548 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -59.99 -35.99 76.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.218 -1.754 . . . . 0.57 107.721 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.38 -44.12 97.69 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.757 -0.589 . . . . 2.03 111.154 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -80.32 -26.58 38.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.002 -1.061 . . . . 2.01 111.703 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -69.39 -23.58 63.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.763 -1.211 . . . . 1.99 110.868 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -69.99 -61.66 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.006 -1.059 . . . . 1.28 111.394 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -70.01 -30.92 68.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.159 -0.963 . . . . 3.38 111.216 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.21 -36.82 78.54 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.912 -1.117 . . . . 3.09 109.648 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 98.5 m-20 -69.94 -19.24 63.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 2.59 111.14 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.91 -45.1 93.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.909 -1.119 . . . . 1.29 110.385 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.8 p -69.98 -39.6 75.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.968 -1.082 . . . . 2.04 110.102 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.16 -39.95 88.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.92 110.028 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 83.2 m-20 -64.52 119.0 9.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 1.83 109.601 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -81.97 -37.73 26.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 2.17 110.294 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.5 m -65.31 -11.54 42.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 1.92 109.769 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.44 131.17 36.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 2.22 109.122 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.3 t -97.19 127.94 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.276 -0.89 . . . . 1.48 109.101 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -103.71 118.0 35.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 2.29 110.174 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.24 118.19 44.36 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 107.867 -1.161 . . . . 1.95 107.867 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 N--CA 1.492 1.403 0 C-N-CA 121.415 1.41 . . . . 2.11 112.367 -179.212 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.422 -0.585 . . . . 2.3 109.422 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -130.19 130.7 45.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.55 109.743 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.2 t -149.82 159.44 44.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 1.2 109.542 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 1.44 109.717 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' TYR . 83.6 Cg_exo . . . . . 0 N--CA 1.497 1.697 0 CA-C-O 120.07 -0.054 . . . . 1.18 112.218 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.11 -8.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.274 1.983 . . . . 1.18 113.65 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.8 m-85 -71.96 144.52 48.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.707 -1.246 . . . . 1.92 109.926 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 m -82.31 169.94 15.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 1.92 109.419 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -60.09 -39.96 87.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.14 -0.975 . . . . 2.23 109.158 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.81 -39.9 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 1.66 109.181 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -47.62 84.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 1.1 110.342 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.07 -41.45 92.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.789 -1.194 . . . . 1.14 108.436 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.32 -42.05 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.048 -1.093 . . . . 1.2 108.048 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.16 -40.02 94.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.584 -0.697 . . . . 1.17 109.47 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.26 -39.92 82.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 1.77 109.603 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.01 81.11 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.329 -0.857 . . . . 1.09 109.252 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.1 mt -61.1 -50.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 1.1 108.757 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -61.23 -40.01 92.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.632 -0.668 . . . . 2.34 109.839 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -78.05 -4.16 45.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 1.71 108.967 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -80.05 119.3 76.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.589 -0.893 . . . . 1.24 108.589 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -40.41 -26.72 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.675 1.583 . . . . 1.64 111.594 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 20' ' ' ALA . 20.7 pt-20 -134.7 153.93 51.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.036 -1.098 . . . . 2.63 108.036 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -67.74 -31.56 71.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 2.55 110.825 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -78.87 123.42 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.686 -1.259 . . . . 2.13 109.704 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 tt -140.39 153.8 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.285 -0.884 . . . . 1.18 109.543 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.1 p -81.91 152.63 26.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 1.4 110.197 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.0 -49.06 79.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.684 -0.858 . . . . 1.39 108.684 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.9 -40.11 87.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.453 -0.78 . . . . 2.03 109.811 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.77 94.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.581 -1.008 . . . . 0.32 110.581 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.04 -41.54 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.317 . . . . 1.14 110.033 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CD1' ' NE2' ' A' ' 49' ' ' GLN . 38.9 m-85 -59.99 -45.37 92.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 2.3 110.731 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.94 -37.32 84.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.041 -1.037 . . . . 3.11 110.852 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.98 -49.04 79.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 2.25 110.68 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.06 -49.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 1.26 110.693 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.47 -39.93 92.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.918 -1.114 . . . . 1.17 110.476 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.52 -40.01 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 1.17 109.47 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -79.76 -69.39 0.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 3.48 109.483 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -89.47 116.53 66.58 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.983 . . . . 2.43 109.019 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.52 -3.93 12.72 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.88 1.72 . . . . 1.69 111.235 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -60.06 -39.75 87.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.594 -0.891 . . . . 4.68 108.594 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' ASN . 93.3 m-85 -69.87 -27.15 64.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.567 -0.708 . . . . 1.91 110.521 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -59.2 -39.96 84.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.823 -1.173 . . . . 3.01 107.994 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -61.3 -40.77 95.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 2.34 109.631 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -111.5 108.5 18.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.329 -0.619 . . . . 2.6 109.329 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -96.64 -40.74 8.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.067 -1.02 . . . . 2.25 110.513 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.21 142.97 27.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.169 -0.957 . . . . 4.59 110.536 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.77 -55.74 0.49 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.562 -1.415 . . . . 1.34 109.562 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -89.23 -3.07 58.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -1.185 . . . . 0.57 109.256 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.423 ' NE2' ' CD1' ' A' ' 31' ' ' TYR . 67.3 tp60 -74.08 -61.7 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 2.03 111.089 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -69.55 -39.93 77.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.302 -0.873 . . . . 2.01 110.656 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.2 m -50.84 -31.09 16.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 1.99 111.008 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.29 -65.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.003 -1.06 . . . . 1.28 110.894 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -69.94 -30.02 67.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 3.38 110.6 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.769 -1.207 . . . . 3.09 108.491 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.427 ' OD1' ' OD1' ' A' ' 59' ' ' ASN . 27.2 t-20 -61.08 -42.86 99.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 2.59 110.144 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.96 -41.66 92.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.993 . . . . 1.29 110.239 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 p -64.05 -50.64 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 2.04 110.625 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 mp -69.94 -40.09 75.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.929 -1.107 . . . . 1.92 110.056 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.651 ' N ' HD21 ' A' ' 59' ' ' ASN . 0.8 OUTLIER -66.73 122.11 16.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.192 -0.943 . . . . 1.83 109.58 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -86.09 -10.2 55.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 2.17 109.34 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.26 -40.02 92.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.288 -0.883 . . . . 1.92 109.061 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -82.74 129.29 34.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.348 -0.982 . . . . 2.22 108.348 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.94 119.93 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 1.48 109.534 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.88 150.06 24.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.298 -1.001 . . . . 2.29 108.298 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.01 91.55 22.94 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.31 -0.869 . . . . 1.95 109.789 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo . . . . . 0 C--N 1.311 -1.409 0 C-N-CA 121.712 1.608 . . . . 2.11 111.318 179.404 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.685 -0.487 . . . . 2.3 109.685 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -122.96 130.98 53.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.227 -0.657 . . . . 0.55 109.227 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 161.67 40.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.331 -0.855 . . . . 1.2 109.528 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.44 109.325 -179.781 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 CA-C-O 120.816 0.256 . . . . 1.18 112.162 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.64 -2.62 12.86 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.519 2.146 . . . . 1.18 112.685 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -64.93 137.45 57.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.814 -1.179 . . . . 1.92 108.735 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -77.83 168.67 19.55 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.285 -1.006 . . . . 1.92 108.285 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -60.0 -37.85 80.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.022 -1.049 . . . . 2.23 108.617 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.9 mm -60.11 -46.29 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 1.66 109.613 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.81 95.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -0.872 . . . . 1.1 110.452 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.76 -40.14 91.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.925 -1.109 . . . . 1.14 108.64 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.12 -42.2 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.471 -0.937 . . . . 1.2 108.471 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -64.38 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 1.17 110.358 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtt -66.32 -39.34 89.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.89 . . . . 1.77 109.658 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.4 92.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.542 -0.724 . . . . 1.09 110.252 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.605 ' CG2' ' HZ2' ' A' ' 23' ' ' LYS . 62.3 mt -69.57 -49.14 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.106 -0.997 . . . . 1.1 109.431 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.03 -40.03 90.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 2.34 110.612 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -82.16 -10.6 59.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 1.71 110.78 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.07 149.17 72.88 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.942 -1.099 . . . . 1.24 109.022 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.62 -57.03 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.441 1.427 . . . . 1.64 110.359 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -104.98 127.07 52.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.94 -1.133 . . . . 2.63 107.94 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.605 ' HZ2' ' CG2' ' A' ' 17' ' ' ILE . 8.7 mtpm? -60.33 -28.91 68.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.962 -1.086 . . . . 2.55 108.927 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -78.05 82.41 4.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.956 -1.127 . . . . 2.13 107.956 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 tt -111.87 148.55 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.767 -0.827 . . . . 1.18 108.767 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.486 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 30.7 p -79.03 161.07 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.116 -0.99 . . . . 1.4 109.233 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.4 tp -60.04 -42.63 94.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.39 108.962 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.76 -40.01 90.91 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.286 -0.884 . . . . 2.03 109.643 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.486 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -60.71 -35.99 90.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.84 -1.304 . . . . 0.32 109.84 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.76 -41.16 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -1.153 . . . . 1.14 110.293 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -60.0 -40.1 88.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.531 -1.355 . . . . 2.3 109.383 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.98 -40.35 88.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.462 -0.774 . . . . 3.11 109.798 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.71 -47.22 73.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 2.25 110.701 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.2 -49.88 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 1.26 110.678 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.1 mtm -62.13 -39.99 94.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.892 -1.13 . . . . 1.17 109.548 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.01 -49.64 75.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 1.17 110.401 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -70.04 -58.85 3.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.921 -1.112 . . . . 3.48 109.848 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -100.04 112.83 64.73 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 2.43 108.892 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.03 -10.16 14.0 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.028 1.819 . . . . 1.69 112.64 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -60.07 -38.17 82.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 4.68 108.953 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 44' ' ' ASN . 69.4 m-85 -63.89 -28.75 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.666 -0.646 . . . . 1.91 110.952 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.89 -39.93 87.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.83 -1.169 . . . . 3.01 109.372 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.77 -40.08 93.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 2.34 109.461 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -114.45 104.74 12.34 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 2.6 108.498 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 53.8 mtpt -98.47 -32.58 11.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 2.25 110.67 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -89.72 137.02 32.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.069 -1.02 . . . . 4.59 110.028 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.44 -64.9 0.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.96 -1.256 . . . . 1.34 109.96 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.451 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 38.0 p-90 -72.88 -37.06 67.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.108 -1.231 . . . . 0.57 110.51 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -60.09 -45.38 93.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 2.03 110.369 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -68.86 -37.66 79.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 2.01 110.255 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 m -59.85 -39.35 84.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 1.99 110.043 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.3 mm -60.01 -46.81 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 1.28 110.224 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.416 HH11 ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -64.75 -41.49 95.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 3.38 109.708 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -60.03 -45.25 93.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.841 . . . . 3.09 109.832 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.07 -39.96 94.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -0.915 . . . . 2.59 109.666 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.89 -46.87 87.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 1.29 110.263 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -64.73 -44.46 90.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.884 -1.135 . . . . 2.04 109.453 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 mt -67.88 -43.26 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.92 109.678 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -85.07 106.89 16.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 1.83 108.76 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -91.01 10.29 27.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 2.17 109.449 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.41 -26.05 67.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.838 . . . . 1.92 109.927 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -79.76 147.91 31.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 2.22 109.122 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.9 t -90.61 118.52 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 1.48 109.08 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -92.33 100.23 12.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 2.29 109.239 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.88 123.78 44.24 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.494 -0.928 . . . . 1.95 108.494 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo . . . . . 0 N--CA 1.494 1.522 0 C-N-CA 122.013 1.809 . . . . 2.11 112.604 -179.754 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.291 -0.633 . . . . 2.3 109.291 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -114.56 130.79 56.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.523 -0.735 . . . . 0.55 109.288 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.547 ' HG1' ' HZ3' ' A' ' 23' ' ' LYS . 15.3 t -158.51 153.67 25.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.943 . . . . 1.2 109.583 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 mt . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 1.44 109.316 179.818 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo . . . . . 0 N--CA 1.495 1.606 0 N-CA-C 112.988 0.342 . . . . 1.18 112.988 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.1 16.9 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.531 2.154 . . . . 1.18 111.691 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -101.22 135.81 42.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.385 -0.822 . . . . 1.92 109.455 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' SER . . . . . 0.649 ' HG ' ' H ' ' A' ' 11' ' ' ALA . 91.8 p -80.21 170.01 17.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.435 -0.791 . . . . 1.92 109.281 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 2.23 108.913 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.05 -40.14 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 1.66 108.542 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.649 ' H ' ' HG ' ' A' ' 8' ' ' SER . . . -66.82 -46.82 73.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 1.1 109.492 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.06 -40.85 90.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.043 -1.035 . . . . 1.14 108.336 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.5 mt -69.91 -41.54 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 1.2 108.959 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -39.94 95.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 1.17 109.268 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.522 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.3 mtt -68.06 -40.0 82.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 1.77 108.829 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -49.5 77.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.567 -0.708 . . . . 1.09 110.073 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.04 -49.9 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 1.1 109.255 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.43 -39.66 92.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.852 -0.53 . . . . 2.34 110.266 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 15' ' ' MET . 69.4 m-80 -80.3 5.0 15.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 1.71 110.112 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.1 148.37 74.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.971 -1.081 . . . . 1.24 109.76 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -33.6 -84.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.912 2.408 . . . . 1.64 112.849 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -90.02 -80.05 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.685 -1.259 . . . . 2.63 108.542 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -159.16 -33.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.895 -1.128 . . . . 2.55 110.117 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -81.42 129.85 34.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.994 -1.066 . . . . 2.13 110.142 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -130.75 138.74 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.611 -0.885 . . . . 1.18 108.611 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.2 p -79.99 162.31 24.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 1.4 109.965 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.04 -47.01 87.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.671 -0.862 . . . . 1.39 108.671 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.442 ' O ' ' OE1' ' A' ' 32' ' ' GLN . 79.7 m-20 -62.55 -39.93 95.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 2.03 109.844 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.07 91.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.536 -1.026 . . . . 0.32 110.536 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.97 -40.69 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.987 -1.302 . . . . 1.14 109.381 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -60.07 -48.68 80.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.108 -0.995 . . . . 2.3 109.955 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 28' ' ' ASN . 4.8 mp0 -59.92 -37.79 80.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 3.11 109.488 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -59.99 -49.99 75.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 2.25 109.64 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -49.97 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.002 -1.061 . . . . 1.26 110.824 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.5 mtm -65.02 -43.49 92.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.89 -1.131 . . . . 1.17 110.781 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.36 -44.86 86.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 1.17 110.626 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.43 HH11 ' HG3' ' A' ' 37' ' ' ARG . 21.7 mmm-85 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.019 -1.051 . . . . 3.48 110.541 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.55 ' C ' ' H ' ' A' ' 40' ' ' PHE . 70.4 m-85 -124.05 82.53 56.31 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.418 -0.801 . . . . 2.43 109.766 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.45 -6.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.562 2.174 . . . . 1.69 111.779 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.55 ' H ' ' C ' ' A' ' 38' ' ' PHE . 49.6 t80 -59.94 -42.76 94.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.515 -0.74 . . . . 4.68 109.898 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.03 -22.15 63.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 1.91 110.937 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -39.84 86.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.912 -1.117 . . . . 3.01 109.705 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.54 2.85 43.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 2.34 109.728 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.501 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 81.3 m-20 -133.92 115.67 14.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.626 -0.672 . . . . 2.6 109.832 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' GLN . 56.0 mttp -110.47 13.74 22.68 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.477 -0.935 . . . . 2.25 108.477 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 48' ' ' TRP . 87.7 mt-30 -47.39 -177.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.995 0.902 . . . . 4.59 111.401 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.9 -8.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.932 -0.867 . . . . 1.34 110.932 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' A' ' 46' ' ' GLN . 3.8 p-90 -59.87 -40.75 89.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.575 -1.544 . . . . 0.57 107.939 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.514 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 58.5 tt0 -60.06 -50.3 74.26 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.261 0.553 . . . . 2.03 111.316 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -73.23 -40.07 64.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.173 . . . . 2.01 110.759 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.3 p -51.94 -30.05 22.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.937 . . . . 1.99 110.773 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.76 -52.26 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.118 . . . . 1.28 110.489 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.6 mtp180 -69.98 -40.67 75.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.052 . . . . 3.38 110.154 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -63.34 -39.98 96.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.079 -1.013 . . . . 3.09 108.659 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.96 -40.0 95.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.093 -1.077 . . . . 2.59 108.093 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.2 mt -68.51 -40.59 80.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 1.29 109.823 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 t -69.95 -44.24 69.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 2.04 109.468 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 mt -69.62 -39.71 77.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 1.92 109.046 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -75.58 105.81 6.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.168 -0.957 . . . . 1.83 109.31 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.47 -1.08 57.92 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.981 -1.118 . . . . 2.17 107.981 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.4 m -60.17 -34.09 73.1 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.042 -0.725 . . . . 1.92 109.042 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.51 155.55 29.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.8 . . . . 2.22 109.025 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 125.73 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.517 -0.74 . . . . 1.48 109.209 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -76.61 154.65 34.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 2.29 109.167 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.24 91.77 49.53 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.49 -0.756 . . . . 1.95 109.0 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 C--N 1.311 -1.443 0 C-N-CA 122.097 1.865 . . . . 2.11 112.524 -179.471 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.442 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 21.6 m-85 . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 108.038 -1.097 . . . . 2.3 108.038 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -110.96 127.16 55.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.55 109.58 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.3 t -141.67 159.19 42.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.305 -0.872 . . . . 1.2 109.686 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.44 109.973 -179.618 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 55.4 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 N-CA-C 112.147 0.018 . . . . 1.18 112.147 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.64 -17.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.546 2.164 . . . . 1.18 113.793 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 6.1 m-85 -67.69 129.04 38.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.766 -1.209 . . . . 1.92 110.171 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.1 p -81.94 177.17 9.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -0.759 . . . . 1.92 109.059 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -59.93 -41.48 91.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 2.23 109.562 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.01 -47.46 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 1.66 109.784 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.89 87.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.913 . . . . 1.1 110.317 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.03 -45.63 92.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.831 -1.168 . . . . 1.14 109.051 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 84.2 mt -62.19 -40.02 86.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.123 -1.065 . . . . 1.2 108.123 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.33 -39.95 94.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.614 -0.679 . . . . 1.17 109.593 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.0 mtt -65.83 -39.91 91.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 1.77 109.76 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.31 89.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 1.09 109.835 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.1 mt -60.02 -49.97 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.151 -0.968 . . . . 1.1 108.543 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.19 -40.04 93.66 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.213 0.53 . . . . 2.34 110.168 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.12 0.7 43.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 1.71 110.45 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 148.42 74.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.96 -1.087 . . . . 1.24 108.759 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.81 -23.53 74.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.608 1.539 . . . . 1.64 109.768 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -138.35 148.79 44.94 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.124 . . . . 2.63 107.964 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -61.64 -36.9 82.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.007 -1.058 . . . . 2.55 108.274 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.377 -0.971 . . . . 2.13 108.377 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.14 152.71 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.368 -0.832 . . . . 1.18 109.048 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.522 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 72.2 p -80.08 153.8 28.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 1.4 109.238 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -59.97 -40.27 88.53 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.446 -0.784 . . . . 1.39 108.889 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -60.17 -40.06 88.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.506 -0.746 . . . . 2.03 109.913 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.522 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -62.92 -38.83 97.22 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.639 -0.985 . . . . 0.32 110.639 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.04 -40.44 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -1.225 . . . . 1.14 110.017 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.533 ' CE1' ' OE1' ' A' ' 49' ' ' GLN . 32.1 m-85 -60.03 -41.95 93.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.901 -1.124 . . . . 2.3 110.263 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.14 -40.24 89.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.297 -0.877 . . . . 3.11 110.078 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.94 -49.63 76.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.672 . . . . 2.25 111.446 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 34' ' ' ILE . 86.2 mt -59.93 -49.86 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 1.26 111.631 -178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.8 mtm -60.0 -40.03 87.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 1.17 111.164 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.29 -46.18 71.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.649 -1.282 . . . . 1.17 111.019 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HA ' ' HE ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -70.0 -40.06 75.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.89 -1.131 . . . . 3.48 109.943 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -121.63 110.04 33.97 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.662 -0.866 . . . . 2.43 108.662 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.471 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 95.8 Cg_endo -79.59 -11.27 14.27 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.927 1.751 . . . . 1.69 113.011 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -58.47 -35.97 72.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.176 -0.952 . . . . 4.68 109.22 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 44' ' ' ASN . 91.5 m-85 -67.6 -29.5 68.86 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.767 -0.583 . . . . 1.91 110.603 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -59.96 -39.96 87.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.027 -1.046 . . . . 3.01 109.582 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 39' ' ' PRO . 54.7 mp0 -66.62 -39.97 88.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.037 -1.039 . . . . 2.34 109.048 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.4 m-20 -106.23 106.49 17.03 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.257 -0.645 . . . . 2.6 109.257 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -98.38 -42.61 7.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.114 -0.991 . . . . 2.25 109.96 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -77.98 140.14 39.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.165 -0.96 . . . . 4.59 109.873 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.86 -59.98 0.34 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.443 -1.063 . . . . 1.34 110.443 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.2 p-90 -89.44 -14.77 34.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.025 -1.279 . . . . 0.57 110.497 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.533 ' OE1' ' CE1' ' A' ' 31' ' ' TYR . 3.2 tp-100 -69.92 -60.02 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 2.03 110.926 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -72.36 -28.67 63.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.906 -1.121 . . . . 2.01 110.942 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -59.95 -38.82 83.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.909 -1.119 . . . . 1.99 109.857 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.95 -44.77 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.938 . . . . 1.28 110.086 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -68.97 -44.79 72.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.791 -1.193 . . . . 3.38 110.482 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -60.01 -41.66 92.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 3.09 109.279 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.689 HD22 HD22 ' A' ' 59' ' ' ASN . 21.7 t-20 -61.96 -42.26 98.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 2.59 108.753 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -60.06 -46.83 88.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.409 -0.807 . . . . 1.29 109.903 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 t -70.4 -41.98 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 2.04 109.961 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.36 -39.96 89.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 1.92 110.084 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.689 HD22 HD22 ' A' ' 55' ' ' ASN . 93.7 m-20 -74.73 119.75 19.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.148 -0.97 . . . . 1.83 108.984 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -89.96 -2.7 58.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 2.17 108.667 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.7 m -62.61 -40.04 95.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.747 . . . . 1.92 109.367 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -80.6 152.62 28.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 2.22 109.421 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.6 t -127.42 128.04 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 1.48 109.589 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -83.82 150.02 26.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 2.29 109.415 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.2 80.03 69.31 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.111 -1.07 . . . . 1.95 108.111 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.249 1.966 . . . . 2.11 112.252 -179.487 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 107.218 -1.401 . . . . 2.3 107.218 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -122.75 134.78 54.43 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.27 -0.894 . . . . 0.55 110.23 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -152.64 161.32 42.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 1.2 109.245 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.033 -1.042 . . . . 1.44 109.488 -179.933 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 7' ' ' TYR . 68.7 Cg_endo . . . . . 0 N--CA 1.491 1.348 0 N-CA-C 111.352 -0.288 . . . . 1.18 111.352 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.74 -24.36 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.249 1.966 . . . . 1.18 113.373 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PRO . 12.4 m-85 -60.61 131.54 51.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 1.92 109.895 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t -81.7 169.21 17.24 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.482 -0.933 . . . . 1.92 108.482 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -60.0 -40.3 88.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 2.23 109.352 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.29 -43.45 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.015 -1.053 . . . . 1.66 108.935 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.17 85.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.8 . . . . 1.1 109.855 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.98 -40.21 88.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 1.14 109.059 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.92 -44.2 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.04 -1.038 . . . . 1.2 108.247 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m -60.56 -40.04 90.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 1.17 110.376 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.97 -39.96 87.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 1.77 109.811 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.11 94.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 1.09 109.961 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.33 -46.3 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 1.1 109.03 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.94 -40.04 87.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.71 -0.619 . . . . 2.34 109.462 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -83.25 -3.06 57.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.933 . . . . 1.71 109.462 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.01 124.84 82.82 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 1.24 109.493 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -42.93 -57.09 1.87 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.397 1.398 . . . . 1.64 110.92 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -97.52 140.82 31.37 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.852 -1.166 . . . . 2.63 107.852 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -59.9 -35.53 75.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 2.55 110.087 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -76.97 129.95 36.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.604 -1.31 . . . . 2.13 108.533 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.0 tt -139.9 147.68 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 1.18 109.694 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -82.66 150.22 26.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.479 -0.763 . . . . 1.4 109.295 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.4 tp -59.97 -41.59 92.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 1.39 108.627 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.33 -41.75 94.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.547 -0.72 . . . . 2.03 110.106 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.51 97.23 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.492 -1.043 . . . . 0.32 110.492 -179.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.99 -39.98 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -1.188 . . . . 1.14 110.284 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.465 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 25.2 m-85 -59.97 -42.0 93.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.636 -1.29 . . . . 2.3 109.569 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.56 -40.67 95.58 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.127 -0.983 . . . . 3.11 109.789 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.26 -49.88 75.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 2.25 111.377 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.07 -44.72 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 1.26 110.738 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.7 mtm -60.01 -41.79 92.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.919 -1.113 . . . . 1.17 109.416 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.02 -40.0 75.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 1.17 110.417 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -68.05 -60.03 2.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 3.48 110.654 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.08 126.31 31.37 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 2.43 109.257 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.64 -16.54 10.37 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.161 1.907 . . . . 1.69 113.555 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.826 -1.171 . . . . 4.68 110.181 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -17.59 64.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 1.91 110.908 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -60.06 -48.66 80.81 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.999 -1.063 . . . . 3.01 109.141 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.728 0.775 . . . . 2.34 110.326 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.453 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 14.6 t-20 -93.96 99.98 12.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.638 -0.664 . . . . 2.6 109.372 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -97.77 -39.26 9.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 2.25 110.189 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -87.66 139.79 30.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 4.59 110.107 -178.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.72 -59.22 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.403 -1.079 . . . . 1.34 110.403 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.453 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 31.7 p-90 -82.48 -12.5 57.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.964 -1.315 . . . . 0.57 110.479 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.465 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 53.4 tt0 -70.0 -54.23 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 2.03 110.739 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.03 -25.93 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.904 -1.123 . . . . 2.01 110.841 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.3 p -60.11 -39.92 87.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 1.99 110.139 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.49 -47.94 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 1.28 110.604 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -69.95 -42.53 73.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.882 -1.136 . . . . 3.38 110.535 -178.83 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -44.8 94.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 3.09 108.961 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 94.0 m-20 -59.98 -40.14 88.07 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.204 -0.935 . . . . 2.59 109.459 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.2 -42.18 98.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 1.29 110.446 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.7 p -66.73 -46.53 75.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.109 -0.994 . . . . 2.04 110.753 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.28 -39.91 74.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.862 -1.149 . . . . 1.92 110.249 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 77.1 m-20 -77.7 118.01 19.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.977 . . . . 1.83 109.351 -179.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.65 -2.96 57.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 2.17 110.017 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CD2' ' A' ' 62' ' ' PHE . 12.2 p -61.41 -32.44 72.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.92 108.868 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.582 ' CD2' ' SG ' ' A' ' 61' ' ' CYS . 90.8 m-85 -79.06 150.06 31.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.438 -0.789 . . . . 2.22 109.194 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.33 122.04 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.777 -0.823 . . . . 1.48 108.777 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -80.78 111.55 17.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 2.29 110.142 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.5 t -103.75 113.68 65.29 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.938 -1.134 . . . . 1.95 107.938 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 C-N-CA 121.816 1.677 . . . . 2.11 112.711 -178.819 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.91 -0.774 . . . . 2.3 108.91 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.05 139.98 51.7 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.403 -0.811 . . . . 0.55 109.843 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -153.23 153.12 32.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 1.2 109.895 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 1.44 108.561 179.175 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.491 1.36 0 N-CA-C 112.635 0.206 . . . . 1.18 112.635 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.25 2.52 8.47 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.633 2.222 . . . . 1.18 113.83 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.59 140.21 58.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.514 -1.367 . . . . 1.92 109.48 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.0 m -74.54 164.33 26.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.893 . . . . 1.92 109.073 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -59.9 -40.07 87.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.166 -0.959 . . . . 2.23 108.622 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.2 mm -69.62 -40.0 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 1.66 108.973 179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.92 95.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 1.1 109.692 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.062 -1.024 . . . . 1.14 108.436 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 1.2 108.807 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -60.73 -40.03 90.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 1.17 109.876 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.2 mtt -67.43 -39.88 85.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.009 . . . . 1.77 109.009 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.33 78.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 1.09 109.802 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.98 -50.02 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.195 -1.039 . . . . 1.1 108.195 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.393 0.616 . . . . 2.34 109.348 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -84.01 -0.51 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 1.71 109.759 -179.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.92 126.48 82.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.057 -1.027 . . . . 1.24 108.836 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -38.79 -28.12 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.785 1.657 . . . . 1.64 111.328 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' ALA . 12.8 pt-20 -145.69 155.28 42.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.174 -1.047 . . . . 2.63 108.174 178.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -60.05 -38.03 81.59 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.174 -0.953 . . . . 2.55 109.687 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -79.07 108.25 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 2.13 109.751 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -133.58 154.39 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.941 -0.763 . . . . 1.18 108.941 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -80.45 155.37 27.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 1.4 110.306 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.98 -43.39 95.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.584 -0.895 . . . . 1.39 108.584 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.1 -39.93 91.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.805 . . . . 2.03 109.748 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.05 96.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.554 -1.018 . . . . 0.32 110.554 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -41.11 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.247 . . . . 1.14 110.123 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -62.48 -38.07 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.161 . . . . 2.3 110.012 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.37 -44.27 84.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.097 -1.002 . . . . 3.11 108.872 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.16 -47.59 85.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.905 . . . . 2.25 110.198 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.3 mt -59.93 -49.98 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.012 . . . . 1.26 110.94 -178.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtm -66.78 -40.03 88.02 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.767 -1.208 . . . . 1.17 109.771 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -70.32 -43.05 71.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.971 -1.08 . . . . 1.17 110.677 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.535 ' NH1' ' CE1' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -69.96 -40.0 75.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.863 -1.148 . . . . 3.48 109.516 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' NH1' ' A' ' 37' ' ' ARG . 62.7 m-85 -127.81 78.17 75.39 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.307 -0.87 . . . . 2.43 109.44 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.68 -7.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.754 2.303 . . . . 1.69 112.434 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.526 ' H ' ' C ' ' A' ' 38' ' ' PHE . 40.3 t80 -59.92 -39.3 85.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 4.68 109.4 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' ASN . 78.6 m-85 -69.81 -20.96 63.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 1.91 110.943 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -59.99 -39.76 86.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.593 -1.317 . . . . 3.01 108.758 179.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -77.91 -9.46 59.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 2.34 109.95 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.504 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 82.9 m-20 -129.27 116.9 19.83 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 2.6 110.237 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 46' ' ' GLN . 67.0 mttm -109.99 11.73 23.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.717 -0.845 . . . . 2.25 108.717 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 48' ' ' TRP . 95.8 mm-40 -48.24 177.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.001 0.905 . . . . 4.59 111.857 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 49' ' ' GLN . . . -42.28 -15.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 CA-C-N 115.779 -0.646 . . . . 1.34 111.509 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' N ' ' O ' ' A' ' 46' ' ' GLN . 9.2 p-90 -51.18 -20.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.514 -1.58 . . . . 0.57 107.893 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' A' ' 47' ' ' GLY . 30.1 tt0 -86.37 -57.13 3.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.28 -0.637 . . . . 2.03 109.28 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.9 -33.96 72.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 2.01 109.589 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.1 m -60.04 -39.95 87.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.99 108.929 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.5 mm -60.13 -49.88 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.539 -0.725 . . . . 1.28 109.65 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -61.9 -44.54 96.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.968 -1.083 . . . . 3.38 108.768 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -60.01 -41.48 92.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.295 -0.878 . . . . 3.09 108.88 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -63.89 -40.1 95.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.567 -0.708 . . . . 2.59 109.341 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.99 -47.81 84.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.12 -0.987 . . . . 1.29 109.691 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.4 m -62.6 -40.13 95.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 2.04 109.164 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 tt -65.84 -50.39 64.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.859 -0.525 . . . . 1.92 110.16 -178.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -69.98 117.47 11.6 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.844 -1.142 . . . . 1.83 108.724 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -90.1 -2.47 58.1 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.476 -0.935 . . . . 2.17 108.476 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.1 m -60.08 -39.12 84.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.254 -0.647 . . . . 1.92 109.254 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.29 150.31 33.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.358 -0.839 . . . . 2.22 109.418 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.0 t -110.7 125.87 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.447 -0.783 . . . . 1.48 109.464 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 139.83 51.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.957 -1.127 . . . . 2.29 107.957 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.09 77.36 61.81 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.201 -0.937 . . . . 1.95 109.366 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.306 -1.697 0 C-N-CA 122.459 2.106 . . . . 2.11 111.557 179.276 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 108.551 -0.907 . . . . 2.3 108.551 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -138.37 149.96 46.09 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.281 -0.887 . . . . 0.55 109.511 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -157.23 159.34 37.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.005 . . . . 1.2 110.003 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.502 -0.925 . . . . 1.44 108.502 179.225 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 N--CA 1.495 1.575 0 N-CA-C 111.618 -0.185 . . . . 1.18 111.618 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.26 4.37 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.481 2.121 . . . . 1.18 113.285 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -82.17 135.89 35.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.718 -1.239 . . . . 1.92 109.136 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -71.72 162.54 29.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 1.92 108.634 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -59.67 -39.9 85.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.93 -1.106 . . . . 2.23 108.629 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.43 -39.98 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 1.66 108.981 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.15 87.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.85 . . . . 1.1 109.884 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.05 -41.68 92.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.884 -1.135 . . . . 1.14 108.792 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.2 mt -70.0 -41.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.372 -0.83 . . . . 1.2 109.663 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -60.41 -42.53 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 1.17 109.448 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.5 mtm -69.92 -36.83 75.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.402 -0.811 . . . . 1.77 109.839 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.5 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 1.09 109.494 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.4 mt -59.98 -49.94 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.39 -0.967 . . . . 1.1 108.39 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.68 -39.95 93.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.447 -0.783 . . . . 2.34 109.324 179.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -80.48 3.82 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.806 . . . . 1.71 109.748 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 147.58 71.34 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 1.24 109.356 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 -20.68 57.46 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.851 1.701 . . . . 1.64 110.041 179.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.25 149.6 36.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.843 -1.169 . . . . 2.63 107.843 178.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -60.6 -39.89 89.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 2.55 110.297 -178.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.86 124.78 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.111 . . . . 2.13 109.017 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.8 tt -138.83 142.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -0.824 . . . . 1.18 109.394 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.4 p -79.89 157.92 26.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.362 -0.836 . . . . 1.4 109.223 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -60.01 -40.23 88.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 1.39 109.392 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -60.03 -41.94 93.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 2.03 110.57 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 -38.56 96.31 Favored Glycine 0 N--CA 1.494 2.516 0 O-C-N 121.193 -0.942 . . . . 0.32 111.203 -178.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.423 HG23 HD11 ' A' ' 30' ' ' ILE . 94.7 mt -59.97 -40.02 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.256 . . . . 1.14 109.79 -179.001 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 33.3 m-85 -59.96 -39.95 87.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.11 -0.994 . . . . 2.3 110.029 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -59.68 -40.01 86.43 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.367 -0.833 . . . . 3.11 110.137 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -60.52 -40.36 91.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 2.25 109.896 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.44 -61.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.107 -0.996 . . . . 1.26 110.624 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.5 mtm -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 1.17 110.446 -178.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.14 -40.12 92.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 1.17 110.471 -179.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -89.17 -55.77 3.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.021 -1.049 . . . . 3.48 110.063 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -96.05 112.47 59.63 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.973 -1.079 . . . . 2.43 108.688 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.96 -7.44 14.32 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.815 1.677 . . . . 1.69 111.884 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.01 -40.06 87.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.773 . . . . 4.68 110.229 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -70.98 -13.13 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 1.91 110.874 -178.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.1 mmm180 -59.99 -40.03 87.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 3.01 110.735 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.32 0.08 55.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 2.34 110.339 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.514 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 68.7 m-80 -133.96 108.55 8.46 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.763 -0.829 . . . . 2.6 108.763 179.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 42' ' ' ARG . 61.1 mttp -111.97 -29.97 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.681 -0.637 . . . . 2.25 110.051 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -90.66 139.42 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 4.59 109.781 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.27 -64.19 0.31 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.435 -1.066 . . . . 1.34 110.435 179.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.514 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 23.1 p-90 -77.05 -20.06 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.316 . . . . 0.57 110.478 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.623 ' NE2' ' NH2' ' A' ' 53' ' ' ARG . 66.7 tt0 -62.29 -52.3 64.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 2.03 110.628 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -68.97 -35.06 76.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 2.01 110.194 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 1.99 109.746 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mm -60.91 -45.99 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 1.28 110.25 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.623 ' NH2' ' NE2' ' A' ' 49' ' ' GLN . 41.7 mtt180 -69.52 -40.12 77.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.951 -1.093 . . . . 3.38 109.888 -178.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -60.14 -40.15 88.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 3.09 108.765 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 95.2 m-20 -61.85 -39.95 93.63 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.54 -0.911 . . . . 2.59 108.54 179.39 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.0 -40.02 75.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 1.29 110.267 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.5 p -74.56 -44.88 48.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 2.04 110.495 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.65 -39.9 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 1.92 110.214 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 96.1 m-20 -66.19 120.3 12.99 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.297 -1.001 . . . . 1.83 108.297 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 25.7 mp0 -87.81 -10.97 49.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.272 -0.893 . . . . 2.17 109.361 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m -64.14 -40.01 95.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.451 -0.78 . . . . 1.92 109.926 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -79.6 127.93 32.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 2.22 109.736 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.37 124.72 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.454 -0.943 . . . . 1.48 108.454 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -94.15 150.66 20.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.012 . . . . 2.29 110.511 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.97 86.62 25.96 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 107.722 -1.214 . . . . 1.95 107.722 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo . . . . . 0 N--CA 1.493 1.485 0 C-N-CA 122.618 2.212 . . . . 2.11 113.694 -178.834 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.418 -0.586 . . . . 2.3 109.418 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -120.05 139.36 52.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.536 -0.727 . . . . 0.55 109.458 179.304 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 t -150.65 167.52 27.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 1.2 109.168 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 1.44 109.495 179.751 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 120.645 0.185 . . . . 1.18 111.967 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.7 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.486 2.124 . . . . 1.18 112.51 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -66.9 131.78 46.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.882 -1.136 . . . . 1.92 108.944 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -72.08 162.99 28.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 1.92 108.906 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -60.01 -33.93 72.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 2.23 108.561 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.8 -40.03 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.401 -0.962 . . . . 1.66 108.401 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.16 90.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 1.1 110.105 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.99 -39.99 87.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.071 -1.018 . . . . 1.14 108.368 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.08 -40.11 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.377 -0.827 . . . . 1.2 108.867 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -67.92 -40.33 83.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 1.17 110.641 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.02 -37.43 75.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 1.77 109.985 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.34 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 1.09 109.761 -179.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.01 -47.38 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 1.1 108.867 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . 0.495 ' NE2' ' HZ3' ' A' ' 23' ' ' LYS . 98.7 mm-40 -68.43 -40.04 81.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 2.34 110.004 -179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -74.71 -13.26 60.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.858 . . . . 1.71 110.387 -179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.9 150.21 74.88 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.996 . . . . 1.24 109.665 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.4 -41.6 15.26 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.019 1.812 . . . . 1.64 110.414 179.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.03 132.57 56.36 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.445 -1.317 . . . . 2.63 107.445 178.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HZ3' ' NE2' ' A' ' 18' ' ' GLN . 68.5 mttm -69.0 -21.57 64.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 2.55 109.981 -178.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.86 33.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 2.13 109.226 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.442 ' H ' ' C ' ' A' ' 23' ' ' LYS . 16.0 tt -56.87 154.54 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 1.18 109.469 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.642 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 69.3 p -79.97 162.43 24.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 1.4 110.152 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.99 -50.01 75.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.481 -0.933 . . . . 1.39 108.481 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -60.51 -39.98 89.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.579 -0.701 . . . . 2.03 110.306 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.642 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -54.14 -38.55 61.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.32 109.389 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.24 -41.54 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -1.172 . . . . 1.14 109.741 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -60.0 -43.35 95.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.12 -0.987 . . . . 2.3 109.952 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -59.99 -40.01 87.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.375 -0.828 . . . . 3.11 109.743 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.03 -45.54 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.794 . . . . 2.25 110.001 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.66 -49.95 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 1.26 110.711 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.04 -42.86 99.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 1.17 111.03 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.1 -40.13 75.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 1.17 111.148 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -70.08 -40.23 75.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.908 -1.12 . . . . 3.48 109.88 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.13 117.49 31.99 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 107.986 -1.116 . . . . 2.43 107.986 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.76 -9.48 17.02 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.838 1.692 . . . . 1.69 112.463 -178.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -59.97 -39.56 86.07 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 4.68 108.999 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.08 -26.54 64.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.569 -0.707 . . . . 1.91 110.559 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -59.99 -33.59 72.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.927 -1.108 . . . . 3.01 108.796 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.01 9.98 33.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 2.34 109.532 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.503 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 60.3 t30 -139.04 125.6 20.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.357 -0.84 . . . . 2.6 109.813 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -124.48 15.14 8.89 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.739 -0.838 . . . . 2.25 108.739 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 48' ' ' TRP . 91.7 mm-40 -61.18 -169.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.142 0.972 . . . . 4.59 112.085 -177.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.05 -8.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 CA-C-N 115.669 -0.696 . . . . 1.34 111.633 -178.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -60.02 -27.7 67.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.476 -1.602 . . . . 0.57 107.947 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -70.04 -58.45 3.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.729 . . . . 2.03 110.947 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -61.79 -39.97 93.58 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 2.01 110.97 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.0 t -56.95 -32.08 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 1.99 110.833 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.09 -57.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.93 -1.106 . . . . 1.28 111.342 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.59 -29.07 28.07 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.736 -1.227 . . . . 3.38 110.359 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.05 -40.02 87.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 3.09 109.633 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -69.42 -24.11 63.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 2.59 110.525 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.96 -40.03 91.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 1.29 109.494 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -60.9 -48.07 83.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 2.04 110.142 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 8.7 mp -68.29 -40.09 81.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 1.92 109.348 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -79.91 113.58 18.18 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.185 -0.947 . . . . 1.83 109.022 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.88 1.17 56.52 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.602 -0.888 . . . . 2.17 108.602 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.04 -36.91 78.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.681 -0.637 . . . . 1.92 109.4 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -78.51 161.44 27.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 2.22 109.583 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.63 130.06 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.543 -0.723 . . . . 1.48 109.636 -179.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -86.96 127.02 35.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 2.29 109.967 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -132.38 71.74 79.0 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 108.581 -0.896 . . . . 1.95 108.581 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 81.1 Cg_exo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.65 2.233 . . . . 2.11 112.272 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 5.7 m-30 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.001 -0.74 . . . . 2.3 109.001 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -134.51 143.13 47.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 0.55 109.67 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -149.54 166.19 29.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.132 -0.98 . . . . 1.2 109.208 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.181 -0.949 . . . . 1.44 109.971 -179.312 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 N--CA 1.492 1.408 0 CA-C-O 120.577 0.157 . . . . 1.18 112.078 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.69 10.06 3.48 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.472 2.115 . . . . 1.18 112.7 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -85.16 140.26 31.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.888 -1.133 . . . . 1.92 109.572 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.7 p -80.04 170.38 16.54 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -0.815 . . . . 1.92 108.872 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -60.0 -40.15 88.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.109 -0.994 . . . . 2.23 109.154 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.8 mm -61.09 -48.07 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.812 . . . . 1.66 109.002 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.47 98.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 1.1 110.295 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.93 -44.01 94.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.939 -1.101 . . . . 1.14 109.189 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.01 -39.98 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 1.2 109.264 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.93 -40.54 97.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 1.17 109.821 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.6 mtm -70.04 -36.57 75.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.872 . . . . 1.77 109.335 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.97 89.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.326 -0.859 . . . . 1.09 109.658 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.0 -50.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.078 -1.014 . . . . 1.1 109.983 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.95 -37.96 76.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.717 -0.614 . . . . 2.34 110.46 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.83 -1.5 25.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 1.71 110.085 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.19 147.91 73.71 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.079 -1.013 . . . . 1.24 109.528 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.02 -19.57 57.62 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.8 1.667 . . . . 1.64 109.9 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -130.71 138.26 49.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.143 -1.428 . . . . 2.63 107.143 178.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -60.0 -39.97 87.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.943 -1.098 . . . . 2.55 109.156 -178.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -79.3 130.79 35.8 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.181 -0.949 . . . . 2.13 108.719 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.06 148.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 1.18 109.473 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.7 p -83.62 167.05 17.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 1.4 110.148 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.94 -49.72 76.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.077 -1.083 . . . . 1.39 108.077 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.08 -40.02 88.11 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.986 -0.552 . . . . 2.03 110.392 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.91 94.52 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.384 -1.086 . . . . 0.32 110.384 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.11 -43.39 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.043 -1.269 . . . . 1.14 109.645 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.458 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 34.6 m-85 -60.02 -40.0 87.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.963 -1.086 . . . . 2.3 110.821 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.95 -42.72 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.899 -1.126 . . . . 3.11 110.74 -178.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.98 -48.56 81.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 2.25 111.414 -179.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.93 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.097 . . . . 1.26 111.401 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 mtm -59.99 -46.14 90.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 1.17 110.673 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.09 -39.89 75.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.885 -1.134 . . . . 1.17 110.064 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -69.09 -39.97 78.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 3.48 110.378 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.537 ' C ' ' H ' ' A' ' 40' ' ' PHE . 67.3 m-85 -131.34 80.04 68.7 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 2.43 110.148 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -45.72 -9.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.698 2.265 . . . . 1.69 112.02 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.537 ' H ' ' C ' ' A' ' 38' ' ' PHE . 31.5 t80 -60.06 -39.93 87.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.464 -0.773 . . . . 4.68 109.833 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -68.2 -20.76 64.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 1.91 110.904 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.402 ' HG2' ' NH1' ' A' ' 42' ' ' ARG . 61.5 mtt-85 -60.03 -40.08 88.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.817 -1.177 . . . . 3.01 109.532 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.38 -40.12 96.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 2.34 110.132 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -105.82 106.08 16.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.813 -0.554 . . . . 2.6 109.795 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 66.8 mttm -97.38 -39.69 9.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.245 -0.909 . . . . 2.25 110.533 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.81 145.8 31.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 4.59 109.894 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.2 -72.64 0.28 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.748 -0.941 . . . . 1.34 110.748 179.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 20.2 p-90 -69.99 -23.94 63.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.016 -1.285 . . . . 0.57 111.438 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.458 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 57.5 tt0 -60.08 -50.47 73.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.668 -1.27 . . . . 2.03 111.407 -178.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -73.84 -33.56 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.778 -1.201 . . . . 2.01 111.32 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.3 p -59.9 -36.37 76.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 1.99 110.757 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.04 -49.85 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.938 -1.101 . . . . 1.28 110.314 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -70.08 -39.38 75.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.222 -0.924 . . . . 3.38 110.622 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -60.02 -39.86 87.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.029 -1.044 . . . . 3.09 108.514 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.051 -1.092 . . . . 2.59 108.051 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.72 -40.05 88.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.49 -0.757 . . . . 1.29 109.646 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.617 ' HG ' ' H ' ' A' ' 58' ' ' LEU . 88.8 p -75.01 -49.3 20.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.091 -1.005 . . . . 2.04 109.99 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.617 ' H ' ' HG ' ' A' ' 57' ' ' SER . 33.3 mt -64.17 -40.19 95.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 1.92 109.274 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . 0.448 ' OD1' ' SG ' ' A' ' 61' ' ' CYS . 8.9 t-20 -83.95 116.93 23.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.402 -0.962 . . . . 1.83 108.402 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.94 1.75 54.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 2.17 109.94 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . 0.448 ' SG ' ' OD1' ' A' ' 59' ' ' ASN . 96.8 m -59.97 -39.96 87.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 1.92 108.638 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -78.95 146.14 33.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 2.22 108.976 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.15 129.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.419 -0.956 . . . . 1.48 108.419 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.25 139.08 57.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 2.29 109.905 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.8 t -112.4 119.98 42.41 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.556 -0.905 . . . . 1.95 108.556 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 C--N 1.313 -1.338 0 C-N-CA 121.531 1.488 . . . . 2.11 112.268 -179.287 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.411 -0.588 . . . . 2.3 109.411 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -113.18 139.93 48.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.055 -0.72 . . . . 0.55 109.055 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 80' ' ' LEU . 15.2 t -143.1 160.69 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.189 -0.944 . . . . 1.2 109.862 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 79' ' ' THR . 81.7 mt . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 1.44 109.575 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.175 0.512 . . . . 5.19 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.6 mt -122.78 148.45 45.35 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.9 -0.778 . . . . 2.08 108.9 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.12 141.11 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.366 -0.834 . . . . 2.23 109.075 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -73.63 165.4 53.39 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 4.16 108.699 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' TYR . 1.8 Cg_endo -84.35 114.18 1.8 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.256 1.971 . . . . 1.18 112.194 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.41 -8.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.538 1.492 . . . . 1.18 111.558 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' PRO . 11.6 m-85 -68.76 138.85 55.18 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.863 . . . . 1.92 109.162 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 t -73.82 164.64 26.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.294 -0.878 . . . . 1.92 108.737 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -59.95 -39.13 84.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.138 -0.976 . . . . 2.23 108.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.8 mm -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 1.66 109.081 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.27 87.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 1.1 109.612 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.07 -43.75 95.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 1.14 108.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.03 -41.98 88.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 1.2 108.106 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -65.56 -40.05 92.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.54 -0.725 . . . . 1.17 110.357 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.595 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.6 mtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -0.967 . . . . 1.77 110.311 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.63 -42.61 75.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 1.09 110.034 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.46 -40.29 88.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.795 . . . . 1.1 109.243 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -66.6 -41.79 87.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.53 -0.731 . . . . 2.34 110.69 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 15' ' ' MET . 19.0 p30 -90.77 7.92 37.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.71 110.258 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.2 116.55 61.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 1.24 109.078 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -43.04 -26.76 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.461 1.441 . . . . 1.64 111.012 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -122.92 131.7 53.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.605 -1.258 . . . . 2.63 107.605 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -60.07 -40.0 88.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.842 -1.161 . . . . 2.55 108.718 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.99 117.76 25.04 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.754 -1.202 . . . . 2.13 107.754 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.85 145.68 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.714 . . . . 1.18 109.46 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.438 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 26.4 p -79.55 162.38 25.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.387 -0.82 . . . . 1.4 109.996 -179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.02 -43.33 95.32 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.15 -1.055 . . . . 1.39 108.15 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.46 -40.04 96.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.55 -0.719 . . . . 2.03 110.141 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.438 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -60.28 -38.46 94.61 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.528 -1.029 . . . . 0.32 110.528 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.96 -40.27 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -1.229 . . . . 1.14 109.752 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.564 ' OH ' ' NE ' ' A' ' 53' ' ' ARG . 24.7 m-85 -60.34 -42.81 96.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.605 -1.309 . . . . 2.3 109.571 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.98 -41.32 91.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 3.11 110.658 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 63.3 t80 -59.99 -49.08 79.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.922 -1.111 . . . . 2.25 110.278 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.01 -40.0 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 1.26 110.566 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.1 mtt -60.82 -44.05 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.859 -1.151 . . . . 1.17 110.1 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.99 -52.08 13.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 1.17 110.721 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -60.06 -46.72 88.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 3.48 109.2 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -122.77 109.52 32.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.561 -0.903 . . . . 2.43 108.561 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.88 -7.55 12.3 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.146 1.897 . . . . 1.69 113.172 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -59.93 -34.33 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.963 -1.086 . . . . 4.68 108.851 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' ASN . 90.4 m-85 -66.2 -26.93 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 1.91 110.658 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -60.04 -38.96 84.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.872 -1.143 . . . . 3.01 109.342 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.04 -39.79 87.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.059 . . . . 2.34 108.721 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.9 m-20 -118.06 105.02 11.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.282 -0.636 . . . . 2.6 109.282 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.455 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 93.5 mttt -90.88 -59.86 2.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 2.25 110.689 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -69.65 140.02 53.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.509 -0.745 . . . . 4.59 110.21 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.9 -59.86 0.45 Allowed Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.221 -1.151 . . . . 1.34 110.221 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.455 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 51.0 p-90 -82.32 -28.92 31.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.263 . . . . 0.57 110.671 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -64.88 -41.11 95.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.937 -1.102 . . . . 2.03 110.06 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -39.53 75.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.388 -0.82 . . . . 2.01 111.695 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.711 -1.243 . . . . 1.99 110.183 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -60.02 -40.05 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 1.28 109.715 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.564 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 20.3 mtt180 -67.22 -37.3 83.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.054 . . . . 3.38 109.504 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.0 -44.18 94.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.829 . . . . 3.09 109.587 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -68.79 -38.61 80.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 2.59 109.419 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.59 59.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 1.29 110.241 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -172.55 -55.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.328 -0.99 . . . . 2.04 108.328 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.58 -39.95 84.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.561 -0.903 . . . . 1.92 108.561 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -71.45 123.36 22.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -0.846 . . . . 1.83 108.727 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -90.06 0.01 57.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.447 -0.783 . . . . 2.17 109.526 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.8 -40.05 94.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 1.92 109.769 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -79.05 150.37 31.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 2.22 109.712 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.481 ' CG2' ' O ' ' A' ' 81' ' ' ASP . 60.6 t -118.67 127.32 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.874 -0.787 . . . . 1.48 108.874 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -92.4 125.0 36.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 2.29 108.525 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.07 79.4 73.02 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 108.91 -0.774 . . . . 1.95 108.91 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.01 151.75 83.07 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.478 2.119 . . . . 2.11 112.268 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -168.58 0.42 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.674 -1.232 . . . . 4.68 107.674 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -70.17 148.72 48.33 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.02 -1.05 . . . . 2.84 109.039 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.98 -20.75 63.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.018 -1.051 . . . . 3.46 109.678 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -60.12 -40.07 88.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 4.77 109.967 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -81.45 123.46 81.06 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 121.154 -0.966 . . . . 5.49 109.005 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -82.18 -157.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.957 1.771 . . . . 4.18 112.164 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.31 -124.07 21.71 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.264 -1.134 . . . . 3.73 110.264 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -62.74 141.46 58.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.535 -0.98 . . . . 4.74 109.796 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.75 36.92 0.9 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.021 -1.232 . . . . 2.52 110.021 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.9 m -156.44 134.75 11.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.032 -1.275 . . . . 2.24 110.31 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.46 155.58 48.28 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.513 -0.921 . . . . 2.3 108.513 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -126.53 134.81 50.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.55 109.233 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -159.01 164.35 35.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.16 -0.963 . . . . 1.2 109.779 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.04 122.1 34.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.189 -0.944 . . . . 1.44 109.423 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.481 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 3.5 m-20 -164.54 157.65 14.8 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 3.72 109.498 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.33 -162.31 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.211 1.941 . . . . 4.1 111.187 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -77.21 59.34 1.75 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.872 -1.158 . . . . 6.82 107.872 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.5 p -83.54 49.03 1.51 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.548 -0.72 . . . . 6.0 110.105 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -57.24 5.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.329 -0.857 . . . . 11.29 109.589 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.503 ' C ' ' H ' ' A' ' 88' ' ' PHE . 32.7 m120 -110.01 19.99 18.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.419 -0.801 . . . . 10.52 110.723 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.5 mmt -69.05 6.15 1.0 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.892 -1.13 . . . . 8.47 109.115 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.503 ' H ' ' C ' ' A' ' 86' ' ' ASN . 55.2 m-85 -60.01 -40.05 87.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 12.49 109.018 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 31.2 mp0 -102.67 139.65 37.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.582 -0.699 . . . . 11.95 109.238 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -129.18 151.85 49.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 12.64 109.428 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.14 -13.65 62.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.532 -1.827 . . . . 11.27 108.532 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.6 p -77.9 -19.97 53.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.549 -0.971 . . . . 11.98 109.01 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -135.82 145.72 46.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.526 -0.734 . . . . 11.29 109.404 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 108.487 -0.931 . . . . 13.39 108.487 179.732 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.352 0.596 . . . . 5.19 109.433 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.52 155.2 28.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 2.08 108.857 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.93 160.04 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.446 -0.784 . . . . 2.23 109.281 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -59.63 120.88 53.04 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.114 -0.991 . . . . 4.16 109.156 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.66 155.57 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.768 1.645 . . . . 1.18 111.848 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.16 1.31 6.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.409 2.072 . . . . 1.18 112.095 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -81.03 133.12 35.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 1.92 109.47 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -69.35 167.2 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.215 -0.928 . . . . 1.92 108.567 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -59.92 -39.98 87.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 2.23 109.041 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.414 HG23 HD12 ' A' ' 10' ' ' ILE . 87.9 mt -65.83 -41.05 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 1.66 110.226 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.8 94.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 1.1 110.344 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.85 -40.12 87.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 1.14 109.079 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 86.5 mt -69.9 -40.0 78.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.223 -0.923 . . . . 1.2 109.391 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -64.28 -40.91 96.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 1.17 109.726 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 73.5 mtm -70.02 -36.93 75.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 1.77 109.474 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.85 84.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 1.09 109.35 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.8 mt -60.08 -50.0 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 1.1 108.856 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -61.72 -40.06 93.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.288 0.566 . . . . 2.34 109.995 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -79.99 -10.07 59.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 1.71 110.379 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 131.48 67.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 1.24 109.488 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.06 -38.93 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.411 1.407 . . . . 1.64 110.896 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -120.03 134.63 55.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.149 -1.056 . . . . 2.63 108.149 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.97 -34.41 73.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.04 -1.038 . . . . 2.55 110.034 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.97 113.91 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.78 -1.2 . . . . 2.13 108.297 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.5 tt -130.01 160.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 1.18 109.445 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.9 p -90.37 165.77 13.67 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.9 0.857 . . . . 1.4 110.714 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 14.3 tp -60.1 -50.02 75.37 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.056 0.932 . . . . 1.39 108.64 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.39 -39.97 94.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.286 0.565 . . . . 2.03 110.208 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.05 96.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.433 -1.067 . . . . 0.32 110.433 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -60.09 -42.04 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.029 -1.277 . . . . 1.14 109.64 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.402 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 34.7 m-85 -59.89 -40.85 90.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.746 -1.221 . . . . 2.3 109.959 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.1 -42.24 94.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 3.11 110.135 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.98 -49.01 79.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 2.25 110.718 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.17 -49.98 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 1.26 111.497 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.7 mtm -60.26 -49.98 75.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.664 -1.273 . . . . 1.17 110.269 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -68.91 -39.99 79.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 1.17 109.539 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -66.17 -49.75 66.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 3.48 109.678 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -119.38 120.19 31.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.594 -0.691 . . . . 2.43 109.301 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.39 -7.49 14.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.863 1.709 . . . . 1.69 112.248 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -60.01 -40.93 90.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.4 -0.812 . . . . 4.68 110.234 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.77 -27.76 67.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 1.91 110.722 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -58.23 -26.04 62.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.045 -1.035 . . . . 3.01 109.436 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.78 1.76 54.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.03 -1.043 . . . . 2.34 110.103 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.536 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 53.4 t30 -147.68 102.36 3.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.393 -0.817 . . . . 2.6 109.278 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -89.16 -64.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 2.25 110.963 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -69.93 144.03 52.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 4.59 110.074 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.44 -58.41 0.4 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.76 -1.336 . . . . 1.34 109.76 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 29.4 p-90 -89.98 -11.66 40.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.25 . . . . 0.57 110.374 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.402 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 56.3 tt0 -68.69 -55.96 9.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 2.03 110.498 -178.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -70.05 -31.52 69.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 2.01 110.58 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.1 p -59.83 -40.44 88.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.052 -1.03 . . . . 1.99 110.81 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mm -60.05 -50.94 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.859 -1.151 . . . . 1.28 110.379 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 46.6 mtp180 -69.97 -37.92 75.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.074 -1.016 . . . . 3.38 110.182 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -59.93 -40.09 87.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 3.09 110.606 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 26.3 p30 -69.99 -18.33 63.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.943 -1.098 . . . . 2.59 110.567 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.431 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 85.6 mt -66.4 -40.09 89.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.794 -1.191 . . . . 1.29 111.115 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -70.04 -48.43 57.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.898 -1.126 . . . . 2.04 110.756 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.2 -39.98 96.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 1.92 110.658 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 76.1 m-20 -76.02 112.96 13.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 1.83 110.069 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.24 -5.95 55.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 2.17 109.484 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -62.82 -35.05 78.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 1.92 110.199 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -78.72 152.53 31.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 2.22 109.618 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 1.48 109.567 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -81.93 149.64 28.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 2.29 110.098 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.12 128.69 14.31 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.625 -0.88 . . . . 1.95 108.625 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.16 -178.16 3.41 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.441 1.427 . . . . 2.11 111.675 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.43 ' NE ' ' OH ' ' A' ' 77' ' ' TYR . 52.4 mtp180 -110.88 160.72 16.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 4.68 109.44 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -61.72 158.06 16.44 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.452 -0.78 . . . . 2.84 109.007 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.44 -21.47 62.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 3.46 110.023 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -60.06 -41.44 92.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.983 . . . . 4.77 109.321 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.547 ' CD ' ' N ' ' A' ' 71' ' ' LYS . 9.6 mptt -84.56 148.16 51.28 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.428 -0.953 . . . . 5.49 108.428 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.15 1.75 6.3 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.955 1.77 . . . . 4.18 112.168 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.49 54.26 3.17 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.771 -1.331 . . . . 3.73 109.771 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -60.0 -40.05 87.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -1.176 . . . . 4.74 108.616 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.88 175.94 42.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.813 -1.715 . . . . 2.52 108.813 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.3 p -100.42 136.17 40.71 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.085 -1.244 . . . . 2.24 109.663 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.43 ' OH ' ' NE ' ' A' ' 67' ' ' ARG . 10.0 m-85 -69.9 158.85 34.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.92 -1.112 . . . . 2.3 108.014 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -120.75 134.38 55.29 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.591 0.71 . . . . 0.55 110.155 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.64 ' HG1' ' H ' ' A' ' 80' ' ' LEU . 8.8 t -153.48 170.75 19.98 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.911 -0.774 . . . . 1.2 108.911 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.64 ' H ' ' HG1' ' A' ' 79' ' ' THR . 51.6 mt -97.0 121.07 38.48 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.062 -1.024 . . . . 1.44 110.203 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -137.1 82.87 29.12 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 107.83 -1.174 . . . . 3.72 107.83 179.085 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 81' ' ' ASP . 69.2 Cg_exo -50.86 -137.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.228 2.619 . . . . 4.1 113.568 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -73.45 60.16 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.974 -1.079 . . . . 6.82 108.967 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 t -60.04 -33.93 72.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.77 -0.826 . . . . 6.0 108.77 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.04 -39.96 87.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.369 -0.832 . . . . 11.29 109.555 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -86.36 23.48 1.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.174 -0.954 . . . . 10.52 110.59 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.438 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 3.5 mmt -73.65 95.57 2.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.93 -1.106 . . . . 8.47 109.125 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -88.87 -17.49 29.53 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.099 -1.074 . . . . 12.49 108.099 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -78.7 160.06 27.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.506 -0.746 . . . . 11.95 109.138 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -68.79 130.82 43.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 12.64 109.674 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 167.38 -120.7 0.92 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.834 -1.307 . . . . 11.27 109.834 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.4 t -73.42 -11.67 60.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -1.093 . . . . 11.98 109.689 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 87' ' ' MET . 77.6 t80 -59.97 -40.02 87.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 11.29 111.094 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 120.715 -1.241 . . . . 13.39 109.706 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.82 0.819 . . . . 5.19 109.266 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.2 mt -82.27 159.8 23.09 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.965 -0.754 . . . . 2.08 108.965 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.0 160.06 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.464 -0.773 . . . . 2.23 109.014 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -56.79 113.96 7.03 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 4.16 109.027 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -45.58 160.57 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.734 1.623 . . . . 1.18 111.839 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.8 4.22 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.412 2.075 . . . . 1.18 112.635 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -82.0 143.01 31.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.974 -1.079 . . . . 1.92 109.803 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 9' ' ' TYR . 27.5 t -75.05 160.2 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.528 -0.916 . . . . 1.92 108.528 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.531 ' N ' ' HG ' ' A' ' 8' ' ' SER . 89.0 m-85 -60.02 -39.95 87.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 2.23 108.682 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.3 mm -65.2 -40.05 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.741 -0.837 . . . . 1.66 108.741 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.72 89.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.958 . . . . 1.1 109.642 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.04 -43.14 95.53 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.025 -1.047 . . . . 1.14 108.656 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.32 -50.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 1.2 109.452 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -61.39 -40.01 92.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 1.17 110.015 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.498 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 74.9 mtp -69.88 -38.48 76.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.431 -0.793 . . . . 1.77 109.967 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.03 -42.22 93.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 1.09 110.032 -179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.31 -49.98 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 1.1 109.588 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.73 -40.02 76.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.722 -0.611 . . . . 2.34 109.959 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 15' ' ' MET . 68.3 m-80 -76.95 -9.92 59.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.85 . . . . 1.71 110.229 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.75 137.67 54.42 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.088 -1.007 . . . . 1.24 109.454 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.81 -65.19 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.867 1.712 . . . . 1.64 110.858 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -99.81 137.84 37.72 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 2.63 107.684 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -62.43 -28.73 70.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.833 -1.167 . . . . 2.55 109.204 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -79.7 98.3 6.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.136 -0.977 . . . . 2.13 108.569 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -119.66 149.68 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.257 -0.646 . . . . 1.18 109.257 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -79.91 161.55 25.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 1.4 110.273 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.9 tp -59.99 -47.25 86.6 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.686 -0.857 . . . . 1.39 108.686 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -59.97 -39.8 86.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.933 -0.766 . . . . 2.03 108.933 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.55 -39.95 95.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.744 -0.942 . . . . 0.32 110.744 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.04 -40.99 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.735 -1.45 . . . . 1.14 109.931 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.445 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 50.8 m-85 -61.59 -40.31 94.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 2.3 110.086 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.93 -40.68 89.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.17 -0.956 . . . . 3.11 109.881 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.49 -0.756 . . . . 2.25 110.744 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.8 -49.97 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.108 -0.995 . . . . 1.26 111.614 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.8 mtm -62.02 -39.98 94.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.1 -1.0 . . . . 1.17 111.398 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 93.1 m-20 -63.76 -51.67 63.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.746 -1.221 . . . . 1.17 112.071 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -74.86 -24.9 58.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.71 -1.244 . . . . 3.48 111.25 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.527 ' C ' ' H ' ' A' ' 40' ' ' PHE . 71.7 m-85 -130.02 77.62 76.24 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.209 -0.932 . . . . 2.43 109.763 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.75 -7.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.735 2.29 . . . . 1.69 111.438 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.527 ' H ' ' C ' ' A' ' 38' ' ' PHE . 11.8 t80 -59.96 -40.44 89.02 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.416 -0.802 . . . . 4.68 109.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -69.92 -24.1 63.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 1.91 110.446 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 61.1 mtt-85 -60.01 -37.87 81.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 3.01 108.884 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.96 9.15 17.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 2.34 109.285 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.566 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 0.5 OUTLIER -138.5 120.47 15.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.418 -0.801 . . . . 2.6 109.428 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' N ' HD21 ' A' ' 44' ' ' ASN . 67.1 mttm -120.24 13.1 11.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.596 -0.89 . . . . 2.25 108.596 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.554 ' H ' ' ND2' ' A' ' 44' ' ' ASN . 27.1 mt-30 -59.91 -168.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.023 0.916 . . . . 4.59 111.438 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.15 -10.96 0.06 OUTLIER Glycine 0 N--CA 1.493 2.472 0 CA-C-N 115.997 -0.547 . . . . 1.34 112.257 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.566 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 4.7 p-90 -59.98 -38.87 83.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.726 . . . . 0.57 108.212 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.445 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 21.2 tt0 -60.03 -50.04 75.29 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.607 -0.683 . . . . 2.03 110.019 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -76.1 -33.95 59.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 2.01 111.369 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -59.92 -38.37 82.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 1.99 111.375 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.98 -51.48 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 1.28 111.37 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' N ' ' HH ' ' A' ' 31' ' ' TYR . 13.8 ptm180 -79.81 -29.44 40.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.652 -1.28 . . . . 3.38 110.483 -179.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.3 t60 -59.92 -42.0 92.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 3.09 109.161 179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -65.47 -39.98 92.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 2.59 109.566 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 41.4 mt -60.15 -45.44 93.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 1.29 110.542 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -63.33 -45.63 90.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.804 -1.185 . . . . 2.04 110.255 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 47.8 mt -69.95 -40.08 75.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.977 -1.077 . . . . 1.92 109.877 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -72.47 117.45 14.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 1.83 109.297 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -90.19 -2.73 58.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.46 -0.775 . . . . 2.17 109.376 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -60.72 -40.06 90.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 1.92 109.453 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -79.95 152.05 29.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 2.22 109.558 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.1 t -115.39 121.57 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.577 -0.702 . . . . 1.48 109.321 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -85.74 127.16 34.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 2.29 108.6 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.7 111.28 58.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 1.95 109.308 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.77 136.02 13.17 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.65 1.567 . . . . 2.11 111.931 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.7 ' H ' ' NE ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -77.11 159.97 29.38 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.208 -0.932 . . . . 4.68 108.968 179.459 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.67 156.76 22.62 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.42 -0.8 . . . . 2.84 109.309 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.91 -33.25 71.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 3.46 109.321 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -60.08 -32.54 71.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 4.77 109.203 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -77.25 126.03 85.65 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.127 -0.983 . . . . 5.49 109.006 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 73' ' ' GLY . 65.1 Cg_endo -84.06 12.55 2.98 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.991 1.794 . . . . 4.18 111.551 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 72' ' ' PRO . . . -43.47 168.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.821 -0.912 . . . . 3.73 110.821 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -82.94 -105.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.642 -0.917 . . . . 4.74 110.042 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.92 -179.35 52.66 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.229 -1.149 . . . . 2.52 110.229 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.2 p -79.89 160.69 25.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.491 -1.006 . . . . 2.24 109.589 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -89.45 153.84 20.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.01 -1.056 . . . . 2.3 109.628 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -111.19 137.13 49.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.695 -0.628 . . . . 0.55 109.976 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -145.25 159.75 42.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.859 . . . . 1.2 109.159 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.46 163.69 24.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 1.44 109.2 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 82' ' ' PRO . 4.8 p30 -59.35 158.55 19.58 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 3.72 109.064 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 81' ' ' ASP . 45.6 Cg_exo -55.12 -141.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.757 1.638 . . . . 4.1 112.329 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -81.96 45.38 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.983 . . . . 6.82 108.825 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -55.45 -24.93 33.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.452 -0.78 . . . . 6.0 109.031 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.68 -39.47 84.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.444 -0.785 . . . . 11.29 109.318 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -68.0 -19.92 64.97 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.192 -0.942 . . . . 10.52 108.676 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 69.0 mtt -90.56 109.24 20.4 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.116 -0.698 . . . . 8.47 109.116 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -69.01 -40.97 78.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.928 -1.107 . . . . 12.49 108.358 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -143.22 154.67 44.08 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.229 -1.026 . . . . 11.95 108.229 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -60.05 141.71 55.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.738 -1.226 . . . . 12.64 109.055 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.57 -7.88 80.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.992 -1.643 . . . . 11.27 108.992 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 94' ' ' LEU . 39.6 t -60.86 -38.2 84.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -1.069 . . . . 11.98 109.522 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 93' ' ' PHE . 55.3 t80 -46.46 -13.76 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.426 -0.796 . . . . 11.29 109.695 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 92' ' ' SER . 64.9 tp . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 13.39 110.161 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mtm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.099 -0.704 . . . . 5.19 109.099 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.3 mt -76.34 158.29 31.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.148 -0.97 . . . . 2.08 109.139 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -108.29 144.98 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.424 -0.798 . . . . 2.23 109.895 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -69.95 149.97 96.38 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.887 . . . . 4.16 109.102 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.12 160.17 36.66 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.182 1.922 . . . . 1.18 112.309 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.27 28.79 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.862 2.375 . . . . 1.18 113.267 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -109.5 134.01 52.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.019 -1.05 . . . . 1.92 108.819 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 174.59 11.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 1.92 108.97 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -59.96 -35.93 76.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 2.23 109.908 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.67 -40.01 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 1.66 110.339 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.0 77.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.938 -1.101 . . . . 1.1 110.887 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.05 -39.94 87.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.907 -1.12 . . . . 1.14 108.623 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 88.9 mt -67.74 -39.97 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.498 -0.751 . . . . 1.2 109.274 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -66.08 -40.07 90.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 1.17 110.755 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.8 mtm -69.91 -39.96 75.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 1.77 109.771 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.21 80.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.441 -0.787 . . . . 1.09 109.4 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 1.1 108.902 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -60.72 -40.08 90.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.695 -0.628 . . . . 2.34 110.15 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -69.91 -17.51 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 1.71 109.568 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.95 148.3 71.76 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 1.24 109.718 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.97 -51.68 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.87 1.713 . . . . 1.64 109.724 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -99.11 139.93 34.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.276 -1.379 . . . . 2.63 107.276 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -67.51 -27.26 66.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.975 -1.078 . . . . 2.55 109.796 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -78.68 115.85 18.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.023 -1.048 . . . . 2.13 108.932 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.17 154.31 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 1.18 109.397 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.2 p -80.11 153.56 28.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 1.4 109.776 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 tp -60.04 -44.28 94.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 1.39 109.288 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.27 -40.08 89.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 2.03 110.427 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.66 97.5 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.14 -1.029 . . . . 0.32 111.011 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.02 -42.28 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.276 . . . . 1.14 110.243 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -60.15 -41.95 93.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.965 -1.085 . . . . 2.3 110.202 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.31 -40.38 90.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.351 -0.843 . . . . 3.11 110.069 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.09 -44.69 96.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 2.25 110.285 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.93 -50.15 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.203 -0.935 . . . . 1.26 110.663 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -62.94 -39.91 96.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.063 -1.023 . . . . 1.17 109.365 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.87 -39.94 76.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 1.17 109.78 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -72.18 -50.52 27.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 3.48 109.434 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -115.16 114.1 43.48 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.782 -0.822 . . . . 2.43 108.782 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.11 -3.8 13.78 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.862 1.708 . . . . 1.69 112.036 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.618 -0.882 . . . . 4.68 108.618 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -70.0 -21.52 63.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -0.754 . . . . 1.91 111.142 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.9 -40.02 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.48 -1.388 . . . . 3.01 109.317 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -61.0 -43.69 98.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.011 . . . . 2.34 109.492 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' TYR . 54.3 t30 -109.39 109.49 20.36 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.986 -0.746 . . . . 2.6 108.986 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 97.9 mttt -102.7 -37.7 7.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 2.25 110.602 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -89.03 139.16 30.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 4.59 110.344 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.58 -66.79 0.23 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.291 . . . . 1.34 109.871 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.413 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 24.7 p-90 -71.32 -37.95 71.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.57 110.744 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.94 -50.05 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 2.03 111.162 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -74.52 -25.54 59.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.843 -1.16 . . . . 2.01 110.583 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 t -60.02 -41.24 91.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.105 -0.997 . . . . 1.99 110.282 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.1 mt -65.74 -40.82 88.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.255 -0.903 . . . . 1.28 110.544 -179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -60.02 -44.08 94.85 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.334 -1.479 . . . . 3.38 108.607 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.697 -0.853 . . . . 3.09 108.697 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -68.44 -39.99 81.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 2.59 110.235 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.75 -40.13 91.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.052 -1.03 . . . . 1.29 110.048 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 t -64.76 -49.68 69.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.883 . . . . 2.04 110.512 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.98 -32.06 70.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.92 109.971 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -74.79 112.21 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 1.83 109.724 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.78 0.0 57.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.4 -0.813 . . . . 2.17 109.692 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.3 p -69.98 -21.37 63.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.983 -1.073 . . . . 1.92 109.727 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.22 153.25 21.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 2.22 109.789 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 81' ' ' ASP . 61.0 t -114.38 124.79 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 1.48 109.62 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -80.0 159.95 26.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 2.29 108.602 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.19 77.53 24.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.002 -1.061 . . . . 1.95 109.585 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.25 124.15 10.03 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.662 2.241 . . . . 2.11 112.241 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' NH1' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -79.07 -161.38 0.3 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.24 -0.913 . . . . 4.68 109.093 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 38.5 p-10 -62.01 142.28 57.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.048 -1.032 . . . . 2.84 110.344 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -69.93 -21.13 63.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 3.46 109.102 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -60.01 -39.96 87.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 4.77 109.885 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -134.1 82.27 48.69 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.322 -0.862 . . . . 5.49 109.285 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -86.32 13.48 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.862 2.375 . . . . 4.18 111.96 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.07 96.83 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.718 -0.953 . . . . 3.73 110.718 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -77.97 10.0 3.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -1.23 . . . . 4.74 109.268 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.07 -131.26 48.26 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.024 -1.23 . . . . 2.52 110.024 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -130.03 146.06 51.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.536 -0.979 . . . . 2.24 109.601 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.504 ' OH ' ' NE ' ' A' ' 67' ' ' ARG . 7.4 m-85 -78.87 159.98 27.53 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.472 -0.936 . . . . 2.3 108.472 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -116.09 137.13 52.4 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.477 -0.764 . . . . 0.55 109.824 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -153.06 160.95 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.912 . . . . 1.2 109.847 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.06 129.81 35.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.211 -0.931 . . . . 1.44 110.109 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.491 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 1.8 m-20 -173.75 156.84 2.73 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.92 -0.77 . . . . 3.72 108.92 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -85.3 -162.61 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.904 1.736 . . . . 4.1 111.025 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -87.55 53.71 2.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.92 -1.112 . . . . 6.82 108.845 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -59.93 -39.98 87.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.4 -0.812 . . . . 6.0 110.415 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.429 ' CD2' ' N ' ' A' ' 86' ' ' ASN . 55.9 p90 -61.56 -39.94 92.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.103 -0.998 . . . . 11.29 110.965 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.429 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 57.8 t30 -75.18 -15.44 60.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 10.52 110.818 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 64.9 mtt -82.56 118.89 23.61 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.287 -0.883 . . . . 8.47 110.083 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -114.6 11.22 16.93 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.895 -0.78 . . . . 12.49 108.895 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.46 ' C ' ' H ' ' A' ' 91' ' ' GLY . 8.9 pt-20 -115.02 -178.35 3.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.681 -0.637 . . . . 11.95 109.671 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -60.63 -4.04 0.84 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.573 -0.705 . . . . 12.64 110.163 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.46 ' H ' ' C ' ' A' ' 89' ' ' GLU . . . 93.95 72.49 1.18 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.062 -1.615 . . . . 11.27 109.062 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.5 t -82.41 85.18 6.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -1.11 . . . . 11.98 109.676 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -60.05 -40.99 91.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.411 -0.806 . . . . 11.29 109.465 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.158 -0.964 . . . . 13.39 108.585 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.27 0.557 . . . . 5.19 109.729 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.24 153.56 48.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.596 -0.69 . . . . 2.08 109.247 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.6 m -130.05 159.91 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.609 -0.682 . . . . 2.23 109.605 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.3 pttm -58.99 119.08 34.81 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 4.16 108.859 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.2 Cg_exo -44.54 121.15 3.09 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.516 1.477 . . . . 1.18 111.295 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -42.25 -12.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.248 1.966 . . . . 1.18 113.767 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.6 m-85 -68.16 141.94 55.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.72 -1.238 . . . . 1.92 109.712 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 m -74.38 163.07 28.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 1.92 109.362 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -59.99 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.948 . . . . 2.23 109.518 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.44 -40.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.075 -1.016 . . . . 1.66 109.055 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.19 87.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 1.1 109.945 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.41 -40.12 89.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 1.14 109.544 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.68 -40.05 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.42 -0.955 . . . . 1.2 108.42 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -60.92 -39.99 91.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.712 . . . . 1.17 109.78 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.459 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 65.4 mtt -68.94 -39.39 79.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 1.77 110.0 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.12 83.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 1.09 109.88 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.44 -49.97 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 1.1 109.5 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.65 -40.02 84.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.797 -0.564 . . . . 2.34 110.482 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 15' ' ' MET . 4.2 m-80 -70.23 -15.43 62.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 1.71 110.414 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 146.67 69.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 1.24 109.26 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.86 -44.44 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.738 1.625 . . . . 1.64 109.968 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -106.19 126.52 52.32 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.459 -1.312 . . . . 2.63 107.459 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -58.56 -24.57 61.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.989 -1.069 . . . . 2.55 108.748 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -80.08 84.98 5.71 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.289 -1.004 . . . . 2.13 108.289 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.3 tt -107.03 147.66 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.568 -0.708 . . . . 1.18 109.102 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -79.18 154.96 28.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 1.4 110.452 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.04 -47.53 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.594 0.711 . . . . 1.39 109.75 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.54 -39.9 89.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 2.03 110.341 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.07 96.56 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.232 -0.917 . . . . 0.32 111.158 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.14 -39.91 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.832 -1.393 . . . . 1.14 109.434 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.728 ' HH ' ' H ' ' A' ' 53' ' ' ARG . 39.5 m-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 2.3 109.528 179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 71.0 tp60 -61.6 -40.02 93.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 3.11 109.702 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.91 -43.7 94.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.581 -0.7 . . . . 2.25 111.32 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.401 HG23 HD11 ' A' ' 34' ' ' ILE . 90.4 mt -69.98 -40.71 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.798 -1.189 . . . . 1.26 111.519 -178.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.12 -39.94 78.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.89 -1.131 . . . . 1.17 110.301 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 96.2 m-20 -71.31 -46.95 59.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.918 -1.114 . . . . 1.17 109.854 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -69.76 -35.44 74.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 3.48 110.366 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.523 ' C ' ' H ' ' A' ' 40' ' ' PHE . 90.9 m-85 -128.7 79.96 73.46 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.345 -0.847 . . . . 2.43 109.854 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.31 -6.07 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.84 2.36 . . . . 1.69 111.718 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.523 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -60.08 -39.5 86.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 4.68 109.459 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.96 -24.1 63.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.565 -0.709 . . . . 1.91 111.125 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.3 mtt-85 -59.55 -40.09 86.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.815 -1.178 . . . . 3.01 109.738 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.93 -19.11 65.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.009 -1.057 . . . . 2.34 109.992 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -133.54 97.56 3.97 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.012 -0.736 . . . . 2.6 109.012 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.409 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 62.7 mttp -88.56 -45.71 9.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 2.25 110.717 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.15 144.3 34.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 4.59 110.121 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.91 -58.04 0.4 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.302 -1.119 . . . . 1.34 110.302 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.409 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.5 p-90 -89.19 -13.5 38.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.028 -1.278 . . . . 0.57 109.962 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -60.26 -50.0 75.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.14 -0.975 . . . . 2.03 111.487 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -75.88 -36.77 59.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 2.01 111.671 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 94.0 p -57.84 -23.07 51.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.988 -1.07 . . . . 1.99 110.836 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mm -75.74 -68.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.963 -1.086 . . . . 1.28 110.727 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.728 ' H ' ' HH ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -68.49 -27.01 65.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.114 -0.991 . . . . 3.38 110.693 -178.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.01 -42.01 93.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 3.09 108.655 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 57' ' ' SER . 96.5 m-20 -62.52 -40.12 95.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.454 -0.779 . . . . 2.59 109.61 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.29 59.21 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 1.29 109.159 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' ASN . 40.1 t -159.97 -54.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.264 -0.897 . . . . 2.04 109.564 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.468 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 7.6 mp -65.85 -40.1 91.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 1.92 109.772 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -69.43 127.95 34.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.125 -0.984 . . . . 1.83 108.797 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.96 -1.71 58.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.511 -0.743 . . . . 2.17 109.373 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.8 m -64.81 -39.91 94.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 1.92 109.195 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -84.18 134.0 34.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 2.22 109.264 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 129.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.784 . . . . 1.48 109.175 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.0 139.56 57.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 2.29 109.041 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.69 123.42 31.3 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.638 -0.875 . . . . 1.95 108.638 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.12 -168.84 0.35 Allowed 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.07 1.18 . . . . 2.11 111.873 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.6 ' NH1' ' CE1' ' A' ' 77' ' ' TYR . 24.2 mtt-85 -128.51 149.99 50.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.436 -0.79 . . . . 4.68 109.686 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 8.5 t70 -86.41 169.05 13.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 2.84 109.218 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 83.1 m-20 -72.44 -22.66 61.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.502 -0.749 . . . . 3.46 110.001 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -60.0 -46.37 89.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.025 -1.047 . . . . 4.77 110.425 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.7 ttpp -137.65 112.15 9.05 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.365 -0.834 . . . . 5.49 108.943 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -85.75 173.11 7.43 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.045 1.83 . . . . 4.18 112.094 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.5 -166.87 20.17 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.424 -1.47 . . . . 3.73 109.424 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.587 ' O ' ' NH2' ' A' ' 67' ' ' ARG . 97.8 mttt -99.38 123.82 43.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -1.092 . . . . 4.74 110.844 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.502 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . 65.27 -125.27 29.18 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.096 -1.202 . . . . 2.52 110.096 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.545 ' N ' ' NH2' ' A' ' 67' ' ' ARG . 7.9 p -139.92 149.58 43.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.46 -1.023 . . . . 2.24 109.027 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.6 ' CE1' ' NH1' ' A' ' 67' ' ' ARG . 32.7 m-85 -76.28 161.71 28.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.912 -1.117 . . . . 2.3 108.485 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -118.73 140.27 50.2 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.663 0.745 . . . . 0.55 110.518 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -148.17 155.5 41.47 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.257 -1.016 . . . . 1.2 108.257 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.78 -39.98 90.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.894 -1.129 . . . . 1.44 109.662 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -167.21 143.49 3.61 Favored Pre-proline 0 C--N 1.296 -1.753 0 O-C-N 121.631 -0.668 . . . . 3.72 109.219 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -53.25 -79.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.262 1.308 . . . . 4.1 112.194 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 48.2 t0 -162.08 42.62 0.14 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.536 -1.283 . . . . 6.82 107.536 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.1 m -45.37 110.0 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.67 -0.644 . . . . 6.0 109.854 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.499 ' CD1' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -89.95 -76.67 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.304 -0.872 . . . . 11.29 108.961 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -99.25 2.18 45.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.438 -0.789 . . . . 10.52 110.441 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 73.1 mtm -90.93 115.35 27.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 8.47 109.235 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -68.9 -36.07 77.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 12.49 108.717 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -69.71 160.11 32.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.463 -0.773 . . . . 11.95 109.479 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.96 44.68 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 12.64 110.781 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.39 -2.65 86.58 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.201 -1.159 . . . . 11.27 110.201 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.0 p -59.96 -38.65 83.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.311 . . . . 11.98 108.749 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -84.26 126.25 32.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.821 . . . . 11.29 109.372 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.345 -0.983 . . . . 13.39 108.345 179.502 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.509 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.259 0.552 . . . . 5.19 109.6 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.84 145.2 43.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.813 . . . . 2.08 109.619 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.99 160.04 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.691 . . . . 2.23 109.459 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 10.1 mptt -76.53 149.88 81.64 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 4.16 109.551 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.18 161.25 45.12 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.658 2.239 . . . . 1.18 111.589 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.67 27.66 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.388 2.059 . . . . 1.18 113.299 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -100.42 133.59 44.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.878 -1.139 . . . . 1.92 108.839 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.62 ' HG ' ' N ' ' A' ' 9' ' ' TYR . 28.3 t -70.31 161.83 29.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 1.92 108.914 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.62 ' N ' ' HG ' ' A' ' 8' ' ' SER . 78.6 m-85 -59.23 -43.05 92.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.98 -1.075 . . . . 2.23 108.307 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.9 mt -65.15 -40.02 87.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.606 -0.887 . . . . 1.66 108.606 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.97 98.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 1.1 109.862 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.01 -40.14 88.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.913 -1.117 . . . . 1.14 108.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.91 -42.14 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.44 -0.787 . . . . 1.2 108.886 179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -60.79 -43.21 98.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.722 -0.611 . . . . 1.17 110.553 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.558 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.8 mtm -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.915 -1.116 . . . . 1.77 109.426 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.401 ' HA ' HD22 ' A' ' 19' ' ' ASN . . . -50.37 -52.34 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.538 -0.726 . . . . 1.09 109.898 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.02 -44.29 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 1.1 109.368 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.1 -46.14 90.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.656 . . . . 2.34 111.187 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 15' ' ' MET . 18.9 p30 -90.04 11.05 21.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.991 -1.068 . . . . 1.71 110.474 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.29 120.39 80.94 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 1.24 108.83 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -41.77 -38.22 4.42 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.443 1.429 . . . . 1.64 110.993 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -112.93 137.23 51.63 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.817 -1.179 . . . . 2.63 107.817 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -60.02 -39.97 87.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.967 -1.083 . . . . 2.55 108.502 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -82.15 129.15 34.75 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.163 -1.051 . . . . 2.13 108.163 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.12 146.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.206 -0.934 . . . . 1.18 110.158 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.77 160.0 26.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.519 -0.738 . . . . 1.4 110.278 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.07 -48.41 81.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.636 -0.875 . . . . 1.39 108.636 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.78 -39.91 90.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 2.03 109.89 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.89 95.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.456 -1.058 . . . . 0.32 110.456 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.12 -42.54 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.322 . . . . 1.14 109.74 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -62.1 -40.1 94.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 2.3 110.736 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.4 -40.17 90.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.953 -1.092 . . . . 3.11 109.614 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 65.6 t80 -60.09 -46.85 88.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 2.25 111.168 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 34' ' ' ILE . 83.3 mt -60.04 -49.83 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.046 -1.034 . . . . 1.26 110.826 -178.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtm -61.86 -40.0 93.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.854 -1.153 . . . . 1.17 110.105 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.65 -39.92 93.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 1.17 110.921 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.435 HH11 ' HG2' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -79.99 -67.69 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.885 -1.134 . . . . 3.48 110.103 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 23.7 m-85 -92.09 115.69 65.11 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 2.43 109.004 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.72 -7.81 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.176 1.918 . . . . 1.69 113.278 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 1.1 m-85 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.122 . . . . 4.68 109.341 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -67.83 -26.78 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.574 -0.704 . . . . 1.91 110.848 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.02 -40.01 87.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.004 . . . . 3.01 109.477 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -71.41 -9.31 57.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 2.34 109.214 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 57.5 t-20 -141.51 99.53 3.58 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.049 -0.723 . . . . 2.6 109.049 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.48 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 65.0 mttm -96.66 -21.48 17.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 2.25 110.911 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -90.66 136.36 33.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.765 -1.209 . . . . 4.59 110.86 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -75.15 0.23 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.594 -1.003 . . . . 1.34 110.594 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.48 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.6 p-90 -62.42 -37.46 85.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.265 -1.138 . . . . 0.57 110.898 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 56.9 tt0 -59.83 -50.33 74.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 2.03 111.661 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.912 -1.118 . . . . 2.01 112.272 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.7 m -59.95 -40.09 87.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.863 -1.148 . . . . 1.99 112.217 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 11.1 mt -61.89 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.629 -1.294 . . . . 1.28 110.691 -178.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -69.18 -29.26 67.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.401 -1.437 . . . . 3.38 109.199 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -69.59 -37.2 76.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.044 -1.465 . . . . 3.09 107.044 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.59 -36.35 78.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.688 -0.632 . . . . 2.59 109.317 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.4 mt -59.99 -42.01 93.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 1.29 110.558 -179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -60.04 -46.86 88.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 2.04 109.87 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' CD1' ' N ' ' A' ' 58' ' ' LEU . 10.1 mp -69.98 -37.86 75.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 1.92 109.439 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -75.8 111.99 11.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.19 -0.944 . . . . 1.83 109.269 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.03 -9.8 52.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 2.17 109.626 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 62' ' ' PHE . 30.1 p -60.06 -35.9 76.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 1.92 109.412 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.413 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 74.8 m-85 -78.1 147.42 34.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 2.22 108.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.47 130.64 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.466 -0.771 . . . . 1.48 110.826 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -76.25 158.67 31.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 2.29 109.176 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.8 t -134.64 84.26 39.86 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.389 -0.82 . . . . 1.95 108.994 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.5 136.19 26.39 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.655 2.237 . . . . 2.11 112.685 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 73' ' ' GLY . 34.4 ptt180 -87.34 149.8 24.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 4.68 109.058 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.15 139.26 58.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.948 -1.095 . . . . 2.84 109.409 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.42 -39.98 92.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 3.46 110.276 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -63.66 -40.11 96.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.922 -1.111 . . . . 4.77 110.424 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -88.8 115.93 64.88 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.801 -1.187 . . . . 5.49 108.471 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -77.12 105.78 2.13 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.502 1.468 . . . . 4.18 111.912 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.518 ' O ' ' NH1' ' A' ' 67' ' ' ARG . . . -100.55 -158.99 27.87 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.543 -1.423 . . . . 3.73 109.543 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -104.46 19.77 19.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.465 -1.02 . . . . 4.74 109.559 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.406 ' H ' HH11 ' A' ' 67' ' ' ARG . . . 116.53 -166.11 12.35 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.115 -1.194 . . . . 2.52 110.115 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.0 t -78.58 145.56 34.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.391 -1.064 . . . . 2.24 109.551 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -104.3 162.15 13.45 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.954 -0.758 . . . . 2.3 108.954 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -117.96 140.01 50.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.509 -0.744 . . . . 0.55 109.589 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -144.09 159.93 41.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.318 -0.864 . . . . 1.2 109.507 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt -76.97 161.21 28.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 1.44 109.302 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.549 ' O ' ' O ' ' A' ' 82' ' ' PRO . 6.1 m-20 -62.2 157.19 55.19 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.596 -0.89 . . . . 3.72 108.596 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 81' ' ' ASP . 74.6 Cg_exo -49.69 -135.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.258 1.972 . . . . 4.1 112.817 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.91 -47.28 86.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.435 -1.416 . . . . 6.82 108.888 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 84' ' ' SER . 3.5 t -179.97 44.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.678 -0.86 . . . . 6.0 108.678 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -62.15 -39.85 94.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.153 -0.967 . . . . 11.29 108.889 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.531 ' C ' ' H ' ' A' ' 88' ' ' PHE . 9.9 t-20 -134.82 27.11 3.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 10.52 109.793 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 7.7 mmt -73.85 15.81 0.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 8.47 109.146 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.531 ' H ' ' C ' ' A' ' 86' ' ' ASN . 73.2 m-85 -89.49 35.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.982 -0.747 . . . . 12.49 108.982 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.468 ' C ' ' H ' ' A' ' 91' ' ' GLY . 10.0 pt-20 -69.86 169.99 12.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 11.95 109.37 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -65.96 1.5 1.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.878 . . . . 12.64 109.691 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.468 ' H ' ' C ' ' A' ' 89' ' ' GLU . . . -92.26 -146.75 19.39 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.972 -1.651 . . . . 11.27 108.972 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 91' ' ' GLY . 12.5 m -173.47 120.36 0.32 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.469 -1.018 . . . . 11.98 109.671 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE2' ' O ' ' A' ' 94' ' ' LEU . 72.7 t80 -82.06 130.03 34.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.121 -0.987 . . . . 11.29 109.151 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 58.8 tp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 13.39 109.212 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.599 0.714 . . . . 5.19 109.19 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.5 mt -69.8 143.16 53.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.5 -0.75 . . . . 2.08 109.321 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.98 159.95 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.648 -0.871 . . . . 2.23 108.648 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -56.25 114.57 7.9 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.011 . . . . 4.16 109.013 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -40.93 154.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.006 1.804 . . . . 1.18 112.577 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.72 30.22 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.507 2.138 . . . . 1.18 111.981 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.31 133.94 53.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.429 -0.794 . . . . 1.92 108.871 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -65.67 160.79 21.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 1.92 108.279 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.886 -1.134 . . . . 2.23 108.221 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.17 -41.36 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 1.66 109.154 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.72 96.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 1.1 109.579 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.96 -41.4 91.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 1.14 108.403 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.3 mt -70.01 -41.9 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.379 -0.826 . . . . 1.2 109.453 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -60.2 -40.02 88.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 1.17 110.139 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.5 mtm -70.02 -37.48 75.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 1.77 110.028 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.17 90.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 1.09 110.185 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.93 -49.98 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 1.1 109.071 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.79 -38.57 86.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.473 0.654 . . . . 2.34 109.71 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -77.12 1.04 19.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 1.71 109.49 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.35 149.9 76.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.187 -0.946 . . . . 1.24 108.705 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -37.33 -73.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.193 1.929 . . . . 1.64 112.59 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.1 -79.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.032 -1.042 . . . . 2.63 110.187 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -165.5 -34.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 2.55 108.997 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' NZ ' ' OD2' ' A' ' 83' ' ' ASP . 63.1 mttp -88.53 138.38 31.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.276 -0.89 . . . . 2.13 109.805 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -140.81 153.8 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.19 -0.944 . . . . 1.18 109.913 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.7 p -86.01 166.08 16.17 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.332 -0.855 . . . . 1.4 110.474 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.2 tp -60.15 -51.59 68.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.872 -1.159 . . . . 1.39 107.872 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.85 -40.01 91.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.782 -0.574 . . . . 2.03 110.445 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -40.02 95.39 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.122 -1.037 . . . . 0.32 110.543 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.51 -43.85 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.02 -1.282 . . . . 1.14 110.363 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.636 ' HH ' ' HE ' ' A' ' 53' ' ' ARG . 39.9 m-85 -60.01 -46.64 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.986 . . . . 2.3 111.989 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.93 -39.29 84.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.771 -1.205 . . . . 3.11 110.076 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -60.01 -40.01 87.79 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.309 -0.87 . . . . 2.25 110.427 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.49 -48.54 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.99 -1.068 . . . . 1.26 111.911 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . 0.561 ' SD ' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -60.05 -39.96 87.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.559 -1.338 . . . . 1.17 110.231 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 88.2 m-20 -68.43 -40.06 81.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.935 -1.103 . . . . 1.17 110.429 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -67.69 -40.01 84.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 3.48 110.27 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.38 122.59 21.02 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.347 -0.845 . . . . 2.43 109.011 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.32 -6.07 16.8 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.55 1.5 . . . . 1.69 111.11 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.07 -44.74 94.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.809 -0.557 . . . . 4.68 110.733 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.38 -23.81 64.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.983 -1.073 . . . . 1.91 111.012 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 64.3 mtt-85 -60.07 -40.05 88.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.84 -1.163 . . . . 3.01 109.393 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.15 -40.01 94.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.883 . . . . 2.34 110.6 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -116.33 112.69 21.9 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.118 -0.697 . . . . 2.6 109.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.55 -66.39 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 2.25 110.438 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -65.33 144.25 57.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 4.59 109.946 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.15 -62.72 0.32 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.582 -1.007 . . . . 1.34 110.582 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 41.9 p-90 -80.86 -12.79 59.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.899 -1.353 . . . . 0.57 110.469 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -70.01 -41.47 74.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 2.03 110.848 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -70.08 -38.28 75.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.32 -0.863 . . . . 2.01 111.352 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.8 t -59.97 -41.14 91.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.954 -1.091 . . . . 1.99 110.662 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.8 mm -59.97 -50.05 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.082 -1.011 . . . . 1.28 110.677 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.636 ' HE ' ' HH ' ' A' ' 31' ' ' TYR . 55.9 mtt180 -63.03 -39.32 94.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.975 -1.078 . . . . 3.38 109.616 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -60.04 -39.98 87.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.38 -0.825 . . . . 3.09 108.797 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -66.58 -39.91 88.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 2.59 109.502 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.48 -39.99 89.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.952 . . . . 1.29 110.282 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -71.2 -39.95 71.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.937 -1.102 . . . . 2.04 110.868 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.1 mt -68.73 -39.99 80.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.074 -1.017 . . . . 1.92 112.049 -178.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -62.02 118.4 7.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.691 -1.255 . . . . 1.83 110.432 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -84.22 -31.61 24.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 2.17 109.622 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p -66.24 -9.18 29.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 1.92 108.965 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -89.85 138.46 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 2.22 107.907 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -123.84 129.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.303 -0.873 . . . . 1.48 110.469 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.2 147.66 38.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.834 . . . . 2.29 108.956 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' PRO . 15.5 t -139.98 64.5 27.66 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.059 -1.026 . . . . 1.95 109.556 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 65' ' ' VAL . 54.8 Cg_exo -35.52 162.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 123.013 2.475 . . . . 2.11 113.375 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -59.79 -172.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.36 -0.837 . . . . 4.68 108.847 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 28.7 t0 -80.0 166.68 21.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 2.84 108.999 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 85.9 m-20 -79.11 -14.36 59.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 3.46 109.96 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -60.56 -40.3 91.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 4.77 109.443 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.527 ' O ' ' O ' ' A' ' 72' ' ' PRO . 2.3 mppt? -86.56 150.43 51.13 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.235 -0.916 . . . . 5.49 109.177 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 71' ' ' LYS . 88.6 Cg_exo -47.89 -131.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 122.689 2.26 . . . . 4.18 113.402 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 72' ' ' PRO . . . -51.38 179.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.118 -1.593 . . . . 3.73 109.118 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -136.18 154.61 50.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.26 -1.141 . . . . 4.74 109.706 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.83 -122.95 1.11 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.22 -1.952 . . . . 2.52 108.22 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -155.28 100.83 2.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.932 -1.334 . . . . 2.24 109.712 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -82.56 160.0 22.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.413 -0.805 . . . . 2.3 108.828 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -141.89 131.43 23.91 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.052 -1.03 . . . . 0.55 110.903 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -155.04 150.94 27.81 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.897 -0.779 . . . . 1.2 108.897 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.25 -40.07 88.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.97 -1.081 . . . . 1.44 109.332 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -154.13 173.13 4.99 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.242 -1.022 . . . . 3.72 108.242 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.82 173.05 14.12 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.784 1.656 . . . . 4.1 111.495 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.533 ' OD2' ' NZ ' ' A' ' 24' ' ' LYS . 97.2 m-20 -84.58 63.81 8.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.958 -1.127 . . . . 6.82 107.958 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.3 t -51.74 -30.05 21.06 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.662 -0.649 . . . . 6.0 109.592 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -64.65 -20.8 66.5 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.025 -1.047 . . . . 11.29 108.999 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -84.25 -0.91 54.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.494 -0.754 . . . . 10.52 110.863 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.3 mtm -70.38 152.4 44.14 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.172 -0.955 . . . . 8.47 109.675 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -60.09 -42.8 95.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.642 -0.661 . . . . 12.49 110.728 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.87 142.44 58.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.948 -1.095 . . . . 11.95 109.848 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -148.98 154.08 38.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.309 -0.869 . . . . 12.64 110.227 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.57 -55.24 4.99 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.861 -1.296 . . . . 11.27 109.861 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -167.09 122.17 1.07 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.234 -1.156 . . . . 11.98 108.973 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 7.8 p90 -111.39 94.15 4.83 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.663 -0.648 . . . . 11.29 109.614 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 13.39 108.807 179.372 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.344 -0.613 . . . . 5.19 109.344 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.33 140.0 39.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.459 -0.776 . . . . 2.08 109.419 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 m -143.86 148.72 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -0.806 . . . . 2.23 109.911 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -70.92 149.99 95.02 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 4.16 108.908 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.03 160.31 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.2 1.933 . . . . 1.18 111.669 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.4 26.61 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.418 2.079 . . . . 1.18 113.565 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.55 137.92 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.848 -1.157 . . . . 1.92 108.372 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 m -77.57 166.41 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 1.92 108.947 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -59.94 -37.87 80.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.082 . . . . 2.23 108.354 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.13 -46.48 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 1.66 109.338 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.71 95.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 1.1 110.786 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.2 mt -59.93 -40.05 87.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.154 . . . . 1.14 108.599 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.41 -44.84 94.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 1.2 108.336 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -67.44 -40.06 85.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.602 -0.686 . . . . 1.17 110.738 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.423 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.4 mtt -66.7 -39.91 88.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 1.77 109.148 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -50.04 75.27 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.537 -0.727 . . . . 1.09 110.107 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.9 mt -60.46 -50.0 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 1.1 109.509 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -40.0 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.664 -0.647 . . . . 2.34 110.576 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 15' ' ' MET . 70.3 m-80 -82.05 1.27 36.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 1.71 109.87 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.42 149.05 74.86 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 1.24 108.634 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 -32.22 91.17 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.614 1.543 . . . . 1.64 109.806 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -124.21 139.99 53.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.797 -1.186 . . . . 2.63 107.797 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -60.07 -38.99 84.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.02 -1.05 . . . . 2.55 108.585 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -77.97 120.18 22.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.926 -1.139 . . . . 2.13 107.926 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.73 148.87 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.248 -0.907 . . . . 1.18 109.971 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.3 p -79.83 160.0 26.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -0.772 . . . . 1.4 110.89 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -66.32 -39.99 89.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.756 -0.831 . . . . 1.39 108.756 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.91 -40.0 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 2.03 109.672 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.72 -38.51 96.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.344 -1.102 . . . . 0.32 110.344 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.99 -42.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 1.14 109.933 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -60.0 -39.11 84.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.959 -1.088 . . . . 2.3 109.588 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.36 91.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.045 -1.035 . . . . 3.11 108.882 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.95 -47.59 85.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 2.25 110.431 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.1 mp -61.73 -49.66 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 1.26 110.276 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.6 mtm -60.07 -39.91 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.808 -1.183 . . . . 1.17 109.889 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.09 -51.85 19.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 1.17 109.431 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.11 -50.0 75.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 3.48 109.312 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.57 110.66 38.66 Favored Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 108.812 -0.81 . . . . 2.43 108.812 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.51 -7.33 12.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.982 1.788 . . . . 1.69 112.514 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -60.57 -40.0 90.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.915 . . . . 4.68 109.605 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.06 -17.82 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.693 -0.629 . . . . 1.91 110.777 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.63 -43.17 93.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 3.01 108.46 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.17 -43.74 97.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.337 -0.852 . . . . 2.34 109.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -102.58 99.02 8.99 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.175 -0.676 . . . . 2.6 109.175 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -94.51 -42.56 8.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 2.25 109.476 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -81.29 149.5 28.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 4.59 109.494 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -73.34 0.28 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.133 -1.187 . . . . 1.34 110.133 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 20.6 p-90 -69.49 -38.73 77.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.57 110.664 -178.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.04 -42.07 93.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 2.03 110.721 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -70.04 -39.57 75.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 2.01 110.826 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -0.948 . . . . 1.99 111.259 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.7 mm -60.0 -50.01 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.835 -1.166 . . . . 1.28 110.126 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -60.35 -49.62 76.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.082 . . . . 3.38 109.44 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.143 -1.058 . . . . 3.09 108.143 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.572 ' ND2' HD22 ' A' ' 59' ' ' ASN . 23.8 t-20 -62.07 -40.34 95.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.473 -0.767 . . . . 2.59 109.097 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.84 -40.06 94.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 1.29 110.456 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.7 m -69.5 -46.84 65.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.983 -1.073 . . . . 2.04 110.43 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.59 -39.98 88.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 1.92 110.245 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.572 HD22 ' ND2' ' A' ' 55' ' ' ASN . 42.7 m-80 -75.29 117.54 17.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 1.83 109.752 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.59 -2.41 57.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 2.17 109.352 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -60.36 -39.94 88.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 1.92 109.591 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -79.71 152.8 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 2.22 109.351 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.7 t -112.7 127.46 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.473 -0.767 . . . . 1.48 109.393 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -68.98 145.76 53.32 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.28 -1.007 . . . . 2.29 108.28 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 t -137.39 76.97 42.11 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.144 -0.972 . . . . 1.95 109.715 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -50.64 160.81 1.54 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.62 2.214 . . . . 2.11 111.881 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -83.48 166.45 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 4.68 109.012 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -77.55 166.48 23.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 2.84 109.745 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.05 -36.45 79.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.542 -0.724 . . . . 3.46 110.882 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -59.99 -40.66 89.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 4.77 110.127 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -84.13 149.52 55.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.924 -1.11 . . . . 5.49 108.702 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.46 141.16 97.04 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.803 1.668 . . . . 4.18 111.397 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.18 80.58 0.49 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 120.101 -1.047 . . . . 3.73 110.609 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 75' ' ' GLY . 66.2 mttm -113.42 130.1 56.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.481 -1.011 . . . . 4.74 109.697 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 74' ' ' LYS . . . 36.26 -152.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 111.026 -0.829 . . . . 2.52 111.026 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.2 t -155.76 140.04 16.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.539 -0.977 . . . . 2.24 108.445 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -77.85 154.89 31.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.692 -1.255 . . . . 2.3 108.273 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -119.95 140.03 51.54 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.758 0.79 . . . . 0.55 110.716 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 t -139.62 162.24 35.58 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.769 -0.826 . . . . 1.2 108.769 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.2 mp -99.2 16.06 24.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.142 -0.974 . . . . 1.44 110.445 -179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -149.35 152.58 35.96 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 120.837 -1.164 . . . . 3.72 111.005 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.55 -153.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.525 2.15 . . . . 4.1 111.783 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' TYR . 42.7 t0 -79.94 71.4 6.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.958 -1.089 . . . . 6.82 108.46 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 84' ' ' SER . 5.7 p -59.3 85.83 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.798 0.809 . . . . 6.0 109.312 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' ASP . 49.2 t80 -82.96 -39.58 21.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 11.29 110.964 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -138.54 29.74 2.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.0 -1.063 . . . . 10.52 110.009 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.617 ' SD ' ' N ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -52.91 140.45 24.53 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.272 -0.893 . . . . 8.47 109.179 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -59.15 -107.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 12.49 109.752 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.49 ' CD ' ' H ' ' A' ' 89' ' ' GLU . 3.5 pm0 -103.8 20.14 18.63 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.277 -0.889 . . . . 11.95 110.01 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -90.89 31.35 1.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 12.64 109.455 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -153.47 -113.91 0.53 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.674 -1.371 . . . . 11.27 109.674 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.4 p -147.04 117.61 7.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -1.195 . . . . 11.98 109.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.524 ' O ' ' CD2' ' A' ' 93' ' ' PHE . 25.0 p90 -94.75 115.39 27.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.363 -0.835 . . . . 11.29 109.192 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.166 -0.959 . . . . 13.39 109.717 -179.682 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mtp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.55 0.691 . . . . 5.19 109.331 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.2 mt -74.25 140.63 45.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.368 -0.832 . . . . 2.08 109.689 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.05 144.11 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.791 -0.818 . . . . 2.23 108.791 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -70.01 148.5 96.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.854 -1.154 . . . . 4.16 108.539 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 50.2 Cg_endo -83.21 124.76 3.83 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.927 1.751 . . . . 1.18 112.133 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.03 -12.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.555 2.17 . . . . 1.18 114.142 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 14.4 m-85 -62.43 140.07 58.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.534 -1.354 . . . . 1.92 109.519 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -79.63 168.23 19.65 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.833 -1.173 . . . . 1.92 107.833 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -60.39 -39.91 89.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.902 -1.124 . . . . 2.23 109.095 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.467 ' CD1' ' OD1' ' A' ' 55' ' ' ASN . 38.8 mm -62.18 -41.1 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 1.66 109.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.97 85.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 1.1 110.154 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.1 -40.06 88.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 1.14 108.972 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.54 -40.05 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 1.2 109.132 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.31 -39.96 96.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.573 -0.704 . . . . 1.17 110.488 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.436 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.5 mtt -65.35 -39.95 92.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 1.77 110.078 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.65 80.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.352 -0.843 . . . . 1.09 109.591 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.23 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 1.1 109.247 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.01 -40.14 88.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.413 0.625 . . . . 2.34 110.125 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 15' ' ' MET . 69.4 m-80 -81.94 -0.12 42.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 1.71 109.613 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.77 123.5 85.29 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.276 -0.89 . . . . 1.24 108.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -42.27 -48.23 6.71 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.44 1.426 . . . . 1.64 110.674 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -105.29 142.0 35.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.601 -1.259 . . . . 2.63 107.601 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -60.02 -37.85 80.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.952 -1.092 . . . . 2.55 109.485 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.74 127.91 33.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.811 -1.181 . . . . 2.13 107.811 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.99 151.53 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 1.18 109.532 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.2 p -81.38 156.92 25.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.246 -0.909 . . . . 1.4 110.005 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.97 -48.3 82.28 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.745 0.783 . . . . 1.39 110.04 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 2.03 110.2 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.49 91.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.403 -1.079 . . . . 0.32 110.403 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.95 -42.98 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -1.209 . . . . 1.14 110.771 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.851 -1.156 . . . . 2.3 110.564 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.13 -39.26 85.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.153 -0.967 . . . . 3.11 110.379 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -59.85 -49.3 78.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 2.25 110.729 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.04 -49.92 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.0 -1.063 . . . . 1.26 110.733 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.7 mtm -60.03 -40.12 88.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.874 -1.141 . . . . 1.17 110.445 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.39 -45.22 94.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.928 -1.107 . . . . 1.17 110.715 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 49.0 mtt-85 -68.02 -48.38 65.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.911 -1.118 . . . . 3.48 111.192 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.14 125.28 26.27 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.158 -0.964 . . . . 2.43 110.521 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.22 -5.0 13.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.971 1.781 . . . . 1.69 110.707 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -60.01 -40.1 88.1 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.335 -0.617 . . . . 4.68 109.335 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.05 -31.28 68.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 1.91 109.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -60.06 -39.94 87.75 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.165 -0.959 . . . . 3.01 109.204 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.26 -40.08 96.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 2.34 110.132 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -110.55 101.37 10.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.175 -0.676 . . . . 2.6 109.175 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -88.53 -40.65 13.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.094 -1.004 . . . . 2.25 110.178 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -78.53 141.68 37.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.003 -1.061 . . . . 4.59 110.421 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.18 -60.37 0.33 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.188 -1.165 . . . . 1.34 110.188 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 24.2 p-90 -88.85 -11.93 43.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -1.223 . . . . 0.57 110.239 -179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -69.85 -56.63 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 2.03 111.4 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.92 -38.75 76.33 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.253 -0.904 . . . . 2.01 112.327 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.5 m -59.99 -39.85 87.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.783 -1.198 . . . . 1.99 111.226 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.06 -68.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.954 -1.091 . . . . 1.28 111.398 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -69.93 -33.13 71.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 3.38 112.375 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -59.98 -40.16 88.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.342 -1.474 . . . . 3.09 107.676 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.738 HD22 HD22 ' A' ' 59' ' ' ASN . 21.8 t-20 -60.09 -40.53 89.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.614 -0.679 . . . . 2.59 109.25 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.27 -40.14 95.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.997 -1.065 . . . . 1.29 109.704 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -64.52 -49.75 70.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 2.04 110.721 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.0 mp -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.882 -1.136 . . . . 1.92 110.069 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.738 HD22 HD22 ' A' ' 55' ' ' ASN . 99.5 m-20 -69.28 121.94 17.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 1.83 110.505 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.5 -3.41 57.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.676 -0.861 . . . . 2.17 108.676 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 1.92 109.524 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -77.3 150.04 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.198 -0.939 . . . . 2.22 109.068 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.5 t -111.05 129.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.534 -0.729 . . . . 1.48 109.573 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -90.64 120.45 31.72 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.194 -1.039 . . . . 2.29 108.194 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.79 127.22 31.7 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 120.807 -1.183 . . . . 1.95 109.326 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.46 151.09 28.91 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.855 1.703 . . . . 2.11 112.008 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.503 ' NE ' ' O ' ' A' ' 74' ' ' LYS . 27.0 mtm180 -80.73 152.79 28.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 4.68 109.742 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -80.64 164.91 22.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.413 -0.804 . . . . 2.84 109.398 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 71' ' ' LYS . 96.6 m-20 -60.03 -39.97 87.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 3.46 109.659 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -49.82 -15.21 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 4.77 109.145 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.45 ' H ' ' C ' ' A' ' 69' ' ' ASP . 57.0 mttp -125.72 79.94 67.32 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 108.688 -0.856 . . . . 5.49 108.688 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.41 132.95 14.05 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.16 1.907 . . . . 4.18 112.45 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.43 -99.59 0.24 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.285 -1.526 . . . . 3.73 109.285 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 92.5 mttt -72.01 155.83 39.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -1.159 . . . . 4.74 109.675 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.84 39.4 1.64 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.225 -1.55 . . . . 2.52 109.225 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.4 p -157.67 152.23 25.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.25 . . . . 2.24 110.533 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -152.17 169.97 21.14 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.473 -1.306 . . . . 2.3 107.473 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -132.89 124.97 28.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.252 -0.905 . . . . 0.55 109.553 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -152.8 152.42 31.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.282 -0.886 . . . . 1.2 109.751 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 81' ' ' ASP . 86.4 mt -78.17 163.49 25.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.816 . . . . 1.44 108.949 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -50.84 177.97 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 3.72 108.608 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.87 -145.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.939 1.759 . . . . 4.1 111.686 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -80.8 57.95 3.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.116 -0.99 . . . . 6.82 109.364 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 83.2 p -79.59 85.63 5.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.198 -0.939 . . . . 6.0 108.978 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.411 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.7 OUTLIER -90.04 -79.41 0.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 11.29 108.866 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.495 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 81.0 m-20 -96.06 6.14 49.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.276 -0.89 . . . . 10.52 109.201 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 87' ' ' MET . 0.4 OUTLIER -60.98 140.63 57.75 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.678 -0.639 . . . . 8.47 109.593 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 86' ' ' ASN . 97.6 m-85 -113.55 106.36 14.45 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.588 -0.893 . . . . 12.49 108.588 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.05 -22.96 67.05 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.885 0.85 . . . . 11.95 108.99 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -99.97 19.27 16.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.629 -0.878 . . . . 12.64 108.629 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -155.66 -131.92 1.49 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.129 -1.588 . . . . 11.27 109.129 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.8 m -102.87 -159.6 0.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.26 -1.141 . . . . 11.98 108.918 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -106.11 -23.04 12.71 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.714 -0.616 . . . . 11.29 110.492 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.874 -1.141 . . . . 13.39 109.412 -179.528 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.174 0.512 . . . . 5.19 109.655 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.3 mt -98.59 140.98 32.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.313 -0.867 . . . . 2.08 109.273 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.49 157.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 2.23 109.868 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.457 ' HZ3' ' ND2' ' A' ' 44' ' ' ASN . 11.5 mptt -79.28 152.22 75.99 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 4.16 108.94 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.15 160.0 48.43 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.169 1.913 . . . . 1.18 111.709 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.17 20.93 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.739 2.293 . . . . 1.18 113.773 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -96.01 137.73 34.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.632 -1.292 . . . . 1.92 109.141 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.7 p -73.33 165.61 24.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 1.92 108.667 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 2.23 109.18 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.35 -39.9 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 1.66 109.64 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.03 99.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 1.1 109.519 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.76 -39.96 90.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 1.14 108.584 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.08 -42.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.546 -0.722 . . . . 1.2 109.766 179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -65.67 -41.3 92.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 1.17 109.744 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.95 -33.87 72.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 1.77 109.887 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.577 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -60.05 -46.61 88.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 1.09 109.783 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.03 -45.35 98.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.061 -1.024 . . . . 1.1 109.807 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -63.15 -43.23 98.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.803 -0.561 . . . . 2.34 112.178 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -89.98 10.34 24.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.713 -1.242 . . . . 1.71 110.085 -178.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.78 150.46 81.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 1.24 108.901 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.68 -24.89 65.3 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.732 1.622 . . . . 1.64 110.196 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -139.91 146.57 39.39 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.754 -1.202 . . . . 2.63 107.754 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -59.97 -39.59 86.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.087 . . . . 2.55 108.885 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.06 129.35 34.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 2.13 109.273 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.9 tt -147.83 143.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.796 -0.816 . . . . 1.18 108.796 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -80.02 163.18 24.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 1.4 110.053 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 16.0 tp -59.93 -40.69 89.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.509 -0.744 . . . . 1.39 109.094 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -60.59 -40.25 91.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.431 -0.793 . . . . 2.03 110.141 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.99 96.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.274 -1.131 . . . . 0.32 110.274 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.48 -40.37 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -1.137 . . . . 1.14 110.517 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.718 ' HH ' ' HE ' ' A' ' 53' ' ' ARG . 29.1 m-85 -60.02 -39.98 87.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.101 . . . . 2.3 110.593 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -59.98 -40.0 87.65 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.949 -1.095 . . . . 3.11 109.903 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . 0.542 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 93.8 t80 -60.02 -49.91 75.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 2.25 111.662 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.69 -49.95 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 1.26 112.154 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 45.7 mtm -60.34 -40.04 89.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.706 -1.246 . . . . 1.17 110.994 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -67.17 -48.65 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 1.17 110.914 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -40.0 75.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.289 -0.882 . . . . 3.48 112.189 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -126.55 80.44 69.78 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.088 -1.007 . . . . 2.43 110.2 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.03 -9.85 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.95 2.433 . . . . 1.69 113.643 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.11 -37.51 80.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.633 -1.292 . . . . 4.68 108.996 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -69.15 -28.03 66.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 1.91 110.898 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -58.84 -39.97 82.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.654 -1.279 . . . . 3.01 108.165 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.29 -40.0 86.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 2.34 109.026 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.489 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 94.8 m-20 -99.92 101.02 12.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.226 -0.657 . . . . 2.6 109.226 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.417 ' O ' ' CD1' ' A' ' 48' ' ' TRP . 92.0 mttt -90.41 -78.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.06 -1.025 . . . . 2.25 110.388 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.03 140.01 57.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 4.59 110.235 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.11 -58.2 0.54 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.66 -1.376 . . . . 1.34 109.66 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.489 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 33.3 p-90 -89.69 -10.58 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -1.235 . . . . 0.57 110.807 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 77.9 mt-30 -68.64 -54.53 15.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.883 -1.136 . . . . 2.03 110.916 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -65.35 -34.8 79.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 2.01 110.948 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.1 p -59.51 -41.51 90.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.917 -1.114 . . . . 1.99 109.933 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.13 -50.03 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 1.28 109.797 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.718 ' HE ' ' HH ' ' A' ' 31' ' ' TYR . 25.4 mtt180 -72.76 -38.84 67.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 3.38 109.864 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 68.5 t60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 3.09 108.674 -179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -65.58 -40.01 92.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.389 -0.819 . . . . 2.59 109.696 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 44.7 mt -60.53 -46.65 89.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 1.29 111.291 -179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -64.66 -39.96 94.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.836 -1.165 . . . . 2.04 110.704 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 43.9 mt -66.99 -37.38 84.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.993 -1.067 . . . . 1.92 109.464 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -79.9 110.54 15.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 1.83 109.608 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.91 -8.61 51.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.768 . . . . 2.17 109.194 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.6 m -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.856 -1.165 . . . . 1.92 107.856 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.24 127.63 32.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.845 -1.168 . . . . 2.22 107.845 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 t -102.54 126.94 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.623 -0.88 . . . . 1.48 108.623 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -97.46 117.84 32.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.868 . . . . 2.29 110.031 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.68 149.48 54.22 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.127 -1.064 . . . . 1.95 108.127 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.45 -154.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.016 1.811 . . . . 2.11 111.051 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -105.44 146.02 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 4.68 109.757 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.476 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 30.2 t0 -89.87 -171.14 3.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 2.84 110.249 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.476 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 79.4 m-20 -60.03 -39.98 87.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.457 -0.777 . . . . 3.46 109.976 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -80.69 57.19 2.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.26 -0.9 . . . . 4.77 109.509 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 114.64 50.7 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.76 -0.588 . . . . 5.49 109.765 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -86.67 6.57 5.31 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.956 1.771 . . . . 4.18 112.764 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.19 67.14 1.21 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.923 -1.271 . . . . 3.73 109.923 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.36 177.97 7.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.224 -1.162 . . . . 4.74 109.37 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.39 -163.1 5.45 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.163 -1.175 . . . . 2.52 110.163 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.9 m -79.24 159.96 27.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -1.018 . . . . 2.24 109.416 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -92.06 135.48 33.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 2.3 109.645 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -108.86 133.54 52.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.521 -0.737 . . . . 0.55 109.657 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -153.76 163.96 39.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 1.2 110.244 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -77.22 169.61 18.02 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.24 -1.022 . . . . 1.44 108.24 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -46.07 140.2 5.14 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.0 -1.063 . . . . 3.72 109.15 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.49 -163.55 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.114 1.876 . . . . 4.1 112.723 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.0 72.62 7.41 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.69 -1.226 . . . . 6.82 107.69 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.1 t -60.05 -37.0 78.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.632 -0.668 . . . . 6.0 109.694 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -59.93 -39.26 84.9 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.225 -0.922 . . . . 11.29 109.987 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -69.39 -7.27 36.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.95 . . . . 10.52 110.327 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.1 mmt -80.4 93.1 5.92 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.255 -0.903 . . . . 8.47 109.729 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -80.17 -9.96 59.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 12.49 109.212 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -73.63 150.27 41.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 11.95 109.78 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -75.79 127.68 33.53 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.195 -0.941 . . . . 12.64 109.454 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.95 117.88 0.07 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.405 -1.478 . . . . 11.27 109.405 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.0 p -63.8 -37.75 88.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -1.103 . . . . 11.98 109.008 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -142.78 150.49 40.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.354 -0.841 . . . . 11.29 109.355 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 13.39 109.678 -179.69 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.443 -0.577 . . . . 5.19 109.443 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.3 mt -83.51 144.93 29.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.157 -0.965 . . . . 2.08 109.719 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.05 159.99 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.046 -0.724 . . . . 2.23 109.046 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 pttm -75.67 118.7 72.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 4.16 108.937 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.59 150.26 0.84 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.687 1.591 . . . . 1.18 111.809 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.21 -12.57 32.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.257 1.971 . . . . 1.18 111.809 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -60.5 134.55 57.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.216 -0.927 . . . . 1.92 108.645 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 p -70.42 162.11 29.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.176 -1.046 . . . . 1.92 108.176 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -58.47 -39.99 81.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 2.23 108.101 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.56 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.411 -0.806 . . . . 1.66 109.155 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.13 91.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 1.1 109.828 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.95 -40.01 87.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.053 -1.03 . . . . 1.14 108.59 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.97 -39.9 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 1.2 109.105 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.76 -39.9 95.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 1.17 110.016 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.48 -38.49 87.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.415 -0.803 . . . . 1.77 109.521 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.57 92.55 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.439 -0.788 . . . . 1.09 109.849 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.4 mt -64.9 -52.92 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 1.1 109.115 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -63.87 -40.01 95.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.731 -0.605 . . . . 2.34 109.539 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -69.96 -21.48 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.543 -0.723 . . . . 1.71 109.967 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 147.31 68.42 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 1.24 108.898 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.38 -48.18 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.866 1.711 . . . . 1.64 110.32 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.88 123.15 45.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.722 -1.214 . . . . 2.63 107.722 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -61.1 -28.12 68.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 2.55 110.368 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -78.8 88.29 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.787 -1.196 . . . . 2.13 108.803 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.33 151.61 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.098 -0.704 . . . . 1.18 109.098 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.527 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 73.2 p -79.91 159.54 26.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 1.4 110.213 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.59 -41.84 95.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.839 -0.8 . . . . 1.39 108.839 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.19 -40.06 88.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 2.03 110.194 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.527 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -61.68 -40.02 98.2 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.693 -0.963 . . . . 0.32 110.693 -179.125 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.77 -39.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.241 . . . . 1.14 110.798 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.488 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 28.0 m-85 -59.97 -43.84 94.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.709 -1.244 . . . . 2.3 110.19 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.0 -39.99 87.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.245 -0.909 . . . . 3.11 109.096 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -59.91 -50.06 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.657 -0.652 . . . . 2.25 110.883 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.66 -48.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.95 -1.093 . . . . 1.26 111.49 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 32.0 mtm -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 1.17 109.938 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 83.1 m-20 -66.39 -47.03 74.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 1.17 110.727 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 3.48 111.06 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 40' ' ' PHE . 65.9 m-85 -126.1 77.22 71.62 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.226 -0.921 . . . . 2.43 109.85 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.76 -7.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.988 2.459 . . . . 1.69 112.808 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' PHE . 24.1 t80 -58.59 -40.03 82.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 4.68 109.091 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 44' ' ' ASN . 96.8 m-85 -69.99 -23.86 63.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.91 111.501 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.0 mtt-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.559 -1.338 . . . . 3.01 108.724 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.2 -37.03 82.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.512 -0.742 . . . . 2.34 110.007 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 33.0 m120 -108.5 119.18 38.77 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.494 0.664 . . . . 2.6 111.002 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 64.3 mttp -119.11 15.0 13.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.033 -1.099 . . . . 2.25 108.033 178.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.07 -118.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.619 -0.675 . . . . 4.59 112.818 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.79 -10.06 67.56 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.18 -0.95 . . . . 1.34 112.275 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 12.5 p-90 -60.03 -36.99 78.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.222 -1.752 . . . . 0.57 107.578 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.488 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 20.1 tt0 -59.99 -50.03 75.34 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.629 -0.669 . . . . 2.03 109.926 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 2.01 111.047 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.9 p -56.86 -34.27 67.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.077 -1.014 . . . . 1.99 111.119 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -59.99 -46.03 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.86 -1.15 . . . . 1.28 109.308 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 26.6 mtt180 -72.94 -39.36 66.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 3.38 110.146 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -59.98 -39.97 87.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 3.09 110.253 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 56' ' ' LEU . 30.0 p30 -75.02 -25.0 58.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.901 -1.124 . . . . 2.59 110.615 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.53 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 56.2 mt -64.15 -42.93 96.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.698 -1.251 . . . . 1.29 110.014 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -69.99 -40.56 75.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.996 -1.065 . . . . 2.04 110.04 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -69.49 -40.0 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.083 . . . . 1.92 109.389 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -75.37 118.7 18.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.263 -0.898 . . . . 1.83 108.898 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.77 -5.66 56.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.505 -0.747 . . . . 2.17 109.072 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.421 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 89.5 m -60.38 -40.03 89.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 1.92 109.351 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -85.71 147.05 26.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 2.22 108.762 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.96 124.6 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 1.48 109.366 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -79.04 129.98 35.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.501 -0.926 . . . . 2.29 108.501 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.66 100.31 50.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.623 -0.673 . . . . 1.95 109.875 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.56 167.62 0.38 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.149 1.899 . . . . 2.11 112.158 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' NE ' ' OH ' ' A' ' 77' ' ' TYR . 16.7 ttt-85 -112.17 161.5 16.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.517 -0.739 . . . . 4.68 109.271 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -69.01 147.39 51.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.032 . . . . 2.84 109.675 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -79.17 -16.92 55.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.366 -0.834 . . . . 3.46 109.966 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -60.06 -40.01 87.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 4.77 109.6 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.18 85.18 41.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.378 -0.971 . . . . 5.49 108.378 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.99 145.52 12.47 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.301 2.001 . . . . 4.18 112.066 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.08 -36.08 0.23 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.285 -1.526 . . . . 3.73 109.285 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -114.17 152.16 31.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.59 -0.947 . . . . 4.74 108.455 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.96 -77.78 0.48 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.909 -1.138 . . . . 2.52 110.319 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 30.7 t -158.1 170.24 22.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -1.202 . . . . 2.24 109.959 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' OH ' ' NE ' ' A' ' 67' ' ' ARG . 7.2 m-85 -108.09 158.53 17.33 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.478 -0.764 . . . . 2.3 109.269 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -119.9 135.5 54.87 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.689 -0.856 . . . . 0.55 108.689 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -150.57 160.38 43.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.119 -0.988 . . . . 1.2 110.025 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.87 159.57 28.84 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.043 -0.725 . . . . 1.44 109.043 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 61' ' ' CYS . 1.4 m-20 -76.72 124.19 87.66 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.054 -1.029 . . . . 3.72 109.045 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.31 -72.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.211 1.274 . . . . 4.1 111.022 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 85' ' ' TYR . 39.8 t0 -157.72 39.77 0.28 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.644 -1.243 . . . . 6.82 107.644 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m -50.13 89.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.18 -0.674 . . . . 6.0 109.18 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' A' ' 83' ' ' ASP . 19.4 t80 -70.72 -48.71 53.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 11.29 110.067 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -150.22 29.61 0.71 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.29 -0.881 . . . . 10.52 109.165 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.8 mtt -84.97 132.61 34.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.517 -0.739 . . . . 8.47 110.203 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -97.32 -0.01 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.367 -0.833 . . . . 12.49 109.475 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -140.15 159.1 42.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 11.95 110.096 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -125.54 129.96 50.76 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.867 -0.79 . . . . 12.64 108.867 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.7 -95.68 0.1 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.653 -1.379 . . . . 11.27 109.653 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 t -105.16 89.18 3.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.452 -1.028 . . . . 11.98 109.259 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.476 ' O ' ' CD2' ' A' ' 93' ' ' PHE . 32.6 p90 -103.48 130.79 50.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 11.29 109.332 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.777 . . . . 13.39 109.067 179.734 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.0 mtm . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.232 -0.655 . . . . 5.19 109.232 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.54 144.24 27.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 2.08 109.835 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.39 164.17 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.335 -0.853 . . . . 2.23 109.183 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 9.6 mptt -87.36 148.97 45.83 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.466 -0.771 . . . . 4.16 109.167 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.68 160.38 37.96 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.465 2.11 . . . . 1.18 112.203 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.19 -1.26 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.834 2.356 . . . . 1.18 113.612 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -72.55 143.41 48.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.593 -1.317 . . . . 1.92 109.416 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.1 p -76.31 163.15 27.29 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.538 -0.912 . . . . 1.92 108.538 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -60.09 -39.93 87.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 2.23 108.647 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.53 -40.02 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.37 -0.831 . . . . 1.66 109.062 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.58 92.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 1.1 110.101 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 1.14 109.128 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.81 -44.68 98.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.176 -1.046 . . . . 1.2 108.176 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -60.11 -39.99 88.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.708 -0.62 . . . . 1.17 109.478 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.9 mtt -68.2 -39.65 82.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.77 110.019 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.64 88.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 1.09 110.495 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.77 -50.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.008 -1.058 . . . . 1.1 109.669 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.99 -39.92 75.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 2.34 110.383 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.14 -32.98 74.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 1.71 109.216 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.78 116.94 62.49 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 1.24 109.134 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -46.54 -33.46 13.12 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.218 1.279 . . . . 1.64 110.696 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -100.04 113.72 26.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.071 -1.085 . . . . 2.63 108.071 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -69.66 -28.81 66.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 2.55 110.077 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -78.47 75.17 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.045 -1.034 . . . . 2.13 108.634 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 tt -100.98 147.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.074 -0.713 . . . . 1.18 109.074 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -80.04 164.88 23.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.422 -0.799 . . . . 1.4 109.679 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.99 -47.19 86.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.214 -1.032 . . . . 1.39 108.214 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.81 -40.04 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.751 -0.593 . . . . 2.03 110.139 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.01 96.39 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.82 -0.912 . . . . 0.32 110.82 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.413 HD13 HG22 ' A' ' 30' ' ' ILE . 96.7 mt -60.01 -43.91 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.941 -1.329 . . . . 1.14 109.594 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.471 ' HH ' ' CG ' ' A' ' 53' ' ' ARG . 37.7 m-85 -60.17 -40.81 91.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 2.3 110.896 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' OE1' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -66.85 -39.97 87.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.917 -1.114 . . . . 3.11 109.821 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.03 -46.62 88.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 2.25 111.014 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.99 -41.11 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 1.26 110.675 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 30.7 mtt -60.12 -39.98 88.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.036 . . . . 1.17 110.36 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' OE1' ' A' ' 32' ' ' GLN . 96.7 m-20 -68.92 -52.86 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 1.17 111.646 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -69.97 -42.89 72.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.873 -1.142 . . . . 3.48 110.07 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.99 101.51 54.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 108.318 -0.993 . . . . 2.43 108.318 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.46 -6.4 13.64 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.958 1.772 . . . . 1.69 112.717 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -60.0 -36.74 77.85 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.883 -1.154 . . . . 4.68 107.883 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -64.5 -25.28 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.844 -0.616 . . . . 1.91 110.402 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.927 -1.108 . . . . 3.01 109.523 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.09 -39.98 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 2.34 109.524 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -103.61 100.8 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.553 -0.906 . . . . 2.6 108.553 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.59 -68.33 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 2.25 110.513 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.03 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.963 -1.085 . . . . 4.59 110.327 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.55 -60.42 0.41 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.611 -0.996 . . . . 1.34 110.611 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -84.85 -27.81 26.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -1.225 . . . . 0.57 110.712 -178.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.45 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 93.1 mt-30 -60.36 -42.56 96.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 2.03 112.027 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -76.92 -33.92 57.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.711 -1.243 . . . . 2.01 111.8 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.401 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 29.1 t -59.89 -40.11 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.858 -1.151 . . . . 1.99 111.406 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.5 mm -62.95 -59.12 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.04 -1.037 . . . . 1.28 111.711 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' CG ' ' HH ' ' A' ' 31' ' ' TYR . 31.9 ptt180 -70.05 -33.53 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.159 . . . . 3.38 110.667 -178.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -59.97 -40.03 87.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 3.09 109.356 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 51' ' ' SER . 94.4 m-20 -70.03 -21.52 63.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 2.59 111.169 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.96 -50.02 75.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.748 -1.22 . . . . 1.29 110.49 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.8 m -60.02 -40.01 87.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 2.04 109.727 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 11.2 mp -66.28 -39.99 89.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 1.92 109.06 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.59 113.97 15.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.424 -0.797 . . . . 1.83 109.887 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -89.99 -6.21 55.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.619 -0.882 . . . . 2.17 108.619 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -62.68 -37.74 87.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 1.92 109.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -78.37 156.53 29.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 2.22 108.582 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.2 t -120.16 129.96 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 1.48 109.608 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.94 142.92 52.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 2.29 109.501 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 57.8 t -127.11 88.2 54.82 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.487 -0.931 . . . . 1.95 108.487 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 88.0 Cg_exo -45.46 175.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.994 1.796 . . . . 2.11 112.032 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.733 HH11 ' H ' ' A' ' 74' ' ' LYS . 82.8 mtm180 -98.3 156.83 16.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.437 -0.79 . . . . 4.68 109.795 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -65.89 166.26 11.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 2.84 109.407 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -52.56 -32.87 43.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 3.46 108.559 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -84.61 58.16 4.75 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.771 -1.196 . . . . 4.77 107.771 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.648 ' HZ1' HH12 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -77.0 130.67 74.89 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.684 -0.635 . . . . 5.49 109.295 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -83.9 2.92 7.97 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.007 1.805 . . . . 4.18 113.056 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.58 55.64 1.64 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.775 -1.33 . . . . 3.73 109.775 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.733 ' H ' HH11 ' A' ' 67' ' ' ARG . 57.0 mtpt -131.67 170.19 15.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.643 -0.916 . . . . 4.74 108.991 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.7 179.27 26.85 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.554 -1.418 . . . . 2.52 109.554 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.2 p -79.12 143.72 35.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -1.201 . . . . 2.24 108.934 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -80.19 156.17 27.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.08 -1.013 . . . . 2.3 108.889 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -119.96 140.03 51.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.55 109.904 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -145.04 160.38 41.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 1.2 109.782 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.4 mt -75.94 169.88 17.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 1.44 108.785 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.18 147.88 64.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.085 -1.009 . . . . 3.72 108.767 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' SER . 46.3 Cg_endo -66.82 -154.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.557 2.171 . . . . 4.1 112.422 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -67.69 52.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 6.82 108.939 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' PRO . 10.0 t -60.28 -37.56 80.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.456 -0.778 . . . . 6.0 109.833 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -57.02 -46.32 82.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.911 -1.118 . . . . 11.29 108.051 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -143.36 84.58 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.459 -0.775 . . . . 10.52 108.914 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -91.09 115.57 28.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.751 -0.593 . . . . 8.47 109.435 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -60.9 -40.09 91.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 12.49 108.764 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.79 159.87 29.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 11.95 109.673 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -60.65 149.86 33.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 12.64 108.994 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.62 -116.28 0.51 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.838 -1.305 . . . . 11.27 109.838 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.51 ' HG ' ' N ' ' A' ' 93' ' ' PHE . 84.6 p -60.14 -39.59 86.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.358 -1.084 . . . . 11.98 110.183 -179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.51 ' N ' ' HG ' ' A' ' 92' ' ' SER . 63.0 t80 -86.31 119.65 26.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.923 -1.111 . . . . 11.29 110.104 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.409 ' CD2' ' N ' ' A' ' 94' ' ' LEU . 3.9 mm? . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 108.107 -1.072 . . . . 13.39 108.107 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.416 -0.587 . . . . 5.19 109.416 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.24 139.99 52.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 2.08 109.515 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.53 147.72 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.335 -0.853 . . . . 2.23 109.639 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -82.67 129.51 62.1 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 4.16 108.664 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.95 152.28 24.68 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.649 1.566 . . . . 1.18 112.551 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 -2.48 12.68 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.63 2.22 . . . . 1.18 113.25 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 143.65 57.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.796 -1.19 . . . . 1.92 109.748 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 t -79.79 165.93 22.25 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.142 -1.058 . . . . 1.92 108.142 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.92 -40.07 87.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.795 -1.19 . . . . 2.23 109.003 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.0 mt -68.12 -40.03 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 1.66 109.957 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.51 92.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.952 -1.092 . . . . 1.1 109.902 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.08 -45.17 93.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.768 -1.208 . . . . 1.14 108.332 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.417 ' CD1' HD22 ' A' ' 55' ' ' ASN . 98.1 mt -63.91 -45.81 95.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.971 -0.751 . . . . 1.2 108.971 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.91 -40.61 98.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 1.17 110.573 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.532 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.5 mtm -70.04 -39.12 75.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.823 -1.173 . . . . 1.77 109.529 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.9 90.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.555 -0.715 . . . . 1.09 110.501 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.54 -49.89 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.979 -1.076 . . . . 1.1 108.656 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -61.48 -39.94 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.366 0.603 . . . . 2.34 109.494 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 15' ' ' MET . 76.2 m-20 -78.32 -6.06 53.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 1.71 110.37 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.34 126.47 83.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 1.24 109.639 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -41.24 -20.71 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.688 1.592 . . . . 1.64 110.931 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 20' ' ' ALA . 13.4 pt-20 -138.5 141.92 39.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 2.63 108.141 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -60.59 -34.66 74.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.98 -1.075 . . . . 2.55 109.111 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.68 118.42 20.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 2.13 109.42 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.69 158.6 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.338 -0.851 . . . . 1.18 109.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.405 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 25.4 p -86.5 161.8 18.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 1.4 111.041 -178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 20.1 tp -61.12 -50.26 73.92 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.185 0.993 . . . . 1.39 109.002 179.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -59.97 -39.84 87.06 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.978 -0.556 . . . . 2.03 110.434 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.405 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -56.94 -39.94 89.79 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.004 -1.094 . . . . 0.32 110.404 -179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.8 -40.87 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.938 -1.331 . . . . 1.14 110.272 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 25.1 m-85 -60.03 -40.18 88.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.052 . . . . 2.3 111.142 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -63.34 -37.59 87.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.976 -1.077 . . . . 3.11 110.963 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.01 -45.17 93.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 2.25 110.76 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.423 HG22 HD12 ' A' ' 34' ' ' ILE . 96.8 mt -69.81 -52.87 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.035 -1.041 . . . . 1.26 112.039 -178.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.6 mtm -61.45 -39.97 92.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 1.17 111.283 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.34 -50.49 71.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 1.17 110.847 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -69.97 -39.98 75.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 3.48 111.382 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.581 ' C ' ' H ' ' A' ' 40' ' ' PHE . 89.7 m-85 -122.32 83.04 46.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 2.43 110.34 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.11 -3.93 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.248 1.966 . . . . 1.69 110.758 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.581 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -59.98 -39.99 87.59 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.653 -0.869 . . . . 4.68 108.653 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.0 -29.7 66.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.577 -0.702 . . . . 1.91 110.655 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -60.07 -39.9 87.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 3.01 109.714 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.4 -40.34 96.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 2.34 109.847 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -111.19 77.27 1.03 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.397 -0.594 . . . . 2.6 109.397 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -69.77 -40.03 76.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 2.25 110.04 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.67 148.08 37.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 4.59 110.41 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -61.65 0.35 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.323 -1.111 . . . . 1.34 110.323 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -89.98 -10.3 45.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -1.227 . . . . 0.57 110.786 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.465 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 62.8 tt0 -65.58 -56.79 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.931 -1.106 . . . . 2.03 110.754 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -70.11 -31.76 69.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 2.01 110.603 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -58.51 -39.55 80.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 1.99 110.539 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 5.4 mm -60.09 -49.77 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 1.28 110.236 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -70.05 -36.01 74.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.247 . . . . 3.38 110.426 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -59.92 -40.25 88.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 3.09 109.797 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.548 ' ND2' ' N ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -67.77 -39.99 84.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.511 -1.276 . . . . 2.59 108.396 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.548 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 54.2 mt -60.07 -48.66 80.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 1.29 110.353 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.5 p -70.05 -41.3 74.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 2.04 110.45 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -69.09 -40.15 78.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.025 . . . . 1.92 109.541 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -74.14 119.51 18.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -0.905 . . . . 1.83 108.723 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.76 -9.84 57.8 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 2.17 109.651 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.0 m -60.09 -39.96 87.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 1.92 109.413 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.77 140.67 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 2.22 108.824 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.56 130.1 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.498 -0.751 . . . . 1.48 109.762 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -73.64 135.57 43.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 2.29 109.211 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 77' ' ' TYR . 77.2 t -130.18 126.55 22.33 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.882 -0.785 . . . . 1.95 108.882 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -82.82 170.9 12.26 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.693 1.595 . . . . 2.11 112.263 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.534 ' NH1' ' OH ' ' A' ' 77' ' ' TYR . 20.5 mtt-85 -69.39 -107.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 4.68 109.383 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -148.1 169.91 18.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.654 -0.653 . . . . 2.84 109.312 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -66.34 -33.42 75.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 3.46 110.492 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -60.02 -39.98 87.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.12 -0.988 . . . . 4.77 110.547 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -119.39 118.02 32.68 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.393 -0.817 . . . . 5.49 109.106 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -41.59 163.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.641 1.561 . . . . 4.18 112.133 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.04 76.85 0.57 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.737 -1.345 . . . . 3.73 109.737 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -60.04 -39.95 87.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -1.114 . . . . 4.74 108.645 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.77 160.46 27.98 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.654 -1.778 . . . . 2.52 108.654 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.6 t -99.03 119.39 37.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.146 -1.208 . . . . 2.24 109.505 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.534 ' OH ' ' NH1' ' A' ' 67' ' ' ARG . 9.5 m-30 -75.37 148.9 38.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 2.3 108.944 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -119.97 141.99 49.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.692 -0.63 . . . . 0.55 109.689 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -143.03 160.04 41.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.21 -0.931 . . . . 1.2 109.37 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.0 mt -86.94 136.6 32.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.173 -0.954 . . . . 1.44 109.909 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.27 133.75 77.64 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 3.72 109.043 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.18 -162.46 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.622 1.548 . . . . 4.1 111.475 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -83.35 45.8 1.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 6.82 108.883 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -52.91 -31.16 38.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 6.0 109.852 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -39.3 86.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 11.29 109.462 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -86.91 9.21 20.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 10.52 111.313 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.1 mmt -81.28 143.39 32.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.807 -1.183 . . . . 8.47 109.661 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -150.03 -139.07 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.409 -0.807 . . . . 12.49 108.864 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -91.66 10.56 27.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.032 -1.042 . . . . 11.95 110.213 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -127.32 135.83 51.09 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.515 -0.74 . . . . 12.64 109.301 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.55 89.23 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.813 -1.315 . . . . 11.27 109.813 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.9 m -99.61 14.18 30.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.373 -1.075 . . . . 11.98 109.252 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -60.05 -49.9 75.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 11.29 109.56 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 108.406 -0.961 . . . . 13.39 108.406 178.886 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.588 0.708 . . . . 5.19 109.458 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.0 mt -118.27 142.26 47.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.222 -0.658 . . . . 2.08 109.222 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.84 160.01 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.311 -0.868 . . . . 2.23 109.785 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -86.31 117.29 68.45 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 4.16 109.049 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -50.33 151.39 9.74 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.249 1.299 . . . . 1.18 111.384 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.4 -5.61 16.31 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.313 2.009 . . . . 1.18 112.84 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -69.98 142.06 52.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.022 -1.049 . . . . 1.92 109.792 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -70.89 160.58 32.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.774 -0.825 . . . . 1.92 108.774 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.046 . . . . 2.23 108.748 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.48 -39.54 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 1.66 109.036 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.42 94.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.321 -0.862 . . . . 1.1 110.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.05 -39.94 87.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 1.14 108.895 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.68 -39.99 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.488 -0.758 . . . . 1.2 108.98 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -65.28 -40.05 93.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.745 . . . . 1.17 110.499 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.0 mtm -69.96 -37.78 75.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 1.77 109.792 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.18 90.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 1.09 110.048 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.96 -49.58 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 1.1 108.672 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.74 -39.63 84.22 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.916 -0.584 . . . . 2.34 110.731 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.63 -19.46 65.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 1.71 109.844 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.58 150.12 75.77 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 1.24 109.292 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.79 -52.14 4.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.653 1.568 . . . . 1.64 109.578 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -100.95 135.99 41.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.066 -1.457 . . . . 2.63 107.066 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -64.53 -19.16 65.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.784 -1.198 . . . . 2.55 109.538 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.13 126.13 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 2.13 108.9 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.8 tt -150.16 152.17 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.229 -0.919 . . . . 1.18 109.532 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -79.97 158.74 26.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 1.4 109.659 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.1 tp -60.08 -42.99 95.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.994 -1.113 . . . . 1.39 107.994 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -62.77 -40.0 95.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.643 -0.66 . . . . 2.03 110.544 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -37.38 91.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.656 -1.378 . . . . 0.32 109.656 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.24 -39.97 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -1.137 . . . . 1.14 110.064 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 27.1 m-85 -64.38 -39.45 93.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.703 -1.248 . . . . 2.3 110.335 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -59.91 -40.54 89.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 3.11 108.972 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.9 -50.05 73.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 2.25 110.875 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.67 -50.16 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.089 -1.007 . . . . 1.26 112.175 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.6 mtm -60.64 -40.09 90.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 1.17 110.514 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.32 -48.49 72.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 1.17 111.38 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -69.75 -43.38 72.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.775 -1.203 . . . . 3.48 109.87 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 111.97 39.72 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.548 -0.908 . . . . 2.43 108.548 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.97 -5.76 14.72 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.873 1.715 . . . . 1.69 112.345 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.01 -38.13 81.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.371 -0.831 . . . . 4.68 109.418 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -69.91 -23.29 63.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.107 -0.996 . . . . 1.91 110.612 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -59.97 -40.37 88.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.897 -1.127 . . . . 3.01 109.543 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -62.5 -41.05 98.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 2.34 110.146 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -115.06 98.54 6.85 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.412 -0.588 . . . . 2.6 109.412 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.439 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 61.4 mttp -85.21 -31.79 23.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.93 . . . . 2.25 109.657 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -90.39 145.01 25.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 4.59 110.733 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.34 -63.92 0.29 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.726 -0.95 . . . . 1.34 110.726 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.439 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 36.7 p-90 -73.08 -34.84 66.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.979 -1.306 . . . . 0.57 111.894 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.61 -40.89 93.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.702 -1.249 . . . . 2.03 110.811 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -64.27 -40.03 95.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.876 -1.14 . . . . 2.01 110.607 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.2 m -60.81 -40.02 91.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 1.99 111.1 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.14 -47.97 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 1.28 110.832 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 13.3 mtp180 -69.84 -37.7 76.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.061 . . . . 3.38 109.875 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 74.9 t60 -59.99 -41.88 93.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.368 -0.832 . . . . 3.09 109.675 -179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -64.18 -40.01 95.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 2.59 109.62 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.01 -40.86 90.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 1.29 110.483 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -69.07 -44.66 72.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.93 -1.106 . . . . 2.04 110.64 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.06 -40.0 75.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 1.92 110.027 -179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -74.66 116.11 14.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.899 -1.126 . . . . 1.83 108.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.87 -3.52 57.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 2.17 110.351 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -70.1 -17.9 63.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 1.92 110.172 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.29 153.61 31.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 2.22 109.132 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.9 t -110.06 128.19 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.534 -0.913 . . . . 1.48 108.534 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -96.85 115.57 27.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 2.29 108.876 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 118.43 44.92 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 107.485 -1.302 . . . . 1.95 107.485 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.16 -169.49 0.78 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.714 1.609 . . . . 2.11 113.043 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.493 HH11 ' HG3' ' A' ' 67' ' ' ARG . 3.7 ptm180 -139.64 -164.76 1.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.577 -0.897 . . . . 4.68 108.577 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -69.08 147.09 51.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.844 -1.16 . . . . 2.84 109.517 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -70.07 -11.57 60.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 3.46 110.207 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.04 -38.89 84.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 4.77 110.224 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.483 ' HZ3' ' CZ ' ' A' ' 67' ' ' ARG . 8.7 mtmp? -122.3 81.12 45.32 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.359 -0.838 . . . . 5.49 110.171 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.81 -0.57 10.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.405 2.07 . . . . 4.18 111.618 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.73 95.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.499 -1.44 . . . . 3.73 109.499 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -77.19 140.81 40.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -1.159 . . . . 4.74 109.193 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.03 -177.59 9.18 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.26 -1.536 . . . . 2.52 109.26 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.4 m -80.33 159.73 25.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -1.191 . . . . 2.24 109.682 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -70.92 150.98 45.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 2.3 109.653 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -121.02 130.7 53.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.599 -0.688 . . . . 0.55 109.437 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 164.28 33.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -0.792 . . . . 1.2 109.193 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.96 65.65 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.319 -0.863 . . . . 1.44 109.09 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -152.72 83.5 4.81 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.166 -0.959 . . . . 3.72 110.583 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.428 ' O ' ' OD1' ' A' ' 83' ' ' ASP . 31.4 Cg_exo -57.06 -77.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.572 2.181 . . . . 4.1 112.186 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 82' ' ' PRO . 63.8 m-20 -155.64 41.56 0.41 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.943 -1.132 . . . . 6.82 107.943 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 m -59.97 -39.8 86.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.703 -0.623 . . . . 6.0 110.632 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -29.54 64.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.66 -1.275 . . . . 11.29 109.462 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -77.7 -7.37 56.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.987 . . . . 10.52 109.744 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.3 mtt -90.69 104.24 16.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.512 -0.743 . . . . 8.47 109.041 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.98 -0.06 57.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 12.49 109.911 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -98.47 155.6 17.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.198 -0.939 . . . . 11.95 109.777 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -90.58 10.73 24.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.365 -0.834 . . . . 12.64 109.948 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.52 70.01 0.04 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.921 -1.672 . . . . 11.27 108.921 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 t -72.37 -69.27 0.41 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.475 -1.015 . . . . 11.98 109.537 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -72.92 -31.84 64.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 11.29 109.863 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.176 -0.953 . . . . 13.39 109.872 -178.668 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.333 -0.617 . . . . 5.19 109.333 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.9 mt -101.31 141.33 34.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.36 -0.837 . . . . 2.08 109.878 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.02 160.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.578 -0.701 . . . . 2.23 109.457 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -71.19 149.07 94.29 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 4.16 109.435 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.1 Cg_endo -78.21 138.45 16.05 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.179 1.92 . . . . 1.18 111.833 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -39.79 -23.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.613 2.209 . . . . 1.18 113.871 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 5' ' ' PRO . 3.6 m-85 -59.96 137.44 58.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 1.92 110.139 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 p -83.1 173.82 11.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.506 -0.746 . . . . 1.92 109.014 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -62.94 -37.94 89.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 2.23 109.113 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -68.22 -41.28 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 1.66 109.741 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.43 86.18 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -0.937 . . . . 1.1 110.533 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.11 -39.86 87.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.238 -1.023 . . . . 1.14 108.238 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.0 mt -66.44 -45.36 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.841 . . . . 1.2 109.184 178.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -42.91 99.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 1.17 111.066 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.9 mtm -70.0 -40.01 75.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 1.77 110.862 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.69 -43.29 72.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -1.0 . . . . 1.09 109.449 -179.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.9 mt -59.93 -45.97 94.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.492 -0.929 . . . . 1.1 108.492 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.0 -45.07 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.193 0.52 . . . . 2.34 110.501 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 15' ' ' MET . 15.6 p30 -91.11 15.44 11.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.866 -1.146 . . . . 1.71 109.874 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.37 129.5 74.64 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 1.24 108.521 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -40.6 -38.05 2.42 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.544 1.496 . . . . 1.64 110.885 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -124.54 154.23 40.91 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.253 -1.388 . . . . 2.63 107.253 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.782 -1.199 . . . . 2.55 108.489 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -90.64 125.84 35.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 2.13 109.031 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.8 tt -132.48 158.16 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.441 -0.787 . . . . 1.18 109.491 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -81.93 158.51 23.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 1.4 110.022 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.5 tp -59.97 -49.0 79.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.488 -0.758 . . . . 1.39 109.005 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -59.95 -39.57 86.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.541 -0.724 . . . . 2.03 109.843 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.58 -40.16 96.0 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.285 -0.96 . . . . 0.32 110.946 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.402 HD12 HG22 ' A' ' 30' ' ' ILE . 84.3 mt -60.71 -42.45 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.841 -1.388 . . . . 1.14 109.555 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -60.94 -40.93 95.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 2.3 110.94 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.244 -0.91 . . . . 3.11 109.5 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -59.92 -47.79 84.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 2.25 109.771 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.97 -50.07 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.264 -0.897 . . . . 1.26 110.576 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.86 -39.9 95.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.879 -1.138 . . . . 1.17 110.216 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.11 -40.1 90.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.109 -0.994 . . . . 1.17 109.519 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -69.12 -54.05 17.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 3.48 110.351 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -110.71 123.56 35.26 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 2.43 109.912 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.84 -6.34 15.93 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.011 1.807 . . . . 1.69 111.197 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.03 -44.56 94.54 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.505 0.669 . . . . 4.68 109.541 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -70.07 -27.17 64.4 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.495 -0.753 . . . . 1.91 110.649 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -60.03 -39.77 87.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.849 -1.157 . . . . 3.01 108.581 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.32 -2.7 29.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 2.34 109.401 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 21.5 t-20 -144.47 98.54 3.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.548 -0.72 . . . . 2.6 109.104 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.415 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 56.3 mtpt -98.04 -32.93 11.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 2.25 110.626 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.84 143.11 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.876 -1.14 . . . . 4.59 110.398 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.61 -72.15 0.27 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.096 -1.201 . . . . 1.34 110.096 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 18.8 p-90 -69.96 -39.35 76.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.208 -1.172 . . . . 0.57 110.874 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.689 HE21 ' NH2' ' A' ' 53' ' ' ARG . 53.5 tt0 -59.99 -50.07 75.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 2.03 110.978 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -73.49 -31.69 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.936 -1.103 . . . . 2.01 110.044 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.8 m -59.93 -40.21 88.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 1.99 110.258 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 mt -69.88 -43.62 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 1.28 109.138 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.689 ' NH2' HE21 ' A' ' 49' ' ' GLN . 67.2 mtt180 -59.99 -47.18 86.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.718 -1.239 . . . . 3.38 108.417 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -60.8 -40.03 91.13 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 3.09 108.467 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.07 -39.94 95.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.861 -0.792 . . . . 2.59 108.861 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 32.5 mt -59.99 -45.87 91.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 1.29 110.105 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.35 -42.44 99.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.902 -1.124 . . . . 2.04 109.337 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 51.6 mt -70.02 -37.22 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 1.92 109.775 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -69.18 117.84 11.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 1.83 109.898 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -90.7 -10.96 41.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 2.17 108.962 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.94 -40.04 87.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.425 -0.797 . . . . 1.92 109.673 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.48 146.19 32.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.297 -0.877 . . . . 2.22 109.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.98 125.35 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.175 -1.046 . . . . 1.48 108.175 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' NZ ' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.42 135.57 38.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 2.29 109.903 -178.64 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.43 139.02 31.48 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.642 -0.873 . . . . 1.95 108.642 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -79.41 -155.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.254 1.969 . . . . 2.11 112.36 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -140.85 169.49 17.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 4.68 108.876 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -60.03 145.49 46.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.043 -1.035 . . . . 2.84 109.316 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.08 -19.87 63.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 3.46 109.998 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -71.17 -9.33 57.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 4.77 110.259 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -130.07 75.3 79.6 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.301 -0.875 . . . . 5.49 110.218 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -86.71 179.59 3.32 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.995 2.463 . . . . 4.18 111.585 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.1 12.7 83.01 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.808 -1.317 . . . . 3.73 109.808 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -122.05 157.54 31.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.618 -0.93 . . . . 4.74 109.117 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.0 -178.11 37.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.338 -1.105 . . . . 2.52 110.338 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -80.0 143.25 34.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -1.047 . . . . 2.24 110.093 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -79.98 159.66 26.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.397 -0.814 . . . . 2.3 109.509 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -132.15 151.53 51.74 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.366 -0.834 . . . . 0.55 109.492 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.5 t -149.99 169.98 19.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.967 -1.083 . . . . 1.2 110.347 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.44 161.46 27.09 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 1.44 110.551 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.35 166.98 16.93 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.991 -0.744 . . . . 3.72 108.991 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.83 -136.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.718 1.612 . . . . 4.1 111.686 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 35.5 p-10 -71.16 -0.7 10.31 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.102 -1.073 . . . . 6.82 108.102 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 m -81.53 37.78 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.688 -0.633 . . . . 6.0 110.032 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.535 ' CE2' ' OD1' ' A' ' 86' ' ' ASN . 10.2 p90 -61.55 -51.31 69.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.057 -1.027 . . . . 11.29 111.182 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.535 ' OD1' ' CE2' ' A' ' 85' ' ' TYR . 51.8 p30 -136.48 21.05 3.14 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.13 -0.981 . . . . 10.52 110.3 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.462 ' C ' ' SD ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -47.49 173.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.555 -0.715 . . . . 8.47 109.907 -179.734 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.0 103.97 16.62 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.144 -1.058 . . . . 12.49 108.144 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -53.64 129.82 34.23 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.361 -0.837 . . . . 11.95 109.611 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -151.24 -163.22 1.71 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 12.64 108.995 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.68 -50.6 59.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.361 -1.496 . . . . 11.27 109.361 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.4 p -160.38 114.2 2.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 11.98 109.438 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -124.9 8.08 8.08 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.502 -0.749 . . . . 11.29 109.02 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.0 tp . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.515 -0.741 . . . . 13.39 109.148 179.839 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.954 -0.758 . . . . 5.19 108.954 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.7 mt -76.18 151.21 36.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.036 -1.04 . . . . 2.08 109.486 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.98 152.76 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.625 -0.672 . . . . 2.23 109.372 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -52.5 129.26 43.68 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 4.16 109.033 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -42.52 158.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.985 1.79 . . . . 1.18 112.384 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.55 -9.25 18.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.542 2.161 . . . . 1.18 112.878 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -67.34 143.32 56.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.955 -1.091 . . . . 1.92 108.993 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.547 ' HG ' ' N ' ' A' ' 9' ' ' TYR . 29.9 t -69.65 159.98 32.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -0.973 . . . . 1.92 108.573 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.547 ' N ' ' HG ' ' A' ' 8' ' ' SER . 74.9 m-85 -59.9 -39.97 87.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.934 -1.104 . . . . 2.23 108.465 -179.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.432 HD11 HG22 ' A' ' 10' ' ' ILE . 96.6 mt -66.53 -39.95 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.786 . . . . 1.66 109.395 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.02 95.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 1.1 110.103 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.06 -40.07 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.198 -0.939 . . . . 1.14 108.588 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.66 -41.93 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 1.2 108.91 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -60.49 -40.1 90.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 1.17 109.676 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.43 -39.94 89.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 1.77 109.175 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.65 85.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.629 -0.67 . . . . 1.09 110.474 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.06 -49.86 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.059 -1.026 . . . . 1.1 108.973 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.57 -40.51 92.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.837 -0.539 . . . . 2.34 110.157 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -70.69 -20.61 62.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 1.71 110.372 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.06 119.85 77.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.091 -1.006 . . . . 1.24 109.812 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.99 -29.55 1.58 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.409 1.406 . . . . 1.64 110.719 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -115.09 128.13 56.04 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.612 -1.255 . . . . 2.63 107.612 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -69.93 -27.31 64.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.922 -1.111 . . . . 2.55 110.142 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -78.54 74.28 5.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.951 -1.093 . . . . 2.13 109.354 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -88.57 147.46 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.815 -0.809 . . . . 1.18 108.815 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -79.04 159.56 27.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 1.4 109.851 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 33.1 tp -60.42 -50.01 75.3 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.63 0.729 . . . . 1.39 109.839 -179.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 2.03 109.744 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -38.62 94.36 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.495 -1.042 . . . . 0.32 110.495 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.424 HD11 HG22 ' A' ' 30' ' ' ILE . 87.9 mt -60.02 -43.71 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.973 -1.31 . . . . 1.14 109.933 -179.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -59.99 -45.38 92.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.953 -1.092 . . . . 2.3 110.366 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -59.98 -40.12 88.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 3.11 110.265 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.92 -46.55 89.01 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.141 -0.974 . . . . 2.25 109.412 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.0 mt -65.78 -49.94 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 1.26 111.499 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.0 mtm -61.11 -40.0 92.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.935 -1.103 . . . . 1.17 110.98 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -66.67 -39.93 88.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 1.17 110.555 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -76.94 -67.04 0.75 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 3.48 111.129 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -85.96 130.44 50.37 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.731 -1.23 . . . . 2.43 109.907 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.63 -13.26 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.186 1.924 . . . . 1.69 113.204 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.94 -44.37 94.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.998 -1.064 . . . . 4.68 110.288 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -70.2 -29.21 66.0 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 1.91 111.114 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.949 -1.094 . . . . 3.01 110.124 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -93.2 0.05 57.0 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.003 -1.061 . . . . 2.34 110.264 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.548 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 59.1 t30 -124.27 129.05 50.08 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.271 0.557 . . . . 2.6 109.547 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -129.12 17.89 6.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.512 -0.742 . . . . 2.25 109.402 -179.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -70.43 -160.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 4.59 111.871 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.61 -9.21 0.25 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 116.112 -0.494 . . . . 1.34 111.917 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.548 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -59.99 -35.99 76.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.218 -1.754 . . . . 0.57 107.721 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.38 -44.12 97.69 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.757 -0.589 . . . . 2.03 111.154 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -80.32 -26.58 38.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.002 -1.061 . . . . 2.01 111.703 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -69.39 -23.58 63.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.763 -1.211 . . . . 1.99 110.868 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -69.99 -61.66 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.006 -1.059 . . . . 1.28 111.394 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -70.01 -30.92 68.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.159 -0.963 . . . . 3.38 111.216 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.21 -36.82 78.54 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.912 -1.117 . . . . 3.09 109.648 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 98.5 m-20 -69.94 -19.24 63.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 2.59 111.14 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.91 -45.1 93.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.909 -1.119 . . . . 1.29 110.385 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.8 p -69.98 -39.6 75.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.968 -1.082 . . . . 2.04 110.102 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.16 -39.95 88.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.92 110.028 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 83.2 m-20 -64.52 119.0 9.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 1.83 109.601 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -81.97 -37.73 26.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 2.17 110.294 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.5 m -65.31 -11.54 42.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 1.92 109.769 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.44 131.17 36.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 2.22 109.122 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.3 t -97.19 127.94 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.276 -0.89 . . . . 1.48 109.101 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -103.71 118.0 35.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 2.29 110.174 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.463 ' O ' ' OG ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -113.24 118.19 44.36 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 107.867 -1.161 . . . . 1.95 107.867 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.71 154.34 43.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.415 1.41 . . . . 2.11 112.367 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -74.07 157.06 36.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.39 -0.819 . . . . 4.68 109.562 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.12 140.05 57.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 2.84 109.585 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -70.0 -19.84 63.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.302 -0.874 . . . . 3.46 109.211 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -60.08 -40.54 89.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 4.77 109.401 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -132.67 82.35 56.61 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.443 -0.786 . . . . 5.49 109.252 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.4 176.64 8.46 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.221 1.947 . . . . 4.18 111.854 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.12 -69.72 0.34 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.282 -1.527 . . . . 3.73 109.282 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' GLY . 68.2 mttm -77.41 149.92 35.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -1.136 . . . . 4.74 109.314 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -45.82 -93.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.043 -1.223 . . . . 2.52 110.043 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 65' ' ' VAL . 7.0 t -152.4 160.05 43.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -1.11 . . . . 2.24 109.612 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -77.71 157.69 29.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 2.3 109.422 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -130.19 130.7 45.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.55 109.743 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.2 t -149.82 159.44 44.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 1.2 109.542 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 81' ' ' ASP . 91.4 mt -80.71 -161.19 0.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 1.44 109.717 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 80' ' ' LEU . 3.0 p-10 -49.98 173.06 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.698 -0.853 . . . . 3.72 108.698 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -66.51 -146.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.794 1.663 . . . . 4.1 112.077 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' TYR . 88.6 m-20 -90.96 17.39 7.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.437 -0.789 . . . . 6.82 109.485 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 92.8 p -47.08 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 6.0 109.064 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -79.93 -70.04 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 11.29 109.658 -178.887 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -127.6 13.08 6.96 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.926 0.87 . . . . 10.52 108.972 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 47.4 mtm -88.68 107.79 19.12 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.697 -0.853 . . . . 8.47 108.697 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -70.0 -39.39 75.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 12.49 110.411 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.56 148.18 52.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 11.95 110.435 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -98.31 11.86 36.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.42 -0.8 . . . . 12.64 110.138 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -151.16 75.61 0.25 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.032 -1.227 . . . . 11.27 110.032 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -145.19 -39.65 0.25 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.103 -1.234 . . . . 11.98 109.619 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 93' ' ' PHE . 62.5 t80 -75.74 -18.91 59.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 11.29 110.682 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 9.3 mp . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.776 -1.202 . . . . 13.39 109.005 -179.294 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.373 0.606 . . . . 5.19 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.0 mt -74.81 149.3 39.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 2.08 109.451 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.08 171.15 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.74 -0.837 . . . . 2.23 108.74 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -88.56 113.25 54.75 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.741 . . . . 4.16 109.225 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' TYR . 83.6 Cg_exo -48.73 122.9 8.74 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.639 1.559 . . . . 1.18 112.218 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.11 -8.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.274 1.983 . . . . 1.18 113.65 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.8 m-85 -71.96 144.52 48.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.707 -1.246 . . . . 1.92 109.926 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 m -82.31 169.94 15.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 1.92 109.419 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -60.09 -39.96 87.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.14 -0.975 . . . . 2.23 109.158 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.81 -39.9 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 1.66 109.181 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -47.62 84.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 1.1 110.342 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.07 -41.45 92.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.789 -1.194 . . . . 1.14 108.436 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.32 -42.05 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.048 -1.093 . . . . 1.2 108.048 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.16 -40.02 94.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.584 -0.697 . . . . 1.17 109.47 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.26 -39.92 82.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 1.77 109.603 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.01 81.11 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.329 -0.857 . . . . 1.09 109.252 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.1 mt -61.1 -50.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 1.1 108.757 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -61.23 -40.01 92.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.632 -0.668 . . . . 2.34 109.839 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -78.05 -4.16 45.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 1.71 108.967 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -80.05 119.3 76.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.589 -0.893 . . . . 1.24 108.589 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -40.41 -26.72 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.675 1.583 . . . . 1.64 111.594 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 20' ' ' ALA . 20.7 pt-20 -134.7 153.93 51.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.036 -1.098 . . . . 2.63 108.036 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -67.74 -31.56 71.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 2.55 110.825 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -78.87 123.42 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.686 -1.259 . . . . 2.13 109.704 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 tt -140.39 153.8 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.285 -0.884 . . . . 1.18 109.543 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.1 p -81.91 152.63 26.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 1.4 110.197 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.0 -49.06 79.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.684 -0.858 . . . . 1.39 108.684 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.9 -40.11 87.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.453 -0.78 . . . . 2.03 109.811 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.77 94.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.581 -1.008 . . . . 0.32 110.581 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.04 -41.54 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.317 . . . . 1.14 110.033 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CD1' ' NE2' ' A' ' 49' ' ' GLN . 38.9 m-85 -59.99 -45.37 92.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 2.3 110.731 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.94 -37.32 84.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.041 -1.037 . . . . 3.11 110.852 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.98 -49.04 79.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 2.25 110.68 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.06 -49.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 1.26 110.693 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.47 -39.93 92.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.918 -1.114 . . . . 1.17 110.476 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.52 -40.01 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 1.17 109.47 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -79.76 -69.39 0.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 3.48 109.483 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -89.47 116.53 66.58 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.983 . . . . 2.43 109.019 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.52 -3.93 12.72 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.88 1.72 . . . . 1.69 111.235 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -60.06 -39.75 87.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.594 -0.891 . . . . 4.68 108.594 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' ASN . 93.3 m-85 -69.87 -27.15 64.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.567 -0.708 . . . . 1.91 110.521 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -59.2 -39.96 84.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.823 -1.173 . . . . 3.01 107.994 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -61.3 -40.77 95.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 2.34 109.631 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -111.5 108.5 18.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.329 -0.619 . . . . 2.6 109.329 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -96.64 -40.74 8.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.067 -1.02 . . . . 2.25 110.513 -179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.21 142.97 27.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.169 -0.957 . . . . 4.59 110.536 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.77 -55.74 0.49 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.562 -1.415 . . . . 1.34 109.562 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 25.6 p-90 -89.23 -3.07 58.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -1.185 . . . . 0.57 109.256 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' NE2' ' CD1' ' A' ' 31' ' ' TYR . 67.3 tp60 -74.08 -61.7 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 2.03 111.089 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -69.55 -39.93 77.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.302 -0.873 . . . . 2.01 110.656 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.2 m -50.84 -31.09 16.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 1.99 111.008 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.29 -65.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.003 -1.06 . . . . 1.28 110.894 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -69.94 -30.02 67.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 3.38 110.6 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.769 -1.207 . . . . 3.09 108.491 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.427 ' OD1' ' OD1' ' A' ' 59' ' ' ASN . 27.2 t-20 -61.08 -42.86 99.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 2.59 110.144 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.96 -41.66 92.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.993 . . . . 1.29 110.239 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 p -64.05 -50.64 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 2.04 110.625 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 mp -69.94 -40.09 75.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.929 -1.107 . . . . 1.92 110.056 -179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.651 ' N ' HD21 ' A' ' 59' ' ' ASN . 0.8 OUTLIER -66.73 122.11 16.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.192 -0.943 . . . . 1.83 109.58 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -86.09 -10.2 55.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 2.17 109.34 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.26 -40.02 92.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.288 -0.883 . . . . 1.92 109.061 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -82.74 129.29 34.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.348 -0.982 . . . . 2.22 108.348 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.94 119.93 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 1.48 109.534 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.88 150.06 24.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.298 -1.001 . . . . 2.29 108.298 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.01 91.55 22.94 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.31 -0.869 . . . . 1.95 109.789 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -47.35 133.92 20.06 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.712 1.608 . . . . 2.11 111.318 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.541 HH11 ' H ' ' A' ' 74' ' ' LYS . 47.2 mtp180 -59.32 152.14 21.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 4.68 109.984 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -68.2 153.99 42.63 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.372 -0.973 . . . . 2.84 108.372 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -69.48 -20.07 63.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.069 -1.019 . . . . 3.46 108.881 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -62.95 -40.07 96.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.71 . . . . 4.77 109.883 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -135.53 85.12 32.26 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 5.49 109.393 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.66 164.77 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.752 2.302 . . . . 4.18 112.335 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.71 -94.91 0.11 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.764 -1.334 . . . . 3.73 109.764 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.541 ' H ' HH11 ' A' ' 67' ' ' ARG . 61.5 mttp -71.63 157.47 37.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.362 -1.081 . . . . 4.74 109.579 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -44.9 -98.51 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.658 -0.977 . . . . 2.52 110.658 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.1 m -144.88 158.58 43.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.003 -1.293 . . . . 2.24 110.152 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -80.01 162.14 25.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.487 -0.758 . . . . 2.3 109.685 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -122.96 130.98 53.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.227 -0.657 . . . . 0.55 109.227 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 161.67 40.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.331 -0.855 . . . . 1.2 109.528 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 81' ' ' ASP . 76.5 mt -73.15 169.72 16.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.44 109.325 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -46.73 167.44 0.15 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 3.72 109.19 -179.21 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 81' ' ' ASP . 51.2 Cg_exo -53.98 -145.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.195 1.93 . . . . 4.1 113.371 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 85' ' ' TYR . 96.0 m-20 -99.53 24.86 7.65 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.341 -0.85 . . . . 6.82 109.263 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.522 ' C ' ' O ' ' A' ' 83' ' ' ASP . 6.2 m 1.95 61.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 112.934 0.716 . . . . 6.0 112.934 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 83' ' ' ASP . 54.3 t80 -90.07 -28.42 19.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 11.29 109.002 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -99.88 13.0 35.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.394 -0.816 . . . . 10.52 109.9 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.476 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 65.4 mmm -85.41 119.32 25.64 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.217 -0.927 . . . . 8.47 109.825 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.457 ' C ' ' H ' ' A' ' 90' ' ' ASN . 49.6 p90 -118.71 25.43 10.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.898 -0.779 . . . . 12.49 108.898 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -57.41 -9.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 11.95 109.535 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.457 ' H ' ' C ' ' A' ' 88' ' ' PHE . 23.8 m120 -132.89 142.02 48.69 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.346 -0.612 . . . . 12.64 109.346 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.92 -37.91 93.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.177 -1.569 . . . . 11.27 109.177 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.8 m -60.01 -39.96 87.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -1.115 . . . . 11.98 109.562 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 87' ' ' MET . 1.3 t80 -74.92 55.98 0.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 11.29 109.094 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.5 tp . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.051 -1.031 . . . . 13.39 109.576 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.48 -0.563 . . . . 5.19 109.48 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.2 mt -70.56 140.86 51.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.89 . . . . 2.08 109.743 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -140.88 148.1 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.387 -0.821 . . . . 2.23 108.977 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -74.5 145.3 82.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.018 -1.051 . . . . 4.16 108.811 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.56 161.21 44.71 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.408 2.072 . . . . 1.18 112.162 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.64 -2.62 12.86 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.519 2.146 . . . . 1.18 112.685 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -64.93 137.45 57.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.814 -1.179 . . . . 1.92 108.735 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -77.83 168.67 19.55 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.285 -1.006 . . . . 1.92 108.285 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -60.0 -37.85 80.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.022 -1.049 . . . . 2.23 108.617 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.9 mm -60.11 -46.29 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 1.66 109.613 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.81 95.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -0.872 . . . . 1.1 110.452 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.76 -40.14 91.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.925 -1.109 . . . . 1.14 108.64 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.12 -42.2 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.471 -0.937 . . . . 1.2 108.471 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -64.38 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 1.17 110.358 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtt -66.32 -39.34 89.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.89 . . . . 1.77 109.658 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.4 92.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.542 -0.724 . . . . 1.09 110.252 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.605 ' CG2' ' HZ2' ' A' ' 23' ' ' LYS . 62.3 mt -69.57 -49.14 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.106 -0.997 . . . . 1.1 109.431 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.03 -40.03 90.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 2.34 110.612 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -82.16 -10.6 59.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 1.71 110.78 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.07 149.17 72.88 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.942 -1.099 . . . . 1.24 109.022 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.62 -57.03 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.441 1.427 . . . . 1.64 110.359 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -104.98 127.07 52.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.94 -1.133 . . . . 2.63 107.94 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.605 ' HZ2' ' CG2' ' A' ' 17' ' ' ILE . 8.7 mtpm? -60.33 -28.91 68.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.962 -1.086 . . . . 2.55 108.927 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -78.05 82.41 4.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.956 -1.127 . . . . 2.13 107.956 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 tt -111.87 148.55 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.767 -0.827 . . . . 1.18 108.767 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.486 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 30.7 p -79.03 161.07 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.116 -0.99 . . . . 1.4 109.233 -179.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.4 tp -60.04 -42.63 94.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 1.39 108.962 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.76 -40.01 90.91 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.286 -0.884 . . . . 2.03 109.643 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.486 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -60.71 -35.99 90.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.84 -1.304 . . . . 0.32 109.84 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.76 -41.16 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -1.153 . . . . 1.14 110.293 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -60.0 -40.1 88.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.531 -1.355 . . . . 2.3 109.383 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.98 -40.35 88.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.462 -0.774 . . . . 3.11 109.798 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.71 -47.22 73.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 2.25 110.701 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.2 -49.88 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 1.26 110.678 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.1 mtm -62.13 -39.99 94.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.892 -1.13 . . . . 1.17 109.548 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.01 -49.64 75.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 1.17 110.401 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -70.04 -58.85 3.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.921 -1.112 . . . . 3.48 109.848 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -100.04 112.83 64.73 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 2.43 108.892 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.03 -10.16 14.0 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.028 1.819 . . . . 1.69 112.64 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -60.07 -38.17 82.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 4.68 108.953 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 44' ' ' ASN . 69.4 m-85 -63.89 -28.75 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.666 -0.646 . . . . 1.91 110.952 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.89 -39.93 87.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.83 -1.169 . . . . 3.01 109.372 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.77 -40.08 93.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 2.34 109.461 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -114.45 104.74 12.34 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 2.6 108.498 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 53.8 mtpt -98.47 -32.58 11.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 2.25 110.67 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -89.72 137.02 32.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.069 -1.02 . . . . 4.59 110.028 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.44 -64.9 0.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.96 -1.256 . . . . 1.34 109.96 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.451 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 38.0 p-90 -72.88 -37.06 67.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.108 -1.231 . . . . 0.57 110.51 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -60.09 -45.38 93.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 2.03 110.369 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -68.86 -37.66 79.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 2.01 110.255 -179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 m -59.85 -39.35 84.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 1.99 110.043 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.3 mm -60.01 -46.81 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 1.28 110.224 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.416 HH11 ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -64.75 -41.49 95.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 3.38 109.708 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -60.03 -45.25 93.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.841 . . . . 3.09 109.832 -179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.07 -39.96 94.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -0.915 . . . . 2.59 109.666 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.89 -46.87 87.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 1.29 110.263 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -64.73 -44.46 90.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.884 -1.135 . . . . 2.04 109.453 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 26.9 mt -67.88 -43.26 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.92 109.678 179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -85.07 106.89 16.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 1.83 108.76 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -91.01 10.29 27.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 2.17 109.449 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.41 -26.05 67.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.838 . . . . 1.92 109.927 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -79.76 147.91 31.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 2.22 109.122 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.427 ' CG2' ' H ' ' A' ' 81' ' ' ASP . 22.9 t -90.61 118.52 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 1.48 109.08 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -92.33 100.23 12.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 2.29 109.239 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.88 123.78 44.24 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.494 -0.928 . . . . 1.95 108.494 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.89 172.89 11.63 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.013 1.809 . . . . 2.11 112.604 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' NH2' ' OH ' ' A' ' 77' ' ' TYR . 16.7 mtt-85 -80.01 159.28 26.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.454 -0.779 . . . . 4.68 109.08 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 7.3 t70 -81.27 167.52 19.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.373 -0.83 . . . . 2.84 110.032 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 87.2 m-20 -62.27 -36.72 82.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.526 -0.734 . . . . 3.46 109.968 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -59.77 -39.84 86.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 4.77 109.381 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -90.62 149.18 40.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.191 -0.943 . . . . 5.49 109.249 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 74' ' ' LYS . 74.1 Cg_endo -74.81 130.56 13.59 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.256 1.971 . . . . 4.18 110.814 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.11 78.17 0.01 OUTLIER Glycine 0 N--CA 1.495 2.576 0 C-N-CA 120.376 -0.916 . . . . 3.73 111.413 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 72' ' ' PRO . 16.2 mtpp -70.23 -39.71 74.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.266 . . . . 4.74 109.104 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.71 -175.88 46.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.362 -1.495 . . . . 2.52 109.362 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 p -97.9 139.82 33.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.272 -1.134 . . . . 2.24 109.387 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.541 ' OH ' ' NH2' ' A' ' 67' ' ' ARG . 29.6 m-85 -87.47 144.22 26.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.101 -1.0 . . . . 2.3 109.291 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -114.56 130.79 56.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.523 -0.735 . . . . 0.55 109.288 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.547 ' HG1' ' HZ3' ' A' ' 23' ' ' LYS . 15.3 t -158.51 153.67 25.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.943 . . . . 1.2 109.583 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 mt -95.08 100.12 11.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 1.44 109.316 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.427 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 1.5 m-20 -140.04 79.05 23.1 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.359 -0.838 . . . . 3.72 109.447 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.87 -141.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.926 2.417 . . . . 4.1 112.293 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 85' ' ' TYR . 40.9 p-10 -93.08 31.79 1.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.363 -0.835 . . . . 6.82 109.242 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -49.57 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.429 -0.795 . . . . 6.0 109.644 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.604 ' CD2' ' ND2' ' A' ' 86' ' ' ASN . 55.8 t80 -61.83 -50.06 73.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 11.29 109.956 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.604 ' ND2' ' CD2' ' A' ' 85' ' ' TYR . 2.8 m-80 -146.52 24.11 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.947 . . . . 10.52 108.933 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 14.4 mmt -69.49 120.34 15.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.319 -0.863 . . . . 8.47 109.403 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -96.53 -27.72 14.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.254 -0.904 . . . . 12.49 109.505 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' ASN . 50.3 mt-10 -141.25 172.74 12.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.794 . . . . 11.95 109.02 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 92' ' ' SER . 7.8 m120 -44.16 166.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 12.64 109.847 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.25 50.35 0.12 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.489 -1.044 . . . . 11.27 110.489 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 90' ' ' ASN . 45.7 t -70.97 -13.77 62.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -1.207 . . . . 11.98 108.727 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -55.57 172.03 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.812 0.815 . . . . 11.29 110.105 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.522 ' CD1' ' N ' ' A' ' 94' ' ' LEU . 7.9 mp . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.674 -0.641 . . . . 13.39 109.47 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.9 ttp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.873 0.844 . . . . 5.19 108.934 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.89 142.83 32.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.922 . . . . 2.08 109.409 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.9 m -145.74 152.75 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.245 -0.909 . . . . 2.23 109.391 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -45.98 107.68 0.71 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.407 -0.808 . . . . 4.16 109.331 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -50.79 150.84 11.9 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.922 1.748 . . . . 1.18 112.988 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.1 16.9 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.531 2.154 . . . . 1.18 111.691 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -101.22 135.81 42.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.385 -0.822 . . . . 1.92 109.455 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.649 ' HG ' ' H ' ' A' ' 11' ' ' ALA . 91.8 p -80.21 170.01 17.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.435 -0.791 . . . . 1.92 109.281 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 2.23 108.913 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.05 -40.14 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 1.66 108.542 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.649 ' H ' ' HG ' ' A' ' 8' ' ' SER . . . -66.82 -46.82 73.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 1.1 109.492 179.593 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.06 -40.85 90.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.043 -1.035 . . . . 1.14 108.336 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.5 mt -69.91 -41.54 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 1.2 108.959 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -39.94 95.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 1.17 109.268 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.522 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.3 mtt -68.06 -40.0 82.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 1.77 108.829 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -49.5 77.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.567 -0.708 . . . . 1.09 110.073 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.04 -49.9 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 1.1 109.255 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.43 -39.66 92.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.852 -0.53 . . . . 2.34 110.266 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 15' ' ' MET . 69.4 m-80 -80.3 5.0 15.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 1.71 110.112 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.1 148.37 74.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.971 -1.081 . . . . 1.24 109.76 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -33.6 -84.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.912 2.408 . . . . 1.64 112.849 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -90.02 -80.05 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.685 -1.259 . . . . 2.63 108.542 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -159.16 -33.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.895 -1.128 . . . . 2.55 110.117 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -81.42 129.85 34.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.994 -1.066 . . . . 2.13 110.142 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -130.75 138.74 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.611 -0.885 . . . . 1.18 108.611 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.2 p -79.99 162.31 24.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 1.4 109.965 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.1 tp -60.04 -47.01 87.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.671 -0.862 . . . . 1.39 108.671 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.442 ' O ' ' OE1' ' A' ' 32' ' ' GLN . 79.7 m-20 -62.55 -39.93 95.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 2.03 109.844 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.07 91.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.536 -1.026 . . . . 0.32 110.536 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.97 -40.69 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.987 -1.302 . . . . 1.14 109.381 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -60.07 -48.68 80.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.108 -0.995 . . . . 2.3 109.955 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 28' ' ' ASN . 4.8 mp0 -59.92 -37.79 80.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 3.11 109.488 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -59.99 -49.99 75.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 2.25 109.64 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -49.97 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.002 -1.061 . . . . 1.26 110.824 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.5 mtm -65.02 -43.49 92.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.89 -1.131 . . . . 1.17 110.781 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.36 -44.86 86.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 1.17 110.626 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HG3' HH11 ' A' ' 37' ' ' ARG . 21.7 mmm-85 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.019 -1.051 . . . . 3.48 110.541 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.55 ' C ' ' H ' ' A' ' 40' ' ' PHE . 70.4 m-85 -124.05 82.53 56.31 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.418 -0.801 . . . . 2.43 109.766 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.45 -6.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.562 2.174 . . . . 1.69 111.779 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.55 ' H ' ' C ' ' A' ' 38' ' ' PHE . 49.6 t80 -59.94 -42.76 94.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.515 -0.74 . . . . 4.68 109.898 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.03 -22.15 63.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 1.91 110.937 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -39.84 86.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.912 -1.117 . . . . 3.01 109.705 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.54 2.85 43.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 2.34 109.728 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.501 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 81.3 m-20 -133.92 115.67 14.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.626 -0.672 . . . . 2.6 109.832 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' GLN . 56.0 mttp -110.47 13.74 22.68 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.477 -0.935 . . . . 2.25 108.477 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 48' ' ' TRP . 87.7 mt-30 -47.39 -177.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.995 0.902 . . . . 4.59 111.401 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.9 -8.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.932 -0.867 . . . . 1.34 110.932 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' A' ' 46' ' ' GLN . 3.8 p-90 -59.87 -40.75 89.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.575 -1.544 . . . . 0.57 107.939 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.514 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 58.5 tt0 -60.06 -50.3 74.26 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.261 0.553 . . . . 2.03 111.316 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -73.23 -40.07 64.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.173 . . . . 2.01 110.759 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.3 p -51.94 -30.05 22.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.937 . . . . 1.99 110.773 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.76 -52.26 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.118 . . . . 1.28 110.489 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.6 mtp180 -69.98 -40.67 75.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.052 . . . . 3.38 110.154 -179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -63.34 -39.98 96.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.079 -1.013 . . . . 3.09 108.659 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.96 -40.0 95.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.093 -1.077 . . . . 2.59 108.093 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.2 mt -68.51 -40.59 80.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 1.29 109.823 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 t -69.95 -44.24 69.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 2.04 109.468 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 mt -69.62 -39.71 77.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 1.92 109.046 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -75.58 105.81 6.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.168 -0.957 . . . . 1.83 109.31 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.47 -1.08 57.92 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.981 -1.118 . . . . 2.17 107.981 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.4 m -60.17 -34.09 73.1 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.042 -0.725 . . . . 1.92 109.042 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.51 155.55 29.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.8 . . . . 2.22 109.025 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 125.73 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.517 -0.74 . . . . 1.48 109.209 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -76.61 154.65 34.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 2.29 109.167 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.24 91.77 49.53 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.49 -0.756 . . . . 1.95 109.0 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -45.1 151.09 0.82 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.097 1.865 . . . . 2.11 112.524 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -114.84 158.98 21.19 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.182 -0.673 . . . . 4.68 109.182 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.12 166.87 0.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.86 . . . . 2.84 110.171 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 71' ' ' LYS . 95.6 m-20 -69.15 -26.06 64.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.513 -0.742 . . . . 3.46 109.881 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -70.35 47.42 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 4.77 109.355 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.43 ' H ' ' C ' ' A' ' 69' ' ' ASP . 4.2 ptmt -98.04 111.95 60.64 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.366 -0.834 . . . . 5.49 109.927 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.7 10.45 3.68 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.966 1.777 . . . . 4.18 111.728 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.58 -77.83 0.09 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.395 -1.482 . . . . 3.73 109.395 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -59.99 141.08 56.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -1.187 . . . . 4.74 108.549 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.21 -14.29 2.73 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 120.357 -0.925 . . . . 2.52 111.962 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.1 m -158.61 154.73 27.02 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.092 -1.828 . . . . 2.24 111.785 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 77' ' ' TYR . 21.6 m-85 -110.57 163.66 13.49 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.038 -1.097 . . . . 2.3 108.038 178.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -110.96 127.16 55.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.55 109.58 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.3 t -141.67 159.19 42.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.305 -0.872 . . . . 1.2 109.686 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 81' ' ' ASP . 75.4 mt -76.27 172.54 12.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.44 109.973 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' LEU . 1.1 m-20 -48.56 176.68 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 108.894 -0.78 . . . . 3.72 108.894 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.58 -142.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.796 1.664 . . . . 4.1 111.233 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 85' ' ' TYR . 74.9 m-20 -88.27 5.47 41.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.981 -1.074 . . . . 6.82 108.874 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 p -54.96 83.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 6.0 108.95 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' A' ' 83' ' ' ASP . 8.7 t80 -80.15 -67.98 0.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 11.29 109.73 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.702 ' H ' HD21 ' A' ' 86' ' ' ASN . 0.0 OUTLIER -109.2 18.27 20.71 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.694 0.759 . . . . 10.52 109.448 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -84.0 123.97 30.56 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.45 0.643 . . . . 8.47 110.346 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -139.08 -0.62 1.84 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.439 -0.788 . . . . 12.49 109.009 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -150.03 170.28 19.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 11.95 109.067 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.513 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -49.37 142.31 7.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 12.64 109.318 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.89 2.73 73.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.932 -1.267 . . . . 11.27 109.932 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.0 p -59.85 -38.63 82.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -1.201 . . . . 11.98 108.894 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -61.88 132.68 53.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 11.29 108.846 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.1 tp . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 13.39 109.026 -179.778 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.761 -0.459 . . . . 5.19 109.761 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 42.4 mt -111.1 140.12 45.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.623 -0.673 . . . . 2.08 109.541 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.1 160.08 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.566 -0.709 . . . . 2.23 109.358 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -70.05 150.31 96.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.241 -1.022 . . . . 4.16 108.241 179.194 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 55.4 Cg_endo -81.57 136.35 9.68 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.091 1.861 . . . . 1.18 112.147 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.64 -17.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.546 2.164 . . . . 1.18 113.793 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 6.1 m-85 -67.69 129.04 38.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.766 -1.209 . . . . 1.92 110.171 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.1 p -81.94 177.17 9.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -0.759 . . . . 1.92 109.059 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -59.93 -41.48 91.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 2.23 109.562 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.01 -47.46 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 1.66 109.784 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.89 87.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.913 . . . . 1.1 110.317 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.03 -45.63 92.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.831 -1.168 . . . . 1.14 109.051 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 84.2 mt -62.19 -40.02 86.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.123 -1.065 . . . . 1.2 108.123 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.33 -39.95 94.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.614 -0.679 . . . . 1.17 109.593 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.0 mtt -65.83 -39.91 91.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 1.77 109.76 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.31 89.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 1.09 109.835 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.1 mt -60.02 -49.97 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.151 -0.968 . . . . 1.1 108.543 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.19 -40.04 93.66 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.213 0.53 . . . . 2.34 110.168 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.12 0.7 43.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 1.71 110.45 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 148.42 74.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.96 -1.087 . . . . 1.24 108.759 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.81 -23.53 74.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.608 1.539 . . . . 1.64 109.768 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -138.35 148.79 44.94 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.124 . . . . 2.63 107.964 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -61.64 -36.9 82.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.007 -1.058 . . . . 2.55 108.274 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.377 -0.971 . . . . 2.13 108.377 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.14 152.71 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.368 -0.832 . . . . 1.18 109.048 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.522 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 72.2 p -80.08 153.8 28.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 1.4 109.238 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -59.97 -40.27 88.53 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.446 -0.784 . . . . 1.39 108.889 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -60.17 -40.06 88.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.506 -0.746 . . . . 2.03 109.913 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.522 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -62.92 -38.83 97.22 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.639 -0.985 . . . . 0.32 110.639 -179.354 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.04 -40.44 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -1.225 . . . . 1.14 110.017 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.533 ' CE1' ' OE1' ' A' ' 49' ' ' GLN . 32.1 m-85 -60.03 -41.95 93.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.901 -1.124 . . . . 2.3 110.263 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.14 -40.24 89.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.297 -0.877 . . . . 3.11 110.078 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.94 -49.63 76.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.672 . . . . 2.25 111.446 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.425 HG23 HD11 ' A' ' 34' ' ' ILE . 86.2 mt -59.93 -49.86 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 1.26 111.631 -178.105 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.8 mtm -60.0 -40.03 87.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 1.17 111.164 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.29 -46.18 71.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.649 -1.282 . . . . 1.17 111.019 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HA ' ' HE ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -70.0 -40.06 75.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.89 -1.131 . . . . 3.48 109.943 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -121.63 110.04 33.97 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.662 -0.866 . . . . 2.43 108.662 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.471 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 95.8 Cg_endo -79.59 -11.27 14.27 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.927 1.751 . . . . 1.69 113.011 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -58.47 -35.97 72.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.176 -0.952 . . . . 4.68 109.22 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 44' ' ' ASN . 91.5 m-85 -67.6 -29.5 68.86 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.767 -0.583 . . . . 1.91 110.603 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -59.96 -39.96 87.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.027 -1.046 . . . . 3.01 109.582 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 39' ' ' PRO . 54.7 mp0 -66.62 -39.97 88.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.037 -1.039 . . . . 2.34 109.048 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.4 m-20 -106.23 106.49 17.03 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.257 -0.645 . . . . 2.6 109.257 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -98.38 -42.61 7.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.114 -0.991 . . . . 2.25 109.96 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -77.98 140.14 39.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.165 -0.96 . . . . 4.59 109.873 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.86 -59.98 0.34 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.443 -1.063 . . . . 1.34 110.443 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 26.2 p-90 -89.44 -14.77 34.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.025 -1.279 . . . . 0.57 110.497 -178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.533 ' OE1' ' CE1' ' A' ' 31' ' ' TYR . 3.2 tp-100 -69.92 -60.02 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 2.03 110.926 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -72.36 -28.67 63.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.906 -1.121 . . . . 2.01 110.942 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -59.95 -38.82 83.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.909 -1.119 . . . . 1.99 109.857 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.95 -44.77 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.938 . . . . 1.28 110.086 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -68.97 -44.79 72.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.791 -1.193 . . . . 3.38 110.482 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -60.01 -41.66 92.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 3.09 109.279 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.689 HD22 HD22 ' A' ' 59' ' ' ASN . 21.7 t-20 -61.96 -42.26 98.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 2.59 108.753 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -60.06 -46.83 88.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.409 -0.807 . . . . 1.29 109.903 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 t -70.4 -41.98 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 2.04 109.961 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.36 -39.96 89.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 1.92 110.084 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.689 HD22 HD22 ' A' ' 55' ' ' ASN . 93.7 m-20 -74.73 119.75 19.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.148 -0.97 . . . . 1.83 108.984 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -89.96 -2.7 58.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 2.17 108.667 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' OD2' ' A' ' 81' ' ' ASP . 93.7 m -62.61 -40.04 95.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.747 . . . . 1.92 109.367 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -80.6 152.62 28.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 2.22 109.421 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.6 t -127.42 128.04 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 1.48 109.589 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -83.82 150.02 26.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 2.29 109.415 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.2 80.03 69.31 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.111 -1.07 . . . . 1.95 108.111 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.63 160.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.249 1.966 . . . . 2.11 112.252 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -76.35 159.29 30.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.157 -0.965 . . . . 4.68 108.742 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -66.82 155.4 38.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.221 -0.924 . . . . 2.84 108.579 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.58 -18.89 61.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.092 -1.005 . . . . 3.46 109.281 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -74.67 -9.12 58.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.414 -0.804 . . . . 4.77 109.408 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 72' ' ' PRO . 34.5 mmtm -130.01 79.92 72.1 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.774 . . . . 5.49 109.393 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 71' ' ' LYS . 48.2 Cg_exo -54.83 -145.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.907 2.405 . . . . 4.18 112.161 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.24 -124.98 34.94 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.237 -1.145 . . . . 3.73 110.237 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -61.26 140.19 58.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -1.074 . . . . 4.74 109.822 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.9 40.67 1.58 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.646 -1.382 . . . . 2.52 109.646 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.6 m -154.84 129.11 8.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.866 -1.373 . . . . 2.24 111.302 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -132.1 158.57 41.28 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.218 -1.401 . . . . 2.3 107.218 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -122.75 134.78 54.43 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.27 -0.894 . . . . 0.55 110.23 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -152.64 161.32 42.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 1.2 109.245 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.57 160.01 26.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.033 -1.042 . . . . 1.44 109.488 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.537 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -53.56 174.33 0.17 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.381 -0.824 . . . . 3.72 108.975 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.54 -140.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.086 1.857 . . . . 4.1 111.709 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 85' ' ' TYR . 34.3 p-10 -82.19 9.25 9.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.286 -0.884 . . . . 6.82 108.698 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 84.7 p -58.09 75.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.569 -0.707 . . . . 6.0 109.892 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 83' ' ' ASP . 21.1 p90 -62.51 -48.81 77.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 11.29 108.349 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.509 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 36.1 m120 -154.03 82.31 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.339 -0.986 . . . . 10.52 108.339 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.511 ' O ' ' SD ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -73.47 132.7 43.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.461 -0.774 . . . . 8.47 109.14 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.48 -39.57 27.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.149 -0.969 . . . . 12.49 110.351 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -119.19 159.88 23.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.569 -0.707 . . . . 11.95 109.812 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -82.53 2.28 33.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.452 -0.78 . . . . 12.64 109.03 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.03 -83.35 0.07 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.267 -1.533 . . . . 11.27 109.267 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 t -85.46 78.6 9.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -1.165 . . . . 11.98 109.254 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -89.95 0.27 57.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 11.29 109.656 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.7 mt . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 13.39 108.685 179.707 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.426 -0.583 . . . . 5.19 109.426 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.93 140.0 30.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 2.08 109.534 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.5 m -145.86 156.02 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.507 -0.746 . . . . 2.23 109.198 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -70.34 147.13 95.03 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.071 -1.018 . . . . 4.16 108.525 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 7' ' ' TYR . 68.7 Cg_endo -79.55 143.08 16.76 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.974 1.783 . . . . 1.18 111.352 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.74 -24.36 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.249 1.966 . . . . 1.18 113.373 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PRO . 12.4 m-85 -60.61 131.54 51.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 1.92 109.895 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t -81.7 169.21 17.24 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.482 -0.933 . . . . 1.92 108.482 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -60.0 -40.3 88.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 2.23 109.352 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.29 -43.45 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.015 -1.053 . . . . 1.66 108.935 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.17 85.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.8 . . . . 1.1 109.855 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.98 -40.21 88.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 1.14 109.059 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.92 -44.2 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.04 -1.038 . . . . 1.2 108.247 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m -60.56 -40.04 90.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 1.17 110.376 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.97 -39.96 87.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 1.77 109.811 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.11 94.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 1.09 109.961 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.33 -46.3 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 1.1 109.03 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.94 -40.04 87.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.71 -0.619 . . . . 2.34 109.462 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -83.25 -3.06 57.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.933 . . . . 1.71 109.462 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.01 124.84 82.82 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 1.24 109.493 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -42.93 -57.09 1.87 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.397 1.398 . . . . 1.64 110.92 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -97.52 140.82 31.37 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.852 -1.166 . . . . 2.63 107.852 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -59.9 -35.53 75.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 2.55 110.087 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -76.97 129.95 36.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.604 -1.31 . . . . 2.13 108.533 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.0 tt -139.9 147.68 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 1.18 109.694 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -82.66 150.22 26.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.479 -0.763 . . . . 1.4 109.295 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.4 tp -59.97 -41.59 92.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 1.39 108.627 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.33 -41.75 94.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.547 -0.72 . . . . 2.03 110.106 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.51 97.23 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.492 -1.043 . . . . 0.32 110.492 -179.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.99 -39.98 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -1.188 . . . . 1.14 110.284 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.465 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 25.2 m-85 -59.97 -42.0 93.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.636 -1.29 . . . . 2.3 109.569 -178.964 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.56 -40.67 95.58 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.127 -0.983 . . . . 3.11 109.789 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.26 -49.88 75.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 2.25 111.377 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.07 -44.72 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 1.26 110.738 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.7 mtm -60.01 -41.79 92.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.919 -1.113 . . . . 1.17 109.416 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.02 -40.0 75.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 1.17 110.417 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -68.05 -60.03 2.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 3.48 110.654 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.08 126.31 31.37 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 2.43 109.257 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.64 -16.54 10.37 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.161 1.907 . . . . 1.69 113.555 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.826 -1.171 . . . . 4.68 110.181 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -17.59 64.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 1.91 110.908 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -60.06 -48.66 80.81 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.999 -1.063 . . . . 3.01 109.141 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.728 0.775 . . . . 2.34 110.326 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.453 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 14.6 t-20 -93.96 99.98 12.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.638 -0.664 . . . . 2.6 109.372 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -97.77 -39.26 9.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 2.25 110.189 -179.63 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -87.66 139.79 30.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 4.59 110.107 -178.429 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.72 -59.22 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.403 -1.079 . . . . 1.34 110.403 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.453 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 31.7 p-90 -82.48 -12.5 57.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.964 -1.315 . . . . 0.57 110.479 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.465 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 53.4 tt0 -70.0 -54.23 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 2.03 110.739 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.03 -25.93 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.904 -1.123 . . . . 2.01 110.841 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.3 p -60.11 -39.92 87.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 1.99 110.139 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.49 -47.94 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 1.28 110.604 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -69.95 -42.53 73.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.882 -1.136 . . . . 3.38 110.535 -178.83 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -44.8 94.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 3.09 108.961 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 94.0 m-20 -59.98 -40.14 88.07 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.204 -0.935 . . . . 2.59 109.459 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.6 mt -61.2 -42.18 98.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 1.29 110.446 -179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.7 p -66.73 -46.53 75.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.109 -0.994 . . . . 2.04 110.753 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.28 -39.91 74.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.862 -1.149 . . . . 1.92 110.249 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 77.1 m-20 -77.7 118.01 19.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.977 . . . . 1.83 109.351 -179.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.65 -2.96 57.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 2.17 110.017 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CD2' ' A' ' 62' ' ' PHE . 12.2 p -61.41 -32.44 72.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.92 108.868 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.582 ' CD2' ' SG ' ' A' ' 61' ' ' CYS . 90.8 m-85 -79.06 150.06 31.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.438 -0.789 . . . . 2.22 109.194 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.33 122.04 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.777 -0.823 . . . . 1.48 108.777 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -80.78 111.55 17.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 2.29 110.142 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.5 t -103.75 113.68 65.29 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.938 -1.134 . . . . 1.95 107.938 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.58 143.19 16.8 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.816 1.677 . . . . 2.11 112.711 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 73' ' ' GLY . 32.2 ptt180 -71.87 142.47 49.56 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.383 -0.823 . . . . 4.68 108.966 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.13 149.22 27.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 2.84 109.143 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.04 -39.88 87.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.138 -0.976 . . . . 3.46 109.679 -179.653 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -64.68 -25.42 67.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -0.982 . . . . 4.77 109.32 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -118.21 90.48 38.09 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.547 -0.721 . . . . 5.49 109.233 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.44 138.94 87.13 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.996 1.797 . . . . 4.18 110.853 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.451 ' O ' ' NH1' ' A' ' 67' ' ' ARG . . . -148.33 -178.57 23.57 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.5 -1.44 . . . . 3.73 109.5 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' GLY . 16.7 mtpp -96.97 138.67 34.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -1.149 . . . . 4.74 109.552 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' LYS . . . 42.27 -125.94 4.14 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.814 -1.314 . . . . 2.52 109.814 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.4 p -130.06 138.72 50.89 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.666 -0.902 . . . . 2.24 108.573 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -67.37 137.68 56.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.054 -1.029 . . . . 2.3 108.91 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.05 139.98 51.7 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.403 -0.811 . . . . 0.55 109.843 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -153.23 153.12 32.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 1.2 109.895 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.0 mt -74.98 -133.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 1.44 108.561 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -139.8 70.69 36.67 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.333 -0.854 . . . . 3.72 108.869 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.17 -145.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.895 2.396 . . . . 4.1 112.163 -179.496 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.533 ' C ' ' H ' ' A' ' 85' ' ' TYR . 28.3 p-10 -72.95 74.42 1.17 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.088 -1.079 . . . . 6.82 108.088 179.276 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.409 ' OG ' ' OG ' ' A' ' 92' ' ' SER . 5.1 p -50.48 -7.58 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.855 -0.528 . . . . 6.0 110.357 -179.004 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.533 ' H ' ' C ' ' A' ' 83' ' ' ASP . 65.6 t80 -61.13 -38.05 84.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.752 -1.218 . . . . 11.29 109.629 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.446 ' OD1' ' OD2' ' A' ' 83' ' ' ASP . 23.2 m120 -70.04 -17.61 63.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 10.52 110.702 -178.657 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 86' ' ' ASN . 64.4 mtt -60.7 -155.77 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.42 -0.912 . . . . 8.47 108.965 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -70.39 -149.95 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.793 -1.192 . . . . 12.49 109.51 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -109.71 15.29 22.89 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.246 0.546 . . . . 11.95 109.818 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -153.36 152.13 30.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 12.64 109.611 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.38 21.85 74.45 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.563 -1.415 . . . . 11.27 109.563 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.409 ' OG ' ' OG ' ' A' ' 84' ' ' SER . 29.3 t -87.06 104.11 16.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.331 -1.099 . . . . 11.98 108.79 179.825 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -58.61 132.65 54.44 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.099 -0.704 . . . . 11.29 109.099 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.544 -0.723 . . . . 13.39 109.748 -179.562 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mtp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.381 -0.6 . . . . 5.19 109.381 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.7 mt -102.31 140.1 37.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.433 -0.792 . . . . 2.08 109.511 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 m -135.13 148.87 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.53 -0.731 . . . . 2.23 109.38 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -70.17 128.22 91.67 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 4.16 108.789 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.01 151.95 11.04 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.839 1.692 . . . . 1.18 112.635 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.25 2.52 8.47 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.633 2.222 . . . . 1.18 113.83 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.59 140.21 58.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.514 -1.367 . . . . 1.92 109.48 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.0 m -74.54 164.33 26.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.893 . . . . 1.92 109.073 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -59.9 -40.07 87.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.166 -0.959 . . . . 2.23 108.622 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.2 mm -69.62 -40.0 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 1.66 108.973 179.591 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.92 95.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 1.1 109.692 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.062 -1.024 . . . . 1.14 108.436 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 1.2 108.807 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -60.73 -40.03 90.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 1.17 109.876 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.2 mtt -67.43 -39.88 85.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.009 . . . . 1.77 109.009 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.33 78.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 1.09 109.802 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.98 -50.02 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.195 -1.039 . . . . 1.1 108.195 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.393 0.616 . . . . 2.34 109.348 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -84.01 -0.51 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 1.71 109.759 -179.382 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.92 126.48 82.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.057 -1.027 . . . . 1.24 108.836 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -38.79 -28.12 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.785 1.657 . . . . 1.64 111.328 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' ALA . 12.8 pt-20 -145.69 155.28 42.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.174 -1.047 . . . . 2.63 108.174 178.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -60.05 -38.03 81.59 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.174 -0.953 . . . . 2.55 109.687 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -79.07 108.25 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 2.13 109.751 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -133.58 154.39 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.941 -0.763 . . . . 1.18 108.941 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -80.45 155.37 27.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 1.4 110.306 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.98 -43.39 95.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.584 -0.895 . . . . 1.39 108.584 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.1 -39.93 91.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.805 . . . . 2.03 109.748 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.05 96.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.554 -1.018 . . . . 0.32 110.554 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -41.11 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.247 . . . . 1.14 110.123 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -62.48 -38.07 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.161 . . . . 2.3 110.012 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.37 -44.27 84.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.097 -1.002 . . . . 3.11 108.872 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.16 -47.59 85.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.905 . . . . 2.25 110.198 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.3 mt -59.93 -49.98 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.012 . . . . 1.26 110.94 -178.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtm -66.78 -40.03 88.02 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.767 -1.208 . . . . 1.17 109.771 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -70.32 -43.05 71.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.971 -1.08 . . . . 1.17 110.677 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.535 ' NH1' ' CE1' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -69.96 -40.0 75.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.863 -1.148 . . . . 3.48 109.516 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' NH1' ' A' ' 37' ' ' ARG . 62.7 m-85 -127.81 78.17 75.39 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.307 -0.87 . . . . 2.43 109.44 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.68 -7.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.754 2.303 . . . . 1.69 112.434 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.526 ' H ' ' C ' ' A' ' 38' ' ' PHE . 40.3 t80 -59.92 -39.3 85.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 4.68 109.4 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' ASN . 78.6 m-85 -69.81 -20.96 63.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 1.91 110.943 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -59.99 -39.76 86.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.593 -1.317 . . . . 3.01 108.758 179.034 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -77.91 -9.46 59.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 2.34 109.95 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.504 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 82.9 m-20 -129.27 116.9 19.83 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 2.6 110.237 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' A' ' 46' ' ' GLN . 67.0 mttm -109.99 11.73 23.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.717 -0.845 . . . . 2.25 108.717 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 48' ' ' TRP . 95.8 mm-40 -48.24 177.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.001 0.905 . . . . 4.59 111.857 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 49' ' ' GLN . . . -42.28 -15.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 CA-C-N 115.779 -0.646 . . . . 1.34 111.509 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' N ' ' O ' ' A' ' 46' ' ' GLN . 9.2 p-90 -51.18 -20.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.514 -1.58 . . . . 0.57 107.893 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' A' ' 47' ' ' GLY . 30.1 tt0 -86.37 -57.13 3.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.28 -0.637 . . . . 2.03 109.28 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.9 -33.96 72.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 2.01 109.589 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.1 m -60.04 -39.95 87.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.99 108.929 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.5 mm -60.13 -49.88 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.539 -0.725 . . . . 1.28 109.65 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -61.9 -44.54 96.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.968 -1.083 . . . . 3.38 108.768 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -60.01 -41.48 92.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.295 -0.878 . . . . 3.09 108.88 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 37.7 t-20 -63.89 -40.1 95.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.567 -0.708 . . . . 2.59 109.341 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.99 -47.81 84.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.12 -0.987 . . . . 1.29 109.691 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.4 m -62.6 -40.13 95.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 2.04 109.164 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 tt -65.84 -50.39 64.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.859 -0.525 . . . . 1.92 110.16 -178.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -69.98 117.47 11.6 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.844 -1.142 . . . . 1.83 108.724 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -90.1 -2.47 58.1 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.476 -0.935 . . . . 2.17 108.476 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.1 m -60.08 -39.12 84.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.254 -0.647 . . . . 1.92 109.254 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.29 150.31 33.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.358 -0.839 . . . . 2.22 109.418 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.0 t -110.7 125.87 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.447 -0.783 . . . . 1.48 109.464 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 139.83 51.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.957 -1.127 . . . . 2.29 107.957 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.09 77.36 61.81 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.201 -0.937 . . . . 1.95 109.366 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.5 169.23 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.459 2.106 . . . . 2.11 111.557 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.536 ' CZ ' ' H ' ' A' ' 74' ' ' LYS . 32.2 mtm180 -83.01 174.94 10.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.165 -0.959 . . . . 4.68 108.758 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -58.97 150.69 23.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.87 . . . . 2.84 108.721 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -68.9 -18.62 64.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.187 -0.946 . . . . 3.46 109.331 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -62.01 -40.0 94.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 4.77 108.766 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.535 ' C ' ' H ' ' A' ' 73' ' ' GLY . 21.8 mmtp -81.62 150.53 66.68 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 108.354 -0.98 . . . . 5.49 108.354 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.71 13.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.81 1.673 . . . . 4.18 112.238 -179.399 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 71' ' ' LYS . . . 56.78 78.98 0.1 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.918 -1.273 . . . . 3.73 109.918 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.536 ' H ' ' CZ ' ' A' ' 67' ' ' ARG . 68.1 mttm -67.64 -32.52 73.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.221 -1.164 . . . . 4.74 109.937 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.35 -161.51 18.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.496 -1.442 . . . . 2.52 109.496 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.8 t -133.41 122.57 23.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.543 -0.975 . . . . 2.24 109.437 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -75.4 176.73 7.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 2.3 108.551 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -138.37 149.96 46.09 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.281 -0.887 . . . . 0.55 109.511 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -157.23 159.34 37.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.005 . . . . 1.2 110.003 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' ASP . 77.4 mt -74.82 171.21 14.39 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.502 -0.925 . . . . 1.44 108.502 179.225 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -49.24 175.73 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.231 -0.918 . . . . 3.72 108.717 -179.893 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.88 -143.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.874 1.716 . . . . 4.1 111.897 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 85' ' ' TYR . 74.2 m-20 -95.49 32.03 1.88 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.723 -0.843 . . . . 6.82 108.723 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 t -63.47 67.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.112 -0.699 . . . . 6.0 109.112 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 83' ' ' ASP . 14.4 t80 -80.02 -69.76 0.57 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.291 -0.88 . . . . 11.29 109.304 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -118.6 20.67 12.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.62 -0.675 . . . . 10.52 109.735 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -83.5 96.3 8.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 8.47 109.186 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -106.07 -0.95 24.38 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.964 -0.754 . . . . 12.49 108.964 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.32 -160.71 0.18 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.47 -0.769 . . . . 11.95 109.138 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.95 -14.22 62.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.043 -1.036 . . . . 12.64 109.538 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.64 77.07 0.89 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.561 -1.416 . . . . 11.27 109.561 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.4 t -101.13 85.46 2.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.409 -1.054 . . . . 11.98 108.877 179.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -60.07 -49.95 75.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 11.29 109.551 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 13.39 109.346 179.858 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 tpp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.143 -0.688 . . . . 5.19 109.143 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.5 mt -113.25 139.4 48.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.349 -0.611 . . . . 2.08 109.349 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.01 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.625 -0.672 . . . . 2.23 109.312 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -66.74 149.74 98.08 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 4.16 110.035 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.92 160.59 33.73 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.624 2.216 . . . . 1.18 111.618 178.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.26 4.37 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.481 2.121 . . . . 1.18 113.285 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -82.17 135.89 35.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.718 -1.239 . . . . 1.92 109.136 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -71.72 162.54 29.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 1.92 108.634 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -59.67 -39.9 85.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.93 -1.106 . . . . 2.23 108.629 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.43 -39.98 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 1.66 108.981 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.15 87.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.85 . . . . 1.1 109.884 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.05 -41.68 92.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.884 -1.135 . . . . 1.14 108.792 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.2 mt -70.0 -41.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.372 -0.83 . . . . 1.2 109.663 179.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -60.41 -42.53 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 1.17 109.448 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.5 mtm -69.92 -36.83 75.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.402 -0.811 . . . . 1.77 109.839 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.5 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 1.09 109.494 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.4 mt -59.98 -49.94 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.39 -0.967 . . . . 1.1 108.39 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.68 -39.95 93.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.447 -0.783 . . . . 2.34 109.324 179.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -80.48 3.82 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.806 . . . . 1.71 109.748 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 147.58 71.34 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 1.24 109.356 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 -20.68 57.46 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.851 1.701 . . . . 1.64 110.041 179.15 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.25 149.6 36.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.843 -1.169 . . . . 2.63 107.843 178.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -60.6 -39.89 89.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 2.55 110.297 -178.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.86 124.78 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.111 . . . . 2.13 109.017 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.8 tt -138.83 142.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -0.824 . . . . 1.18 109.394 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.4 p -79.89 157.92 26.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.362 -0.836 . . . . 1.4 109.223 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -60.01 -40.23 88.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 1.39 109.392 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -60.03 -41.94 93.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 2.03 110.57 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 -38.56 96.31 Favored Glycine 0 N--CA 1.494 2.516 0 O-C-N 121.193 -0.942 . . . . 0.32 111.203 -178.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.423 HD11 HG23 ' A' ' 30' ' ' ILE . 94.7 mt -59.97 -40.02 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.256 . . . . 1.14 109.79 -179.001 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.432 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 33.3 m-85 -59.96 -39.95 87.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.11 -0.994 . . . . 2.3 110.029 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -59.68 -40.01 86.43 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.367 -0.833 . . . . 3.11 110.137 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -60.52 -40.36 91.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 2.25 109.896 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.44 -61.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.107 -0.996 . . . . 1.26 110.624 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.5 mtm -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 1.17 110.446 -178.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.14 -40.12 92.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 1.17 110.471 -179.105 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -89.17 -55.77 3.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.021 -1.049 . . . . 3.48 110.063 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -96.05 112.47 59.63 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.973 -1.079 . . . . 2.43 108.688 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.96 -7.44 14.32 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.815 1.677 . . . . 1.69 111.884 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.01 -40.06 87.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.773 . . . . 4.68 110.229 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -70.98 -13.13 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 1.91 110.874 -178.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.1 mmm180 -59.99 -40.03 87.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 3.01 110.735 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.32 0.08 55.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 2.34 110.339 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.514 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 68.7 m-80 -133.96 108.55 8.46 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.763 -0.829 . . . . 2.6 108.763 179.144 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 42' ' ' ARG . 61.1 mttp -111.97 -29.97 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.681 -0.637 . . . . 2.25 110.051 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -90.66 139.42 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 4.59 109.781 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.27 -64.19 0.31 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.435 -1.066 . . . . 1.34 110.435 179.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.514 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 23.1 p-90 -77.05 -20.06 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.316 . . . . 0.57 110.478 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.623 ' NE2' ' NH2' ' A' ' 53' ' ' ARG . 66.7 tt0 -62.29 -52.3 64.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 2.03 110.628 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -68.97 -35.06 76.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 2.01 110.194 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 1.99 109.746 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mm -60.91 -45.99 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 1.28 110.25 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.623 ' NH2' ' NE2' ' A' ' 49' ' ' GLN . 41.7 mtt180 -69.52 -40.12 77.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.951 -1.093 . . . . 3.38 109.888 -178.83 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -60.14 -40.15 88.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 3.09 108.765 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 95.2 m-20 -61.85 -39.95 93.63 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.54 -0.911 . . . . 2.59 108.54 179.39 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.1 mt -70.0 -40.02 75.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 1.29 110.267 179.805 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.5 p -74.56 -44.88 48.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 2.04 110.495 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.65 -39.9 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 1.92 110.214 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 96.1 m-20 -66.19 120.3 12.99 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.297 -1.001 . . . . 1.83 108.297 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' OE1' ' N ' ' A' ' 60' ' ' GLU . 25.7 mp0 -87.81 -10.97 49.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.272 -0.893 . . . . 2.17 109.361 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m -64.14 -40.01 95.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.451 -0.78 . . . . 1.92 109.926 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -79.6 127.93 32.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 2.22 109.736 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.37 124.72 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.454 -0.943 . . . . 1.48 108.454 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -94.15 150.66 20.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.012 . . . . 2.29 110.511 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.97 86.62 25.96 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 107.722 -1.214 . . . . 1.95 107.722 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -42.87 167.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.618 2.212 . . . . 2.11 113.694 -178.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.671 HH22 ' N ' ' A' ' 73' ' ' GLY . 84.9 mtm180 -86.11 -179.38 6.73 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.944 -0.762 . . . . 4.68 108.944 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.51 151.37 44.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.313 -0.995 . . . . 2.84 108.313 178.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -66.0 -19.97 66.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.025 -1.047 . . . . 3.46 109.612 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -94.91 2.52 55.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.192 -0.942 . . . . 4.77 110.681 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -129.96 80.03 71.97 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 5.49 110.084 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.514 ' C ' HH12 ' A' ' 67' ' ' ARG . 66.9 Cg_endo -90.44 -165.91 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.414 2.743 . . . . 4.18 112.005 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.671 ' N ' HH22 ' A' ' 67' ' ' ARG . . . 107.46 -85.06 0.4 Allowed Glycine 0 N--CA 1.498 2.824 0 O-C-N 121.191 -0.943 . . . . 3.73 111.502 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.541 ' N ' ' NH1' ' A' ' 67' ' ' ARG . 24.5 mtpp -66.59 166.94 11.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -1.153 . . . . 4.74 111.39 -178.087 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.14 178.84 29.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.85 -1.3 . . . . 2.52 109.85 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.4 p -80.17 169.34 17.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -1.086 . . . . 2.24 110.047 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -90.38 144.91 25.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 2.3 109.418 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -120.05 139.36 52.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.536 -0.727 . . . . 0.55 109.458 179.304 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 t -150.65 167.52 27.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 1.2 109.168 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.96 168.41 17.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 1.44 109.495 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.13 128.71 87.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 3.72 109.605 -178.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.76 -152.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.302 2.002 . . . . 4.1 111.617 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -76.18 71.67 2.93 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.747 -1.205 . . . . 6.82 107.747 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 p -69.99 -17.25 63.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.653 -0.654 . . . . 6.0 110.64 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -32.88 74.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.835 -1.166 . . . . 11.29 108.809 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 87' ' ' MET . 28.0 m120 -97.97 19.41 13.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.281 -0.887 . . . . 10.52 109.662 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -48.11 175.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 8.47 109.692 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -81.75 73.32 8.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.209 -0.932 . . . . 12.49 108.559 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' A' ' 91' ' ' GLY . 10.6 pt-20 -65.26 143.47 57.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 11.95 109.721 -179.414 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -94.98 13.5 24.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.416 -0.803 . . . . 12.64 109.698 -179.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.407 ' O ' ' OE1' ' A' ' 89' ' ' GLU . . . -169.66 -125.77 0.82 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.874 -1.155 . . . . 11.27 110.228 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.3 p -135.12 46.38 2.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -1.001 . . . . 11.98 109.416 -179.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.97 -40.57 89.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 11.29 111.347 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.674 -1.266 . . . . 13.39 109.337 -178.983 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.03 -0.73 . . . . 5.19 109.03 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.6 mt -85.95 147.73 26.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.514 -0.742 . . . . 2.08 109.095 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.54 142.51 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -0.959 . . . . 2.23 109.754 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -78.17 140.7 61.64 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.364 -0.835 . . . . 4.16 108.749 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.37 159.61 39.82 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.024 1.816 . . . . 1.18 111.967 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.7 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.486 2.124 . . . . 1.18 112.51 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -66.9 131.78 46.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.882 -1.136 . . . . 1.92 108.944 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -72.08 162.99 28.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 1.92 108.906 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -60.01 -33.93 72.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 2.23 108.561 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.8 -40.03 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.401 -0.962 . . . . 1.66 108.401 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.16 90.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 1.1 110.105 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.99 -39.99 87.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.071 -1.018 . . . . 1.14 108.368 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.08 -40.11 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.377 -0.827 . . . . 1.2 108.867 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -67.92 -40.33 83.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 1.17 110.641 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.02 -37.43 75.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 1.77 109.985 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.34 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 1.09 109.761 -179.333 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.01 -47.38 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 1.1 108.867 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . 0.495 ' NE2' ' HZ3' ' A' ' 23' ' ' LYS . 98.7 mm-40 -68.43 -40.04 81.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 2.34 110.004 -179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -74.71 -13.26 60.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.858 . . . . 1.71 110.387 -179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.9 150.21 74.88 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.996 . . . . 1.24 109.665 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.4 -41.6 15.26 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.019 1.812 . . . . 1.64 110.414 179.164 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.03 132.57 56.36 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.445 -1.317 . . . . 2.63 107.445 178.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.495 ' HZ3' ' NE2' ' A' ' 18' ' ' GLN . 68.5 mttm -69.0 -21.57 64.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 2.55 109.981 -178.455 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.86 33.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 2.13 109.226 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.442 ' H ' ' C ' ' A' ' 23' ' ' LYS . 16.0 tt -56.87 154.54 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 1.18 109.469 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.642 ' HG1' ' H ' ' A' ' 29' ' ' GLY . 69.3 p -79.97 162.43 24.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 1.4 110.152 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.99 -50.01 75.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.481 -0.933 . . . . 1.39 108.481 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -60.51 -39.98 89.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.579 -0.701 . . . . 2.03 110.306 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.642 ' H ' ' HG1' ' A' ' 26' ' ' THR . . . -54.14 -38.55 61.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.32 109.389 -179.411 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.24 -41.54 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -1.172 . . . . 1.14 109.741 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -60.0 -43.35 95.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.12 -0.987 . . . . 2.3 109.952 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -59.99 -40.01 87.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.375 -0.828 . . . . 3.11 109.743 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.03 -45.54 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.794 . . . . 2.25 110.001 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.66 -49.95 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 1.26 110.711 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.04 -42.86 99.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 1.17 111.03 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.1 -40.13 75.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 1.17 111.148 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -70.08 -40.23 75.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.908 -1.12 . . . . 3.48 109.88 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.13 117.49 31.99 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 107.986 -1.116 . . . . 2.43 107.986 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.76 -9.48 17.02 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.838 1.692 . . . . 1.69 112.463 -178.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -59.97 -39.56 86.07 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 4.68 108.999 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.08 -26.54 64.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.569 -0.707 . . . . 1.91 110.559 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -59.99 -33.59 72.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.927 -1.108 . . . . 3.01 108.796 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.01 9.98 33.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 2.34 109.532 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.503 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 60.3 t30 -139.04 125.6 20.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.357 -0.84 . . . . 2.6 109.813 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -124.48 15.14 8.89 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.739 -0.838 . . . . 2.25 108.739 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 48' ' ' TRP . 91.7 mm-40 -61.18 -169.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.142 0.972 . . . . 4.59 112.085 -177.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.05 -8.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 CA-C-N 115.669 -0.696 . . . . 1.34 111.633 -178.469 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -60.02 -27.7 67.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.476 -1.602 . . . . 0.57 107.947 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -70.04 -58.45 3.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.729 . . . . 2.03 110.947 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -61.79 -39.97 93.58 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 2.01 110.97 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.0 t -56.95 -32.08 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 1.99 110.833 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.09 -57.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.93 -1.106 . . . . 1.28 111.342 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.59 -29.07 28.07 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.736 -1.227 . . . . 3.38 110.359 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.05 -40.02 87.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 3.09 109.633 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -69.42 -24.11 63.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 2.59 110.525 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.96 -40.03 91.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 1.29 109.494 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -60.9 -48.07 83.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 2.04 110.142 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 58' ' ' LEU . 8.7 mp -68.29 -40.09 81.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 1.92 109.348 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -79.91 113.58 18.18 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.185 -0.947 . . . . 1.83 109.022 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.88 1.17 56.52 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.602 -0.888 . . . . 2.17 108.602 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.04 -36.91 78.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.681 -0.637 . . . . 1.92 109.4 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -78.51 161.44 27.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 2.22 109.583 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.63 130.06 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.543 -0.723 . . . . 1.48 109.636 -179.352 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -86.96 127.02 35.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 2.29 109.967 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -132.38 71.74 79.0 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 108.581 -0.896 . . . . 1.95 108.581 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 81.1 Cg_exo -44.63 177.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.65 2.233 . . . . 2.11 112.272 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -75.18 160.73 30.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 4.68 108.67 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 6.9 t0 -58.04 166.69 1.46 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.043 -1.036 . . . . 2.84 109.114 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 99.0 m-20 -68.08 -25.79 65.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 3.46 109.548 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -60.11 -40.01 88.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 4.77 109.648 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.7 mmtm -79.63 139.29 54.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 5.49 109.253 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.96 -10.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.06 1.84 . . . . 4.18 113.009 179.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' LYS . . . 86.65 50.24 3.84 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.87 -1.292 . . . . 3.73 109.87 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -85.42 144.18 28.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.204 -1.174 . . . . 4.74 109.721 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 47.18 -162.18 0.25 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.661 -1.376 . . . . 2.52 109.661 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 p -157.08 130.75 8.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -1.105 . . . . 2.24 108.911 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 5.7 m-30 -80.36 160.01 25.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 2.3 109.001 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -134.51 143.13 47.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 0.55 109.67 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -149.54 166.19 29.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.132 -0.98 . . . . 1.2 109.208 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 mt -101.84 119.72 39.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.181 -0.949 . . . . 1.44 109.971 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -171.71 73.76 0.49 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.898 . . . . 3.72 110.116 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.91 -143.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.697 2.264 . . . . 4.1 111.82 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 85' ' ' TYR . 40.5 m-20 -88.62 44.59 1.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 6.82 108.853 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 m -62.62 71.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.561 -0.712 . . . . 6.0 109.277 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' A' ' 83' ' ' ASP . 83.0 t80 -61.64 -44.87 96.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.463 -0.773 . . . . 11.29 109.941 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . 0.419 ' OD1' ' CE1' ' A' ' 88' ' ' PHE . 50.1 t-20 -140.44 31.1 1.91 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.277 -0.889 . . . . 10.52 109.011 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.405 ' O ' ' O ' ' A' ' 90' ' ' ASN . 15.0 mmt -89.58 2.37 54.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -0.763 . . . . 8.47 109.912 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CE1' ' OD1' ' A' ' 86' ' ' ASN . 49.6 p90 -70.04 -20.09 63.27 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.305 -0.872 . . . . 12.49 109.385 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.23 -40.02 92.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 11.95 109.684 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.405 ' O ' ' O ' ' A' ' 87' ' ' MET . 28.9 m120 -140.05 148.13 41.35 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.159 -0.682 . . . . 12.64 109.159 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -99.95 10.17 60.24 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.968 -1.253 . . . . 11.27 109.968 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.2 m -130.27 78.38 1.84 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.442 -1.034 . . . . 11.98 109.895 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . 0.536 ' O ' ' CD2' ' A' ' 93' ' ' PHE . 13.7 p90 -108.39 97.88 7.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.782 -0.821 . . . . 11.29 108.782 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.7 tt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.159 -0.963 . . . . 13.39 110.121 -179.237 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.152 -0.685 . . . . 5.19 109.152 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.9 mt -109.92 143.45 39.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.475 -0.765 . . . . 2.08 109.196 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.62 158.62 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.306 -0.871 . . . . 2.23 109.032 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.27 146.84 94.93 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.047 -1.033 . . . . 4.16 108.928 179.784 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.2 159.23 33.45 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.099 1.866 . . . . 1.18 112.078 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.69 10.06 3.48 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.472 2.115 . . . . 1.18 112.7 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -85.16 140.26 31.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.888 -1.133 . . . . 1.92 109.572 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.7 p -80.04 170.38 16.54 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -0.815 . . . . 1.92 108.872 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -60.0 -40.15 88.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.109 -0.994 . . . . 2.23 109.154 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.8 mm -61.09 -48.07 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.812 . . . . 1.66 109.002 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.47 98.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 1.1 110.295 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.93 -44.01 94.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.939 -1.101 . . . . 1.14 109.189 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.01 -39.98 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 1.2 109.264 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.93 -40.54 97.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 1.17 109.821 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.6 mtm -70.04 -36.57 75.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.872 . . . . 1.77 109.335 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.97 89.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.326 -0.859 . . . . 1.09 109.658 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.0 -50.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.078 -1.014 . . . . 1.1 109.983 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.95 -37.96 76.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.717 -0.614 . . . . 2.34 110.46 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.83 -1.5 25.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 1.71 110.085 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.19 147.91 73.71 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.079 -1.013 . . . . 1.24 109.528 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.02 -19.57 57.62 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.8 1.667 . . . . 1.64 109.9 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -130.71 138.26 49.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.143 -1.428 . . . . 2.63 107.143 178.517 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -60.0 -39.97 87.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.943 -1.098 . . . . 2.55 109.156 -178.585 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -79.3 130.79 35.8 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.181 -0.949 . . . . 2.13 108.719 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.06 148.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 1.18 109.473 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.7 p -83.62 167.05 17.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 1.4 110.148 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.94 -49.72 76.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.077 -1.083 . . . . 1.39 108.077 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.08 -40.02 88.11 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.986 -0.552 . . . . 2.03 110.392 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.91 94.52 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.384 -1.086 . . . . 0.32 110.384 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.11 -43.39 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.043 -1.269 . . . . 1.14 109.645 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.458 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 34.6 m-85 -60.02 -40.0 87.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.963 -1.086 . . . . 2.3 110.821 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.95 -42.72 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.899 -1.126 . . . . 3.11 110.74 -178.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.98 -48.56 81.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 2.25 111.414 -179.16 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.93 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.097 . . . . 1.26 111.401 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 mtm -59.99 -46.14 90.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 1.17 110.673 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.09 -39.89 75.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.885 -1.134 . . . . 1.17 110.064 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -69.09 -39.97 78.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 3.48 110.378 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.537 ' C ' ' H ' ' A' ' 40' ' ' PHE . 67.3 m-85 -131.34 80.04 68.7 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 2.43 110.148 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -45.72 -9.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.698 2.265 . . . . 1.69 112.02 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.537 ' H ' ' C ' ' A' ' 38' ' ' PHE . 31.5 t80 -60.06 -39.93 87.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.464 -0.773 . . . . 4.68 109.833 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -68.2 -20.76 64.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 1.91 110.904 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.402 ' HG2' ' NH1' ' A' ' 42' ' ' ARG . 61.5 mtt-85 -60.03 -40.08 88.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.817 -1.177 . . . . 3.01 109.532 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.38 -40.12 96.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 2.34 110.132 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -105.82 106.08 16.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.813 -0.554 . . . . 2.6 109.795 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.414 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 66.8 mttm -97.38 -39.69 9.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.245 -0.909 . . . . 2.25 110.533 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.81 145.8 31.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 4.59 109.894 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.2 -72.64 0.28 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.748 -0.941 . . . . 1.34 110.748 179.121 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TRP . . . . . 0.414 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 20.2 p-90 -69.99 -23.94 63.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.016 -1.285 . . . . 0.57 111.438 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.458 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 57.5 tt0 -60.08 -50.47 73.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.668 -1.27 . . . . 2.03 111.407 -178.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -73.84 -33.56 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.778 -1.201 . . . . 2.01 111.32 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.3 p -59.9 -36.37 76.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 1.99 110.757 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.04 -49.85 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.938 -1.101 . . . . 1.28 110.314 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -70.08 -39.38 75.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.222 -0.924 . . . . 3.38 110.622 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -60.02 -39.86 87.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.029 -1.044 . . . . 3.09 108.514 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.051 -1.092 . . . . 2.59 108.051 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 91.6 mt -66.72 -40.05 88.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.49 -0.757 . . . . 1.29 109.646 179.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.617 ' HG ' ' H ' ' A' ' 58' ' ' LEU . 88.8 p -75.01 -49.3 20.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.091 -1.005 . . . . 2.04 109.99 -179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.617 ' H ' ' HG ' ' A' ' 57' ' ' SER . 33.3 mt -64.17 -40.19 95.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 1.92 109.274 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . 0.448 ' OD1' ' SG ' ' A' ' 61' ' ' CYS . 8.9 t-20 -83.95 116.93 23.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.402 -0.962 . . . . 1.83 108.402 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.94 1.75 54.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 2.17 109.94 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.448 ' SG ' ' OD1' ' A' ' 59' ' ' ASN . 96.8 m -59.97 -39.96 87.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 1.92 108.638 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -78.95 146.14 33.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 2.22 108.976 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.15 129.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.419 -0.956 . . . . 1.48 108.419 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.25 139.08 57.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 2.29 109.905 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.8 t -112.4 119.98 42.41 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.556 -0.905 . . . . 1.95 108.556 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.86 178.84 6.91 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.531 1.488 . . . . 2.11 112.268 -179.287 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' NE ' ' O ' ' A' ' 74' ' ' LYS . 20.0 ptt-85 -138.1 159.02 43.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 4.68 109.112 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 36.2 t0 -64.99 169.33 5.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.115 -0.991 . . . . 2.84 108.497 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 72.5 m-20 -89.68 -3.34 58.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.135 -0.978 . . . . 3.46 109.97 -179.393 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -93.09 5.42 51.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.101 -0.999 . . . . 4.77 109.234 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -129.98 78.65 74.53 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.504 -0.747 . . . . 5.49 109.429 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 74' ' ' LYS . 2.9 Cg_exo -73.25 -166.82 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.723 2.282 . . . . 4.18 112.163 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.24 -62.87 0.39 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.898 -1.281 . . . . 3.73 109.898 179.677 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.48 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -68.6 137.62 54.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -1.17 . . . . 4.74 108.942 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.66 -155.98 31.89 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.141 -1.584 . . . . 2.52 109.141 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.3 m -78.59 131.51 36.76 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.27 -1.136 . . . . 2.24 108.249 179.308 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -78.4 159.98 28.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.036 -1.04 . . . . 2.3 109.411 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -113.18 139.93 48.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.055 -0.72 . . . . 0.55 109.055 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 80' ' ' LEU . 15.2 t -143.1 160.69 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.189 -0.944 . . . . 1.2 109.862 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 79' ' ' THR . 81.7 mt -59.69 -121.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 1.44 109.575 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 82' ' ' PRO . 23.3 t0 -137.23 72.53 52.45 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.383 -0.969 . . . . 3.72 108.383 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 81' ' ' ASP . 62.8 Cg_exo -52.4 -130.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.275 2.65 . . . . 4.1 112.89 -179.373 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -89.89 78.92 6.72 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.901 -1.148 . . . . 6.82 107.901 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.7 p -61.73 -12.46 16.81 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.49 0.662 . . . . 6.0 109.276 -179.246 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.15 -26.16 62.35 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.551 -0.907 . . . . 11.29 108.551 178.859 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.96 -20.06 63.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -0.929 . . . . 10.52 109.532 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 88' ' ' PHE . 68.6 mtm -79.98 -172.95 3.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.785 -0.821 . . . . 8.47 108.785 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' MET . 63.9 m-85 -62.2 -136.89 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.127 -0.983 . . . . 12.49 109.7 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -130.19 21.55 5.28 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.598 -0.689 . . . . 11.95 109.815 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -125.88 130.41 51.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.494 -0.754 . . . . 12.64 109.72 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.43 -136.83 4.26 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.875 -1.69 . . . . 11.27 108.875 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.4 p -113.71 5.74 16.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.692 -0.887 . . . . 11.98 109.896 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -82.86 124.41 30.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.027 -1.045 . . . . 11.29 109.283 -179.924 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 10.9 mp . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 13.39 109.147 -179.968 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' TYR . 1.8 Cg_endo . . . . . 0 N--CA 1.492 1.421 0 CA-C-O 119.984 -0.09 . . . . 0.72999999999999998 112.194 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.41 -8.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.538 1.492 . . . . 0.83999999999999997 111.558 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' PRO . 11.6 m-85 -68.76 138.85 55.18 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.863 . . . . 1.1499999999999999 109.162 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 t -73.82 164.64 26.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.294 -0.878 . . . . 1.3899999999999999 108.737 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -59.95 -39.13 84.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.138 -0.976 . . . . 1.3200000000000001 108.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.8 mm -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.95999999999999996 109.081 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.27 87.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 0.38 109.612 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.07 -43.75 95.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.37 108.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.03 -41.98 88.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 0.48999999999999999 108.106 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -65.56 -40.05 92.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.54 -0.725 . . . . 0.39000000000000001 110.357 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.595 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.6 mtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -0.967 . . . . 1.1399999999999999 110.311 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.63 -42.61 75.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 0.32000000000000001 110.034 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.46 -40.29 88.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.795 . . . . 0.33000000000000002 109.243 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -66.6 -41.79 87.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.53 -0.731 . . . . 1.8200000000000001 110.69 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 15' ' ' MET . 19.0 p30 -90.77 7.92 37.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.6699999999999999 110.258 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.2 116.55 61.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.63 109.078 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -43.04 -26.76 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.461 1.441 . . . . 1.29 111.012 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -122.92 131.7 53.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.605 -1.258 . . . . 2.6299999999999999 107.605 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -60.07 -40.0 88.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.842 -1.161 . . . . 2.02 108.718 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.99 117.76 25.04 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.754 -1.202 . . . . 1.55 107.754 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.85 145.68 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.714 . . . . 0.46999999999999997 109.46 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.4 p -79.55 162.38 25.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.387 -0.82 . . . . 0.81000000000000005 109.996 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.02 -43.33 95.32 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.15 -1.055 . . . . 0.69999999999999996 108.15 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.46 -40.04 96.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.55 -0.719 . . . . 1.25 110.141 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.28 -38.46 94.61 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.528 -1.029 . . . . 0.28999999999999998 110.528 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.96 -40.27 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -1.229 . . . . 0.34999999999999998 109.752 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.564 ' OH ' ' NE ' ' A' ' 53' ' ' ARG . 24.7 m-85 -60.34 -42.81 96.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.605 -1.309 . . . . 1.3999999999999999 109.571 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.98 -41.32 91.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 2.5099999999999998 110.658 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 63.3 t80 -59.99 -49.08 79.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.922 -1.111 . . . . 1.3700000000000001 110.278 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.01 -40.0 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 0.58999999999999997 110.566 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.1 mtt -60.82 -44.05 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.859 -1.151 . . . . 0.68999999999999995 110.1 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.99 -52.08 13.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 1.1699999999999999 110.721 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -60.06 -46.72 88.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 3.0 109.2 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -122.77 109.52 32.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.561 -0.903 . . . . 1.54 108.561 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.88 -7.55 12.3 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.146 1.897 . . . . 1.21 113.172 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -59.93 -34.33 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.963 -1.086 . . . . 3.7400000000000002 108.851 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' ASN . 90.4 m-85 -66.2 -26.93 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 1.1200000000000001 110.658 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -60.04 -38.96 84.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.872 -1.143 . . . . 2.5099999999999998 109.342 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.04 -39.79 87.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.059 . . . . 2.3399999999999999 108.721 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.9 m-20 -118.06 105.02 11.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.282 -0.636 . . . . 2.0099999999999998 109.282 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 93.5 mttt -90.88 -59.86 2.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 1.6799999999999999 110.689 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -69.65 140.02 53.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.509 -0.745 . . . . 3.98 110.21 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.9 -59.86 0.45 Allowed Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.221 -1.151 . . . . 0.78000000000000003 110.221 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.519 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 51.0 p-90 -82.32 -28.92 31.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.263 . . . . 0.44 110.671 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.88 -41.11 95.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.937 -1.102 . . . . 1.96 110.06 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -39.53 75.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.388 -0.82 . . . . 1.28 111.695 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.711 -1.243 . . . . 1.49 110.183 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -60.02 -40.05 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 0.64000000000000001 109.715 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.564 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 20.3 mtt180 -67.22 -37.3 83.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.054 . . . . 2.7599999999999998 109.504 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.0 -44.18 94.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.829 . . . . 2.48 109.587 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -68.79 -38.61 80.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 2.0699999999999998 109.419 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.59 59.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.78000000000000003 110.241 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -172.55 -55.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.328 -0.99 . . . . 1.6000000000000001 108.328 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.58 -39.95 84.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.561 -0.903 . . . . 1.3799999999999999 108.561 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -71.45 123.36 22.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -0.846 . . . . 1.4199999999999999 108.727 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -90.06 0.01 57.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.447 -0.783 . . . . 2.1699999999999999 109.526 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.8 -40.05 94.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 1.5600000000000001 109.769 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -79.05 150.37 31.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 1.3200000000000001 109.712 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.67 127.32 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.874 -0.787 . . . . 0.91000000000000003 108.874 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -92.4 125.0 36.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 1.8100000000000001 108.525 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.07 79.4 73.02 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 108.91 -0.774 . . . . 1.28 108.91 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo . . . . . 0 C--N 1.305 -1.732 0 C-N-CA 122.478 2.119 . . . . 1.6499999999999999 112.268 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.513 -0.921 . . . . 1.3899999999999999 108.513 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -126.53 134.81 50.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.46000000000000002 109.233 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -159.01 164.35 35.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.16 -0.963 . . . . 0.56000000000000005 109.779 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.189 -0.944 . . . . 1.4199999999999999 109.423 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 N--CA 1.492 1.402 0 CA-C-O 120.646 0.186 . . . . 0.72999999999999998 111.848 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.16 1.31 6.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.409 2.072 . . . . 0.83999999999999997 112.095 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -81.03 133.12 35.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 1.1499999999999999 109.47 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -69.35 167.2 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.215 -0.928 . . . . 1.3899999999999999 108.567 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -59.92 -39.98 87.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 1.3200000000000001 109.041 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -65.83 -41.05 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 0.95999999999999996 110.226 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.8 94.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.38 110.344 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.85 -40.12 87.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 0.37 109.079 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.496 HD11 HD21 ' A' ' 55' ' ' ASN . 86.5 mt -69.9 -40.0 78.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.223 -0.923 . . . . 0.48999999999999999 109.391 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -64.28 -40.91 96.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.39000000000000001 109.726 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 73.5 mtm -70.02 -36.93 75.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 1.1399999999999999 109.474 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.85 84.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 0.32000000000000001 109.35 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.8 mt -60.08 -50.0 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.33000000000000002 108.856 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -61.72 -40.06 93.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.288 0.566 . . . . 1.8200000000000001 109.995 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -79.99 -10.07 59.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 1.6699999999999999 110.379 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 131.48 67.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 0.63 109.488 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.06 -38.93 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.411 1.407 . . . . 1.29 110.896 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -120.03 134.63 55.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.149 -1.056 . . . . 2.6299999999999999 108.149 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.97 -34.41 73.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.04 -1.038 . . . . 2.02 110.034 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.97 113.91 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.78 -1.2 . . . . 1.55 108.297 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.5 tt -130.01 160.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 0.46999999999999997 109.445 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.9 p -90.37 165.77 13.67 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.9 0.857 . . . . 0.81000000000000005 110.714 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.652 HD11 ' HG2' ' A' ' 53' ' ' ARG . 14.3 tp -60.1 -50.02 75.37 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.056 0.932 . . . . 0.69999999999999996 108.64 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.39 -39.97 94.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.286 0.565 . . . . 1.25 110.208 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.05 96.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.433 -1.067 . . . . 0.28999999999999998 110.433 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -60.09 -42.04 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.029 -1.277 . . . . 0.34999999999999998 109.64 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -59.89 -40.85 90.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.746 -1.221 . . . . 1.3999999999999999 109.959 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -60.1 -42.24 94.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 2.5099999999999998 110.135 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.98 -49.01 79.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 1.3700000000000001 110.718 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.17 -49.98 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 0.58999999999999997 111.497 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.7 mtm -60.26 -49.98 75.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.664 -1.273 . . . . 0.68999999999999995 110.269 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -68.91 -39.99 79.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 1.1699999999999999 109.539 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -66.17 -49.75 66.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 3.0 109.678 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -119.38 120.19 31.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.594 -0.691 . . . . 1.54 109.301 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.39 -7.49 14.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.863 1.709 . . . . 1.21 112.248 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -60.01 -40.93 90.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.4 -0.812 . . . . 3.7400000000000002 110.234 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.77 -27.76 67.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 1.1200000000000001 110.722 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -58.23 -26.04 62.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.045 -1.035 . . . . 2.5099999999999998 109.436 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.78 1.76 54.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.03 -1.043 . . . . 2.3399999999999999 110.103 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.536 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 53.4 t30 -147.68 102.36 3.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.393 -0.817 . . . . 2.0099999999999998 109.278 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.7 mttt -89.16 -64.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 1.6799999999999999 110.963 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -69.93 144.03 52.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 3.98 110.074 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.44 -58.41 0.4 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.76 -1.336 . . . . 0.78000000000000003 109.76 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 29.4 p-90 -89.98 -11.66 40.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.25 . . . . 0.44 110.374 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.69 -55.96 9.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 1.96 110.498 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -70.05 -31.52 69.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 1.28 110.58 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.1 p -59.83 -40.44 88.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.052 -1.03 . . . . 1.49 110.81 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mm -60.05 -50.94 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.859 -1.151 . . . . 0.64000000000000001 110.379 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.652 ' HG2' HD11 ' A' ' 27' ' ' LEU . 46.6 mtp180 -69.97 -37.92 75.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.074 -1.016 . . . . 2.7599999999999998 110.182 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -59.93 -40.09 87.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 2.48 110.606 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 26.3 p30 -69.99 -18.33 63.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.943 -1.098 . . . . 2.0699999999999998 110.567 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.431 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 85.6 mt -66.4 -40.09 89.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.794 -1.191 . . . . 0.78000000000000003 111.115 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -70.04 -48.43 57.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.898 -1.126 . . . . 1.6000000000000001 110.756 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.2 -39.98 96.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 1.3799999999999999 110.658 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 76.1 m-20 -76.02 112.96 13.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 1.4199999999999999 110.069 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.24 -5.95 55.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 2.1699999999999999 109.484 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -62.82 -35.05 78.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 1.5600000000000001 110.199 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -78.72 152.53 31.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 1.3200000000000001 109.618 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 0.91000000000000003 109.567 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -81.93 149.64 28.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 1.8100000000000001 110.098 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.12 128.69 14.31 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.625 -0.88 . . . . 1.28 108.625 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.493 1.454 0 C-N-CA 121.441 1.427 . . . . 1.6499999999999999 111.675 179.771 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.014 -1.106 . . . . 1.3899999999999999 108.014 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -120.75 134.38 55.29 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.591 0.71 . . . . 0.46000000000000002 110.155 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 170.75 19.98 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.911 -0.774 . . . . 0.56000000000000005 108.911 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.6 mt . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.062 -1.024 . . . . 1.4199999999999999 110.203 -179.61 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo . . . . . 0 N--CA 1.494 1.519 0 CA-C-O 120.563 0.151 . . . . 0.72999999999999998 111.839 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.8 4.22 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.412 2.075 . . . . 0.83999999999999997 112.635 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -82.0 143.01 31.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.974 -1.079 . . . . 1.1499999999999999 109.803 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.5 t -75.05 160.2 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.528 -0.916 . . . . 1.3899999999999999 108.528 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -60.02 -39.95 87.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 1.3200000000000001 108.682 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.3 mm -65.2 -40.05 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.741 -0.837 . . . . 0.95999999999999996 108.741 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.72 89.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.958 . . . . 0.38 109.642 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.04 -43.14 95.53 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.025 -1.047 . . . . 0.37 108.656 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.403 HG21 HD21 ' A' ' 56' ' ' LEU . 85.5 mt -69.32 -50.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.48999999999999999 109.452 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -61.39 -40.01 92.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 0.39000000000000001 110.015 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.9 mtp -69.88 -38.48 76.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.431 -0.793 . . . . 1.1399999999999999 109.967 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 20' ' ' ALA . . . -60.03 -42.22 93.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.32000000000000001 110.032 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.31 -49.98 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.33000000000000002 109.588 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.73 -40.02 76.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.722 -0.611 . . . . 1.8200000000000001 109.959 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -76.95 -9.92 59.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.85 . . . . 1.6699999999999999 110.229 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 16' ' ' ALA . . . -79.75 137.67 54.42 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.088 -1.007 . . . . 0.63 109.454 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.81 -65.19 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.867 1.712 . . . . 1.29 110.858 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -99.81 137.84 37.72 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 2.6299999999999999 107.684 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -62.43 -28.73 70.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.833 -1.167 . . . . 2.02 109.204 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -79.7 98.3 6.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.136 -0.977 . . . . 1.55 108.569 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -119.66 149.68 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.257 -0.646 . . . . 0.46999999999999997 109.257 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -79.91 161.55 25.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.81000000000000005 110.273 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.9 tp -59.99 -47.25 86.6 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.686 -0.857 . . . . 0.69999999999999996 108.686 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -59.97 -39.8 86.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.933 -0.766 . . . . 1.25 108.933 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.55 -39.95 95.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.744 -0.942 . . . . 0.28999999999999998 110.744 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.04 -40.99 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.735 -1.45 . . . . 0.34999999999999998 109.931 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -61.59 -40.31 94.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 1.3999999999999999 110.086 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.93 -40.68 89.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.17 -0.956 . . . . 2.5099999999999998 109.881 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.49 -0.756 . . . . 1.3700000000000001 110.744 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.8 -49.97 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.108 -0.995 . . . . 0.58999999999999997 111.614 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.8 mtm -62.02 -39.98 94.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.1 -1.0 . . . . 0.68999999999999995 111.398 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 93.1 m-20 -63.76 -51.67 63.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.746 -1.221 . . . . 1.1699999999999999 112.071 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -74.86 -24.9 58.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.71 -1.244 . . . . 3.0 111.25 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.494 ' C ' ' H ' ' A' ' 40' ' ' PHE . 71.7 m-85 -130.02 77.62 76.24 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.209 -0.932 . . . . 1.54 109.763 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.75 -7.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.735 2.29 . . . . 1.21 111.438 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.494 ' H ' ' C ' ' A' ' 38' ' ' PHE . 11.8 t80 -59.96 -40.44 89.02 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.416 -0.802 . . . . 3.7400000000000002 109.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -69.92 -24.1 63.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 1.1200000000000001 110.446 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.412 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 61.1 mtt-85 -60.01 -37.87 81.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 2.5099999999999998 108.884 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.96 9.15 17.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 2.3399999999999999 109.285 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.566 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 52.8 t-20 -138.5 120.47 15.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.418 -0.801 . . . . 2.0099999999999998 109.428 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -120.24 13.1 11.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.596 -0.89 . . . . 1.6799999999999999 108.596 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 48' ' ' TRP . 96.6 mt-30 -59.91 -168.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.023 0.916 . . . . 3.98 111.438 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.15 -10.96 0.06 OUTLIER Glycine 0 N--CA 1.493 2.472 0 CA-C-N 115.997 -0.547 . . . . 0.78000000000000003 112.257 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.566 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 4.7 p-90 -59.98 -38.87 83.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.726 . . . . 0.44 108.212 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 21.2 tt0 -60.03 -50.04 75.29 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.607 -0.683 . . . . 1.96 110.019 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -76.1 -33.95 59.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 1.28 111.369 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -59.92 -38.37 82.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 1.49 111.375 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.98 -51.48 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 0.64000000000000001 111.37 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -79.81 -29.44 40.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.652 -1.28 . . . . 2.7599999999999998 110.483 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.535 ' CE1' HD11 ' A' ' 58' ' ' LEU . 54.3 t60 -59.92 -42.0 92.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 2.48 109.161 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -65.47 -39.98 92.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 2.0699999999999998 109.566 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 13' ' ' ILE . 41.4 mt -60.15 -45.44 93.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.78000000000000003 110.542 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -63.33 -45.63 90.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.804 -1.185 . . . . 1.6000000000000001 110.255 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.535 HD11 ' CE1' ' A' ' 54' ' ' HIS . 47.8 mt -69.95 -40.08 75.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.977 -1.077 . . . . 1.3799999999999999 109.877 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -72.47 117.45 14.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 1.4199999999999999 109.297 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -90.19 -2.73 58.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.46 -0.775 . . . . 2.1699999999999999 109.376 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -60.72 -40.06 90.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 1.5600000000000001 109.453 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -79.95 152.05 29.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 1.3200000000000001 109.558 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.1 t -115.39 121.57 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.577 -0.702 . . . . 0.91000000000000003 109.321 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -85.74 127.16 34.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 1.8100000000000001 108.6 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.7 111.28 58.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 1.28 109.308 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--N 1.314 -1.267 0 C-N-CA 121.65 1.567 . . . . 1.6499999999999999 111.931 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.628 -0.508 . . . . 1.3899999999999999 109.628 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -111.19 137.13 49.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.695 -0.628 . . . . 0.46000000000000002 109.976 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -145.25 159.75 42.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.859 . . . . 0.56000000000000005 109.159 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 1.4199999999999999 109.2 179.784 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 N--CA 1.495 1.6 0 CA-C-O 120.804 0.251 . . . . 0.72999999999999998 112.309 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.27 28.79 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.862 2.375 . . . . 0.83999999999999997 113.267 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -109.5 134.01 52.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.019 -1.05 . . . . 1.1499999999999999 108.819 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 174.59 11.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 1.3899999999999999 108.97 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -59.96 -35.93 76.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 1.3200000000000001 109.908 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.67 -40.01 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 0.95999999999999996 110.339 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.0 77.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.938 -1.101 . . . . 0.38 110.887 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.05 -39.94 87.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.907 -1.12 . . . . 0.37 108.623 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 52' ' ' ILE . 88.9 mt -67.74 -39.97 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.498 -0.751 . . . . 0.48999999999999999 109.274 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -66.08 -40.07 90.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 0.39000000000000001 110.755 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.8 mtm -69.91 -39.96 75.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 1.1399999999999999 109.771 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.21 80.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.441 -0.787 . . . . 0.32000000000000001 109.4 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.33000000000000002 108.902 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -60.72 -40.08 90.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.695 -0.628 . . . . 1.8200000000000001 110.15 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.406 HD21 ' HZ ' ' A' ' 33' ' ' PHE . 70.3 m-20 -69.91 -17.51 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 1.6699999999999999 109.568 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.95 148.3 71.76 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.63 109.718 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.97 -51.68 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.87 1.713 . . . . 1.29 109.724 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -99.11 139.93 34.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.276 -1.379 . . . . 2.6299999999999999 107.276 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -67.51 -27.26 66.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.975 -1.078 . . . . 2.02 109.796 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -78.68 115.85 18.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.023 -1.048 . . . . 1.55 108.932 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.17 154.31 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 0.46999999999999997 109.397 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.2 p -80.11 153.56 28.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.81000000000000005 109.776 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 tp -60.04 -44.28 94.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.69999999999999996 109.288 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -60.27 -40.08 89.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 1.25 110.427 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.66 97.5 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.14 -1.029 . . . . 0.28999999999999998 111.011 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.02 -42.28 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.276 . . . . 0.34999999999999998 110.243 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -60.15 -41.95 93.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.965 -1.085 . . . . 1.3999999999999999 110.202 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.31 -40.38 90.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.351 -0.843 . . . . 2.5099999999999998 110.069 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.406 ' HZ ' HD21 ' A' ' 19' ' ' ASN . 64.8 t80 -61.09 -44.69 96.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 1.3700000000000001 110.285 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.93 -50.15 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.203 -0.935 . . . . 0.58999999999999997 110.663 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -62.94 -39.91 96.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.063 -1.023 . . . . 0.68999999999999995 109.365 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.87 -39.94 76.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 1.1699999999999999 109.78 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -72.18 -50.52 27.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 3.0 109.434 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -115.16 114.1 43.48 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.782 -0.822 . . . . 1.54 108.782 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.11 -3.8 13.78 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.862 1.708 . . . . 1.21 112.036 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.618 -0.882 . . . . 3.7400000000000002 108.618 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -70.0 -21.52 63.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -0.754 . . . . 1.1200000000000001 111.142 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.9 -40.02 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.48 -1.388 . . . . 2.5099999999999998 109.317 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -61.0 -43.69 98.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.011 . . . . 2.3399999999999999 109.492 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' TYR . 54.3 t30 -109.39 109.49 20.36 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.986 -0.746 . . . . 2.0099999999999998 108.986 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 97.9 mttt -102.7 -37.7 7.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 1.6799999999999999 110.602 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -89.03 139.16 30.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 3.98 110.344 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.58 -66.79 0.23 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.291 . . . . 0.78000000000000003 109.871 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 24.7 p-90 -71.32 -37.95 71.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.44 110.744 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.94 -50.05 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 1.96 111.162 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -74.52 -25.54 59.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.843 -1.16 . . . . 1.28 110.583 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 t -60.02 -41.24 91.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.105 -0.997 . . . . 1.49 110.282 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 13' ' ' ILE . 41.1 mt -65.74 -40.82 88.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.255 -0.903 . . . . 0.64000000000000001 110.544 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -60.02 -44.08 94.85 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.334 -1.479 . . . . 2.7599999999999998 108.607 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.697 -0.853 . . . . 2.48 108.697 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -68.44 -39.99 81.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 2.0699999999999998 110.235 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.75 -40.13 91.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.052 -1.03 . . . . 0.78000000000000003 110.048 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 t -64.76 -49.68 69.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.883 . . . . 1.6000000000000001 110.512 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.98 -32.06 70.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.3799999999999999 109.971 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -74.79 112.21 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 1.4199999999999999 109.724 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.78 0.0 57.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.4 -0.813 . . . . 2.1699999999999999 109.692 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.3 p -69.98 -21.37 63.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.983 -1.073 . . . . 1.5600000000000001 109.727 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.22 153.25 21.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 1.3200000000000001 109.789 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.0 t -114.38 124.79 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 0.91000000000000003 109.62 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -80.0 159.95 26.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 1.8100000000000001 108.602 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.19 77.53 24.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.002 -1.061 . . . . 1.28 109.585 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo . . . . . 0 C--N 1.309 -1.507 0 C-N-CA 122.662 2.241 . . . . 1.6499999999999999 112.241 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.472 -0.936 . . . . 1.3899999999999999 108.472 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -116.09 137.13 52.4 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.477 -0.764 . . . . 0.46000000000000002 109.824 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -153.06 160.95 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.912 . . . . 0.56000000000000005 109.847 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.211 -0.931 . . . . 1.4199999999999999 110.109 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.2 Cg_exo . . . . . 0 N--CA 1.491 1.376 0 N-CA-C 111.295 -0.31 . . . . 0.72999999999999998 111.295 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -42.25 -12.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.248 1.966 . . . . 0.83999999999999997 113.767 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.6 m-85 -68.16 141.94 55.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.72 -1.238 . . . . 1.1499999999999999 109.712 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 m -74.38 163.07 28.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 1.3899999999999999 109.362 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -59.99 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.948 . . . . 1.3200000000000001 109.518 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.44 -40.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.075 -1.016 . . . . 0.95999999999999996 109.055 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.19 87.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.38 109.945 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.41 -40.12 89.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.37 109.544 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.68 -40.05 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.42 -0.955 . . . . 0.48999999999999999 108.42 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -60.92 -39.99 91.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.712 . . . . 0.39000000000000001 109.78 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.459 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 65.4 mtt -68.94 -39.39 79.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 1.1399999999999999 110.0 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.12 83.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.32000000000000001 109.88 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.44 -49.97 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.33000000000000002 109.5 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.65 -40.02 84.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.797 -0.564 . . . . 1.8200000000000001 110.482 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 15' ' ' MET . 4.2 m-80 -70.23 -15.43 62.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 1.6699999999999999 110.414 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 146.67 69.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.63 109.26 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.86 -44.44 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.738 1.625 . . . . 1.29 109.968 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -106.19 126.52 52.32 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.459 -1.312 . . . . 2.6299999999999999 107.459 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -58.56 -24.57 61.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.989 -1.069 . . . . 2.02 108.748 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -80.08 84.98 5.71 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.289 -1.004 . . . . 1.55 108.289 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.3 tt -107.03 147.66 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.568 -0.708 . . . . 0.46999999999999997 109.102 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -79.18 154.96 28.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.81000000000000005 110.452 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.04 -47.53 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.594 0.711 . . . . 0.69999999999999996 109.75 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.54 -39.9 89.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 1.25 110.341 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.07 96.56 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.232 -0.917 . . . . 0.28999999999999998 111.158 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.14 -39.91 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.832 -1.393 . . . . 0.34999999999999998 109.434 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 1.3999999999999999 109.528 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -61.6 -40.02 93.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 2.5099999999999998 109.702 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.91 -43.7 94.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.581 -0.7 . . . . 1.3700000000000001 111.32 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.98 -40.71 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.798 -1.189 . . . . 0.58999999999999997 111.519 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.12 -39.94 78.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.89 -1.131 . . . . 0.68999999999999995 110.301 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 96.2 m-20 -71.31 -46.95 59.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.918 -1.114 . . . . 1.1699999999999999 109.854 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -69.76 -35.44 74.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 3.0 110.366 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' C ' ' H ' ' A' ' 40' ' ' PHE . 90.9 m-85 -128.7 79.96 73.46 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.345 -0.847 . . . . 1.54 109.854 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.31 -6.07 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.84 2.36 . . . . 1.21 111.718 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -60.08 -39.5 86.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 3.7400000000000002 109.459 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.96 -24.1 63.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.565 -0.709 . . . . 1.1200000000000001 111.125 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.3 mtt-85 -59.55 -40.09 86.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.815 -1.178 . . . . 2.5099999999999998 109.738 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.93 -19.11 65.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.009 -1.057 . . . . 2.3399999999999999 109.992 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -133.54 97.56 3.97 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.012 -0.736 . . . . 2.0099999999999998 109.012 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 62.7 mttp -88.56 -45.71 9.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 1.6799999999999999 110.717 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.15 144.3 34.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 3.98 110.121 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.91 -58.04 0.4 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.302 -1.119 . . . . 0.78000000000000003 110.302 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.472 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.5 p-90 -89.19 -13.5 38.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.028 -1.278 . . . . 0.44 109.962 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -60.26 -50.0 75.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.14 -0.975 . . . . 1.96 111.487 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -75.88 -36.77 59.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 1.28 111.671 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 94.0 p -57.84 -23.07 51.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.988 -1.07 . . . . 1.49 110.836 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mm -75.74 -68.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.963 -1.086 . . . . 0.64000000000000001 110.727 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -68.49 -27.01 65.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.114 -0.991 . . . . 2.7599999999999998 110.693 -178.289 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.01 -42.01 93.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 2.48 108.655 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 57' ' ' SER . 96.5 m-20 -62.52 -40.12 95.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.454 -0.779 . . . . 2.0699999999999998 109.61 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.29 59.21 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 0.78000000000000003 109.159 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' ASN . 40.1 t -159.97 -54.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.264 -0.897 . . . . 1.6000000000000001 109.564 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 58' ' ' LEU . 7.6 mp -65.85 -40.1 91.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 1.3799999999999999 109.772 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -69.43 127.95 34.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.125 -0.984 . . . . 1.4199999999999999 108.797 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.96 -1.71 58.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.511 -0.743 . . . . 2.1699999999999999 109.373 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.8 m -64.81 -39.91 94.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 1.5600000000000001 109.195 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -84.18 134.0 34.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 1.3200000000000001 109.264 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 129.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.784 . . . . 0.91000000000000003 109.175 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.0 139.56 57.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 1.8100000000000001 109.041 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.69 123.42 31.3 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.638 -0.875 . . . . 1.28 108.638 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.491 1.353 0 C-N-CA 121.07 1.18 . . . . 1.6499999999999999 111.873 -179.318 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 108.485 -0.932 . . . . 1.3899999999999999 108.485 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -118.73 140.27 50.2 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.663 0.745 . . . . 0.46000000000000002 110.518 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -148.17 155.5 41.47 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.257 -1.016 . . . . 0.56000000000000005 108.257 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.49 1.533 0 O-C-N 120.894 -1.129 . . . . 1.4199999999999999 109.662 -179.51 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.494 1.539 0 CA-C-O 120.723 0.218 . . . . 0.72999999999999998 111.589 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.67 27.66 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.388 2.059 . . . . 0.83999999999999997 113.299 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -100.42 133.59 44.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.878 -1.139 . . . . 1.1499999999999999 108.839 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -70.31 161.83 29.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 1.3899999999999999 108.914 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -59.23 -43.05 92.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.98 -1.075 . . . . 1.3200000000000001 108.307 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.462 ' HA ' HD12 ' A' ' 13' ' ' ILE . 81.9 mt -65.15 -40.02 87.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.606 -0.887 . . . . 0.95999999999999996 108.606 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.97 98.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 0.38 109.862 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.01 -40.14 88.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.913 -1.117 . . . . 0.37 108.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.691 HD11 HG23 ' A' ' 52' ' ' ILE . 96.4 mt -62.91 -42.14 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.44 -0.787 . . . . 0.48999999999999999 108.886 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -60.79 -43.21 98.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.722 -0.611 . . . . 0.39000000000000001 110.553 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.558 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.8 mtm -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.915 -1.116 . . . . 1.1399999999999999 109.426 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 19' ' ' ASN . . . -50.37 -52.34 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.538 -0.726 . . . . 0.32000000000000001 109.898 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.02 -44.29 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.33000000000000002 109.368 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.1 -46.14 90.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.656 . . . . 1.8200000000000001 111.187 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 15' ' ' MET . 18.9 p30 -90.04 11.05 21.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.991 -1.068 . . . . 1.6699999999999999 110.474 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.29 120.39 80.94 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 0.63 108.83 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -41.77 -38.22 4.42 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.443 1.429 . . . . 1.29 110.993 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -112.93 137.23 51.63 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.817 -1.179 . . . . 2.6299999999999999 107.817 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -60.02 -39.97 87.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.967 -1.083 . . . . 2.02 108.502 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -82.15 129.15 34.75 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.163 -1.051 . . . . 1.55 108.163 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.12 146.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.206 -0.934 . . . . 0.46999999999999997 110.158 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.77 160.0 26.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.519 -0.738 . . . . 0.81000000000000005 110.278 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.07 -48.41 81.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.636 -0.875 . . . . 0.69999999999999996 108.636 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.78 -39.91 90.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 1.25 109.89 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.89 95.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.456 -1.058 . . . . 0.28999999999999998 110.456 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.12 -42.54 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.322 . . . . 0.34999999999999998 109.74 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -62.1 -40.1 94.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 1.3999999999999999 110.736 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.4 -40.17 90.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.953 -1.092 . . . . 2.5099999999999998 109.614 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 65.6 t80 -60.09 -46.85 88.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 1.3700000000000001 111.168 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.04 -49.83 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.046 -1.034 . . . . 0.58999999999999997 110.826 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtm -61.86 -40.0 93.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.854 -1.153 . . . . 0.68999999999999995 110.105 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.65 -39.92 93.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 1.1699999999999999 110.921 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -79.99 -67.69 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.885 -1.134 . . . . 3.0 110.103 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 23.7 m-85 -92.09 115.69 65.11 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 1.54 109.004 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.72 -7.81 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.176 1.918 . . . . 1.21 113.278 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 1.1 m-85 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.122 . . . . 3.7400000000000002 109.341 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -67.83 -26.78 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.574 -0.704 . . . . 1.1200000000000001 110.848 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.02 -40.01 87.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.004 . . . . 2.5099999999999998 109.477 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -71.41 -9.31 57.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 2.3399999999999999 109.214 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 57.5 t-20 -141.51 99.53 3.58 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.049 -0.723 . . . . 2.0099999999999998 109.049 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.539 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 65.0 mttm -96.66 -21.48 17.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 1.6799999999999999 110.911 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -90.66 136.36 33.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.765 -1.209 . . . . 3.98 110.86 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -75.15 0.23 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.594 -1.003 . . . . 0.78000000000000003 110.594 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.539 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.6 p-90 -62.42 -37.46 85.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.265 -1.138 . . . . 0.44 110.898 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 56.9 tt0 -59.83 -50.33 74.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 1.96 111.661 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.912 -1.118 . . . . 1.28 112.272 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.7 m -59.95 -40.09 87.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.863 -1.148 . . . . 1.49 112.217 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.691 HG23 HD11 ' A' ' 13' ' ' ILE . 11.1 mt -61.89 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.629 -1.294 . . . . 0.64000000000000001 110.691 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -69.18 -29.26 67.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.401 -1.437 . . . . 2.7599999999999998 109.199 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -69.59 -37.2 76.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.044 -1.465 . . . . 2.48 107.044 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.59 -36.35 78.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.688 -0.632 . . . . 2.0699999999999998 109.317 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 56' ' ' LEU . 82.4 mt -59.99 -42.01 93.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.78000000000000003 110.558 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -60.04 -46.86 88.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 1.6000000000000001 109.87 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 58' ' ' LEU . 10.1 mp -69.98 -37.86 75.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 1.3799999999999999 109.439 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.8 111.99 11.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.19 -0.944 . . . . 1.4199999999999999 109.269 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.03 -9.8 52.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 2.1699999999999999 109.626 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 62' ' ' PHE . 30.1 p -60.06 -35.9 76.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 1.5600000000000001 109.412 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.413 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 74.8 m-85 -78.1 147.42 34.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 1.3200000000000001 108.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.47 130.64 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.466 -0.771 . . . . 0.91000000000000003 110.826 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -76.25 158.67 31.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 1.8100000000000001 109.176 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.8 t -134.64 84.26 39.86 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.389 -0.82 . . . . 1.28 108.994 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo . . . . . 0 C--N 1.31 -1.478 0 C-N-CA 122.655 2.237 . . . . 1.6499999999999999 112.685 -179.311 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 108.954 -0.758 . . . . 1.3899999999999999 108.954 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -117.96 140.01 50.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.509 -0.744 . . . . 0.46000000000000002 109.589 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -144.09 159.93 41.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.318 -0.864 . . . . 0.56000000000000005 109.507 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 1.4199999999999999 109.302 179.695 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 N--CA 1.491 1.376 0 N-CA-C 112.577 0.183 . . . . 0.72999999999999998 112.577 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.72 30.22 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.507 2.138 . . . . 0.83999999999999997 111.981 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.31 133.94 53.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.429 -0.794 . . . . 1.1499999999999999 108.871 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -65.67 160.79 21.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 1.3899999999999999 108.279 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.886 -1.134 . . . . 1.3200000000000001 108.221 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.17 -41.36 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 0.95999999999999996 109.154 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.72 96.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.38 109.579 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.96 -41.4 91.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 0.37 108.403 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.3 mt -70.01 -41.9 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.379 -0.826 . . . . 0.48999999999999999 109.453 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -60.2 -40.02 88.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.39000000000000001 110.139 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.5 mtm -70.02 -37.48 75.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 1.1399999999999999 110.028 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.17 90.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.32000000000000001 110.185 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.93 -49.98 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.33000000000000002 109.071 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.79 -38.57 86.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.473 0.654 . . . . 1.8200000000000001 109.71 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.438 HD21 ' HZ ' ' A' ' 33' ' ' PHE . 74.5 m-20 -77.12 1.04 19.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 1.6699999999999999 109.49 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.35 149.9 76.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.187 -0.946 . . . . 0.63 108.705 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -37.33 -73.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.193 1.929 . . . . 1.29 112.59 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.1 -79.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.032 -1.042 . . . . 2.6299999999999999 110.187 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -165.5 -34.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 2.02 108.997 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -88.53 138.38 31.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.276 -0.89 . . . . 1.55 109.805 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -140.81 153.8 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.19 -0.944 . . . . 0.46999999999999997 109.913 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.7 p -86.01 166.08 16.17 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.332 -0.855 . . . . 0.81000000000000005 110.474 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 27' ' ' LEU . 20.2 tp -60.15 -51.59 68.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.872 -1.159 . . . . 0.69999999999999996 107.872 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.85 -40.01 91.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.782 -0.574 . . . . 1.25 110.445 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -40.02 95.39 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.122 -1.037 . . . . 0.28999999999999998 110.543 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.51 -43.85 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.02 -1.282 . . . . 0.34999999999999998 110.363 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.561 ' O ' ' SD ' ' A' ' 35' ' ' MET . 39.9 m-85 -60.01 -46.64 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.986 . . . . 1.3999999999999999 111.989 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.93 -39.29 84.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.771 -1.205 . . . . 2.5099999999999998 110.076 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.438 ' HZ ' HD21 ' A' ' 19' ' ' ASN . 78.7 t80 -60.01 -40.01 87.79 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.309 -0.87 . . . . 1.3700000000000001 110.427 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.49 -48.54 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.99 -1.068 . . . . 0.58999999999999997 111.911 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . 0.561 ' SD ' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -60.05 -39.96 87.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.559 -1.338 . . . . 0.68999999999999995 110.231 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 88.2 m-20 -68.43 -40.06 81.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.935 -1.103 . . . . 1.1699999999999999 110.429 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -67.69 -40.01 84.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 3.0 110.27 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.38 122.59 21.02 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.347 -0.845 . . . . 1.54 109.011 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.32 -6.07 16.8 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.55 1.5 . . . . 1.21 111.11 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.07 -44.74 94.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.809 -0.557 . . . . 3.7400000000000002 110.733 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.38 -23.81 64.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.983 -1.073 . . . . 1.1200000000000001 111.012 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 64.3 mtt-85 -60.07 -40.05 88.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.84 -1.163 . . . . 2.5099999999999998 109.393 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.15 -40.01 94.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.883 . . . . 2.3399999999999999 110.6 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -116.33 112.69 21.9 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.118 -0.697 . . . . 2.0099999999999998 109.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.2 mttt -95.55 -66.39 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 1.6799999999999999 110.438 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -65.33 144.25 57.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 3.98 109.946 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.15 -62.72 0.32 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.582 -1.007 . . . . 0.78000000000000003 110.582 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 41.9 p-90 -80.86 -12.79 59.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.899 -1.353 . . . . 0.44 110.469 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -70.01 -41.47 74.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 1.96 110.848 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -70.08 -38.28 75.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.32 -0.863 . . . . 1.28 111.352 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 23.8 t -59.97 -41.14 91.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.954 -1.091 . . . . 1.49 110.662 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.8 mm -59.97 -50.05 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.082 -1.011 . . . . 0.64000000000000001 110.677 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -63.03 -39.32 94.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.975 -1.078 . . . . 2.7599999999999998 109.616 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.537 ' NE2' HD11 ' A' ' 58' ' ' LEU . 19.8 t60 -60.04 -39.98 87.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.38 -0.825 . . . . 2.48 108.797 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 51' ' ' SER . 19.2 m-80 -66.58 -39.91 88.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 2.0699999999999998 109.502 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.48 -39.99 89.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.952 . . . . 0.78000000000000003 110.282 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -71.2 -39.95 71.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.937 -1.102 . . . . 1.6000000000000001 110.868 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.537 HD11 ' NE2' ' A' ' 54' ' ' HIS . 79.1 mt -68.73 -39.99 80.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.074 -1.017 . . . . 1.3799999999999999 112.049 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -62.02 118.4 7.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.691 -1.255 . . . . 1.4199999999999999 110.432 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -84.22 -31.61 24.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 2.1699999999999999 109.622 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p -66.24 -9.18 29.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 1.5600000000000001 108.965 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -89.85 138.46 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 1.3200000000000001 107.907 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -123.84 129.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.303 -0.873 . . . . 0.91000000000000003 110.469 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.2 147.66 38.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.834 . . . . 1.8100000000000001 108.956 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' PRO . 15.5 t -139.98 64.5 27.66 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.059 -1.026 . . . . 1.28 109.556 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 65' ' ' VAL . 54.8 Cg_exo . . . . . 0 C--N 1.307 -1.621 0 C-N-CA 123.013 2.475 . . . . 1.6499999999999999 113.375 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 108.828 -0.804 . . . . 1.3899999999999999 108.828 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -141.89 131.43 23.91 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.052 -1.03 . . . . 0.46000000000000002 110.903 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -155.04 150.94 27.81 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.897 -0.779 . . . . 0.56000000000000005 108.897 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.97 -1.081 . . . . 1.4199999999999999 109.332 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.492 1.419 0 CA-C-O 120.644 0.185 . . . . 0.72999999999999998 111.669 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.4 26.61 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.418 2.079 . . . . 0.83999999999999997 113.565 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.55 137.92 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.848 -1.157 . . . . 1.1499999999999999 108.372 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 m -77.57 166.41 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 1.3899999999999999 108.947 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -59.94 -37.87 80.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.082 . . . . 1.3200000000000001 108.354 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.13 -46.48 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.95999999999999996 109.338 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.71 95.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.38 110.786 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.2 mt -59.93 -40.05 87.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.154 . . . . 0.37 108.599 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.41 -44.84 94.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 0.48999999999999999 108.336 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -67.44 -40.06 85.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.602 -0.686 . . . . 0.39000000000000001 110.738 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtt -66.7 -39.91 88.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 1.1399999999999999 109.148 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -50.04 75.27 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.537 -0.727 . . . . 0.32000000000000001 110.107 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 80' ' ' LEU . 80.9 mt -60.46 -50.0 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 0.33000000000000002 109.509 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -40.0 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.664 -0.647 . . . . 1.8200000000000001 110.576 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -82.05 1.27 36.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 1.6699999999999999 109.87 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.42 149.05 74.86 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 0.63 108.634 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 -32.22 91.17 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.614 1.543 . . . . 1.29 109.806 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -124.21 139.99 53.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.797 -1.186 . . . . 2.6299999999999999 107.797 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -60.07 -38.99 84.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.02 -1.05 . . . . 2.02 108.585 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -77.97 120.18 22.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.926 -1.139 . . . . 1.55 107.926 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.73 148.87 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.248 -0.907 . . . . 0.46999999999999997 109.971 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.3 p -79.83 160.0 26.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -0.772 . . . . 0.81000000000000005 110.89 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -66.32 -39.99 89.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.756 -0.831 . . . . 0.69999999999999996 108.756 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.91 -40.0 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 1.25 109.672 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.72 -38.51 96.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.344 -1.102 . . . . 0.28999999999999998 110.344 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.99 -42.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 0.34999999999999998 109.933 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -60.0 -39.11 84.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.959 -1.088 . . . . 1.3999999999999999 109.588 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.36 91.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.045 -1.035 . . . . 2.5099999999999998 108.882 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.95 -47.59 85.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 1.3700000000000001 110.431 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.446 HG21 ' CZ3' ' A' ' 48' ' ' TRP . 2.1 mp -61.73 -49.66 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 0.58999999999999997 110.276 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.6 mtm -60.07 -39.91 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.808 -1.183 . . . . 0.68999999999999995 109.889 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.09 -51.85 19.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 1.1699999999999999 109.431 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.11 -50.0 75.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 3.0 109.312 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.57 110.66 38.66 Favored Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 108.812 -0.81 . . . . 1.54 108.812 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.51 -7.33 12.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.982 1.788 . . . . 1.21 112.514 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -60.57 -40.0 90.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.915 . . . . 3.7400000000000002 109.605 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.06 -17.82 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.693 -0.629 . . . . 1.1200000000000001 110.777 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.63 -43.17 93.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 2.5099999999999998 108.46 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.17 -43.74 97.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.337 -0.852 . . . . 2.3399999999999999 109.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -102.58 99.02 8.99 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.175 -0.676 . . . . 2.0099999999999998 109.175 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -94.51 -42.56 8.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 1.6799999999999999 109.476 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -81.29 149.5 28.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 3.98 109.494 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -73.34 0.28 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.133 -1.187 . . . . 0.78000000000000003 110.133 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.446 ' CZ3' HG21 ' A' ' 34' ' ' ILE . 20.6 p-90 -69.49 -38.73 77.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.44 110.664 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -60.04 -42.07 93.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 1.96 110.721 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -70.04 -39.57 75.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 1.28 110.826 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -0.948 . . . . 1.49 111.259 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.7 mm -60.0 -50.01 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.835 -1.166 . . . . 0.64000000000000001 110.126 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -60.35 -49.62 76.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.082 . . . . 2.7599999999999998 109.44 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.143 -1.058 . . . . 2.48 108.143 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -62.07 -40.34 95.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.473 -0.767 . . . . 2.0699999999999998 109.097 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.84 -40.06 94.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 0.78000000000000003 110.456 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.7 m -69.5 -46.84 65.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.983 -1.073 . . . . 1.6000000000000001 110.43 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.59 -39.98 88.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 1.3799999999999999 110.245 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -75.29 117.54 17.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 1.4199999999999999 109.752 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.59 -2.41 57.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 2.1699999999999999 109.352 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -60.36 -39.94 88.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 1.5600000000000001 109.591 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -79.71 152.8 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 1.3200000000000001 109.351 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.7 t -112.7 127.46 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.473 -0.767 . . . . 0.91000000000000003 109.393 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -68.98 145.76 53.32 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.28 -1.007 . . . . 1.8100000000000001 108.28 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 t -137.39 76.97 42.11 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.144 -0.972 . . . . 1.28 109.715 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo . . . . . 0 C--N 1.306 -1.659 0 C-N-CA 122.62 2.214 . . . . 1.6499999999999999 111.881 179.444 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 108.273 -1.01 . . . . 1.3899999999999999 108.273 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -119.95 140.03 51.54 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.758 0.79 . . . . 0.46000000000000002 110.716 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 t -139.62 162.24 35.58 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.769 -0.826 . . . . 0.56000000000000005 108.769 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 17' ' ' ILE . 2.2 mp . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.142 -0.974 . . . . 1.4199999999999999 110.445 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 50.2 Cg_endo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.094 -0.044 . . . . 0.72999999999999998 112.133 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.03 -12.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.555 2.17 . . . . 0.83999999999999997 114.142 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 14.4 m-85 -62.43 140.07 58.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.534 -1.354 . . . . 1.1499999999999999 109.519 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -79.63 168.23 19.65 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.833 -1.173 . . . . 1.3899999999999999 107.833 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -60.39 -39.91 89.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.902 -1.124 . . . . 1.3200000000000001 109.095 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.467 ' CD1' ' OD1' ' A' ' 55' ' ' ASN . 38.8 mm -62.18 -41.1 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.95999999999999996 109.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.97 85.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.38 110.154 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.1 -40.06 88.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 0.37 108.972 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.54 -40.05 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.48999999999999999 109.132 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.31 -39.96 96.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.573 -0.704 . . . . 0.39000000000000001 110.488 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.436 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.5 mtt -65.35 -39.95 92.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 1.1399999999999999 110.078 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.65 80.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.352 -0.843 . . . . 0.32000000000000001 109.591 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.23 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 0.33000000000000002 109.247 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.01 -40.14 88.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.413 0.625 . . . . 1.8200000000000001 110.125 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 15' ' ' MET . 69.4 m-80 -81.94 -0.12 42.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 1.6699999999999999 109.613 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.77 123.5 85.29 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.276 -0.89 . . . . 0.63 108.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -42.27 -48.23 6.71 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.44 1.426 . . . . 1.29 110.674 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -105.29 142.0 35.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.601 -1.259 . . . . 2.6299999999999999 107.601 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -60.02 -37.85 80.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.952 -1.092 . . . . 2.02 109.485 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.74 127.91 33.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.811 -1.181 . . . . 1.55 107.811 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.99 151.53 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 0.46999999999999997 109.532 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.2 p -81.38 156.92 25.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.246 -0.909 . . . . 0.81000000000000005 110.005 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.97 -48.3 82.28 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.745 0.783 . . . . 0.69999999999999996 110.04 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 1.25 110.2 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.49 91.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.403 -1.079 . . . . 0.28999999999999998 110.403 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.95 -42.98 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -1.209 . . . . 0.34999999999999998 110.771 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.851 -1.156 . . . . 1.3999999999999999 110.564 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.13 -39.26 85.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.153 -0.967 . . . . 2.5099999999999998 110.379 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -59.85 -49.3 78.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 1.3700000000000001 110.729 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.04 -49.92 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.0 -1.063 . . . . 0.58999999999999997 110.733 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.7 mtm -60.03 -40.12 88.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.874 -1.141 . . . . 0.68999999999999995 110.445 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.39 -45.22 94.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.928 -1.107 . . . . 1.1699999999999999 110.715 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 37' ' ' ARG . 49.0 mtt-85 -68.02 -48.38 65.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.911 -1.118 . . . . 3.0 111.192 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.14 125.28 26.27 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.158 -0.964 . . . . 1.54 110.521 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.22 -5.0 13.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.971 1.781 . . . . 1.21 110.707 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -60.01 -40.1 88.1 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.335 -0.617 . . . . 3.7400000000000002 109.335 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.05 -31.28 68.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 1.1200000000000001 109.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -60.06 -39.94 87.75 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.165 -0.959 . . . . 2.5099999999999998 109.204 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.26 -40.08 96.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 2.3399999999999999 110.132 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -110.55 101.37 10.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.175 -0.676 . . . . 2.0099999999999998 109.175 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 68.5 mttm -88.53 -40.65 13.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.094 -1.004 . . . . 1.6799999999999999 110.178 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -78.53 141.68 37.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.003 -1.061 . . . . 3.98 110.421 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.18 -60.37 0.33 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.188 -1.165 . . . . 0.78000000000000003 110.188 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.424 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 24.2 p-90 -88.85 -11.93 43.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -1.223 . . . . 0.44 110.239 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -69.85 -56.63 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 1.96 111.4 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.92 -38.75 76.33 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.253 -0.904 . . . . 1.28 112.327 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.5 m -59.99 -39.85 87.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.783 -1.198 . . . . 1.49 111.226 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.06 -68.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.954 -1.091 . . . . 0.64000000000000001 111.398 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -69.93 -33.13 71.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 2.7599999999999998 112.375 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -59.98 -40.16 88.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.342 -1.474 . . . . 2.48 107.676 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.467 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 21.8 t-20 -60.09 -40.53 89.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.614 -0.679 . . . . 2.0699999999999998 109.25 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.27 -40.14 95.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.997 -1.065 . . . . 0.78000000000000003 109.704 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -64.52 -49.75 70.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 1.6000000000000001 110.721 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.0 mp -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.882 -1.136 . . . . 1.3799999999999999 110.069 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.407 ' HA ' HD21 ' A' ' 59' ' ' ASN . 9.0 m120 -69.28 121.94 17.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 1.4199999999999999 110.505 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.5 -3.41 57.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.676 -0.861 . . . . 2.1699999999999999 108.676 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 1.5600000000000001 109.524 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -77.3 150.04 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.198 -0.939 . . . . 1.3200000000000001 109.068 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.5 t -111.05 129.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.534 -0.729 . . . . 0.91000000000000003 109.573 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -90.64 120.45 31.72 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.194 -1.039 . . . . 1.8100000000000001 108.194 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.79 127.22 31.7 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 120.807 -1.183 . . . . 1.28 109.326 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 N--CA 1.493 1.455 0 C-N-CA 121.855 1.703 . . . . 1.6499999999999999 112.008 179.419 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 107.473 -1.306 . . . . 1.3899999999999999 107.473 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -132.89 124.97 28.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.252 -0.905 . . . . 0.46000000000000002 109.553 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -152.8 152.42 31.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.282 -0.886 . . . . 0.56000000000000005 109.751 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.816 . . . . 1.4199999999999999 108.949 179.497 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 120.806 0.252 . . . . 0.72999999999999998 111.709 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.17 20.93 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.739 2.293 . . . . 0.83999999999999997 113.773 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -96.01 137.73 34.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.632 -1.292 . . . . 1.1499999999999999 109.141 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.7 p -73.33 165.61 24.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 1.3899999999999999 108.667 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 1.3200000000000001 109.18 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.35 -39.9 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.95999999999999996 109.64 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.03 99.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 0.38 109.519 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.76 -39.96 90.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.37 108.584 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.449 HG21 HD21 ' A' ' 56' ' ' LEU . 96.6 mt -70.08 -42.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.546 -0.722 . . . . 0.48999999999999999 109.766 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -65.67 -41.3 92.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.39000000000000001 109.744 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.95 -33.87 72.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 1.1399999999999999 109.887 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.432 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -60.05 -46.61 88.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 0.32000000000000001 109.783 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.03 -45.35 98.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.061 -1.024 . . . . 0.33000000000000002 109.807 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -63.15 -43.23 98.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.803 -0.561 . . . . 1.8200000000000001 112.178 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.679 ' ND2' ' CE1' ' A' ' 33' ' ' PHE . 44.9 p-10 -89.98 10.34 24.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.713 -1.242 . . . . 1.6699999999999999 110.085 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.78 150.46 81.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 0.63 108.901 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.68 -24.89 65.3 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.732 1.622 . . . . 1.29 110.196 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -139.91 146.57 39.39 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.754 -1.202 . . . . 2.6299999999999999 107.754 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -59.97 -39.59 86.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.087 . . . . 2.02 108.885 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.06 129.35 34.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 1.55 109.273 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.9 tt -147.83 143.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.796 -0.816 . . . . 0.46999999999999997 108.796 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -80.02 163.18 24.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.81000000000000005 110.053 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.451 HD13 ' CD1' ' A' ' 56' ' ' LEU . 16.0 tp -59.93 -40.69 89.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.509 -0.744 . . . . 0.69999999999999996 109.094 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -60.59 -40.25 91.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.431 -0.793 . . . . 1.25 110.141 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.99 96.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.274 -1.131 . . . . 0.28999999999999998 110.274 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.48 -40.37 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -1.137 . . . . 0.34999999999999998 110.517 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.426 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 29.1 m-85 -60.02 -39.98 87.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.101 . . . . 1.3999999999999999 110.593 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -59.98 -40.0 87.65 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.949 -1.095 . . . . 2.5099999999999998 109.903 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.679 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 93.8 t80 -60.02 -49.91 75.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 1.3700000000000001 111.662 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.69 -49.95 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 0.58999999999999997 112.154 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 45.7 mtm -60.34 -40.04 89.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.706 -1.246 . . . . 0.68999999999999995 110.994 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -67.17 -48.65 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 1.1699999999999999 110.914 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -40.0 75.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.289 -0.882 . . . . 3.0 112.189 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -126.55 80.44 69.78 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.088 -1.007 . . . . 1.54 110.2 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.03 -9.85 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.95 2.433 . . . . 1.21 113.643 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.11 -37.51 80.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.633 -1.292 . . . . 3.7400000000000002 108.996 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -69.15 -28.03 66.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 1.1200000000000001 110.898 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -58.84 -39.97 82.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.654 -1.279 . . . . 2.5099999999999998 108.165 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.29 -40.0 86.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 2.3399999999999999 109.026 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.489 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 94.8 m-20 -99.92 101.02 12.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.226 -0.657 . . . . 2.0099999999999998 109.226 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 92.0 mttt -90.41 -78.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.06 -1.025 . . . . 1.6799999999999999 110.388 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.03 140.01 57.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 3.98 110.235 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.11 -58.2 0.54 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.66 -1.376 . . . . 0.78000000000000003 109.66 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.489 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 33.3 p-90 -89.69 -10.58 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -1.235 . . . . 0.44 110.807 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 77.9 mt-30 -68.64 -54.53 15.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.883 -1.136 . . . . 1.96 110.916 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -65.35 -34.8 79.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 1.28 110.948 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.1 p -59.51 -41.51 90.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.917 -1.114 . . . . 1.49 109.933 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.13 -50.03 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.64000000000000001 109.797 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 25.4 mtt180 -72.76 -38.84 67.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 2.7599999999999998 109.864 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.508 ' NE2' HD11 ' A' ' 58' ' ' LEU . 68.5 t60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 2.48 108.674 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -65.58 -40.01 92.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.389 -0.819 . . . . 2.0699999999999998 109.696 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.451 ' CD1' HD13 ' A' ' 27' ' ' LEU . 44.7 mt -60.53 -46.65 89.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.78000000000000003 111.291 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -64.66 -39.96 94.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.836 -1.165 . . . . 1.6000000000000001 110.704 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.508 HD11 ' NE2' ' A' ' 54' ' ' HIS . 43.9 mt -66.99 -37.38 84.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.993 -1.067 . . . . 1.3799999999999999 109.464 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -79.9 110.54 15.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 1.4199999999999999 109.608 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.91 -8.61 51.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.768 . . . . 2.1699999999999999 109.194 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.6 m -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.856 -1.165 . . . . 1.5600000000000001 107.856 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.24 127.63 32.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.845 -1.168 . . . . 1.3200000000000001 107.845 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 t -102.54 126.94 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.623 -0.88 . . . . 0.91000000000000003 108.623 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -97.46 117.84 32.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.868 . . . . 1.8100000000000001 110.031 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.68 149.48 54.22 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.127 -1.064 . . . . 1.28 108.127 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.31 -1.452 0 C-N-CA 122.016 1.811 . . . . 1.6499999999999999 111.051 179.571 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.645 -0.502 . . . . 1.3899999999999999 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -108.86 133.54 52.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.521 -0.737 . . . . 0.46000000000000002 109.657 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -153.76 163.96 39.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.56000000000000005 110.244 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.24 -1.022 . . . . 1.4199999999999999 108.24 179.176 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo . . . . . 0 N--CA 1.491 1.375 0 N-CA-C 111.809 -0.112 . . . . 0.72999999999999998 111.809 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.21 -12.57 32.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.257 1.971 . . . . 0.83999999999999997 111.809 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -60.5 134.55 57.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.216 -0.927 . . . . 1.1499999999999999 108.645 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 p -70.42 162.11 29.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.176 -1.046 . . . . 1.3899999999999999 108.176 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -58.47 -39.99 81.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 1.3200000000000001 108.101 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.56 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.411 -0.806 . . . . 0.95999999999999996 109.155 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.13 91.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 0.38 109.828 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.95 -40.01 87.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.053 -1.03 . . . . 0.37 108.59 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.97 -39.9 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.48999999999999999 109.105 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.76 -39.9 95.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 0.39000000000000001 110.016 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.48 -38.49 87.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.415 -0.803 . . . . 1.1399999999999999 109.521 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.57 92.55 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.439 -0.788 . . . . 0.32000000000000001 109.849 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.4 mt -64.9 -52.92 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 0.33000000000000002 109.115 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -63.87 -40.01 95.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.731 -0.605 . . . . 1.8200000000000001 109.539 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -69.96 -21.48 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.543 -0.723 . . . . 1.6699999999999999 109.967 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 147.31 68.42 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 0.63 108.898 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.38 -48.18 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.866 1.711 . . . . 1.29 110.32 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.88 123.15 45.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.722 -1.214 . . . . 2.6299999999999999 107.722 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -61.1 -28.12 68.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 2.02 110.368 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -78.8 88.29 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.787 -1.196 . . . . 1.55 108.803 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.33 151.61 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.098 -0.704 . . . . 0.46999999999999997 109.098 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.2 p -79.91 159.54 26.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.81000000000000005 110.213 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.59 -41.84 95.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.839 -0.8 . . . . 0.69999999999999996 108.839 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.19 -40.06 88.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 1.25 110.194 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.68 -40.02 98.2 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.693 -0.963 . . . . 0.28999999999999998 110.693 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.77 -39.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.241 . . . . 0.34999999999999998 110.798 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.471 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 28.0 m-85 -59.97 -43.84 94.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.709 -1.244 . . . . 1.3999999999999999 110.19 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.0 -39.99 87.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.245 -0.909 . . . . 2.5099999999999998 109.096 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -59.91 -50.06 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.657 -0.652 . . . . 1.3700000000000001 110.883 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.66 -48.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.95 -1.093 . . . . 0.58999999999999997 111.49 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 32.0 mtm -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 0.68999999999999995 109.938 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 83.1 m-20 -66.39 -47.03 74.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 1.1699999999999999 110.727 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 3.0 111.06 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 40' ' ' PHE . 65.9 m-85 -126.1 77.22 71.62 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.226 -0.921 . . . . 1.54 109.85 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.76 -7.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.988 2.459 . . . . 1.21 112.808 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' PHE . 24.1 t80 -58.59 -40.03 82.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 3.7400000000000002 109.091 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 44' ' ' ASN . 96.8 m-85 -69.99 -23.86 63.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.1200000000000001 111.501 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.0 mtt-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.559 -1.338 . . . . 2.5099999999999998 108.724 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.2 -37.03 82.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.512 -0.742 . . . . 2.3399999999999999 110.007 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 33.0 m120 -108.5 119.18 38.77 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.494 0.664 . . . . 2.0099999999999998 111.002 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 64.3 mttp -119.11 15.0 13.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.033 -1.099 . . . . 1.6799999999999999 108.033 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.07 -118.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.619 -0.675 . . . . 3.98 112.818 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.79 -10.06 67.56 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.18 -0.95 . . . . 0.78000000000000003 112.275 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 12.5 p-90 -60.03 -36.99 78.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.222 -1.752 . . . . 0.44 107.578 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -59.99 -50.03 75.34 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.629 -0.669 . . . . 1.96 109.926 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 1.28 111.047 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.9 p -56.86 -34.27 67.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.077 -1.014 . . . . 1.49 111.119 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -59.99 -46.03 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.86 -1.15 . . . . 0.64000000000000001 109.308 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 26.6 mtt180 -72.94 -39.36 66.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 2.7599999999999998 110.146 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -59.98 -39.97 87.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 2.48 110.253 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 56' ' ' LEU . 30.0 p30 -75.02 -25.0 58.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.901 -1.124 . . . . 2.0699999999999998 110.615 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.53 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 56.2 mt -64.15 -42.93 96.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.698 -1.251 . . . . 0.78000000000000003 110.014 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -69.99 -40.56 75.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.996 -1.065 . . . . 1.6000000000000001 110.04 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -69.49 -40.0 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.083 . . . . 1.3799999999999999 109.389 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -75.37 118.7 18.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.263 -0.898 . . . . 1.4199999999999999 108.898 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.77 -5.66 56.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.505 -0.747 . . . . 2.1699999999999999 109.072 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 89.5 m -60.38 -40.03 89.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 1.5600000000000001 109.351 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -85.71 147.05 26.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 1.3200000000000001 108.762 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.96 124.6 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 0.91000000000000003 109.366 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -79.04 129.98 35.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.501 -0.926 . . . . 1.8100000000000001 108.501 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.66 100.31 50.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.623 -0.673 . . . . 1.28 109.875 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.563 0 C-N-CA 122.149 1.899 . . . . 1.6499999999999999 112.158 179.504 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.269 -0.641 . . . . 1.3899999999999999 109.269 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -119.9 135.5 54.87 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.689 -0.856 . . . . 0.46000000000000002 108.689 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -150.57 160.38 43.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.119 -0.988 . . . . 0.56000000000000005 110.025 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.043 -0.725 . . . . 1.4199999999999999 109.043 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 N--CA 1.494 1.544 0 CA-C-O 120.753 0.231 . . . . 0.72999999999999998 112.203 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.19 -1.26 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.834 2.356 . . . . 0.83999999999999997 113.612 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -72.55 143.41 48.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.593 -1.317 . . . . 1.1499999999999999 109.416 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.1 p -76.31 163.15 27.29 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.538 -0.912 . . . . 1.3899999999999999 108.538 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -60.09 -39.93 87.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 1.3200000000000001 108.647 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.53 -40.02 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.37 -0.831 . . . . 0.95999999999999996 109.062 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.58 92.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 0.38 110.101 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 0.37 109.128 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.81 -44.68 98.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.176 -1.046 . . . . 0.48999999999999999 108.176 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -60.11 -39.99 88.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.708 -0.62 . . . . 0.39000000000000001 109.478 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.9 mtt -68.2 -39.65 82.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.1399999999999999 110.019 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.64 88.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.32000000000000001 110.495 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.77 -50.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.008 -1.058 . . . . 0.33000000000000002 109.669 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.99 -39.92 75.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 1.8200000000000001 110.383 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -64.14 -32.98 74.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 1.6699999999999999 109.216 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.78 116.94 62.49 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 0.63 109.134 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -46.54 -33.46 13.12 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.218 1.279 . . . . 1.29 110.696 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -100.04 113.72 26.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.071 -1.085 . . . . 2.6299999999999999 108.071 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -69.66 -28.81 66.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 2.02 110.077 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -78.47 75.17 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.045 -1.034 . . . . 1.55 108.634 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 tt -100.98 147.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.074 -0.713 . . . . 0.46999999999999997 109.074 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -80.04 164.88 23.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.422 -0.799 . . . . 0.81000000000000005 109.679 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.99 -47.19 86.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.214 -1.032 . . . . 0.69999999999999996 108.214 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.81 -40.04 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.751 -0.593 . . . . 1.25 110.139 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.01 96.39 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.82 -0.912 . . . . 0.28999999999999998 110.82 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -43.91 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.941 -1.329 . . . . 0.34999999999999998 109.594 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 37.7 m-85 -60.17 -40.81 91.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 1.3999999999999999 110.896 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' OE1' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -66.85 -39.97 87.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.917 -1.114 . . . . 2.5099999999999998 109.821 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.03 -46.62 88.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 1.3700000000000001 111.014 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.99 -41.11 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 0.58999999999999997 110.675 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 30.7 mtt -60.12 -39.98 88.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.036 . . . . 0.68999999999999995 110.36 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' OE1' ' A' ' 32' ' ' GLN . 96.7 m-20 -68.92 -52.86 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 1.1699999999999999 111.646 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -69.97 -42.89 72.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.873 -1.142 . . . . 3.0 110.07 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.99 101.51 54.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 108.318 -0.993 . . . . 1.54 108.318 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.46 -6.4 13.64 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.958 1.772 . . . . 1.21 112.717 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -60.0 -36.74 77.85 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.883 -1.154 . . . . 3.7400000000000002 107.883 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -64.5 -25.28 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.844 -0.616 . . . . 1.1200000000000001 110.402 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.927 -1.108 . . . . 2.5099999999999998 109.523 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.09 -39.98 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 2.3399999999999999 109.524 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -103.61 100.8 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.553 -0.906 . . . . 2.0099999999999998 108.553 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.6 mttt -94.59 -68.33 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 1.6799999999999999 110.513 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.03 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.963 -1.085 . . . . 3.98 110.327 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.55 -60.42 0.41 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.611 -0.996 . . . . 0.78000000000000003 110.611 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 37.1 p-90 -84.85 -27.81 26.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -1.225 . . . . 0.44 110.712 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.421 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 93.1 mt-30 -60.36 -42.56 96.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 1.96 112.027 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -76.92 -33.92 57.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.711 -1.243 . . . . 1.28 111.8 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . 0.401 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 29.1 t -59.89 -40.11 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.858 -1.151 . . . . 1.49 111.406 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.5 mm -62.95 -59.12 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.04 -1.037 . . . . 0.64000000000000001 111.711 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -70.05 -33.53 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.159 . . . . 2.7599999999999998 110.667 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -59.97 -40.03 87.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 2.48 109.356 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 51' ' ' SER . 94.4 m-20 -70.03 -21.52 63.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 2.0699999999999998 111.169 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.96 -50.02 75.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.748 -1.22 . . . . 0.78000000000000003 110.49 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.8 m -60.02 -40.01 87.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 1.6000000000000001 109.727 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' ' 58' ' ' LEU . 11.2 mp -66.28 -39.99 89.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 1.3799999999999999 109.06 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.59 113.97 15.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.424 -0.797 . . . . 1.4199999999999999 109.887 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -89.99 -6.21 55.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.619 -0.882 . . . . 2.1699999999999999 108.619 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -62.68 -37.74 87.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 1.5600000000000001 109.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -78.37 156.53 29.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 1.3200000000000001 108.582 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.2 t -120.16 129.96 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 0.91000000000000003 109.608 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.94 142.92 52.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 1.8100000000000001 109.501 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 57.8 t -127.11 88.2 54.82 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.487 -0.931 . . . . 1.28 108.487 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 88.0 Cg_exo . . . . . 0 C--N 1.308 -1.571 0 C-N-CA 121.994 1.796 . . . . 1.6499999999999999 112.032 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.889 -0.782 . . . . 1.3899999999999999 108.889 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -119.96 140.03 51.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.46000000000000002 109.904 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -145.04 160.38 41.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 0.56000000000000005 109.782 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 1.4199999999999999 108.785 179.059 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.62 0.175 . . . . 0.72999999999999998 112.551 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 -2.48 12.68 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.63 2.22 . . . . 0.83999999999999997 113.25 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 143.65 57.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.796 -1.19 . . . . 1.1499999999999999 109.748 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 t -79.79 165.93 22.25 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.142 -1.058 . . . . 1.3899999999999999 108.142 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.92 -40.07 87.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.795 -1.19 . . . . 1.3200000000000001 109.003 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.0 mt -68.12 -40.03 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.95999999999999996 109.957 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.51 92.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.952 -1.092 . . . . 0.38 109.902 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.08 -45.17 93.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.768 -1.208 . . . . 0.37 108.332 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.609 HD11 HD22 ' A' ' 55' ' ' ASN . 98.1 mt -63.91 -45.81 95.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.971 -0.751 . . . . 0.48999999999999999 108.971 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.91 -40.61 98.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.39000000000000001 110.573 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.04 -39.12 75.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.823 -1.173 . . . . 1.1399999999999999 109.529 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.9 90.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.555 -0.715 . . . . 0.32000000000000001 110.501 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.54 -49.89 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.979 -1.076 . . . . 0.33000000000000002 108.656 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -61.48 -39.94 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.366 0.603 . . . . 1.8200000000000001 109.494 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -78.32 -6.06 53.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 1.6699999999999999 110.37 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.34 126.47 83.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.63 109.639 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -41.24 -20.71 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.688 1.592 . . . . 1.29 110.931 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 20' ' ' ALA . 13.4 pt-20 -138.5 141.92 39.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 2.6299999999999999 108.141 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -60.59 -34.66 74.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.98 -1.075 . . . . 2.02 109.111 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.68 118.42 20.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 1.55 109.42 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.69 158.6 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.338 -0.851 . . . . 0.46999999999999997 109.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 p -86.5 161.8 18.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 0.81000000000000005 111.041 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 27' ' ' LEU . 20.1 tp -61.12 -50.26 73.92 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.185 0.993 . . . . 0.69999999999999996 109.002 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -59.97 -39.84 87.06 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.978 -0.556 . . . . 1.25 110.434 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.94 -39.94 89.79 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.004 -1.094 . . . . 0.28999999999999998 110.404 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.8 -40.87 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.938 -1.331 . . . . 0.34999999999999998 110.272 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 25.1 m-85 -60.03 -40.18 88.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.052 . . . . 1.3999999999999999 111.142 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -63.34 -37.59 87.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.976 -1.077 . . . . 2.5099999999999998 110.963 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.01 -45.17 93.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 1.3700000000000001 110.76 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.81 -52.87 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.035 -1.041 . . . . 0.58999999999999997 112.039 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.6 mtm -61.45 -39.97 92.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 0.68999999999999995 111.283 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.34 -50.49 71.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 1.1699999999999999 110.847 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -69.97 -39.98 75.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 3.0 111.382 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.555 ' C ' ' H ' ' A' ' 40' ' ' PHE . 89.7 m-85 -122.32 83.04 46.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 1.54 110.34 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.11 -3.93 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.248 1.966 . . . . 1.21 110.758 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -59.98 -39.99 87.59 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.653 -0.869 . . . . 3.7400000000000002 108.653 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.0 -29.7 66.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.577 -0.702 . . . . 1.1200000000000001 110.655 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -60.07 -39.9 87.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 2.5099999999999998 109.714 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.4 -40.34 96.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 2.3399999999999999 109.847 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -111.19 77.27 1.03 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.397 -0.594 . . . . 2.0099999999999998 109.397 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -69.77 -40.03 76.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 1.6799999999999999 110.04 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.67 148.08 37.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 3.98 110.41 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -61.65 0.35 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.323 -1.111 . . . . 0.78000000000000003 110.323 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -89.98 -10.3 45.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -1.227 . . . . 0.44 110.786 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 62.8 tt0 -65.58 -56.79 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.931 -1.106 . . . . 1.96 110.754 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -70.11 -31.76 69.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 1.28 110.603 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -58.51 -39.55 80.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 1.49 110.539 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.62 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 5.4 mm -60.09 -49.77 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 0.64000000000000001 110.236 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -70.05 -36.01 74.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.247 . . . . 2.7599999999999998 110.426 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -59.92 -40.25 88.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 2.48 109.797 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 52' ' ' ILE . 13.3 p30 -67.77 -39.99 84.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.511 -1.276 . . . . 2.0699999999999998 108.396 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.2 mt -60.07 -48.66 80.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.78000000000000003 110.353 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.5 p -70.05 -41.3 74.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 1.6000000000000001 110.45 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -69.09 -40.15 78.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.025 . . . . 1.3799999999999999 109.541 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -74.14 119.51 18.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -0.905 . . . . 1.4199999999999999 108.723 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.76 -9.84 57.8 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 2.1699999999999999 109.651 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.0 m -60.09 -39.96 87.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 1.5600000000000001 109.413 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.77 140.67 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 1.3200000000000001 108.824 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.56 130.1 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.498 -0.751 . . . . 0.91000000000000003 109.762 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -73.64 135.57 43.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 1.8100000000000001 109.211 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 77' ' ' TYR . 77.2 t -130.18 126.55 22.33 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.882 -0.785 . . . . 1.28 108.882 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.491 1.374 0 C-N-CA 121.693 1.595 . . . . 1.6499999999999999 112.263 179.698 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 65' ' ' VAL . 9.5 m-30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.944 -0.762 . . . . 1.3899999999999999 108.944 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -119.97 141.99 49.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.692 -0.63 . . . . 0.46000000000000002 109.689 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -143.03 160.04 41.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.21 -0.931 . . . . 0.56000000000000005 109.37 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.173 -0.954 . . . . 1.4199999999999999 109.909 -179.534 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo . . . . . 0 N--CA 1.494 1.504 0 N-CA-C 111.384 -0.275 . . . . 0.72999999999999998 111.384 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.4 -5.61 16.31 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.313 2.009 . . . . 0.83999999999999997 112.84 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -69.98 142.06 52.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.022 -1.049 . . . . 1.1499999999999999 109.792 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -70.89 160.58 32.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.774 -0.825 . . . . 1.3899999999999999 108.774 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.046 . . . . 1.3200000000000001 108.748 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.48 -39.54 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.95999999999999996 109.036 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.42 94.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.321 -0.862 . . . . 0.38 110.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.05 -39.94 87.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 0.37 108.895 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.68 -39.99 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.488 -0.758 . . . . 0.48999999999999999 108.98 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -65.28 -40.05 93.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.745 . . . . 0.39000000000000001 110.499 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.0 mtm -69.96 -37.78 75.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 1.1399999999999999 109.792 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.18 90.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 0.32000000000000001 110.048 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.96 -49.58 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.33000000000000002 108.672 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.74 -39.63 84.22 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.916 -0.584 . . . . 1.8200000000000001 110.731 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.571 HD21 ' HZ ' ' A' ' 33' ' ' PHE . 39.2 m-20 -67.63 -19.46 65.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 1.6699999999999999 109.844 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.58 150.12 75.77 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.63 109.292 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.79 -52.14 4.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.653 1.568 . . . . 1.29 109.578 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -100.95 135.99 41.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.066 -1.457 . . . . 2.6299999999999999 107.066 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -64.53 -19.16 65.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.784 -1.198 . . . . 2.02 109.538 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.13 126.13 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 1.55 108.9 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.8 tt -150.16 152.17 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.229 -0.919 . . . . 0.46999999999999997 109.532 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -79.97 158.74 26.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.81000000000000005 109.659 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.496 HD21 ' NE ' ' A' ' 53' ' ' ARG . 57.1 tp -60.08 -42.99 95.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.994 -1.113 . . . . 0.69999999999999996 107.994 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -62.77 -40.0 95.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.643 -0.66 . . . . 1.25 110.544 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -37.38 91.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.656 -1.378 . . . . 0.28999999999999998 109.656 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.24 -39.97 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -1.137 . . . . 0.34999999999999998 110.064 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 27.1 m-85 -64.38 -39.45 93.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.703 -1.248 . . . . 1.3999999999999999 110.335 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.91 -40.54 89.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 2.5099999999999998 108.972 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . 0.571 ' HZ ' HD21 ' A' ' 19' ' ' ASN . 64.4 t80 -61.9 -50.05 73.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 1.3700000000000001 110.875 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.67 -50.16 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.089 -1.007 . . . . 0.58999999999999997 112.175 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.6 mtm -60.64 -40.09 90.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 0.68999999999999995 110.514 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.32 -48.49 72.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 1.1699999999999999 111.38 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -69.75 -43.38 72.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.775 -1.203 . . . . 3.0 109.87 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 111.97 39.72 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.548 -0.908 . . . . 1.54 108.548 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.97 -5.76 14.72 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.873 1.715 . . . . 1.21 112.345 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.01 -38.13 81.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.371 -0.831 . . . . 3.7400000000000002 109.418 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -69.91 -23.29 63.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.107 -0.996 . . . . 1.1200000000000001 110.612 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -59.97 -40.37 88.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.897 -1.127 . . . . 2.5099999999999998 109.543 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -62.5 -41.05 98.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 2.3399999999999999 110.146 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -115.06 98.54 6.85 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.412 -0.588 . . . . 2.0099999999999998 109.412 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 61.4 mttp -85.21 -31.79 23.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.93 . . . . 1.6799999999999999 109.657 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -90.39 145.01 25.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 3.98 110.733 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.34 -63.92 0.29 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.726 -0.95 . . . . 0.78000000000000003 110.726 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.492 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 36.7 p-90 -73.08 -34.84 66.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.979 -1.306 . . . . 0.44 111.894 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -60.61 -40.89 93.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.702 -1.249 . . . . 1.96 110.811 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -64.27 -40.03 95.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.876 -1.14 . . . . 1.28 110.607 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.2 m -60.81 -40.02 91.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 1.49 111.1 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.14 -47.97 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 0.64000000000000001 110.832 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 13.3 mtp180 -69.84 -37.7 76.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.061 . . . . 2.7599999999999998 109.875 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.505 ' NE2' HD11 ' A' ' 58' ' ' LEU . 74.9 t60 -59.99 -41.88 93.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.368 -0.832 . . . . 2.48 109.675 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.18 -40.01 95.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 2.0699999999999998 109.62 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.01 -40.86 90.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.78000000000000003 110.483 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -69.07 -44.66 72.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.93 -1.106 . . . . 1.6000000000000001 110.64 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.505 HD11 ' NE2' ' A' ' 54' ' ' HIS . 82.2 mt -70.06 -40.0 75.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 1.3799999999999999 110.027 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -74.66 116.11 14.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.899 -1.126 . . . . 1.4199999999999999 108.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.87 -3.52 57.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 2.1699999999999999 110.351 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -70.1 -17.9 63.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 1.5600000000000001 110.172 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.29 153.61 31.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 1.3200000000000001 109.132 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.9 t -110.06 128.19 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.534 -0.913 . . . . 0.91000000000000003 108.534 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -96.85 115.57 27.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 1.8100000000000001 108.876 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 118.43 44.92 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 107.485 -1.302 . . . . 1.28 107.485 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.492 1.429 0 C-N-CA 121.714 1.609 . . . . 1.6499999999999999 113.043 -178.884 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.653 -0.499 . . . . 1.3899999999999999 109.653 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -121.02 130.7 53.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.599 -0.688 . . . . 0.46000000000000002 109.437 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 164.28 33.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -0.792 . . . . 0.56000000000000005 109.193 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.319 -0.863 . . . . 1.4199999999999999 109.09 179.774 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.1 Cg_endo . . . . . 0 N--CA 1.494 1.503 0 N-CA-C 111.833 -0.103 . . . . 0.72999999999999998 111.833 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -39.79 -23.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.613 2.209 . . . . 0.83999999999999997 113.871 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 5' ' ' PRO . 3.6 m-85 -59.96 137.44 58.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 1.1499999999999999 110.139 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 p -83.1 173.82 11.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.506 -0.746 . . . . 1.3899999999999999 109.014 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -62.94 -37.94 89.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 1.3200000000000001 109.113 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -68.22 -41.28 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 0.95999999999999996 109.741 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.43 86.18 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -0.937 . . . . 0.38 110.533 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.11 -39.86 87.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.238 -1.023 . . . . 0.37 108.238 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.513 HD13 HD21 ' A' ' 56' ' ' LEU . 97.0 mt -66.44 -45.36 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.841 . . . . 0.48999999999999999 109.184 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -42.91 99.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.39000000000000001 111.066 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.9 mtm -70.0 -40.01 75.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 1.1399999999999999 110.862 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.409 ' HA ' HD21 ' A' ' 19' ' ' ASN . . . -54.69 -43.29 72.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -1.0 . . . . 0.32000000000000001 109.449 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.9 mt -59.93 -45.97 94.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.492 -0.929 . . . . 0.33000000000000002 108.492 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.0 -45.07 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.193 0.52 . . . . 1.8200000000000001 110.501 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 15' ' ' MET . 15.6 p30 -91.11 15.44 11.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.866 -1.146 . . . . 1.6699999999999999 109.874 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.37 129.5 74.64 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 0.63 108.521 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -40.6 -38.05 2.42 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.544 1.496 . . . . 1.29 110.885 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -124.54 154.23 40.91 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.253 -1.388 . . . . 2.6299999999999999 107.253 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.782 -1.199 . . . . 2.02 108.489 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -90.64 125.84 35.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 1.55 109.031 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.8 tt -132.48 158.16 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.441 -0.787 . . . . 0.46999999999999997 109.491 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -81.93 158.51 23.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 0.81000000000000005 110.022 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.5 tp -59.97 -49.0 79.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.488 -0.758 . . . . 0.69999999999999996 109.005 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -59.95 -39.57 86.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.541 -0.724 . . . . 1.25 109.843 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.58 -40.16 96.0 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.285 -0.96 . . . . 0.28999999999999998 110.946 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.71 -42.45 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.841 -1.388 . . . . 0.34999999999999998 109.555 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -60.94 -40.93 95.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 1.3999999999999999 110.94 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.244 -0.91 . . . . 2.5099999999999998 109.5 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -59.92 -47.79 84.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 1.3700000000000001 109.771 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.97 -50.07 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.264 -0.897 . . . . 0.58999999999999997 110.576 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.86 -39.9 95.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.879 -1.138 . . . . 0.68999999999999995 110.216 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.11 -40.1 90.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.109 -0.994 . . . . 1.1699999999999999 109.519 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -69.12 -54.05 17.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 3.0 110.351 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -110.71 123.56 35.26 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 1.54 109.912 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.84 -6.34 15.93 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.011 1.807 . . . . 1.21 111.197 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.03 -44.56 94.54 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.505 0.669 . . . . 3.7400000000000002 109.541 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -70.07 -27.17 64.4 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.495 -0.753 . . . . 1.1200000000000001 110.649 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -60.03 -39.77 87.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.849 -1.157 . . . . 2.5099999999999998 108.581 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.32 -2.7 29.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 2.3399999999999999 109.401 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 21.5 t-20 -144.47 98.54 3.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.548 -0.72 . . . . 2.0099999999999998 109.104 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 56.3 mtpt -98.04 -32.93 11.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 1.6799999999999999 110.626 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.84 143.11 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.876 -1.14 . . . . 3.98 110.398 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.61 -72.15 0.27 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.096 -1.201 . . . . 0.78000000000000003 110.096 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 18.8 p-90 -69.96 -39.35 76.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.208 -1.172 . . . . 0.44 110.874 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.429 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 8.4 tt0 -59.99 -50.07 75.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 1.96 110.978 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -73.49 -31.69 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.936 -1.103 . . . . 1.28 110.044 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.8 m -59.93 -40.21 88.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 1.49 110.258 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 13' ' ' ILE . 17.0 mt -69.88 -43.62 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 0.64000000000000001 109.138 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -59.99 -47.18 86.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.718 -1.239 . . . . 2.7599999999999998 108.417 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' NE2' HD11 ' A' ' 58' ' ' LEU . 84.1 t60 -60.8 -40.03 91.13 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 2.48 108.467 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.07 -39.94 95.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.861 -0.792 . . . . 2.0699999999999998 108.861 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.513 HD21 HD13 ' A' ' 13' ' ' ILE . 32.5 mt -59.99 -45.87 91.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 0.78000000000000003 110.105 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.35 -42.44 99.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.902 -1.124 . . . . 1.6000000000000001 109.337 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.454 HD11 ' NE2' ' A' ' 54' ' ' HIS . 51.6 mt -70.02 -37.22 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 1.3799999999999999 109.775 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -69.18 117.84 11.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 1.4199999999999999 109.898 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -90.7 -10.96 41.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 2.1699999999999999 108.962 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.94 -40.04 87.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.425 -0.797 . . . . 1.5600000000000001 109.673 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.48 146.19 32.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.297 -0.877 . . . . 1.3200000000000001 109.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.98 125.35 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.175 -1.046 . . . . 0.91000000000000003 108.175 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' NZ ' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.42 135.57 38.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 1.8100000000000001 109.903 -178.64 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.43 139.02 31.48 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.642 -0.873 . . . . 1.28 108.642 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo . . . . . 0 N--CA 1.494 1.547 0 C-N-CA 122.254 1.969 . . . . 1.6499999999999999 112.36 -179.963 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.509 -0.552 . . . . 1.3899999999999999 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -132.15 151.53 51.74 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.366 -0.834 . . . . 0.46000000000000002 109.492 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.5 t -149.99 169.98 19.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.967 -1.083 . . . . 0.56000000000000005 110.347 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 1.4199999999999999 110.551 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo . . . . . 0 N--CA 1.495 1.607 0 CA-C-O 120.582 0.159 . . . . 0.72999999999999998 112.384 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.55 -9.25 18.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.542 2.161 . . . . 0.83999999999999997 112.878 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -67.34 143.32 56.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.955 -1.091 . . . . 1.1499999999999999 108.993 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.9 t -69.65 159.98 32.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -0.973 . . . . 1.3899999999999999 108.573 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -59.9 -39.97 87.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.934 -1.104 . . . . 1.3200000000000001 108.465 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.53 -39.95 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.786 . . . . 0.95999999999999996 109.395 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.02 95.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.38 110.103 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.06 -40.07 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.198 -0.939 . . . . 0.37 108.588 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.66 -41.93 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 0.48999999999999999 108.91 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -60.49 -40.1 90.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 0.39000000000000001 109.676 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.43 -39.94 89.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 1.1399999999999999 109.175 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.65 85.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.629 -0.67 . . . . 0.32000000000000001 110.474 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.06 -49.86 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.059 -1.026 . . . . 0.33000000000000002 108.973 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.57 -40.51 92.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.837 -0.539 . . . . 1.8200000000000001 110.157 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -70.69 -20.61 62.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 1.6699999999999999 110.372 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.06 119.85 77.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.091 -1.006 . . . . 0.63 109.812 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.99 -29.55 1.58 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.409 1.406 . . . . 1.29 110.719 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -115.09 128.13 56.04 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.612 -1.255 . . . . 2.6299999999999999 107.612 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -69.93 -27.31 64.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.922 -1.111 . . . . 2.02 110.142 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -78.54 74.28 5.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.951 -1.093 . . . . 1.55 109.354 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -88.57 147.46 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.815 -0.809 . . . . 0.46999999999999997 108.815 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -79.04 159.56 27.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.81000000000000005 109.851 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 27' ' ' LEU . 33.1 tp -60.42 -50.01 75.3 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.63 0.729 . . . . 0.69999999999999996 109.839 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 1.25 109.744 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -38.62 94.36 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.495 -1.042 . . . . 0.28999999999999998 110.495 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.02 -43.71 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.973 -1.31 . . . . 0.34999999999999998 109.933 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -59.99 -45.38 92.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.953 -1.092 . . . . 1.3999999999999999 110.366 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -59.98 -40.12 88.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 2.5099999999999998 110.265 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.92 -46.55 89.01 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.141 -0.974 . . . . 1.3700000000000001 109.412 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.0 mt -65.78 -49.94 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.58999999999999997 111.499 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.0 mtm -61.11 -40.0 92.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.935 -1.103 . . . . 0.68999999999999995 110.98 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -66.67 -39.93 88.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 1.1699999999999999 110.555 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -76.94 -67.04 0.75 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 3.0 111.129 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -85.96 130.44 50.37 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.731 -1.23 . . . . 1.54 109.907 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.63 -13.26 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.186 1.924 . . . . 1.21 113.204 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.94 -44.37 94.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.998 -1.064 . . . . 3.7400000000000002 110.288 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -70.2 -29.21 66.0 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 1.1200000000000001 111.114 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.949 -1.094 . . . . 2.5099999999999998 110.124 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -93.2 0.05 57.0 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.003 -1.061 . . . . 2.3399999999999999 110.264 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.548 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 59.1 t30 -124.27 129.05 50.08 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.271 0.557 . . . . 2.0099999999999998 109.547 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 32.1 mmtp -129.12 17.89 6.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.512 -0.742 . . . . 1.6799999999999999 109.402 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -70.43 -160.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 3.98 111.871 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.61 -9.21 0.25 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 116.112 -0.494 . . . . 0.78000000000000003 111.917 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.548 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -59.99 -35.99 76.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.218 -1.754 . . . . 0.44 107.721 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.38 -44.12 97.69 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.757 -0.589 . . . . 1.96 111.154 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.32 -26.58 38.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.002 -1.061 . . . . 1.28 111.703 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -69.39 -23.58 63.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.763 -1.211 . . . . 1.49 110.868 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -69.99 -61.66 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.006 -1.059 . . . . 0.64000000000000001 111.394 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -70.01 -30.92 68.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.159 -0.963 . . . . 2.7599999999999998 111.216 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.21 -36.82 78.54 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.912 -1.117 . . . . 2.48 109.648 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 98.5 m-20 -69.94 -19.24 63.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 2.0699999999999998 111.14 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.91 -45.1 93.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.909 -1.119 . . . . 0.78000000000000003 110.385 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.8 p -69.98 -39.6 75.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.968 -1.082 . . . . 1.6000000000000001 110.102 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.16 -39.95 88.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.3799999999999999 110.028 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 83.2 m-20 -64.52 119.0 9.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 1.4199999999999999 109.601 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -81.97 -37.73 26.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 2.1699999999999999 110.294 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.5 m -65.31 -11.54 42.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 1.5600000000000001 109.769 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.44 131.17 36.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 1.3200000000000001 109.122 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.3 t -97.19 127.94 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.276 -0.89 . . . . 0.91000000000000003 109.101 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -103.71 118.0 35.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 1.8100000000000001 110.174 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.24 118.19 44.36 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 107.867 -1.161 . . . . 1.28 107.867 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 N--CA 1.492 1.403 0 C-N-CA 121.415 1.41 . . . . 1.6499999999999999 112.367 -179.212 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.422 -0.585 . . . . 1.3899999999999999 109.422 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -130.19 130.7 45.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.46000000000000002 109.743 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.2 t -149.82 159.44 44.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 0.56000000000000005 109.542 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 1.4199999999999999 109.717 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' TYR . 83.6 Cg_exo . . . . . 0 N--CA 1.497 1.697 0 CA-C-O 120.07 -0.054 . . . . 0.72999999999999998 112.218 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.11 -8.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.274 1.983 . . . . 0.83999999999999997 113.65 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.8 m-85 -71.96 144.52 48.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.707 -1.246 . . . . 1.1499999999999999 109.926 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 m -82.31 169.94 15.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 1.3899999999999999 109.419 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -60.09 -39.96 87.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.14 -0.975 . . . . 1.3200000000000001 109.158 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.81 -39.9 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.95999999999999996 109.181 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -47.62 84.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.38 110.342 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.07 -41.45 92.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.789 -1.194 . . . . 0.37 108.436 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.32 -42.05 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.048 -1.093 . . . . 0.48999999999999999 108.048 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.16 -40.02 94.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.584 -0.697 . . . . 0.39000000000000001 109.47 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.26 -39.92 82.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 1.1399999999999999 109.603 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.01 81.11 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.329 -0.857 . . . . 0.32000000000000001 109.252 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 70.1 mt -61.1 -50.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.33000000000000002 108.757 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.23 -40.01 92.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.632 -0.668 . . . . 1.8200000000000001 109.839 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -78.05 -4.16 45.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 1.6699999999999999 108.967 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -80.05 119.3 76.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.589 -0.893 . . . . 0.63 108.589 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -40.41 -26.72 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.675 1.583 . . . . 1.29 111.594 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 20' ' ' ALA . 20.7 pt-20 -134.7 153.93 51.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.036 -1.098 . . . . 2.6299999999999999 108.036 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -67.74 -31.56 71.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 2.02 110.825 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -78.87 123.42 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.686 -1.259 . . . . 1.55 109.704 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 tt -140.39 153.8 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.285 -0.884 . . . . 0.46999999999999997 109.543 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.1 p -81.91 152.63 26.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 0.81000000000000005 110.197 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.0 -49.06 79.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.684 -0.858 . . . . 0.69999999999999996 108.684 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.9 -40.11 87.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.453 -0.78 . . . . 1.25 109.811 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.77 94.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.581 -1.008 . . . . 0.28999999999999998 110.581 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.04 -41.54 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.317 . . . . 0.34999999999999998 110.033 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -59.99 -45.37 92.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 1.3999999999999999 110.731 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.94 -37.32 84.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.041 -1.037 . . . . 2.5099999999999998 110.852 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.98 -49.04 79.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 1.3700000000000001 110.68 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.06 -49.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 0.58999999999999997 110.693 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.47 -39.93 92.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.918 -1.114 . . . . 0.68999999999999995 110.476 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.52 -40.01 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 1.1699999999999999 109.47 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -79.76 -69.39 0.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 3.0 109.483 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -89.47 116.53 66.58 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.983 . . . . 1.54 109.019 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.52 -3.93 12.72 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.88 1.72 . . . . 1.21 111.235 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -60.06 -39.75 87.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.594 -0.891 . . . . 3.7400000000000002 108.594 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' ASN . 93.3 m-85 -69.87 -27.15 64.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.567 -0.708 . . . . 1.1200000000000001 110.521 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -59.2 -39.96 84.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.823 -1.173 . . . . 2.5099999999999998 107.994 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -61.3 -40.77 95.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 2.3399999999999999 109.631 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -111.5 108.5 18.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.329 -0.619 . . . . 2.0099999999999998 109.329 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 66.3 mttm -96.64 -40.74 8.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.067 -1.02 . . . . 1.6799999999999999 110.513 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.21 142.97 27.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.169 -0.957 . . . . 3.98 110.536 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.77 -55.74 0.49 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.562 -1.415 . . . . 0.78000000000000003 109.562 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.448 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.6 p-90 -89.23 -3.07 58.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -1.185 . . . . 0.44 109.256 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -74.08 -61.7 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 1.96 111.089 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -69.55 -39.93 77.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.302 -0.873 . . . . 1.28 110.656 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.2 m -50.84 -31.09 16.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 1.49 111.008 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.29 -65.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.003 -1.06 . . . . 0.64000000000000001 110.894 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -69.94 -30.02 67.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 2.7599999999999998 110.6 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.769 -1.207 . . . . 2.48 108.491 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.427 ' OD1' ' OD1' ' A' ' 59' ' ' ASN . 27.2 t-20 -61.08 -42.86 99.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 2.0699999999999998 110.144 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.96 -41.66 92.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.993 . . . . 0.78000000000000003 110.239 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 p -64.05 -50.64 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 1.6000000000000001 110.625 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.4 mp -69.94 -40.09 75.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.929 -1.107 . . . . 1.3799999999999999 110.056 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.68 ' N ' HD22 ' A' ' 59' ' ' ASN . 0.8 OUTLIER -66.73 122.11 16.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.192 -0.943 . . . . 1.4199999999999999 109.58 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -86.09 -10.2 55.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 2.1699999999999999 109.34 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.26 -40.02 92.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.288 -0.883 . . . . 1.5600000000000001 109.061 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -82.74 129.29 34.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.348 -0.982 . . . . 1.3200000000000001 108.348 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.94 119.93 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.91000000000000003 109.534 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.88 150.06 24.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.298 -1.001 . . . . 1.8100000000000001 108.298 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.01 91.55 22.94 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.31 -0.869 . . . . 1.28 109.789 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo . . . . . 0 C--N 1.311 -1.409 0 C-N-CA 121.712 1.608 . . . . 1.6499999999999999 111.318 179.404 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.685 -0.487 . . . . 1.3899999999999999 109.685 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -122.96 130.98 53.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.227 -0.657 . . . . 0.46000000000000002 109.227 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 161.67 40.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.331 -0.855 . . . . 0.56000000000000005 109.528 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 76.5 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.4199999999999999 109.325 -179.781 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 CA-C-O 120.816 0.256 . . . . 0.72999999999999998 112.162 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.64 -2.62 12.86 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.519 2.146 . . . . 0.83999999999999997 112.685 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -64.93 137.45 57.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.814 -1.179 . . . . 1.1499999999999999 108.735 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -77.83 168.67 19.55 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.285 -1.006 . . . . 1.3899999999999999 108.285 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -60.0 -37.85 80.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.022 -1.049 . . . . 1.3200000000000001 108.617 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.9 mm -60.11 -46.29 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.95999999999999996 109.613 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.81 95.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -0.872 . . . . 0.38 110.452 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.76 -40.14 91.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.925 -1.109 . . . . 0.37 108.64 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.12 -42.2 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.471 -0.937 . . . . 0.48999999999999999 108.471 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -64.38 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 0.39000000000000001 110.358 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtt -66.32 -39.34 89.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.89 . . . . 1.1399999999999999 109.658 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 20' ' ' ALA . . . -60.14 -41.4 92.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.542 -0.724 . . . . 0.32000000000000001 110.252 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.503 ' CG2' ' HZ3' ' A' ' 23' ' ' LYS . 62.3 mt -69.57 -49.14 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.106 -0.997 . . . . 0.33000000000000002 109.431 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.03 -40.03 90.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 1.8200000000000001 110.612 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -82.16 -10.6 59.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 1.6699999999999999 110.78 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 16' ' ' ALA . . . -79.07 149.17 72.88 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.942 -1.099 . . . . 0.63 109.022 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.62 -57.03 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.441 1.427 . . . . 1.29 110.359 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -104.98 127.07 52.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.94 -1.133 . . . . 2.6299999999999999 107.94 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HZ3' ' CG2' ' A' ' 17' ' ' ILE . 8.7 mtpm? -60.33 -28.91 68.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.962 -1.086 . . . . 2.02 108.927 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -78.05 82.41 4.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.956 -1.127 . . . . 1.55 107.956 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 tt -111.87 148.55 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.767 -0.827 . . . . 0.46999999999999997 108.767 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.7 p -79.03 161.07 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.116 -0.99 . . . . 0.81000000000000005 109.233 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.4 tp -60.04 -42.63 94.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.69999999999999996 108.962 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.76 -40.01 90.91 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.286 -0.884 . . . . 1.25 109.643 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.71 -35.99 90.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.84 -1.304 . . . . 0.28999999999999998 109.84 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.76 -41.16 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -1.153 . . . . 0.34999999999999998 110.293 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -60.0 -40.1 88.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.531 -1.355 . . . . 1.3999999999999999 109.383 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.98 -40.35 88.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.462 -0.774 . . . . 2.5099999999999998 109.798 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.71 -47.22 73.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 1.3700000000000001 110.701 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.2 -49.88 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 0.58999999999999997 110.678 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.1 mtm -62.13 -39.99 94.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.892 -1.13 . . . . 0.68999999999999995 109.548 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.01 -49.64 75.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 1.1699999999999999 110.401 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -70.04 -58.85 3.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.921 -1.112 . . . . 3.0 109.848 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -100.04 112.83 64.73 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 1.54 108.892 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.03 -10.16 14.0 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.028 1.819 . . . . 1.21 112.64 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -60.07 -38.17 82.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 3.7400000000000002 108.953 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 44' ' ' ASN . 69.4 m-85 -63.89 -28.75 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.666 -0.646 . . . . 1.1200000000000001 110.952 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.89 -39.93 87.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.83 -1.169 . . . . 2.5099999999999998 109.372 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.77 -40.08 93.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 2.3399999999999999 109.461 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -114.45 104.74 12.34 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 2.0099999999999998 108.498 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 53.8 mtpt -98.47 -32.58 11.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 1.6799999999999999 110.67 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -89.72 137.02 32.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.069 -1.02 . . . . 3.98 110.028 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.44 -64.9 0.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.96 -1.256 . . . . 0.78000000000000003 109.96 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.511 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 38.0 p-90 -72.88 -37.06 67.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.108 -1.231 . . . . 0.44 110.51 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -60.09 -45.38 93.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 1.96 110.369 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.4 ' HA ' HH11 ' A' ' 53' ' ' ARG . 98.5 m-20 -68.86 -37.66 79.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 1.28 110.255 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 m -59.85 -39.35 84.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 1.49 110.043 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.3 mm -60.01 -46.81 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 0.64000000000000001 110.224 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.425 ' HG3' HH11 ' A' ' 53' ' ' ARG . 1.0 OUTLIER -64.75 -41.49 95.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 2.7599999999999998 109.708 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' HIS . . . . . 0.483 ' NE2' HD11 ' A' ' 58' ' ' LEU . 13.3 t60 -60.03 -45.25 93.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.841 . . . . 2.48 109.832 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.07 -39.96 94.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -0.915 . . . . 2.0699999999999998 109.666 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.89 -46.87 87.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.78000000000000003 110.263 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -64.73 -44.46 90.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.884 -1.135 . . . . 1.6000000000000001 109.453 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.483 HD11 ' NE2' ' A' ' 54' ' ' HIS . 26.9 mt -67.88 -43.26 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.3799999999999999 109.678 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -85.07 106.89 16.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 1.4199999999999999 108.76 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -91.01 10.29 27.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 2.1699999999999999 109.449 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.41 -26.05 67.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.838 . . . . 1.5600000000000001 109.927 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -79.76 147.91 31.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 1.3200000000000001 109.122 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.9 t -90.61 118.52 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.91000000000000003 109.08 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -92.33 100.23 12.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 1.8100000000000001 109.239 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.88 123.78 44.24 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.494 -0.928 . . . . 1.28 108.494 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo . . . . . 0 N--CA 1.494 1.522 0 C-N-CA 122.013 1.809 . . . . 1.6499999999999999 112.604 -179.754 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.291 -0.633 . . . . 1.3899999999999999 109.291 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -114.56 130.79 56.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.523 -0.735 . . . . 0.46000000000000002 109.288 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.3 t -158.51 153.67 25.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.943 . . . . 0.56000000000000005 109.583 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 mt . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 1.4199999999999999 109.316 179.818 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo . . . . . 0 N--CA 1.495 1.606 0 N-CA-C 112.988 0.342 . . . . 0.72999999999999998 112.988 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.1 16.9 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.531 2.154 . . . . 0.83999999999999997 111.691 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -101.22 135.81 42.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.385 -0.822 . . . . 1.1499999999999999 109.455 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 91.8 p -80.21 170.01 17.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.435 -0.791 . . . . 1.3899999999999999 109.281 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 1.3200000000000001 108.913 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.05 -40.14 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.95999999999999996 108.542 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.82 73.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.38 109.492 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.06 -40.85 90.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.043 -1.035 . . . . 0.37 108.336 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.5 mt -69.91 -41.54 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 0.48999999999999999 108.959 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -39.94 95.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.39000000000000001 109.268 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.3 mtt -68.06 -40.0 82.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 1.1399999999999999 108.829 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -49.5 77.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.567 -0.708 . . . . 0.32000000000000001 110.073 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.04 -49.9 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 0.33000000000000002 109.255 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.43 -39.66 92.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.852 -0.53 . . . . 1.8200000000000001 110.266 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -80.3 5.0 15.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 1.6699999999999999 110.112 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.1 148.37 74.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.971 -1.081 . . . . 0.63 109.76 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -33.6 -84.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.912 2.408 . . . . 1.29 112.849 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -90.02 -80.05 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.685 -1.259 . . . . 2.6299999999999999 108.542 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -159.16 -33.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.895 -1.128 . . . . 2.02 110.117 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -81.42 129.85 34.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.994 -1.066 . . . . 1.55 110.142 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -130.75 138.74 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.611 -0.885 . . . . 0.46999999999999997 108.611 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.2 p -79.99 162.31 24.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 0.81000000000000005 109.965 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.711 HD21 ' HG2' ' A' ' 53' ' ' ARG . 52.1 tp -60.04 -47.01 87.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.671 -0.862 . . . . 0.69999999999999996 108.671 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.442 ' O ' ' OE1' ' A' ' 32' ' ' GLN . 79.7 m-20 -62.55 -39.93 95.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 1.25 109.844 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.07 91.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.536 -1.026 . . . . 0.28999999999999998 110.536 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.97 -40.69 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.987 -1.302 . . . . 0.34999999999999998 109.381 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -60.07 -48.68 80.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.108 -0.995 . . . . 1.3999999999999999 109.955 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 28' ' ' ASN . 4.8 mp0 -59.92 -37.79 80.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 2.5099999999999998 109.488 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -59.99 -49.99 75.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 1.3700000000000001 109.64 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -49.97 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.002 -1.061 . . . . 0.58999999999999997 110.824 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.5 mtm -65.02 -43.49 92.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.89 -1.131 . . . . 0.68999999999999995 110.781 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.36 -44.86 86.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 1.1699999999999999 110.626 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.446 HH11 ' HG3' ' A' ' 37' ' ' ARG . 21.7 mmm-85 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.019 -1.051 . . . . 3.0 110.541 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 40' ' ' PHE . 70.4 m-85 -124.05 82.53 56.31 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.418 -0.801 . . . . 1.54 109.766 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.45 -6.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.562 2.174 . . . . 1.21 111.779 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 38' ' ' PHE . 49.6 t80 -59.94 -42.76 94.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.515 -0.74 . . . . 3.7400000000000002 109.898 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.03 -22.15 63.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 1.1200000000000001 110.937 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -39.84 86.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.912 -1.117 . . . . 2.5099999999999998 109.705 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.54 2.85 43.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 2.3399999999999999 109.728 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.501 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 81.3 m-20 -133.92 115.67 14.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.626 -0.672 . . . . 2.0099999999999998 109.832 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' GLN . 56.0 mttp -110.47 13.74 22.68 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.477 -0.935 . . . . 1.6799999999999999 108.477 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 48' ' ' TRP . 87.7 mt-30 -47.39 -177.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.995 0.902 . . . . 3.98 111.401 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.9 -8.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.932 -0.867 . . . . 0.78000000000000003 110.932 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' A' ' 46' ' ' GLN . 3.8 p-90 -59.87 -40.75 89.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.575 -1.544 . . . . 0.44 107.939 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.514 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 58.5 tt0 -60.06 -50.3 74.26 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.261 0.553 . . . . 1.96 111.316 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -73.23 -40.07 64.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.173 . . . . 1.28 110.759 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.3 p -51.94 -30.05 22.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.937 . . . . 1.49 110.773 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.76 -52.26 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.118 . . . . 0.64000000000000001 110.489 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG2' HD21 ' A' ' 27' ' ' LEU . 32.6 mtp180 -69.98 -40.67 75.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.052 . . . . 2.7599999999999998 110.154 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -63.34 -39.98 96.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.079 -1.013 . . . . 2.48 108.659 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.96 -40.0 95.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.093 -1.077 . . . . 2.0699999999999998 108.093 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.2 mt -68.51 -40.59 80.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.78000000000000003 109.823 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 t -69.95 -44.24 69.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 1.6000000000000001 109.468 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 mt -69.62 -39.71 77.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 1.3799999999999999 109.046 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -75.58 105.81 6.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.168 -0.957 . . . . 1.4199999999999999 109.31 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.47 -1.08 57.92 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.981 -1.118 . . . . 2.1699999999999999 107.981 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.4 m -60.17 -34.09 73.1 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.042 -0.725 . . . . 1.5600000000000001 109.042 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.51 155.55 29.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.8 . . . . 1.3200000000000001 109.025 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 125.73 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.517 -0.74 . . . . 0.91000000000000003 109.209 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -76.61 154.65 34.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 1.8100000000000001 109.167 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.24 91.77 49.53 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.49 -0.756 . . . . 1.28 109.0 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 C--N 1.311 -1.443 0 C-N-CA 122.097 1.865 . . . . 1.6499999999999999 112.524 -179.471 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.442 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 21.6 m-85 . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 108.038 -1.097 . . . . 1.3899999999999999 108.038 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -110.96 127.16 55.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.46000000000000002 109.58 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.3 t -141.67 159.19 42.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.305 -0.872 . . . . 0.56000000000000005 109.686 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.4199999999999999 109.973 -179.618 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 55.4 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 N-CA-C 112.147 0.018 . . . . 0.72999999999999998 112.147 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.64 -17.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.546 2.164 . . . . 0.83999999999999997 113.793 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 6.1 m-85 -67.69 129.04 38.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.766 -1.209 . . . . 1.1499999999999999 110.171 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.1 p -81.94 177.17 9.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -0.759 . . . . 1.3899999999999999 109.059 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -59.93 -41.48 91.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 1.3200000000000001 109.562 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.01 -47.46 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.95999999999999996 109.784 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.89 87.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.913 . . . . 0.38 110.317 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.03 -45.63 92.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.831 -1.168 . . . . 0.37 109.051 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 84.2 mt -62.19 -40.02 86.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.123 -1.065 . . . . 0.48999999999999999 108.123 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.33 -39.95 94.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.614 -0.679 . . . . 0.39000000000000001 109.593 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.0 mtt -65.83 -39.91 91.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 1.1399999999999999 109.76 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.31 89.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 0.32000000000000001 109.835 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.1 mt -60.02 -49.97 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.151 -0.968 . . . . 0.33000000000000002 108.543 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -65.19 -40.04 93.66 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.213 0.53 . . . . 1.8200000000000001 110.168 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.12 0.7 43.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 1.6699999999999999 110.45 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 148.42 74.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.96 -1.087 . . . . 0.63 108.759 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.81 -23.53 74.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.608 1.539 . . . . 1.29 109.768 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -138.35 148.79 44.94 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.124 . . . . 2.6299999999999999 107.964 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -61.64 -36.9 82.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.007 -1.058 . . . . 2.02 108.274 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.377 -0.971 . . . . 1.55 108.377 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.14 152.71 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.368 -0.832 . . . . 0.46999999999999997 109.048 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.2 p -80.08 153.8 28.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 0.81000000000000005 109.238 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -59.97 -40.27 88.53 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.446 -0.784 . . . . 0.69999999999999996 108.889 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.17 -40.06 88.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.506 -0.746 . . . . 1.25 109.913 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.92 -38.83 97.22 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.639 -0.985 . . . . 0.28999999999999998 110.639 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.04 -40.44 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -1.225 . . . . 0.34999999999999998 110.017 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.533 ' CE1' ' OE1' ' A' ' 49' ' ' GLN . 32.1 m-85 -60.03 -41.95 93.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.901 -1.124 . . . . 1.3999999999999999 110.263 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.14 -40.24 89.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.297 -0.877 . . . . 2.5099999999999998 110.078 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.94 -49.63 76.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.672 . . . . 1.3700000000000001 111.446 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.2 mt -59.93 -49.86 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 0.58999999999999997 111.631 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.8 mtm -60.0 -40.03 87.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 0.68999999999999995 111.164 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.29 -46.18 71.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.649 -1.282 . . . . 1.1699999999999999 111.019 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' HE ' ' HA ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -70.0 -40.06 75.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.89 -1.131 . . . . 3.0 109.943 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -121.63 110.04 33.97 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.662 -0.866 . . . . 1.54 108.662 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.471 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 95.8 Cg_endo -79.59 -11.27 14.27 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.927 1.751 . . . . 1.21 113.011 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -58.47 -35.97 72.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.176 -0.952 . . . . 3.7400000000000002 109.22 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 44' ' ' ASN . 91.5 m-85 -67.6 -29.5 68.86 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.767 -0.583 . . . . 1.1200000000000001 110.603 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -59.96 -39.96 87.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.027 -1.046 . . . . 2.5099999999999998 109.582 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 39' ' ' PRO . 54.7 mp0 -66.62 -39.97 88.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.037 -1.039 . . . . 2.3399999999999999 109.048 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.4 m-20 -106.23 106.49 17.03 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.257 -0.645 . . . . 2.0099999999999998 109.257 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 59.1 mttm -98.38 -42.61 7.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.114 -0.991 . . . . 1.6799999999999999 109.96 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -77.98 140.14 39.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.165 -0.96 . . . . 3.98 109.873 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.86 -59.98 0.34 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.443 -1.063 . . . . 0.78000000000000003 110.443 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.422 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 26.2 p-90 -89.44 -14.77 34.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.025 -1.279 . . . . 0.44 110.497 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.533 ' OE1' ' CE1' ' A' ' 31' ' ' TYR . 3.2 tp-100 -69.92 -60.02 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 1.96 110.926 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -72.36 -28.67 63.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.906 -1.121 . . . . 1.28 110.942 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -59.95 -38.82 83.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.909 -1.119 . . . . 1.49 109.857 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.95 -44.77 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.938 . . . . 0.64000000000000001 110.086 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -68.97 -44.79 72.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.791 -1.193 . . . . 2.7599999999999998 110.482 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -60.01 -41.66 92.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 2.48 109.279 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -61.96 -42.26 98.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 2.0699999999999998 108.753 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -60.06 -46.83 88.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.409 -0.807 . . . . 0.78000000000000003 109.903 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 t -70.4 -41.98 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 1.6000000000000001 109.961 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.36 -39.96 89.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 1.3799999999999999 110.084 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -74.73 119.75 19.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.148 -0.97 . . . . 1.4199999999999999 108.984 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -89.96 -2.7 58.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 2.1699999999999999 108.667 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.7 m -62.61 -40.04 95.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.747 . . . . 1.5600000000000001 109.367 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -80.6 152.62 28.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 1.3200000000000001 109.421 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.6 t -127.42 128.04 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 0.91000000000000003 109.589 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -83.82 150.02 26.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 1.8100000000000001 109.415 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.2 80.03 69.31 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.111 -1.07 . . . . 1.28 108.111 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.249 1.966 . . . . 1.6499999999999999 112.252 -179.487 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 107.218 -1.401 . . . . 1.3899999999999999 107.218 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -122.75 134.78 54.43 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.27 -0.894 . . . . 0.46000000000000002 110.23 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -152.64 161.32 42.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 0.56000000000000005 109.245 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.033 -1.042 . . . . 1.4199999999999999 109.488 -179.933 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 7' ' ' TYR . 68.7 Cg_endo . . . . . 0 N--CA 1.491 1.348 0 N-CA-C 111.352 -0.288 . . . . 0.72999999999999998 111.352 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.74 -24.36 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.249 1.966 . . . . 0.83999999999999997 113.373 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PRO . 12.4 m-85 -60.61 131.54 51.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 1.1499999999999999 109.895 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t -81.7 169.21 17.24 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.482 -0.933 . . . . 1.3899999999999999 108.482 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -60.0 -40.3 88.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 1.3200000000000001 109.352 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.29 -43.45 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.015 -1.053 . . . . 0.95999999999999996 108.935 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.17 85.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.8 . . . . 0.38 109.855 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.98 -40.21 88.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 0.37 109.059 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.92 -44.2 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.04 -1.038 . . . . 0.48999999999999999 108.247 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m -60.56 -40.04 90.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 0.39000000000000001 110.376 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.97 -39.96 87.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 1.1399999999999999 109.811 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.11 94.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.32000000000000001 109.961 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.33 -46.3 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.33000000000000002 109.03 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.94 -40.04 87.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.71 -0.619 . . . . 1.8200000000000001 109.462 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -83.25 -3.06 57.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.933 . . . . 1.6699999999999999 109.462 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.01 124.84 82.82 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 0.63 109.493 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -42.93 -57.09 1.87 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.397 1.398 . . . . 1.29 110.92 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -97.52 140.82 31.37 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.852 -1.166 . . . . 2.6299999999999999 107.852 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -59.9 -35.53 75.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 2.02 110.087 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -76.97 129.95 36.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.604 -1.31 . . . . 1.55 108.533 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.0 tt -139.9 147.68 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 0.46999999999999997 109.694 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -82.66 150.22 26.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.479 -0.763 . . . . 0.81000000000000005 109.295 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 56' ' ' LEU . 51.4 tp -59.97 -41.59 92.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.69999999999999996 108.627 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.33 -41.75 94.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.547 -0.72 . . . . 1.25 110.106 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.51 97.23 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.492 -1.043 . . . . 0.28999999999999998 110.492 -179.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.99 -39.98 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -1.188 . . . . 0.34999999999999998 110.284 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -59.97 -42.0 93.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.636 -1.29 . . . . 1.3999999999999999 109.569 -178.964 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.56 -40.67 95.58 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.127 -0.983 . . . . 2.5099999999999998 109.789 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.26 -49.88 75.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 1.3700000000000001 111.377 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.07 -44.72 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 0.58999999999999997 110.738 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.7 mtm -60.01 -41.79 92.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.919 -1.113 . . . . 0.68999999999999995 109.416 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.02 -40.0 75.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 1.1699999999999999 110.417 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -68.05 -60.03 2.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 3.0 110.654 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.08 126.31 31.37 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 1.54 109.257 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.64 -16.54 10.37 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.161 1.907 . . . . 1.21 113.555 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.826 -1.171 . . . . 3.7400000000000002 110.181 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -17.59 64.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 1.1200000000000001 110.908 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -60.06 -48.66 80.81 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.999 -1.063 . . . . 2.5099999999999998 109.141 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.728 0.775 . . . . 2.3399999999999999 110.326 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.453 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 14.6 t-20 -93.96 99.98 12.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.638 -0.664 . . . . 2.0099999999999998 109.372 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 62.0 mttp -97.77 -39.26 9.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 1.6799999999999999 110.189 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -87.66 139.79 30.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 3.98 110.107 -178.429 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.72 -59.22 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.403 -1.079 . . . . 0.78000000000000003 110.403 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.453 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 31.7 p-90 -82.48 -12.5 57.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.964 -1.315 . . . . 0.44 110.479 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.0 -54.23 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 1.96 110.739 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -70.03 -25.93 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.904 -1.123 . . . . 1.28 110.841 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.3 p -60.11 -39.92 87.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 1.49 110.139 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.49 -47.94 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.64000000000000001 110.604 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -69.95 -42.53 73.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.882 -1.136 . . . . 2.7599999999999998 110.535 -178.83 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -44.8 94.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 2.48 108.961 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -59.98 -40.14 88.07 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.204 -0.935 . . . . 2.0699999999999998 109.459 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.463 ' CD1' HD13 ' A' ' 27' ' ' LEU . 86.6 mt -61.2 -42.18 98.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 0.78000000000000003 110.446 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.7 p -66.73 -46.53 75.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.109 -0.994 . . . . 1.6000000000000001 110.753 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.28 -39.91 74.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.862 -1.149 . . . . 1.3799999999999999 110.249 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -77.7 118.01 19.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.977 . . . . 1.4199999999999999 109.351 -179.116 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.65 -2.96 57.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 2.1699999999999999 110.017 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CD2' ' A' ' 62' ' ' PHE . 12.2 p -61.41 -32.44 72.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.5600000000000001 108.868 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.582 ' CD2' ' SG ' ' A' ' 61' ' ' CYS . 90.8 m-85 -79.06 150.06 31.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.438 -0.789 . . . . 1.3200000000000001 109.194 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.33 122.04 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.777 -0.823 . . . . 0.91000000000000003 108.777 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -80.78 111.55 17.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 1.8100000000000001 110.142 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.5 t -103.75 113.68 65.29 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.938 -1.134 . . . . 1.28 107.938 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 C-N-CA 121.816 1.677 . . . . 1.6499999999999999 112.711 -178.819 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.91 -0.774 . . . . 1.3899999999999999 108.91 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.05 139.98 51.7 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.403 -0.811 . . . . 0.46000000000000002 109.843 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -153.23 153.12 32.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.56000000000000005 109.895 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 1.4199999999999999 108.561 179.175 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.491 1.36 0 N-CA-C 112.635 0.206 . . . . 0.72999999999999998 112.635 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.25 2.52 8.47 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.633 2.222 . . . . 0.83999999999999997 113.83 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.59 140.21 58.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.514 -1.367 . . . . 1.1499999999999999 109.48 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.0 m -74.54 164.33 26.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.893 . . . . 1.3899999999999999 109.073 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -59.9 -40.07 87.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.166 -0.959 . . . . 1.3200000000000001 108.622 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 55' ' ' ASN . 32.2 mm -69.62 -40.0 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.95999999999999996 108.973 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.92 95.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 0.38 109.692 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.062 -1.024 . . . . 0.37 108.436 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 0.48999999999999999 108.807 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -60.73 -40.03 90.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 0.39000000000000001 109.876 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.2 mtt -67.43 -39.88 85.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.009 . . . . 1.1399999999999999 109.009 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.33 78.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 0.32000000000000001 109.802 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.98 -50.02 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.195 -1.039 . . . . 0.33000000000000002 108.195 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.393 0.616 . . . . 1.8200000000000001 109.348 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -84.01 -0.51 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 1.6699999999999999 109.759 -179.382 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.92 126.48 82.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.057 -1.027 . . . . 0.63 108.836 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -38.79 -28.12 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.785 1.657 . . . . 1.29 111.328 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' ALA . 12.8 pt-20 -145.69 155.28 42.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.174 -1.047 . . . . 2.6299999999999999 108.174 178.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -60.05 -38.03 81.59 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.174 -0.953 . . . . 2.02 109.687 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -79.07 108.25 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 1.55 109.751 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -133.58 154.39 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.941 -0.763 . . . . 0.46999999999999997 108.941 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -80.45 155.37 27.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.81000000000000005 110.306 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.98 -43.39 95.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.584 -0.895 . . . . 0.69999999999999996 108.584 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.1 -39.93 91.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.805 . . . . 1.25 109.748 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.05 96.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.554 -1.018 . . . . 0.28999999999999998 110.554 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -41.11 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.247 . . . . 0.34999999999999998 110.123 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -62.48 -38.07 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.161 . . . . 1.3999999999999999 110.012 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.37 -44.27 84.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.097 -1.002 . . . . 2.5099999999999998 108.872 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.16 -47.59 85.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.905 . . . . 1.3700000000000001 110.198 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.3 mt -59.93 -49.98 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.012 . . . . 0.58999999999999997 110.94 -178.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtm -66.78 -40.03 88.02 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.767 -1.208 . . . . 0.68999999999999995 109.771 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -70.32 -43.05 71.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.971 -1.08 . . . . 1.1699999999999999 110.677 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.535 ' NH1' ' CE1' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -69.96 -40.0 75.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.863 -1.148 . . . . 3.0 109.516 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' NH1' ' A' ' 37' ' ' ARG . 62.7 m-85 -127.81 78.17 75.39 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.307 -0.87 . . . . 1.54 109.44 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.68 -7.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.754 2.303 . . . . 1.21 112.434 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' PHE . 40.3 t80 -59.92 -39.3 85.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 3.7400000000000002 109.4 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' ASN . 78.6 m-85 -69.81 -20.96 63.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 1.1200000000000001 110.943 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -59.99 -39.76 86.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.593 -1.317 . . . . 2.5099999999999998 108.758 179.034 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -77.91 -9.46 59.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 2.3399999999999999 109.95 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.504 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 82.9 m-20 -129.27 116.9 19.83 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 2.0099999999999998 110.237 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 67.0 mttm -109.99 11.73 23.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.717 -0.845 . . . . 1.6799999999999999 108.717 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 48' ' ' TRP . 95.8 mm-40 -48.24 177.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.001 0.905 . . . . 3.98 111.857 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 49' ' ' GLN . . . -42.28 -15.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 CA-C-N 115.779 -0.646 . . . . 0.78000000000000003 111.509 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' N ' ' O ' ' A' ' 46' ' ' GLN . 9.2 p-90 -51.18 -20.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.514 -1.58 . . . . 0.44 107.893 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' A' ' 47' ' ' GLY . 30.1 tt0 -86.37 -57.13 3.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.28 -0.637 . . . . 1.96 109.28 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.9 -33.96 72.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 1.28 109.589 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.1 m -60.04 -39.95 87.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.49 108.929 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.5 mm -60.13 -49.88 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.539 -0.725 . . . . 0.64000000000000001 109.65 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -61.9 -44.54 96.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.968 -1.083 . . . . 2.7599999999999998 108.768 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -60.01 -41.48 92.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.295 -0.878 . . . . 2.48 108.88 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.633 HD21 HD11 ' A' ' 10' ' ' ILE . 37.7 t-20 -63.89 -40.1 95.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.567 -0.708 . . . . 2.0699999999999998 109.341 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.99 -47.81 84.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.12 -0.987 . . . . 0.78000000000000003 109.691 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.4 m -62.6 -40.13 95.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 1.6000000000000001 109.164 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 58' ' ' LEU . 3.3 tt -65.84 -50.39 64.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.859 -0.525 . . . . 1.3799999999999999 110.16 -178.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -69.98 117.47 11.6 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.844 -1.142 . . . . 1.4199999999999999 108.724 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -90.1 -2.47 58.1 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.476 -0.935 . . . . 2.1699999999999999 108.476 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.1 m -60.08 -39.12 84.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.254 -0.647 . . . . 1.5600000000000001 109.254 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.29 150.31 33.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.358 -0.839 . . . . 1.3200000000000001 109.418 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.0 t -110.7 125.87 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.447 -0.783 . . . . 0.91000000000000003 109.464 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 139.83 51.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.957 -1.127 . . . . 1.8100000000000001 107.957 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.09 77.36 61.81 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.201 -0.937 . . . . 1.28 109.366 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.306 -1.697 0 C-N-CA 122.459 2.106 . . . . 1.6499999999999999 111.557 179.276 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 108.551 -0.907 . . . . 1.3899999999999999 108.551 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -138.37 149.96 46.09 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.281 -0.887 . . . . 0.46000000000000002 109.511 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -157.23 159.34 37.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.005 . . . . 0.56000000000000005 110.003 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.502 -0.925 . . . . 1.4199999999999999 108.502 179.225 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 N--CA 1.495 1.575 0 N-CA-C 111.618 -0.185 . . . . 0.72999999999999998 111.618 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.26 4.37 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.481 2.121 . . . . 0.83999999999999997 113.285 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -82.17 135.89 35.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.718 -1.239 . . . . 1.1499999999999999 109.136 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -71.72 162.54 29.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 1.3899999999999999 108.634 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -59.67 -39.9 85.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.93 -1.106 . . . . 1.3200000000000001 108.629 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.43 -39.98 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.95999999999999996 108.981 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.15 87.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.85 . . . . 0.38 109.884 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.05 -41.68 92.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.884 -1.135 . . . . 0.37 108.792 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.516 HG21 HD21 ' A' ' 56' ' ' LEU . 92.2 mt -70.0 -41.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.372 -0.83 . . . . 0.48999999999999999 109.663 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -60.41 -42.53 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 0.39000000000000001 109.448 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.5 mtm -69.92 -36.83 75.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.402 -0.811 . . . . 1.1399999999999999 109.839 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.5 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.32000000000000001 109.494 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.4 mt -59.98 -49.94 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.39 -0.967 . . . . 0.33000000000000002 108.39 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.68 -39.95 93.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.447 -0.783 . . . . 1.8200000000000001 109.324 179.329 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -80.48 3.82 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.806 . . . . 1.6699999999999999 109.748 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 147.58 71.34 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 0.63 109.356 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 -20.68 57.46 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.851 1.701 . . . . 1.29 110.041 179.15 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.25 149.6 36.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.843 -1.169 . . . . 2.6299999999999999 107.843 178.24 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -60.6 -39.89 89.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 2.02 110.297 -178.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.86 124.78 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.111 . . . . 1.55 109.017 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.8 tt -138.83 142.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -0.824 . . . . 0.46999999999999997 109.394 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.4 p -79.89 157.92 26.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.362 -0.836 . . . . 0.81000000000000005 109.223 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -60.01 -40.23 88.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.69999999999999996 109.392 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -60.03 -41.94 93.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 1.25 110.57 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 -38.56 96.31 Favored Glycine 0 N--CA 1.494 2.516 0 O-C-N 121.193 -0.942 . . . . 0.28999999999999998 111.203 -178.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.97 -40.02 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.256 . . . . 0.34999999999999998 109.79 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 33.3 m-85 -59.96 -39.95 87.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.11 -0.994 . . . . 1.3999999999999999 110.029 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -59.68 -40.01 86.43 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.367 -0.833 . . . . 2.5099999999999998 110.137 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -60.52 -40.36 91.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 1.3700000000000001 109.896 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.44 -61.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.107 -0.996 . . . . 0.58999999999999997 110.624 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.5 mtm -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 0.68999999999999995 110.446 -178.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.14 -40.12 92.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 1.1699999999999999 110.471 -179.105 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -89.17 -55.77 3.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.021 -1.049 . . . . 3.0 110.063 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -96.05 112.47 59.63 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.973 -1.079 . . . . 1.54 108.688 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.96 -7.44 14.32 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.815 1.677 . . . . 1.21 111.884 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.01 -40.06 87.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.773 . . . . 3.7400000000000002 110.229 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -70.98 -13.13 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 1.1200000000000001 110.874 -178.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.1 mmm180 -59.99 -40.03 87.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 2.5099999999999998 110.735 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.32 0.08 55.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 2.3399999999999999 110.339 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.514 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 68.7 m-80 -133.96 108.55 8.46 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.763 -0.829 . . . . 2.0099999999999998 108.763 179.144 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 42' ' ' ARG . 61.1 mttp -111.97 -29.97 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.681 -0.637 . . . . 1.6799999999999999 110.051 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -90.66 139.42 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 3.98 109.781 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.27 -64.19 0.31 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.435 -1.066 . . . . 0.78000000000000003 110.435 179.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.514 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 23.1 p-90 -77.05 -20.06 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.316 . . . . 0.44 110.478 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.473 ' OE1' ' NH2' ' A' ' 53' ' ' ARG . 9.6 tt0 -62.29 -52.3 64.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 1.96 110.628 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -68.97 -35.06 76.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 1.28 110.194 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 1.49 109.746 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mm -60.91 -45.99 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.64000000000000001 110.25 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.473 ' NH2' ' OE1' ' A' ' 49' ' ' GLN . 41.7 mtt180 -69.52 -40.12 77.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.951 -1.093 . . . . 2.7599999999999998 109.888 -178.83 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -60.14 -40.15 88.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 2.48 108.765 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 95.2 m-20 -61.85 -39.95 93.63 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.54 -0.911 . . . . 2.0699999999999998 108.54 179.39 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 13' ' ' ILE . 78.1 mt -70.0 -40.02 75.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.78000000000000003 110.267 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.5 p -74.56 -44.88 48.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 1.6000000000000001 110.495 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.65 -39.9 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 1.3799999999999999 110.214 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 96.1 m-20 -66.19 120.3 12.99 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.297 -1.001 . . . . 1.4199999999999999 108.297 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 25.7 mp0 -87.81 -10.97 49.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.272 -0.893 . . . . 2.1699999999999999 109.361 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m -64.14 -40.01 95.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.451 -0.78 . . . . 1.5600000000000001 109.926 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -79.6 127.93 32.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 1.3200000000000001 109.736 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.37 124.72 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.454 -0.943 . . . . 0.91000000000000003 108.454 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -94.15 150.66 20.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.012 . . . . 1.8100000000000001 110.511 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.97 86.62 25.96 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 107.722 -1.214 . . . . 1.28 107.722 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo . . . . . 0 N--CA 1.493 1.485 0 C-N-CA 122.618 2.212 . . . . 1.6499999999999999 113.694 -178.834 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.418 -0.586 . . . . 1.3899999999999999 109.418 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -120.05 139.36 52.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.536 -0.727 . . . . 0.46000000000000002 109.458 179.304 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 t -150.65 167.52 27.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 0.56000000000000005 109.168 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 1.4199999999999999 109.495 179.751 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 120.645 0.185 . . . . 0.72999999999999998 111.967 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.7 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.486 2.124 . . . . 0.83999999999999997 112.51 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -66.9 131.78 46.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.882 -1.136 . . . . 1.1499999999999999 108.944 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -72.08 162.99 28.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 1.3899999999999999 108.906 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -60.01 -33.93 72.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 1.3200000000000001 108.561 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.8 -40.03 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.401 -0.962 . . . . 0.95999999999999996 108.401 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.16 90.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 0.38 110.105 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.99 -39.99 87.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.071 -1.018 . . . . 0.37 108.368 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.08 -40.11 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.377 -0.827 . . . . 0.48999999999999999 108.867 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -67.92 -40.33 83.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 0.39000000000000001 110.641 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.02 -37.43 75.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 1.1399999999999999 109.985 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.34 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 0.32000000000000001 109.761 -179.333 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.01 -47.38 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.33000000000000002 108.867 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -68.43 -40.04 81.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 1.8200000000000001 110.004 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -74.71 -13.26 60.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.858 . . . . 1.6699999999999999 110.387 -179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.9 150.21 74.88 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.996 . . . . 0.63 109.665 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.4 -41.6 15.26 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.019 1.812 . . . . 1.29 110.414 179.164 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.03 132.57 56.36 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.445 -1.317 . . . . 2.6299999999999999 107.445 178.299 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 25' ' ' ILE . 68.5 mttm -69.0 -21.57 64.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 2.02 109.981 -178.455 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.86 33.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 1.55 109.226 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.401 ' H ' ' C ' ' A' ' 23' ' ' LYS . 16.0 tt -56.87 154.54 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.46999999999999997 109.469 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -79.97 162.43 24.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.81000000000000005 110.152 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.99 -50.01 75.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.481 -0.933 . . . . 0.69999999999999996 108.481 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -60.51 -39.98 89.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.579 -0.701 . . . . 1.25 110.306 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.14 -38.55 61.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.28999999999999998 109.389 -179.411 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.24 -41.54 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -1.172 . . . . 0.34999999999999998 109.741 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -60.0 -43.35 95.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.12 -0.987 . . . . 1.3999999999999999 109.952 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -59.99 -40.01 87.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.375 -0.828 . . . . 2.5099999999999998 109.743 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.03 -45.54 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.794 . . . . 1.3700000000000001 110.001 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.66 -49.95 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.58999999999999997 110.711 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.04 -42.86 99.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 0.68999999999999995 111.03 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.1 -40.13 75.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 1.1699999999999999 111.148 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -70.08 -40.23 75.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.908 -1.12 . . . . 3.0 109.88 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.13 117.49 31.99 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 107.986 -1.116 . . . . 1.54 107.986 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.76 -9.48 17.02 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.838 1.692 . . . . 1.21 112.463 -178.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -59.97 -39.56 86.07 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 3.7400000000000002 108.999 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.08 -26.54 64.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.569 -0.707 . . . . 1.1200000000000001 110.559 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -59.99 -33.59 72.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.927 -1.108 . . . . 2.5099999999999998 108.796 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.01 9.98 33.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 2.3399999999999999 109.532 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.503 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 60.3 t30 -139.04 125.6 20.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.357 -0.84 . . . . 2.0099999999999998 109.813 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -124.48 15.14 8.89 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.739 -0.838 . . . . 1.6799999999999999 108.739 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 48' ' ' TRP . 91.7 mm-40 -61.18 -169.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.142 0.972 . . . . 3.98 112.085 -177.869 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.05 -8.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 CA-C-N 115.669 -0.696 . . . . 0.78000000000000003 111.633 -178.469 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -60.02 -27.7 67.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.476 -1.602 . . . . 0.44 107.947 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.04 -58.45 3.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.729 . . . . 1.96 110.947 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -61.79 -39.97 93.58 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 1.28 110.97 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.0 t -56.95 -32.08 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 1.49 110.833 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.09 -57.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.93 -1.106 . . . . 0.64000000000000001 111.342 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.59 -29.07 28.07 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.736 -1.227 . . . . 2.7599999999999998 110.359 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.05 -40.02 87.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 2.48 109.633 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -69.42 -24.11 63.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 2.0699999999999998 110.525 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.96 -40.03 91.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 0.78000000000000003 109.494 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -60.9 -48.07 83.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 1.6000000000000001 110.142 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.7 mp -68.29 -40.09 81.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 1.3799999999999999 109.348 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -79.91 113.58 18.18 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.185 -0.947 . . . . 1.4199999999999999 109.022 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.88 1.17 56.52 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.602 -0.888 . . . . 2.1699999999999999 108.602 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.04 -36.91 78.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.681 -0.637 . . . . 1.5600000000000001 109.4 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -78.51 161.44 27.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 1.3200000000000001 109.583 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.63 130.06 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.543 -0.723 . . . . 0.91000000000000003 109.636 -179.352 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -86.96 127.02 35.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 1.8100000000000001 109.967 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -132.38 71.74 79.0 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 108.581 -0.896 . . . . 1.28 108.581 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 81.1 Cg_exo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.65 2.233 . . . . 1.6499999999999999 112.272 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 5.7 m-30 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.001 -0.74 . . . . 1.3899999999999999 109.001 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -134.51 143.13 47.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 0.46000000000000002 109.67 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -149.54 166.19 29.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.132 -0.98 . . . . 0.56000000000000005 109.208 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.181 -0.949 . . . . 1.4199999999999999 109.971 -179.312 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 N--CA 1.492 1.408 0 CA-C-O 120.577 0.157 . . . . 0.72999999999999998 112.078 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.69 10.06 3.48 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.472 2.115 . . . . 0.83999999999999997 112.7 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -85.16 140.26 31.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.888 -1.133 . . . . 1.1499999999999999 109.572 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.7 p -80.04 170.38 16.54 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -0.815 . . . . 1.3899999999999999 108.872 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -60.0 -40.15 88.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.109 -0.994 . . . . 1.3200000000000001 109.154 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.8 mm -61.09 -48.07 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.812 . . . . 0.95999999999999996 109.002 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.47 98.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.38 110.295 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.93 -44.01 94.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.939 -1.101 . . . . 0.37 109.189 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.01 -39.98 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.48999999999999999 109.264 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.93 -40.54 97.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.39000000000000001 109.821 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.6 mtm -70.04 -36.57 75.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.872 . . . . 1.1399999999999999 109.335 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.97 89.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.326 -0.859 . . . . 0.32000000000000001 109.658 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.0 -50.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.078 -1.014 . . . . 0.33000000000000002 109.983 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.95 -37.96 76.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.717 -0.614 . . . . 1.8200000000000001 110.46 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -75.83 -1.5 25.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 1.6699999999999999 110.085 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.19 147.91 73.71 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.079 -1.013 . . . . 0.63 109.528 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.02 -19.57 57.62 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.8 1.667 . . . . 1.29 109.9 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -130.71 138.26 49.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.143 -1.428 . . . . 2.6299999999999999 107.143 178.517 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -60.0 -39.97 87.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.943 -1.098 . . . . 2.02 109.156 -178.585 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -79.3 130.79 35.8 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.181 -0.949 . . . . 1.55 108.719 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.06 148.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.46999999999999997 109.473 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.7 p -83.62 167.05 17.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.81000000000000005 110.148 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.94 -49.72 76.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.077 -1.083 . . . . 0.69999999999999996 108.077 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.08 -40.02 88.11 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.986 -0.552 . . . . 1.25 110.392 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.91 94.52 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.384 -1.086 . . . . 0.28999999999999998 110.384 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.11 -43.39 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.043 -1.269 . . . . 0.34999999999999998 109.645 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -60.02 -40.0 87.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.963 -1.086 . . . . 1.3999999999999999 110.821 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.95 -42.72 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.899 -1.126 . . . . 2.5099999999999998 110.74 -178.237 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.98 -48.56 81.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 1.3700000000000001 111.414 -179.16 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.93 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.097 . . . . 0.58999999999999997 111.401 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 mtm -59.99 -46.14 90.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 0.68999999999999995 110.673 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.09 -39.89 75.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.885 -1.134 . . . . 1.1699999999999999 110.064 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -69.09 -39.97 78.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 3.0 110.378 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 40' ' ' PHE . 67.3 m-85 -131.34 80.04 68.7 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 1.54 110.148 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -45.72 -9.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.698 2.265 . . . . 1.21 112.02 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 38' ' ' PHE . 31.5 t80 -60.06 -39.93 87.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.464 -0.773 . . . . 3.7400000000000002 109.833 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -68.2 -20.76 64.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 1.1200000000000001 110.904 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HG2' ' NH1' ' A' ' 42' ' ' ARG . 61.5 mtt-85 -60.03 -40.08 88.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.817 -1.177 . . . . 2.5099999999999998 109.532 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.38 -40.12 96.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 2.3399999999999999 110.132 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -105.82 106.08 16.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.813 -0.554 . . . . 2.0099999999999998 109.795 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 66.8 mttm -97.38 -39.69 9.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.245 -0.909 . . . . 1.6799999999999999 110.533 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.81 145.8 31.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 3.98 109.894 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.2 -72.64 0.28 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.748 -0.941 . . . . 0.78000000000000003 110.748 179.121 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 20.2 p-90 -69.99 -23.94 63.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.016 -1.285 . . . . 0.44 111.438 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.08 -50.47 73.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.668 -1.27 . . . . 1.96 111.407 -178.516 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -73.84 -33.56 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.778 -1.201 . . . . 1.28 111.32 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.3 p -59.9 -36.37 76.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 1.49 110.757 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.04 -49.85 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.938 -1.101 . . . . 0.64000000000000001 110.314 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -70.08 -39.38 75.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.222 -0.924 . . . . 2.7599999999999998 110.622 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -60.02 -39.86 87.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.029 -1.044 . . . . 2.48 108.514 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.051 -1.092 . . . . 2.0699999999999998 108.051 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 56' ' ' LEU . 91.6 mt -66.72 -40.05 88.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.49 -0.757 . . . . 0.78000000000000003 109.646 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.8 p -75.01 -49.3 20.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.091 -1.005 . . . . 1.6000000000000001 109.99 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.3 mt -64.17 -40.19 95.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 1.3799999999999999 109.274 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ASN . . . . . 0.448 ' OD1' ' SG ' ' A' ' 61' ' ' CYS . 8.9 t-20 -83.95 116.93 23.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.402 -0.962 . . . . 1.4199999999999999 108.402 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.94 1.75 54.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 2.1699999999999999 109.94 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' CYS . . . . . 0.448 ' SG ' ' OD1' ' A' ' 59' ' ' ASN . 96.8 m -59.97 -39.96 87.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 1.5600000000000001 108.638 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -78.95 146.14 33.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 1.3200000000000001 108.976 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.15 129.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.419 -0.956 . . . . 0.91000000000000003 108.419 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.25 139.08 57.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 1.8100000000000001 109.905 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.8 t -112.4 119.98 42.41 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.556 -0.905 . . . . 1.28 108.556 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 C--N 1.313 -1.338 0 C-N-CA 121.531 1.488 . . . . 1.6499999999999999 112.268 -179.287 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.411 -0.588 . . . . 1.3899999999999999 109.411 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -113.18 139.93 48.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.055 -0.72 . . . . 0.46000000000000002 109.055 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 80' ' ' LEU . 15.2 t -143.1 160.69 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.189 -0.944 . . . . 0.56000000000000005 109.862 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 79' ' ' THR . 81.7 mt . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 1.4199999999999999 109.575 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.175 0.512 . . . . 4.8099999999999996 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.6 mt -122.78 148.45 45.35 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.9 -0.778 . . . . 1.71 108.9 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.12 141.11 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.366 -0.834 . . . . 1.79 109.075 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -73.63 165.4 53.39 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 3.6899999999999999 108.699 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' TYR . 1.8 Cg_endo -84.35 114.18 1.8 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.256 1.971 . . . . 0.72999999999999998 112.194 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.41 -8.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.538 1.492 . . . . 0.83999999999999997 111.558 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' PRO . 11.6 m-85 -68.76 138.85 55.18 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.863 . . . . 1.1499999999999999 109.162 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 t -73.82 164.64 26.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.294 -0.878 . . . . 1.3899999999999999 108.737 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -59.95 -39.13 84.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.138 -0.976 . . . . 1.3200000000000001 108.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.8 mm -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.95999999999999996 109.081 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.27 87.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 0.38 109.612 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.07 -43.75 95.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.37 108.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.03 -41.98 88.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 0.48999999999999999 108.106 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -65.56 -40.05 92.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.54 -0.725 . . . . 0.39000000000000001 110.357 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.595 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.6 mtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -0.967 . . . . 1.1399999999999999 110.311 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.63 -42.61 75.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 0.32000000000000001 110.034 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.46 -40.29 88.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.795 . . . . 0.33000000000000002 109.243 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -66.6 -41.79 87.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.53 -0.731 . . . . 1.8200000000000001 110.69 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 15' ' ' MET . 19.0 p30 -90.77 7.92 37.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.6699999999999999 110.258 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.2 116.55 61.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.63 109.078 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -43.04 -26.76 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.461 1.441 . . . . 1.29 111.012 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -122.92 131.7 53.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.605 -1.258 . . . . 2.6299999999999999 107.605 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -60.07 -40.0 88.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.842 -1.161 . . . . 2.02 108.718 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.99 117.76 25.04 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.754 -1.202 . . . . 1.55 107.754 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.85 145.68 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.714 . . . . 0.46999999999999997 109.46 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.4 p -79.55 162.38 25.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.387 -0.82 . . . . 0.81000000000000005 109.996 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.02 -43.33 95.32 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.15 -1.055 . . . . 0.69999999999999996 108.15 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.46 -40.04 96.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.55 -0.719 . . . . 1.25 110.141 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.28 -38.46 94.61 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.528 -1.029 . . . . 0.28999999999999998 110.528 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.96 -40.27 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -1.229 . . . . 0.34999999999999998 109.752 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.564 ' OH ' ' NE ' ' A' ' 53' ' ' ARG . 24.7 m-85 -60.34 -42.81 96.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.605 -1.309 . . . . 1.3999999999999999 109.571 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.98 -41.32 91.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 2.5099999999999998 110.658 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 63.3 t80 -59.99 -49.08 79.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.922 -1.111 . . . . 1.3700000000000001 110.278 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.01 -40.0 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 0.58999999999999997 110.566 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.1 mtt -60.82 -44.05 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.859 -1.151 . . . . 0.68999999999999995 110.1 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.99 -52.08 13.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 1.1699999999999999 110.721 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -60.06 -46.72 88.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 3.0 109.2 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -122.77 109.52 32.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.561 -0.903 . . . . 1.54 108.561 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.88 -7.55 12.3 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.146 1.897 . . . . 1.21 113.172 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -59.93 -34.33 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.963 -1.086 . . . . 3.7400000000000002 108.851 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' ASN . 90.4 m-85 -66.2 -26.93 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 1.1200000000000001 110.658 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -60.04 -38.96 84.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.872 -1.143 . . . . 2.5099999999999998 109.342 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.04 -39.79 87.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.059 . . . . 2.3399999999999999 108.721 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.9 m-20 -118.06 105.02 11.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.282 -0.636 . . . . 2.0099999999999998 109.282 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 93.5 mttt -90.88 -59.86 2.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 1.6799999999999999 110.689 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -69.65 140.02 53.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.509 -0.745 . . . . 3.98 110.21 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.9 -59.86 0.45 Allowed Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.221 -1.151 . . . . 0.78000000000000003 110.221 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.519 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 51.0 p-90 -82.32 -28.92 31.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.263 . . . . 0.44 110.671 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -64.88 -41.11 95.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.937 -1.102 . . . . 1.96 110.06 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -39.53 75.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.388 -0.82 . . . . 1.28 111.695 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.711 -1.243 . . . . 1.49 110.183 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -60.02 -40.05 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 0.64000000000000001 109.715 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.564 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 20.3 mtt180 -67.22 -37.3 83.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.054 . . . . 2.7599999999999998 109.504 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.0 -44.18 94.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.829 . . . . 2.48 109.587 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -68.79 -38.61 80.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 2.0699999999999998 109.419 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.59 59.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.78000000000000003 110.241 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -172.55 -55.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.328 -0.99 . . . . 1.6000000000000001 108.328 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.58 -39.95 84.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.561 -0.903 . . . . 1.3799999999999999 108.561 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -71.45 123.36 22.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -0.846 . . . . 1.4199999999999999 108.727 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -90.06 0.01 57.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.447 -0.783 . . . . 2.1699999999999999 109.526 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.8 -40.05 94.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 1.5600000000000001 109.769 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -79.05 150.37 31.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 1.3200000000000001 109.712 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.553 HG21 ' CB ' ' A' ' 81' ' ' ASP . 60.6 t -118.67 127.32 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.874 -0.787 . . . . 0.91000000000000003 108.874 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -92.4 125.0 36.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 1.8100000000000001 108.525 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.07 79.4 73.02 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 108.91 -0.774 . . . . 1.28 108.91 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.01 151.75 83.07 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.478 2.119 . . . . 1.6499999999999999 112.268 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -168.58 0.42 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.674 -1.232 . . . . 4.0899999999999999 107.674 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -70.17 148.72 48.33 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.02 -1.05 . . . . 2.8399999999999999 109.039 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.98 -20.75 63.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.018 -1.051 . . . . 3.46 109.678 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -60.12 -40.07 88.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 4.5 109.967 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -81.45 123.46 81.06 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 121.154 -0.966 . . . . 5.1200000000000001 109.005 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -82.18 -157.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.957 1.771 . . . . 3.6299999999999999 112.164 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.31 -124.07 21.71 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.264 -1.134 . . . . 3.1499999999999999 110.264 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -62.74 141.46 58.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.535 -0.98 . . . . 4.3600000000000003 109.796 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.75 36.92 0.9 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.021 -1.232 . . . . 2.0299999999999998 110.021 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.9 m -156.44 134.75 11.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.032 -1.275 . . . . 1.8 110.31 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.46 155.58 48.28 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.513 -0.921 . . . . 1.3899999999999999 108.513 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -126.53 134.81 50.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.46000000000000002 109.233 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -159.01 164.35 35.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.16 -0.963 . . . . 0.56000000000000005 109.779 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.04 122.1 34.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.189 -0.944 . . . . 1.4199999999999999 109.423 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.553 ' CB ' HG21 ' A' ' 63' ' ' VAL . 3.5 m-20 -164.54 157.65 14.8 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 3.7200000000000002 109.498 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.33 -162.31 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.211 1.941 . . . . 3.5499999999999998 111.187 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -77.21 59.34 1.75 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.872 -1.158 . . . . 6.8200000000000003 107.872 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.5 p -83.54 49.03 1.51 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.548 -0.72 . . . . 6.0 110.105 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -57.24 5.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.329 -0.857 . . . . 11.0 109.589 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 88' ' ' PHE . 32.7 m120 -110.01 19.99 18.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.419 -0.801 . . . . 10.0 110.723 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.5 mmt -69.05 6.15 1.0 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.892 -1.13 . . . . 8.4700000000000006 109.115 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 86' ' ' ASN . 55.2 m-85 -60.01 -40.05 87.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 11.970000000000001 109.018 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 31.2 mp0 -102.67 139.65 37.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.582 -0.699 . . . . 11.949999999999999 109.238 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -129.18 151.85 49.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 12.32 109.428 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.14 -13.65 62.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.532 -1.827 . . . . 11.16 108.532 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.6 p -77.9 -19.97 53.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.549 -0.971 . . . . 11.800000000000001 109.01 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -135.82 145.72 46.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.526 -0.734 . . . . 10.779999999999999 109.404 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 108.487 -0.931 . . . . 13.119999999999999 108.487 179.732 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.352 0.596 . . . . 4.8099999999999996 109.433 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.52 155.2 28.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 1.71 108.857 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.93 160.04 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.446 -0.784 . . . . 1.79 109.281 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -59.63 120.88 53.04 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.114 -0.991 . . . . 3.6899999999999999 109.156 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.66 155.57 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.768 1.645 . . . . 0.72999999999999998 111.848 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.16 1.31 6.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.409 2.072 . . . . 0.83999999999999997 112.095 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -81.03 133.12 35.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 1.1499999999999999 109.47 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -69.35 167.2 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.215 -0.928 . . . . 1.3899999999999999 108.567 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -59.92 -39.98 87.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 1.3200000000000001 109.041 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -65.83 -41.05 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 0.95999999999999996 110.226 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.8 94.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.38 110.344 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.85 -40.12 87.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 0.37 109.079 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.496 HD11 HD21 ' A' ' 55' ' ' ASN . 86.5 mt -69.9 -40.0 78.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.223 -0.923 . . . . 0.48999999999999999 109.391 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -64.28 -40.91 96.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.39000000000000001 109.726 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 73.5 mtm -70.02 -36.93 75.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 1.1399999999999999 109.474 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.85 84.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 0.32000000000000001 109.35 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.8 mt -60.08 -50.0 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.33000000000000002 108.856 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -61.72 -40.06 93.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.288 0.566 . . . . 1.8200000000000001 109.995 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -79.99 -10.07 59.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 1.6699999999999999 110.379 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 131.48 67.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 0.63 109.488 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.06 -38.93 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.411 1.407 . . . . 1.29 110.896 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -120.03 134.63 55.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.149 -1.056 . . . . 2.6299999999999999 108.149 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.97 -34.41 73.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.04 -1.038 . . . . 2.02 110.034 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.97 113.91 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.78 -1.2 . . . . 1.55 108.297 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.5 tt -130.01 160.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 0.46999999999999997 109.445 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.9 p -90.37 165.77 13.67 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.9 0.857 . . . . 0.81000000000000005 110.714 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.652 HD11 ' HG2' ' A' ' 53' ' ' ARG . 14.3 tp -60.1 -50.02 75.37 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.056 0.932 . . . . 0.69999999999999996 108.64 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.39 -39.97 94.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.286 0.565 . . . . 1.25 110.208 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.05 96.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.433 -1.067 . . . . 0.28999999999999998 110.433 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -60.09 -42.04 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.029 -1.277 . . . . 0.34999999999999998 109.64 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -59.89 -40.85 90.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.746 -1.221 . . . . 1.3999999999999999 109.959 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -60.1 -42.24 94.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 2.5099999999999998 110.135 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.98 -49.01 79.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 1.3700000000000001 110.718 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.17 -49.98 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 0.58999999999999997 111.497 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.7 mtm -60.26 -49.98 75.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.664 -1.273 . . . . 0.68999999999999995 110.269 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -68.91 -39.99 79.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 1.1699999999999999 109.539 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -66.17 -49.75 66.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 3.0 109.678 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -119.38 120.19 31.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.594 -0.691 . . . . 1.54 109.301 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.39 -7.49 14.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.863 1.709 . . . . 1.21 112.248 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -60.01 -40.93 90.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.4 -0.812 . . . . 3.7400000000000002 110.234 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.77 -27.76 67.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 1.1200000000000001 110.722 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -58.23 -26.04 62.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.045 -1.035 . . . . 2.5099999999999998 109.436 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.78 1.76 54.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.03 -1.043 . . . . 2.3399999999999999 110.103 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.536 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 53.4 t30 -147.68 102.36 3.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.393 -0.817 . . . . 2.0099999999999998 109.278 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.7 mttt -89.16 -64.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 1.6799999999999999 110.963 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -69.93 144.03 52.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 3.98 110.074 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.44 -58.41 0.4 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.76 -1.336 . . . . 0.78000000000000003 109.76 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 29.4 p-90 -89.98 -11.66 40.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.25 . . . . 0.44 110.374 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.69 -55.96 9.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 1.96 110.498 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -70.05 -31.52 69.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 1.28 110.58 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.1 p -59.83 -40.44 88.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.052 -1.03 . . . . 1.49 110.81 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mm -60.05 -50.94 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.859 -1.151 . . . . 0.64000000000000001 110.379 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.652 ' HG2' HD11 ' A' ' 27' ' ' LEU . 46.6 mtp180 -69.97 -37.92 75.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.074 -1.016 . . . . 2.7599999999999998 110.182 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -59.93 -40.09 87.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 2.48 110.606 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 26.3 p30 -69.99 -18.33 63.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.943 -1.098 . . . . 2.0699999999999998 110.567 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.431 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 85.6 mt -66.4 -40.09 89.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.794 -1.191 . . . . 0.78000000000000003 111.115 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -70.04 -48.43 57.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.898 -1.126 . . . . 1.6000000000000001 110.756 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.2 -39.98 96.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 1.3799999999999999 110.658 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 76.1 m-20 -76.02 112.96 13.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 1.4199999999999999 110.069 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.24 -5.95 55.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 2.1699999999999999 109.484 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -62.82 -35.05 78.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 1.5600000000000001 110.199 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -78.72 152.53 31.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 1.3200000000000001 109.618 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 0.91000000000000003 109.567 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -81.93 149.64 28.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 1.8100000000000001 110.098 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.12 128.69 14.31 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.625 -0.88 . . . . 1.28 108.625 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.16 -178.16 3.41 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.441 1.427 . . . . 1.6499999999999999 111.675 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.43 ' NE ' ' OH ' ' A' ' 77' ' ' TYR . 52.4 mtp180 -110.88 160.72 16.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 4.0899999999999999 109.44 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -61.72 158.06 16.44 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.452 -0.78 . . . . 2.8399999999999999 109.007 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.44 -21.47 62.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 3.46 110.023 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -60.06 -41.44 92.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.983 . . . . 4.5 109.321 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.547 ' CD ' ' N ' ' A' ' 71' ' ' LYS . 9.6 mptt -84.56 148.16 51.28 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.428 -0.953 . . . . 5.1200000000000001 108.428 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.15 1.75 6.3 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.955 1.77 . . . . 3.6299999999999999 112.168 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.49 54.26 3.17 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.771 -1.331 . . . . 3.1499999999999999 109.771 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -60.0 -40.05 87.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -1.176 . . . . 4.3600000000000003 108.616 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.88 175.94 42.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.813 -1.715 . . . . 2.0299999999999998 108.813 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.3 p -100.42 136.17 40.71 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.085 -1.244 . . . . 1.8 109.663 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.43 ' OH ' ' NE ' ' A' ' 67' ' ' ARG . 10.0 m-85 -69.9 158.85 34.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.92 -1.112 . . . . 1.3899999999999999 108.014 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -120.75 134.38 55.29 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.591 0.71 . . . . 0.46000000000000002 110.155 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 170.75 19.98 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.911 -0.774 . . . . 0.56000000000000005 108.911 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.6 mt -97.0 121.07 38.48 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.062 -1.024 . . . . 1.4199999999999999 110.203 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -137.1 82.87 29.12 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 107.83 -1.174 . . . . 3.7200000000000002 107.83 179.085 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 81' ' ' ASP . 69.2 Cg_exo -50.86 -137.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.228 2.619 . . . . 3.5499999999999998 113.568 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -73.45 60.16 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.974 -1.079 . . . . 6.8200000000000003 108.967 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 t -60.04 -33.93 72.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.77 -0.826 . . . . 6.0 108.77 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.04 -39.96 87.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.369 -0.832 . . . . 11.0 109.555 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -86.36 23.48 1.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.174 -0.954 . . . . 10.0 110.59 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.438 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 3.5 mmt -73.65 95.57 2.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.93 -1.106 . . . . 8.4700000000000006 109.125 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -88.87 -17.49 29.53 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.099 -1.074 . . . . 11.970000000000001 108.099 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -78.7 160.06 27.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.506 -0.746 . . . . 11.949999999999999 109.138 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -68.79 130.82 43.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 12.32 109.674 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 167.38 -120.7 0.92 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.834 -1.307 . . . . 11.16 109.834 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.4 t -73.42 -11.67 60.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -1.093 . . . . 11.800000000000001 109.689 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 87' ' ' MET . 77.6 t80 -59.97 -40.02 87.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 10.779999999999999 111.094 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.465 HD23 ' H ' ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 120.715 -1.241 . . . . 13.119999999999999 109.706 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.82 0.819 . . . . 4.8099999999999996 109.266 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.2 mt -82.27 159.8 23.09 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.965 -0.754 . . . . 1.71 108.965 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.0 160.06 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.464 -0.773 . . . . 1.79 109.014 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HD2' ' H ' ' A' ' 4' ' ' LYS . 2.3 mptp? -56.79 113.96 7.03 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 3.6899999999999999 109.027 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -45.58 160.57 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.734 1.623 . . . . 0.72999999999999998 111.839 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.8 4.22 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.412 2.075 . . . . 0.83999999999999997 112.635 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -82.0 143.01 31.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.974 -1.079 . . . . 1.1499999999999999 109.803 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.5 t -75.05 160.2 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.528 -0.916 . . . . 1.3899999999999999 108.528 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -60.02 -39.95 87.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 1.3200000000000001 108.682 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.3 mm -65.2 -40.05 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.741 -0.837 . . . . 0.95999999999999996 108.741 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.72 89.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.958 . . . . 0.38 109.642 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.04 -43.14 95.53 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.025 -1.047 . . . . 0.37 108.656 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.403 HG21 HD21 ' A' ' 56' ' ' LEU . 85.5 mt -69.32 -50.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.48999999999999999 109.452 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -61.39 -40.01 92.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 0.39000000000000001 110.015 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.9 mtp -69.88 -38.48 76.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.431 -0.793 . . . . 1.1399999999999999 109.967 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 20' ' ' ALA . . . -60.03 -42.22 93.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.32000000000000001 110.032 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.31 -49.98 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.33000000000000002 109.588 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.73 -40.02 76.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.722 -0.611 . . . . 1.8200000000000001 109.959 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -76.95 -9.92 59.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.85 . . . . 1.6699999999999999 110.229 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 16' ' ' ALA . . . -79.75 137.67 54.42 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.088 -1.007 . . . . 0.63 109.454 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.81 -65.19 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.867 1.712 . . . . 1.29 110.858 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -99.81 137.84 37.72 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 2.6299999999999999 107.684 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -62.43 -28.73 70.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.833 -1.167 . . . . 2.02 109.204 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -79.7 98.3 6.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.136 -0.977 . . . . 1.55 108.569 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -119.66 149.68 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.257 -0.646 . . . . 0.46999999999999997 109.257 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -79.91 161.55 25.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.81000000000000005 110.273 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.9 tp -59.99 -47.25 86.6 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.686 -0.857 . . . . 0.69999999999999996 108.686 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -59.97 -39.8 86.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.933 -0.766 . . . . 1.25 108.933 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.55 -39.95 95.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.744 -0.942 . . . . 0.28999999999999998 110.744 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.04 -40.99 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.735 -1.45 . . . . 0.34999999999999998 109.931 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -61.59 -40.31 94.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 1.3999999999999999 110.086 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.93 -40.68 89.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.17 -0.956 . . . . 2.5099999999999998 109.881 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.49 -0.756 . . . . 1.3700000000000001 110.744 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.8 -49.97 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.108 -0.995 . . . . 0.58999999999999997 111.614 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.8 mtm -62.02 -39.98 94.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.1 -1.0 . . . . 0.68999999999999995 111.398 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 93.1 m-20 -63.76 -51.67 63.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.746 -1.221 . . . . 1.1699999999999999 112.071 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -74.86 -24.9 58.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.71 -1.244 . . . . 3.0 111.25 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.494 ' C ' ' H ' ' A' ' 40' ' ' PHE . 71.7 m-85 -130.02 77.62 76.24 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.209 -0.932 . . . . 1.54 109.763 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.75 -7.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.735 2.29 . . . . 1.21 111.438 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.494 ' H ' ' C ' ' A' ' 38' ' ' PHE . 11.8 t80 -59.96 -40.44 89.02 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.416 -0.802 . . . . 3.7400000000000002 109.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -69.92 -24.1 63.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 1.1200000000000001 110.446 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 61.1 mtt-85 -60.01 -37.87 81.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 2.5099999999999998 108.884 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.96 9.15 17.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 2.3399999999999999 109.285 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.566 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 52.8 t-20 -138.5 120.47 15.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.418 -0.801 . . . . 2.0099999999999998 109.428 -179.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -120.24 13.1 11.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.596 -0.89 . . . . 1.6799999999999999 108.596 179.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.443 ' O ' ' N ' ' A' ' 48' ' ' TRP . 96.6 mt-30 -59.91 -168.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.023 0.916 . . . . 3.98 111.438 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.15 -10.96 0.06 OUTLIER Glycine 0 N--CA 1.493 2.472 0 CA-C-N 115.997 -0.547 . . . . 0.78000000000000003 112.257 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.566 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 4.7 p-90 -59.98 -38.87 83.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.726 . . . . 0.44 108.212 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 21.2 tt0 -60.03 -50.04 75.29 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.607 -0.683 . . . . 1.96 110.019 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -76.1 -33.95 59.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 1.28 111.369 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -59.92 -38.37 82.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 1.49 111.375 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.98 -51.48 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 0.64000000000000001 111.37 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -79.81 -29.44 40.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.652 -1.28 . . . . 2.7599999999999998 110.483 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.535 ' CE1' HD11 ' A' ' 58' ' ' LEU . 54.3 t60 -59.92 -42.0 92.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 2.48 109.161 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -65.47 -39.98 92.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 2.0699999999999998 109.566 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 13' ' ' ILE . 41.4 mt -60.15 -45.44 93.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.78000000000000003 110.542 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -63.33 -45.63 90.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.804 -1.185 . . . . 1.6000000000000001 110.255 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.535 HD11 ' CE1' ' A' ' 54' ' ' HIS . 47.8 mt -69.95 -40.08 75.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.977 -1.077 . . . . 1.3799999999999999 109.877 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -72.47 117.45 14.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 1.4199999999999999 109.297 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -90.19 -2.73 58.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.46 -0.775 . . . . 2.1699999999999999 109.376 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -60.72 -40.06 90.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 1.5600000000000001 109.453 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -79.95 152.05 29.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 1.3200000000000001 109.558 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.1 t -115.39 121.57 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.577 -0.702 . . . . 0.91000000000000003 109.321 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -85.74 127.16 34.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 1.8100000000000001 108.6 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.7 111.28 58.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 1.28 109.308 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.77 136.02 13.17 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.65 1.567 . . . . 1.6499999999999999 111.931 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.747 ' NE ' ' H ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -77.11 159.97 29.38 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.208 -0.932 . . . . 4.0899999999999999 108.968 179.459 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.67 156.76 22.62 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.42 -0.8 . . . . 2.8399999999999999 109.309 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.91 -33.25 71.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 3.46 109.321 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -60.08 -32.54 71.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 4.5 109.203 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -77.25 126.03 85.65 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.127 -0.983 . . . . 5.1200000000000001 109.006 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 73' ' ' GLY . 65.1 Cg_endo -84.06 12.55 2.98 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.991 1.794 . . . . 3.6299999999999999 111.551 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 72' ' ' PRO . . . -43.47 168.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.821 -0.912 . . . . 3.1499999999999999 110.821 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -82.94 -105.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.642 -0.917 . . . . 4.3600000000000003 110.042 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.92 -179.35 52.66 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.229 -1.149 . . . . 2.0299999999999998 110.229 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.2 p -79.89 160.69 25.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.491 -1.006 . . . . 1.8 109.589 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -89.45 153.84 20.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.01 -1.056 . . . . 1.3899999999999999 109.628 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -111.19 137.13 49.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.695 -0.628 . . . . 0.46000000000000002 109.976 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -145.25 159.75 42.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.859 . . . . 0.56000000000000005 109.159 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.46 163.69 24.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 1.4199999999999999 109.2 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 82' ' ' PRO . 4.8 p30 -59.35 158.55 19.58 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 3.7200000000000002 109.064 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 81' ' ' ASP . 45.6 Cg_exo -55.12 -141.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.757 1.638 . . . . 3.5499999999999998 112.329 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -81.96 45.38 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.983 . . . . 6.8200000000000003 108.825 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -55.45 -24.93 33.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.452 -0.78 . . . . 6.0 109.031 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.68 -39.47 84.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.444 -0.785 . . . . 11.0 109.318 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -68.0 -19.92 64.97 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.192 -0.942 . . . . 10.0 108.676 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 69.0 mtt -90.56 109.24 20.4 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.116 -0.698 . . . . 8.4700000000000006 109.116 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -69.01 -40.97 78.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.928 -1.107 . . . . 11.970000000000001 108.358 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -143.22 154.67 44.08 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.229 -1.026 . . . . 11.949999999999999 108.229 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -60.05 141.71 55.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.738 -1.226 . . . . 12.32 109.055 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.57 -7.88 80.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.992 -1.643 . . . . 11.16 108.992 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 94' ' ' LEU . 39.6 t -60.86 -38.2 84.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -1.069 . . . . 11.800000000000001 109.522 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.408 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 55.3 t80 -46.46 -13.76 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.426 -0.796 . . . . 10.779999999999999 109.695 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 92' ' ' SER . 64.9 tp . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 13.119999999999999 110.161 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mtm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.099 -0.704 . . . . 4.8099999999999996 109.099 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.3 mt -76.34 158.29 31.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.148 -0.97 . . . . 1.71 109.139 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -108.29 144.98 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.424 -0.798 . . . . 1.79 109.895 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -69.95 149.97 96.38 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.887 . . . . 3.6899999999999999 109.102 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.12 160.17 36.66 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.182 1.922 . . . . 0.72999999999999998 112.309 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.27 28.79 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.862 2.375 . . . . 0.83999999999999997 113.267 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -109.5 134.01 52.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.019 -1.05 . . . . 1.1499999999999999 108.819 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 174.59 11.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 1.3899999999999999 108.97 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -59.96 -35.93 76.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 1.3200000000000001 109.908 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.67 -40.01 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 0.95999999999999996 110.339 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.0 77.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.938 -1.101 . . . . 0.38 110.887 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.05 -39.94 87.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.907 -1.12 . . . . 0.37 108.623 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 52' ' ' ILE . 88.9 mt -67.74 -39.97 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.498 -0.751 . . . . 0.48999999999999999 109.274 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -66.08 -40.07 90.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 0.39000000000000001 110.755 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.8 mtm -69.91 -39.96 75.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 1.1399999999999999 109.771 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.21 80.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.441 -0.787 . . . . 0.32000000000000001 109.4 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.33000000000000002 108.902 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.8 mm100 -60.72 -40.08 90.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.695 -0.628 . . . . 1.8200000000000001 110.15 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.406 HD21 ' HZ ' ' A' ' 33' ' ' PHE . 70.3 m-20 -69.91 -17.51 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 1.6699999999999999 109.568 -179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.95 148.3 71.76 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.63 109.718 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.97 -51.68 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.87 1.713 . . . . 1.29 109.724 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -99.11 139.93 34.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.276 -1.379 . . . . 2.6299999999999999 107.276 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -67.51 -27.26 66.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.975 -1.078 . . . . 2.02 109.796 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -78.68 115.85 18.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.023 -1.048 . . . . 1.55 108.932 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.17 154.31 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 0.46999999999999997 109.397 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.2 p -80.11 153.56 28.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.81000000000000005 109.776 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 tp -60.04 -44.28 94.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.69999999999999996 109.288 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -60.27 -40.08 89.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 1.25 110.427 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.66 97.5 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.14 -1.029 . . . . 0.28999999999999998 111.011 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.02 -42.28 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.276 . . . . 0.34999999999999998 110.243 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -60.15 -41.95 93.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.965 -1.085 . . . . 1.3999999999999999 110.202 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.31 -40.38 90.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.351 -0.843 . . . . 2.5099999999999998 110.069 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.406 ' HZ ' HD21 ' A' ' 19' ' ' ASN . 64.8 t80 -61.09 -44.69 96.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 1.3700000000000001 110.285 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.93 -50.15 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.203 -0.935 . . . . 0.58999999999999997 110.663 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -62.94 -39.91 96.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.063 -1.023 . . . . 0.68999999999999995 109.365 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.87 -39.94 76.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 1.1699999999999999 109.78 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -72.18 -50.52 27.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 3.0 109.434 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -115.16 114.1 43.48 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.782 -0.822 . . . . 1.54 108.782 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.11 -3.8 13.78 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.862 1.708 . . . . 1.21 112.036 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.618 -0.882 . . . . 3.7400000000000002 108.618 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -70.0 -21.52 63.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -0.754 . . . . 1.1200000000000001 111.142 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.9 -40.02 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.48 -1.388 . . . . 2.5099999999999998 109.317 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -61.0 -43.69 98.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.011 . . . . 2.3399999999999999 109.492 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' TYR . 54.3 t30 -109.39 109.49 20.36 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.986 -0.746 . . . . 2.0099999999999998 108.986 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 97.9 mttt -102.7 -37.7 7.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 1.6799999999999999 110.602 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -89.03 139.16 30.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 3.98 110.344 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.58 -66.79 0.23 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.291 . . . . 0.78000000000000003 109.871 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 24.7 p-90 -71.32 -37.95 71.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.44 110.744 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.94 -50.05 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 1.96 111.162 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -74.52 -25.54 59.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.843 -1.16 . . . . 1.28 110.583 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 t -60.02 -41.24 91.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.105 -0.997 . . . . 1.49 110.282 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 13' ' ' ILE . 41.1 mt -65.74 -40.82 88.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.255 -0.903 . . . . 0.64000000000000001 110.544 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -60.02 -44.08 94.85 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.334 -1.479 . . . . 2.7599999999999998 108.607 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.697 -0.853 . . . . 2.48 108.697 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -68.44 -39.99 81.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 2.0699999999999998 110.235 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.75 -40.13 91.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.052 -1.03 . . . . 0.78000000000000003 110.048 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 t -64.76 -49.68 69.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.883 . . . . 1.6000000000000001 110.512 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.98 -32.06 70.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.3799999999999999 109.971 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -74.79 112.21 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 1.4199999999999999 109.724 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.78 0.0 57.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.4 -0.813 . . . . 2.1699999999999999 109.692 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.3 p -69.98 -21.37 63.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.983 -1.073 . . . . 1.5600000000000001 109.727 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.22 153.25 21.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 1.3200000000000001 109.789 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 81' ' ' ASP . 61.0 t -114.38 124.79 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 0.91000000000000003 109.62 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -80.0 159.95 26.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 1.8100000000000001 108.602 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.19 77.53 24.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.002 -1.061 . . . . 1.28 109.585 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.25 124.15 10.03 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.662 2.241 . . . . 1.6499999999999999 112.241 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' NH1' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -79.07 -161.38 0.3 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.24 -0.913 . . . . 4.0899999999999999 109.093 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 38.5 p-10 -62.01 142.28 57.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.048 -1.032 . . . . 2.8399999999999999 110.344 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -69.93 -21.13 63.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 3.46 109.102 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -60.01 -39.96 87.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 4.5 109.885 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -134.1 82.27 48.69 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.322 -0.862 . . . . 5.1200000000000001 109.285 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -86.32 13.48 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.862 2.375 . . . . 3.6299999999999999 111.96 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.07 96.83 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.718 -0.953 . . . . 3.1499999999999999 110.718 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -77.97 10.0 3.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -1.23 . . . . 4.3600000000000003 109.268 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.07 -131.26 48.26 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.024 -1.23 . . . . 2.0299999999999998 110.024 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -130.03 146.06 51.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.536 -0.979 . . . . 1.8 109.601 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.504 ' OH ' ' NE ' ' A' ' 67' ' ' ARG . 7.4 m-85 -78.87 159.98 27.53 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.472 -0.936 . . . . 1.3899999999999999 108.472 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -116.09 137.13 52.4 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.477 -0.764 . . . . 0.46000000000000002 109.824 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -153.06 160.95 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.912 . . . . 0.56000000000000005 109.847 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.06 129.81 35.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.211 -0.931 . . . . 1.4199999999999999 110.109 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.491 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 1.8 m-20 -173.75 156.84 2.73 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.92 -0.77 . . . . 3.7200000000000002 108.92 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -85.3 -162.61 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.904 1.736 . . . . 3.5499999999999998 111.025 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -87.55 53.71 2.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.92 -1.112 . . . . 6.8200000000000003 108.845 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -59.93 -39.98 87.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.4 -0.812 . . . . 6.0 110.415 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.429 ' CD2' ' N ' ' A' ' 86' ' ' ASN . 55.9 p90 -61.56 -39.94 92.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.103 -0.998 . . . . 11.0 110.965 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.429 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 57.8 t30 -75.18 -15.44 60.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 10.0 110.818 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 64.9 mtt -82.56 118.89 23.61 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.287 -0.883 . . . . 8.4700000000000006 110.083 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -114.6 11.22 16.93 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.895 -0.78 . . . . 11.970000000000001 108.895 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 91' ' ' GLY . 8.9 pt-20 -115.02 -178.35 3.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.681 -0.637 . . . . 11.949999999999999 109.671 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -60.63 -4.04 0.84 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.573 -0.705 . . . . 12.32 110.163 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.456 ' H ' ' HG3' ' A' ' 89' ' ' GLU . . . 93.95 72.49 1.18 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.062 -1.615 . . . . 11.16 109.062 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.5 t -82.41 85.18 6.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -1.11 . . . . 11.800000000000001 109.676 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -60.05 -40.99 91.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.411 -0.806 . . . . 10.779999999999999 109.465 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.158 -0.964 . . . . 13.119999999999999 108.585 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.27 0.557 . . . . 4.8099999999999996 109.729 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.24 153.56 48.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.596 -0.69 . . . . 1.71 109.247 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.6 m -130.05 159.91 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.609 -0.682 . . . . 1.79 109.605 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' A' ' 4' ' ' LYS . 8.3 pttm -58.99 119.08 34.81 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 3.6899999999999999 108.859 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.2 Cg_exo -44.54 121.15 3.09 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.516 1.477 . . . . 0.72999999999999998 111.295 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -42.25 -12.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.248 1.966 . . . . 0.83999999999999997 113.767 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.6 m-85 -68.16 141.94 55.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.72 -1.238 . . . . 1.1499999999999999 109.712 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 m -74.38 163.07 28.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 1.3899999999999999 109.362 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -59.99 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.948 . . . . 1.3200000000000001 109.518 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.44 -40.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.075 -1.016 . . . . 0.95999999999999996 109.055 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.19 87.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.38 109.945 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.41 -40.12 89.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.37 109.544 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.68 -40.05 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.42 -0.955 . . . . 0.48999999999999999 108.42 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -60.92 -39.99 91.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.712 . . . . 0.39000000000000001 109.78 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.459 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 65.4 mtt -68.94 -39.39 79.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 1.1399999999999999 110.0 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.12 83.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.32000000000000001 109.88 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.44 -49.97 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.33000000000000002 109.5 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.65 -40.02 84.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.797 -0.564 . . . . 1.8200000000000001 110.482 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 15' ' ' MET . 4.2 m-80 -70.23 -15.43 62.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 1.6699999999999999 110.414 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 146.67 69.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.63 109.26 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.86 -44.44 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.738 1.625 . . . . 1.29 109.968 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -106.19 126.52 52.32 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.459 -1.312 . . . . 2.6299999999999999 107.459 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -58.56 -24.57 61.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.989 -1.069 . . . . 2.02 108.748 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -80.08 84.98 5.71 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.289 -1.004 . . . . 1.55 108.289 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.3 tt -107.03 147.66 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.568 -0.708 . . . . 0.46999999999999997 109.102 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -79.18 154.96 28.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.81000000000000005 110.452 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.04 -47.53 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.594 0.711 . . . . 0.69999999999999996 109.75 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.54 -39.9 89.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 1.25 110.341 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.07 96.56 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.232 -0.917 . . . . 0.28999999999999998 111.158 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.14 -39.91 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.832 -1.393 . . . . 0.34999999999999998 109.434 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 1.3999999999999999 109.528 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -61.6 -40.02 93.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 2.5099999999999998 109.702 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.91 -43.7 94.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.581 -0.7 . . . . 1.3700000000000001 111.32 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.98 -40.71 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.798 -1.189 . . . . 0.58999999999999997 111.519 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.12 -39.94 78.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.89 -1.131 . . . . 0.68999999999999995 110.301 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 96.2 m-20 -71.31 -46.95 59.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.918 -1.114 . . . . 1.1699999999999999 109.854 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -69.76 -35.44 74.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 3.0 110.366 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' C ' ' H ' ' A' ' 40' ' ' PHE . 90.9 m-85 -128.7 79.96 73.46 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.345 -0.847 . . . . 1.54 109.854 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.31 -6.07 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.84 2.36 . . . . 1.21 111.718 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -60.08 -39.5 86.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 3.7400000000000002 109.459 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.96 -24.1 63.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.565 -0.709 . . . . 1.1200000000000001 111.125 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.3 mtt-85 -59.55 -40.09 86.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.815 -1.178 . . . . 2.5099999999999998 109.738 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.93 -19.11 65.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.009 -1.057 . . . . 2.3399999999999999 109.992 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -133.54 97.56 3.97 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.012 -0.736 . . . . 2.0099999999999998 109.012 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 62.7 mttp -88.56 -45.71 9.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 1.6799999999999999 110.717 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.15 144.3 34.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 3.98 110.121 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.91 -58.04 0.4 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.302 -1.119 . . . . 0.78000000000000003 110.302 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.472 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.5 p-90 -89.19 -13.5 38.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.028 -1.278 . . . . 0.44 109.962 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -60.26 -50.0 75.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.14 -0.975 . . . . 1.96 111.487 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -75.88 -36.77 59.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 1.28 111.671 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 94.0 p -57.84 -23.07 51.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.988 -1.07 . . . . 1.49 110.836 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mm -75.74 -68.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.963 -1.086 . . . . 0.64000000000000001 110.727 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.575 ' CG ' HH11 ' A' ' 53' ' ' ARG . 0.0 OUTLIER -68.49 -27.01 65.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.114 -0.991 . . . . 2.7599999999999998 110.693 -178.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.01 -42.01 93.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 2.48 108.655 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 57' ' ' SER . 96.5 m-20 -62.52 -40.12 95.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.454 -0.779 . . . . 2.0699999999999998 109.61 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.29 59.21 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 0.78000000000000003 109.159 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' ASN . 40.1 t -159.97 -54.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.264 -0.897 . . . . 1.6000000000000001 109.564 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.6 mp -65.85 -40.1 91.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 1.3799999999999999 109.772 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -69.43 127.95 34.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.125 -0.984 . . . . 1.4199999999999999 108.797 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.96 -1.71 58.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.511 -0.743 . . . . 2.1699999999999999 109.373 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.8 m -64.81 -39.91 94.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 1.5600000000000001 109.195 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -84.18 134.0 34.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 1.3200000000000001 109.264 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 129.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.784 . . . . 0.91000000000000003 109.175 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.0 139.56 57.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 1.8100000000000001 109.041 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.69 123.42 31.3 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.638 -0.875 . . . . 1.28 108.638 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.12 -168.84 0.35 Allowed 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.07 1.18 . . . . 1.6499999999999999 111.873 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.6 ' NH1' ' CE1' ' A' ' 77' ' ' TYR . 24.2 mtt-85 -128.51 149.99 50.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.436 -0.79 . . . . 4.0899999999999999 109.686 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 8.5 t70 -86.41 169.05 13.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 2.8399999999999999 109.218 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 83.1 m-20 -72.44 -22.66 61.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.502 -0.749 . . . . 3.46 110.001 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -60.0 -46.37 89.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.025 -1.047 . . . . 4.5 110.425 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.7 ttpp -137.65 112.15 9.05 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.365 -0.834 . . . . 5.1200000000000001 108.943 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -85.75 173.11 7.43 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.045 1.83 . . . . 3.6299999999999999 112.094 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.5 -166.87 20.17 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.424 -1.47 . . . . 3.1499999999999999 109.424 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.587 ' O ' ' NH2' ' A' ' 67' ' ' ARG . 97.8 mttt -99.38 123.82 43.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -1.092 . . . . 4.3600000000000003 110.844 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.502 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . 65.27 -125.27 29.18 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.096 -1.202 . . . . 2.0299999999999998 110.096 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.545 ' N ' ' NH2' ' A' ' 67' ' ' ARG . 7.9 p -139.92 149.58 43.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.46 -1.023 . . . . 1.8 109.027 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.6 ' CE1' ' NH1' ' A' ' 67' ' ' ARG . 32.7 m-85 -76.28 161.71 28.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.912 -1.117 . . . . 1.3899999999999999 108.485 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -118.73 140.27 50.2 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.663 0.745 . . . . 0.46000000000000002 110.518 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -148.17 155.5 41.47 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.257 -1.016 . . . . 0.56000000000000005 108.257 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.78 -39.98 90.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.894 -1.129 . . . . 1.4199999999999999 109.662 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -167.21 143.49 3.61 Favored Pre-proline 0 C--N 1.296 -1.753 0 O-C-N 121.631 -0.668 . . . . 3.7200000000000002 109.219 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -53.25 -79.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.262 1.308 . . . . 3.5499999999999998 112.194 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 48.2 t0 -162.08 42.62 0.14 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.536 -1.283 . . . . 6.8200000000000003 107.536 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.1 m -45.37 110.0 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.67 -0.644 . . . . 6.0 109.854 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.499 ' CD1' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -89.95 -76.67 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.304 -0.872 . . . . 11.0 108.961 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -99.25 2.18 45.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.438 -0.789 . . . . 10.0 110.441 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 73.1 mtm -90.93 115.35 27.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 8.4700000000000006 109.235 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -68.9 -36.07 77.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 11.970000000000001 108.717 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -69.71 160.11 32.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.463 -0.773 . . . . 11.949999999999999 109.479 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.96 44.68 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 12.32 110.781 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.39 -2.65 86.58 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.201 -1.159 . . . . 11.16 110.201 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.0 p -59.96 -38.65 83.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.311 . . . . 11.800000000000001 108.749 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -84.26 126.25 32.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.821 . . . . 10.779999999999999 109.372 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.345 -0.983 . . . . 13.119999999999999 108.345 179.502 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.259 0.552 . . . . 4.8099999999999996 109.6 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.84 145.2 43.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.813 . . . . 1.71 109.619 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.99 160.04 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.691 . . . . 1.79 109.459 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 10.1 mptt -76.53 149.88 81.64 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 3.6899999999999999 109.551 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.18 161.25 45.12 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.658 2.239 . . . . 0.72999999999999998 111.589 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.67 27.66 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.388 2.059 . . . . 0.83999999999999997 113.299 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -100.42 133.59 44.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.878 -1.139 . . . . 1.1499999999999999 108.839 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -70.31 161.83 29.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 1.3899999999999999 108.914 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -59.23 -43.05 92.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.98 -1.075 . . . . 1.3200000000000001 108.307 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.462 ' HA ' HD12 ' A' ' 13' ' ' ILE . 81.9 mt -65.15 -40.02 87.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.606 -0.887 . . . . 0.95999999999999996 108.606 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.97 98.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 0.38 109.862 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.01 -40.14 88.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.913 -1.117 . . . . 0.37 108.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.691 HD11 HG23 ' A' ' 52' ' ' ILE . 96.4 mt -62.91 -42.14 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.44 -0.787 . . . . 0.48999999999999999 108.886 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -60.79 -43.21 98.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.722 -0.611 . . . . 0.39000000000000001 110.553 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.558 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.8 mtm -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.915 -1.116 . . . . 1.1399999999999999 109.426 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 19' ' ' ASN . . . -50.37 -52.34 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.538 -0.726 . . . . 0.32000000000000001 109.898 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.02 -44.29 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.33000000000000002 109.368 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.1 -46.14 90.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.656 . . . . 1.8200000000000001 111.187 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 15' ' ' MET . 18.9 p30 -90.04 11.05 21.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.991 -1.068 . . . . 1.6699999999999999 110.474 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.29 120.39 80.94 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 0.63 108.83 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -41.77 -38.22 4.42 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.443 1.429 . . . . 1.29 110.993 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -112.93 137.23 51.63 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.817 -1.179 . . . . 2.6299999999999999 107.817 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -60.02 -39.97 87.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.967 -1.083 . . . . 2.02 108.502 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -82.15 129.15 34.75 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.163 -1.051 . . . . 1.55 108.163 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.12 146.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.206 -0.934 . . . . 0.46999999999999997 110.158 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.77 160.0 26.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.519 -0.738 . . . . 0.81000000000000005 110.278 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.07 -48.41 81.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.636 -0.875 . . . . 0.69999999999999996 108.636 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.78 -39.91 90.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 1.25 109.89 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.89 95.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.456 -1.058 . . . . 0.28999999999999998 110.456 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.12 -42.54 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.322 . . . . 0.34999999999999998 109.74 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -62.1 -40.1 94.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 1.3999999999999999 110.736 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.2 tt0 -60.4 -40.17 90.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.953 -1.092 . . . . 2.5099999999999998 109.614 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 65.6 t80 -60.09 -46.85 88.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 1.3700000000000001 111.168 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.04 -49.83 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.046 -1.034 . . . . 0.58999999999999997 110.826 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtm -61.86 -40.0 93.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.854 -1.153 . . . . 0.68999999999999995 110.105 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.65 -39.92 93.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 1.1699999999999999 110.921 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.458 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.1 OUTLIER -79.99 -67.69 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.885 -1.134 . . . . 3.0 110.103 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 23.7 m-85 -92.09 115.69 65.11 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 1.54 109.004 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.72 -7.81 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.176 1.918 . . . . 1.21 113.278 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 1.1 m-85 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.122 . . . . 3.7400000000000002 109.341 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -67.83 -26.78 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.574 -0.704 . . . . 1.1200000000000001 110.848 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.02 -40.01 87.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.004 . . . . 2.5099999999999998 109.477 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -71.41 -9.31 57.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 2.3399999999999999 109.214 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 57.5 t-20 -141.51 99.53 3.58 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.049 -0.723 . . . . 2.0099999999999998 109.049 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.539 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 65.0 mttm -96.66 -21.48 17.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 1.6799999999999999 110.911 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -90.66 136.36 33.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.765 -1.209 . . . . 3.98 110.86 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -75.15 0.23 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.594 -1.003 . . . . 0.78000000000000003 110.594 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.539 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.6 p-90 -62.42 -37.46 85.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.265 -1.138 . . . . 0.44 110.898 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 56.9 tt0 -59.83 -50.33 74.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 1.96 111.661 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.912 -1.118 . . . . 1.28 112.272 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.7 m -59.95 -40.09 87.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.863 -1.148 . . . . 1.49 112.217 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.691 HG23 HD11 ' A' ' 13' ' ' ILE . 11.1 mt -61.89 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.629 -1.294 . . . . 0.64000000000000001 110.691 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -69.18 -29.26 67.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.401 -1.437 . . . . 2.7599999999999998 109.199 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -69.59 -37.2 76.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.044 -1.465 . . . . 2.48 107.044 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.59 -36.35 78.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.688 -0.632 . . . . 2.0699999999999998 109.317 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 56' ' ' LEU . 82.4 mt -59.99 -42.01 93.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.78000000000000003 110.558 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -60.04 -46.86 88.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 1.6000000000000001 109.87 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 58' ' ' LEU . 10.1 mp -69.98 -37.86 75.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 1.3799999999999999 109.439 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -75.8 111.99 11.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.19 -0.944 . . . . 1.4199999999999999 109.269 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.03 -9.8 52.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 2.1699999999999999 109.626 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 62' ' ' PHE . 30.1 p -60.06 -35.9 76.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 1.5600000000000001 109.412 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.413 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 74.8 m-85 -78.1 147.42 34.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 1.3200000000000001 108.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.47 130.64 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.466 -0.771 . . . . 0.91000000000000003 110.826 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -76.25 158.67 31.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 1.8100000000000001 109.176 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.8 t -134.64 84.26 39.86 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.389 -0.82 . . . . 1.28 108.994 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.5 136.19 26.39 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.655 2.237 . . . . 1.6499999999999999 112.685 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 73' ' ' GLY . 34.4 ptt180 -87.34 149.8 24.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 4.0899999999999999 109.058 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.15 139.26 58.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.948 -1.095 . . . . 2.8399999999999999 109.409 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.42 -39.98 92.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 3.46 110.276 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -63.66 -40.11 96.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.922 -1.111 . . . . 4.5 110.424 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -88.8 115.93 64.88 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.801 -1.187 . . . . 5.1200000000000001 108.471 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -77.12 105.78 2.13 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.502 1.468 . . . . 3.6299999999999999 111.912 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.518 ' O ' ' NH1' ' A' ' 67' ' ' ARG . . . -100.55 -158.99 27.87 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.543 -1.423 . . . . 3.1499999999999999 109.543 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -104.46 19.77 19.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.465 -1.02 . . . . 4.3600000000000003 109.559 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' H ' HH11 ' A' ' 67' ' ' ARG . . . 116.53 -166.11 12.35 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.115 -1.194 . . . . 2.0299999999999998 110.115 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.0 t -78.58 145.56 34.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.391 -1.064 . . . . 1.8 109.551 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -104.3 162.15 13.45 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.954 -0.758 . . . . 1.3899999999999999 108.954 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -117.96 140.01 50.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.509 -0.744 . . . . 0.46000000000000002 109.589 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -144.09 159.93 41.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.318 -0.864 . . . . 0.56000000000000005 109.507 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt -76.97 161.21 28.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 1.4199999999999999 109.302 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.549 ' O ' ' O ' ' A' ' 82' ' ' PRO . 6.1 m-20 -62.2 157.19 55.19 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.596 -0.89 . . . . 3.7200000000000002 108.596 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 81' ' ' ASP . 74.6 Cg_exo -49.69 -135.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.258 1.972 . . . . 3.5499999999999998 112.817 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.91 -47.28 86.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.435 -1.416 . . . . 6.8200000000000003 108.888 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 84' ' ' SER . 3.5 t -179.97 44.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.678 -0.86 . . . . 6.0 108.678 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -62.15 -39.85 94.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.153 -0.967 . . . . 11.0 108.889 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 88' ' ' PHE . 9.9 t-20 -134.82 27.11 3.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 10.0 109.793 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 7.7 mmt -73.85 15.81 0.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 8.4700000000000006 109.146 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' H ' ' C ' ' A' ' 86' ' ' ASN . 73.2 m-85 -89.49 35.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.982 -0.747 . . . . 11.970000000000001 108.982 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 91' ' ' GLY . 10.0 pt-20 -69.86 169.99 12.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 11.949999999999999 109.37 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -65.96 1.5 1.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.878 . . . . 12.32 109.691 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 89' ' ' GLU . . . -92.26 -146.75 19.39 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.972 -1.651 . . . . 11.16 108.972 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 m -173.47 120.36 0.32 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.469 -1.018 . . . . 11.800000000000001 109.671 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE2' ' O ' ' A' ' 94' ' ' LEU . 72.7 t80 -82.06 130.03 34.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.121 -0.987 . . . . 10.779999999999999 109.151 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 58.8 tp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 13.119999999999999 109.212 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.599 0.714 . . . . 4.8099999999999996 109.19 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.5 mt -69.8 143.16 53.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.5 -0.75 . . . . 1.71 109.321 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.98 159.95 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.648 -0.871 . . . . 1.79 108.648 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -56.25 114.57 7.9 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.011 . . . . 3.6899999999999999 109.013 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -40.93 154.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.006 1.804 . . . . 0.72999999999999998 112.577 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.72 30.22 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.507 2.138 . . . . 0.83999999999999997 111.981 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.31 133.94 53.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.429 -0.794 . . . . 1.1499999999999999 108.871 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -65.67 160.79 21.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 1.3899999999999999 108.279 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.886 -1.134 . . . . 1.3200000000000001 108.221 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.17 -41.36 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 0.95999999999999996 109.154 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.72 96.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.38 109.579 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.96 -41.4 91.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 0.37 108.403 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.3 mt -70.01 -41.9 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.379 -0.826 . . . . 0.48999999999999999 109.453 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -60.2 -40.02 88.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.39000000000000001 110.139 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.5 mtm -70.02 -37.48 75.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 1.1399999999999999 110.028 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.17 90.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.32000000000000001 110.185 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.93 -49.98 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.33000000000000002 109.071 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.79 -38.57 86.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.473 0.654 . . . . 1.8200000000000001 109.71 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.438 HD21 ' HZ ' ' A' ' 33' ' ' PHE . 74.5 m-20 -77.12 1.04 19.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 1.6699999999999999 109.49 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.35 149.9 76.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.187 -0.946 . . . . 0.63 108.705 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -37.33 -73.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.193 1.929 . . . . 1.29 112.59 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.1 -79.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.032 -1.042 . . . . 2.6299999999999999 110.187 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -165.5 -34.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 2.02 108.997 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' NZ ' ' OD2' ' A' ' 83' ' ' ASP . 63.1 mttp -88.53 138.38 31.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.276 -0.89 . . . . 1.55 109.805 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -140.81 153.8 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.19 -0.944 . . . . 0.46999999999999997 109.913 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.7 p -86.01 166.08 16.17 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.332 -0.855 . . . . 0.81000000000000005 110.474 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 27' ' ' LEU . 20.2 tp -60.15 -51.59 68.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.872 -1.159 . . . . 0.69999999999999996 107.872 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.85 -40.01 91.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.782 -0.574 . . . . 1.25 110.445 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -40.02 95.39 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.122 -1.037 . . . . 0.28999999999999998 110.543 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.51 -43.85 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.02 -1.282 . . . . 0.34999999999999998 110.363 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.561 ' O ' ' SD ' ' A' ' 35' ' ' MET . 39.9 m-85 -60.01 -46.64 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.986 . . . . 1.3999999999999999 111.989 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.93 -39.29 84.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.771 -1.205 . . . . 2.5099999999999998 110.076 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.438 ' HZ ' HD21 ' A' ' 19' ' ' ASN . 78.7 t80 -60.01 -40.01 87.79 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.309 -0.87 . . . . 1.3700000000000001 110.427 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.49 -48.54 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.99 -1.068 . . . . 0.58999999999999997 111.911 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . 0.561 ' SD ' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -60.05 -39.96 87.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.559 -1.338 . . . . 0.68999999999999995 110.231 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 88.2 m-20 -68.43 -40.06 81.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.935 -1.103 . . . . 1.1699999999999999 110.429 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -67.69 -40.01 84.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 3.0 110.27 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.38 122.59 21.02 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.347 -0.845 . . . . 1.54 109.011 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.32 -6.07 16.8 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.55 1.5 . . . . 1.21 111.11 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.07 -44.74 94.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.809 -0.557 . . . . 3.7400000000000002 110.733 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.38 -23.81 64.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.983 -1.073 . . . . 1.1200000000000001 111.012 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 64.3 mtt-85 -60.07 -40.05 88.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.84 -1.163 . . . . 2.5099999999999998 109.393 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.15 -40.01 94.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.883 . . . . 2.3399999999999999 110.6 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -116.33 112.69 21.9 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.118 -0.697 . . . . 2.0099999999999998 109.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.2 mttt -95.55 -66.39 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 1.6799999999999999 110.438 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -65.33 144.25 57.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 3.98 109.946 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.15 -62.72 0.32 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.582 -1.007 . . . . 0.78000000000000003 110.582 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 41.9 p-90 -80.86 -12.79 59.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.899 -1.353 . . . . 0.44 110.469 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -70.01 -41.47 74.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 1.96 110.848 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -70.08 -38.28 75.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.32 -0.863 . . . . 1.28 111.352 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.441 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 23.8 t -59.97 -41.14 91.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.954 -1.091 . . . . 1.49 110.662 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.8 mm -59.97 -50.05 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.082 -1.011 . . . . 0.64000000000000001 110.677 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -63.03 -39.32 94.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.975 -1.078 . . . . 2.7599999999999998 109.616 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.537 ' NE2' HD11 ' A' ' 58' ' ' LEU . 19.8 t60 -60.04 -39.98 87.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.38 -0.825 . . . . 2.48 108.797 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.441 ' ND2' ' O ' ' A' ' 51' ' ' SER . 19.2 m-80 -66.58 -39.91 88.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 2.0699999999999998 109.502 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.48 -39.99 89.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.952 . . . . 0.78000000000000003 110.282 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -71.2 -39.95 71.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.937 -1.102 . . . . 1.6000000000000001 110.868 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD11 ' NE2' ' A' ' 54' ' ' HIS . 79.1 mt -68.73 -39.99 80.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.074 -1.017 . . . . 1.3799999999999999 112.049 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -62.02 118.4 7.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.691 -1.255 . . . . 1.4199999999999999 110.432 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -84.22 -31.61 24.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 2.1699999999999999 109.622 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p -66.24 -9.18 29.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 1.5600000000000001 108.965 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -89.85 138.46 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 1.3200000000000001 107.907 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -123.84 129.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.303 -0.873 . . . . 0.91000000000000003 110.469 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.2 147.66 38.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.834 . . . . 1.8100000000000001 108.956 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' PRO . 15.5 t -139.98 64.5 27.66 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.059 -1.026 . . . . 1.28 109.556 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 65' ' ' VAL . 54.8 Cg_exo -35.52 162.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 123.013 2.475 . . . . 1.6499999999999999 113.375 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -59.79 -172.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.36 -0.837 . . . . 4.0899999999999999 108.847 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 28.7 t0 -80.0 166.68 21.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 2.8399999999999999 108.999 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 85.9 m-20 -79.11 -14.36 59.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 3.46 109.96 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -60.56 -40.3 91.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 4.5 109.443 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.527 ' O ' ' O ' ' A' ' 72' ' ' PRO . 2.3 mppt? -86.56 150.43 51.13 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.235 -0.916 . . . . 5.1200000000000001 109.177 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 71' ' ' LYS . 88.6 Cg_exo -47.89 -131.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 122.689 2.26 . . . . 3.6299999999999999 113.402 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 72' ' ' PRO . . . -51.38 179.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.118 -1.593 . . . . 3.1499999999999999 109.118 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -136.18 154.61 50.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.26 -1.141 . . . . 4.3600000000000003 109.706 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.83 -122.95 1.11 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.22 -1.952 . . . . 2.0299999999999998 108.22 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -155.28 100.83 2.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.932 -1.334 . . . . 1.8 109.712 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -82.56 160.0 22.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.413 -0.805 . . . . 1.3899999999999999 108.828 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -141.89 131.43 23.91 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.052 -1.03 . . . . 0.46000000000000002 110.903 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -155.04 150.94 27.81 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.897 -0.779 . . . . 0.56000000000000005 108.897 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.25 -40.07 88.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.97 -1.081 . . . . 1.4199999999999999 109.332 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -154.13 173.13 4.99 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.242 -1.022 . . . . 3.7200000000000002 108.242 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.82 173.05 14.12 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.784 1.656 . . . . 3.5499999999999998 111.495 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.533 ' OD2' ' NZ ' ' A' ' 24' ' ' LYS . 97.2 m-20 -84.58 63.81 8.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.958 -1.127 . . . . 6.8200000000000003 107.958 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.3 t -51.74 -30.05 21.06 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.662 -0.649 . . . . 6.0 109.592 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -64.65 -20.8 66.5 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.025 -1.047 . . . . 11.0 108.999 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -84.25 -0.91 54.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.494 -0.754 . . . . 10.0 110.863 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.3 mtm -70.38 152.4 44.14 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.172 -0.955 . . . . 8.4700000000000006 109.675 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -60.09 -42.8 95.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.642 -0.661 . . . . 11.970000000000001 110.728 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.87 142.44 58.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.948 -1.095 . . . . 11.949999999999999 109.848 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -148.98 154.08 38.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.309 -0.869 . . . . 12.32 110.227 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.57 -55.24 4.99 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.861 -1.296 . . . . 11.16 109.861 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -167.09 122.17 1.07 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.234 -1.156 . . . . 11.800000000000001 108.973 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 93' ' ' PHE . 7.8 p90 -111.39 94.15 4.83 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.663 -0.648 . . . . 10.779999999999999 109.614 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.448 HD12 ' N ' ' A' ' 94' ' ' LEU . 10.7 mp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 13.119999999999999 108.807 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.344 -0.613 . . . . 4.8099999999999996 109.344 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.33 140.0 39.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.459 -0.776 . . . . 1.71 109.419 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 m -143.86 148.72 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -0.806 . . . . 1.79 109.911 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -70.92 149.99 95.02 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 3.6899999999999999 108.908 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.03 160.31 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.2 1.933 . . . . 0.72999999999999998 111.669 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.4 26.61 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.418 2.079 . . . . 0.83999999999999997 113.565 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.55 137.92 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.848 -1.157 . . . . 1.1499999999999999 108.372 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 m -77.57 166.41 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 1.3899999999999999 108.947 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -59.94 -37.87 80.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.082 . . . . 1.3200000000000001 108.354 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.0 mm -61.13 -46.48 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.95999999999999996 109.338 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.71 95.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.38 110.786 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.2 mt -59.93 -40.05 87.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.154 . . . . 0.37 108.599 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.41 -44.84 94.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 0.48999999999999999 108.336 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -67.44 -40.06 85.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.602 -0.686 . . . . 0.39000000000000001 110.738 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.4 mtt -66.7 -39.91 88.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 1.1399999999999999 109.148 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -50.04 75.27 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.537 -0.727 . . . . 0.32000000000000001 110.107 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 80' ' ' LEU . 80.9 mt -60.46 -50.0 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 0.33000000000000002 109.509 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -40.0 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.664 -0.647 . . . . 1.8200000000000001 110.576 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 31.0 m120 -82.05 1.27 36.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 1.6699999999999999 109.87 -179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.42 149.05 74.86 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 0.63 108.634 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 -32.22 91.17 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.614 1.543 . . . . 1.29 109.806 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -124.21 139.99 53.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.797 -1.186 . . . . 2.6299999999999999 107.797 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -60.07 -38.99 84.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.02 -1.05 . . . . 2.02 108.585 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -77.97 120.18 22.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.926 -1.139 . . . . 1.55 107.926 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.73 148.87 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.248 -0.907 . . . . 0.46999999999999997 109.971 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.3 p -79.83 160.0 26.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -0.772 . . . . 0.81000000000000005 110.89 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -66.32 -39.99 89.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.756 -0.831 . . . . 0.69999999999999996 108.756 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.91 -40.0 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 1.25 109.672 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.72 -38.51 96.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.344 -1.102 . . . . 0.28999999999999998 110.344 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.99 -42.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 0.34999999999999998 109.933 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -60.0 -39.11 84.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.959 -1.088 . . . . 1.3999999999999999 109.588 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.36 91.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.045 -1.035 . . . . 2.5099999999999998 108.882 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.95 -47.59 85.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 1.3700000000000001 110.431 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.446 HG21 ' CZ3' ' A' ' 48' ' ' TRP . 2.1 mp -61.73 -49.66 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 0.58999999999999997 110.276 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.6 mtm -60.07 -39.91 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.808 -1.183 . . . . 0.68999999999999995 109.889 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.09 -51.85 19.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 1.1699999999999999 109.431 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.11 -50.0 75.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 3.0 109.312 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.57 110.66 38.66 Favored Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 108.812 -0.81 . . . . 1.54 108.812 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.51 -7.33 12.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.982 1.788 . . . . 1.21 112.514 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -60.57 -40.0 90.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.915 . . . . 3.7400000000000002 109.605 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.06 -17.82 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.693 -0.629 . . . . 1.1200000000000001 110.777 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.63 -43.17 93.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 2.5099999999999998 108.46 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.17 -43.74 97.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.337 -0.852 . . . . 2.3399999999999999 109.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -102.58 99.02 8.99 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.175 -0.676 . . . . 2.0099999999999998 109.175 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -94.51 -42.56 8.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 1.6799999999999999 109.476 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -81.29 149.5 28.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 3.98 109.494 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -73.34 0.28 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.133 -1.187 . . . . 0.78000000000000003 110.133 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.446 ' CZ3' HG21 ' A' ' 34' ' ' ILE . 20.6 p-90 -69.49 -38.73 77.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.44 110.664 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -60.04 -42.07 93.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 1.96 110.721 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -70.04 -39.57 75.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 1.28 110.826 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -0.948 . . . . 1.49 111.259 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.7 mm -60.0 -50.01 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.835 -1.166 . . . . 0.64000000000000001 110.126 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -60.35 -49.62 76.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.082 . . . . 2.7599999999999998 109.44 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.143 -1.058 . . . . 2.48 108.143 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -62.07 -40.34 95.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.473 -0.767 . . . . 2.0699999999999998 109.097 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.84 -40.06 94.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 0.78000000000000003 110.456 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.7 m -69.5 -46.84 65.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.983 -1.073 . . . . 1.6000000000000001 110.43 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.59 -39.98 88.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 1.3799999999999999 110.245 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -75.29 117.54 17.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 1.4199999999999999 109.752 -179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.59 -2.41 57.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 2.1699999999999999 109.352 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -60.36 -39.94 88.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 1.5600000000000001 109.591 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -79.71 152.8 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 1.3200000000000001 109.351 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.7 t -112.7 127.46 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.473 -0.767 . . . . 0.91000000000000003 109.393 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -68.98 145.76 53.32 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.28 -1.007 . . . . 1.8100000000000001 108.28 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 t -137.39 76.97 42.11 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.144 -0.972 . . . . 1.28 109.715 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -50.64 160.81 1.54 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.62 2.214 . . . . 1.6499999999999999 111.881 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -83.48 166.45 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 4.0899999999999999 109.012 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -77.55 166.48 23.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 2.8399999999999999 109.745 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.05 -36.45 79.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.542 -0.724 . . . . 3.46 110.882 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -59.99 -40.66 89.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 4.5 110.127 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -84.13 149.52 55.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.924 -1.11 . . . . 5.1200000000000001 108.702 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.46 141.16 97.04 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.803 1.668 . . . . 3.6299999999999999 111.397 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.18 80.58 0.49 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 120.101 -1.047 . . . . 3.1499999999999999 110.609 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 75' ' ' GLY . 66.2 mttm -113.42 130.1 56.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.481 -1.011 . . . . 4.3600000000000003 109.697 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 74' ' ' LYS . . . 36.26 -152.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 111.026 -0.829 . . . . 2.0299999999999998 111.026 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.2 t -155.76 140.04 16.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.539 -0.977 . . . . 1.8 108.445 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -77.85 154.89 31.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.692 -1.255 . . . . 1.3899999999999999 108.273 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -119.95 140.03 51.54 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.758 0.79 . . . . 0.46000000000000002 110.716 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 t -139.62 162.24 35.58 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.769 -0.826 . . . . 0.56000000000000005 108.769 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 17' ' ' ILE . 2.2 mp -99.2 16.06 24.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.142 -0.974 . . . . 1.4199999999999999 110.445 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -149.35 152.58 35.96 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 120.837 -1.164 . . . . 3.7200000000000002 111.005 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.55 -153.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.525 2.15 . . . . 3.5499999999999998 111.783 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' TYR . 42.7 t0 -79.94 71.4 6.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.958 -1.089 . . . . 6.8200000000000003 108.46 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 84' ' ' SER . 5.7 p -59.3 85.83 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.798 0.809 . . . . 6.0 109.312 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' ASP . 49.2 t80 -82.96 -39.58 21.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 11.0 110.964 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -138.54 29.74 2.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.0 -1.063 . . . . 10.0 110.009 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.617 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -52.91 140.45 24.53 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.272 -0.893 . . . . 8.4700000000000006 109.179 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -59.15 -107.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 11.970000000000001 109.752 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 89' ' ' GLU . 3.5 pm0 -103.8 20.14 18.63 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.277 -0.889 . . . . 11.949999999999999 110.01 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -90.89 31.35 1.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 12.32 109.455 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -153.47 -113.91 0.53 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.674 -1.371 . . . . 11.16 109.674 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.4 p -147.04 117.61 7.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -1.195 . . . . 11.800000000000001 109.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.524 ' CD2' ' O ' ' A' ' 93' ' ' PHE . 25.0 p90 -94.75 115.39 27.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.363 -0.835 . . . . 10.779999999999999 109.192 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.166 -0.959 . . . . 13.119999999999999 109.717 -179.682 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mtp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.55 0.691 . . . . 4.8099999999999996 109.331 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.2 mt -74.25 140.63 45.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.368 -0.832 . . . . 1.71 109.689 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.05 144.11 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.791 -0.818 . . . . 1.79 108.791 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -70.01 148.5 96.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.854 -1.154 . . . . 3.6899999999999999 108.539 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 50.2 Cg_endo -83.21 124.76 3.83 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.927 1.751 . . . . 0.72999999999999998 112.133 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.03 -12.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.555 2.17 . . . . 0.83999999999999997 114.142 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 14.4 m-85 -62.43 140.07 58.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.534 -1.354 . . . . 1.1499999999999999 109.519 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -79.63 168.23 19.65 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.833 -1.173 . . . . 1.3899999999999999 107.833 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -60.39 -39.91 89.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.902 -1.124 . . . . 1.3200000000000001 109.095 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.467 ' CD1' ' OD1' ' A' ' 55' ' ' ASN . 38.8 mm -62.18 -41.1 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.95999999999999996 109.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.97 85.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.38 110.154 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.1 -40.06 88.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 0.37 108.972 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.54 -40.05 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.48999999999999999 109.132 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.31 -39.96 96.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.573 -0.704 . . . . 0.39000000000000001 110.488 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.436 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.5 mtt -65.35 -39.95 92.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 1.1399999999999999 110.078 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.65 80.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.352 -0.843 . . . . 0.32000000000000001 109.591 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.23 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 0.33000000000000002 109.247 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.01 -40.14 88.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.413 0.625 . . . . 1.8200000000000001 110.125 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 15' ' ' MET . 69.4 m-80 -81.94 -0.12 42.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 1.6699999999999999 109.613 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.77 123.5 85.29 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.276 -0.89 . . . . 0.63 108.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -42.27 -48.23 6.71 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.44 1.426 . . . . 1.29 110.674 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -105.29 142.0 35.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.601 -1.259 . . . . 2.6299999999999999 107.601 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -60.02 -37.85 80.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.952 -1.092 . . . . 2.02 109.485 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.74 127.91 33.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.811 -1.181 . . . . 1.55 107.811 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.99 151.53 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 0.46999999999999997 109.532 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.2 p -81.38 156.92 25.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.246 -0.909 . . . . 0.81000000000000005 110.005 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.97 -48.3 82.28 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.745 0.783 . . . . 0.69999999999999996 110.04 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 1.25 110.2 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.49 91.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.403 -1.079 . . . . 0.28999999999999998 110.403 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.95 -42.98 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -1.209 . . . . 0.34999999999999998 110.771 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.851 -1.156 . . . . 1.3999999999999999 110.564 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.13 -39.26 85.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.153 -0.967 . . . . 2.5099999999999998 110.379 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -59.85 -49.3 78.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 1.3700000000000001 110.729 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.04 -49.92 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.0 -1.063 . . . . 0.58999999999999997 110.733 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.7 mtm -60.03 -40.12 88.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.874 -1.141 . . . . 0.68999999999999995 110.445 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.39 -45.22 94.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.928 -1.107 . . . . 1.1699999999999999 110.715 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 37' ' ' ARG . 49.0 mtt-85 -68.02 -48.38 65.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.911 -1.118 . . . . 3.0 111.192 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.14 125.28 26.27 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.158 -0.964 . . . . 1.54 110.521 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.22 -5.0 13.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.971 1.781 . . . . 1.21 110.707 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -60.01 -40.1 88.1 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.335 -0.617 . . . . 3.7400000000000002 109.335 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.05 -31.28 68.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 1.1200000000000001 109.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -60.06 -39.94 87.75 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.165 -0.959 . . . . 2.5099999999999998 109.204 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.26 -40.08 96.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 2.3399999999999999 110.132 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -110.55 101.37 10.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.175 -0.676 . . . . 2.0099999999999998 109.175 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 68.5 mttm -88.53 -40.65 13.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.094 -1.004 . . . . 1.6799999999999999 110.178 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -78.53 141.68 37.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.003 -1.061 . . . . 3.98 110.421 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.18 -60.37 0.33 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.188 -1.165 . . . . 0.78000000000000003 110.188 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.424 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 24.2 p-90 -88.85 -11.93 43.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -1.223 . . . . 0.44 110.239 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -69.85 -56.63 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 1.96 111.4 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.92 -38.75 76.33 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.253 -0.904 . . . . 1.28 112.327 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.5 m -59.99 -39.85 87.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.783 -1.198 . . . . 1.49 111.226 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.06 -68.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.954 -1.091 . . . . 0.64000000000000001 111.398 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -69.93 -33.13 71.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 2.7599999999999998 112.375 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -59.98 -40.16 88.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.342 -1.474 . . . . 2.48 107.676 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.467 ' OD1' ' CD1' ' A' ' 10' ' ' ILE . 21.8 t-20 -60.09 -40.53 89.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.614 -0.679 . . . . 2.0699999999999998 109.25 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.27 -40.14 95.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.997 -1.065 . . . . 0.78000000000000003 109.704 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -64.52 -49.75 70.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 1.6000000000000001 110.721 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.424 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.0 mp -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.882 -1.136 . . . . 1.3799999999999999 110.069 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.407 ' HA ' HD21 ' A' ' 59' ' ' ASN . 9.0 m120 -69.28 121.94 17.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 1.4199999999999999 110.505 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.5 -3.41 57.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.676 -0.861 . . . . 2.1699999999999999 108.676 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 1.5600000000000001 109.524 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -77.3 150.04 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.198 -0.939 . . . . 1.3200000000000001 109.068 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.5 t -111.05 129.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.534 -0.729 . . . . 0.91000000000000003 109.573 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -90.64 120.45 31.72 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.194 -1.039 . . . . 1.8100000000000001 108.194 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.79 127.22 31.7 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 120.807 -1.183 . . . . 1.28 109.326 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.46 151.09 28.91 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.855 1.703 . . . . 1.6499999999999999 112.008 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.503 ' NE ' ' O ' ' A' ' 74' ' ' LYS . 27.0 mtm180 -80.73 152.79 28.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 4.0899999999999999 109.742 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -80.64 164.91 22.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.413 -0.804 . . . . 2.8399999999999999 109.398 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' C ' ' N ' ' A' ' 71' ' ' LYS . 96.6 m-20 -60.03 -39.97 87.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 3.46 109.659 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -49.82 -15.21 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 4.5 109.145 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.446 ' N ' ' C ' ' A' ' 69' ' ' ASP . 57.0 mttp -125.72 79.94 67.32 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 108.688 -0.856 . . . . 5.1200000000000001 108.688 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.41 132.95 14.05 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.16 1.907 . . . . 3.6299999999999999 112.45 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.43 -99.59 0.24 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.285 -1.526 . . . . 3.1499999999999999 109.285 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 92.5 mttt -72.01 155.83 39.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -1.159 . . . . 4.3600000000000003 109.675 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.84 39.4 1.64 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.225 -1.55 . . . . 2.0299999999999998 109.225 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.4 p -157.67 152.23 25.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.25 . . . . 1.8 110.533 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -152.17 169.97 21.14 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.473 -1.306 . . . . 1.3899999999999999 107.473 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -132.89 124.97 28.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.252 -0.905 . . . . 0.46000000000000002 109.553 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -152.8 152.42 31.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.282 -0.886 . . . . 0.56000000000000005 109.751 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 81' ' ' ASP . 86.4 mt -78.17 163.49 25.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.816 . . . . 1.4199999999999999 108.949 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -50.84 177.97 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 3.7200000000000002 108.608 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.87 -145.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.939 1.759 . . . . 3.5499999999999998 111.686 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -80.8 57.95 3.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.116 -0.99 . . . . 6.8200000000000003 109.364 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 83.2 p -79.59 85.63 5.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.198 -0.939 . . . . 6.0 108.978 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.411 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.7 OUTLIER -90.04 -79.41 0.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 11.0 108.866 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.495 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 81.0 m-20 -96.06 6.14 49.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.276 -0.89 . . . . 10.0 109.201 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.512 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.4 OUTLIER -60.98 140.63 57.75 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.678 -0.639 . . . . 8.4700000000000006 109.593 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 86' ' ' ASN . 97.6 m-85 -113.55 106.36 14.45 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.588 -0.893 . . . . 11.970000000000001 108.588 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.05 -22.96 67.05 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.885 0.85 . . . . 11.949999999999999 108.99 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -99.97 19.27 16.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.629 -0.878 . . . . 12.32 108.629 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -155.66 -131.92 1.49 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.129 -1.588 . . . . 11.16 109.129 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.8 m -102.87 -159.6 0.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.26 -1.141 . . . . 11.800000000000001 108.918 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -106.11 -23.04 12.71 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.714 -0.616 . . . . 10.779999999999999 110.492 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.874 -1.141 . . . . 13.119999999999999 109.412 -179.528 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.174 0.512 . . . . 4.8099999999999996 109.655 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.3 mt -98.59 140.98 32.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.313 -0.867 . . . . 1.71 109.273 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.49 157.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 1.79 109.868 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 11.5 mptt -79.28 152.22 75.99 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 3.6899999999999999 108.94 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.15 160.0 48.43 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.169 1.913 . . . . 0.72999999999999998 111.709 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.17 20.93 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.739 2.293 . . . . 0.83999999999999997 113.773 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -96.01 137.73 34.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.632 -1.292 . . . . 1.1499999999999999 109.141 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.7 p -73.33 165.61 24.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 1.3899999999999999 108.667 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 1.3200000000000001 109.18 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.35 -39.9 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.95999999999999996 109.64 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.03 99.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 0.38 109.519 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.76 -39.96 90.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.37 108.584 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.449 HG21 HD21 ' A' ' 56' ' ' LEU . 96.6 mt -70.08 -42.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.546 -0.722 . . . . 0.48999999999999999 109.766 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -65.67 -41.3 92.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.39000000000000001 109.744 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.95 -33.87 72.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 1.1399999999999999 109.887 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.432 ' O ' ' OD1' ' A' ' 19' ' ' ASN . . . -60.05 -46.61 88.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 0.32000000000000001 109.783 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.03 -45.35 98.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.061 -1.024 . . . . 0.33000000000000002 109.807 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -63.15 -43.23 98.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.803 -0.561 . . . . 1.8200000000000001 112.178 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.679 ' ND2' ' CE1' ' A' ' 33' ' ' PHE . 44.9 p-10 -89.98 10.34 24.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.713 -1.242 . . . . 1.6699999999999999 110.085 -178.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.78 150.46 81.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 0.63 108.901 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.68 -24.89 65.3 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.732 1.622 . . . . 1.29 110.196 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -139.91 146.57 39.39 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.754 -1.202 . . . . 2.6299999999999999 107.754 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -59.97 -39.59 86.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.087 . . . . 2.02 108.885 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.06 129.35 34.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 1.55 109.273 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.9 tt -147.83 143.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.796 -0.816 . . . . 0.46999999999999997 108.796 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -80.02 163.18 24.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.81000000000000005 110.053 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.451 HD13 ' CD1' ' A' ' 56' ' ' LEU . 16.0 tp -59.93 -40.69 89.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.509 -0.744 . . . . 0.69999999999999996 109.094 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -60.59 -40.25 91.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.431 -0.793 . . . . 1.25 110.141 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.99 96.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.274 -1.131 . . . . 0.28999999999999998 110.274 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.48 -40.37 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -1.137 . . . . 0.34999999999999998 110.517 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.426 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 29.1 m-85 -60.02 -39.98 87.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.101 . . . . 1.3999999999999999 110.593 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -59.98 -40.0 87.65 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.949 -1.095 . . . . 2.5099999999999998 109.903 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.679 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 93.8 t80 -60.02 -49.91 75.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 1.3700000000000001 111.662 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.69 -49.95 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 0.58999999999999997 112.154 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 45.7 mtm -60.34 -40.04 89.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.706 -1.246 . . . . 0.68999999999999995 110.994 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -67.17 -48.65 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 1.1699999999999999 110.914 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -40.0 75.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.289 -0.882 . . . . 3.0 112.189 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -126.55 80.44 69.78 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.088 -1.007 . . . . 1.54 110.2 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.03 -9.85 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.95 2.433 . . . . 1.21 113.643 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.11 -37.51 80.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.633 -1.292 . . . . 3.7400000000000002 108.996 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -69.15 -28.03 66.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 1.1200000000000001 110.898 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -58.84 -39.97 82.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.654 -1.279 . . . . 2.5099999999999998 108.165 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.29 -40.0 86.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 2.3399999999999999 109.026 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.489 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 94.8 m-20 -99.92 101.02 12.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.226 -0.657 . . . . 2.0099999999999998 109.226 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 92.0 mttt -90.41 -78.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.06 -1.025 . . . . 1.6799999999999999 110.388 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.03 140.01 57.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 3.98 110.235 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.11 -58.2 0.54 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.66 -1.376 . . . . 0.78000000000000003 109.66 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.489 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 33.3 p-90 -89.69 -10.58 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -1.235 . . . . 0.44 110.807 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 77.9 mt-30 -68.64 -54.53 15.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.883 -1.136 . . . . 1.96 110.916 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -65.35 -34.8 79.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 1.28 110.948 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.1 p -59.51 -41.51 90.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.917 -1.114 . . . . 1.49 109.933 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.13 -50.03 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.64000000000000001 109.797 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 25.4 mtt180 -72.76 -38.84 67.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 2.7599999999999998 109.864 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.508 ' NE2' HD11 ' A' ' 58' ' ' LEU . 68.5 t60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 2.48 108.674 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -65.58 -40.01 92.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.389 -0.819 . . . . 2.0699999999999998 109.696 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.451 ' CD1' HD13 ' A' ' 27' ' ' LEU . 44.7 mt -60.53 -46.65 89.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.78000000000000003 111.291 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -64.66 -39.96 94.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.836 -1.165 . . . . 1.6000000000000001 110.704 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.508 HD11 ' NE2' ' A' ' 54' ' ' HIS . 43.9 mt -66.99 -37.38 84.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.993 -1.067 . . . . 1.3799999999999999 109.464 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -79.9 110.54 15.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 1.4199999999999999 109.608 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.91 -8.61 51.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.768 . . . . 2.1699999999999999 109.194 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.6 m -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.856 -1.165 . . . . 1.5600000000000001 107.856 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.24 127.63 32.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.845 -1.168 . . . . 1.3200000000000001 107.845 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 t -102.54 126.94 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.623 -0.88 . . . . 0.91000000000000003 108.623 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -97.46 117.84 32.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.868 . . . . 1.8100000000000001 110.031 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.68 149.48 54.22 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.127 -1.064 . . . . 1.28 108.127 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.45 -154.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.016 1.811 . . . . 1.6499999999999999 111.051 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -105.44 146.02 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 4.0899999999999999 109.757 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 30.2 t0 -89.87 -171.14 3.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 2.8399999999999999 110.249 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 79.4 m-20 -60.03 -39.98 87.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.457 -0.777 . . . . 3.46 109.976 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -80.69 57.19 2.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.26 -0.9 . . . . 4.5 109.509 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 114.64 50.7 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.76 -0.588 . . . . 5.1200000000000001 109.765 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -86.67 6.57 5.31 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.956 1.771 . . . . 3.6299999999999999 112.764 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.19 67.14 1.21 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.923 -1.271 . . . . 3.1499999999999999 109.923 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.36 177.97 7.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.224 -1.162 . . . . 4.3600000000000003 109.37 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.39 -163.1 5.45 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.163 -1.175 . . . . 2.0299999999999998 110.163 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.9 m -79.24 159.96 27.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -1.018 . . . . 1.8 109.416 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -92.06 135.48 33.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 1.3899999999999999 109.645 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -108.86 133.54 52.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.521 -0.737 . . . . 0.46000000000000002 109.657 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -153.76 163.96 39.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.56000000000000005 110.244 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -77.22 169.61 18.02 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.24 -1.022 . . . . 1.4199999999999999 108.24 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -46.07 140.2 5.14 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.0 -1.063 . . . . 3.7200000000000002 109.15 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.49 -163.55 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.114 1.876 . . . . 3.5499999999999998 112.723 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.0 72.62 7.41 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.69 -1.226 . . . . 6.8200000000000003 107.69 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.1 t -60.05 -37.0 78.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.632 -0.668 . . . . 6.0 109.694 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -59.93 -39.26 84.9 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.225 -0.922 . . . . 11.0 109.987 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -69.39 -7.27 36.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.95 . . . . 10.0 110.327 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.1 mmt -80.4 93.1 5.92 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.255 -0.903 . . . . 8.4700000000000006 109.729 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -80.17 -9.96 59.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 11.970000000000001 109.212 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -73.63 150.27 41.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 11.949999999999999 109.78 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -75.79 127.68 33.53 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.195 -0.941 . . . . 12.32 109.454 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.95 117.88 0.07 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.405 -1.478 . . . . 11.16 109.405 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.0 p -63.8 -37.75 88.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -1.103 . . . . 11.800000000000001 109.008 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -142.78 150.49 40.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.354 -0.841 . . . . 10.779999999999999 109.355 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 13.119999999999999 109.678 -179.69 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.443 -0.577 . . . . 4.8099999999999996 109.443 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.3 mt -83.51 144.93 29.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.157 -0.965 . . . . 1.71 109.719 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.05 159.99 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.046 -0.724 . . . . 1.79 109.046 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 pttm -75.67 118.7 72.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 3.6899999999999999 108.937 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.59 150.26 0.84 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.687 1.591 . . . . 0.72999999999999998 111.809 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.21 -12.57 32.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.257 1.971 . . . . 0.83999999999999997 111.809 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -60.5 134.55 57.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.216 -0.927 . . . . 1.1499999999999999 108.645 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 p -70.42 162.11 29.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.176 -1.046 . . . . 1.3899999999999999 108.176 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -58.47 -39.99 81.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 1.3200000000000001 108.101 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.56 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.411 -0.806 . . . . 0.95999999999999996 109.155 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.13 91.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 0.38 109.828 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.95 -40.01 87.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.053 -1.03 . . . . 0.37 108.59 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.97 -39.9 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.48999999999999999 109.105 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.76 -39.9 95.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 0.39000000000000001 110.016 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.48 -38.49 87.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.415 -0.803 . . . . 1.1399999999999999 109.521 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.57 92.55 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.439 -0.788 . . . . 0.32000000000000001 109.849 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.4 mt -64.9 -52.92 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 0.33000000000000002 109.115 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -63.87 -40.01 95.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.731 -0.605 . . . . 1.8200000000000001 109.539 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -69.96 -21.48 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.543 -0.723 . . . . 1.6699999999999999 109.967 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 147.31 68.42 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 0.63 108.898 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.38 -48.18 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.866 1.711 . . . . 1.29 110.32 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.88 123.15 45.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.722 -1.214 . . . . 2.6299999999999999 107.722 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -61.1 -28.12 68.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 2.02 110.368 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -78.8 88.29 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.787 -1.196 . . . . 1.55 108.803 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.33 151.61 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.098 -0.704 . . . . 0.46999999999999997 109.098 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.2 p -79.91 159.54 26.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.81000000000000005 110.213 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.59 -41.84 95.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.839 -0.8 . . . . 0.69999999999999996 108.839 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.19 -40.06 88.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 1.25 110.194 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.68 -40.02 98.2 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.693 -0.963 . . . . 0.28999999999999998 110.693 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.77 -39.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.241 . . . . 0.34999999999999998 110.798 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.471 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 28.0 m-85 -59.97 -43.84 94.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.709 -1.244 . . . . 1.3999999999999999 110.19 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.0 -39.99 87.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.245 -0.909 . . . . 2.5099999999999998 109.096 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -59.91 -50.06 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.657 -0.652 . . . . 1.3700000000000001 110.883 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.66 -48.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.95 -1.093 . . . . 0.58999999999999997 111.49 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 32.0 mtm -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 0.68999999999999995 109.938 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 83.1 m-20 -66.39 -47.03 74.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 1.1699999999999999 110.727 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 3.0 111.06 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 40' ' ' PHE . 65.9 m-85 -126.1 77.22 71.62 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.226 -0.921 . . . . 1.54 109.85 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.76 -7.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.988 2.459 . . . . 1.21 112.808 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' PHE . 24.1 t80 -58.59 -40.03 82.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 3.7400000000000002 109.091 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 44' ' ' ASN . 96.8 m-85 -69.99 -23.86 63.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.1200000000000001 111.501 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.0 mtt-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.559 -1.338 . . . . 2.5099999999999998 108.724 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.2 -37.03 82.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.512 -0.742 . . . . 2.3399999999999999 110.007 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 33.0 m120 -108.5 119.18 38.77 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.494 0.664 . . . . 2.0099999999999998 111.002 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 64.3 mttp -119.11 15.0 13.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.033 -1.099 . . . . 1.6799999999999999 108.033 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.07 -118.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.619 -0.675 . . . . 3.98 112.818 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.79 -10.06 67.56 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.18 -0.95 . . . . 0.78000000000000003 112.275 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 12.5 p-90 -60.03 -36.99 78.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.222 -1.752 . . . . 0.44 107.578 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -59.99 -50.03 75.34 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.629 -0.669 . . . . 1.96 109.926 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 1.28 111.047 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.9 p -56.86 -34.27 67.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.077 -1.014 . . . . 1.49 111.119 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -59.99 -46.03 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.86 -1.15 . . . . 0.64000000000000001 109.308 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 26.6 mtt180 -72.94 -39.36 66.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 2.7599999999999998 110.146 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 72.1 t60 -59.98 -39.97 87.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 2.48 110.253 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 56' ' ' LEU . 30.0 p30 -75.02 -25.0 58.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.901 -1.124 . . . . 2.0699999999999998 110.615 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.53 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 56.2 mt -64.15 -42.93 96.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.698 -1.251 . . . . 0.78000000000000003 110.014 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -69.99 -40.56 75.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.996 -1.065 . . . . 1.6000000000000001 110.04 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -69.49 -40.0 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.083 . . . . 1.3799999999999999 109.389 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -75.37 118.7 18.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.263 -0.898 . . . . 1.4199999999999999 108.898 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.77 -5.66 56.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.505 -0.747 . . . . 2.1699999999999999 109.072 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.421 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 89.5 m -60.38 -40.03 89.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 1.5600000000000001 109.351 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -85.71 147.05 26.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 1.3200000000000001 108.762 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.96 124.6 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 0.91000000000000003 109.366 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -79.04 129.98 35.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.501 -0.926 . . . . 1.8100000000000001 108.501 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.489 ' C ' ' HG ' ' A' ' 76' ' ' SER . 21.7 t -112.66 100.31 50.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.623 -0.673 . . . . 1.28 109.875 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.56 167.62 0.38 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.149 1.899 . . . . 1.6499999999999999 112.158 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' NE ' ' OH ' ' A' ' 77' ' ' TYR . 16.7 ttt-85 -112.17 161.5 16.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.517 -0.739 . . . . 4.0899999999999999 109.271 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -69.01 147.39 51.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.032 . . . . 2.8399999999999999 109.675 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -79.17 -16.92 55.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.366 -0.834 . . . . 3.46 109.966 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -60.06 -40.01 87.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 4.5 109.6 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HB3' HH12 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -121.18 85.18 41.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.378 -0.971 . . . . 5.1200000000000001 108.378 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.99 145.52 12.47 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.301 2.001 . . . . 3.6299999999999999 112.066 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.08 -36.08 0.23 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.285 -1.526 . . . . 3.1499999999999999 109.285 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -114.17 152.16 31.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.59 -0.947 . . . . 4.3600000000000003 108.455 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.96 -77.78 0.48 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.909 -1.138 . . . . 2.0299999999999998 110.319 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.489 ' HG ' ' C ' ' A' ' 65' ' ' VAL . 30.7 t -158.1 170.24 22.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -1.202 . . . . 1.8 109.959 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' OH ' ' NE ' ' A' ' 67' ' ' ARG . 7.2 m-85 -108.09 158.53 17.33 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.478 -0.764 . . . . 1.3899999999999999 109.269 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -119.9 135.5 54.87 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.689 -0.856 . . . . 0.46000000000000002 108.689 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -150.57 160.38 43.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.119 -0.988 . . . . 0.56000000000000005 110.025 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.87 159.57 28.84 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.043 -0.725 . . . . 1.4199999999999999 109.043 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 61' ' ' CYS . 1.4 m-20 -76.72 124.19 87.66 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.054 -1.029 . . . . 3.7200000000000002 109.045 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.31 -72.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.211 1.274 . . . . 3.5499999999999998 111.022 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 85' ' ' TYR . 39.8 t0 -157.72 39.77 0.28 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.644 -1.243 . . . . 6.8200000000000003 107.644 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m -50.13 89.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.18 -0.674 . . . . 6.0 109.18 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' A' ' 83' ' ' ASP . 19.4 t80 -70.72 -48.71 53.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 11.0 110.067 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -150.22 29.61 0.71 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.29 -0.881 . . . . 10.0 109.165 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.8 mtt -84.97 132.61 34.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.517 -0.739 . . . . 8.4700000000000006 110.203 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -97.32 -0.01 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.367 -0.833 . . . . 11.970000000000001 109.475 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -140.15 159.1 42.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 11.949999999999999 110.096 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -125.54 129.96 50.76 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.867 -0.79 . . . . 12.32 108.867 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.7 -95.68 0.1 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.653 -1.379 . . . . 11.16 109.653 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 t -105.16 89.18 3.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.452 -1.028 . . . . 11.800000000000001 109.259 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.476 ' CD2' ' O ' ' A' ' 93' ' ' PHE . 32.6 p90 -103.48 130.79 50.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 10.779999999999999 109.332 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.777 . . . . 13.119999999999999 109.067 179.734 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.0 mtm . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.232 -0.655 . . . . 4.8099999999999996 109.232 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.54 144.24 27.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 1.71 109.835 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.39 164.17 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.335 -0.853 . . . . 1.79 109.183 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 9.6 mptt -87.36 148.97 45.83 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.466 -0.771 . . . . 3.6899999999999999 109.167 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.68 160.38 37.96 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.465 2.11 . . . . 0.72999999999999998 112.203 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.19 -1.26 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.834 2.356 . . . . 0.83999999999999997 113.612 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -72.55 143.41 48.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.593 -1.317 . . . . 1.1499999999999999 109.416 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.1 p -76.31 163.15 27.29 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.538 -0.912 . . . . 1.3899999999999999 108.538 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -60.09 -39.93 87.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 1.3200000000000001 108.647 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.53 -40.02 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.37 -0.831 . . . . 0.95999999999999996 109.062 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.58 92.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 0.38 110.101 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 0.37 109.128 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.81 -44.68 98.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.176 -1.046 . . . . 0.48999999999999999 108.176 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -60.11 -39.99 88.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.708 -0.62 . . . . 0.39000000000000001 109.478 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.9 mtt -68.2 -39.65 82.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.1399999999999999 110.019 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.64 88.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.32000000000000001 110.495 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.77 -50.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.008 -1.058 . . . . 0.33000000000000002 109.669 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.99 -39.92 75.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 1.8200000000000001 110.383 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -64.14 -32.98 74.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 1.6699999999999999 109.216 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.78 116.94 62.49 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 0.63 109.134 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -46.54 -33.46 13.12 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.218 1.279 . . . . 1.29 110.696 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -100.04 113.72 26.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.071 -1.085 . . . . 2.6299999999999999 108.071 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -69.66 -28.81 66.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 2.02 110.077 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -78.47 75.17 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.045 -1.034 . . . . 1.55 108.634 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 tt -100.98 147.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.074 -0.713 . . . . 0.46999999999999997 109.074 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -80.04 164.88 23.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.422 -0.799 . . . . 0.81000000000000005 109.679 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.99 -47.19 86.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.214 -1.032 . . . . 0.69999999999999996 108.214 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.81 -40.04 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.751 -0.593 . . . . 1.25 110.139 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.01 96.39 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.82 -0.912 . . . . 0.28999999999999998 110.82 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -43.91 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.941 -1.329 . . . . 0.34999999999999998 109.594 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 37.7 m-85 -60.17 -40.81 91.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 1.3999999999999999 110.896 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' OE1' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -66.85 -39.97 87.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.917 -1.114 . . . . 2.5099999999999998 109.821 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.03 -46.62 88.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 1.3700000000000001 111.014 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.99 -41.11 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 0.58999999999999997 110.675 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 30.7 mtt -60.12 -39.98 88.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.036 . . . . 0.68999999999999995 110.36 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' OE1' ' A' ' 32' ' ' GLN . 96.7 m-20 -68.92 -52.86 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 1.1699999999999999 111.646 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -69.97 -42.89 72.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.873 -1.142 . . . . 3.0 110.07 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.99 101.51 54.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 108.318 -0.993 . . . . 1.54 108.318 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.46 -6.4 13.64 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.958 1.772 . . . . 1.21 112.717 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -60.0 -36.74 77.85 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.883 -1.154 . . . . 3.7400000000000002 107.883 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -64.5 -25.28 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.844 -0.616 . . . . 1.1200000000000001 110.402 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.927 -1.108 . . . . 2.5099999999999998 109.523 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.09 -39.98 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 2.3399999999999999 109.524 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -103.61 100.8 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.553 -0.906 . . . . 2.0099999999999998 108.553 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.6 mttt -94.59 -68.33 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 1.6799999999999999 110.513 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.03 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.963 -1.085 . . . . 3.98 110.327 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.55 -60.42 0.41 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.611 -0.996 . . . . 0.78000000000000003 110.611 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 37.1 p-90 -84.85 -27.81 26.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -1.225 . . . . 0.44 110.712 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 93.1 mt-30 -60.36 -42.56 96.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 1.96 112.027 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -76.92 -33.92 57.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.711 -1.243 . . . . 1.28 111.8 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.401 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 29.1 t -59.89 -40.11 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.858 -1.151 . . . . 1.49 111.406 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.5 mm -62.95 -59.12 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.04 -1.037 . . . . 0.64000000000000001 111.711 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -70.05 -33.53 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.159 . . . . 2.7599999999999998 110.667 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -59.97 -40.03 87.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 2.48 109.356 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 51' ' ' SER . 94.4 m-20 -70.03 -21.52 63.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 2.0699999999999998 111.169 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.96 -50.02 75.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.748 -1.22 . . . . 0.78000000000000003 110.49 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.8 m -60.02 -40.01 87.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 1.6000000000000001 109.727 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.463 HD12 ' N ' ' A' ' 58' ' ' LEU . 11.2 mp -66.28 -39.99 89.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 1.3799999999999999 109.06 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.59 113.97 15.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.424 -0.797 . . . . 1.4199999999999999 109.887 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -89.99 -6.21 55.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.619 -0.882 . . . . 2.1699999999999999 108.619 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -62.68 -37.74 87.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 1.5600000000000001 109.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -78.37 156.53 29.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 1.3200000000000001 108.582 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.2 t -120.16 129.96 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 0.91000000000000003 109.608 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.94 142.92 52.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 1.8100000000000001 109.501 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 57.8 t -127.11 88.2 54.82 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.487 -0.931 . . . . 1.28 108.487 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 88.0 Cg_exo -45.46 175.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.994 1.796 . . . . 1.6499999999999999 112.032 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.773 HH11 ' H ' ' A' ' 74' ' ' LYS . 82.8 mtm180 -98.3 156.83 16.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.437 -0.79 . . . . 4.0899999999999999 109.795 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -65.89 166.26 11.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 2.8399999999999999 109.407 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -52.56 -32.87 43.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 3.46 108.559 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -84.61 58.16 4.75 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.771 -1.196 . . . . 4.5 107.771 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.583 ' HZ3' HH12 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -77.0 130.67 74.89 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.684 -0.635 . . . . 5.1200000000000001 109.295 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -83.9 2.92 7.97 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.007 1.805 . . . . 3.6299999999999999 113.056 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.58 55.64 1.64 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.775 -1.33 . . . . 3.1499999999999999 109.775 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.773 ' H ' HH11 ' A' ' 67' ' ' ARG . 57.0 mtpt -131.67 170.19 15.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.643 -0.916 . . . . 4.3600000000000003 108.991 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.7 179.27 26.85 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.554 -1.418 . . . . 2.0299999999999998 109.554 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.2 p -79.12 143.72 35.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -1.201 . . . . 1.8 108.934 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -80.19 156.17 27.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.08 -1.013 . . . . 1.3899999999999999 108.889 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -119.96 140.03 51.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.46000000000000002 109.904 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -145.04 160.38 41.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 0.56000000000000005 109.782 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.4 mt -75.94 169.88 17.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 1.4199999999999999 108.785 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.18 147.88 64.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.085 -1.009 . . . . 3.7200000000000002 108.767 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' SER . 46.3 Cg_endo -66.82 -154.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.557 2.171 . . . . 3.5499999999999998 112.422 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -67.69 52.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 6.8200000000000003 108.939 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' PRO . 10.0 t -60.28 -37.56 80.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.456 -0.778 . . . . 6.0 109.833 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -57.02 -46.32 82.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.911 -1.118 . . . . 11.0 108.051 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -143.36 84.58 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.459 -0.775 . . . . 10.0 108.914 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.5 ' SD ' ' O ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -91.09 115.57 28.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.751 -0.593 . . . . 8.4700000000000006 109.435 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -60.9 -40.09 91.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 11.970000000000001 108.764 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.79 159.87 29.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 11.949999999999999 109.673 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -60.65 149.86 33.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 12.32 108.994 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.62 -116.28 0.51 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.838 -1.305 . . . . 11.16 109.838 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.6 p -60.14 -39.59 86.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.358 -1.084 . . . . 11.800000000000001 110.183 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.522 ' C ' HD22 ' A' ' 94' ' ' LEU . 63.0 t80 -86.31 119.65 26.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.923 -1.111 . . . . 10.779999999999999 110.104 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 93' ' ' PHE . 3.9 mm? . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 108.107 -1.072 . . . . 13.119999999999999 108.107 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.416 -0.587 . . . . 4.8099999999999996 109.416 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.24 139.99 52.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 1.71 109.515 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.53 147.72 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.335 -0.853 . . . . 1.79 109.639 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -82.67 129.51 62.1 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 3.6899999999999999 108.664 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.95 152.28 24.68 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.649 1.566 . . . . 0.72999999999999998 112.551 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 -2.48 12.68 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.63 2.22 . . . . 0.83999999999999997 113.25 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 143.65 57.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.796 -1.19 . . . . 1.1499999999999999 109.748 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 t -79.79 165.93 22.25 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.142 -1.058 . . . . 1.3899999999999999 108.142 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.92 -40.07 87.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.795 -1.19 . . . . 1.3200000000000001 109.003 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.0 mt -68.12 -40.03 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.95999999999999996 109.957 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.51 92.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.952 -1.092 . . . . 0.38 109.902 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.08 -45.17 93.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.768 -1.208 . . . . 0.37 108.332 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.609 HD11 HD22 ' A' ' 55' ' ' ASN . 98.1 mt -63.91 -45.81 95.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.971 -0.751 . . . . 0.48999999999999999 108.971 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.91 -40.61 98.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.39000000000000001 110.573 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.04 -39.12 75.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.823 -1.173 . . . . 1.1399999999999999 109.529 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.9 90.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.555 -0.715 . . . . 0.32000000000000001 110.501 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.54 -49.89 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.979 -1.076 . . . . 0.33000000000000002 108.656 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -61.48 -39.94 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.366 0.603 . . . . 1.8200000000000001 109.494 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 32.1 m120 -78.32 -6.06 53.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 1.6699999999999999 110.37 -179.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.34 126.47 83.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.63 109.639 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -41.24 -20.71 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.688 1.592 . . . . 1.29 110.931 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 20' ' ' ALA . 13.4 pt-20 -138.5 141.92 39.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 2.6299999999999999 108.141 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -60.59 -34.66 74.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.98 -1.075 . . . . 2.02 109.111 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.68 118.42 20.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 1.55 109.42 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.69 158.6 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.338 -0.851 . . . . 0.46999999999999997 109.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 p -86.5 161.8 18.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 0.81000000000000005 111.041 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 27' ' ' LEU . 20.1 tp -61.12 -50.26 73.92 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.185 0.993 . . . . 0.69999999999999996 109.002 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -59.97 -39.84 87.06 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.978 -0.556 . . . . 1.25 110.434 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.94 -39.94 89.79 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.004 -1.094 . . . . 0.28999999999999998 110.404 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.8 -40.87 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.938 -1.331 . . . . 0.34999999999999998 110.272 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 25.1 m-85 -60.03 -40.18 88.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.052 . . . . 1.3999999999999999 111.142 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -63.34 -37.59 87.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.976 -1.077 . . . . 2.5099999999999998 110.963 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.01 -45.17 93.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 1.3700000000000001 110.76 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.81 -52.87 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.035 -1.041 . . . . 0.58999999999999997 112.039 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.6 mtm -61.45 -39.97 92.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 0.68999999999999995 111.283 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.34 -50.49 71.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 1.1699999999999999 110.847 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -69.97 -39.98 75.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 3.0 111.382 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.555 ' C ' ' H ' ' A' ' 40' ' ' PHE . 89.7 m-85 -122.32 83.04 46.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 1.54 110.34 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.11 -3.93 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.248 1.966 . . . . 1.21 110.758 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -59.98 -39.99 87.59 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.653 -0.869 . . . . 3.7400000000000002 108.653 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.0 -29.7 66.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.577 -0.702 . . . . 1.1200000000000001 110.655 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -60.07 -39.9 87.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 2.5099999999999998 109.714 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.4 -40.34 96.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 2.3399999999999999 109.847 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -111.19 77.27 1.03 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.397 -0.594 . . . . 2.0099999999999998 109.397 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -69.77 -40.03 76.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 1.6799999999999999 110.04 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.67 148.08 37.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 3.98 110.41 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -61.65 0.35 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.323 -1.111 . . . . 0.78000000000000003 110.323 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -89.98 -10.3 45.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -1.227 . . . . 0.44 110.786 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 62.8 tt0 -65.58 -56.79 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.931 -1.106 . . . . 1.96 110.754 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -70.11 -31.76 69.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 1.28 110.603 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -58.51 -39.55 80.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 1.49 110.539 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.62 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 5.4 mm -60.09 -49.77 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 0.64000000000000001 110.236 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -70.05 -36.01 74.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.247 . . . . 2.7599999999999998 110.426 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -59.92 -40.25 88.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 2.48 109.797 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.62 ' ND2' ' O ' ' A' ' 52' ' ' ILE . 13.3 p30 -67.77 -39.99 84.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.511 -1.276 . . . . 2.0699999999999998 108.396 179.454 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 54.2 mt -60.07 -48.66 80.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.78000000000000003 110.353 179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.5 p -70.05 -41.3 74.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 1.6000000000000001 110.45 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -69.09 -40.15 78.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.025 . . . . 1.3799999999999999 109.541 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -74.14 119.51 18.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -0.905 . . . . 1.4199999999999999 108.723 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.76 -9.84 57.8 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 2.1699999999999999 109.651 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.0 m -60.09 -39.96 87.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 1.5600000000000001 109.413 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.77 140.67 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 1.3200000000000001 108.824 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.56 130.1 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.498 -0.751 . . . . 0.91000000000000003 109.762 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -73.64 135.57 43.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 1.8100000000000001 109.211 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 77' ' ' TYR . 77.2 t -130.18 126.55 22.33 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.882 -0.785 . . . . 1.28 108.882 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -82.82 170.9 12.26 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.693 1.595 . . . . 1.6499999999999999 112.263 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.534 ' NH1' ' OH ' ' A' ' 77' ' ' TYR . 20.5 mtt-85 -69.39 -107.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 4.0899999999999999 109.383 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -148.1 169.91 18.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.654 -0.653 . . . . 2.8399999999999999 109.312 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -66.34 -33.42 75.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 3.46 110.492 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -60.02 -39.98 87.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.12 -0.988 . . . . 4.5 110.547 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -119.39 118.02 32.68 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.393 -0.817 . . . . 5.1200000000000001 109.106 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -41.59 163.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.641 1.561 . . . . 3.6299999999999999 112.133 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.04 76.85 0.57 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.737 -1.345 . . . . 3.1499999999999999 109.737 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -60.04 -39.95 87.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -1.114 . . . . 4.3600000000000003 108.645 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.77 160.46 27.98 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.654 -1.778 . . . . 2.0299999999999998 108.654 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.6 t -99.03 119.39 37.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.146 -1.208 . . . . 1.8 109.505 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.534 ' OH ' ' NH1' ' A' ' 67' ' ' ARG . 9.5 m-30 -75.37 148.9 38.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 1.3899999999999999 108.944 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -119.97 141.99 49.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.692 -0.63 . . . . 0.46000000000000002 109.689 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -143.03 160.04 41.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.21 -0.931 . . . . 0.56000000000000005 109.37 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.0 mt -86.94 136.6 32.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.173 -0.954 . . . . 1.4199999999999999 109.909 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.27 133.75 77.64 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 3.7200000000000002 109.043 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.18 -162.46 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.622 1.548 . . . . 3.5499999999999998 111.475 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -83.35 45.8 1.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 6.8200000000000003 108.883 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -52.91 -31.16 38.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 6.0 109.852 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -39.3 86.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 11.0 109.462 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -86.91 9.21 20.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 10.0 111.313 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.1 mmt -81.28 143.39 32.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.807 -1.183 . . . . 8.4700000000000006 109.661 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -150.03 -139.07 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.409 -0.807 . . . . 11.970000000000001 108.864 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -91.66 10.56 27.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.032 -1.042 . . . . 11.949999999999999 110.213 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -127.32 135.83 51.09 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.515 -0.74 . . . . 12.32 109.301 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.55 89.23 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.813 -1.315 . . . . 11.16 109.813 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.9 m -99.61 14.18 30.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.373 -1.075 . . . . 11.800000000000001 109.252 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -60.05 -49.9 75.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 10.779999999999999 109.56 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 108.406 -0.961 . . . . 13.119999999999999 108.406 178.886 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.588 0.708 . . . . 4.8099999999999996 109.458 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.0 mt -118.27 142.26 47.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.222 -0.658 . . . . 1.71 109.222 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.84 160.01 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.311 -0.868 . . . . 1.79 109.785 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -86.31 117.29 68.45 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 3.6899999999999999 109.049 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -50.33 151.39 9.74 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.249 1.299 . . . . 0.72999999999999998 111.384 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.4 -5.61 16.31 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.313 2.009 . . . . 0.83999999999999997 112.84 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -69.98 142.06 52.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.022 -1.049 . . . . 1.1499999999999999 109.792 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -70.89 160.58 32.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.774 -0.825 . . . . 1.3899999999999999 108.774 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.046 . . . . 1.3200000000000001 108.748 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.48 -39.54 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.95999999999999996 109.036 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.42 94.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.321 -0.862 . . . . 0.38 110.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.05 -39.94 87.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 0.37 108.895 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.68 -39.99 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.488 -0.758 . . . . 0.48999999999999999 108.98 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -65.28 -40.05 93.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.745 . . . . 0.39000000000000001 110.499 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.0 mtm -69.96 -37.78 75.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 1.1399999999999999 109.792 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.18 90.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 0.32000000000000001 110.048 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.96 -49.58 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.33000000000000002 108.672 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.74 -39.63 84.22 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.916 -0.584 . . . . 1.8200000000000001 110.731 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.571 HD21 ' HZ ' ' A' ' 33' ' ' PHE . 39.2 m-20 -67.63 -19.46 65.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 1.6699999999999999 109.844 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.58 150.12 75.77 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.63 109.292 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.79 -52.14 4.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.653 1.568 . . . . 1.29 109.578 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -100.95 135.99 41.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.066 -1.457 . . . . 2.6299999999999999 107.066 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -64.53 -19.16 65.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.784 -1.198 . . . . 2.02 109.538 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.13 126.13 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 1.55 108.9 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.8 tt -150.16 152.17 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.229 -0.919 . . . . 0.46999999999999997 109.532 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -79.97 158.74 26.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.81000000000000005 109.659 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.496 HD21 ' NE ' ' A' ' 53' ' ' ARG . 57.1 tp -60.08 -42.99 95.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.994 -1.113 . . . . 0.69999999999999996 107.994 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -62.77 -40.0 95.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.643 -0.66 . . . . 1.25 110.544 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -37.38 91.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.656 -1.378 . . . . 0.28999999999999998 109.656 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.24 -39.97 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -1.137 . . . . 0.34999999999999998 110.064 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 27.1 m-85 -64.38 -39.45 93.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.703 -1.248 . . . . 1.3999999999999999 110.335 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 10.4 tp-100 -59.91 -40.54 89.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 2.5099999999999998 108.972 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . 0.571 ' HZ ' HD21 ' A' ' 19' ' ' ASN . 64.4 t80 -61.9 -50.05 73.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 1.3700000000000001 110.875 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.67 -50.16 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.089 -1.007 . . . . 0.58999999999999997 112.175 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.6 mtm -60.64 -40.09 90.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 0.68999999999999995 110.514 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.32 -48.49 72.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 1.1699999999999999 111.38 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -69.75 -43.38 72.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.775 -1.203 . . . . 3.0 109.87 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 111.97 39.72 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.548 -0.908 . . . . 1.54 108.548 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.97 -5.76 14.72 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.873 1.715 . . . . 1.21 112.345 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.01 -38.13 81.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.371 -0.831 . . . . 3.7400000000000002 109.418 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -69.91 -23.29 63.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.107 -0.996 . . . . 1.1200000000000001 110.612 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -59.97 -40.37 88.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.897 -1.127 . . . . 2.5099999999999998 109.543 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -62.5 -41.05 98.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 2.3399999999999999 110.146 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -115.06 98.54 6.85 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.412 -0.588 . . . . 2.0099999999999998 109.412 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 61.4 mttp -85.21 -31.79 23.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.93 . . . . 1.6799999999999999 109.657 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -90.39 145.01 25.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 3.98 110.733 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.34 -63.92 0.29 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.726 -0.95 . . . . 0.78000000000000003 110.726 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.492 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 36.7 p-90 -73.08 -34.84 66.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.979 -1.306 . . . . 0.44 111.894 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -60.61 -40.89 93.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.702 -1.249 . . . . 1.96 110.811 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -64.27 -40.03 95.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.876 -1.14 . . . . 1.28 110.607 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.2 m -60.81 -40.02 91.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 1.49 111.1 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.14 -47.97 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 0.64000000000000001 110.832 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 13.3 mtp180 -69.84 -37.7 76.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.061 . . . . 2.7599999999999998 109.875 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.505 ' NE2' HD11 ' A' ' 58' ' ' LEU . 74.9 t60 -59.99 -41.88 93.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.368 -0.832 . . . . 2.48 109.675 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -64.18 -40.01 95.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 2.0699999999999998 109.62 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.01 -40.86 90.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.78000000000000003 110.483 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -69.07 -44.66 72.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.93 -1.106 . . . . 1.6000000000000001 110.64 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.505 HD11 ' NE2' ' A' ' 54' ' ' HIS . 82.2 mt -70.06 -40.0 75.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 1.3799999999999999 110.027 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -74.66 116.11 14.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.899 -1.126 . . . . 1.4199999999999999 108.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.87 -3.52 57.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 2.1699999999999999 110.351 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -70.1 -17.9 63.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 1.5600000000000001 110.172 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.29 153.61 31.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 1.3200000000000001 109.132 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.9 t -110.06 128.19 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.534 -0.913 . . . . 0.91000000000000003 108.534 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -96.85 115.57 27.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 1.8100000000000001 108.876 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 118.43 44.92 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 107.485 -1.302 . . . . 1.28 107.485 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.16 -169.49 0.78 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.714 1.609 . . . . 1.6499999999999999 113.043 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.515 HH11 ' HG3' ' A' ' 67' ' ' ARG . 3.7 ptm180 -139.64 -164.76 1.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.577 -0.897 . . . . 4.0899999999999999 108.577 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -69.08 147.09 51.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.844 -1.16 . . . . 2.8399999999999999 109.517 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -70.07 -11.57 60.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 3.46 110.207 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.04 -38.89 84.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 4.5 110.224 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HZ2' ' HB2' ' A' ' 71' ' ' LYS . 8.7 mtmp? -122.3 81.12 45.32 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.359 -0.838 . . . . 5.1200000000000001 110.171 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.81 -0.57 10.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.405 2.07 . . . . 3.6299999999999999 111.618 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.73 95.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.499 -1.44 . . . . 3.1499999999999999 109.499 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -77.19 140.81 40.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -1.159 . . . . 4.3600000000000003 109.193 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.03 -177.59 9.18 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.26 -1.536 . . . . 2.0299999999999998 109.26 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.4 m -80.33 159.73 25.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -1.191 . . . . 1.8 109.682 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -70.92 150.98 45.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 1.3899999999999999 109.653 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -121.02 130.7 53.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.599 -0.688 . . . . 0.46000000000000002 109.437 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 164.28 33.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -0.792 . . . . 0.56000000000000005 109.193 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.96 65.65 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.319 -0.863 . . . . 1.4199999999999999 109.09 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -152.72 83.5 4.81 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.166 -0.959 . . . . 3.7200000000000002 110.583 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.428 ' O ' ' OD1' ' A' ' 83' ' ' ASP . 31.4 Cg_exo -57.06 -77.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.572 2.181 . . . . 3.5499999999999998 112.186 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 82' ' ' PRO . 63.8 m-20 -155.64 41.56 0.41 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.943 -1.132 . . . . 6.8200000000000003 107.943 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 m -59.97 -39.8 86.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.703 -0.623 . . . . 6.0 110.632 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -29.54 64.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.66 -1.275 . . . . 11.0 109.462 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 31.9 m120 -77.7 -7.37 56.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.987 . . . . 10.0 109.744 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.3 mtt -90.69 104.24 16.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.512 -0.743 . . . . 8.4700000000000006 109.041 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.98 -0.06 57.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 11.970000000000001 109.911 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -98.47 155.6 17.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.198 -0.939 . . . . 11.949999999999999 109.777 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -90.58 10.73 24.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.365 -0.834 . . . . 12.32 109.948 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.52 70.01 0.04 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.921 -1.672 . . . . 11.16 108.921 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 t -72.37 -69.27 0.41 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.475 -1.015 . . . . 11.800000000000001 109.537 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -72.92 -31.84 64.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 10.779999999999999 109.863 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.176 -0.953 . . . . 13.119999999999999 109.872 -178.668 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.333 -0.617 . . . . 4.8099999999999996 109.333 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.9 mt -101.31 141.33 34.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.36 -0.837 . . . . 1.71 109.878 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.02 160.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.578 -0.701 . . . . 1.79 109.457 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -71.19 149.07 94.29 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 3.6899999999999999 109.435 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.1 Cg_endo -78.21 138.45 16.05 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.179 1.92 . . . . 0.72999999999999998 111.833 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -39.79 -23.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.613 2.209 . . . . 0.83999999999999997 113.871 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 5' ' ' PRO . 3.6 m-85 -59.96 137.44 58.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 1.1499999999999999 110.139 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 p -83.1 173.82 11.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.506 -0.746 . . . . 1.3899999999999999 109.014 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -62.94 -37.94 89.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 1.3200000000000001 109.113 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -68.22 -41.28 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 0.95999999999999996 109.741 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.43 86.18 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -0.937 . . . . 0.38 110.533 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.11 -39.86 87.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.238 -1.023 . . . . 0.37 108.238 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.513 HD13 HD21 ' A' ' 56' ' ' LEU . 97.0 mt -66.44 -45.36 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.841 . . . . 0.48999999999999999 109.184 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -42.91 99.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.39000000000000001 111.066 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.9 mtm -70.0 -40.01 75.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 1.1399999999999999 110.862 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' HA ' HD21 ' A' ' 19' ' ' ASN . . . -54.69 -43.29 72.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -1.0 . . . . 0.32000000000000001 109.449 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.9 mt -59.93 -45.97 94.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.492 -0.929 . . . . 0.33000000000000002 108.492 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.0 -45.07 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.193 0.52 . . . . 1.8200000000000001 110.501 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 15' ' ' MET . 15.6 p30 -91.11 15.44 11.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.866 -1.146 . . . . 1.6699999999999999 109.874 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.37 129.5 74.64 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 0.63 108.521 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -40.6 -38.05 2.42 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.544 1.496 . . . . 1.29 110.885 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -124.54 154.23 40.91 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.253 -1.388 . . . . 2.6299999999999999 107.253 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.782 -1.199 . . . . 2.02 108.489 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -90.64 125.84 35.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 1.55 109.031 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.8 tt -132.48 158.16 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.441 -0.787 . . . . 0.46999999999999997 109.491 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -81.93 158.51 23.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 0.81000000000000005 110.022 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.5 tp -59.97 -49.0 79.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.488 -0.758 . . . . 0.69999999999999996 109.005 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -59.95 -39.57 86.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.541 -0.724 . . . . 1.25 109.843 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.58 -40.16 96.0 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.285 -0.96 . . . . 0.28999999999999998 110.946 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.71 -42.45 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.841 -1.388 . . . . 0.34999999999999998 109.555 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -60.94 -40.93 95.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 1.3999999999999999 110.94 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 83.1 mm-40 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.244 -0.91 . . . . 2.5099999999999998 109.5 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -59.92 -47.79 84.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 1.3700000000000001 109.771 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.97 -50.07 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.264 -0.897 . . . . 0.58999999999999997 110.576 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.86 -39.9 95.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.879 -1.138 . . . . 0.68999999999999995 110.216 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.11 -40.1 90.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.109 -0.994 . . . . 1.1699999999999999 109.519 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -69.12 -54.05 17.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 3.0 110.351 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -110.71 123.56 35.26 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 1.54 109.912 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.84 -6.34 15.93 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.011 1.807 . . . . 1.21 111.197 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.03 -44.56 94.54 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.505 0.669 . . . . 3.7400000000000002 109.541 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -70.07 -27.17 64.4 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.495 -0.753 . . . . 1.1200000000000001 110.649 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -60.03 -39.77 87.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.849 -1.157 . . . . 2.5099999999999998 108.581 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.32 -2.7 29.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 2.3399999999999999 109.401 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 21.5 t-20 -144.47 98.54 3.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.548 -0.72 . . . . 2.0099999999999998 109.104 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 56.3 mtpt -98.04 -32.93 11.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 1.6799999999999999 110.626 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.84 143.11 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.876 -1.14 . . . . 3.98 110.398 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.61 -72.15 0.27 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.096 -1.201 . . . . 0.78000000000000003 110.096 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 18.8 p-90 -69.96 -39.35 76.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.208 -1.172 . . . . 0.44 110.874 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.429 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 8.4 tt0 -59.99 -50.07 75.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 1.96 110.978 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -73.49 -31.69 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.936 -1.103 . . . . 1.28 110.044 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.8 m -59.93 -40.21 88.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 1.49 110.258 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 13' ' ' ILE . 17.0 mt -69.88 -43.62 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 0.64000000000000001 109.138 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -59.99 -47.18 86.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.718 -1.239 . . . . 2.7599999999999998 108.417 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' NE2' HD11 ' A' ' 58' ' ' LEU . 84.1 t60 -60.8 -40.03 91.13 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 2.48 108.467 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.07 -39.94 95.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.861 -0.792 . . . . 2.0699999999999998 108.861 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.513 HD21 HD13 ' A' ' 13' ' ' ILE . 32.5 mt -59.99 -45.87 91.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 0.78000000000000003 110.105 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.35 -42.44 99.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.902 -1.124 . . . . 1.6000000000000001 109.337 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.454 HD11 ' NE2' ' A' ' 54' ' ' HIS . 51.6 mt -70.02 -37.22 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 1.3799999999999999 109.775 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -69.18 117.84 11.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 1.4199999999999999 109.898 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -90.7 -10.96 41.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 2.1699999999999999 108.962 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.94 -40.04 87.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.425 -0.797 . . . . 1.5600000000000001 109.673 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.48 146.19 32.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.297 -0.877 . . . . 1.3200000000000001 109.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.98 125.35 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.175 -1.046 . . . . 0.91000000000000003 108.175 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' NZ ' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.42 135.57 38.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 1.8100000000000001 109.903 -178.64 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.43 139.02 31.48 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.642 -0.873 . . . . 1.28 108.642 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -79.41 -155.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.254 1.969 . . . . 1.6499999999999999 112.36 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HG2' ' NH1' ' A' ' 67' ' ' ARG . 20.0 ptt-85 -140.85 169.49 17.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 4.0899999999999999 108.876 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -60.03 145.49 46.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.043 -1.035 . . . . 2.8399999999999999 109.316 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.08 -19.87 63.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 3.46 109.998 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -71.17 -9.33 57.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 4.5 110.259 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -130.07 75.3 79.6 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.301 -0.875 . . . . 5.1200000000000001 110.218 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -86.71 179.59 3.32 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.995 2.463 . . . . 3.6299999999999999 111.585 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.1 12.7 83.01 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.808 -1.317 . . . . 3.1499999999999999 109.808 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -122.05 157.54 31.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.618 -0.93 . . . . 4.3600000000000003 109.117 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.0 -178.11 37.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.338 -1.105 . . . . 2.0299999999999998 110.338 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -80.0 143.25 34.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -1.047 . . . . 1.8 110.093 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -79.98 159.66 26.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.397 -0.814 . . . . 1.3899999999999999 109.509 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -132.15 151.53 51.74 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.366 -0.834 . . . . 0.46000000000000002 109.492 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.5 t -149.99 169.98 19.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.967 -1.083 . . . . 0.56000000000000005 110.347 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.44 161.46 27.09 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 1.4199999999999999 110.551 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.35 166.98 16.93 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.991 -0.744 . . . . 3.7200000000000002 108.991 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.83 -136.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.718 1.612 . . . . 3.5499999999999998 111.686 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 35.5 p-10 -71.16 -0.7 10.31 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.102 -1.073 . . . . 6.8200000000000003 108.102 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 m -81.53 37.78 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.688 -0.633 . . . . 6.0 110.032 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.535 ' CE2' ' OD1' ' A' ' 86' ' ' ASN . 10.2 p90 -61.55 -51.31 69.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.057 -1.027 . . . . 11.0 111.182 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.535 ' OD1' ' CE2' ' A' ' 85' ' ' TYR . 51.8 p30 -136.48 21.05 3.14 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.13 -0.981 . . . . 10.0 110.3 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.462 ' C ' ' SD ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -47.49 173.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.555 -0.715 . . . . 8.4700000000000006 109.907 -179.734 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.0 103.97 16.62 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.144 -1.058 . . . . 11.970000000000001 108.144 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -53.64 129.82 34.23 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.361 -0.837 . . . . 11.949999999999999 109.611 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -151.24 -163.22 1.71 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 12.32 108.995 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.68 -50.6 59.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.361 -1.496 . . . . 11.16 109.361 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.4 p -160.38 114.2 2.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 11.800000000000001 109.438 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -124.9 8.08 8.08 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.502 -0.749 . . . . 10.779999999999999 109.02 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.0 tp . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.515 -0.741 . . . . 13.119999999999999 109.148 179.839 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.954 -0.758 . . . . 4.8099999999999996 108.954 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.7 mt -76.18 151.21 36.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.036 -1.04 . . . . 1.71 109.486 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.98 152.76 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.625 -0.672 . . . . 1.79 109.372 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -52.5 129.26 43.68 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 3.6899999999999999 109.033 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -42.52 158.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.985 1.79 . . . . 0.72999999999999998 112.384 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.55 -9.25 18.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.542 2.161 . . . . 0.83999999999999997 112.878 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -67.34 143.32 56.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.955 -1.091 . . . . 1.1499999999999999 108.993 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.9 t -69.65 159.98 32.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -0.973 . . . . 1.3899999999999999 108.573 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -59.9 -39.97 87.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.934 -1.104 . . . . 1.3200000000000001 108.465 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.53 -39.95 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.786 . . . . 0.95999999999999996 109.395 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.02 95.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.38 110.103 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.06 -40.07 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.198 -0.939 . . . . 0.37 108.588 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.66 -41.93 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 0.48999999999999999 108.91 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -60.49 -40.1 90.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 0.39000000000000001 109.676 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.43 -39.94 89.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 1.1399999999999999 109.175 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.65 85.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.629 -0.67 . . . . 0.32000000000000001 110.474 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.06 -49.86 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.059 -1.026 . . . . 0.33000000000000002 108.973 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.57 -40.51 92.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.837 -0.539 . . . . 1.8200000000000001 110.157 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 93.5 m-20 -70.69 -20.61 62.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 1.6699999999999999 110.372 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.06 119.85 77.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.091 -1.006 . . . . 0.63 109.812 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.99 -29.55 1.58 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.409 1.406 . . . . 1.29 110.719 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -115.09 128.13 56.04 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.612 -1.255 . . . . 2.6299999999999999 107.612 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -69.93 -27.31 64.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.922 -1.111 . . . . 2.02 110.142 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -78.54 74.28 5.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.951 -1.093 . . . . 1.55 109.354 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -88.57 147.46 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.815 -0.809 . . . . 0.46999999999999997 108.815 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -79.04 159.56 27.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.81000000000000005 109.851 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 27' ' ' LEU . 33.1 tp -60.42 -50.01 75.3 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.63 0.729 . . . . 0.69999999999999996 109.839 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 1.25 109.744 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -38.62 94.36 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.495 -1.042 . . . . 0.28999999999999998 110.495 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.02 -43.71 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.973 -1.31 . . . . 0.34999999999999998 109.933 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -59.99 -45.38 92.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.953 -1.092 . . . . 1.3999999999999999 110.366 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -59.98 -40.12 88.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 2.5099999999999998 110.265 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.92 -46.55 89.01 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.141 -0.974 . . . . 1.3700000000000001 109.412 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.0 mt -65.78 -49.94 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.58999999999999997 111.499 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.0 mtm -61.11 -40.0 92.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.935 -1.103 . . . . 0.68999999999999995 110.98 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -66.67 -39.93 88.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 1.1699999999999999 110.555 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -76.94 -67.04 0.75 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 3.0 111.129 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -85.96 130.44 50.37 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.731 -1.23 . . . . 1.54 109.907 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.63 -13.26 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.186 1.924 . . . . 1.21 113.204 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.94 -44.37 94.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.998 -1.064 . . . . 3.7400000000000002 110.288 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -70.2 -29.21 66.0 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 1.1200000000000001 111.114 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.949 -1.094 . . . . 2.5099999999999998 110.124 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -93.2 0.05 57.0 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.003 -1.061 . . . . 2.3399999999999999 110.264 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.548 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 59.1 t30 -124.27 129.05 50.08 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.271 0.557 . . . . 2.0099999999999998 109.547 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 32.1 mmtp -129.12 17.89 6.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.512 -0.742 . . . . 1.6799999999999999 109.402 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -70.43 -160.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 3.98 111.871 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.61 -9.21 0.25 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 116.112 -0.494 . . . . 0.78000000000000003 111.917 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.548 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -59.99 -35.99 76.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.218 -1.754 . . . . 0.44 107.721 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.38 -44.12 97.69 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.757 -0.589 . . . . 1.96 111.154 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -80.32 -26.58 38.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.002 -1.061 . . . . 1.28 111.703 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -69.39 -23.58 63.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.763 -1.211 . . . . 1.49 110.868 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -69.99 -61.66 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.006 -1.059 . . . . 0.64000000000000001 111.394 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -70.01 -30.92 68.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.159 -0.963 . . . . 2.7599999999999998 111.216 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.21 -36.82 78.54 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.912 -1.117 . . . . 2.48 109.648 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 98.5 m-20 -69.94 -19.24 63.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 2.0699999999999998 111.14 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.91 -45.1 93.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.909 -1.119 . . . . 0.78000000000000003 110.385 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.8 p -69.98 -39.6 75.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.968 -1.082 . . . . 1.6000000000000001 110.102 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.16 -39.95 88.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.3799999999999999 110.028 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 83.2 m-20 -64.52 119.0 9.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 1.4199999999999999 109.601 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -81.97 -37.73 26.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 2.1699999999999999 110.294 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.5 m -65.31 -11.54 42.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 1.5600000000000001 109.769 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.44 131.17 36.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 1.3200000000000001 109.122 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.3 t -97.19 127.94 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.276 -0.89 . . . . 0.91000000000000003 109.101 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -103.71 118.0 35.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 1.8100000000000001 110.174 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.463 ' O ' ' OG ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -113.24 118.19 44.36 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 107.867 -1.161 . . . . 1.28 107.867 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.71 154.34 43.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.415 1.41 . . . . 1.6499999999999999 112.367 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -74.07 157.06 36.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.39 -0.819 . . . . 4.0899999999999999 109.562 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.12 140.05 57.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 2.8399999999999999 109.585 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -70.0 -19.84 63.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.302 -0.874 . . . . 3.46 109.211 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -60.08 -40.54 89.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 4.5 109.401 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -132.67 82.35 56.61 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.443 -0.786 . . . . 5.1200000000000001 109.252 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.4 176.64 8.46 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.221 1.947 . . . . 3.6299999999999999 111.854 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.12 -69.72 0.34 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.282 -1.527 . . . . 3.1499999999999999 109.282 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' GLY . 68.2 mttm -77.41 149.92 35.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -1.136 . . . . 4.3600000000000003 109.314 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -45.82 -93.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.043 -1.223 . . . . 2.0299999999999998 110.043 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 65' ' ' VAL . 7.0 t -152.4 160.05 43.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -1.11 . . . . 1.8 109.612 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -77.71 157.69 29.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 1.3899999999999999 109.422 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -130.19 130.7 45.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.46000000000000002 109.743 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.2 t -149.82 159.44 44.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 0.56000000000000005 109.542 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 81' ' ' ASP . 91.4 mt -80.71 -161.19 0.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 1.4199999999999999 109.717 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 80' ' ' LEU . 3.0 p-10 -49.98 173.06 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.698 -0.853 . . . . 3.7200000000000002 108.698 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -66.51 -146.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.794 1.663 . . . . 3.5499999999999998 112.077 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' TYR . 88.6 m-20 -90.96 17.39 7.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.437 -0.789 . . . . 6.8200000000000003 109.485 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 92.8 p -47.08 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 6.0 109.064 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -79.93 -70.04 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 11.0 109.658 -178.887 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -127.6 13.08 6.96 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.926 0.87 . . . . 10.0 108.972 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 47.4 mtm -88.68 107.79 19.12 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.697 -0.853 . . . . 8.4700000000000006 108.697 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -70.0 -39.39 75.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 11.970000000000001 110.411 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.56 148.18 52.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 11.949999999999999 110.435 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -98.31 11.86 36.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.42 -0.8 . . . . 12.32 110.138 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -151.16 75.61 0.25 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.032 -1.227 . . . . 11.16 110.032 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -145.19 -39.65 0.25 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.103 -1.234 . . . . 11.800000000000001 109.619 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 93' ' ' PHE . 62.5 t80 -75.74 -18.91 59.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 10.779999999999999 110.682 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.521 HD12 ' N ' ' A' ' 94' ' ' LEU . 9.3 mp . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.776 -1.202 . . . . 13.119999999999999 109.005 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.373 0.606 . . . . 4.8099999999999996 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.0 mt -74.81 149.3 39.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 1.71 109.451 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.08 171.15 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.74 -0.837 . . . . 1.79 108.74 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -88.56 113.25 54.75 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.741 . . . . 3.6899999999999999 109.225 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' TYR . 83.6 Cg_exo -48.73 122.9 8.74 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.639 1.559 . . . . 0.72999999999999998 112.218 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.11 -8.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.274 1.983 . . . . 0.83999999999999997 113.65 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.8 m-85 -71.96 144.52 48.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.707 -1.246 . . . . 1.1499999999999999 109.926 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 m -82.31 169.94 15.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 1.3899999999999999 109.419 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -60.09 -39.96 87.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.14 -0.975 . . . . 1.3200000000000001 109.158 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.81 -39.9 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.95999999999999996 109.181 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -47.62 84.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.38 110.342 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.07 -41.45 92.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.789 -1.194 . . . . 0.37 108.436 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.32 -42.05 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.048 -1.093 . . . . 0.48999999999999999 108.048 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.16 -40.02 94.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.584 -0.697 . . . . 0.39000000000000001 109.47 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.26 -39.92 82.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 1.1399999999999999 109.603 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.01 81.11 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.329 -0.857 . . . . 0.32000000000000001 109.252 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 70.1 mt -61.1 -50.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.33000000000000002 108.757 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 28.9 mm100 -61.23 -40.01 92.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.632 -0.668 . . . . 1.8200000000000001 109.839 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -78.05 -4.16 45.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 1.6699999999999999 108.967 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -80.05 119.3 76.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.589 -0.893 . . . . 0.63 108.589 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -40.41 -26.72 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.675 1.583 . . . . 1.29 111.594 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 20' ' ' ALA . 20.7 pt-20 -134.7 153.93 51.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.036 -1.098 . . . . 2.6299999999999999 108.036 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -67.74 -31.56 71.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 2.02 110.825 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -78.87 123.42 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.686 -1.259 . . . . 1.55 109.704 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 tt -140.39 153.8 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.285 -0.884 . . . . 0.46999999999999997 109.543 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.1 p -81.91 152.63 26.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 0.81000000000000005 110.197 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.0 -49.06 79.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.684 -0.858 . . . . 0.69999999999999996 108.684 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.9 -40.11 87.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.453 -0.78 . . . . 1.25 109.811 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.77 94.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.581 -1.008 . . . . 0.28999999999999998 110.581 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.04 -41.54 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.317 . . . . 0.34999999999999998 110.033 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -59.99 -45.37 92.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 1.3999999999999999 110.731 -179.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.94 -37.32 84.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.041 -1.037 . . . . 2.5099999999999998 110.852 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.98 -49.04 79.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 1.3700000000000001 110.68 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.06 -49.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 0.58999999999999997 110.693 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.47 -39.93 92.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.918 -1.114 . . . . 0.68999999999999995 110.476 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.52 -40.01 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 1.1699999999999999 109.47 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -79.76 -69.39 0.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 3.0 109.483 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -89.47 116.53 66.58 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.983 . . . . 1.54 109.019 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.52 -3.93 12.72 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.88 1.72 . . . . 1.21 111.235 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -60.06 -39.75 87.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.594 -0.891 . . . . 3.7400000000000002 108.594 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' ASN . 93.3 m-85 -69.87 -27.15 64.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.567 -0.708 . . . . 1.1200000000000001 110.521 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -59.2 -39.96 84.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.823 -1.173 . . . . 2.5099999999999998 107.994 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -61.3 -40.77 95.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 2.3399999999999999 109.631 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -111.5 108.5 18.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.329 -0.619 . . . . 2.0099999999999998 109.329 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 66.3 mttm -96.64 -40.74 8.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.067 -1.02 . . . . 1.6799999999999999 110.513 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.21 142.97 27.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.169 -0.957 . . . . 3.98 110.536 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.77 -55.74 0.49 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.562 -1.415 . . . . 0.78000000000000003 109.562 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.448 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.6 p-90 -89.23 -3.07 58.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -1.185 . . . . 0.44 109.256 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -74.08 -61.7 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 1.96 111.089 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -69.55 -39.93 77.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.302 -0.873 . . . . 1.28 110.656 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.2 m -50.84 -31.09 16.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 1.49 111.008 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.29 -65.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.003 -1.06 . . . . 0.64000000000000001 110.894 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -69.94 -30.02 67.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 2.7599999999999998 110.6 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.769 -1.207 . . . . 2.48 108.491 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.427 ' OD1' ' OD1' ' A' ' 59' ' ' ASN . 27.2 t-20 -61.08 -42.86 99.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 2.0699999999999998 110.144 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.96 -41.66 92.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.993 . . . . 0.78000000000000003 110.239 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 p -64.05 -50.64 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 1.6000000000000001 110.625 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.4 mp -69.94 -40.09 75.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.929 -1.107 . . . . 1.3799999999999999 110.056 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.68 ' N ' HD22 ' A' ' 59' ' ' ASN . 0.8 OUTLIER -66.73 122.11 16.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.192 -0.943 . . . . 1.4199999999999999 109.58 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -86.09 -10.2 55.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 2.1699999999999999 109.34 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.26 -40.02 92.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.288 -0.883 . . . . 1.5600000000000001 109.061 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -82.74 129.29 34.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.348 -0.982 . . . . 1.3200000000000001 108.348 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.94 119.93 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.91000000000000003 109.534 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.88 150.06 24.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.298 -1.001 . . . . 1.8100000000000001 108.298 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.01 91.55 22.94 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.31 -0.869 . . . . 1.28 109.789 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -47.35 133.92 20.06 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.712 1.608 . . . . 1.6499999999999999 111.318 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.59 HH11 ' H ' ' A' ' 74' ' ' LYS . 47.2 mtp180 -59.32 152.14 21.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 4.0899999999999999 109.984 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -68.2 153.99 42.63 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.372 -0.973 . . . . 2.8399999999999999 108.372 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -69.48 -20.07 63.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.069 -1.019 . . . . 3.46 108.881 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -62.95 -40.07 96.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.71 . . . . 4.5 109.883 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -135.53 85.12 32.26 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 5.1200000000000001 109.393 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.66 164.77 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.752 2.302 . . . . 3.6299999999999999 112.335 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.71 -94.91 0.11 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.764 -1.334 . . . . 3.1499999999999999 109.764 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.59 ' H ' HH11 ' A' ' 67' ' ' ARG . 61.5 mttp -71.63 157.47 37.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.362 -1.081 . . . . 4.3600000000000003 109.579 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -44.9 -98.51 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.658 -0.977 . . . . 2.0299999999999998 110.658 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.1 m -144.88 158.58 43.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.003 -1.293 . . . . 1.8 110.152 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -80.01 162.14 25.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.487 -0.758 . . . . 1.3899999999999999 109.685 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -122.96 130.98 53.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.227 -0.657 . . . . 0.46000000000000002 109.227 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 161.67 40.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.331 -0.855 . . . . 0.56000000000000005 109.528 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' O ' ' O ' ' A' ' 81' ' ' ASP . 76.5 mt -73.15 169.72 16.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.4199999999999999 109.325 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -46.73 167.44 0.15 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 3.7200000000000002 109.19 -179.21 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 81' ' ' ASP . 51.2 Cg_exo -53.98 -145.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.195 1.93 . . . . 3.5499999999999998 113.371 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 85' ' ' TYR . 96.0 m-20 -99.53 24.86 7.65 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.341 -0.85 . . . . 6.8200000000000003 109.263 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.522 ' C ' ' O ' ' A' ' 83' ' ' ASP . 6.2 m 1.95 61.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 112.934 0.716 . . . . 6.0 112.934 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 83' ' ' ASP . 54.3 t80 -90.07 -28.42 19.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 11.0 109.002 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -99.88 13.0 35.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.394 -0.816 . . . . 10.0 109.9 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.476 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 65.4 mmm -85.41 119.32 25.64 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.217 -0.927 . . . . 8.4700000000000006 109.825 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.402 ' C ' ' H ' ' A' ' 90' ' ' ASN . 49.6 p90 -118.71 25.43 10.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.898 -0.779 . . . . 11.970000000000001 108.898 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -57.41 -9.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 11.949999999999999 109.535 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 88' ' ' PHE . 23.8 m120 -132.89 142.02 48.69 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.346 -0.612 . . . . 12.32 109.346 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.92 -37.91 93.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.177 -1.569 . . . . 11.16 109.177 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.8 m -60.01 -39.96 87.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -1.115 . . . . 11.800000000000001 109.562 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 87' ' ' MET . 1.3 t80 -74.92 55.98 0.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 10.779999999999999 109.094 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.5 tp . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.051 -1.031 . . . . 13.119999999999999 109.576 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.48 -0.563 . . . . 4.8099999999999996 109.48 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.2 mt -70.56 140.86 51.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.89 . . . . 1.71 109.743 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -140.88 148.1 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.387 -0.821 . . . . 1.79 108.977 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -74.5 145.3 82.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.018 -1.051 . . . . 3.6899999999999999 108.811 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.56 161.21 44.71 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.408 2.072 . . . . 0.72999999999999998 112.162 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.64 -2.62 12.86 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.519 2.146 . . . . 0.83999999999999997 112.685 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -64.93 137.45 57.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.814 -1.179 . . . . 1.1499999999999999 108.735 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -77.83 168.67 19.55 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.285 -1.006 . . . . 1.3899999999999999 108.285 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -60.0 -37.85 80.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.022 -1.049 . . . . 1.3200000000000001 108.617 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.9 mm -60.11 -46.29 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.95999999999999996 109.613 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.81 95.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -0.872 . . . . 0.38 110.452 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.76 -40.14 91.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.925 -1.109 . . . . 0.37 108.64 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.12 -42.2 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.471 -0.937 . . . . 0.48999999999999999 108.471 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -64.38 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 0.39000000000000001 110.358 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtt -66.32 -39.34 89.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.89 . . . . 1.1399999999999999 109.658 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 20' ' ' ALA . . . -60.14 -41.4 92.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.542 -0.724 . . . . 0.32000000000000001 110.252 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.503 ' CG2' ' HZ3' ' A' ' 23' ' ' LYS . 62.3 mt -69.57 -49.14 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.106 -0.997 . . . . 0.33000000000000002 109.431 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.03 -40.03 90.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 1.8200000000000001 110.612 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -82.16 -10.6 59.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 1.6699999999999999 110.78 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 16' ' ' ALA . . . -79.07 149.17 72.88 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.942 -1.099 . . . . 0.63 109.022 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.62 -57.03 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.441 1.427 . . . . 1.29 110.359 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -104.98 127.07 52.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.94 -1.133 . . . . 2.6299999999999999 107.94 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HZ3' ' CG2' ' A' ' 17' ' ' ILE . 8.7 mtpm? -60.33 -28.91 68.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.962 -1.086 . . . . 2.02 108.927 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -78.05 82.41 4.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.956 -1.127 . . . . 1.55 107.956 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 tt -111.87 148.55 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.767 -0.827 . . . . 0.46999999999999997 108.767 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.7 p -79.03 161.07 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.116 -0.99 . . . . 0.81000000000000005 109.233 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.4 tp -60.04 -42.63 94.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.69999999999999996 108.962 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.76 -40.01 90.91 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.286 -0.884 . . . . 1.25 109.643 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.71 -35.99 90.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.84 -1.304 . . . . 0.28999999999999998 109.84 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.76 -41.16 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -1.153 . . . . 0.34999999999999998 110.293 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -60.0 -40.1 88.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.531 -1.355 . . . . 1.3999999999999999 109.383 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.98 -40.35 88.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.462 -0.774 . . . . 2.5099999999999998 109.798 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.71 -47.22 73.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 1.3700000000000001 110.701 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.2 -49.88 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 0.58999999999999997 110.678 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.1 mtm -62.13 -39.99 94.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.892 -1.13 . . . . 0.68999999999999995 109.548 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.01 -49.64 75.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 1.1699999999999999 110.401 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -70.04 -58.85 3.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.921 -1.112 . . . . 3.0 109.848 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -100.04 112.83 64.73 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 1.54 108.892 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.03 -10.16 14.0 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.028 1.819 . . . . 1.21 112.64 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -60.07 -38.17 82.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 3.7400000000000002 108.953 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 44' ' ' ASN . 69.4 m-85 -63.89 -28.75 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.666 -0.646 . . . . 1.1200000000000001 110.952 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.89 -39.93 87.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.83 -1.169 . . . . 2.5099999999999998 109.372 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.77 -40.08 93.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 2.3399999999999999 109.461 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -114.45 104.74 12.34 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 2.0099999999999998 108.498 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 53.8 mtpt -98.47 -32.58 11.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 1.6799999999999999 110.67 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -89.72 137.02 32.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.069 -1.02 . . . . 3.98 110.028 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.44 -64.9 0.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.96 -1.256 . . . . 0.78000000000000003 109.96 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.511 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 38.0 p-90 -72.88 -37.06 67.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.108 -1.231 . . . . 0.44 110.51 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -60.09 -45.38 93.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 1.96 110.369 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.4 ' HA ' HH11 ' A' ' 53' ' ' ARG . 98.5 m-20 -68.86 -37.66 79.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 1.28 110.255 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 m -59.85 -39.35 84.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 1.49 110.043 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.3 mm -60.01 -46.81 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 0.64000000000000001 110.224 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -64.75 -41.49 95.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 2.7599999999999998 109.708 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' HIS . . . . . 0.483 ' NE2' HD11 ' A' ' 58' ' ' LEU . 13.3 t60 -60.03 -45.25 93.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.841 . . . . 2.48 109.832 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.07 -39.96 94.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -0.915 . . . . 2.0699999999999998 109.666 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.89 -46.87 87.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.78000000000000003 110.263 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -64.73 -44.46 90.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.884 -1.135 . . . . 1.6000000000000001 109.453 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.483 HD11 ' NE2' ' A' ' 54' ' ' HIS . 26.9 mt -67.88 -43.26 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.3799999999999999 109.678 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -85.07 106.89 16.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 1.4199999999999999 108.76 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -91.01 10.29 27.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 2.1699999999999999 109.449 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.41 -26.05 67.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.838 . . . . 1.5600000000000001 109.927 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -79.76 147.91 31.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 1.3200000000000001 109.122 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' CG2' ' H ' ' A' ' 81' ' ' ASP . 22.9 t -90.61 118.52 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.91000000000000003 109.08 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -92.33 100.23 12.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 1.8100000000000001 109.239 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.88 123.78 44.24 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.494 -0.928 . . . . 1.28 108.494 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.89 172.89 11.63 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.013 1.809 . . . . 1.6499999999999999 112.604 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' NH2' ' OH ' ' A' ' 77' ' ' TYR . 16.7 mtt-85 -80.01 159.28 26.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.454 -0.779 . . . . 4.0899999999999999 109.08 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 7.3 t70 -81.27 167.52 19.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.373 -0.83 . . . . 2.8399999999999999 110.032 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 87.2 m-20 -62.27 -36.72 82.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.526 -0.734 . . . . 3.46 109.968 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -59.77 -39.84 86.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 4.5 109.381 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -90.62 149.18 40.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.191 -0.943 . . . . 5.1200000000000001 109.249 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 74' ' ' LYS . 74.1 Cg_endo -74.81 130.56 13.59 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.256 1.971 . . . . 3.6299999999999999 110.814 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.11 78.17 0.01 OUTLIER Glycine 0 N--CA 1.495 2.576 0 C-N-CA 120.376 -0.916 . . . . 3.1499999999999999 111.413 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 72' ' ' PRO . 16.2 mtpp -70.23 -39.71 74.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.266 . . . . 4.3600000000000003 109.104 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.71 -175.88 46.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.362 -1.495 . . . . 2.0299999999999998 109.362 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 p -97.9 139.82 33.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.272 -1.134 . . . . 1.8 109.387 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.541 ' OH ' ' NH2' ' A' ' 67' ' ' ARG . 29.6 m-85 -87.47 144.22 26.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.101 -1.0 . . . . 1.3899999999999999 109.291 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -114.56 130.79 56.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.523 -0.735 . . . . 0.46000000000000002 109.288 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.3 t -158.51 153.67 25.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.943 . . . . 0.56000000000000005 109.583 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 mt -95.08 100.12 11.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 1.4199999999999999 109.316 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.499 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 1.5 m-20 -140.04 79.05 23.1 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.359 -0.838 . . . . 3.7200000000000002 109.447 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.87 -141.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.926 2.417 . . . . 3.5499999999999998 112.293 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 85' ' ' TYR . 40.9 p-10 -93.08 31.79 1.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.363 -0.835 . . . . 6.8200000000000003 109.242 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -49.57 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.429 -0.795 . . . . 6.0 109.644 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 83' ' ' ASP . 55.8 t80 -61.83 -50.06 73.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 11.0 109.956 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.451 ' OD1' ' CD2' ' A' ' 85' ' ' TYR . 4.4 m120 -146.52 24.11 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.947 . . . . 10.0 108.933 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 14.4 mmt -69.49 120.34 15.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.319 -0.863 . . . . 8.4700000000000006 109.403 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -96.53 -27.72 14.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.254 -0.904 . . . . 11.970000000000001 109.505 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' ASN . 50.3 mt-10 -141.25 172.74 12.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.794 . . . . 11.949999999999999 109.02 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 92' ' ' SER . 95.7 m-20 -44.16 166.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 12.32 109.847 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.25 50.35 0.12 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.489 -1.044 . . . . 11.16 110.489 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 90' ' ' ASN . 45.7 t -70.97 -13.77 62.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -1.207 . . . . 11.800000000000001 108.727 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -55.57 172.03 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.812 0.815 . . . . 10.779999999999999 110.105 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.581 ' N ' HD12 ' A' ' 94' ' ' LEU . 7.9 mp . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.674 -0.641 . . . . 13.119999999999999 109.47 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.9 ttp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.873 0.844 . . . . 4.8099999999999996 108.934 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.89 142.83 32.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.922 . . . . 1.71 109.409 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.9 m -145.74 152.75 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.245 -0.909 . . . . 1.79 109.391 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -45.98 107.68 0.71 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.407 -0.808 . . . . 3.6899999999999999 109.331 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -50.79 150.84 11.9 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.922 1.748 . . . . 0.72999999999999998 112.988 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.1 16.9 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.531 2.154 . . . . 0.83999999999999997 111.691 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -101.22 135.81 42.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.385 -0.822 . . . . 1.1499999999999999 109.455 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 91.8 p -80.21 170.01 17.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.435 -0.791 . . . . 1.3899999999999999 109.281 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 1.3200000000000001 108.913 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.05 -40.14 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.95999999999999996 108.542 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.82 73.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.38 109.492 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.06 -40.85 90.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.043 -1.035 . . . . 0.37 108.336 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.5 mt -69.91 -41.54 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 0.48999999999999999 108.959 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -39.94 95.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.39000000000000001 109.268 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.3 mtt -68.06 -40.0 82.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 1.1399999999999999 108.829 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -49.5 77.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.567 -0.708 . . . . 0.32000000000000001 110.073 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.04 -49.9 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 0.33000000000000002 109.255 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.43 -39.66 92.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.852 -0.53 . . . . 1.8200000000000001 110.266 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.5 m120 -80.3 5.0 15.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 1.6699999999999999 110.112 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.1 148.37 74.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.971 -1.081 . . . . 0.63 109.76 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -33.6 -84.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.912 2.408 . . . . 1.29 112.849 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -90.02 -80.05 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.685 -1.259 . . . . 2.6299999999999999 108.542 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -159.16 -33.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.895 -1.128 . . . . 2.02 110.117 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -81.42 129.85 34.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.994 -1.066 . . . . 1.55 110.142 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -130.75 138.74 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.611 -0.885 . . . . 0.46999999999999997 108.611 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.2 p -79.99 162.31 24.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 0.81000000000000005 109.965 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.711 HD21 ' HG2' ' A' ' 53' ' ' ARG . 52.1 tp -60.04 -47.01 87.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.671 -0.862 . . . . 0.69999999999999996 108.671 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.442 ' O ' ' OE1' ' A' ' 32' ' ' GLN . 25.9 m120 -62.55 -39.93 95.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 1.25 109.844 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.07 91.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.536 -1.026 . . . . 0.28999999999999998 110.536 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.97 -40.69 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.987 -1.302 . . . . 0.34999999999999998 109.381 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -60.07 -48.68 80.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.108 -0.995 . . . . 1.3999999999999999 109.955 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 28' ' ' ASN . 4.8 mp0 -59.92 -37.79 80.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 2.5099999999999998 109.488 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -59.99 -49.99 75.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 1.3700000000000001 109.64 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -49.97 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.002 -1.061 . . . . 0.58999999999999997 110.824 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.5 mtm -65.02 -43.49 92.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.89 -1.131 . . . . 0.68999999999999995 110.781 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.36 -44.86 86.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 1.1699999999999999 110.626 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.446 HH11 ' HG3' ' A' ' 37' ' ' ARG . 21.7 mmm-85 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.019 -1.051 . . . . 3.0 110.541 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 40' ' ' PHE . 70.4 m-85 -124.05 82.53 56.31 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.418 -0.801 . . . . 1.54 109.766 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.45 -6.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.562 2.174 . . . . 1.21 111.779 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 38' ' ' PHE . 49.6 t80 -59.94 -42.76 94.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.515 -0.74 . . . . 3.7400000000000002 109.898 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.03 -22.15 63.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 1.1200000000000001 110.937 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -39.84 86.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.912 -1.117 . . . . 2.5099999999999998 109.705 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.54 2.85 43.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 2.3399999999999999 109.728 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.501 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 81.3 m-20 -133.92 115.67 14.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.626 -0.672 . . . . 2.0099999999999998 109.832 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' GLN . 56.0 mttp -110.47 13.74 22.68 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.477 -0.935 . . . . 1.6799999999999999 108.477 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 48' ' ' TRP . 87.7 mt-30 -47.39 -177.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.995 0.902 . . . . 3.98 111.401 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.9 -8.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.932 -0.867 . . . . 0.78000000000000003 110.932 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' A' ' 46' ' ' GLN . 3.8 p-90 -59.87 -40.75 89.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.575 -1.544 . . . . 0.44 107.939 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.514 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 58.5 tt0 -60.06 -50.3 74.26 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.261 0.553 . . . . 1.96 111.316 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -73.23 -40.07 64.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.173 . . . . 1.28 110.759 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.3 p -51.94 -30.05 22.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.937 . . . . 1.49 110.773 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.76 -52.26 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.118 . . . . 0.64000000000000001 110.489 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG2' HD21 ' A' ' 27' ' ' LEU . 32.6 mtp180 -69.98 -40.67 75.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.052 . . . . 2.7599999999999998 110.154 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -63.34 -39.98 96.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.079 -1.013 . . . . 2.48 108.659 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.96 -40.0 95.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.093 -1.077 . . . . 2.0699999999999998 108.093 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.2 mt -68.51 -40.59 80.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.78000000000000003 109.823 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 t -69.95 -44.24 69.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 1.6000000000000001 109.468 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 mt -69.62 -39.71 77.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 1.3799999999999999 109.046 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -75.58 105.81 6.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.168 -0.957 . . . . 1.4199999999999999 109.31 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.47 -1.08 57.92 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.981 -1.118 . . . . 2.1699999999999999 107.981 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.4 m -60.17 -34.09 73.1 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.042 -0.725 . . . . 1.5600000000000001 109.042 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.51 155.55 29.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.8 . . . . 1.3200000000000001 109.025 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 125.73 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.517 -0.74 . . . . 0.91000000000000003 109.209 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -76.61 154.65 34.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 1.8100000000000001 109.167 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.24 91.77 49.53 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.49 -0.756 . . . . 1.28 109.0 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -45.1 151.09 0.82 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.097 1.865 . . . . 1.6499999999999999 112.524 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -114.84 158.98 21.19 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.182 -0.673 . . . . 4.0899999999999999 109.182 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.12 166.87 0.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.86 . . . . 2.8399999999999999 110.171 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' LYS . 95.6 m-20 -69.15 -26.06 64.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.513 -0.742 . . . . 3.46 109.881 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -70.35 47.42 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 4.5 109.355 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 69' ' ' ASP . 4.2 ptmt -98.04 111.95 60.64 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.366 -0.834 . . . . 5.1200000000000001 109.927 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.7 10.45 3.68 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.966 1.777 . . . . 3.6299999999999999 111.728 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.58 -77.83 0.09 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.395 -1.482 . . . . 3.1499999999999999 109.395 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -59.99 141.08 56.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -1.187 . . . . 4.3600000000000003 108.549 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.21 -14.29 2.73 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 120.357 -0.925 . . . . 2.0299999999999998 111.962 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.1 m -158.61 154.73 27.02 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.092 -1.828 . . . . 1.8 111.785 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.442 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 21.6 m-85 -110.57 163.66 13.49 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.038 -1.097 . . . . 1.3899999999999999 108.038 178.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -110.96 127.16 55.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.46000000000000002 109.58 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.3 t -141.67 159.19 42.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.305 -0.872 . . . . 0.56000000000000005 109.686 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 81' ' ' ASP . 75.4 mt -76.27 172.54 12.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.4199999999999999 109.973 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' LEU . 1.1 m-20 -48.56 176.68 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 108.894 -0.78 . . . . 3.7200000000000002 108.894 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.58 -142.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.796 1.664 . . . . 3.5499999999999998 111.233 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 85' ' ' TYR . 74.9 m-20 -88.27 5.47 41.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.981 -1.074 . . . . 6.8200000000000003 108.874 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 p -54.96 83.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 6.0 108.95 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' A' ' 83' ' ' ASP . 8.7 t80 -80.15 -67.98 0.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 11.0 109.73 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 43.4 p-10 -109.2 18.27 20.71 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.694 0.759 . . . . 10.0 109.448 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -84.0 123.97 30.56 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.45 0.643 . . . . 8.4700000000000006 110.346 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -139.08 -0.62 1.84 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.439 -0.788 . . . . 11.970000000000001 109.009 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -150.03 170.28 19.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 11.949999999999999 109.067 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.8 p30 -49.37 142.31 7.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 12.32 109.318 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.89 2.73 73.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.932 -1.267 . . . . 11.16 109.932 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.0 p -59.85 -38.63 82.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -1.201 . . . . 11.800000000000001 108.894 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -61.88 132.68 53.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 10.779999999999999 108.846 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.1 tp . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 13.119999999999999 109.026 -179.778 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.761 -0.459 . . . . 4.8099999999999996 109.761 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 42.4 mt -111.1 140.12 45.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.623 -0.673 . . . . 1.71 109.541 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.1 160.08 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.566 -0.709 . . . . 1.79 109.358 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -70.05 150.31 96.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.241 -1.022 . . . . 3.6899999999999999 108.241 179.194 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 55.4 Cg_endo -81.57 136.35 9.68 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.091 1.861 . . . . 0.72999999999999998 112.147 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.64 -17.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.546 2.164 . . . . 0.83999999999999997 113.793 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 6.1 m-85 -67.69 129.04 38.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.766 -1.209 . . . . 1.1499999999999999 110.171 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.1 p -81.94 177.17 9.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -0.759 . . . . 1.3899999999999999 109.059 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -59.93 -41.48 91.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 1.3200000000000001 109.562 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.01 -47.46 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.95999999999999996 109.784 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.89 87.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.913 . . . . 0.38 110.317 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.03 -45.63 92.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.831 -1.168 . . . . 0.37 109.051 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 84.2 mt -62.19 -40.02 86.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.123 -1.065 . . . . 0.48999999999999999 108.123 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.33 -39.95 94.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.614 -0.679 . . . . 0.39000000000000001 109.593 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.0 mtt -65.83 -39.91 91.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 1.1399999999999999 109.76 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.31 89.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 0.32000000000000001 109.835 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.1 mt -60.02 -49.97 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.151 -0.968 . . . . 0.33000000000000002 108.543 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -65.19 -40.04 93.66 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.213 0.53 . . . . 1.8200000000000001 110.168 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.12 0.7 43.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 1.6699999999999999 110.45 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 148.42 74.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.96 -1.087 . . . . 0.63 108.759 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.81 -23.53 74.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.608 1.539 . . . . 1.29 109.768 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -138.35 148.79 44.94 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.124 . . . . 2.6299999999999999 107.964 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -61.64 -36.9 82.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.007 -1.058 . . . . 2.02 108.274 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.377 -0.971 . . . . 1.55 108.377 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.14 152.71 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.368 -0.832 . . . . 0.46999999999999997 109.048 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.2 p -80.08 153.8 28.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 0.81000000000000005 109.238 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -59.97 -40.27 88.53 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.446 -0.784 . . . . 0.69999999999999996 108.889 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.17 -40.06 88.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.506 -0.746 . . . . 1.25 109.913 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.92 -38.83 97.22 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.639 -0.985 . . . . 0.28999999999999998 110.639 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.04 -40.44 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -1.225 . . . . 0.34999999999999998 110.017 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.533 ' CE1' ' OE1' ' A' ' 49' ' ' GLN . 32.1 m-85 -60.03 -41.95 93.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.901 -1.124 . . . . 1.3999999999999999 110.263 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.14 -40.24 89.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.297 -0.877 . . . . 2.5099999999999998 110.078 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.94 -49.63 76.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.672 . . . . 1.3700000000000001 111.446 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.2 mt -59.93 -49.86 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 0.58999999999999997 111.631 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.8 mtm -60.0 -40.03 87.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 0.68999999999999995 111.164 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.29 -46.18 71.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.649 -1.282 . . . . 1.1699999999999999 111.019 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' HE ' ' HA ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -70.0 -40.06 75.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.89 -1.131 . . . . 3.0 109.943 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -121.63 110.04 33.97 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.662 -0.866 . . . . 1.54 108.662 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.471 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 95.8 Cg_endo -79.59 -11.27 14.27 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.927 1.751 . . . . 1.21 113.011 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -58.47 -35.97 72.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.176 -0.952 . . . . 3.7400000000000002 109.22 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 44' ' ' ASN . 91.5 m-85 -67.6 -29.5 68.86 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.767 -0.583 . . . . 1.1200000000000001 110.603 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -59.96 -39.96 87.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.027 -1.046 . . . . 2.5099999999999998 109.582 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 39' ' ' PRO . 54.7 mp0 -66.62 -39.97 88.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.037 -1.039 . . . . 2.3399999999999999 109.048 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.4 m-20 -106.23 106.49 17.03 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.257 -0.645 . . . . 2.0099999999999998 109.257 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 59.1 mttm -98.38 -42.61 7.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.114 -0.991 . . . . 1.6799999999999999 109.96 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -77.98 140.14 39.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.165 -0.96 . . . . 3.98 109.873 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.86 -59.98 0.34 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.443 -1.063 . . . . 0.78000000000000003 110.443 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.422 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 26.2 p-90 -89.44 -14.77 34.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.025 -1.279 . . . . 0.44 110.497 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.533 ' OE1' ' CE1' ' A' ' 31' ' ' TYR . 3.2 tp-100 -69.92 -60.02 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 1.96 110.926 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -72.36 -28.67 63.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.906 -1.121 . . . . 1.28 110.942 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -59.95 -38.82 83.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.909 -1.119 . . . . 1.49 109.857 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.95 -44.77 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.938 . . . . 0.64000000000000001 110.086 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -68.97 -44.79 72.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.791 -1.193 . . . . 2.7599999999999998 110.482 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -60.01 -41.66 92.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 2.48 109.279 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -61.96 -42.26 98.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 2.0699999999999998 108.753 179.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -60.06 -46.83 88.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.409 -0.807 . . . . 0.78000000000000003 109.903 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 t -70.4 -41.98 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 1.6000000000000001 109.961 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.36 -39.96 89.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 1.3799999999999999 110.084 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -74.73 119.75 19.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.148 -0.97 . . . . 1.4199999999999999 108.984 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -89.96 -2.7 58.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 2.1699999999999999 108.667 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' OD2' ' A' ' 81' ' ' ASP . 93.7 m -62.61 -40.04 95.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.747 . . . . 1.5600000000000001 109.367 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -80.6 152.62 28.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 1.3200000000000001 109.421 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.6 t -127.42 128.04 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 0.91000000000000003 109.589 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -83.82 150.02 26.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 1.8100000000000001 109.415 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.2 80.03 69.31 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.111 -1.07 . . . . 1.28 108.111 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.63 160.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.249 1.966 . . . . 1.6499999999999999 112.252 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -76.35 159.29 30.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.157 -0.965 . . . . 4.0899999999999999 108.742 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -66.82 155.4 38.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.221 -0.924 . . . . 2.8399999999999999 108.579 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.58 -18.89 61.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.092 -1.005 . . . . 3.46 109.281 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -74.67 -9.12 58.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.414 -0.804 . . . . 4.5 109.408 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 72' ' ' PRO . 34.5 mmtm -130.01 79.92 72.1 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.774 . . . . 5.1200000000000001 109.393 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 71' ' ' LYS . 48.2 Cg_exo -54.83 -145.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.907 2.405 . . . . 3.6299999999999999 112.161 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.24 -124.98 34.94 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.237 -1.145 . . . . 3.1499999999999999 110.237 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -61.26 140.19 58.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -1.074 . . . . 4.3600000000000003 109.822 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.9 40.67 1.58 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.646 -1.382 . . . . 2.0299999999999998 109.646 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.6 m -154.84 129.11 8.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.866 -1.373 . . . . 1.8 111.302 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -132.1 158.57 41.28 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.218 -1.401 . . . . 1.3899999999999999 107.218 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -122.75 134.78 54.43 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.27 -0.894 . . . . 0.46000000000000002 110.23 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -152.64 161.32 42.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 0.56000000000000005 109.245 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.57 160.01 26.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.033 -1.042 . . . . 1.4199999999999999 109.488 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -53.56 174.33 0.17 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.381 -0.824 . . . . 3.7200000000000002 108.975 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.54 -140.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.086 1.857 . . . . 3.5499999999999998 111.709 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 85' ' ' TYR . 34.3 p-10 -82.19 9.25 9.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.286 -0.884 . . . . 6.8200000000000003 108.698 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 84.7 p -58.09 75.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.569 -0.707 . . . . 6.0 109.892 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 83' ' ' ASP . 21.1 p90 -62.51 -48.81 77.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 11.0 108.349 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.509 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 36.1 m120 -154.03 82.31 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.339 -0.986 . . . . 10.0 108.339 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.511 ' SD ' ' O ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -73.47 132.7 43.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.461 -0.774 . . . . 8.4700000000000006 109.14 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.48 -39.57 27.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.149 -0.969 . . . . 11.970000000000001 110.351 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -119.19 159.88 23.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.569 -0.707 . . . . 11.949999999999999 109.812 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -82.53 2.28 33.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.452 -0.78 . . . . 12.32 109.03 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.03 -83.35 0.07 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.267 -1.533 . . . . 11.16 109.267 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 t -85.46 78.6 9.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -1.165 . . . . 11.800000000000001 109.254 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -89.95 0.27 57.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 10.779999999999999 109.656 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.7 mt . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 13.119999999999999 108.685 179.707 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.426 -0.583 . . . . 4.8099999999999996 109.426 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.93 140.0 30.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 1.71 109.534 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.5 m -145.86 156.02 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.507 -0.746 . . . . 1.79 109.198 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -70.34 147.13 95.03 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.071 -1.018 . . . . 3.6899999999999999 108.525 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 7' ' ' TYR . 68.7 Cg_endo -79.55 143.08 16.76 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.974 1.783 . . . . 0.72999999999999998 111.352 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.74 -24.36 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.249 1.966 . . . . 0.83999999999999997 113.373 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PRO . 12.4 m-85 -60.61 131.54 51.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 1.1499999999999999 109.895 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t -81.7 169.21 17.24 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.482 -0.933 . . . . 1.3899999999999999 108.482 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -60.0 -40.3 88.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 1.3200000000000001 109.352 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.29 -43.45 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.015 -1.053 . . . . 0.95999999999999996 108.935 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.17 85.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.8 . . . . 0.38 109.855 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.98 -40.21 88.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 0.37 109.059 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.92 -44.2 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.04 -1.038 . . . . 0.48999999999999999 108.247 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m -60.56 -40.04 90.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 0.39000000000000001 110.376 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.97 -39.96 87.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 1.1399999999999999 109.811 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.11 94.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.32000000000000001 109.961 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.33 -46.3 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.33000000000000002 109.03 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.94 -40.04 87.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.71 -0.619 . . . . 1.8200000000000001 109.462 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -83.25 -3.06 57.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.933 . . . . 1.6699999999999999 109.462 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.01 124.84 82.82 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 0.63 109.493 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -42.93 -57.09 1.87 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.397 1.398 . . . . 1.29 110.92 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -97.52 140.82 31.37 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.852 -1.166 . . . . 2.6299999999999999 107.852 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -59.9 -35.53 75.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 2.02 110.087 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -76.97 129.95 36.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.604 -1.31 . . . . 1.55 108.533 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.0 tt -139.9 147.68 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 0.46999999999999997 109.694 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -82.66 150.22 26.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.479 -0.763 . . . . 0.81000000000000005 109.295 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 56' ' ' LEU . 51.4 tp -59.97 -41.59 92.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.69999999999999996 108.627 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.33 -41.75 94.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.547 -0.72 . . . . 1.25 110.106 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.51 97.23 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.492 -1.043 . . . . 0.28999999999999998 110.492 -179.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.99 -39.98 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -1.188 . . . . 0.34999999999999998 110.284 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -59.97 -42.0 93.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.636 -1.29 . . . . 1.3999999999999999 109.569 -178.964 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.56 -40.67 95.58 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.127 -0.983 . . . . 2.5099999999999998 109.789 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.26 -49.88 75.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 1.3700000000000001 111.377 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.07 -44.72 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 0.58999999999999997 110.738 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.7 mtm -60.01 -41.79 92.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.919 -1.113 . . . . 0.68999999999999995 109.416 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.02 -40.0 75.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 1.1699999999999999 110.417 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -68.05 -60.03 2.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 3.0 110.654 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.08 126.31 31.37 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 1.54 109.257 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.64 -16.54 10.37 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.161 1.907 . . . . 1.21 113.555 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.826 -1.171 . . . . 3.7400000000000002 110.181 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -17.59 64.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 1.1200000000000001 110.908 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -60.06 -48.66 80.81 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.999 -1.063 . . . . 2.5099999999999998 109.141 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.728 0.775 . . . . 2.3399999999999999 110.326 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.453 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 14.6 t-20 -93.96 99.98 12.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.638 -0.664 . . . . 2.0099999999999998 109.372 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 62.0 mttp -97.77 -39.26 9.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 1.6799999999999999 110.189 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -87.66 139.79 30.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 3.98 110.107 -178.429 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.72 -59.22 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.403 -1.079 . . . . 0.78000000000000003 110.403 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.453 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 31.7 p-90 -82.48 -12.5 57.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.964 -1.315 . . . . 0.44 110.479 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.0 -54.23 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 1.96 110.739 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -70.03 -25.93 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.904 -1.123 . . . . 1.28 110.841 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.3 p -60.11 -39.92 87.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 1.49 110.139 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.49 -47.94 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.64000000000000001 110.604 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -69.95 -42.53 73.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.882 -1.136 . . . . 2.7599999999999998 110.535 -178.83 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -44.8 94.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 2.48 108.961 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -59.98 -40.14 88.07 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.204 -0.935 . . . . 2.0699999999999998 109.459 -179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.463 ' CD1' HD13 ' A' ' 27' ' ' LEU . 86.6 mt -61.2 -42.18 98.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 0.78000000000000003 110.446 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.7 p -66.73 -46.53 75.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.109 -0.994 . . . . 1.6000000000000001 110.753 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.28 -39.91 74.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.862 -1.149 . . . . 1.3799999999999999 110.249 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 33.9 m120 -77.7 118.01 19.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.977 . . . . 1.4199999999999999 109.351 -179.116 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.65 -2.96 57.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 2.1699999999999999 110.017 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CD2' ' A' ' 62' ' ' PHE . 12.2 p -61.41 -32.44 72.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.5600000000000001 108.868 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.582 ' CD2' ' SG ' ' A' ' 61' ' ' CYS . 90.8 m-85 -79.06 150.06 31.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.438 -0.789 . . . . 1.3200000000000001 109.194 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.33 122.04 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.777 -0.823 . . . . 0.91000000000000003 108.777 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -80.78 111.55 17.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 1.8100000000000001 110.142 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.5 t -103.75 113.68 65.29 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.938 -1.134 . . . . 1.28 107.938 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.58 143.19 16.8 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.816 1.677 . . . . 1.6499999999999999 112.711 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 73' ' ' GLY . 32.2 ptt180 -71.87 142.47 49.56 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.383 -0.823 . . . . 4.0899999999999999 108.966 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.13 149.22 27.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 2.8399999999999999 109.143 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.04 -39.88 87.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.138 -0.976 . . . . 3.46 109.679 -179.653 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -64.68 -25.42 67.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -0.982 . . . . 4.5 109.32 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -118.21 90.48 38.09 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.547 -0.721 . . . . 5.1200000000000001 109.233 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.44 138.94 87.13 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.996 1.797 . . . . 3.6299999999999999 110.853 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.451 ' O ' ' NH1' ' A' ' 67' ' ' ARG . . . -148.33 -178.57 23.57 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.5 -1.44 . . . . 3.1499999999999999 109.5 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' GLY . 16.7 mtpp -96.97 138.67 34.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -1.149 . . . . 4.3600000000000003 109.552 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' LYS . . . 42.27 -125.94 4.14 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.814 -1.314 . . . . 2.0299999999999998 109.814 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.4 p -130.06 138.72 50.89 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.666 -0.902 . . . . 1.8 108.573 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -67.37 137.68 56.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.054 -1.029 . . . . 1.3899999999999999 108.91 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.05 139.98 51.7 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.403 -0.811 . . . . 0.46000000000000002 109.843 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -153.23 153.12 32.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.56000000000000005 109.895 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.0 mt -74.98 -133.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 1.4199999999999999 108.561 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -139.8 70.69 36.67 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.333 -0.854 . . . . 3.7200000000000002 108.869 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.17 -145.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.895 2.396 . . . . 3.5499999999999998 112.163 -179.496 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 85' ' ' TYR . 28.3 p-10 -72.95 74.42 1.17 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.088 -1.079 . . . . 6.8200000000000003 108.088 179.276 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 p -50.48 -7.58 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.855 -0.528 . . . . 6.0 110.357 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 83' ' ' ASP . 65.6 t80 -61.13 -38.05 84.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.752 -1.218 . . . . 11.0 109.629 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.446 ' OD1' ' OD2' ' A' ' 83' ' ' ASP . 23.2 m120 -70.04 -17.61 63.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 10.0 110.702 -178.657 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 86' ' ' ASN . 64.4 mtt -60.7 -155.77 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.42 -0.912 . . . . 8.4700000000000006 108.965 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -70.39 -149.95 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.793 -1.192 . . . . 11.970000000000001 109.51 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -109.71 15.29 22.89 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.246 0.546 . . . . 11.949999999999999 109.818 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -153.36 152.13 30.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 12.32 109.611 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.38 21.85 74.45 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.563 -1.415 . . . . 11.16 109.563 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.3 t -87.06 104.11 16.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.331 -1.099 . . . . 11.800000000000001 108.79 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -58.61 132.65 54.44 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.099 -0.704 . . . . 10.779999999999999 109.099 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.544 -0.723 . . . . 13.119999999999999 109.748 -179.562 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mtp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.381 -0.6 . . . . 4.8099999999999996 109.381 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.7 mt -102.31 140.1 37.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.433 -0.792 . . . . 1.71 109.511 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 m -135.13 148.87 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.53 -0.731 . . . . 1.79 109.38 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -70.17 128.22 91.67 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 3.6899999999999999 108.789 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.01 151.95 11.04 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.839 1.692 . . . . 0.72999999999999998 112.635 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.25 2.52 8.47 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.633 2.222 . . . . 0.83999999999999997 113.83 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.59 140.21 58.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.514 -1.367 . . . . 1.1499999999999999 109.48 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.0 m -74.54 164.33 26.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.893 . . . . 1.3899999999999999 109.073 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -59.9 -40.07 87.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.166 -0.959 . . . . 1.3200000000000001 108.622 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 55' ' ' ASN . 32.2 mm -69.62 -40.0 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.95999999999999996 108.973 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.92 95.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 0.38 109.692 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.062 -1.024 . . . . 0.37 108.436 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 0.48999999999999999 108.807 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -60.73 -40.03 90.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 0.39000000000000001 109.876 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.2 mtt -67.43 -39.88 85.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.009 . . . . 1.1399999999999999 109.009 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.33 78.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 0.32000000000000001 109.802 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.98 -50.02 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.195 -1.039 . . . . 0.33000000000000002 108.195 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.393 0.616 . . . . 1.8200000000000001 109.348 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -84.01 -0.51 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 1.6699999999999999 109.759 -179.382 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.92 126.48 82.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.057 -1.027 . . . . 0.63 108.836 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -38.79 -28.12 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.785 1.657 . . . . 1.29 111.328 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' ALA . 12.8 pt-20 -145.69 155.28 42.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.174 -1.047 . . . . 2.6299999999999999 108.174 178.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -60.05 -38.03 81.59 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.174 -0.953 . . . . 2.02 109.687 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -79.07 108.25 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 1.55 109.751 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -133.58 154.39 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.941 -0.763 . . . . 0.46999999999999997 108.941 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -80.45 155.37 27.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.81000000000000005 110.306 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.98 -43.39 95.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.584 -0.895 . . . . 0.69999999999999996 108.584 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.1 -39.93 91.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.805 . . . . 1.25 109.748 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.05 96.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.554 -1.018 . . . . 0.28999999999999998 110.554 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -41.11 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.247 . . . . 0.34999999999999998 110.123 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -62.48 -38.07 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.161 . . . . 1.3999999999999999 110.012 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.37 -44.27 84.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.097 -1.002 . . . . 2.5099999999999998 108.872 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.16 -47.59 85.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.905 . . . . 1.3700000000000001 110.198 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.3 mt -59.93 -49.98 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.012 . . . . 0.58999999999999997 110.94 -178.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtm -66.78 -40.03 88.02 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.767 -1.208 . . . . 0.68999999999999995 109.771 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -70.32 -43.05 71.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.971 -1.08 . . . . 1.1699999999999999 110.677 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.535 ' NH1' ' CE1' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -69.96 -40.0 75.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.863 -1.148 . . . . 3.0 109.516 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' NH1' ' A' ' 37' ' ' ARG . 62.7 m-85 -127.81 78.17 75.39 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.307 -0.87 . . . . 1.54 109.44 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.68 -7.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.754 2.303 . . . . 1.21 112.434 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' PHE . 40.3 t80 -59.92 -39.3 85.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 3.7400000000000002 109.4 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' ASN . 78.6 m-85 -69.81 -20.96 63.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 1.1200000000000001 110.943 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -59.99 -39.76 86.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.593 -1.317 . . . . 2.5099999999999998 108.758 179.034 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -77.91 -9.46 59.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 2.3399999999999999 109.95 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.504 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 82.9 m-20 -129.27 116.9 19.83 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 2.0099999999999998 110.237 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 67.0 mttm -109.99 11.73 23.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.717 -0.845 . . . . 1.6799999999999999 108.717 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 48' ' ' TRP . 95.8 mm-40 -48.24 177.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.001 0.905 . . . . 3.98 111.857 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 49' ' ' GLN . . . -42.28 -15.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 CA-C-N 115.779 -0.646 . . . . 0.78000000000000003 111.509 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' N ' ' O ' ' A' ' 46' ' ' GLN . 9.2 p-90 -51.18 -20.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.514 -1.58 . . . . 0.44 107.893 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' A' ' 47' ' ' GLY . 30.1 tt0 -86.37 -57.13 3.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.28 -0.637 . . . . 1.96 109.28 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.9 -33.96 72.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 1.28 109.589 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.1 m -60.04 -39.95 87.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.49 108.929 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.5 mm -60.13 -49.88 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.539 -0.725 . . . . 0.64000000000000001 109.65 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -61.9 -44.54 96.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.968 -1.083 . . . . 2.7599999999999998 108.768 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -60.01 -41.48 92.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.295 -0.878 . . . . 2.48 108.88 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.633 HD21 HD11 ' A' ' 10' ' ' ILE . 37.7 t-20 -63.89 -40.1 95.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.567 -0.708 . . . . 2.0699999999999998 109.341 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.99 -47.81 84.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.12 -0.987 . . . . 0.78000000000000003 109.691 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.4 m -62.6 -40.13 95.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 1.6000000000000001 109.164 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.458 HD23 ' O ' ' A' ' 58' ' ' LEU . 3.3 tt -65.84 -50.39 64.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.859 -0.525 . . . . 1.3799999999999999 110.16 -178.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -69.98 117.47 11.6 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.844 -1.142 . . . . 1.4199999999999999 108.724 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -90.1 -2.47 58.1 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.476 -0.935 . . . . 2.1699999999999999 108.476 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.1 m -60.08 -39.12 84.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.254 -0.647 . . . . 1.5600000000000001 109.254 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.29 150.31 33.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.358 -0.839 . . . . 1.3200000000000001 109.418 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.0 t -110.7 125.87 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.447 -0.783 . . . . 0.91000000000000003 109.464 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 139.83 51.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.957 -1.127 . . . . 1.8100000000000001 107.957 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.09 77.36 61.81 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.201 -0.937 . . . . 1.28 109.366 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.5 169.23 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.459 2.106 . . . . 1.6499999999999999 111.557 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' CZ ' ' H ' ' A' ' 74' ' ' LYS . 32.2 mtm180 -83.01 174.94 10.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.165 -0.959 . . . . 4.0899999999999999 108.758 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -58.97 150.69 23.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.87 . . . . 2.8399999999999999 108.721 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -68.9 -18.62 64.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.187 -0.946 . . . . 3.46 109.331 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -62.01 -40.0 94.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 4.5 108.766 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' A' ' 73' ' ' GLY . 21.8 mmtp -81.62 150.53 66.68 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 108.354 -0.98 . . . . 5.1200000000000001 108.354 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.71 13.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.81 1.673 . . . . 3.6299999999999999 112.238 -179.399 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 71' ' ' LYS . . . 56.78 78.98 0.1 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.918 -1.273 . . . . 3.1499999999999999 109.918 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.572 ' H ' ' CZ ' ' A' ' 67' ' ' ARG . 68.1 mttm -67.64 -32.52 73.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.221 -1.164 . . . . 4.3600000000000003 109.937 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.35 -161.51 18.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.496 -1.442 . . . . 2.0299999999999998 109.496 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.8 t -133.41 122.57 23.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.543 -0.975 . . . . 1.8 109.437 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -75.4 176.73 7.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 1.3899999999999999 108.551 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -138.37 149.96 46.09 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.281 -0.887 . . . . 0.46000000000000002 109.511 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -157.23 159.34 37.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.005 . . . . 0.56000000000000005 110.003 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' ASP . 77.4 mt -74.82 171.21 14.39 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.502 -0.925 . . . . 1.4199999999999999 108.502 179.225 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -49.24 175.73 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.231 -0.918 . . . . 3.7200000000000002 108.717 -179.893 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.88 -143.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.874 1.716 . . . . 3.5499999999999998 111.897 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 85' ' ' TYR . 74.2 m-20 -95.49 32.03 1.88 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.723 -0.843 . . . . 6.8200000000000003 108.723 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 t -63.47 67.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.112 -0.699 . . . . 6.0 109.112 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 83' ' ' ASP . 14.4 t80 -80.02 -69.76 0.57 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.291 -0.88 . . . . 11.0 109.304 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -118.6 20.67 12.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.62 -0.675 . . . . 10.0 109.735 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -83.5 96.3 8.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 8.4700000000000006 109.186 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -106.07 -0.95 24.38 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.964 -0.754 . . . . 11.970000000000001 108.964 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.32 -160.71 0.18 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.47 -0.769 . . . . 11.949999999999999 109.138 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 71.1 m-20 -66.95 -14.22 62.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.043 -1.036 . . . . 12.32 109.538 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.64 77.07 0.89 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.561 -1.416 . . . . 11.16 109.561 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.4 t -101.13 85.46 2.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.409 -1.054 . . . . 11.800000000000001 108.877 179.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -60.07 -49.95 75.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 10.779999999999999 109.551 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 13.119999999999999 109.346 179.858 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 tpp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.143 -0.688 . . . . 4.8099999999999996 109.143 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.5 mt -113.25 139.4 48.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.349 -0.611 . . . . 1.71 109.349 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.01 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.625 -0.672 . . . . 1.79 109.312 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -66.74 149.74 98.08 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 3.6899999999999999 110.035 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.92 160.59 33.73 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.624 2.216 . . . . 0.72999999999999998 111.618 178.952 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.26 4.37 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.481 2.121 . . . . 0.83999999999999997 113.285 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -82.17 135.89 35.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.718 -1.239 . . . . 1.1499999999999999 109.136 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -71.72 162.54 29.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 1.3899999999999999 108.634 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -59.67 -39.9 85.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.93 -1.106 . . . . 1.3200000000000001 108.629 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.43 -39.98 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.95999999999999996 108.981 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.15 87.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.85 . . . . 0.38 109.884 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.05 -41.68 92.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.884 -1.135 . . . . 0.37 108.792 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.516 HG21 HD21 ' A' ' 56' ' ' LEU . 92.2 mt -70.0 -41.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.372 -0.83 . . . . 0.48999999999999999 109.663 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -60.41 -42.53 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 0.39000000000000001 109.448 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.5 mtm -69.92 -36.83 75.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.402 -0.811 . . . . 1.1399999999999999 109.839 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.5 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.32000000000000001 109.494 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.4 mt -59.98 -49.94 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.39 -0.967 . . . . 0.33000000000000002 108.39 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.68 -39.95 93.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.447 -0.783 . . . . 1.8200000000000001 109.324 179.329 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 58.7 m-20 -80.48 3.82 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.806 . . . . 1.6699999999999999 109.748 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 147.58 71.34 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 0.63 109.356 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 -20.68 57.46 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.851 1.701 . . . . 1.29 110.041 179.15 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.25 149.6 36.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.843 -1.169 . . . . 2.6299999999999999 107.843 178.24 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -60.6 -39.89 89.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 2.02 110.297 -178.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.86 124.78 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.111 . . . . 1.55 109.017 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.8 tt -138.83 142.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -0.824 . . . . 0.46999999999999997 109.394 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.4 p -79.89 157.92 26.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.362 -0.836 . . . . 0.81000000000000005 109.223 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -60.01 -40.23 88.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.69999999999999996 109.392 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -60.03 -41.94 93.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 1.25 110.57 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 -38.56 96.31 Favored Glycine 0 N--CA 1.494 2.516 0 O-C-N 121.193 -0.942 . . . . 0.28999999999999998 111.203 -178.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.97 -40.02 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.256 . . . . 0.34999999999999998 109.79 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 33.3 m-85 -59.96 -39.95 87.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.11 -0.994 . . . . 1.3999999999999999 110.029 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -59.68 -40.01 86.43 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.367 -0.833 . . . . 2.5099999999999998 110.137 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -60.52 -40.36 91.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 1.3700000000000001 109.896 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.44 -61.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.107 -0.996 . . . . 0.58999999999999997 110.624 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.5 mtm -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 0.68999999999999995 110.446 -178.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.14 -40.12 92.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 1.1699999999999999 110.471 -179.105 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -89.17 -55.77 3.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.021 -1.049 . . . . 3.0 110.063 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -96.05 112.47 59.63 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.973 -1.079 . . . . 1.54 108.688 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.96 -7.44 14.32 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.815 1.677 . . . . 1.21 111.884 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.01 -40.06 87.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.773 . . . . 3.7400000000000002 110.229 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -70.98 -13.13 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 1.1200000000000001 110.874 -178.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.1 mmm180 -59.99 -40.03 87.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 2.5099999999999998 110.735 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.32 0.08 55.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 2.3399999999999999 110.339 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.514 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 68.7 m-80 -133.96 108.55 8.46 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.763 -0.829 . . . . 2.0099999999999998 108.763 179.144 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 42' ' ' ARG . 61.1 mttp -111.97 -29.97 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.681 -0.637 . . . . 1.6799999999999999 110.051 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -90.66 139.42 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 3.98 109.781 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.27 -64.19 0.31 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.435 -1.066 . . . . 0.78000000000000003 110.435 179.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.514 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 23.1 p-90 -77.05 -20.06 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.316 . . . . 0.44 110.478 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.473 ' OE1' ' NH2' ' A' ' 53' ' ' ARG . 9.6 tt0 -62.29 -52.3 64.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 1.96 110.628 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -68.97 -35.06 76.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 1.28 110.194 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 1.49 109.746 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mm -60.91 -45.99 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.64000000000000001 110.25 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.473 ' NH2' ' OE1' ' A' ' 49' ' ' GLN . 41.7 mtt180 -69.52 -40.12 77.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.951 -1.093 . . . . 2.7599999999999998 109.888 -178.83 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -60.14 -40.15 88.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 2.48 108.765 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 95.2 m-20 -61.85 -39.95 93.63 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.54 -0.911 . . . . 2.0699999999999998 108.54 179.39 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 13' ' ' ILE . 78.1 mt -70.0 -40.02 75.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.78000000000000003 110.267 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.5 p -74.56 -44.88 48.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 1.6000000000000001 110.495 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.65 -39.9 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 1.3799999999999999 110.214 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 96.1 m-20 -66.19 120.3 12.99 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.297 -1.001 . . . . 1.4199999999999999 108.297 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 25.7 mp0 -87.81 -10.97 49.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.272 -0.893 . . . . 2.1699999999999999 109.361 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m -64.14 -40.01 95.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.451 -0.78 . . . . 1.5600000000000001 109.926 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -79.6 127.93 32.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 1.3200000000000001 109.736 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.37 124.72 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.454 -0.943 . . . . 0.91000000000000003 108.454 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -94.15 150.66 20.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.012 . . . . 1.8100000000000001 110.511 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.97 86.62 25.96 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 107.722 -1.214 . . . . 1.28 107.722 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -42.87 167.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.618 2.212 . . . . 1.6499999999999999 113.694 -178.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.687 HH22 ' N ' ' A' ' 73' ' ' GLY . 84.9 mtm180 -86.11 -179.38 6.73 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.944 -0.762 . . . . 4.0899999999999999 108.944 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.51 151.37 44.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.313 -0.995 . . . . 2.8399999999999999 108.313 178.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -66.0 -19.97 66.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.025 -1.047 . . . . 3.46 109.612 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -94.91 2.52 55.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.192 -0.942 . . . . 4.5 110.681 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -129.96 80.03 71.97 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 5.1200000000000001 110.084 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.524 ' C ' HH12 ' A' ' 67' ' ' ARG . 66.9 Cg_endo -90.44 -165.91 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.414 2.743 . . . . 3.6299999999999999 112.005 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.687 ' N ' HH22 ' A' ' 67' ' ' ARG . . . 107.46 -85.06 0.4 Allowed Glycine 0 N--CA 1.498 2.824 0 O-C-N 121.191 -0.943 . . . . 3.1499999999999999 111.502 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.541 ' N ' ' NH1' ' A' ' 67' ' ' ARG . 24.5 mtpp -66.59 166.94 11.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -1.153 . . . . 4.3600000000000003 111.39 -178.087 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.14 178.84 29.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.85 -1.3 . . . . 2.0299999999999998 109.85 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.4 p -80.17 169.34 17.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -1.086 . . . . 1.8 110.047 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -90.38 144.91 25.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 1.3899999999999999 109.418 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -120.05 139.36 52.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.536 -0.727 . . . . 0.46000000000000002 109.458 179.304 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 t -150.65 167.52 27.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 0.56000000000000005 109.168 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.96 168.41 17.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 1.4199999999999999 109.495 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.13 128.71 87.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 3.7200000000000002 109.605 -178.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.76 -152.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.302 2.002 . . . . 3.5499999999999998 111.617 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -76.18 71.67 2.93 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.747 -1.205 . . . . 6.8200000000000003 107.747 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 p -69.99 -17.25 63.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.653 -0.654 . . . . 6.0 110.64 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -32.88 74.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.835 -1.166 . . . . 11.0 108.809 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 87' ' ' MET . 28.0 m120 -97.97 19.41 13.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.281 -0.887 . . . . 10.0 109.662 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -48.11 175.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 8.4700000000000006 109.692 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -81.75 73.32 8.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.209 -0.932 . . . . 11.970000000000001 108.559 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' A' ' 91' ' ' GLY . 10.6 pt-20 -65.26 143.47 57.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 11.949999999999999 109.721 -179.414 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -94.98 13.5 24.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.416 -0.803 . . . . 12.32 109.698 -179.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.407 ' O ' ' OE1' ' A' ' 89' ' ' GLU . . . -169.66 -125.77 0.82 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.874 -1.155 . . . . 11.16 110.228 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.3 p -135.12 46.38 2.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -1.001 . . . . 11.800000000000001 109.416 -179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.97 -40.57 89.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 10.779999999999999 111.347 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.674 -1.266 . . . . 13.119999999999999 109.337 -178.983 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.03 -0.73 . . . . 4.8099999999999996 109.03 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.6 mt -85.95 147.73 26.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.514 -0.742 . . . . 1.71 109.095 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.54 142.51 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -0.959 . . . . 1.79 109.754 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -78.17 140.7 61.64 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.364 -0.835 . . . . 3.6899999999999999 108.749 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.37 159.61 39.82 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.024 1.816 . . . . 0.72999999999999998 111.967 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.7 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.486 2.124 . . . . 0.83999999999999997 112.51 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -66.9 131.78 46.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.882 -1.136 . . . . 1.1499999999999999 108.944 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -72.08 162.99 28.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 1.3899999999999999 108.906 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -60.01 -33.93 72.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 1.3200000000000001 108.561 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.8 -40.03 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.401 -0.962 . . . . 0.95999999999999996 108.401 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.16 90.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 0.38 110.105 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.99 -39.99 87.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.071 -1.018 . . . . 0.37 108.368 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.08 -40.11 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.377 -0.827 . . . . 0.48999999999999999 108.867 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -67.92 -40.33 83.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 0.39000000000000001 110.641 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.02 -37.43 75.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 1.1399999999999999 109.985 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.34 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 0.32000000000000001 109.761 -179.333 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.01 -47.38 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.33000000000000002 108.867 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 29.8 mm100 -68.43 -40.04 81.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 1.8200000000000001 110.004 -179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 28.7 m120 -74.71 -13.26 60.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.858 . . . . 1.6699999999999999 110.387 -179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.9 150.21 74.88 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.996 . . . . 0.63 109.665 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.4 -41.6 15.26 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.019 1.812 . . . . 1.29 110.414 179.164 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.03 132.57 56.36 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.445 -1.317 . . . . 2.6299999999999999 107.445 178.299 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' C ' ' H ' ' A' ' 25' ' ' ILE . 68.5 mttm -69.0 -21.57 64.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 2.02 109.981 -178.455 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.86 33.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 1.55 109.226 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.401 ' H ' ' C ' ' A' ' 23' ' ' LYS . 16.0 tt -56.87 154.54 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.46999999999999997 109.469 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -79.97 162.43 24.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.81000000000000005 110.152 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.99 -50.01 75.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.481 -0.933 . . . . 0.69999999999999996 108.481 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -60.51 -39.98 89.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.579 -0.701 . . . . 1.25 110.306 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.14 -38.55 61.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.28999999999999998 109.389 -179.411 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.24 -41.54 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -1.172 . . . . 0.34999999999999998 109.741 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -60.0 -43.35 95.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.12 -0.987 . . . . 1.3999999999999999 109.952 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -59.99 -40.01 87.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.375 -0.828 . . . . 2.5099999999999998 109.743 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.03 -45.54 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.794 . . . . 1.3700000000000001 110.001 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.66 -49.95 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.58999999999999997 110.711 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.04 -42.86 99.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 0.68999999999999995 111.03 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.1 -40.13 75.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 1.1699999999999999 111.148 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -70.08 -40.23 75.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.908 -1.12 . . . . 3.0 109.88 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.13 117.49 31.99 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 107.986 -1.116 . . . . 1.54 107.986 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.76 -9.48 17.02 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.838 1.692 . . . . 1.21 112.463 -178.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -59.97 -39.56 86.07 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 3.7400000000000002 108.999 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.08 -26.54 64.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.569 -0.707 . . . . 1.1200000000000001 110.559 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -59.99 -33.59 72.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.927 -1.108 . . . . 2.5099999999999998 108.796 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.01 9.98 33.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 2.3399999999999999 109.532 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.503 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 60.3 t30 -139.04 125.6 20.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.357 -0.84 . . . . 2.0099999999999998 109.813 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -124.48 15.14 8.89 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.739 -0.838 . . . . 1.6799999999999999 108.739 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 48' ' ' TRP . 91.7 mm-40 -61.18 -169.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.142 0.972 . . . . 3.98 112.085 -177.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.05 -8.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 CA-C-N 115.669 -0.696 . . . . 0.78000000000000003 111.633 -178.469 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -60.02 -27.7 67.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.476 -1.602 . . . . 0.44 107.947 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.04 -58.45 3.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.729 . . . . 1.96 110.947 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.9 m-20 -61.79 -39.97 93.58 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 1.28 110.97 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.0 t -56.95 -32.08 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 1.49 110.833 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.09 -57.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.93 -1.106 . . . . 0.64000000000000001 111.342 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.59 -29.07 28.07 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.736 -1.227 . . . . 2.7599999999999998 110.359 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.05 -40.02 87.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 2.48 109.633 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -69.42 -24.11 63.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 2.0699999999999998 110.525 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.96 -40.03 91.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 0.78000000000000003 109.494 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -60.9 -48.07 83.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 1.6000000000000001 110.142 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.7 mp -68.29 -40.09 81.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 1.3799999999999999 109.348 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -79.91 113.58 18.18 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.185 -0.947 . . . . 1.4199999999999999 109.022 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.88 1.17 56.52 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.602 -0.888 . . . . 2.1699999999999999 108.602 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.04 -36.91 78.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.681 -0.637 . . . . 1.5600000000000001 109.4 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -78.51 161.44 27.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 1.3200000000000001 109.583 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.63 130.06 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.543 -0.723 . . . . 0.91000000000000003 109.636 -179.352 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -86.96 127.02 35.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 1.8100000000000001 109.967 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -132.38 71.74 79.0 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 108.581 -0.896 . . . . 1.28 108.581 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 81.1 Cg_exo -44.63 177.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.65 2.233 . . . . 1.6499999999999999 112.272 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -75.18 160.73 30.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 4.0899999999999999 108.67 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 6.9 t0 -58.04 166.69 1.46 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.043 -1.036 . . . . 2.8399999999999999 109.114 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 99.0 m-20 -68.08 -25.79 65.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 3.46 109.548 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -60.11 -40.01 88.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 4.5 109.648 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.7 mmtm -79.63 139.29 54.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 5.1200000000000001 109.253 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.96 -10.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.06 1.84 . . . . 3.6299999999999999 113.009 179.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' LYS . . . 86.65 50.24 3.84 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.87 -1.292 . . . . 3.1499999999999999 109.87 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -85.42 144.18 28.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.204 -1.174 . . . . 4.3600000000000003 109.721 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 47.18 -162.18 0.25 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.661 -1.376 . . . . 2.0299999999999998 109.661 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 p -157.08 130.75 8.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -1.105 . . . . 1.8 108.911 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 5.7 m-30 -80.36 160.01 25.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 1.3899999999999999 109.001 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -134.51 143.13 47.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 0.46000000000000002 109.67 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -149.54 166.19 29.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.132 -0.98 . . . . 0.56000000000000005 109.208 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 mt -101.84 119.72 39.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.181 -0.949 . . . . 1.4199999999999999 109.971 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -171.71 73.76 0.49 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.898 . . . . 3.7200000000000002 110.116 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.91 -143.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.697 2.264 . . . . 3.5499999999999998 111.82 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 85' ' ' TYR . 40.5 m-20 -88.62 44.59 1.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 6.8200000000000003 108.853 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 m -62.62 71.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.561 -0.712 . . . . 6.0 109.277 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' A' ' 83' ' ' ASP . 83.0 t80 -61.64 -44.87 96.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.463 -0.773 . . . . 11.0 109.941 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' ASN . . . . . 0.419 ' OD1' ' CE1' ' A' ' 88' ' ' PHE . 50.1 t-20 -140.44 31.1 1.91 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.277 -0.889 . . . . 10.0 109.011 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.405 ' O ' ' O ' ' A' ' 90' ' ' ASN . 15.0 mmt -89.58 2.37 54.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -0.763 . . . . 8.4700000000000006 109.912 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CE1' ' OD1' ' A' ' 86' ' ' ASN . 49.6 p90 -70.04 -20.09 63.27 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.305 -0.872 . . . . 11.970000000000001 109.385 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.23 -40.02 92.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 11.949999999999999 109.684 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.405 ' O ' ' O ' ' A' ' 87' ' ' MET . 28.9 m120 -140.05 148.13 41.35 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.159 -0.682 . . . . 12.32 109.159 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -99.95 10.17 60.24 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.968 -1.253 . . . . 11.16 109.968 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.2 m -130.27 78.38 1.84 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.442 -1.034 . . . . 11.800000000000001 109.895 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.536 ' CD2' ' O ' ' A' ' 93' ' ' PHE . 13.7 p90 -108.39 97.88 7.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.782 -0.821 . . . . 10.779999999999999 108.782 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.679 ' O ' HD23 ' A' ' 94' ' ' LEU . 3.7 tt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.159 -0.963 . . . . 13.119999999999999 110.121 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.152 -0.685 . . . . 4.8099999999999996 109.152 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.9 mt -109.92 143.45 39.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.475 -0.765 . . . . 1.71 109.196 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.62 158.62 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.306 -0.871 . . . . 1.79 109.032 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.444 ' HD3' ' H ' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -70.27 146.84 94.93 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.047 -1.033 . . . . 3.6899999999999999 108.928 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.2 159.23 33.45 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.099 1.866 . . . . 0.72999999999999998 112.078 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.69 10.06 3.48 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.472 2.115 . . . . 0.83999999999999997 112.7 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -85.16 140.26 31.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.888 -1.133 . . . . 1.1499999999999999 109.572 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.7 p -80.04 170.38 16.54 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -0.815 . . . . 1.3899999999999999 108.872 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -60.0 -40.15 88.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.109 -0.994 . . . . 1.3200000000000001 109.154 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.8 mm -61.09 -48.07 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.812 . . . . 0.95999999999999996 109.002 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.47 98.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.38 110.295 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.93 -44.01 94.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.939 -1.101 . . . . 0.37 109.189 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.01 -39.98 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.48999999999999999 109.264 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.93 -40.54 97.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.39000000000000001 109.821 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.6 mtm -70.04 -36.57 75.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.872 . . . . 1.1399999999999999 109.335 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.97 89.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.326 -0.859 . . . . 0.32000000000000001 109.658 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.0 -50.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.078 -1.014 . . . . 0.33000000000000002 109.983 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.95 -37.96 76.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.717 -0.614 . . . . 1.8200000000000001 110.46 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -75.83 -1.5 25.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 1.6699999999999999 110.085 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.19 147.91 73.71 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.079 -1.013 . . . . 0.63 109.528 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.02 -19.57 57.62 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.8 1.667 . . . . 1.29 109.9 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -130.71 138.26 49.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.143 -1.428 . . . . 2.6299999999999999 107.143 178.517 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -60.0 -39.97 87.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.943 -1.098 . . . . 2.02 109.156 -178.585 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -79.3 130.79 35.8 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.181 -0.949 . . . . 1.55 108.719 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.06 148.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.46999999999999997 109.473 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.7 p -83.62 167.05 17.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.81000000000000005 110.148 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.94 -49.72 76.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.077 -1.083 . . . . 0.69999999999999996 108.077 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.08 -40.02 88.11 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.986 -0.552 . . . . 1.25 110.392 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.91 94.52 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.384 -1.086 . . . . 0.28999999999999998 110.384 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.11 -43.39 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.043 -1.269 . . . . 0.34999999999999998 109.645 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -60.02 -40.0 87.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.963 -1.086 . . . . 1.3999999999999999 110.821 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.95 -42.72 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.899 -1.126 . . . . 2.5099999999999998 110.74 -178.237 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.98 -48.56 81.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 1.3700000000000001 111.414 -179.16 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.93 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.097 . . . . 0.58999999999999997 111.401 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 mtm -59.99 -46.14 90.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 0.68999999999999995 110.673 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.09 -39.89 75.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.885 -1.134 . . . . 1.1699999999999999 110.064 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -69.09 -39.97 78.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 3.0 110.378 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 40' ' ' PHE . 67.3 m-85 -131.34 80.04 68.7 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 1.54 110.148 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -45.72 -9.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.698 2.265 . . . . 1.21 112.02 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 38' ' ' PHE . 31.5 t80 -60.06 -39.93 87.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.464 -0.773 . . . . 3.7400000000000002 109.833 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -68.2 -20.76 64.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 1.1200000000000001 110.904 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HG2' ' NH1' ' A' ' 42' ' ' ARG . 61.5 mtt-85 -60.03 -40.08 88.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.817 -1.177 . . . . 2.5099999999999998 109.532 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.38 -40.12 96.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 2.3399999999999999 110.132 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -105.82 106.08 16.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.813 -0.554 . . . . 2.0099999999999998 109.795 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 66.8 mttm -97.38 -39.69 9.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.245 -0.909 . . . . 1.6799999999999999 110.533 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.81 145.8 31.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 3.98 109.894 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.2 -72.64 0.28 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.748 -0.941 . . . . 0.78000000000000003 110.748 179.121 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 20.2 p-90 -69.99 -23.94 63.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.016 -1.285 . . . . 0.44 111.438 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.08 -50.47 73.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.668 -1.27 . . . . 1.96 111.407 -178.516 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -73.84 -33.56 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.778 -1.201 . . . . 1.28 111.32 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.3 p -59.9 -36.37 76.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 1.49 110.757 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.04 -49.85 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.938 -1.101 . . . . 0.64000000000000001 110.314 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -70.08 -39.38 75.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.222 -0.924 . . . . 2.7599999999999998 110.622 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 4.8 m-70 -60.02 -39.86 87.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.029 -1.044 . . . . 2.48 108.514 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.051 -1.092 . . . . 2.0699999999999998 108.051 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 56' ' ' LEU . 91.6 mt -66.72 -40.05 88.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.49 -0.757 . . . . 0.78000000000000003 109.646 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.8 p -75.01 -49.3 20.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.091 -1.005 . . . . 1.6000000000000001 109.99 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.3 mt -64.17 -40.19 95.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 1.3799999999999999 109.274 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ASN . . . . . 0.448 ' OD1' ' SG ' ' A' ' 61' ' ' CYS . 8.9 t-20 -83.95 116.93 23.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.402 -0.962 . . . . 1.4199999999999999 108.402 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.94 1.75 54.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 2.1699999999999999 109.94 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.448 ' SG ' ' OD1' ' A' ' 59' ' ' ASN . 96.8 m -59.97 -39.96 87.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 1.5600000000000001 108.638 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -78.95 146.14 33.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 1.3200000000000001 108.976 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.15 129.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.419 -0.956 . . . . 0.91000000000000003 108.419 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.25 139.08 57.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 1.8100000000000001 109.905 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.8 t -112.4 119.98 42.41 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.556 -0.905 . . . . 1.28 108.556 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.86 178.84 6.91 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.531 1.488 . . . . 1.6499999999999999 112.268 -179.287 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' NE ' ' O ' ' A' ' 74' ' ' LYS . 20.0 ptt-85 -138.1 159.02 43.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 4.0899999999999999 109.112 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 36.2 t0 -64.99 169.33 5.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.115 -0.991 . . . . 2.8399999999999999 108.497 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 72.5 m-20 -89.68 -3.34 58.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.135 -0.978 . . . . 3.46 109.97 -179.393 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -93.09 5.42 51.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.101 -0.999 . . . . 4.5 109.234 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -129.98 78.65 74.53 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.504 -0.747 . . . . 5.1200000000000001 109.429 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 74' ' ' LYS . 2.9 Cg_exo -73.25 -166.82 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.723 2.282 . . . . 3.6299999999999999 112.163 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.24 -62.87 0.39 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.898 -1.281 . . . . 3.1499999999999999 109.898 179.677 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.48 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -68.6 137.62 54.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -1.17 . . . . 4.3600000000000003 108.942 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.66 -155.98 31.89 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.141 -1.584 . . . . 2.0299999999999998 109.141 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.3 m -78.59 131.51 36.76 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.27 -1.136 . . . . 1.8 108.249 179.308 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -78.4 159.98 28.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.036 -1.04 . . . . 1.3899999999999999 109.411 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -113.18 139.93 48.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.055 -0.72 . . . . 0.46000000000000002 109.055 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 80' ' ' LEU . 15.2 t -143.1 160.69 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.189 -0.944 . . . . 0.56000000000000005 109.862 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 79' ' ' THR . 81.7 mt -59.69 -121.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 1.4199999999999999 109.575 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 82' ' ' PRO . 23.3 t0 -137.23 72.53 52.45 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.383 -0.969 . . . . 3.7200000000000002 108.383 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 81' ' ' ASP . 62.8 Cg_exo -52.4 -130.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.275 2.65 . . . . 3.5499999999999998 112.89 -179.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -89.89 78.92 6.72 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.901 -1.148 . . . . 6.8200000000000003 107.901 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.7 p -61.73 -12.46 16.81 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.49 0.662 . . . . 6.0 109.276 -179.246 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.15 -26.16 62.35 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.551 -0.907 . . . . 11.0 108.551 178.859 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -69.96 -20.06 63.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -0.929 . . . . 10.0 109.532 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 88' ' ' PHE . 68.6 mtm -79.98 -172.95 3.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.785 -0.821 . . . . 8.4700000000000006 108.785 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' MET . 63.9 m-85 -62.2 -136.89 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.127 -0.983 . . . . 11.970000000000001 109.7 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -130.19 21.55 5.28 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.598 -0.689 . . . . 11.949999999999999 109.815 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -125.88 130.41 51.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.494 -0.754 . . . . 12.32 109.72 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.43 -136.83 4.26 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.875 -1.69 . . . . 11.16 108.875 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.4 p -113.71 5.74 16.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.692 -0.887 . . . . 11.800000000000001 109.896 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' C ' HD12 ' A' ' 94' ' ' LEU . 47.6 t80 -82.86 124.41 30.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.027 -1.045 . . . . 10.779999999999999 109.283 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.445 HD12 ' N ' ' A' ' 94' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 13.119999999999999 109.147 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' TYR . 1.8 Cg_endo . . . . . 0 N--CA 1.492 1.421 0 CA-C-O 119.984 -0.09 . . . . 0.73 112.194 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.41 -8.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.538 1.492 . . . . 0.84 111.558 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' PRO . 11.6 m-85 -68.76 138.85 55.18 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.863 . . . . 1.15 109.162 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 t -73.82 164.64 26.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.294 -0.878 . . . . 1.39 108.737 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -59.95 -39.13 84.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.138 -0.976 . . . . 1.32 108.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.8 mm -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.96 109.081 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.27 87.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 0.38 109.612 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.07 -43.75 95.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.37 108.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.03 -41.98 88.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 0.49 108.106 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -65.56 -40.05 92.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.54 -0.725 . . . . 0.39 110.357 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.595 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.6 mtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -0.967 . . . . 1.14 110.311 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.63 -42.61 75.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 0.32 110.034 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.46 -40.29 88.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.795 . . . . 0.33 109.243 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.422 HE21 ' HA ' ' A' ' 15' ' ' MET . 34.1 mt-30 -66.6 -41.79 87.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.53 -0.731 . . . . 1.82 110.69 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 15' ' ' MET . 19.0 p30 -90.77 7.92 37.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.67 110.258 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.2 116.55 61.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.63 109.078 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -43.04 -26.76 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.461 1.441 . . . . 1.29 111.012 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -122.92 131.7 53.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.605 -1.258 . . . . 2.63 107.605 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -60.07 -40.0 88.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.842 -1.161 . . . . 2.02 108.718 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.99 117.76 25.04 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.754 -1.202 . . . . 1.55 107.754 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.85 145.68 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.714 . . . . 0.47 109.46 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.4 p -79.55 162.38 25.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.387 -0.82 . . . . 0.81 109.996 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.02 -43.33 95.32 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.15 -1.055 . . . . 0.7 108.15 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.46 -40.04 96.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.55 -0.719 . . . . 1.25 110.141 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.28 -38.46 94.61 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.528 -1.029 . . . . 0.29 110.528 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.96 -40.27 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -1.229 . . . . 0.35 109.752 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.564 ' OH ' ' NE ' ' A' ' 53' ' ' ARG . 24.7 m-85 -60.34 -42.81 96.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.605 -1.309 . . . . 1.4 109.571 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.98 -41.32 91.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 2.51 110.658 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 63.3 t80 -59.99 -49.08 79.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.922 -1.111 . . . . 1.37 110.278 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.01 -40.0 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 0.59 110.566 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.1 mtt -60.82 -44.05 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.859 -1.151 . . . . 0.69 110.1 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.99 -52.08 13.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 1.17 110.721 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -60.06 -46.72 88.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 3.0 109.2 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -122.77 109.52 32.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.561 -0.903 . . . . 1.54 108.561 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.88 -7.55 12.3 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.146 1.897 . . . . 1.21 113.172 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -59.93 -34.33 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.963 -1.086 . . . . 3.74 108.851 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' ASN . 90.4 m-85 -66.2 -26.93 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 1.12 110.658 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -60.04 -38.96 84.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.872 -1.143 . . . . 2.51 109.342 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.04 -39.79 87.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.059 . . . . 2.34 108.721 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.9 m-20 -118.06 105.02 11.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.282 -0.636 . . . . 2.01 109.282 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 93.5 mttt -90.88 -59.86 2.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 1.68 110.689 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -69.65 140.02 53.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.509 -0.745 . . . . 3.98 110.21 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.9 -59.86 0.45 Allowed Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.221 -1.151 . . . . 0.78 110.221 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.519 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 51.0 p-90 -82.32 -28.92 31.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.263 . . . . 0.44 110.671 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -64.88 -41.11 95.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.937 -1.102 . . . . 1.96 110.06 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -39.53 75.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.388 -0.82 . . . . 1.28 111.695 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.711 -1.243 . . . . 1.49 110.183 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -60.02 -40.05 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 0.64 109.715 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.564 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 20.3 mtt180 -67.22 -37.3 83.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.054 . . . . 2.76 109.504 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.0 -44.18 94.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.829 . . . . 2.48 109.587 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -68.79 -38.61 80.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 2.07 109.419 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.59 59.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.78 110.241 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -172.55 -55.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.328 -0.99 . . . . 1.6 108.328 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.58 -39.95 84.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.561 -0.903 . . . . 1.38 108.561 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -71.45 123.36 22.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -0.846 . . . . 1.42 108.727 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -90.06 0.01 57.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.447 -0.783 . . . . 2.17 109.526 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.8 -40.05 94.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 1.56 109.769 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -79.05 150.37 31.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 1.32 109.712 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.6 t -118.67 127.32 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.874 -0.787 . . . . 0.91 108.874 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -92.4 125.0 36.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 1.81 108.525 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.07 79.4 73.02 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 108.91 -0.774 . . . . 1.28 108.91 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo . . . . . 0 C--N 1.305 -1.732 0 C-N-CA 122.478 2.119 . . . . 1.65 112.268 -179.54 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 108.513 -0.921 . . . . 1.39 108.513 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -126.53 134.81 50.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.46 109.233 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -159.01 164.35 35.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.16 -0.963 . . . . 0.56 109.779 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.7 mt . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.189 -0.944 . . . . 1.42 109.423 -179.995 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo . . . . . 0 N--CA 1.492 1.402 0 CA-C-O 120.646 0.186 . . . . 0.73 111.848 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.16 1.31 6.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.409 2.072 . . . . 0.84 112.095 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -81.03 133.12 35.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 1.15 109.47 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -69.35 167.2 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.215 -0.928 . . . . 1.39 108.567 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -59.92 -39.98 87.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 1.32 109.041 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -65.83 -41.05 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 0.96 110.226 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.8 94.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.38 110.344 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.85 -40.12 87.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 0.37 109.079 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.496 HD11 HD21 ' A' ' 55' ' ' ASN . 86.5 mt -69.9 -40.0 78.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.223 -0.923 . . . . 0.49 109.391 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -64.28 -40.91 96.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.39 109.726 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 73.5 mtm -70.02 -36.93 75.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 1.14 109.474 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.85 84.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 0.32 109.35 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.8 mt -60.08 -50.0 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.33 108.856 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -61.72 -40.06 93.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.288 0.566 . . . . 1.82 109.995 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -79.99 -10.07 59.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 1.67 110.379 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 131.48 67.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 0.63 109.488 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.06 -38.93 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.411 1.407 . . . . 1.29 110.896 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -120.03 134.63 55.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.149 -1.056 . . . . 2.63 108.149 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.97 -34.41 73.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.04 -1.038 . . . . 2.02 110.034 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.97 113.91 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.78 -1.2 . . . . 1.55 108.297 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.5 tt -130.01 160.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 0.47 109.445 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.9 p -90.37 165.77 13.67 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.9 0.857 . . . . 0.81 110.714 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.652 HD11 ' HG2' ' A' ' 53' ' ' ARG . 14.3 tp -60.1 -50.02 75.37 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.056 0.932 . . . . 0.7 108.64 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.39 -39.97 94.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.286 0.565 . . . . 1.25 110.208 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.05 96.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.433 -1.067 . . . . 0.29 110.433 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -60.09 -42.04 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.029 -1.277 . . . . 0.35 109.64 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -59.89 -40.85 90.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.746 -1.221 . . . . 1.4 109.959 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.1 -42.24 94.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 2.51 110.135 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.98 -49.01 79.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 1.37 110.718 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.17 -49.98 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 0.59 111.497 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.7 mtm -60.26 -49.98 75.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.664 -1.273 . . . . 0.69 110.269 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -68.91 -39.99 79.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 1.17 109.539 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -66.17 -49.75 66.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 3.0 109.678 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -119.38 120.19 31.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.594 -0.691 . . . . 1.54 109.301 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.39 -7.49 14.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.863 1.709 . . . . 1.21 112.248 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -60.01 -40.93 90.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.4 -0.812 . . . . 3.74 110.234 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.77 -27.76 67.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 1.12 110.722 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -58.23 -26.04 62.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.045 -1.035 . . . . 2.51 109.436 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.78 1.76 54.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.03 -1.043 . . . . 2.34 110.103 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.536 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 53.4 t30 -147.68 102.36 3.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.393 -0.817 . . . . 2.01 109.278 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.428 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.7 mttt -89.16 -64.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 1.68 110.963 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -69.93 144.03 52.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 3.98 110.074 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.44 -58.41 0.4 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.76 -1.336 . . . . 0.78 109.76 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 29.4 p-90 -89.98 -11.66 40.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.25 . . . . 0.44 110.374 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.69 -55.96 9.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 1.96 110.498 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -70.05 -31.52 69.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 1.28 110.58 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.1 p -59.83 -40.44 88.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.052 -1.03 . . . . 1.49 110.81 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mm -60.05 -50.94 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.859 -1.151 . . . . 0.64 110.379 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.652 ' HG2' HD11 ' A' ' 27' ' ' LEU . 46.6 mtp180 -69.97 -37.92 75.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.074 -1.016 . . . . 2.76 110.182 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -59.93 -40.09 87.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 2.48 110.606 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 26.3 p30 -69.99 -18.33 63.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.943 -1.098 . . . . 2.07 110.567 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.431 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 85.6 mt -66.4 -40.09 89.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.794 -1.191 . . . . 0.78 111.115 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -70.04 -48.43 57.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.898 -1.126 . . . . 1.6 110.756 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.2 -39.98 96.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 1.38 110.658 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 76.1 m-20 -76.02 112.96 13.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 1.42 110.069 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.24 -5.95 55.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 2.17 109.484 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -62.82 -35.05 78.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 1.56 110.199 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -78.72 152.53 31.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 1.32 109.618 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 0.91 109.567 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -81.93 149.64 28.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 1.81 110.098 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.12 128.69 14.31 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.625 -0.88 . . . . 1.28 108.625 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 N--CA 1.493 1.454 0 C-N-CA 121.441 1.427 . . . . 1.65 111.675 179.771 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 108.014 -1.106 . . . . 1.39 108.014 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -120.75 134.38 55.29 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.591 0.71 . . . . 0.46 110.155 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 170.75 19.98 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.911 -0.774 . . . . 0.56 108.911 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.6 mt . . . . . 0 N--CA 1.495 1.795 0 O-C-N 121.062 -1.024 . . . . 1.42 110.203 -179.61 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo . . . . . 0 N--CA 1.494 1.519 0 CA-C-O 120.563 0.151 . . . . 0.73 111.839 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.8 4.22 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.412 2.075 . . . . 0.84 112.635 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -82.0 143.01 31.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.974 -1.079 . . . . 1.15 109.803 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.5 t -75.05 160.2 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.528 -0.916 . . . . 1.39 108.528 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -60.02 -39.95 87.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 1.32 108.682 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.3 mm -65.2 -40.05 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.741 -0.837 . . . . 0.96 108.741 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.72 89.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.958 . . . . 0.38 109.642 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.04 -43.14 95.53 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.025 -1.047 . . . . 0.37 108.656 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.403 HG21 HD21 ' A' ' 56' ' ' LEU . 85.5 mt -69.32 -50.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.49 109.452 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -61.39 -40.01 92.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 0.39 110.015 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.534 ' C ' HD22 ' A' ' 19' ' ' ASN . 74.9 mtp -69.88 -38.48 76.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.431 -0.793 . . . . 1.14 109.967 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 20' ' ' ALA . . . -60.03 -42.22 93.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.32 110.032 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.31 -49.98 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.33 109.588 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.73 -40.02 76.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.722 -0.611 . . . . 1.82 109.959 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 15' ' ' MET . 68.3 m-80 -76.95 -9.92 59.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.85 . . . . 1.67 110.229 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 16' ' ' ALA . . . -79.75 137.67 54.42 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.088 -1.007 . . . . 0.63 109.454 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.81 -65.19 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.867 1.712 . . . . 1.29 110.858 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -99.81 137.84 37.72 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 2.63 107.684 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -62.43 -28.73 70.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.833 -1.167 . . . . 2.02 109.204 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -79.7 98.3 6.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.136 -0.977 . . . . 1.55 108.569 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -119.66 149.68 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.257 -0.646 . . . . 0.47 109.257 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -79.91 161.55 25.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.81 110.273 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.9 tp -59.99 -47.25 86.6 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.686 -0.857 . . . . 0.7 108.686 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -59.97 -39.8 86.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.933 -0.766 . . . . 1.25 108.933 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.55 -39.95 95.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.744 -0.942 . . . . 0.29 110.744 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.04 -40.99 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.735 -1.45 . . . . 0.35 109.931 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -61.59 -40.31 94.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 1.4 110.086 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.93 -40.68 89.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.17 -0.956 . . . . 2.51 109.881 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.49 -0.756 . . . . 1.37 110.744 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.8 -49.97 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.108 -0.995 . . . . 0.59 111.614 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.8 mtm -62.02 -39.98 94.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.1 -1.0 . . . . 0.69 111.398 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.412 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 93.1 m-20 -63.76 -51.67 63.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.746 -1.221 . . . . 1.17 112.071 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -74.86 -24.9 58.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.71 -1.244 . . . . 3.0 111.25 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.494 ' C ' ' H ' ' A' ' 40' ' ' PHE . 71.7 m-85 -130.02 77.62 76.24 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.209 -0.932 . . . . 1.54 109.763 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.75 -7.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.735 2.29 . . . . 1.21 111.438 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.494 ' H ' ' C ' ' A' ' 38' ' ' PHE . 11.8 t80 -59.96 -40.44 89.02 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.416 -0.802 . . . . 3.74 109.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -69.92 -24.1 63.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 1.12 110.446 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.412 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 61.1 mtt-85 -60.01 -37.87 81.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 2.51 108.884 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.96 9.15 17.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 2.34 109.285 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.618 ' ND2' ' H ' ' A' ' 46' ' ' GLN . 0.5 OUTLIER -138.5 120.47 15.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.418 -0.801 . . . . 2.01 109.428 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.44 ' N ' HD22 ' A' ' 44' ' ' ASN . 67.1 mttm -120.24 13.1 11.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.596 -0.89 . . . . 1.68 108.596 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.618 ' H ' ' ND2' ' A' ' 44' ' ' ASN . 27.1 mt-30 -59.91 -168.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.023 0.916 . . . . 3.98 111.438 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.15 -10.96 0.06 OUTLIER Glycine 0 N--CA 1.493 2.472 0 CA-C-N 115.997 -0.547 . . . . 0.78 112.257 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.566 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 4.7 p-90 -59.98 -38.87 83.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.726 . . . . 0.44 108.212 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.417 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 21.2 tt0 -60.03 -50.04 75.29 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.607 -0.683 . . . . 1.96 110.019 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -76.1 -33.95 59.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 1.28 111.369 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -59.92 -38.37 82.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 1.49 111.375 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.98 -51.48 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 0.64 111.37 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -79.81 -29.44 40.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.652 -1.28 . . . . 2.76 110.483 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.535 ' CE1' HD11 ' A' ' 58' ' ' LEU . 54.3 t60 -59.92 -42.0 92.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 2.48 109.161 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -65.47 -39.98 92.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 2.07 109.566 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 13' ' ' ILE . 41.4 mt -60.15 -45.44 93.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.78 110.542 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -63.33 -45.63 90.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.804 -1.185 . . . . 1.6 110.255 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.535 HD11 ' CE1' ' A' ' 54' ' ' HIS . 47.8 mt -69.95 -40.08 75.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.977 -1.077 . . . . 1.38 109.877 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -72.47 117.45 14.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 1.42 109.297 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -90.19 -2.73 58.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.46 -0.775 . . . . 2.17 109.376 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -60.72 -40.06 90.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 1.56 109.453 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -79.95 152.05 29.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 1.32 109.558 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.1 t -115.39 121.57 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.577 -0.702 . . . . 0.91 109.321 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -85.74 127.16 34.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 1.81 108.6 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.7 111.28 58.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 1.28 109.308 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo . . . . . 0 C--N 1.314 -1.267 0 C-N-CA 121.65 1.567 . . . . 1.65 111.931 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 109.628 -0.508 . . . . 1.39 109.628 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -111.19 137.13 49.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.695 -0.628 . . . . 0.46 109.976 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -145.25 159.75 42.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.859 . . . . 0.56 109.159 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 1.42 109.2 179.784 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo . . . . . 0 N--CA 1.495 1.6 0 CA-C-O 120.804 0.251 . . . . 0.73 112.309 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.27 28.79 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.862 2.375 . . . . 0.84 113.267 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -109.5 134.01 52.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.019 -1.05 . . . . 1.15 108.819 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 174.59 11.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 1.39 108.97 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -59.96 -35.93 76.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 1.32 109.908 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.67 -40.01 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 0.96 110.339 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.0 77.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.938 -1.101 . . . . 0.38 110.887 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.05 -39.94 87.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.907 -1.12 . . . . 0.37 108.623 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 52' ' ' ILE . 88.9 mt -67.74 -39.97 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.498 -0.751 . . . . 0.49 109.274 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -66.08 -40.07 90.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 0.39 110.755 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.8 mtm -69.91 -39.96 75.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 1.14 109.771 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.21 80.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.441 -0.787 . . . . 0.32 109.4 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.33 108.902 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -60.72 -40.08 90.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.695 -0.628 . . . . 1.82 110.15 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -69.91 -17.51 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 1.67 109.568 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.95 148.3 71.76 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.63 109.718 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.97 -51.68 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.87 1.713 . . . . 1.29 109.724 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -99.11 139.93 34.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.276 -1.379 . . . . 2.63 107.276 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -67.51 -27.26 66.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.975 -1.078 . . . . 2.02 109.796 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -78.68 115.85 18.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.023 -1.048 . . . . 1.55 108.932 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.17 154.31 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 0.47 109.397 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.2 p -80.11 153.56 28.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.81 109.776 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 tp -60.04 -44.28 94.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.7 109.288 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.27 -40.08 89.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 1.25 110.427 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.66 97.5 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.14 -1.029 . . . . 0.29 111.011 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.02 -42.28 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.276 . . . . 0.35 110.243 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -60.15 -41.95 93.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.965 -1.085 . . . . 1.4 110.202 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.31 -40.38 90.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.351 -0.843 . . . . 2.51 110.069 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.09 -44.69 96.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 1.37 110.285 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.93 -50.15 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.203 -0.935 . . . . 0.59 110.663 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -62.94 -39.91 96.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.063 -1.023 . . . . 0.69 109.365 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.87 -39.94 76.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 1.17 109.78 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -72.18 -50.52 27.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 3.0 109.434 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -115.16 114.1 43.48 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.782 -0.822 . . . . 1.54 108.782 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.11 -3.8 13.78 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.862 1.708 . . . . 1.21 112.036 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.618 -0.882 . . . . 3.74 108.618 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -70.0 -21.52 63.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -0.754 . . . . 1.12 111.142 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.9 -40.02 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.48 -1.388 . . . . 2.51 109.317 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -61.0 -43.69 98.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.011 . . . . 2.34 109.492 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' TYR . 54.3 t30 -109.39 109.49 20.36 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.986 -0.746 . . . . 2.01 108.986 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 97.9 mttt -102.7 -37.7 7.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 1.68 110.602 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -89.03 139.16 30.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 3.98 110.344 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.58 -66.79 0.23 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.291 . . . . 0.78 109.871 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 24.7 p-90 -71.32 -37.95 71.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.44 110.744 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.94 -50.05 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 1.96 111.162 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -74.52 -25.54 59.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.843 -1.16 . . . . 1.28 110.583 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 t -60.02 -41.24 91.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.105 -0.997 . . . . 1.49 110.282 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 13' ' ' ILE . 41.1 mt -65.74 -40.82 88.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.255 -0.903 . . . . 0.64 110.544 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -60.02 -44.08 94.85 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.334 -1.479 . . . . 2.76 108.607 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.697 -0.853 . . . . 2.48 108.697 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -68.44 -39.99 81.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 2.07 110.235 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.75 -40.13 91.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.052 -1.03 . . . . 0.78 110.048 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 t -64.76 -49.68 69.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.883 . . . . 1.6 110.512 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.98 -32.06 70.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.38 109.971 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -74.79 112.21 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 1.42 109.724 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.78 0.0 57.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.4 -0.813 . . . . 2.17 109.692 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.3 p -69.98 -21.37 63.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.983 -1.073 . . . . 1.56 109.727 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.22 153.25 21.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 1.32 109.789 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.0 t -114.38 124.79 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 0.91 109.62 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -80.0 159.95 26.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 1.81 108.602 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.19 77.53 24.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.002 -1.061 . . . . 1.28 109.585 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo . . . . . 0 C--N 1.309 -1.507 0 C-N-CA 122.662 2.241 . . . . 1.65 112.241 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 108.472 -0.936 . . . . 1.39 108.472 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -116.09 137.13 52.4 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.477 -0.764 . . . . 0.46 109.824 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -153.06 160.95 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.912 . . . . 0.56 109.847 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.1 mt . . . . . 0 N--CA 1.496 1.843 0 O-C-N 121.211 -0.931 . . . . 1.42 110.109 -179.796 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.2 Cg_exo . . . . . 0 N--CA 1.491 1.376 0 N-CA-C 111.295 -0.31 . . . . 0.73 111.295 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -42.25 -12.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.248 1.966 . . . . 0.84 113.767 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.6 m-85 -68.16 141.94 55.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.72 -1.238 . . . . 1.15 109.712 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 m -74.38 163.07 28.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 1.39 109.362 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -59.99 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.948 . . . . 1.32 109.518 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.44 -40.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.075 -1.016 . . . . 0.96 109.055 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.19 87.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.38 109.945 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.41 -40.12 89.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.37 109.544 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.68 -40.05 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.42 -0.955 . . . . 0.49 108.42 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -60.92 -39.99 91.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.712 . . . . 0.39 109.78 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.459 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 65.4 mtt -68.94 -39.39 79.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 1.14 110.0 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.12 83.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.32 109.88 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.44 -49.97 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.33 109.5 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.65 -40.02 84.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.797 -0.564 . . . . 1.82 110.482 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 15' ' ' MET . 4.2 m-80 -70.23 -15.43 62.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 1.67 110.414 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 146.67 69.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.63 109.26 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.86 -44.44 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.738 1.625 . . . . 1.29 109.968 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -106.19 126.52 52.32 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.459 -1.312 . . . . 2.63 107.459 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -58.56 -24.57 61.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.989 -1.069 . . . . 2.02 108.748 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -80.08 84.98 5.71 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.289 -1.004 . . . . 1.55 108.289 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.3 tt -107.03 147.66 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.568 -0.708 . . . . 0.47 109.102 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -79.18 154.96 28.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.81 110.452 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.04 -47.53 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.594 0.711 . . . . 0.7 109.75 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.54 -39.9 89.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 1.25 110.341 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.07 96.56 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.232 -0.917 . . . . 0.29 111.158 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.14 -39.91 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.832 -1.393 . . . . 0.35 109.434 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 1.4 109.528 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.41 HE21 ' CG ' ' A' ' 36' ' ' ASP . 71.0 tp60 -61.6 -40.02 93.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 2.51 109.702 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.91 -43.7 94.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.581 -0.7 . . . . 1.37 111.32 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.98 -40.71 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.798 -1.189 . . . . 0.59 111.519 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.12 -39.94 78.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.89 -1.131 . . . . 0.69 110.301 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 96.2 m-20 -71.31 -46.95 59.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.918 -1.114 . . . . 1.17 109.854 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -69.76 -35.44 74.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 3.0 110.366 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.504 ' C ' ' H ' ' A' ' 40' ' ' PHE . 90.9 m-85 -128.7 79.96 73.46 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.345 -0.847 . . . . 1.54 109.854 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.31 -6.07 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.84 2.36 . . . . 1.21 111.718 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -60.08 -39.5 86.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 3.74 109.459 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.96 -24.1 63.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.565 -0.709 . . . . 1.12 111.125 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.3 mtt-85 -59.55 -40.09 86.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.815 -1.178 . . . . 2.51 109.738 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.93 -19.11 65.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.009 -1.057 . . . . 2.34 109.992 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -133.54 97.56 3.97 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.012 -0.736 . . . . 2.01 109.012 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 62.7 mttp -88.56 -45.71 9.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 1.68 110.717 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.15 144.3 34.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 3.98 110.121 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.91 -58.04 0.4 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.302 -1.119 . . . . 0.78 110.302 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.472 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.5 p-90 -89.19 -13.5 38.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.028 -1.278 . . . . 0.44 109.962 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -60.26 -50.0 75.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.14 -0.975 . . . . 1.96 111.487 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -75.88 -36.77 59.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 1.28 111.671 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 94.0 p -57.84 -23.07 51.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.988 -1.07 . . . . 1.49 110.836 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mm -75.74 -68.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.963 -1.086 . . . . 0.64 110.727 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.575 HH11 ' CG ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -68.49 -27.01 65.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.114 -0.991 . . . . 2.76 110.693 -178.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.01 -42.01 93.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 2.48 108.655 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 57' ' ' SER . 96.5 m-20 -62.52 -40.12 95.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.454 -0.779 . . . . 2.07 109.61 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.29 59.21 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 0.78 109.159 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' ASN . 40.1 t -159.97 -54.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.264 -0.897 . . . . 1.6 109.564 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.662 ' N ' HD12 ' A' ' 58' ' ' LEU . 7.6 mp -65.85 -40.1 91.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 1.38 109.772 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -69.43 127.95 34.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.125 -0.984 . . . . 1.42 108.797 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.96 -1.71 58.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.511 -0.743 . . . . 2.17 109.373 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.8 m -64.81 -39.91 94.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 1.56 109.195 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -84.18 134.0 34.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 1.32 109.264 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 129.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.784 . . . . 0.91 109.175 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.0 139.56 57.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 1.81 109.041 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.69 123.42 31.3 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.638 -0.875 . . . . 1.28 108.638 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo . . . . . 0 N--CA 1.491 1.353 0 C-N-CA 121.07 1.18 . . . . 1.65 111.873 -179.318 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 108.485 -0.932 . . . . 1.39 108.485 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -118.73 140.27 50.2 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.663 0.745 . . . . 0.46 110.518 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -148.17 155.5 41.47 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.257 -1.016 . . . . 0.56 108.257 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.49 1.533 0 O-C-N 120.894 -1.129 . . . . 1.42 109.662 -179.51 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 N--CA 1.494 1.539 0 CA-C-O 120.723 0.218 . . . . 0.73 111.589 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.67 27.66 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.388 2.059 . . . . 0.84 113.299 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -100.42 133.59 44.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.878 -1.139 . . . . 1.15 108.839 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -70.31 161.83 29.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 1.39 108.914 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -59.23 -43.05 92.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.98 -1.075 . . . . 1.32 108.307 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.462 ' HA ' HD12 ' A' ' 13' ' ' ILE . 81.9 mt -65.15 -40.02 87.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.606 -0.887 . . . . 0.96 108.606 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.97 98.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 0.38 109.862 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.01 -40.14 88.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.913 -1.117 . . . . 0.37 108.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.691 HD11 HG23 ' A' ' 52' ' ' ILE . 96.4 mt -62.91 -42.14 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.44 -0.787 . . . . 0.49 108.886 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -60.79 -43.21 98.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.722 -0.611 . . . . 0.39 110.553 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.558 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.8 mtm -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.915 -1.116 . . . . 1.14 109.426 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 19' ' ' ASN . . . -50.37 -52.34 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.538 -0.726 . . . . 0.32 109.898 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.02 -44.29 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.33 109.368 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.1 -46.14 90.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.656 . . . . 1.82 111.187 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 15' ' ' MET . 18.9 p30 -90.04 11.05 21.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.991 -1.068 . . . . 1.67 110.474 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.29 120.39 80.94 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 0.63 108.83 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -41.77 -38.22 4.42 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.443 1.429 . . . . 1.29 110.993 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -112.93 137.23 51.63 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.817 -1.179 . . . . 2.63 107.817 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -60.02 -39.97 87.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.967 -1.083 . . . . 2.02 108.502 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -82.15 129.15 34.75 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.163 -1.051 . . . . 1.55 108.163 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.12 146.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.206 -0.934 . . . . 0.47 110.158 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.77 160.0 26.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.519 -0.738 . . . . 0.81 110.278 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.07 -48.41 81.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.636 -0.875 . . . . 0.7 108.636 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.78 -39.91 90.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 1.25 109.89 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.89 95.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.456 -1.058 . . . . 0.29 110.456 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.12 -42.54 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.322 . . . . 0.35 109.74 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -62.1 -40.1 94.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 1.4 110.736 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.4 -40.17 90.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.953 -1.092 . . . . 2.51 109.614 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 65.6 t80 -60.09 -46.85 88.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 1.37 111.168 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.04 -49.83 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.046 -1.034 . . . . 0.59 110.826 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtm -61.86 -40.0 93.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.854 -1.153 . . . . 0.69 110.105 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.65 -39.92 93.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 1.17 110.921 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.458 ' HG2' HH11 ' A' ' 37' ' ' ARG . 0.1 OUTLIER -79.99 -67.69 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.885 -1.134 . . . . 3.0 110.103 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 38' ' ' PHE . 23.7 m-85 -92.09 115.69 65.11 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 1.54 109.004 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.72 -7.81 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.176 1.918 . . . . 1.21 113.278 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 1.1 m-85 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.122 . . . . 3.74 109.341 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -67.83 -26.78 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.574 -0.704 . . . . 1.12 110.848 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.02 -40.01 87.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.004 . . . . 2.51 109.477 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -71.41 -9.31 57.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 2.34 109.214 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 57.5 t-20 -141.51 99.53 3.58 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.049 -0.723 . . . . 2.01 109.049 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.539 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 65.0 mttm -96.66 -21.48 17.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 1.68 110.911 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -90.66 136.36 33.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.765 -1.209 . . . . 3.98 110.86 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -75.15 0.23 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.594 -1.003 . . . . 0.78 110.594 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.539 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.6 p-90 -62.42 -37.46 85.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.265 -1.138 . . . . 0.44 110.898 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.416 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 56.9 tt0 -59.83 -50.33 74.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 1.96 111.661 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.912 -1.118 . . . . 1.28 112.272 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.7 m -59.95 -40.09 87.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.863 -1.148 . . . . 1.49 112.217 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.691 HG23 HD11 ' A' ' 13' ' ' ILE . 11.1 mt -61.89 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.629 -1.294 . . . . 0.64 110.691 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -69.18 -29.26 67.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.401 -1.437 . . . . 2.76 109.199 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -69.59 -37.2 76.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.044 -1.465 . . . . 2.48 107.044 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.59 -36.35 78.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.688 -0.632 . . . . 2.07 109.317 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 56' ' ' LEU . 82.4 mt -59.99 -42.01 93.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.78 110.558 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -60.04 -46.86 88.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 1.6 109.87 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.536 ' N ' HD12 ' A' ' 58' ' ' LEU . 10.1 mp -69.98 -37.86 75.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 1.38 109.439 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.425 HD21 HD11 ' A' ' 10' ' ' ILE . 92.6 m-20 -75.8 111.99 11.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.19 -0.944 . . . . 1.42 109.269 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.03 -9.8 52.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 2.17 109.626 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 62' ' ' PHE . 30.1 p -60.06 -35.9 76.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 1.56 109.412 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.413 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 74.8 m-85 -78.1 147.42 34.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 1.32 108.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.47 130.64 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.466 -0.771 . . . . 0.91 110.826 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -76.25 158.67 31.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 1.81 109.176 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.8 t -134.64 84.26 39.86 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.389 -0.82 . . . . 1.28 108.994 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo . . . . . 0 C--N 1.31 -1.478 0 C-N-CA 122.655 2.237 . . . . 1.65 112.685 -179.311 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 . . . . . 0 N--CA 1.494 1.73 0 N-CA-C 108.954 -0.758 . . . . 1.39 108.954 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -117.96 140.01 50.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.509 -0.744 . . . . 0.46 109.589 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -144.09 159.93 41.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.318 -0.864 . . . . 0.56 109.507 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 1.42 109.302 179.695 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo . . . . . 0 N--CA 1.491 1.376 0 N-CA-C 112.577 0.183 . . . . 0.73 112.577 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.72 30.22 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.507 2.138 . . . . 0.84 111.981 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.31 133.94 53.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.429 -0.794 . . . . 1.15 108.871 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -65.67 160.79 21.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 1.39 108.279 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.886 -1.134 . . . . 1.32 108.221 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.17 -41.36 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 0.96 109.154 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.72 96.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.38 109.579 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.96 -41.4 91.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 0.37 108.403 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.3 mt -70.01 -41.9 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.379 -0.826 . . . . 0.49 109.453 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -60.2 -40.02 88.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.39 110.139 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.5 mtm -70.02 -37.48 75.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 1.14 110.028 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.17 90.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.32 110.185 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.93 -49.98 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.33 109.071 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.79 -38.57 86.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.473 0.654 . . . . 1.82 109.71 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -77.12 1.04 19.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 1.67 109.49 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.35 149.9 76.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.187 -0.946 . . . . 0.63 108.705 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -37.33 -73.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.193 1.929 . . . . 1.29 112.59 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.1 -79.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.032 -1.042 . . . . 2.63 110.187 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -165.5 -34.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 2.02 108.997 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -88.53 138.38 31.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.276 -0.89 . . . . 1.55 109.805 -179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -140.81 153.8 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.19 -0.944 . . . . 0.47 109.913 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.7 p -86.01 166.08 16.17 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.332 -0.855 . . . . 0.81 110.474 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 27' ' ' LEU . 20.2 tp -60.15 -51.59 68.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.872 -1.159 . . . . 0.7 107.872 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.85 -40.01 91.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.782 -0.574 . . . . 1.25 110.445 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -40.02 95.39 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.122 -1.037 . . . . 0.29 110.543 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.51 -43.85 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.02 -1.282 . . . . 0.35 110.363 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.561 ' O ' ' SD ' ' A' ' 35' ' ' MET . 39.9 m-85 -60.01 -46.64 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.986 . . . . 1.4 111.989 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.93 -39.29 84.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.771 -1.205 . . . . 2.51 110.076 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -60.01 -40.01 87.79 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.309 -0.87 . . . . 1.37 110.427 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.49 -48.54 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.99 -1.068 . . . . 0.59 111.911 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . 0.561 ' SD ' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -60.05 -39.96 87.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.559 -1.338 . . . . 0.69 110.231 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 88.2 m-20 -68.43 -40.06 81.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.935 -1.103 . . . . 1.17 110.429 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -67.69 -40.01 84.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 3.0 110.27 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.38 122.59 21.02 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.347 -0.845 . . . . 1.54 109.011 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.32 -6.07 16.8 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.55 1.5 . . . . 1.21 111.11 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.07 -44.74 94.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.809 -0.557 . . . . 3.74 110.733 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.38 -23.81 64.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.983 -1.073 . . . . 1.12 111.012 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 64.3 mtt-85 -60.07 -40.05 88.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.84 -1.163 . . . . 2.51 109.393 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.15 -40.01 94.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.883 . . . . 2.34 110.6 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -116.33 112.69 21.9 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.118 -0.697 . . . . 2.01 109.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.2 mttt -95.55 -66.39 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 1.68 110.438 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -65.33 144.25 57.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 3.98 109.946 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.15 -62.72 0.32 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.582 -1.007 . . . . 0.78 110.582 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 41.9 p-90 -80.86 -12.79 59.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.899 -1.353 . . . . 0.44 110.469 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -70.01 -41.47 74.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 1.96 110.848 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -70.08 -38.28 75.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.32 -0.863 . . . . 1.28 111.352 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.8 t -59.97 -41.14 91.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.954 -1.091 . . . . 1.49 110.662 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.8 mm -59.97 -50.05 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.082 -1.011 . . . . 0.64 110.677 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -63.03 -39.32 94.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.975 -1.078 . . . . 2.76 109.616 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.537 ' NE2' HD11 ' A' ' 58' ' ' LEU . 19.8 t60 -60.04 -39.98 87.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.38 -0.825 . . . . 2.48 108.797 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -66.58 -39.91 88.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 2.07 109.502 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.48 -39.99 89.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.952 . . . . 0.78 110.282 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -71.2 -39.95 71.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.937 -1.102 . . . . 1.6 110.868 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.537 HD11 ' NE2' ' A' ' 54' ' ' HIS . 79.1 mt -68.73 -39.99 80.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.074 -1.017 . . . . 1.38 112.049 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -62.02 118.4 7.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.691 -1.255 . . . . 1.42 110.432 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -84.22 -31.61 24.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 2.17 109.622 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p -66.24 -9.18 29.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 1.56 108.965 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -89.85 138.46 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 1.32 107.907 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -123.84 129.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.303 -0.873 . . . . 0.91 110.469 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.2 147.66 38.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.834 . . . . 1.81 108.956 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' PRO . 15.5 t -139.98 64.5 27.66 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.059 -1.026 . . . . 1.28 109.556 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 65' ' ' VAL . 54.8 Cg_exo . . . . . 0 C--N 1.307 -1.621 0 C-N-CA 123.013 2.475 . . . . 1.65 113.375 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 108.828 -0.804 . . . . 1.39 108.828 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -141.89 131.43 23.91 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.052 -1.03 . . . . 0.46 110.903 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -155.04 150.94 27.81 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.897 -0.779 . . . . 0.56 108.897 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.9 mt . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.97 -1.081 . . . . 1.42 109.332 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo . . . . . 0 N--CA 1.492 1.419 0 CA-C-O 120.644 0.185 . . . . 0.73 111.669 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.4 26.61 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.418 2.079 . . . . 0.84 113.565 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.55 137.92 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.848 -1.157 . . . . 1.15 108.372 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 m -77.57 166.41 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 1.39 108.947 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -59.94 -37.87 80.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.082 . . . . 1.32 108.354 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 55' ' ' ASN . 38.0 mm -61.13 -46.48 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.96 109.338 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.71 95.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.38 110.786 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.2 mt -59.93 -40.05 87.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.154 . . . . 0.37 108.599 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.41 -44.84 94.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 0.49 108.336 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -67.44 -40.06 85.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.602 -0.686 . . . . 0.39 110.738 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.423 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.4 mtt -66.7 -39.91 88.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 1.14 109.148 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -50.04 75.27 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.537 -0.727 . . . . 0.32 110.107 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 80' ' ' LEU . 80.9 mt -60.46 -50.0 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 0.33 109.509 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -40.0 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.664 -0.647 . . . . 1.82 110.576 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 15' ' ' MET . 70.3 m-80 -82.05 1.27 36.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 1.67 109.87 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.42 149.05 74.86 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 0.63 108.634 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 -32.22 91.17 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.614 1.543 . . . . 1.29 109.806 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -124.21 139.99 53.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.797 -1.186 . . . . 2.63 107.797 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -60.07 -38.99 84.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.02 -1.05 . . . . 2.02 108.585 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -77.97 120.18 22.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.926 -1.139 . . . . 1.55 107.926 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.73 148.87 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.248 -0.907 . . . . 0.47 109.971 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.3 p -79.83 160.0 26.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -0.772 . . . . 0.81 110.89 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -66.32 -39.99 89.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.756 -0.831 . . . . 0.7 108.756 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.91 -40.0 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 1.25 109.672 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.72 -38.51 96.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.344 -1.102 . . . . 0.29 110.344 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.99 -42.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 0.35 109.933 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -60.0 -39.11 84.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.959 -1.088 . . . . 1.4 109.588 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.36 91.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.045 -1.035 . . . . 2.51 108.882 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.95 -47.59 85.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 1.37 110.431 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.446 HG21 ' CZ3' ' A' ' 48' ' ' TRP . 2.1 mp -61.73 -49.66 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 0.59 110.276 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.6 mtm -60.07 -39.91 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.808 -1.183 . . . . 0.69 109.889 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.09 -51.85 19.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 1.17 109.431 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.11 -50.0 75.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 3.0 109.312 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.57 110.66 38.66 Favored Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 108.812 -0.81 . . . . 1.54 108.812 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.51 -7.33 12.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.982 1.788 . . . . 1.21 112.514 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -60.57 -40.0 90.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.915 . . . . 3.74 109.605 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.06 -17.82 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.693 -0.629 . . . . 1.12 110.777 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.63 -43.17 93.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 2.51 108.46 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.17 -43.74 97.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.337 -0.852 . . . . 2.34 109.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -102.58 99.02 8.99 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.175 -0.676 . . . . 2.01 109.175 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -94.51 -42.56 8.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 1.68 109.476 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -81.29 149.5 28.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 3.98 109.494 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -73.34 0.28 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.133 -1.187 . . . . 0.78 110.133 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.446 ' CZ3' HG21 ' A' ' 34' ' ' ILE . 20.6 p-90 -69.49 -38.73 77.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.44 110.664 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.04 -42.07 93.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 1.96 110.721 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -70.04 -39.57 75.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 1.28 110.826 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -0.948 . . . . 1.49 111.259 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.7 mm -60.0 -50.01 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.835 -1.166 . . . . 0.64 110.126 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -60.35 -49.62 76.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.082 . . . . 2.76 109.44 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.143 -1.058 . . . . 2.48 108.143 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.585 ' ND2' HD21 ' A' ' 59' ' ' ASN . 23.8 t-20 -62.07 -40.34 95.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.473 -0.767 . . . . 2.07 109.097 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.84 -40.06 94.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 0.78 110.456 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.7 m -69.5 -46.84 65.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.983 -1.073 . . . . 1.6 110.43 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.59 -39.98 88.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 1.38 110.245 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.585 HD21 ' ND2' ' A' ' 55' ' ' ASN . 42.7 m-80 -75.29 117.54 17.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 1.42 109.752 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.59 -2.41 57.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 2.17 109.352 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -60.36 -39.94 88.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 1.56 109.591 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -79.71 152.8 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 1.32 109.351 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.7 t -112.7 127.46 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.473 -0.767 . . . . 0.91 109.393 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -68.98 145.76 53.32 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.28 -1.007 . . . . 1.81 108.28 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 t -137.39 76.97 42.11 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.144 -0.972 . . . . 1.28 109.715 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo . . . . . 0 C--N 1.306 -1.659 0 C-N-CA 122.62 2.214 . . . . 1.65 111.881 179.444 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 108.273 -1.01 . . . . 1.39 108.273 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -119.95 140.03 51.54 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.758 0.79 . . . . 0.46 110.716 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 t -139.62 162.24 35.58 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.769 -0.826 . . . . 0.56 108.769 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 17' ' ' ILE . 2.2 mp . . . . . 0 N--CA 1.497 1.897 0 O-C-N 121.142 -0.974 . . . . 1.42 110.445 -179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 50.2 Cg_endo . . . . . 0 N--CA 1.49 1.296 0 CA-C-O 120.094 -0.044 . . . . 0.73 112.133 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.03 -12.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.555 2.17 . . . . 0.84 114.142 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 14.4 m-85 -62.43 140.07 58.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.534 -1.354 . . . . 1.15 109.519 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -79.63 168.23 19.65 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.833 -1.173 . . . . 1.39 107.833 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -60.39 -39.91 89.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.902 -1.124 . . . . 1.32 109.095 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.467 ' CD1' ' OD1' ' A' ' 55' ' ' ASN . 38.8 mm -62.18 -41.1 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.96 109.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.97 85.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.38 110.154 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.1 -40.06 88.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 0.37 108.972 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.54 -40.05 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.49 109.132 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.31 -39.96 96.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.573 -0.704 . . . . 0.39 110.488 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.436 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.5 mtt -65.35 -39.95 92.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 1.14 110.078 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.65 80.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.352 -0.843 . . . . 0.32 109.591 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.23 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 0.33 109.247 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.01 -40.14 88.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.413 0.625 . . . . 1.82 110.125 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 15' ' ' MET . 69.4 m-80 -81.94 -0.12 42.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 1.67 109.613 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.77 123.5 85.29 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.276 -0.89 . . . . 0.63 108.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -42.27 -48.23 6.71 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.44 1.426 . . . . 1.29 110.674 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -105.29 142.0 35.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.601 -1.259 . . . . 2.63 107.601 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -60.02 -37.85 80.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.952 -1.092 . . . . 2.02 109.485 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.74 127.91 33.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.811 -1.181 . . . . 1.55 107.811 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.99 151.53 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 0.47 109.532 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.2 p -81.38 156.92 25.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.246 -0.909 . . . . 0.81 110.005 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.97 -48.3 82.28 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.745 0.783 . . . . 0.7 110.04 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 1.25 110.2 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.49 91.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.403 -1.079 . . . . 0.29 110.403 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.95 -42.98 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -1.209 . . . . 0.35 110.771 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.851 -1.156 . . . . 1.4 110.564 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.13 -39.26 85.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.153 -0.967 . . . . 2.51 110.379 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -59.85 -49.3 78.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 1.37 110.729 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.04 -49.92 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.0 -1.063 . . . . 0.59 110.733 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.7 mtm -60.03 -40.12 88.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.874 -1.141 . . . . 0.69 110.445 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.39 -45.22 94.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.928 -1.107 . . . . 1.17 110.715 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 37' ' ' ARG . 49.0 mtt-85 -68.02 -48.38 65.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.911 -1.118 . . . . 3.0 111.192 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.14 125.28 26.27 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.158 -0.964 . . . . 1.54 110.521 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.22 -5.0 13.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.971 1.781 . . . . 1.21 110.707 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -60.01 -40.1 88.1 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.335 -0.617 . . . . 3.74 109.335 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.05 -31.28 68.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 1.12 109.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -60.06 -39.94 87.75 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.165 -0.959 . . . . 2.51 109.204 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.26 -40.08 96.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 2.34 110.132 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -110.55 101.37 10.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.175 -0.676 . . . . 2.01 109.175 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 68.5 mttm -88.53 -40.65 13.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.094 -1.004 . . . . 1.68 110.178 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -78.53 141.68 37.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.003 -1.061 . . . . 3.98 110.421 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.18 -60.37 0.33 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.188 -1.165 . . . . 0.78 110.188 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.424 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 24.2 p-90 -88.85 -11.93 43.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -1.223 . . . . 0.44 110.239 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -69.85 -56.63 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 1.96 111.4 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.92 -38.75 76.33 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.253 -0.904 . . . . 1.28 112.327 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.5 m -59.99 -39.85 87.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.783 -1.198 . . . . 1.49 111.226 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.06 -68.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.954 -1.091 . . . . 0.64 111.398 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -69.93 -33.13 71.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 2.76 112.375 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -59.98 -40.16 88.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.342 -1.474 . . . . 2.48 107.676 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.794 HD21 HD21 ' A' ' 59' ' ' ASN . 21.8 t-20 -60.09 -40.53 89.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.614 -0.679 . . . . 2.07 109.25 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.27 -40.14 95.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.997 -1.065 . . . . 0.78 109.704 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -64.52 -49.75 70.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 1.6 110.721 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.0 mp -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.882 -1.136 . . . . 1.38 110.069 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.794 HD21 HD21 ' A' ' 55' ' ' ASN . 99.5 m-20 -69.28 121.94 17.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 1.42 110.505 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.5 -3.41 57.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.676 -0.861 . . . . 2.17 108.676 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 1.56 109.524 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -77.3 150.04 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.198 -0.939 . . . . 1.32 109.068 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.5 t -111.05 129.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.534 -0.729 . . . . 0.91 109.573 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -90.64 120.45 31.72 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.194 -1.039 . . . . 1.81 108.194 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.79 127.22 31.7 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 120.807 -1.183 . . . . 1.28 109.326 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo . . . . . 0 N--CA 1.493 1.455 0 C-N-CA 121.855 1.703 . . . . 1.65 112.008 179.419 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 107.473 -1.306 . . . . 1.39 107.473 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -132.89 124.97 28.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.252 -0.905 . . . . 0.46 109.553 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -152.8 152.42 31.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.282 -0.886 . . . . 0.56 109.751 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.4 mt . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.816 . . . . 1.42 108.949 179.497 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo . . . . . 0 N--CA 1.492 1.39 0 CA-C-O 120.806 0.252 . . . . 0.73 111.709 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.17 20.93 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.739 2.293 . . . . 0.84 113.773 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -96.01 137.73 34.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.632 -1.292 . . . . 1.15 109.141 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.7 p -73.33 165.61 24.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 1.39 108.667 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 1.32 109.18 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.35 -39.9 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.96 109.64 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.03 99.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 0.38 109.519 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.76 -39.96 90.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.37 108.584 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.449 HG21 HD21 ' A' ' 56' ' ' LEU . 96.6 mt -70.08 -42.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.546 -0.722 . . . . 0.49 109.766 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -65.67 -41.3 92.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.39 109.744 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.95 -33.87 72.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 1.14 109.887 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.577 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -60.05 -46.61 88.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 0.32 109.783 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.03 -45.35 98.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.061 -1.024 . . . . 0.33 109.807 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -63.15 -43.23 98.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.803 -0.561 . . . . 1.82 112.178 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -89.98 10.34 24.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.713 -1.242 . . . . 1.67 110.085 -178.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.78 150.46 81.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 0.63 108.901 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.68 -24.89 65.3 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.732 1.622 . . . . 1.29 110.196 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -139.91 146.57 39.39 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.754 -1.202 . . . . 2.63 107.754 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -59.97 -39.59 86.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.087 . . . . 2.02 108.885 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.06 129.35 34.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 1.55 109.273 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.9 tt -147.83 143.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.796 -0.816 . . . . 0.47 108.796 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -80.02 163.18 24.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.81 110.053 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.451 HD13 ' CD1' ' A' ' 56' ' ' LEU . 16.0 tp -59.93 -40.69 89.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.509 -0.744 . . . . 0.7 109.094 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -60.59 -40.25 91.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.431 -0.793 . . . . 1.25 110.141 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.99 96.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.274 -1.131 . . . . 0.29 110.274 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.48 -40.37 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -1.137 . . . . 0.35 110.517 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.426 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 29.1 m-85 -60.02 -39.98 87.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.101 . . . . 1.4 110.593 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -59.98 -40.0 87.65 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.949 -1.095 . . . . 2.51 109.903 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . 0.542 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 93.8 t80 -60.02 -49.91 75.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 1.37 111.662 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.69 -49.95 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 0.59 112.154 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 45.7 mtm -60.34 -40.04 89.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.706 -1.246 . . . . 0.69 110.994 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -67.17 -48.65 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 1.17 110.914 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -40.0 75.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.289 -0.882 . . . . 3.0 112.189 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -126.55 80.44 69.78 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.088 -1.007 . . . . 1.54 110.2 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.03 -9.85 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.95 2.433 . . . . 1.21 113.643 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.11 -37.51 80.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.633 -1.292 . . . . 3.74 108.996 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -69.15 -28.03 66.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 1.12 110.898 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -58.84 -39.97 82.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.654 -1.279 . . . . 2.51 108.165 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.29 -40.0 86.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 2.34 109.026 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.489 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 94.8 m-20 -99.92 101.02 12.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.226 -0.657 . . . . 2.01 109.226 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 92.0 mttt -90.41 -78.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.06 -1.025 . . . . 1.68 110.388 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.03 140.01 57.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 3.98 110.235 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.11 -58.2 0.54 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.66 -1.376 . . . . 0.78 109.66 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.489 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 33.3 p-90 -89.69 -10.58 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -1.235 . . . . 0.44 110.807 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 77.9 mt-30 -68.64 -54.53 15.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.883 -1.136 . . . . 1.96 110.916 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -65.35 -34.8 79.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 1.28 110.948 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.1 p -59.51 -41.51 90.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.917 -1.114 . . . . 1.49 109.933 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.13 -50.03 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.64 109.797 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.426 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 25.4 mtt180 -72.76 -38.84 67.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 2.76 109.864 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.508 ' NE2' HD11 ' A' ' 58' ' ' LEU . 68.5 t60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 2.48 108.674 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -65.58 -40.01 92.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.389 -0.819 . . . . 2.07 109.696 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.451 ' CD1' HD13 ' A' ' 27' ' ' LEU . 44.7 mt -60.53 -46.65 89.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.78 111.291 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -64.66 -39.96 94.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.836 -1.165 . . . . 1.6 110.704 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.508 HD11 ' NE2' ' A' ' 54' ' ' HIS . 43.9 mt -66.99 -37.38 84.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.993 -1.067 . . . . 1.38 109.464 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -79.9 110.54 15.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 1.42 109.608 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.91 -8.61 51.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.768 . . . . 2.17 109.194 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.6 m -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.856 -1.165 . . . . 1.56 107.856 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.24 127.63 32.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.845 -1.168 . . . . 1.32 107.845 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 t -102.54 126.94 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.623 -0.88 . . . . 0.91 108.623 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -97.46 117.84 32.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.868 . . . . 1.81 110.031 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.68 149.48 54.22 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.127 -1.064 . . . . 1.28 108.127 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--N 1.31 -1.452 0 C-N-CA 122.016 1.811 . . . . 1.65 111.051 179.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.645 -0.502 . . . . 1.39 109.645 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -108.86 133.54 52.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.521 -0.737 . . . . 0.46 109.657 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -153.76 163.96 39.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.56 110.244 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 108.24 -1.022 . . . . 1.42 108.24 179.176 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo . . . . . 0 N--CA 1.491 1.375 0 N-CA-C 111.809 -0.112 . . . . 0.73 111.809 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.21 -12.57 32.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.257 1.971 . . . . 0.84 111.809 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -60.5 134.55 57.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.216 -0.927 . . . . 1.15 108.645 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 p -70.42 162.11 29.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.176 -1.046 . . . . 1.39 108.176 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -58.47 -39.99 81.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 1.32 108.101 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.56 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.411 -0.806 . . . . 0.96 109.155 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.13 91.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 0.38 109.828 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.95 -40.01 87.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.053 -1.03 . . . . 0.37 108.59 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.97 -39.9 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.49 109.105 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.76 -39.9 95.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 0.39 110.016 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.48 -38.49 87.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.415 -0.803 . . . . 1.14 109.521 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.57 92.55 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.439 -0.788 . . . . 0.32 109.849 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.4 mt -64.9 -52.92 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 0.33 109.115 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -63.87 -40.01 95.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.731 -0.605 . . . . 1.82 109.539 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -69.96 -21.48 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.543 -0.723 . . . . 1.67 109.967 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 147.31 68.42 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 0.63 108.898 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.38 -48.18 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.866 1.711 . . . . 1.29 110.32 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.88 123.15 45.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.722 -1.214 . . . . 2.63 107.722 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -61.1 -28.12 68.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 2.02 110.368 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -78.8 88.29 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.787 -1.196 . . . . 1.55 108.803 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.33 151.61 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.098 -0.704 . . . . 0.47 109.098 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.2 p -79.91 159.54 26.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.81 110.213 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.59 -41.84 95.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.839 -0.8 . . . . 0.7 108.839 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.19 -40.06 88.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 1.25 110.194 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.68 -40.02 98.2 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.693 -0.963 . . . . 0.29 110.693 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.77 -39.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.241 . . . . 0.35 110.798 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.471 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 28.0 m-85 -59.97 -43.84 94.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.709 -1.244 . . . . 1.4 110.19 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.0 -39.99 87.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.245 -0.909 . . . . 2.51 109.096 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -59.91 -50.06 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.657 -0.652 . . . . 1.37 110.883 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.66 -48.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.95 -1.093 . . . . 0.59 111.49 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 32.0 mtm -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 0.69 109.938 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 83.1 m-20 -66.39 -47.03 74.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 1.17 110.727 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 3.0 111.06 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 40' ' ' PHE . 65.9 m-85 -126.1 77.22 71.62 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.226 -0.921 . . . . 1.54 109.85 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.76 -7.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.988 2.459 . . . . 1.21 112.808 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' PHE . 24.1 t80 -58.59 -40.03 82.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 3.74 109.091 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 44' ' ' ASN . 96.8 m-85 -69.99 -23.86 63.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.12 111.501 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.0 mtt-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.559 -1.338 . . . . 2.51 108.724 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.2 -37.03 82.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.512 -0.742 . . . . 2.34 110.007 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 33.0 m120 -108.5 119.18 38.77 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.494 0.664 . . . . 2.01 111.002 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 64.3 mttp -119.11 15.0 13.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.033 -1.099 . . . . 1.68 108.033 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.07 -118.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.619 -0.675 . . . . 3.98 112.818 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.79 -10.06 67.56 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.18 -0.95 . . . . 0.78 112.275 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 12.5 p-90 -60.03 -36.99 78.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.222 -1.752 . . . . 0.44 107.578 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -59.99 -50.03 75.34 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.629 -0.669 . . . . 1.96 109.926 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 1.28 111.047 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.9 p -56.86 -34.27 67.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.077 -1.014 . . . . 1.49 111.119 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -59.99 -46.03 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.86 -1.15 . . . . 0.64 109.308 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.471 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 26.6 mtt180 -72.94 -39.36 66.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 2.76 110.146 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -59.98 -39.97 87.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 2.48 110.253 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 56' ' ' LEU . 30.0 p30 -75.02 -25.0 58.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.901 -1.124 . . . . 2.07 110.615 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.53 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 56.2 mt -64.15 -42.93 96.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.698 -1.251 . . . . 0.78 110.014 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -69.99 -40.56 75.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.996 -1.065 . . . . 1.6 110.04 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -69.49 -40.0 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.083 . . . . 1.38 109.389 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -75.37 118.7 18.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.263 -0.898 . . . . 1.42 108.898 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.77 -5.66 56.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.505 -0.747 . . . . 2.17 109.072 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 89.5 m -60.38 -40.03 89.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 1.56 109.351 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -85.71 147.05 26.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 1.32 108.762 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.96 124.6 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 0.91 109.366 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -79.04 129.98 35.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.501 -0.926 . . . . 1.81 108.501 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.7 t -112.66 100.31 50.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.623 -0.673 . . . . 1.28 109.875 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 N--CA 1.495 1.563 0 C-N-CA 122.149 1.899 . . . . 1.65 112.158 179.504 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.269 -0.641 . . . . 1.39 109.269 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -119.9 135.5 54.87 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.689 -0.856 . . . . 0.46 108.689 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -150.57 160.38 43.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.119 -0.988 . . . . 0.56 110.025 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.043 -0.725 . . . . 1.42 109.043 179.982 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo . . . . . 0 N--CA 1.494 1.544 0 CA-C-O 120.753 0.231 . . . . 0.73 112.203 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.19 -1.26 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.834 2.356 . . . . 0.84 113.612 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -72.55 143.41 48.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.593 -1.317 . . . . 1.15 109.416 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.1 p -76.31 163.15 27.29 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.538 -0.912 . . . . 1.39 108.538 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -60.09 -39.93 87.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 1.32 108.647 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.53 -40.02 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.37 -0.831 . . . . 0.96 109.062 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.58 92.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 0.38 110.101 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 0.37 109.128 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.81 -44.68 98.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.176 -1.046 . . . . 0.49 108.176 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -60.11 -39.99 88.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.708 -0.62 . . . . 0.39 109.478 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.9 mtt -68.2 -39.65 82.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.14 110.019 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.64 88.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.32 110.495 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.77 -50.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.008 -1.058 . . . . 0.33 109.669 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.99 -39.92 75.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 1.82 110.383 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.14 -32.98 74.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 1.67 109.216 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.78 116.94 62.49 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 0.63 109.134 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -46.54 -33.46 13.12 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.218 1.279 . . . . 1.29 110.696 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -100.04 113.72 26.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.071 -1.085 . . . . 2.63 108.071 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -69.66 -28.81 66.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 2.02 110.077 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -78.47 75.17 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.045 -1.034 . . . . 1.55 108.634 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 tt -100.98 147.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.074 -0.713 . . . . 0.47 109.074 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -80.04 164.88 23.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.422 -0.799 . . . . 0.81 109.679 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.99 -47.19 86.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.214 -1.032 . . . . 0.7 108.214 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.81 -40.04 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.751 -0.593 . . . . 1.25 110.139 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.01 96.39 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.82 -0.912 . . . . 0.29 110.82 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -43.91 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.941 -1.329 . . . . 0.35 109.594 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 37.7 m-85 -60.17 -40.81 91.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 1.4 110.896 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' OE1' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -66.85 -39.97 87.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.917 -1.114 . . . . 2.51 109.821 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.03 -46.62 88.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 1.37 111.014 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.99 -41.11 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 0.59 110.675 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 30.7 mtt -60.12 -39.98 88.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.036 . . . . 0.69 110.36 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' OE1' ' A' ' 32' ' ' GLN . 96.7 m-20 -68.92 -52.86 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 1.17 111.646 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -69.97 -42.89 72.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.873 -1.142 . . . . 3.0 110.07 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.99 101.51 54.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 108.318 -0.993 . . . . 1.54 108.318 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.46 -6.4 13.64 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.958 1.772 . . . . 1.21 112.717 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -60.0 -36.74 77.85 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.883 -1.154 . . . . 3.74 107.883 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -64.5 -25.28 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.844 -0.616 . . . . 1.12 110.402 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.927 -1.108 . . . . 2.51 109.523 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.09 -39.98 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 2.34 109.524 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -103.61 100.8 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.553 -0.906 . . . . 2.01 108.553 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.6 mttt -94.59 -68.33 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 1.68 110.513 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.03 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.963 -1.085 . . . . 3.98 110.327 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.55 -60.42 0.41 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.611 -0.996 . . . . 0.78 110.611 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.425 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 37.1 p-90 -84.85 -27.81 26.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -1.225 . . . . 0.44 110.712 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.421 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 93.1 mt-30 -60.36 -42.56 96.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 1.96 112.027 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -76.92 -33.92 57.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.711 -1.243 . . . . 1.28 111.8 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . 0.401 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 29.1 t -59.89 -40.11 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.858 -1.151 . . . . 1.49 111.406 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.5 mm -62.95 -59.12 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.04 -1.037 . . . . 0.64 111.711 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -70.05 -33.53 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.159 . . . . 2.76 110.667 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -59.97 -40.03 87.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 2.48 109.356 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 51' ' ' SER . 94.4 m-20 -70.03 -21.52 63.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 2.07 111.169 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.96 -50.02 75.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.748 -1.22 . . . . 0.78 110.49 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.8 m -60.02 -40.01 87.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 1.6 109.727 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 58' ' ' LEU . 11.2 mp -66.28 -39.99 89.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 1.38 109.06 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.59 113.97 15.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.424 -0.797 . . . . 1.42 109.887 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -89.99 -6.21 55.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.619 -0.882 . . . . 2.17 108.619 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -62.68 -37.74 87.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 1.56 109.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -78.37 156.53 29.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 1.32 108.582 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.2 t -120.16 129.96 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 0.91 109.608 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.94 142.92 52.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 1.81 109.501 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 57.8 t -127.11 88.2 54.82 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.487 -0.931 . . . . 1.28 108.487 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 88.0 Cg_exo . . . . . 0 C--N 1.308 -1.571 0 C-N-CA 121.994 1.796 . . . . 1.65 112.032 -179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.889 -0.782 . . . . 1.39 108.889 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -119.96 140.03 51.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.46 109.904 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -145.04 160.38 41.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 0.56 109.782 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.4 mt . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 1.42 108.785 179.059 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo . . . . . 0 N--CA 1.493 1.48 0 CA-C-O 120.62 0.175 . . . . 0.73 112.551 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 -2.48 12.68 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.63 2.22 . . . . 0.84 113.25 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 143.65 57.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.796 -1.19 . . . . 1.15 109.748 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 t -79.79 165.93 22.25 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.142 -1.058 . . . . 1.39 108.142 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.92 -40.07 87.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.795 -1.19 . . . . 1.32 109.003 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.0 mt -68.12 -40.03 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.96 109.957 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.51 92.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.952 -1.092 . . . . 0.38 109.902 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.08 -45.17 93.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.768 -1.208 . . . . 0.37 108.332 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.452 ' CD1' HD21 ' A' ' 55' ' ' ASN . 98.1 mt -63.91 -45.81 95.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.971 -0.751 . . . . 0.49 108.971 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.91 -40.61 98.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.39 110.573 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.532 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.5 mtm -70.04 -39.12 75.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.823 -1.173 . . . . 1.14 109.529 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.9 90.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.555 -0.715 . . . . 0.32 110.501 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.54 -49.89 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.979 -1.076 . . . . 0.33 108.656 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -61.48 -39.94 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.366 0.603 . . . . 1.82 109.494 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 15' ' ' MET . 76.2 m-20 -78.32 -6.06 53.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 1.67 110.37 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.34 126.47 83.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.63 109.639 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -41.24 -20.71 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.688 1.592 . . . . 1.29 110.931 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 20' ' ' ALA . 13.4 pt-20 -138.5 141.92 39.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 2.63 108.141 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -60.59 -34.66 74.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.98 -1.075 . . . . 2.02 109.111 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.68 118.42 20.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 1.55 109.42 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.69 158.6 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.338 -0.851 . . . . 0.47 109.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 p -86.5 161.8 18.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 0.81 111.041 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 27' ' ' LEU . 20.1 tp -61.12 -50.26 73.92 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.185 0.993 . . . . 0.7 109.002 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -59.97 -39.84 87.06 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.978 -0.556 . . . . 1.25 110.434 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.94 -39.94 89.79 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.004 -1.094 . . . . 0.29 110.404 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.8 -40.87 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.938 -1.331 . . . . 0.35 110.272 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 25.1 m-85 -60.03 -40.18 88.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.052 . . . . 1.4 111.142 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -63.34 -37.59 87.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.976 -1.077 . . . . 2.51 110.963 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.01 -45.17 93.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 1.37 110.76 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.81 -52.87 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.035 -1.041 . . . . 0.59 112.039 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.6 mtm -61.45 -39.97 92.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 0.69 111.283 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.34 -50.49 71.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 1.17 110.847 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -69.97 -39.98 75.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 3.0 111.382 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.555 ' C ' ' H ' ' A' ' 40' ' ' PHE . 89.7 m-85 -122.32 83.04 46.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 1.54 110.34 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.11 -3.93 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.248 1.966 . . . . 1.21 110.758 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -59.98 -39.99 87.59 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.653 -0.869 . . . . 3.74 108.653 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.0 -29.7 66.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.577 -0.702 . . . . 1.12 110.655 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -60.07 -39.9 87.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 2.51 109.714 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.4 -40.34 96.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 2.34 109.847 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -111.19 77.27 1.03 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.397 -0.594 . . . . 2.01 109.397 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -69.77 -40.03 76.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 1.68 110.04 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.67 148.08 37.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 3.98 110.41 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -61.65 0.35 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.323 -1.111 . . . . 0.78 110.323 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -89.98 -10.3 45.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -1.227 . . . . 0.44 110.786 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 62.8 tt0 -65.58 -56.79 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.931 -1.106 . . . . 1.96 110.754 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -70.11 -31.76 69.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 1.28 110.603 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -58.51 -39.55 80.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 1.49 110.539 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.469 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 5.4 mm -60.09 -49.77 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 0.64 110.236 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -70.05 -36.01 74.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.247 . . . . 2.76 110.426 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -59.92 -40.25 88.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 2.48 109.797 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.548 ' ND2' ' N ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -67.77 -39.99 84.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.511 -1.276 . . . . 2.07 108.396 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.548 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 54.2 mt -60.07 -48.66 80.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.78 110.353 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.5 p -70.05 -41.3 74.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 1.6 110.45 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -69.09 -40.15 78.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.025 . . . . 1.38 109.541 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -74.14 119.51 18.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -0.905 . . . . 1.42 108.723 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.76 -9.84 57.8 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 2.17 109.651 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.0 m -60.09 -39.96 87.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 1.56 109.413 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.77 140.67 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 1.32 108.824 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.56 130.1 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.498 -0.751 . . . . 0.91 109.762 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -73.64 135.57 43.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 1.81 109.211 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 77' ' ' TYR . 77.2 t -130.18 126.55 22.33 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.882 -0.785 . . . . 1.28 108.882 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 N--CA 1.491 1.374 0 C-N-CA 121.693 1.595 . . . . 1.65 112.263 179.698 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.456 ' N ' ' O ' ' A' ' 65' ' ' VAL . 9.5 m-30 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 108.944 -0.762 . . . . 1.39 108.944 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -119.97 141.99 49.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.692 -0.63 . . . . 0.46 109.689 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -143.03 160.04 41.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.21 -0.931 . . . . 0.56 109.37 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.0 mt . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.173 -0.954 . . . . 1.42 109.909 -179.534 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo . . . . . 0 N--CA 1.494 1.504 0 N-CA-C 111.384 -0.275 . . . . 0.73 111.384 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.4 -5.61 16.31 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.313 2.009 . . . . 0.84 112.84 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -69.98 142.06 52.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.022 -1.049 . . . . 1.15 109.792 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -70.89 160.58 32.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.774 -0.825 . . . . 1.39 108.774 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.046 . . . . 1.32 108.748 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.48 -39.54 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.96 109.036 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.42 94.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.321 -0.862 . . . . 0.38 110.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.05 -39.94 87.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 0.37 108.895 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.68 -39.99 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.488 -0.758 . . . . 0.49 108.98 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -65.28 -40.05 93.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.745 . . . . 0.39 110.499 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.0 mtm -69.96 -37.78 75.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 1.14 109.792 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.18 90.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 0.32 110.048 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.96 -49.58 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.33 108.672 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.74 -39.63 84.22 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.916 -0.584 . . . . 1.82 110.731 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.63 -19.46 65.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 1.67 109.844 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.58 150.12 75.77 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.63 109.292 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.79 -52.14 4.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.653 1.568 . . . . 1.29 109.578 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -100.95 135.99 41.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.066 -1.457 . . . . 2.63 107.066 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -64.53 -19.16 65.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.784 -1.198 . . . . 2.02 109.538 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.13 126.13 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 1.55 108.9 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.8 tt -150.16 152.17 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.229 -0.919 . . . . 0.47 109.532 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -79.97 158.74 26.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.81 109.659 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.496 HD21 ' NE ' ' A' ' 53' ' ' ARG . 57.1 tp -60.08 -42.99 95.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.994 -1.113 . . . . 0.7 107.994 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -62.77 -40.0 95.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.643 -0.66 . . . . 1.25 110.544 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -37.38 91.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.656 -1.378 . . . . 0.29 109.656 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.24 -39.97 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -1.137 . . . . 0.35 110.064 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.503 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 27.1 m-85 -64.38 -39.45 93.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.703 -1.248 . . . . 1.4 110.335 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -59.91 -40.54 89.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 2.51 108.972 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.9 -50.05 73.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 1.37 110.875 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.67 -50.16 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.089 -1.007 . . . . 0.59 112.175 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.6 mtm -60.64 -40.09 90.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 0.69 110.514 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.32 -48.49 72.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 1.17 111.38 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -69.75 -43.38 72.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.775 -1.203 . . . . 3.0 109.87 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 111.97 39.72 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.548 -0.908 . . . . 1.54 108.548 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.97 -5.76 14.72 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.873 1.715 . . . . 1.21 112.345 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.01 -38.13 81.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.371 -0.831 . . . . 3.74 109.418 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -69.91 -23.29 63.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.107 -0.996 . . . . 1.12 110.612 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -59.97 -40.37 88.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.897 -1.127 . . . . 2.51 109.543 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -62.5 -41.05 98.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 2.34 110.146 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -115.06 98.54 6.85 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.412 -0.588 . . . . 2.01 109.412 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 61.4 mttp -85.21 -31.79 23.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.93 . . . . 1.68 109.657 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -90.39 145.01 25.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 3.98 110.733 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.34 -63.92 0.29 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.726 -0.95 . . . . 0.78 110.726 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.492 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 36.7 p-90 -73.08 -34.84 66.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.979 -1.306 . . . . 0.44 111.894 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.61 -40.89 93.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.702 -1.249 . . . . 1.96 110.811 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -64.27 -40.03 95.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.876 -1.14 . . . . 1.28 110.607 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.2 m -60.81 -40.02 91.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 1.49 111.1 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.14 -47.97 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 0.64 110.832 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.503 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 13.3 mtp180 -69.84 -37.7 76.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.061 . . . . 2.76 109.875 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.505 ' NE2' HD11 ' A' ' 58' ' ' LEU . 74.9 t60 -59.99 -41.88 93.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.368 -0.832 . . . . 2.48 109.675 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -64.18 -40.01 95.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 2.07 109.62 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.01 -40.86 90.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.78 110.483 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -69.07 -44.66 72.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.93 -1.106 . . . . 1.6 110.64 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.505 HD11 ' NE2' ' A' ' 54' ' ' HIS . 82.2 mt -70.06 -40.0 75.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 1.38 110.027 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -74.66 116.11 14.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.899 -1.126 . . . . 1.42 108.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.87 -3.52 57.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 2.17 110.351 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -70.1 -17.9 63.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 1.56 110.172 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.29 153.61 31.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 1.32 109.132 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.9 t -110.06 128.19 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.534 -0.913 . . . . 0.91 108.534 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -96.85 115.57 27.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 1.81 108.876 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 118.43 44.92 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 107.485 -1.302 . . . . 1.28 107.485 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 N--CA 1.492 1.429 0 C-N-CA 121.714 1.609 . . . . 1.65 113.043 -178.884 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.653 -0.499 . . . . 1.39 109.653 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -121.02 130.7 53.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.599 -0.688 . . . . 0.46 109.437 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 164.28 33.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -0.792 . . . . 0.56 109.193 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.5 mt . . . . . 0 N--CA 1.496 1.841 0 O-C-N 121.319 -0.863 . . . . 1.42 109.09 179.774 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.1 Cg_endo . . . . . 0 N--CA 1.494 1.503 0 N-CA-C 111.833 -0.103 . . . . 0.73 111.833 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -39.79 -23.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.613 2.209 . . . . 0.84 113.871 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 5' ' ' PRO . 3.6 m-85 -59.96 137.44 58.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 1.15 110.139 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 p -83.1 173.82 11.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.506 -0.746 . . . . 1.39 109.014 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -62.94 -37.94 89.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 1.32 109.113 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -68.22 -41.28 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 0.96 109.741 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.43 86.18 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -0.937 . . . . 0.38 110.533 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.11 -39.86 87.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.238 -1.023 . . . . 0.37 108.238 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.513 HD13 HD21 ' A' ' 56' ' ' LEU . 97.0 mt -66.44 -45.36 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.841 . . . . 0.49 109.184 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -42.91 99.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.39 111.066 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.9 mtm -70.0 -40.01 75.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 1.14 110.862 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.409 ' HA ' HD21 ' A' ' 19' ' ' ASN . . . -54.69 -43.29 72.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -1.0 . . . . 0.32 109.449 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.9 mt -59.93 -45.97 94.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.492 -0.929 . . . . 0.33 108.492 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.0 -45.07 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.193 0.52 . . . . 1.82 110.501 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 15' ' ' MET . 15.6 p30 -91.11 15.44 11.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.866 -1.146 . . . . 1.67 109.874 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.37 129.5 74.64 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 0.63 108.521 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -40.6 -38.05 2.42 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.544 1.496 . . . . 1.29 110.885 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -124.54 154.23 40.91 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.253 -1.388 . . . . 2.63 107.253 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.782 -1.199 . . . . 2.02 108.489 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -90.64 125.84 35.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 1.55 109.031 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.8 tt -132.48 158.16 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.441 -0.787 . . . . 0.47 109.491 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -81.93 158.51 23.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 0.81 110.022 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.5 tp -59.97 -49.0 79.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.488 -0.758 . . . . 0.7 109.005 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -59.95 -39.57 86.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.541 -0.724 . . . . 1.25 109.843 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.58 -40.16 96.0 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.285 -0.96 . . . . 0.29 110.946 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.71 -42.45 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.841 -1.388 . . . . 0.35 109.555 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -60.94 -40.93 95.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 1.4 110.94 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.244 -0.91 . . . . 2.51 109.5 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -59.92 -47.79 84.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 1.37 109.771 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.97 -50.07 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.264 -0.897 . . . . 0.59 110.576 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.86 -39.9 95.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.879 -1.138 . . . . 0.69 110.216 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.11 -40.1 90.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.109 -0.994 . . . . 1.17 109.519 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -69.12 -54.05 17.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 3.0 110.351 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -110.71 123.56 35.26 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 1.54 109.912 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.84 -6.34 15.93 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.011 1.807 . . . . 1.21 111.197 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.03 -44.56 94.54 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.505 0.669 . . . . 3.74 109.541 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -70.07 -27.17 64.4 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.495 -0.753 . . . . 1.12 110.649 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -60.03 -39.77 87.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.849 -1.157 . . . . 2.51 108.581 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.32 -2.7 29.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 2.34 109.401 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.532 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 21.5 t-20 -144.47 98.54 3.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.548 -0.72 . . . . 2.01 109.104 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 56.3 mtpt -98.04 -32.93 11.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 1.68 110.626 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.84 143.11 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.876 -1.14 . . . . 3.98 110.398 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.61 -72.15 0.27 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.096 -1.201 . . . . 0.78 110.096 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 18.8 p-90 -69.96 -39.35 76.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.208 -1.172 . . . . 0.44 110.874 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.727 HE21 ' NH2' ' A' ' 53' ' ' ARG . 53.5 tt0 -59.99 -50.07 75.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 1.96 110.978 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -73.49 -31.69 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.936 -1.103 . . . . 1.28 110.044 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.8 m -59.93 -40.21 88.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 1.49 110.258 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 13' ' ' ILE . 17.0 mt -69.88 -43.62 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 0.64 109.138 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.727 ' NH2' HE21 ' A' ' 49' ' ' GLN . 67.2 mtt180 -59.99 -47.18 86.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.718 -1.239 . . . . 2.76 108.417 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.454 ' NE2' HD11 ' A' ' 58' ' ' LEU . 84.1 t60 -60.8 -40.03 91.13 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 2.48 108.467 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.07 -39.94 95.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.861 -0.792 . . . . 2.07 108.861 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.513 HD21 HD13 ' A' ' 13' ' ' ILE . 32.5 mt -59.99 -45.87 91.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 0.78 110.105 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.35 -42.44 99.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.902 -1.124 . . . . 1.6 109.337 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.454 HD11 ' NE2' ' A' ' 54' ' ' HIS . 51.6 mt -70.02 -37.22 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 1.38 109.775 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -69.18 117.84 11.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 1.42 109.898 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -90.7 -10.96 41.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 2.17 108.962 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.94 -40.04 87.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.425 -0.797 . . . . 1.56 109.673 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.48 146.19 32.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.297 -0.877 . . . . 1.32 109.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.98 125.35 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.175 -1.046 . . . . 0.91 108.175 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.448 ' NZ ' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.42 135.57 38.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 1.81 109.903 -178.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.43 139.02 31.48 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.642 -0.873 . . . . 1.28 108.642 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo . . . . . 0 N--CA 1.494 1.547 0 C-N-CA 122.254 1.969 . . . . 1.65 112.36 -179.963 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.509 -0.552 . . . . 1.39 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -132.15 151.53 51.74 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.366 -0.834 . . . . 0.46 109.492 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.5 t -149.99 169.98 19.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.967 -1.083 . . . . 0.56 110.347 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.8 mt . . . . . 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 1.42 110.551 -179.881 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo . . . . . 0 N--CA 1.495 1.607 0 CA-C-O 120.582 0.159 . . . . 0.73 112.384 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.55 -9.25 18.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.542 2.161 . . . . 0.84 112.878 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -67.34 143.32 56.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.955 -1.091 . . . . 1.15 108.993 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.9 t -69.65 159.98 32.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -0.973 . . . . 1.39 108.573 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -59.9 -39.97 87.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.934 -1.104 . . . . 1.32 108.465 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.53 -39.95 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.786 . . . . 0.96 109.395 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.02 95.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.38 110.103 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.06 -40.07 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.198 -0.939 . . . . 0.37 108.588 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.66 -41.93 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 0.49 108.91 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -60.49 -40.1 90.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 0.39 109.676 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.43 -39.94 89.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 1.14 109.175 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.65 85.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.629 -0.67 . . . . 0.32 110.474 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.06 -49.86 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.059 -1.026 . . . . 0.33 108.973 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.57 -40.51 92.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.837 -0.539 . . . . 1.82 110.157 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -70.69 -20.61 62.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 1.67 110.372 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.06 119.85 77.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.091 -1.006 . . . . 0.63 109.812 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.99 -29.55 1.58 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.409 1.406 . . . . 1.29 110.719 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -115.09 128.13 56.04 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.612 -1.255 . . . . 2.63 107.612 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -69.93 -27.31 64.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.922 -1.111 . . . . 2.02 110.142 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -78.54 74.28 5.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.951 -1.093 . . . . 1.55 109.354 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -88.57 147.46 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.815 -0.809 . . . . 0.47 108.815 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -79.04 159.56 27.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.81 109.851 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 27' ' ' LEU . 33.1 tp -60.42 -50.01 75.3 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.63 0.729 . . . . 0.7 109.839 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 1.25 109.744 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -38.62 94.36 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.495 -1.042 . . . . 0.29 110.495 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.02 -43.71 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.973 -1.31 . . . . 0.35 109.933 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -59.99 -45.38 92.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.953 -1.092 . . . . 1.4 110.366 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -59.98 -40.12 88.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 2.51 110.265 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.92 -46.55 89.01 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.141 -0.974 . . . . 1.37 109.412 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.0 mt -65.78 -49.94 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.59 111.499 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.0 mtm -61.11 -40.0 92.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.935 -1.103 . . . . 0.69 110.98 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -66.67 -39.93 88.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 1.17 110.555 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -76.94 -67.04 0.75 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 3.0 111.129 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -85.96 130.44 50.37 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.731 -1.23 . . . . 1.54 109.907 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.63 -13.26 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.186 1.924 . . . . 1.21 113.204 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.94 -44.37 94.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.998 -1.064 . . . . 3.74 110.288 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -70.2 -29.21 66.0 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 1.12 111.114 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.949 -1.094 . . . . 2.51 110.124 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -93.2 0.05 57.0 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.003 -1.061 . . . . 2.34 110.264 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.548 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 59.1 t30 -124.27 129.05 50.08 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.271 0.557 . . . . 2.01 109.547 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 32.1 mmtp -129.12 17.89 6.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.512 -0.742 . . . . 1.68 109.402 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -70.43 -160.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 3.98 111.871 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.61 -9.21 0.25 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 116.112 -0.494 . . . . 0.78 111.917 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.548 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -59.99 -35.99 76.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.218 -1.754 . . . . 0.44 107.721 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.38 -44.12 97.69 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.757 -0.589 . . . . 1.96 111.154 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -80.32 -26.58 38.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.002 -1.061 . . . . 1.28 111.703 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -69.39 -23.58 63.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.763 -1.211 . . . . 1.49 110.868 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -69.99 -61.66 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.006 -1.059 . . . . 0.64 111.394 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -70.01 -30.92 68.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.159 -0.963 . . . . 2.76 111.216 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.21 -36.82 78.54 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.912 -1.117 . . . . 2.48 109.648 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 98.5 m-20 -69.94 -19.24 63.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 2.07 111.14 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.91 -45.1 93.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.909 -1.119 . . . . 0.78 110.385 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.8 p -69.98 -39.6 75.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.968 -1.082 . . . . 1.6 110.102 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.16 -39.95 88.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.38 110.028 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 83.2 m-20 -64.52 119.0 9.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 1.42 109.601 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -81.97 -37.73 26.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 2.17 110.294 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.5 m -65.31 -11.54 42.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 1.56 109.769 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.44 131.17 36.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 1.32 109.122 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.3 t -97.19 127.94 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.276 -0.89 . . . . 0.91 109.101 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -103.71 118.0 35.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 1.81 110.174 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -113.24 118.19 44.36 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 107.867 -1.161 . . . . 1.28 107.867 179.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo . . . . . 0 N--CA 1.492 1.403 0 C-N-CA 121.415 1.41 . . . . 1.65 112.367 -179.212 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.422 -0.585 . . . . 1.39 109.422 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -130.19 130.7 45.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.46 109.743 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.2 t -149.82 159.44 44.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 0.56 109.542 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.4 mt . . . . . 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 1.42 109.717 -179.976 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' TYR . 83.6 Cg_exo . . . . . 0 N--CA 1.497 1.697 0 CA-C-O 120.07 -0.054 . . . . 0.73 112.218 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.11 -8.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.274 1.983 . . . . 0.84 113.65 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.8 m-85 -71.96 144.52 48.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.707 -1.246 . . . . 1.15 109.926 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 m -82.31 169.94 15.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 1.39 109.419 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -60.09 -39.96 87.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.14 -0.975 . . . . 1.32 109.158 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.81 -39.9 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.96 109.181 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -47.62 84.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.38 110.342 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.07 -41.45 92.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.789 -1.194 . . . . 0.37 108.436 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.32 -42.05 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.048 -1.093 . . . . 0.49 108.048 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.16 -40.02 94.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.584 -0.697 . . . . 0.39 109.47 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.26 -39.92 82.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 1.14 109.603 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.01 81.11 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.329 -0.857 . . . . 0.32 109.252 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 70.1 mt -61.1 -50.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.33 108.757 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.401 HE21 HD11 ' A' ' 80' ' ' LEU . 99.1 mm-40 -61.23 -40.01 92.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.632 -0.668 . . . . 1.82 109.839 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -78.05 -4.16 45.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 1.67 108.967 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -80.05 119.3 76.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.589 -0.893 . . . . 0.63 108.589 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -40.41 -26.72 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.675 1.583 . . . . 1.29 111.594 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 20' ' ' ALA . 20.7 pt-20 -134.7 153.93 51.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.036 -1.098 . . . . 2.63 108.036 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -67.74 -31.56 71.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 2.02 110.825 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -78.87 123.42 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.686 -1.259 . . . . 1.55 109.704 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 tt -140.39 153.8 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.285 -0.884 . . . . 0.47 109.543 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.1 p -81.91 152.63 26.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 0.81 110.197 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.0 -49.06 79.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.684 -0.858 . . . . 0.7 108.684 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.9 -40.11 87.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.453 -0.78 . . . . 1.25 109.811 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.77 94.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.581 -1.008 . . . . 0.29 110.581 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.04 -41.54 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.317 . . . . 0.35 110.033 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CD1' ' NE2' ' A' ' 49' ' ' GLN . 38.9 m-85 -59.99 -45.37 92.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 1.4 110.731 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.94 -37.32 84.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.041 -1.037 . . . . 2.51 110.852 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.98 -49.04 79.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 1.37 110.68 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.06 -49.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 0.59 110.693 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.47 -39.93 92.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.918 -1.114 . . . . 0.69 110.476 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.52 -40.01 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 1.17 109.47 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -79.76 -69.39 0.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 3.0 109.483 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -89.47 116.53 66.58 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.983 . . . . 1.54 109.019 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.52 -3.93 12.72 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.88 1.72 . . . . 1.21 111.235 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -60.06 -39.75 87.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.594 -0.891 . . . . 3.74 108.594 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' ASN . 93.3 m-85 -69.87 -27.15 64.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.567 -0.708 . . . . 1.12 110.521 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -59.2 -39.96 84.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.823 -1.173 . . . . 2.51 107.994 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -61.3 -40.77 95.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 2.34 109.631 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -111.5 108.5 18.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.329 -0.619 . . . . 2.01 109.329 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 66.3 mttm -96.64 -40.74 8.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.067 -1.02 . . . . 1.68 110.513 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.21 142.97 27.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.169 -0.957 . . . . 3.98 110.536 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.77 -55.74 0.49 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.562 -1.415 . . . . 0.78 109.562 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.448 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.6 p-90 -89.23 -3.07 58.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -1.185 . . . . 0.44 109.256 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.423 ' NE2' ' CD1' ' A' ' 31' ' ' TYR . 67.3 tp60 -74.08 -61.7 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 1.96 111.089 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -69.55 -39.93 77.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.302 -0.873 . . . . 1.28 110.656 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.2 m -50.84 -31.09 16.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 1.49 111.008 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.29 -65.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.003 -1.06 . . . . 0.64 110.894 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -69.94 -30.02 67.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 2.76 110.6 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.769 -1.207 . . . . 2.48 108.491 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.427 ' OD1' ' OD1' ' A' ' 59' ' ' ASN . 27.2 t-20 -61.08 -42.86 99.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 2.07 110.144 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.96 -41.66 92.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.993 . . . . 0.78 110.239 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 p -64.05 -50.64 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 1.6 110.625 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.4 mp -69.94 -40.09 75.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.929 -1.107 . . . . 1.38 110.056 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.68 HD22 ' N ' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -66.73 122.11 16.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.192 -0.943 . . . . 1.42 109.58 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -86.09 -10.2 55.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 2.17 109.34 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.26 -40.02 92.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.288 -0.883 . . . . 1.56 109.061 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -82.74 129.29 34.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.348 -0.982 . . . . 1.32 108.348 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.94 119.93 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.91 109.534 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.88 150.06 24.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.298 -1.001 . . . . 1.81 108.298 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.01 91.55 22.94 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.31 -0.869 . . . . 1.28 109.789 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo . . . . . 0 C--N 1.311 -1.409 0 C-N-CA 121.712 1.608 . . . . 1.65 111.318 179.404 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 . . . . . 0 N--CA 1.491 1.625 0 N-CA-C 109.685 -0.487 . . . . 1.39 109.685 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -122.96 130.98 53.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.227 -0.657 . . . . 0.46 109.227 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 161.67 40.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.331 -0.855 . . . . 0.56 109.528 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.401 HD11 HE21 ' A' ' 18' ' ' GLN . 76.5 mt . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.42 109.325 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.495 1.612 0 CA-C-O 120.816 0.256 . . . . 0.73 112.162 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.64 -2.62 12.86 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.519 2.146 . . . . 0.84 112.685 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -64.93 137.45 57.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.814 -1.179 . . . . 1.15 108.735 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -77.83 168.67 19.55 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.285 -1.006 . . . . 1.39 108.285 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -60.0 -37.85 80.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.022 -1.049 . . . . 1.32 108.617 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.9 mm -60.11 -46.29 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.96 109.613 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.81 95.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -0.872 . . . . 0.38 110.452 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.76 -40.14 91.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.925 -1.109 . . . . 0.37 108.64 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.12 -42.2 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.471 -0.937 . . . . 0.49 108.471 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -64.38 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 0.39 110.358 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtt -66.32 -39.34 89.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.89 . . . . 1.14 109.658 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 20' ' ' ALA . . . -60.14 -41.4 92.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.542 -0.724 . . . . 0.32 110.252 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.503 ' CG2' ' HZ3' ' A' ' 23' ' ' LYS . 62.3 mt -69.57 -49.14 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.106 -0.997 . . . . 0.33 109.431 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.03 -40.03 90.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 1.82 110.612 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -82.16 -10.6 59.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 1.67 110.78 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 16' ' ' ALA . . . -79.07 149.17 72.88 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.942 -1.099 . . . . 0.63 109.022 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.62 -57.03 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.441 1.427 . . . . 1.29 110.359 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -104.98 127.07 52.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.94 -1.133 . . . . 2.63 107.94 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HZ3' ' CG2' ' A' ' 17' ' ' ILE . 8.7 mtpm? -60.33 -28.91 68.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.962 -1.086 . . . . 2.02 108.927 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -78.05 82.41 4.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.956 -1.127 . . . . 1.55 107.956 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 tt -111.87 148.55 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.767 -0.827 . . . . 0.47 108.767 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.7 p -79.03 161.07 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.116 -0.99 . . . . 0.81 109.233 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.4 tp -60.04 -42.63 94.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.7 108.962 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.76 -40.01 90.91 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.286 -0.884 . . . . 1.25 109.643 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.71 -35.99 90.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.84 -1.304 . . . . 0.29 109.84 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.76 -41.16 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -1.153 . . . . 0.35 110.293 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -60.0 -40.1 88.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.531 -1.355 . . . . 1.4 109.383 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.98 -40.35 88.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.462 -0.774 . . . . 2.51 109.798 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.71 -47.22 73.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 1.37 110.701 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.2 -49.88 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 0.59 110.678 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.1 mtm -62.13 -39.99 94.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.892 -1.13 . . . . 0.69 109.548 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.01 -49.64 75.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 1.17 110.401 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -70.04 -58.85 3.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.921 -1.112 . . . . 3.0 109.848 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -100.04 112.83 64.73 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 1.54 108.892 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.03 -10.16 14.0 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.028 1.819 . . . . 1.21 112.64 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.5 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -60.07 -38.17 82.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 3.74 108.953 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 44' ' ' ASN . 69.4 m-85 -63.89 -28.75 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.666 -0.646 . . . . 1.12 110.952 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.89 -39.93 87.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.83 -1.169 . . . . 2.51 109.372 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.77 -40.08 93.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 2.34 109.461 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -114.45 104.74 12.34 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 2.01 108.498 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 53.8 mtpt -98.47 -32.58 11.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 1.68 110.67 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -89.72 137.02 32.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.069 -1.02 . . . . 3.98 110.028 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.44 -64.9 0.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.96 -1.256 . . . . 0.78 109.96 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.511 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 38.0 p-90 -72.88 -37.06 67.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.108 -1.231 . . . . 0.44 110.51 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -60.09 -45.38 93.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 1.96 110.369 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.4 ' HA ' HH11 ' A' ' 53' ' ' ARG . 98.5 m-20 -68.86 -37.66 79.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 1.28 110.255 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 m -59.85 -39.35 84.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 1.49 110.043 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.3 mm -60.01 -46.81 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 0.64 110.224 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.425 HH11 ' HG3' ' A' ' 53' ' ' ARG . 1.0 OUTLIER -64.75 -41.49 95.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 2.76 109.708 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . 0.483 ' NE2' HD11 ' A' ' 58' ' ' LEU . 13.3 t60 -60.03 -45.25 93.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.841 . . . . 2.48 109.832 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.07 -39.96 94.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -0.915 . . . . 2.07 109.666 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.89 -46.87 87.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.78 110.263 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -64.73 -44.46 90.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.884 -1.135 . . . . 1.6 109.453 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.483 HD11 ' NE2' ' A' ' 54' ' ' HIS . 26.9 mt -67.88 -43.26 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.38 109.678 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -85.07 106.89 16.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 1.42 108.76 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -91.01 10.29 27.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 2.17 109.449 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.41 -26.05 67.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.838 . . . . 1.56 109.927 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -79.76 147.91 31.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 1.32 109.122 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.9 t -90.61 118.52 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.91 109.08 -179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -92.33 100.23 12.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 1.81 109.239 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.88 123.78 44.24 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.494 -0.928 . . . . 1.28 108.494 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo . . . . . 0 N--CA 1.494 1.522 0 C-N-CA 122.013 1.809 . . . . 1.65 112.604 -179.754 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.6 m-85 . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.291 -0.633 . . . . 1.39 109.291 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -114.56 130.79 56.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.523 -0.735 . . . . 0.46 109.288 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.3 t -158.51 153.67 25.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.943 . . . . 0.56 109.583 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 mt . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 1.42 109.316 179.818 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo . . . . . 0 N--CA 1.495 1.606 0 N-CA-C 112.988 0.342 . . . . 0.73 112.988 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.1 16.9 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.531 2.154 . . . . 0.84 111.691 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -101.22 135.81 42.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.385 -0.822 . . . . 1.15 109.455 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 91.8 p -80.21 170.01 17.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.435 -0.791 . . . . 1.39 109.281 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 1.32 108.913 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.05 -40.14 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.96 108.542 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.82 73.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.38 109.492 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.06 -40.85 90.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.043 -1.035 . . . . 0.37 108.336 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.5 mt -69.91 -41.54 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 0.49 108.959 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -39.94 95.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.39 109.268 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.522 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.3 mtt -68.06 -40.0 82.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 1.14 108.829 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -49.5 77.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.567 -0.708 . . . . 0.32 110.073 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.04 -49.9 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 0.33 109.255 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.43 -39.66 92.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.852 -0.53 . . . . 1.82 110.266 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 15' ' ' MET . 69.4 m-80 -80.3 5.0 15.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 1.67 110.112 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.1 148.37 74.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.971 -1.081 . . . . 0.63 109.76 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -33.6 -84.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.912 2.408 . . . . 1.29 112.849 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -90.02 -80.05 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.685 -1.259 . . . . 2.63 108.542 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -159.16 -33.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.895 -1.128 . . . . 2.02 110.117 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -81.42 129.85 34.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.994 -1.066 . . . . 1.55 110.142 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -130.75 138.74 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.611 -0.885 . . . . 0.47 108.611 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.2 p -79.99 162.31 24.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 0.81 109.965 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.711 HD21 ' HG2' ' A' ' 53' ' ' ARG . 52.1 tp -60.04 -47.01 87.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.671 -0.862 . . . . 0.7 108.671 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.442 ' O ' ' OE1' ' A' ' 32' ' ' GLN . 79.7 m-20 -62.55 -39.93 95.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 1.25 109.844 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.07 91.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.536 -1.026 . . . . 0.29 110.536 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.97 -40.69 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.987 -1.302 . . . . 0.35 109.381 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -60.07 -48.68 80.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.108 -0.995 . . . . 1.4 109.955 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 28' ' ' ASN . 4.8 mp0 -59.92 -37.79 80.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 2.51 109.488 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -59.99 -49.99 75.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 1.37 109.64 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -49.97 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.002 -1.061 . . . . 0.59 110.824 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.5 mtm -65.02 -43.49 92.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.89 -1.131 . . . . 0.69 110.781 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.36 -44.86 86.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 1.17 110.626 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.446 HH11 ' HG3' ' A' ' 37' ' ' ARG . 21.7 mmm-85 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.019 -1.051 . . . . 3.0 110.541 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 40' ' ' PHE . 70.4 m-85 -124.05 82.53 56.31 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.418 -0.801 . . . . 1.54 109.766 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.45 -6.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.562 2.174 . . . . 1.21 111.779 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 38' ' ' PHE . 49.6 t80 -59.94 -42.76 94.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.515 -0.74 . . . . 3.74 109.898 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.03 -22.15 63.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 1.12 110.937 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -39.84 86.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.912 -1.117 . . . . 2.51 109.705 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.54 2.85 43.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 2.34 109.728 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.501 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 81.3 m-20 -133.92 115.67 14.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.626 -0.672 . . . . 2.01 109.832 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' GLN . 56.0 mttp -110.47 13.74 22.68 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.477 -0.935 . . . . 1.68 108.477 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 48' ' ' TRP . 87.7 mt-30 -47.39 -177.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.995 0.902 . . . . 3.98 111.401 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.9 -8.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.932 -0.867 . . . . 0.78 110.932 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' A' ' 46' ' ' GLN . 3.8 p-90 -59.87 -40.75 89.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.575 -1.544 . . . . 0.44 107.939 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.514 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 58.5 tt0 -60.06 -50.3 74.26 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.261 0.553 . . . . 1.96 111.316 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -73.23 -40.07 64.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.173 . . . . 1.28 110.759 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.3 p -51.94 -30.05 22.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.937 . . . . 1.49 110.773 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.76 -52.26 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.118 . . . . 0.64 110.489 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG2' HD21 ' A' ' 27' ' ' LEU . 32.6 mtp180 -69.98 -40.67 75.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.052 . . . . 2.76 110.154 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -63.34 -39.98 96.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.079 -1.013 . . . . 2.48 108.659 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.96 -40.0 95.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.093 -1.077 . . . . 2.07 108.093 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.2 mt -68.51 -40.59 80.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.78 109.823 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 t -69.95 -44.24 69.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 1.6 109.468 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 mt -69.62 -39.71 77.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 1.38 109.046 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -75.58 105.81 6.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.168 -0.957 . . . . 1.42 109.31 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.47 -1.08 57.92 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.981 -1.118 . . . . 2.17 107.981 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.4 m -60.17 -34.09 73.1 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.042 -0.725 . . . . 1.56 109.042 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.51 155.55 29.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.8 . . . . 1.32 109.025 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 125.73 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.517 -0.74 . . . . 0.91 109.209 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -76.61 154.65 34.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 1.81 109.167 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.24 91.77 49.53 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.49 -0.756 . . . . 1.28 109.0 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo . . . . . 0 C--N 1.311 -1.443 0 C-N-CA 122.097 1.865 . . . . 1.65 112.524 -179.471 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.442 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 21.6 m-85 . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 108.038 -1.097 . . . . 1.39 108.038 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -110.96 127.16 55.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.46 109.58 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.3 t -141.67 159.19 42.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.305 -0.872 . . . . 0.56 109.686 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 75.4 mt . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.42 109.973 -179.618 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 55.4 Cg_endo . . . . . 0 N--CA 1.491 1.331 0 N-CA-C 112.147 0.018 . . . . 0.73 112.147 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.64 -17.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.546 2.164 . . . . 0.84 113.793 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 6.1 m-85 -67.69 129.04 38.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.766 -1.209 . . . . 1.15 110.171 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.1 p -81.94 177.17 9.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -0.759 . . . . 1.39 109.059 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -59.93 -41.48 91.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 1.32 109.562 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.01 -47.46 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.96 109.784 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.89 87.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.913 . . . . 0.38 110.317 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.03 -45.63 92.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.831 -1.168 . . . . 0.37 109.051 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 84.2 mt -62.19 -40.02 86.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.123 -1.065 . . . . 0.49 108.123 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.33 -39.95 94.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.614 -0.679 . . . . 0.39 109.593 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.0 mtt -65.83 -39.91 91.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 1.14 109.76 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.31 89.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 0.32 109.835 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.1 mt -60.02 -49.97 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.151 -0.968 . . . . 0.33 108.543 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.19 -40.04 93.66 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.213 0.53 . . . . 1.82 110.168 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.12 0.7 43.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 1.67 110.45 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 148.42 74.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.96 -1.087 . . . . 0.63 108.759 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.81 -23.53 74.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.608 1.539 . . . . 1.29 109.768 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -138.35 148.79 44.94 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.124 . . . . 2.63 107.964 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -61.64 -36.9 82.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.007 -1.058 . . . . 2.02 108.274 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.377 -0.971 . . . . 1.55 108.377 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.14 152.71 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.368 -0.832 . . . . 0.47 109.048 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.2 p -80.08 153.8 28.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 0.81 109.238 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -59.97 -40.27 88.53 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.446 -0.784 . . . . 0.7 108.889 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -60.17 -40.06 88.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.506 -0.746 . . . . 1.25 109.913 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.92 -38.83 97.22 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.639 -0.985 . . . . 0.29 110.639 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.04 -40.44 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -1.225 . . . . 0.35 110.017 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.533 ' CE1' ' OE1' ' A' ' 49' ' ' GLN . 32.1 m-85 -60.03 -41.95 93.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.901 -1.124 . . . . 1.4 110.263 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.14 -40.24 89.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.297 -0.877 . . . . 2.51 110.078 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.94 -49.63 76.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.672 . . . . 1.37 111.446 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.2 mt -59.93 -49.86 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 0.59 111.631 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.8 mtm -60.0 -40.03 87.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 0.69 111.164 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.29 -46.18 71.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.649 -1.282 . . . . 1.17 111.019 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.441 ' HA ' ' HE ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -70.0 -40.06 75.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.89 -1.131 . . . . 3.0 109.943 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -121.63 110.04 33.97 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.662 -0.866 . . . . 1.54 108.662 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.471 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 95.8 Cg_endo -79.59 -11.27 14.27 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.927 1.751 . . . . 1.21 113.011 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -58.47 -35.97 72.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.176 -0.952 . . . . 3.74 109.22 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 44' ' ' ASN . 91.5 m-85 -67.6 -29.5 68.86 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.767 -0.583 . . . . 1.12 110.603 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -59.96 -39.96 87.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.027 -1.046 . . . . 2.51 109.582 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 39' ' ' PRO . 54.7 mp0 -66.62 -39.97 88.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.037 -1.039 . . . . 2.34 109.048 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.4 m-20 -106.23 106.49 17.03 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.257 -0.645 . . . . 2.01 109.257 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 59.1 mttm -98.38 -42.61 7.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.114 -0.991 . . . . 1.68 109.96 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -77.98 140.14 39.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.165 -0.96 . . . . 3.98 109.873 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.86 -59.98 0.34 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.443 -1.063 . . . . 0.78 110.443 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.422 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 26.2 p-90 -89.44 -14.77 34.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.025 -1.279 . . . . 0.44 110.497 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.533 ' OE1' ' CE1' ' A' ' 31' ' ' TYR . 3.2 tp-100 -69.92 -60.02 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 1.96 110.926 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -72.36 -28.67 63.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.906 -1.121 . . . . 1.28 110.942 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -59.95 -38.82 83.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.909 -1.119 . . . . 1.49 109.857 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.95 -44.77 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.938 . . . . 0.64 110.086 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -68.97 -44.79 72.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.791 -1.193 . . . . 2.76 110.482 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -60.01 -41.66 92.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 2.48 109.279 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.736 HD21 HD21 ' A' ' 59' ' ' ASN . 21.7 t-20 -61.96 -42.26 98.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 2.07 108.753 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -60.06 -46.83 88.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.409 -0.807 . . . . 0.78 109.903 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 t -70.4 -41.98 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 1.6 109.961 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.36 -39.96 89.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 1.38 110.084 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.736 HD21 HD21 ' A' ' 55' ' ' ASN . 93.7 m-20 -74.73 119.75 19.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.148 -0.97 . . . . 1.42 108.984 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -89.96 -2.7 58.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 2.17 108.667 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.7 m -62.61 -40.04 95.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.747 . . . . 1.56 109.367 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -80.6 152.62 28.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 1.32 109.421 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.6 t -127.42 128.04 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 0.91 109.589 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -83.82 150.02 26.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 1.81 109.415 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.2 80.03 69.31 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.111 -1.07 . . . . 1.28 108.111 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo . . . . . 0 C--N 1.309 -1.518 0 C-N-CA 122.249 1.966 . . . . 1.65 112.252 -179.487 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.497 1.912 0 N-CA-C 107.218 -1.401 . . . . 1.39 107.218 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -122.75 134.78 54.43 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.27 -0.894 . . . . 0.46 110.23 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -152.64 161.32 42.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 0.56 109.245 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.6 mt . . . . . 0 N--CA 1.492 1.649 0 O-C-N 121.033 -1.042 . . . . 1.42 109.488 -179.933 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 7' ' ' TYR . 68.7 Cg_endo . . . . . 0 N--CA 1.491 1.348 0 N-CA-C 111.352 -0.288 . . . . 0.73 111.352 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.74 -24.36 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.249 1.966 . . . . 0.84 113.373 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PRO . 12.4 m-85 -60.61 131.54 51.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 1.15 109.895 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t -81.7 169.21 17.24 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.482 -0.933 . . . . 1.39 108.482 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -60.0 -40.3 88.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 1.32 109.352 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.29 -43.45 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.015 -1.053 . . . . 0.96 108.935 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.17 85.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.8 . . . . 0.38 109.855 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.98 -40.21 88.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 0.37 109.059 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.92 -44.2 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.04 -1.038 . . . . 0.49 108.247 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m -60.56 -40.04 90.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 0.39 110.376 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.97 -39.96 87.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 1.14 109.811 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.11 94.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.32 109.961 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.33 -46.3 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.33 109.03 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.94 -40.04 87.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.71 -0.619 . . . . 1.82 109.462 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -83.25 -3.06 57.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.933 . . . . 1.67 109.462 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.01 124.84 82.82 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 0.63 109.493 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -42.93 -57.09 1.87 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.397 1.398 . . . . 1.29 110.92 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -97.52 140.82 31.37 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.852 -1.166 . . . . 2.63 107.852 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -59.9 -35.53 75.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 2.02 110.087 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -76.97 129.95 36.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.604 -1.31 . . . . 1.55 108.533 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.0 tt -139.9 147.68 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 0.47 109.694 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -82.66 150.22 26.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.479 -0.763 . . . . 0.81 109.295 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 56' ' ' LEU . 51.4 tp -59.97 -41.59 92.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.7 108.627 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.33 -41.75 94.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.547 -0.72 . . . . 1.25 110.106 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.51 97.23 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.492 -1.043 . . . . 0.29 110.492 -179.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.99 -39.98 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -1.188 . . . . 0.35 110.284 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -59.97 -42.0 93.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.636 -1.29 . . . . 1.4 109.569 -178.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.56 -40.67 95.58 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.127 -0.983 . . . . 2.51 109.789 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.26 -49.88 75.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 1.37 111.377 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.07 -44.72 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 0.59 110.738 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.7 mtm -60.01 -41.79 92.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.919 -1.113 . . . . 0.69 109.416 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.02 -40.0 75.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 1.17 110.417 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -68.05 -60.03 2.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 3.0 110.654 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.08 126.31 31.37 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 1.54 109.257 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.64 -16.54 10.37 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.161 1.907 . . . . 1.21 113.555 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.826 -1.171 . . . . 3.74 110.181 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -17.59 64.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 1.12 110.908 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -60.06 -48.66 80.81 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.999 -1.063 . . . . 2.51 109.141 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.728 0.775 . . . . 2.34 110.326 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.453 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 14.6 t-20 -93.96 99.98 12.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.638 -0.664 . . . . 2.01 109.372 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.449 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 62.0 mttp -97.77 -39.26 9.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 1.68 110.189 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -87.66 139.79 30.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 3.98 110.107 -178.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.72 -59.22 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.403 -1.079 . . . . 0.78 110.403 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.453 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 31.7 p-90 -82.48 -12.5 57.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.964 -1.315 . . . . 0.44 110.479 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.0 -54.23 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 1.96 110.739 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.03 -25.93 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.904 -1.123 . . . . 1.28 110.841 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.3 p -60.11 -39.92 87.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 1.49 110.139 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.49 -47.94 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.64 110.604 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -69.95 -42.53 73.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.882 -1.136 . . . . 2.76 110.535 -178.83 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -44.8 94.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 2.48 108.961 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 94.0 m-20 -59.98 -40.14 88.07 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.204 -0.935 . . . . 2.07 109.459 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.463 ' CD1' HD13 ' A' ' 27' ' ' LEU . 86.6 mt -61.2 -42.18 98.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 0.78 110.446 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.7 p -66.73 -46.53 75.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.109 -0.994 . . . . 1.6 110.753 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.28 -39.91 74.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.862 -1.149 . . . . 1.38 110.249 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 77.1 m-20 -77.7 118.01 19.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.977 . . . . 1.42 109.351 -179.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.65 -2.96 57.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 2.17 110.017 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CD2' ' A' ' 62' ' ' PHE . 12.2 p -61.41 -32.44 72.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.56 108.868 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.582 ' CD2' ' SG ' ' A' ' 61' ' ' CYS . 90.8 m-85 -79.06 150.06 31.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.438 -0.789 . . . . 1.32 109.194 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.33 122.04 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.777 -0.823 . . . . 0.91 108.777 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -80.78 111.55 17.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 1.81 110.142 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.5 t -103.75 113.68 65.29 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.938 -1.134 . . . . 1.28 107.938 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 N--CA 1.492 1.412 0 C-N-CA 121.816 1.677 . . . . 1.65 112.711 -178.819 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 108.91 -0.774 . . . . 1.39 108.91 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.05 139.98 51.7 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.403 -0.811 . . . . 0.46 109.843 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -153.23 153.12 32.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.56 109.895 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.0 mt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 1.42 108.561 179.175 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo . . . . . 0 N--CA 1.491 1.36 0 N-CA-C 112.635 0.206 . . . . 0.73 112.635 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.25 2.52 8.47 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.633 2.222 . . . . 0.84 113.83 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.59 140.21 58.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.514 -1.367 . . . . 1.15 109.48 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.0 m -74.54 164.33 26.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.893 . . . . 1.39 109.073 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -59.9 -40.07 87.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.166 -0.959 . . . . 1.32 108.622 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 55' ' ' ASN . 32.2 mm -69.62 -40.0 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.96 108.973 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.92 95.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 0.38 109.692 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.062 -1.024 . . . . 0.37 108.436 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 0.49 108.807 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -60.73 -40.03 90.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 0.39 109.876 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.2 mtt -67.43 -39.88 85.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.009 . . . . 1.14 109.009 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.33 78.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 0.32 109.802 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.98 -50.02 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.195 -1.039 . . . . 0.33 108.195 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.393 0.616 . . . . 1.82 109.348 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -84.01 -0.51 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 1.67 109.759 -179.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.92 126.48 82.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.057 -1.027 . . . . 0.63 108.836 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -38.79 -28.12 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.785 1.657 . . . . 1.29 111.328 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' ALA . 12.8 pt-20 -145.69 155.28 42.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.174 -1.047 . . . . 2.63 108.174 178.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -60.05 -38.03 81.59 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.174 -0.953 . . . . 2.02 109.687 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -79.07 108.25 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 1.55 109.751 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -133.58 154.39 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.941 -0.763 . . . . 0.47 108.941 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -80.45 155.37 27.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.81 110.306 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.98 -43.39 95.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.584 -0.895 . . . . 0.7 108.584 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.1 -39.93 91.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.805 . . . . 1.25 109.748 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.05 96.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.554 -1.018 . . . . 0.29 110.554 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -41.11 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.247 . . . . 0.35 110.123 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -62.48 -38.07 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.161 . . . . 1.4 110.012 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.37 -44.27 84.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.097 -1.002 . . . . 2.51 108.872 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.16 -47.59 85.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.905 . . . . 1.37 110.198 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.3 mt -59.93 -49.98 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.012 . . . . 0.59 110.94 -178.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtm -66.78 -40.03 88.02 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.767 -1.208 . . . . 0.69 109.771 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -70.32 -43.05 71.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.971 -1.08 . . . . 1.17 110.677 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.535 ' NH1' ' CE1' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -69.96 -40.0 75.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.863 -1.148 . . . . 3.0 109.516 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' NH1' ' A' ' 37' ' ' ARG . 62.7 m-85 -127.81 78.17 75.39 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.307 -0.87 . . . . 1.54 109.44 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.68 -7.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.754 2.303 . . . . 1.21 112.434 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' PHE . 40.3 t80 -59.92 -39.3 85.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 3.74 109.4 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' ASN . 78.6 m-85 -69.81 -20.96 63.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 1.12 110.943 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -59.99 -39.76 86.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.593 -1.317 . . . . 2.51 108.758 179.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -77.91 -9.46 59.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 2.34 109.95 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.504 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 82.9 m-20 -129.27 116.9 19.83 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 2.01 110.237 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 67.0 mttm -109.99 11.73 23.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.717 -0.845 . . . . 1.68 108.717 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 48' ' ' TRP . 95.8 mm-40 -48.24 177.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.001 0.905 . . . . 3.98 111.857 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 49' ' ' GLN . . . -42.28 -15.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 CA-C-N 115.779 -0.646 . . . . 0.78 111.509 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.538 ' N ' ' O ' ' A' ' 46' ' ' GLN . 9.2 p-90 -51.18 -20.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.514 -1.58 . . . . 0.44 107.893 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' A' ' 47' ' ' GLY . 30.1 tt0 -86.37 -57.13 3.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.28 -0.637 . . . . 1.96 109.28 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.9 -33.96 72.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 1.28 109.589 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.1 m -60.04 -39.95 87.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.49 108.929 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.5 mm -60.13 -49.88 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.539 -0.725 . . . . 0.64 109.65 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -61.9 -44.54 96.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.968 -1.083 . . . . 2.76 108.768 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -60.01 -41.48 92.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.295 -0.878 . . . . 2.48 108.88 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.633 HD21 HD11 ' A' ' 10' ' ' ILE . 37.7 t-20 -63.89 -40.1 95.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.567 -0.708 . . . . 2.07 109.341 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.99 -47.81 84.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.12 -0.987 . . . . 0.78 109.691 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.4 m -62.6 -40.13 95.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 1.6 109.164 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 58' ' ' LEU . 3.3 tt -65.84 -50.39 64.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.859 -0.525 . . . . 1.38 110.16 -178.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -69.98 117.47 11.6 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.844 -1.142 . . . . 1.42 108.724 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -90.1 -2.47 58.1 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.476 -0.935 . . . . 2.17 108.476 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.1 m -60.08 -39.12 84.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.254 -0.647 . . . . 1.56 109.254 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.29 150.31 33.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.358 -0.839 . . . . 1.32 109.418 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.0 t -110.7 125.87 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.447 -0.783 . . . . 0.91 109.464 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 139.83 51.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.957 -1.127 . . . . 1.81 107.957 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.09 77.36 61.81 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.201 -0.937 . . . . 1.28 109.366 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 C--N 1.306 -1.697 0 C-N-CA 122.459 2.106 . . . . 1.65 111.557 179.276 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 108.551 -0.907 . . . . 1.39 108.551 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -138.37 149.96 46.09 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.281 -0.887 . . . . 0.46 109.511 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -157.23 159.34 37.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.005 . . . . 0.56 110.003 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 108.502 -0.925 . . . . 1.42 108.502 179.225 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo . . . . . 0 N--CA 1.495 1.575 0 N-CA-C 111.618 -0.185 . . . . 0.73 111.618 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.26 4.37 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.481 2.121 . . . . 0.84 113.285 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -82.17 135.89 35.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.718 -1.239 . . . . 1.15 109.136 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -71.72 162.54 29.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 1.39 108.634 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -59.67 -39.9 85.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.93 -1.106 . . . . 1.32 108.629 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.43 -39.98 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.96 108.981 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.15 87.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.85 . . . . 0.38 109.884 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.05 -41.68 92.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.884 -1.135 . . . . 0.37 108.792 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.516 HG21 HD21 ' A' ' 56' ' ' LEU . 92.2 mt -70.0 -41.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.372 -0.83 . . . . 0.49 109.663 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -60.41 -42.53 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 0.39 109.448 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.5 mtm -69.92 -36.83 75.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.402 -0.811 . . . . 1.14 109.839 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.5 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.32 109.494 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.4 mt -59.98 -49.94 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.39 -0.967 . . . . 0.33 108.39 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.68 -39.95 93.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.447 -0.783 . . . . 1.82 109.324 179.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -80.48 3.82 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.806 . . . . 1.67 109.748 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 147.58 71.34 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 0.63 109.356 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 -20.68 57.46 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.851 1.701 . . . . 1.29 110.041 179.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.25 149.6 36.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.843 -1.169 . . . . 2.63 107.843 178.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -60.6 -39.89 89.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 2.02 110.297 -178.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.86 124.78 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.111 . . . . 1.55 109.017 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.8 tt -138.83 142.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -0.824 . . . . 0.47 109.394 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.4 p -79.89 157.92 26.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.362 -0.836 . . . . 0.81 109.223 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -60.01 -40.23 88.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.7 109.392 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -60.03 -41.94 93.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 1.25 110.57 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 -38.56 96.31 Favored Glycine 0 N--CA 1.494 2.516 0 O-C-N 121.193 -0.942 . . . . 0.29 111.203 -178.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.97 -40.02 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.256 . . . . 0.35 109.79 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.403 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 33.3 m-85 -59.96 -39.95 87.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.11 -0.994 . . . . 1.4 110.029 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -59.68 -40.01 86.43 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.367 -0.833 . . . . 2.51 110.137 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -60.52 -40.36 91.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 1.37 109.896 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.44 -61.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.107 -0.996 . . . . 0.59 110.624 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.5 mtm -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 0.69 110.446 -178.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.14 -40.12 92.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 1.17 110.471 -179.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -89.17 -55.77 3.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.021 -1.049 . . . . 3.0 110.063 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -96.05 112.47 59.63 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.973 -1.079 . . . . 1.54 108.688 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.96 -7.44 14.32 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.815 1.677 . . . . 1.21 111.884 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.01 -40.06 87.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.773 . . . . 3.74 110.229 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -70.98 -13.13 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 1.12 110.874 -178.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.1 mmm180 -59.99 -40.03 87.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 2.51 110.735 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.32 0.08 55.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 2.34 110.339 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.514 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 68.7 m-80 -133.96 108.55 8.46 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.763 -0.829 . . . . 2.01 108.763 179.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 42' ' ' ARG . 61.1 mttp -111.97 -29.97 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.681 -0.637 . . . . 1.68 110.051 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -90.66 139.42 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 3.98 109.781 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.27 -64.19 0.31 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.435 -1.066 . . . . 0.78 110.435 179.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.514 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 23.1 p-90 -77.05 -20.06 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.316 . . . . 0.44 110.478 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.623 ' NE2' ' NH2' ' A' ' 53' ' ' ARG . 66.7 tt0 -62.29 -52.3 64.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 1.96 110.628 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -68.97 -35.06 76.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 1.28 110.194 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 1.49 109.746 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mm -60.91 -45.99 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.64 110.25 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.623 ' NH2' ' NE2' ' A' ' 49' ' ' GLN . 41.7 mtt180 -69.52 -40.12 77.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.951 -1.093 . . . . 2.76 109.888 -178.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -60.14 -40.15 88.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 2.48 108.765 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.422 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 95.2 m-20 -61.85 -39.95 93.63 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.54 -0.911 . . . . 2.07 108.54 179.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 13' ' ' ILE . 78.1 mt -70.0 -40.02 75.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.78 110.267 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.5 p -74.56 -44.88 48.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 1.6 110.495 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.65 -39.9 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 1.38 110.214 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 96.1 m-20 -66.19 120.3 12.99 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.297 -1.001 . . . . 1.42 108.297 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 25.7 mp0 -87.81 -10.97 49.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.272 -0.893 . . . . 2.17 109.361 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m -64.14 -40.01 95.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.451 -0.78 . . . . 1.56 109.926 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -79.6 127.93 32.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 1.32 109.736 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.37 124.72 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.454 -0.943 . . . . 0.91 108.454 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -94.15 150.66 20.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.012 . . . . 1.81 110.511 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.97 86.62 25.96 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 107.722 -1.214 . . . . 1.28 107.722 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo . . . . . 0 N--CA 1.493 1.485 0 C-N-CA 122.618 2.212 . . . . 1.65 113.694 -178.834 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 . . . . . 0 N--CA 1.492 1.666 0 N-CA-C 109.418 -0.586 . . . . 1.39 109.418 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -120.05 139.36 52.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.536 -0.727 . . . . 0.46 109.458 179.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 t -150.65 167.52 27.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 0.56 109.168 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 1.42 109.495 179.751 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo . . . . . 0 N--CA 1.492 1.403 0 CA-C-O 120.645 0.185 . . . . 0.73 111.967 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.7 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.486 2.124 . . . . 0.84 112.51 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -66.9 131.78 46.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.882 -1.136 . . . . 1.15 108.944 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -72.08 162.99 28.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 1.39 108.906 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -60.01 -33.93 72.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 1.32 108.561 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.8 -40.03 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.401 -0.962 . . . . 0.96 108.401 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.16 90.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 0.38 110.105 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.99 -39.99 87.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.071 -1.018 . . . . 0.37 108.368 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.08 -40.11 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.377 -0.827 . . . . 0.49 108.867 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -67.92 -40.33 83.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 0.39 110.641 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.02 -37.43 75.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 1.14 109.985 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.34 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 0.32 109.761 -179.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.01 -47.38 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.33 108.867 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.459 ' NE2' ' NZ ' ' A' ' 23' ' ' LYS . 98.7 mm-40 -68.43 -40.04 81.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 1.82 110.004 -179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -74.71 -13.26 60.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.858 . . . . 1.67 110.387 -179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.9 150.21 74.88 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.996 . . . . 0.63 109.665 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.4 -41.6 15.26 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.019 1.812 . . . . 1.29 110.414 179.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.03 132.57 56.36 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.445 -1.317 . . . . 2.63 107.445 178.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' NE2' ' A' ' 18' ' ' GLN . 68.5 mttm -69.0 -21.57 64.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 2.02 109.981 -178.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.86 33.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 1.55 109.226 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.401 ' H ' ' C ' ' A' ' 23' ' ' LYS . 16.0 tt -56.87 154.54 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.47 109.469 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -79.97 162.43 24.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.81 110.152 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.99 -50.01 75.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.481 -0.933 . . . . 0.7 108.481 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -60.51 -39.98 89.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.579 -0.701 . . . . 1.25 110.306 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.14 -38.55 61.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.29 109.389 -179.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.24 -41.54 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -1.172 . . . . 0.35 109.741 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -60.0 -43.35 95.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.12 -0.987 . . . . 1.4 109.952 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -59.99 -40.01 87.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.375 -0.828 . . . . 2.51 109.743 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.03 -45.54 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.794 . . . . 1.37 110.001 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.66 -49.95 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.59 110.711 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.04 -42.86 99.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 0.69 111.03 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.1 -40.13 75.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 1.17 111.148 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -70.08 -40.23 75.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.908 -1.12 . . . . 3.0 109.88 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.13 117.49 31.99 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 107.986 -1.116 . . . . 1.54 107.986 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.76 -9.48 17.02 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.838 1.692 . . . . 1.21 112.463 -178.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.523 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -59.97 -39.56 86.07 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 3.74 108.999 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.08 -26.54 64.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.569 -0.707 . . . . 1.12 110.559 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -59.99 -33.59 72.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.927 -1.108 . . . . 2.51 108.796 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.01 9.98 33.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 2.34 109.532 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.503 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 60.3 t30 -139.04 125.6 20.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.357 -0.84 . . . . 2.01 109.813 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -124.48 15.14 8.89 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.739 -0.838 . . . . 1.68 108.739 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 48' ' ' TRP . 91.7 mm-40 -61.18 -169.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.142 0.972 . . . . 3.98 112.085 -177.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.05 -8.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 CA-C-N 115.669 -0.696 . . . . 0.78 111.633 -178.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -60.02 -27.7 67.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.476 -1.602 . . . . 0.44 107.947 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -70.04 -58.45 3.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.729 . . . . 1.96 110.947 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -61.79 -39.97 93.58 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 1.28 110.97 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.0 t -56.95 -32.08 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 1.49 110.833 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.09 -57.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.93 -1.106 . . . . 0.64 111.342 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.59 -29.07 28.07 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.736 -1.227 . . . . 2.76 110.359 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.05 -40.02 87.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 2.48 109.633 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -69.42 -24.11 63.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 2.07 110.525 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.96 -40.03 91.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 0.78 109.494 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -60.9 -48.07 83.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 1.6 110.142 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.599 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.7 mp -68.29 -40.09 81.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 1.38 109.348 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -79.91 113.58 18.18 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.185 -0.947 . . . . 1.42 109.022 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.88 1.17 56.52 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.602 -0.888 . . . . 2.17 108.602 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.04 -36.91 78.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.681 -0.637 . . . . 1.56 109.4 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -78.51 161.44 27.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 1.32 109.583 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.63 130.06 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.543 -0.723 . . . . 0.91 109.636 -179.352 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -86.96 127.02 35.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 1.81 109.967 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -132.38 71.74 79.0 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 108.581 -0.896 . . . . 1.28 108.581 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 81.1 Cg_exo . . . . . 0 C--N 1.309 -1.537 0 C-N-CA 122.65 2.233 . . . . 1.65 112.272 -179.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 5.7 m-30 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.001 -0.74 . . . . 1.39 109.001 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -134.51 143.13 47.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 0.46 109.67 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -149.54 166.19 29.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.132 -0.98 . . . . 0.56 109.208 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 mt . . . . . 0 N--CA 1.496 1.838 0 O-C-N 121.181 -0.949 . . . . 1.42 109.971 -179.312 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 N--CA 1.492 1.408 0 CA-C-O 120.577 0.157 . . . . 0.73 112.078 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.69 10.06 3.48 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.472 2.115 . . . . 0.84 112.7 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -85.16 140.26 31.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.888 -1.133 . . . . 1.15 109.572 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.7 p -80.04 170.38 16.54 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -0.815 . . . . 1.39 108.872 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -60.0 -40.15 88.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.109 -0.994 . . . . 1.32 109.154 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.8 mm -61.09 -48.07 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.812 . . . . 0.96 109.002 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.47 98.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.38 110.295 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.93 -44.01 94.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.939 -1.101 . . . . 0.37 109.189 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.01 -39.98 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.49 109.264 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.93 -40.54 97.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.39 109.821 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.6 mtm -70.04 -36.57 75.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.872 . . . . 1.14 109.335 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.97 89.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.326 -0.859 . . . . 0.32 109.658 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.0 -50.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.078 -1.014 . . . . 0.33 109.983 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.95 -37.96 76.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.717 -0.614 . . . . 1.82 110.46 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.83 -1.5 25.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 1.67 110.085 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.19 147.91 73.71 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.079 -1.013 . . . . 0.63 109.528 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.02 -19.57 57.62 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.8 1.667 . . . . 1.29 109.9 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -130.71 138.26 49.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.143 -1.428 . . . . 2.63 107.143 178.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -60.0 -39.97 87.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.943 -1.098 . . . . 2.02 109.156 -178.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -79.3 130.79 35.8 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.181 -0.949 . . . . 1.55 108.719 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.06 148.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.47 109.473 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.7 p -83.62 167.05 17.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.81 110.148 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.94 -49.72 76.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.077 -1.083 . . . . 0.7 108.077 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.08 -40.02 88.11 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.986 -0.552 . . . . 1.25 110.392 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.91 94.52 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.384 -1.086 . . . . 0.29 110.384 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.11 -43.39 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.043 -1.269 . . . . 0.35 109.645 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -60.02 -40.0 87.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.963 -1.086 . . . . 1.4 110.821 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.95 -42.72 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.899 -1.126 . . . . 2.51 110.74 -178.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.98 -48.56 81.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 1.37 111.414 -179.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.93 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.097 . . . . 0.59 111.401 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 mtm -59.99 -46.14 90.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 0.69 110.673 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.09 -39.89 75.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.885 -1.134 . . . . 1.17 110.064 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -69.09 -39.97 78.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 3.0 110.378 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 40' ' ' PHE . 67.3 m-85 -131.34 80.04 68.7 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 1.54 110.148 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -45.72 -9.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.698 2.265 . . . . 1.21 112.02 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 38' ' ' PHE . 31.5 t80 -60.06 -39.93 87.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.464 -0.773 . . . . 3.74 109.833 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -68.2 -20.76 64.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 1.12 110.904 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HG2' ' NH1' ' A' ' 42' ' ' ARG . 61.5 mtt-85 -60.03 -40.08 88.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.817 -1.177 . . . . 2.51 109.532 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.38 -40.12 96.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 2.34 110.132 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -105.82 106.08 16.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.813 -0.554 . . . . 2.01 109.795 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 66.8 mttm -97.38 -39.69 9.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.245 -0.909 . . . . 1.68 110.533 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.81 145.8 31.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 3.98 109.894 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.2 -72.64 0.28 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.748 -0.941 . . . . 0.78 110.748 179.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TRP . . . . . 0.474 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 20.2 p-90 -69.99 -23.94 63.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.016 -1.285 . . . . 0.44 111.438 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.08 -50.47 73.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.668 -1.27 . . . . 1.96 111.407 -178.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -73.84 -33.56 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.778 -1.201 . . . . 1.28 111.32 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.3 p -59.9 -36.37 76.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 1.49 110.757 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.04 -49.85 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.938 -1.101 . . . . 0.64 110.314 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -70.08 -39.38 75.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.222 -0.924 . . . . 2.76 110.622 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -60.02 -39.86 87.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.029 -1.044 . . . . 2.48 108.514 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.051 -1.092 . . . . 2.07 108.051 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 56' ' ' LEU . 91.6 mt -66.72 -40.05 88.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.49 -0.757 . . . . 0.78 109.646 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.8 p -75.01 -49.3 20.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.091 -1.005 . . . . 1.6 109.99 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.3 mt -64.17 -40.19 95.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 1.38 109.274 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . 0.448 ' OD1' ' SG ' ' A' ' 61' ' ' CYS . 8.9 t-20 -83.95 116.93 23.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.402 -0.962 . . . . 1.42 108.402 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.94 1.75 54.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 2.17 109.94 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . 0.448 ' SG ' ' OD1' ' A' ' 59' ' ' ASN . 96.8 m -59.97 -39.96 87.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 1.56 108.638 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -78.95 146.14 33.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 1.32 108.976 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.15 129.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.419 -0.956 . . . . 0.91 108.419 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.25 139.08 57.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 1.81 109.905 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.8 t -112.4 119.98 42.41 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.556 -0.905 . . . . 1.28 108.556 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo . . . . . 0 C--N 1.313 -1.338 0 C-N-CA 121.531 1.488 . . . . 1.65 112.268 -179.287 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 109.411 -0.588 . . . . 1.39 109.411 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -113.18 139.93 48.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.055 -0.72 . . . . 0.46 109.055 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 80' ' ' LEU . 15.2 t -143.1 160.69 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.189 -0.944 . . . . 0.56 109.862 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 79' ' ' THR . 81.7 mt . . . . . 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 1.42 109.575 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.8 ttm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.175 0.512 . . . . 4.81 109.834 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.6 mt -122.78 148.45 45.35 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 108.9 -0.778 . . . . 1.71 108.9 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.8 m -136.12 141.11 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.366 -0.834 . . . . 1.79 109.075 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.7 mmtm -73.63 165.4 53.39 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.959 . . . . 3.69 108.699 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.51 ' O ' ' N ' ' A' ' 7' ' ' TYR . 1.8 Cg_endo -84.35 114.18 1.8 Allowed 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.256 1.971 . . . . 0.73 112.194 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -48.41 -8.03 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.394 0 C-N-CA 121.538 1.492 . . . . 0.84 111.558 178.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.51 ' N ' ' O ' ' A' ' 5' ' ' PRO . 11.6 m-85 -68.76 138.85 55.18 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.32 -0.863 . . . . 1.15 109.162 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.9 t -73.82 164.64 26.37 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.294 -0.878 . . . . 1.39 108.737 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 55.5 m-85 -59.95 -39.13 84.51 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.138 -0.976 . . . . 1.32 108.97 -179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 38.8 mm -65.95 -40.0 86.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.182 -0.949 . . . . 0.96 109.081 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.85 -40.27 87.86 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.117 -0.99 . . . . 0.38 109.612 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.07 -43.75 95.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.112 -0.993 . . . . 0.37 108.769 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.03 -41.98 88.14 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.106 -1.072 . . . . 0.49 108.106 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.5 m -65.56 -40.05 92.36 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.54 -0.725 . . . . 0.39 110.357 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.595 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.6 mtt -70.04 -40.03 75.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.153 -0.967 . . . . 1.14 110.311 -179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.63 -42.61 75.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.41 -0.806 . . . . 0.32 110.034 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 71.3 mt -64.46 -40.29 88.54 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.427 -0.795 . . . . 0.33 109.243 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.422 HE21 ' HA ' ' A' ' 15' ' ' MET . 34.1 mt-30 -66.6 -41.79 87.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.53 -0.731 . . . . 1.82 110.69 -179.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 15' ' ' MET . 19.0 p30 -90.77 7.92 37.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.67 110.258 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.2 116.55 61.17 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.11 -0.994 . . . . 0.63 109.078 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_exo -43.04 -26.76 0.79 Allowed 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.461 1.441 . . . . 1.29 111.012 179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -122.92 131.7 53.85 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.605 -1.258 . . . . 2.63 107.605 179.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.6 mmtm -60.07 -40.0 88.0 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.842 -1.161 . . . . 2.02 108.718 -179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -85.99 117.76 25.04 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.754 -1.202 . . . . 1.55 107.754 178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.8 tt -129.85 145.68 35.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.557 -0.714 . . . . 0.47 109.46 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.4 p -79.55 162.38 25.4 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.387 -0.82 . . . . 0.81 109.996 -179.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 48.9 tp -60.02 -43.33 95.32 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.15 -1.055 . . . . 0.7 108.15 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -63.46 -40.04 96.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.55 -0.719 . . . . 1.25 110.141 179.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.28 -38.46 94.61 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.528 -1.029 . . . . 0.29 110.528 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.0 mt -59.96 -40.27 82.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.11 -1.229 . . . . 0.35 109.752 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.564 ' OH ' ' NE ' ' A' ' 53' ' ' ARG . 24.7 m-85 -60.34 -42.81 96.45 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.605 -1.309 . . . . 1.4 109.571 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -59.98 -41.32 91.73 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.111 -0.993 . . . . 2.51 110.658 -178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.533 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 63.3 t80 -59.99 -49.08 79.09 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.922 -1.111 . . . . 1.37 110.278 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 87.2 mt -60.01 -40.0 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.427 -0.795 . . . . 0.59 110.566 -178.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.1 mtt -60.82 -44.05 97.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.859 -1.151 . . . . 0.69 110.1 -179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -73.99 -52.08 13.9 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.135 -0.978 . . . . 1.17 110.721 -179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 tpt180 -60.06 -46.72 88.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.05 -1.031 . . . . 3.0 109.2 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -122.77 109.52 32.24 Favored Pre-proline 0 N--CA 1.495 1.821 0 N-CA-C 108.561 -0.903 . . . . 1.54 108.561 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -81.88 -7.55 12.3 Favored 'Trans proline' 0 N--CA 1.494 1.52 0 C-N-CA 122.146 1.897 . . . . 1.21 113.172 -178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.422 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -59.93 -34.33 73.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.963 -1.086 . . . . 3.74 108.851 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.431 ' O ' ' O ' ' A' ' 44' ' ' ASN . 90.4 m-85 -66.2 -26.93 67.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.617 -0.677 . . . . 1.12 110.658 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -60.04 -38.96 84.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.872 -1.143 . . . . 2.51 109.342 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -60.04 -39.79 87.15 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.006 -1.059 . . . . 2.34 108.721 179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.431 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.9 m-20 -118.06 105.02 11.42 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 109.282 -0.636 . . . . 2.01 109.282 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 93.5 mttt -90.88 -59.86 2.06 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.232 -0.917 . . . . 1.68 110.689 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 46.5 mt-30 -69.65 140.02 53.6 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.509 -0.745 . . . . 3.98 110.21 -178.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.9 -59.86 0.45 Allowed Glycine 0 N--CA 1.496 2.667 0 N-CA-C 110.221 -1.151 . . . . 0.78 110.221 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.519 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 51.0 p-90 -82.32 -28.92 31.38 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.052 -1.263 . . . . 0.44 110.671 -178.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -64.88 -41.11 95.91 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.937 -1.102 . . . . 1.96 110.06 -179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -70.07 -39.53 75.59 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.388 -0.82 . . . . 1.28 111.695 -179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.5 m -60.0 -39.96 87.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.711 -1.243 . . . . 1.49 110.183 -178.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 41.3 mm -60.02 -40.05 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.028 -1.045 . . . . 0.64 109.715 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.564 ' NE ' ' OH ' ' A' ' 31' ' ' TYR . 20.3 mtt180 -67.22 -37.3 83.35 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.014 -1.054 . . . . 2.76 109.504 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.0 -44.18 94.71 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.373 -0.829 . . . . 2.48 109.587 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -68.79 -38.61 80.11 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.312 -0.867 . . . . 2.07 109.419 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 78.8 mt -69.59 59.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.193 -0.942 . . . . 0.78 110.241 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -172.55 -55.64 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.328 -0.99 . . . . 1.6 108.328 179.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 16.6 mt -67.58 -39.95 84.84 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.561 -0.903 . . . . 1.38 108.561 179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -71.45 123.36 22.21 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.346 -0.846 . . . . 1.42 108.727 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -90.06 0.01 57.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.447 -0.783 . . . . 2.17 109.526 -179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.5 m -64.8 -40.05 94.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.313 -0.867 . . . . 1.56 109.769 179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -79.05 150.37 31.89 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.093 -1.004 . . . . 1.32 109.712 -179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.553 HG21 ' CB ' ' A' ' 81' ' ' ASP . 60.6 t -118.67 127.32 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.874 -0.787 . . . . 0.91 108.874 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -92.4 125.0 36.86 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.212 -0.93 . . . . 1.81 108.525 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.07 79.4 73.02 Favored Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 108.91 -0.774 . . . . 1.28 108.91 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.01 151.75 83.07 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.478 2.119 . . . . 1.65 112.268 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.23 -168.58 0.42 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.674 -1.232 . . . . 4.09 107.674 178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -70.17 148.72 48.33 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.02 -1.05 . . . . 2.84 109.039 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -69.98 -20.75 63.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.018 -1.051 . . . . 3.46 109.678 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -60.12 -40.07 88.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 4.5 109.967 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -81.45 123.46 81.06 Favored Pre-proline 0 C--N 1.305 -1.343 0 O-C-N 121.154 -0.966 . . . . 5.12 109.005 -179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -82.18 -157.78 0.09 OUTLIER 'Trans proline' 0 N--CA 1.492 1.397 0 C-N-CA 121.957 1.771 . . . . 3.63 112.164 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 67.31 -124.07 21.71 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 110.264 -1.134 . . . . 3.15 110.264 179.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 20.2 mtmm -62.74 141.46 58.57 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.535 -0.98 . . . . 4.36 109.796 -179.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -150.75 36.92 0.9 Allowed Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.021 -1.232 . . . . 2.03 110.021 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.9 m -156.44 134.75 11.39 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.032 -1.275 . . . . 1.8 110.31 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 31.2 m-85 -132.46 155.58 48.28 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.513 -0.921 . . . . 1.39 108.513 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -126.53 134.81 50.78 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.495 -0.753 . . . . 0.46 109.233 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -159.01 164.35 35.6 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.16 -0.963 . . . . 0.56 109.779 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 93.7 mt -92.04 122.1 34.23 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.189 -0.944 . . . . 1.42 109.423 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.553 ' CB ' HG21 ' A' ' 63' ' ' VAL . 3.5 m-20 -164.54 157.65 14.8 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.211 -0.931 . . . . 3.72 109.498 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -83.33 -162.31 0.17 Allowed 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.211 1.941 . . . . 3.55 111.187 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.8 m-20 -77.21 59.34 1.75 Allowed 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.872 -1.158 . . . . 6.82 107.872 178.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.5 p -83.54 49.03 1.51 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.548 -0.72 . . . . 6.0 110.105 -178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -57.24 5.51 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.329 -0.857 . . . . 11.0 109.589 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.458 ' C ' ' H ' ' A' ' 88' ' ' PHE . 32.7 m120 -110.01 19.99 18.42 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.419 -0.801 . . . . 10.0 110.723 -179.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.5 mmt -69.05 6.15 1.0 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.892 -1.13 . . . . 8.47 109.115 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.458 ' H ' ' C ' ' A' ' 86' ' ' ASN . 55.2 m-85 -60.01 -40.05 87.91 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.503 -0.748 . . . . 11.97 109.018 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.464 ' OE1' ' N ' ' A' ' 89' ' ' GLU . 31.2 mp0 -102.67 139.65 37.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.582 -0.699 . . . . 11.95 109.238 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -129.18 151.85 49.4 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.551 -0.718 . . . . 12.32 109.428 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.14 -13.65 62.81 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 108.532 -1.827 . . . . 11.16 108.532 -179.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.6 p -77.9 -19.97 53.75 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.549 -0.971 . . . . 11.8 109.01 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -135.82 145.72 46.77 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.526 -0.734 . . . . 10.78 109.404 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.2 mt . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 108.487 -0.931 . . . . 13.12 108.487 179.732 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptp . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.352 0.596 . . . . 4.81 109.433 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 83.8 mt -79.52 155.2 28.33 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.259 -0.901 . . . . 1.71 108.857 179.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.0 m -129.93 160.04 41.37 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.446 -0.784 . . . . 1.79 109.281 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.7 pttp -59.63 120.88 53.04 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.114 -0.991 . . . . 3.69 109.156 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -42.66 155.57 0.11 Allowed 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.768 1.645 . . . . 0.73 111.848 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.16 1.31 6.78 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.409 2.072 . . . . 0.84 112.095 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -81.03 133.12 35.42 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.207 -0.933 . . . . 1.15 109.47 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 55.2 m -69.35 167.2 16.98 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.215 -0.928 . . . . 1.39 108.567 179.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -59.92 -39.98 87.3 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.019 -1.051 . . . . 1.32 109.041 -179.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 87.9 mt -65.83 -41.05 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.46 -0.775 . . . . 0.96 110.226 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.14 -39.8 94.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.122 -0.986 . . . . 0.38 110.344 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 87.8 mt -59.85 -40.12 87.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.041 -1.037 . . . . 0.37 109.079 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.496 HD11 HD21 ' A' ' 55' ' ' ASN . 86.5 mt -69.9 -40.0 78.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.223 -0.923 . . . . 0.49 109.391 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 91.2 m -64.28 -40.91 96.93 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.267 -0.895 . . . . 0.39 109.726 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 73.5 mtm -70.02 -36.93 75.46 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 1.14 109.474 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.95 -46.85 84.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.47 -0.769 . . . . 0.32 109.35 -179.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.8 mt -60.08 -50.0 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.341 -0.849 . . . . 0.33 108.856 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -61.72 -40.06 93.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 121.288 0.566 . . . . 1.82 109.995 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -79.99 -10.07 59.74 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.303 -0.873 . . . . 1.67 110.379 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.76 131.48 67.39 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.105 -0.997 . . . . 0.63 109.488 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -43.06 -38.93 7.73 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.411 1.407 . . . . 1.29 110.896 179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.5 mm-40 -120.03 134.63 55.19 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.149 -1.056 . . . . 2.63 108.149 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -59.97 -34.41 73.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.04 -1.038 . . . . 2.02 110.034 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -77.97 113.91 16.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.78 -1.2 . . . . 1.55 108.297 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.5 tt -130.01 160.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.653 -0.654 . . . . 0.47 109.445 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.9 p -90.37 165.77 13.67 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.9 0.857 . . . . 0.81 110.714 -179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.652 HD11 ' HG2' ' A' ' 53' ' ' ARG . 14.3 tp -60.1 -50.02 75.37 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 122.056 0.932 . . . . 0.7 108.64 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -62.39 -39.97 94.94 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-O 121.286 0.565 . . . . 1.25 110.208 -179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.99 -40.05 96.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.433 -1.067 . . . . 0.29 110.433 -178.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.1 mt -60.09 -42.04 88.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.029 -1.277 . . . . 0.35 109.64 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.7 m-85 -59.89 -40.85 90.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.746 -1.221 . . . . 1.4 109.959 179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.1 -42.24 94.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.149 -0.97 . . . . 2.51 110.135 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -59.98 -49.01 79.34 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 1.37 110.718 -179.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 95.1 mt -60.17 -49.98 82.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.121 -0.987 . . . . 0.59 111.497 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 74.7 mtm -60.26 -49.98 75.44 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.664 -1.273 . . . . 0.69 110.269 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -68.91 -39.99 79.37 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 1.17 109.539 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -66.17 -49.75 66.31 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.329 -0.857 . . . . 3.0 109.678 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -119.38 120.19 31.09 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.594 -0.691 . . . . 1.54 109.301 -179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -79.39 -7.49 14.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.863 1.709 . . . . 1.21 112.248 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -60.01 -40.93 90.94 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.4 -0.812 . . . . 3.74 110.234 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -66.77 -27.76 67.85 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.269 -0.895 . . . . 1.12 110.722 -178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -58.23 -26.04 62.39 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.045 -1.035 . . . . 2.51 109.436 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -88.78 1.76 54.67 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.03 -1.043 . . . . 2.34 110.103 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.536 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 53.4 t30 -147.68 102.36 3.42 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.393 -0.817 . . . . 2.01 109.278 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.428 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.7 mttt -89.16 -64.77 1.09 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.124 -0.985 . . . . 1.68 110.963 -179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.4 mt-30 -69.93 144.03 52.53 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.09 -1.006 . . . . 3.98 110.074 -178.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.44 -58.41 0.4 Allowed Glycine 0 N--CA 1.494 2.564 0 N-CA-C 109.76 -1.336 . . . . 0.78 109.76 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.536 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 29.4 p-90 -89.98 -11.66 40.99 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.075 -1.25 . . . . 0.44 110.374 -179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -68.69 -55.96 9.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.847 -1.158 . . . . 1.96 110.498 -178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -70.05 -31.52 69.18 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.056 -1.027 . . . . 1.28 110.58 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 87.1 p -59.83 -40.44 88.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.052 -1.03 . . . . 1.49 110.81 -178.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.1 mm -60.05 -50.94 78.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.859 -1.151 . . . . 0.64 110.379 -179.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.652 ' HG2' HD11 ' A' ' 27' ' ' LEU . 46.6 mtp180 -69.97 -37.92 75.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.074 -1.016 . . . . 2.76 110.182 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -59.93 -40.09 87.72 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.328 -0.858 . . . . 2.48 110.606 -178.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.503 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 26.3 p30 -69.99 -18.33 63.33 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.943 -1.098 . . . . 2.07 110.567 -179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.431 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 85.6 mt -66.4 -40.09 89.41 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.794 -1.191 . . . . 0.78 111.115 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.4 t -70.04 -48.43 57.97 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.898 -1.126 . . . . 1.6 110.756 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.2 -39.98 96.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.102 -0.999 . . . . 1.38 110.658 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.503 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 76.1 m-20 -76.02 112.96 13.0 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.055 -1.028 . . . . 1.42 110.069 -178.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -90.24 -5.95 55.77 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.515 -0.741 . . . . 2.17 109.484 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.2 p -62.82 -35.05 78.66 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.298 -0.876 . . . . 1.56 110.199 -179.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -78.72 152.53 31.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 1.32 109.618 -179.499 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 41.6 t -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.609 -0.682 . . . . 0.91 109.567 -179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -81.93 149.64 28.11 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.28 -0.887 . . . . 1.81 110.098 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.8 t -139.12 128.69 14.31 Favored Pre-proline 0 N--CA 1.496 1.865 0 N-CA-C 108.625 -0.88 . . . . 1.28 108.625 179.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.16 -178.16 3.41 Favored 'Trans proline' 0 N--CA 1.493 1.454 0 C-N-CA 121.441 1.427 . . . . 1.65 111.675 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.43 ' NE ' ' OH ' ' A' ' 77' ' ' TYR . 52.4 mtp180 -110.88 160.72 16.52 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.519 -0.738 . . . . 4.09 109.44 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -61.72 158.06 16.44 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.452 -0.78 . . . . 2.84 109.007 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -60.44 -21.47 62.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.24 -0.912 . . . . 3.46 110.023 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -60.06 -41.44 92.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.128 -0.983 . . . . 4.5 109.321 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.547 ' CD ' ' N ' ' A' ' 71' ' ' LYS . 9.6 mptt -84.56 148.16 51.28 Favored Pre-proline 0 N--CA 1.49 1.546 0 N-CA-C 108.428 -0.953 . . . . 5.12 108.428 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -73.15 1.75 6.3 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 121.955 1.77 . . . . 3.63 112.168 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 83.49 54.26 3.17 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.771 -1.331 . . . . 3.15 109.771 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 50.2 mtpt -60.0 -40.05 87.89 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.201 -1.176 . . . . 4.36 108.616 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -166.88 175.94 42.02 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.813 -1.715 . . . . 2.03 108.813 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.3 p -100.42 136.17 40.71 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.085 -1.244 . . . . 1.8 109.663 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.43 ' OH ' ' NE ' ' A' ' 67' ' ' ARG . 10.0 m-85 -69.9 158.85 34.77 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.92 -1.112 . . . . 1.39 108.014 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -120.75 134.38 55.29 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.591 0.71 . . . . 0.46 110.155 -179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -153.48 170.75 19.98 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 108.911 -0.774 . . . . 0.56 108.911 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.6 mt -97.0 121.07 38.48 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.062 -1.024 . . . . 1.42 110.203 -179.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -137.1 82.87 29.12 Favored Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 107.83 -1.174 . . . . 3.72 107.83 179.085 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.479 ' O ' ' O ' ' A' ' 81' ' ' ASP . 69.2 Cg_exo -50.86 -137.16 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.837 0 C-N-CA 123.228 2.619 . . . . 3.55 113.568 -178.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -73.45 60.16 0.63 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.974 -1.079 . . . . 6.82 108.967 -179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.0 t -60.04 -33.93 72.69 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.77 -0.826 . . . . 6.0 108.77 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -60.04 -39.96 87.73 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.369 -0.832 . . . . 11.0 109.555 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -86.36 23.48 1.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.174 -0.954 . . . . 10.0 110.59 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.438 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 3.5 mmt -73.65 95.57 2.35 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.93 -1.106 . . . . 8.47 109.125 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -88.87 -17.49 29.53 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.099 -1.074 . . . . 11.97 108.099 179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 80.6 mm-40 -78.7 160.06 27.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.506 -0.746 . . . . 11.95 109.138 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 33.6 m120 -68.79 130.82 43.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 12.32 109.674 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 167.38 -120.7 0.92 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.834 -1.307 . . . . 11.16 109.834 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.4 t -73.42 -11.67 60.55 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.343 -1.093 . . . . 11.8 109.689 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.438 ' CD1' ' O ' ' A' ' 87' ' ' MET . 77.6 t80 -59.97 -40.02 87.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.402 -0.811 . . . . 10.78 111.094 -179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.726 0 O-C-N 120.715 -1.241 . . . . 13.12 109.706 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.6 ptp . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 121.82 0.819 . . . . 4.81 109.266 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 51.2 mt -82.27 159.8 23.09 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 108.965 -0.754 . . . . 1.71 108.965 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.0 160.06 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.464 -0.773 . . . . 1.79 109.014 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HD2' ' H ' ' A' ' 4' ' ' LYS . 2.3 mptp? -56.79 113.96 7.03 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.251 -0.905 . . . . 3.69 109.027 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_exo -45.58 160.57 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.519 0 C-N-CA 121.734 1.623 . . . . 0.73 111.839 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -80.8 4.22 7.12 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.412 2.075 . . . . 0.84 112.635 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 73.9 m-85 -82.0 143.01 31.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.974 -1.079 . . . . 1.15 109.803 -179.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 27.5 t -75.05 160.2 30.79 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.528 -0.916 . . . . 1.39 108.528 179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -60.02 -39.95 87.64 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.981 -1.074 . . . . 1.32 108.682 -179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 41.3 mm -65.2 -40.05 87.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 N-CA-C 108.741 -0.837 . . . . 0.96 108.741 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.18 -46.72 89.34 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.168 -0.958 . . . . 0.38 109.642 179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 96.2 mt -60.04 -43.14 95.53 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.025 -1.047 . . . . 0.37 108.656 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.403 HG21 HD21 ' A' ' 56' ' ' LEU . 85.5 mt -69.32 -50.38 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.234 -0.916 . . . . 0.49 109.452 179.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -61.39 -40.01 92.79 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.529 -0.732 . . . . 0.39 110.015 -179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.534 ' C ' HD22 ' A' ' 19' ' ' ASN . 74.9 mtp -69.88 -38.48 76.39 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.431 -0.793 . . . . 1.14 109.967 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 20' ' ' ALA . . . -60.03 -42.22 93.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.245 -0.909 . . . . 0.32 110.032 -179.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.1 mt -61.31 -49.98 82.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.33 109.588 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -69.73 -40.02 76.47 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.722 -0.611 . . . . 1.82 109.959 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.534 HD22 ' C ' ' A' ' 15' ' ' MET . 68.3 m-80 -76.95 -9.92 59.01 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.339 -0.85 . . . . 1.67 110.229 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 16' ' ' ALA . . . -79.75 137.67 54.42 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.088 -1.007 . . . . 0.63 109.454 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -39.81 -65.19 0.18 Allowed 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.867 1.712 . . . . 1.29 110.858 178.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -99.81 137.84 37.72 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 107.684 -1.228 . . . . 2.63 107.684 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -62.43 -28.73 70.0 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.833 -1.167 . . . . 2.02 109.204 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -79.7 98.3 6.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.136 -0.977 . . . . 1.55 108.569 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.9 tt -119.66 149.68 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 N-CA-C 109.257 -0.646 . . . . 0.47 109.257 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 50.4 p -79.91 161.55 25.48 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.336 -0.853 . . . . 0.81 110.273 -179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 43.9 tp -59.99 -47.25 86.6 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.686 -0.857 . . . . 0.7 108.686 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -59.97 -39.8 86.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.933 -0.766 . . . . 1.25 108.933 178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.55 -39.95 95.68 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 110.744 -0.942 . . . . 0.29 110.744 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.1 mt -60.04 -40.99 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.735 -1.45 . . . . 0.35 109.931 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 50.8 m-85 -61.59 -40.31 94.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.905 -1.122 . . . . 1.4 110.086 -179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -59.93 -40.68 89.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.17 -0.956 . . . . 2.51 109.881 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 68.0 t80 -59.97 -49.97 75.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.49 -0.756 . . . . 1.37 110.744 -179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.8 -49.97 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.108 -0.995 . . . . 0.59 111.614 -178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.8 mtm -62.02 -39.98 94.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.1 -1.0 . . . . 0.69 111.398 -178.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.412 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 93.1 m-20 -63.76 -51.67 63.81 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.746 -1.221 . . . . 1.17 112.071 -178.337 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 44.9 mtp180 -74.86 -24.9 58.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.71 -1.244 . . . . 3.0 111.25 -178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.494 ' C ' ' H ' ' A' ' 40' ' ' PHE . 71.7 m-85 -130.02 77.62 76.24 Favored Pre-proline 0 N--CA 1.497 1.889 0 O-C-N 121.209 -0.932 . . . . 1.54 109.763 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -49.75 -7.25 0.08 OUTLIER 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.735 2.29 . . . . 1.21 111.438 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.494 ' H ' ' C ' ' A' ' 38' ' ' PHE . 11.8 t80 -59.96 -40.44 89.02 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.416 -0.802 . . . . 3.74 109.23 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.419 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -69.92 -24.1 63.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.337 -0.852 . . . . 1.12 110.446 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 61.1 mtt-85 -60.01 -37.87 81.02 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.975 -1.078 . . . . 2.51 108.884 179.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -85.96 9.15 17.82 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.253 -0.905 . . . . 2.34 109.285 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.618 ' ND2' ' H ' ' A' ' 46' ' ' GLN . 0.5 OUTLIER -138.5 120.47 15.51 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.418 -0.801 . . . . 2.01 109.428 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.44 ' N ' HD22 ' A' ' 44' ' ' ASN . 67.1 mttm -120.24 13.1 11.93 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 108.596 -0.89 . . . . 1.68 108.596 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.618 ' H ' ' ND2' ' A' ' 44' ' ' ASN . 27.1 mt-30 -59.91 -168.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 CA-C-O 122.023 0.916 . . . . 3.98 111.438 -178.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -47.15 -10.96 0.06 OUTLIER Glycine 0 N--CA 1.493 2.472 0 CA-C-N 115.997 -0.547 . . . . 0.78 112.257 -178.081 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.566 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 4.7 p-90 -59.98 -38.87 83.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.266 -1.726 . . . . 0.44 108.212 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.417 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 21.2 tt0 -60.03 -50.04 75.29 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.607 -0.683 . . . . 1.96 110.019 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -76.1 -33.95 59.5 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 1.28 111.369 -178.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.6 m -59.92 -38.37 82.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.246 -0.909 . . . . 1.49 111.375 -178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.9 mm -59.98 -51.48 72.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 0.64 111.37 -177.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.8 ptm180 -79.81 -29.44 40.28 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.652 -1.28 . . . . 2.76 110.483 -179.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.535 ' CE1' HD11 ' A' ' 58' ' ' LEU . 54.3 t60 -59.92 -42.0 92.96 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.999 -1.063 . . . . 2.48 109.161 179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -65.47 -39.98 92.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 2.07 109.566 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.403 HD21 HG21 ' A' ' 13' ' ' ILE . 41.4 mt -60.15 -45.44 93.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.78 110.542 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 75.2 m -63.33 -45.63 90.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.804 -1.185 . . . . 1.6 110.255 -179.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.535 HD11 ' CE1' ' A' ' 54' ' ' HIS . 47.8 mt -69.95 -40.08 75.65 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.977 -1.077 . . . . 1.38 109.877 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -72.47 117.45 14.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.222 -0.924 . . . . 1.42 109.297 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 71.9 mm-40 -90.19 -2.73 58.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.46 -0.775 . . . . 2.17 109.376 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 62.5 m -60.72 -40.06 90.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.242 -0.911 . . . . 1.56 109.453 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -79.95 152.05 29.73 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.345 -0.847 . . . . 1.32 109.558 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 60.1 t -115.39 121.57 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.577 -0.702 . . . . 0.91 109.321 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 2.9 ptpp? -85.74 127.16 34.45 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.261 -0.899 . . . . 1.81 108.6 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 38.9 t -97.7 111.28 58.4 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.336 -0.853 . . . . 1.28 109.308 -179.459 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -78.77 136.02 13.17 Favored 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.65 1.567 . . . . 1.65 111.931 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.747 ' H ' ' NE ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -77.11 159.97 29.38 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.208 -0.932 . . . . 4.09 108.968 179.459 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -62.67 156.76 22.62 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.42 -0.8 . . . . 2.84 109.309 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -59.91 -33.25 71.62 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.904 . . . . 3.46 109.321 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -60.08 -32.54 71.04 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.93 . . . . 4.5 109.203 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -77.25 126.03 85.65 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.127 -0.983 . . . . 5.12 109.006 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.416 ' O ' ' O ' ' A' ' 73' ' ' GLY . 65.1 Cg_endo -84.06 12.55 2.98 Favored 'Trans proline' 0 N--CA 1.492 1.402 0 C-N-CA 121.991 1.794 . . . . 3.63 111.551 179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.416 ' O ' ' O ' ' A' ' 72' ' ' PRO . . . -43.47 168.74 0.01 OUTLIER Glycine 0 N--CA 1.492 2.412 0 N-CA-C 110.821 -0.912 . . . . 3.15 110.821 -179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.7 mtmm -82.94 -105.99 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.642 -0.917 . . . . 4.36 110.042 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -82.92 -179.35 52.66 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 110.229 -1.149 . . . . 2.03 110.229 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.2 p -79.89 160.69 25.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.491 -1.006 . . . . 1.8 109.589 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -89.45 153.84 20.51 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.01 -1.056 . . . . 1.39 109.628 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 86.1 m95 -111.19 137.13 49.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.695 -0.628 . . . . 0.46 109.976 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.4 t -145.25 159.75 42.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.325 -0.859 . . . . 0.56 109.159 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.8 mt -79.46 163.69 24.55 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.211 -0.931 . . . . 1.42 109.2 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.47 ' O ' ' O ' ' A' ' 82' ' ' PRO . 4.8 p30 -59.35 158.55 19.58 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.261 -0.9 . . . . 3.72 109.064 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.47 ' O ' ' O ' ' A' ' 81' ' ' ASP . 45.6 Cg_exo -55.12 -141.86 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.706 0 C-N-CA 121.757 1.638 . . . . 3.55 112.329 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -81.96 45.38 0.91 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.128 -0.983 . . . . 6.82 108.825 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -55.45 -24.93 33.55 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.452 -0.78 . . . . 6.0 109.031 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -59.68 -39.47 84.62 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.444 -0.785 . . . . 11.0 109.318 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -68.0 -19.92 64.97 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.192 -0.942 . . . . 10.0 108.676 179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 69.0 mtt -90.56 109.24 20.4 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 109.116 -0.698 . . . . 8.47 109.116 179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 61.9 m-85 -69.01 -40.97 78.38 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.928 -1.107 . . . . 11.97 108.358 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -143.22 154.67 44.08 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.229 -1.026 . . . . 11.95 108.229 178.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -60.05 141.71 55.25 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.738 -1.226 . . . . 12.32 109.055 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.57 -7.88 80.67 Favored Glycine 0 N--CA 1.493 2.477 0 N-CA-C 108.992 -1.643 . . . . 11.16 108.992 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.54 ' O ' ' N ' ' A' ' 94' ' ' LEU . 39.6 t -60.86 -38.2 84.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.383 -1.069 . . . . 11.8 109.522 179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.408 ' CD1' ' O ' ' A' ' 93' ' ' PHE . 55.3 t80 -46.46 -13.76 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.426 -0.796 . . . . 10.78 109.695 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.54 ' N ' ' O ' ' A' ' 92' ' ' SER . 64.9 tp . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 13.12 110.161 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.2 mtm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.099 -0.704 . . . . 4.81 109.099 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 78.3 mt -76.34 158.29 31.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.148 -0.97 . . . . 1.71 109.139 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -108.29 144.98 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.897 0 O-C-N 121.424 -0.798 . . . . 1.79 109.895 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.6 pttp -69.95 149.97 96.38 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.28 -0.887 . . . . 3.69 109.102 179.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -76.12 160.17 36.66 Favored 'Trans proline' 0 N--CA 1.495 1.6 0 C-N-CA 122.182 1.922 . . . . 0.73 112.309 -179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -73.27 28.79 0.3 Allowed 'Trans proline' 0 N--CA 1.496 1.663 0 C-N-CA 122.862 2.375 . . . . 0.84 113.267 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -109.5 134.01 52.4 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.019 -1.05 . . . . 1.15 108.819 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 95.1 p -80.06 174.59 11.44 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 1.39 108.97 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.5 m-85 -59.96 -35.93 76.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 1.32 109.908 -179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.67 -40.01 81.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 0.96 110.339 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -69.53 -40.0 77.17 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.938 -1.101 . . . . 0.38 110.887 -178.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.7 mt -60.05 -39.94 87.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.907 -1.12 . . . . 0.37 108.623 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.508 HD11 HG23 ' A' ' 52' ' ' ILE . 88.9 mt -67.74 -39.97 82.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.498 -0.751 . . . . 0.49 109.274 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -66.08 -40.07 90.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.516 -0.74 . . . . 0.39 110.755 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.8 mtm -69.91 -39.96 75.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.172 -0.955 . . . . 1.14 109.771 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.8 -48.21 80.35 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.441 -0.787 . . . . 0.32 109.4 -179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -50.01 81.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.22 -0.925 . . . . 0.33 108.902 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 89.4 mm-40 -60.72 -40.08 90.99 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.695 -0.628 . . . . 1.82 110.15 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -69.91 -17.51 63.34 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.357 -0.839 . . . . 1.67 109.568 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.95 148.3 71.76 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.239 -0.913 . . . . 0.63 109.718 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.97 -51.68 0.78 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 121.87 1.713 . . . . 1.29 109.724 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -99.11 139.93 34.03 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 107.276 -1.379 . . . . 2.63 107.276 178.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.5 mmtt -67.51 -27.26 66.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.975 -1.078 . . . . 2.02 109.796 -178.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -78.68 115.85 18.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.023 -1.048 . . . . 1.55 108.932 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.17 154.31 30.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.626 -0.671 . . . . 0.47 109.397 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 34.2 p -80.11 153.56 28.62 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.315 -0.866 . . . . 0.81 109.776 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 13.2 tp -60.04 -44.28 94.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.446 -0.784 . . . . 0.7 109.288 179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -60.27 -40.08 89.11 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.239 -0.913 . . . . 1.25 110.427 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.14 -40.66 97.5 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.14 -1.029 . . . . 0.29 111.011 -178.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.02 -42.28 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.03 -1.276 . . . . 0.35 110.243 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -60.15 -41.95 93.86 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.965 -1.085 . . . . 1.4 110.202 -179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.1 mm100 -60.31 -40.38 90.37 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.351 -0.843 . . . . 2.51 110.069 -178.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -61.09 -44.69 96.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.201 -0.937 . . . . 1.37 110.285 -179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 88.4 mt -59.93 -50.15 81.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.203 -0.935 . . . . 0.59 110.663 -178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.5 mtm -62.94 -39.91 96.05 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.063 -1.023 . . . . 0.69 109.365 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -69.87 -39.94 76.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.242 -0.911 . . . . 1.17 109.78 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 24.8 tpt180 -72.18 -50.52 27.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.06 -1.025 . . . . 3.0 109.434 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -115.16 114.1 43.48 Favored Pre-proline 0 N--CA 1.497 1.898 0 N-CA-C 108.782 -0.822 . . . . 1.54 108.782 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -78.11 -3.8 13.78 Favored 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 121.862 1.708 . . . . 1.21 112.036 -179.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -59.93 -39.68 86.3 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.618 -0.882 . . . . 3.74 108.618 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.439 ' O ' ' O ' ' A' ' 44' ' ' ASN . 95.6 m-85 -70.0 -21.52 63.21 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.493 -0.754 . . . . 1.12 111.142 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -59.9 -40.02 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.48 -1.388 . . . . 2.51 109.317 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 65.5 mm-40 -61.0 -43.69 98.52 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.082 -1.011 . . . . 2.34 109.492 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.439 ' O ' ' O ' ' A' ' 41' ' ' TYR . 54.3 t30 -109.39 109.49 20.36 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.986 -0.746 . . . . 2.01 108.986 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 97.9 mttt -102.7 -37.7 7.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.377 -0.827 . . . . 1.68 110.602 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -89.03 139.16 30.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.183 -0.948 . . . . 3.98 110.344 -178.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.58 -66.79 0.23 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.871 -1.291 . . . . 0.78 109.871 179.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 24.7 p-90 -71.32 -37.95 71.72 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -1.127 . . . . 0.44 110.744 -179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 62.4 tt0 -59.94 -50.05 75.3 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.179 -0.951 . . . . 1.96 111.162 -178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 -74.52 -25.54 59.41 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.843 -1.16 . . . . 1.28 110.583 -178.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.8 t -60.02 -41.24 91.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.105 -0.997 . . . . 1.49 110.282 -178.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.508 HG23 HD11 ' A' ' 13' ' ' ILE . 41.1 mt -65.74 -40.82 88.87 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 O-C-N 121.255 -0.903 . . . . 0.64 110.544 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -60.02 -44.08 94.85 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.334 -1.479 . . . . 2.76 108.607 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 71.8 t60 -60.0 -40.01 87.75 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.697 -0.853 . . . . 2.48 108.697 179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -68.44 -39.99 81.28 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.464 -0.772 . . . . 2.07 110.235 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 89.4 mt -60.75 -40.13 91.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.052 -1.03 . . . . 0.78 110.048 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 41.0 t -64.76 -49.68 69.8 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.288 -0.883 . . . . 1.6 110.512 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 80.9 mt -69.98 -32.06 70.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.177 -0.952 . . . . 1.38 109.971 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -74.79 112.21 10.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.137 -0.977 . . . . 1.42 109.724 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -90.78 0.0 57.58 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.4 -0.813 . . . . 2.17 109.692 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.3 p -69.98 -21.37 63.24 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.983 -1.073 . . . . 1.56 109.727 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 -87.22 153.25 21.64 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.32 -0.862 . . . . 1.32 109.789 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.491 ' CG2' ' O ' ' A' ' 81' ' ' ASP . 61.0 t -114.38 124.79 71.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.443 -0.786 . . . . 0.91 109.62 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 58.6 mttt -80.0 159.95 26.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.119 -0.988 . . . . 1.81 108.602 179.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.8 t -140.19 77.53 24.89 Favored Pre-proline 0 N--CA 1.495 1.818 0 O-C-N 121.002 -1.061 . . . . 1.28 109.585 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -48.25 124.15 10.03 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.662 2.241 . . . . 1.65 112.241 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.515 ' NH1' ' OD1' ' A' ' 68' ' ' ASP . 0.8 OUTLIER -79.07 -161.38 0.3 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.24 -0.913 . . . . 4.09 109.093 179.871 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 38.5 p-10 -62.01 142.28 57.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.048 -1.032 . . . . 2.84 110.344 -179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 76.0 m-20 -69.93 -21.13 63.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.316 -0.865 . . . . 3.46 109.102 179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -60.01 -39.96 87.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.397 -0.814 . . . . 4.5 109.885 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -134.1 82.27 48.69 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.322 -0.862 . . . . 5.12 109.285 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -86.32 13.48 2.72 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.862 2.375 . . . . 3.63 111.96 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -60.23 -40.07 96.83 Favored Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.718 -0.953 . . . . 3.15 110.718 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -77.97 10.0 3.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.109 -1.23 . . . . 4.36 109.268 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 61.07 -131.26 48.26 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 110.024 -1.23 . . . . 2.03 110.024 179.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.2 m -130.03 146.06 51.69 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.536 -0.979 . . . . 1.8 109.601 -179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.504 ' OH ' ' NE ' ' A' ' 67' ' ' ARG . 7.4 m-85 -78.87 159.98 27.53 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.472 -0.936 . . . . 1.39 108.472 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 68.7 m95 -116.09 137.13 52.4 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.477 -0.764 . . . . 0.46 109.824 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.2 t -153.06 160.95 43.01 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.24 -0.912 . . . . 0.56 109.847 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.1 mt -89.06 129.81 35.62 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.211 -0.931 . . . . 1.42 110.109 -179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.491 ' O ' ' CG2' ' A' ' 63' ' ' VAL . 1.8 m-20 -173.75 156.84 2.73 Favored Pre-proline 0 N--CA 1.49 1.569 0 N-CA-C 108.92 -0.77 . . . . 3.72 108.92 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -85.3 -162.61 0.16 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.904 1.736 . . . . 3.55 111.025 178.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -87.55 53.71 2.88 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.92 -1.112 . . . . 6.82 108.845 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 47.5 t -59.93 -39.98 87.35 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.4 -0.812 . . . . 6.0 110.415 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.429 ' CD2' ' N ' ' A' ' 86' ' ' ASN . 55.9 p90 -61.56 -39.94 92.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.103 -0.998 . . . . 11.0 110.965 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.429 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 57.8 t30 -75.18 -15.44 60.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 10.0 110.818 -178.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 64.9 mtt -82.56 118.89 23.61 Favored 'General case' 0 C--N 1.297 -1.678 0 O-C-N 121.287 -0.883 . . . . 8.47 110.083 -179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -114.6 11.22 16.93 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.895 -0.78 . . . . 11.97 108.895 179.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.456 ' HG3' ' H ' ' A' ' 91' ' ' GLY . 8.9 pt-20 -115.02 -178.35 3.35 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.681 -0.637 . . . . 11.95 109.671 -179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -60.63 -4.04 0.84 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.573 -0.705 . . . . 12.32 110.163 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.456 ' H ' ' HG3' ' A' ' 89' ' ' GLU . . . 93.95 72.49 1.18 Allowed Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.062 -1.615 . . . . 11.16 109.062 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.5 t -82.41 85.18 6.95 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.314 -1.11 . . . . 11.8 109.676 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 64.1 t80 -60.05 -40.99 91.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.411 -0.806 . . . . 10.78 109.465 179.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.4 tp . . . . . 0 N--CA 1.488 1.469 0 O-C-N 121.158 -0.964 . . . . 13.12 108.585 179.806 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttm . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.27 0.557 . . . . 4.81 109.729 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 95.8 mt -130.24 153.56 48.48 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.596 -0.69 . . . . 1.71 109.247 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.6 m -130.05 159.91 41.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.609 -0.682 . . . . 1.79 109.605 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.428 ' HG2' ' H ' ' A' ' 4' ' ' LYS . 8.3 pttm -58.99 119.08 34.81 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.363 -0.836 . . . . 3.69 108.859 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.2 Cg_exo -44.54 121.15 3.09 Favored 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 121.516 1.477 . . . . 0.73 111.295 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_exo -42.25 -12.11 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.248 1.966 . . . . 0.84 113.767 -179.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.532 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.6 m-85 -68.16 141.94 55.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.72 -1.238 . . . . 1.15 109.712 -179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 66.7 m -74.38 163.07 28.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.434 -0.791 . . . . 1.39 109.362 179.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -59.99 -40.01 87.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.184 -0.948 . . . . 1.32 109.518 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 35.8 mm -67.44 -40.07 83.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.075 -1.016 . . . . 0.96 109.055 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.19 87.55 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 0.38 109.945 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -60.41 -40.12 89.86 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.37 109.544 -179.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.68 -40.05 78.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 N-CA-C 108.42 -0.955 . . . . 0.49 108.42 179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -60.92 -39.99 91.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.56 -0.712 . . . . 0.39 109.78 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.459 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 65.4 mtt -68.94 -39.39 79.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.42 -0.8 . . . . 1.14 110.0 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.82 -47.12 83.53 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.279 -0.888 . . . . 0.32 109.88 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.4 mt -60.44 -49.97 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.343 -0.848 . . . . 0.33 109.5 -179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -67.65 -40.02 84.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.797 -0.564 . . . . 1.82 110.482 -179.19 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' A' ' 15' ' ' MET . 4.2 m-80 -70.23 -15.43 62.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 1.67 110.414 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.81 146.67 69.15 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.911 -1.118 . . . . 0.63 109.26 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -64.86 -44.44 10.18 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 121.738 1.625 . . . . 1.29 109.968 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -106.19 126.52 52.32 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.459 -1.312 . . . . 2.63 107.459 178.131 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 32.3 mmtp -58.56 -24.57 61.05 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.989 -1.069 . . . . 2.02 108.748 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.3 mttp -80.08 84.98 5.71 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.289 -1.004 . . . . 1.55 108.289 179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.3 tt -107.03 147.66 12.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.568 -0.708 . . . . 0.47 109.102 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.4 m -79.18 154.96 28.87 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.239 -0.913 . . . . 0.81 110.452 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 47.1 tp -60.04 -47.53 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.594 0.711 . . . . 0.7 109.75 -179.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.54 -39.9 89.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.205 -0.934 . . . . 1.25 110.341 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.04 -40.07 96.56 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.232 -0.917 . . . . 0.29 111.158 -178.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.14 -39.91 81.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 120.832 -1.393 . . . . 0.35 109.434 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -60.08 -40.04 88.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.997 -1.064 . . . . 1.4 109.528 179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.41 HE21 ' CG ' ' A' ' 36' ' ' ASP . 71.0 tp60 -61.6 -40.02 93.31 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.298 -0.876 . . . . 2.51 109.702 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -59.91 -43.7 94.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.581 -0.7 . . . . 1.37 111.32 -178.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.4 mt -69.98 -40.71 78.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.798 -1.189 . . . . 0.59 111.519 -178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 69.4 mtm -69.12 -39.94 78.61 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.89 -1.131 . . . . 0.69 110.301 -179.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.532 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 96.2 m-20 -71.31 -46.95 59.52 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.918 -1.114 . . . . 1.17 109.854 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -69.76 -35.44 74.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.358 -0.839 . . . . 3.0 110.366 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.504 ' C ' ' H ' ' A' ' 40' ' ' PHE . 90.9 m-85 -128.7 79.96 73.46 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 121.345 -0.847 . . . . 1.54 109.854 -179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_exo -50.31 -6.07 0.08 OUTLIER 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 122.84 2.36 . . . . 1.21 111.718 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.504 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -60.08 -39.5 86.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.596 -0.69 . . . . 3.74 109.459 179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -69.96 -24.1 63.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.565 -0.709 . . . . 1.12 111.125 -178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.532 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.3 mtt-85 -59.55 -40.09 86.13 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.815 -1.178 . . . . 2.51 109.738 -179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -66.93 -19.11 65.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.009 -1.057 . . . . 2.34 109.992 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -133.54 97.56 3.97 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 109.012 -0.736 . . . . 2.01 109.012 179.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.472 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 62.7 mttp -88.56 -45.71 9.67 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.044 -1.035 . . . . 1.68 110.717 -179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -79.15 144.3 34.62 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.126 -0.984 . . . . 3.98 110.121 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.91 -58.04 0.4 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.302 -1.119 . . . . 0.78 110.302 179.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.472 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.5 p-90 -89.19 -13.5 38.17 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.028 -1.278 . . . . 0.44 109.962 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.9 tt0 -60.26 -50.0 75.4 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.14 -0.975 . . . . 1.96 111.487 -178.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -75.88 -36.77 59.41 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.042 -1.036 . . . . 1.28 111.671 -178.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 94.0 p -57.84 -23.07 51.06 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.988 -1.07 . . . . 1.49 110.836 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.7 mm -75.74 -68.42 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 120.963 -1.086 . . . . 0.64 110.727 -179.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.575 HH11 ' CG ' ' A' ' 53' ' ' ARG . 0.0 OUTLIER -68.49 -27.01 65.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.114 -0.991 . . . . 2.76 110.693 -178.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 86.2 t60 -60.01 -42.01 93.38 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.842 -1.161 . . . . 2.48 108.655 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.55 ' O ' ' N ' ' A' ' 57' ' ' SER . 96.5 m-20 -62.52 -40.12 95.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.454 -0.779 . . . . 2.07 109.61 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 55.1 mt -65.29 59.21 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.383 -0.823 . . . . 0.78 109.159 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.55 ' N ' ' O ' ' A' ' 55' ' ' ASN . 40.1 t -159.97 -54.87 0.06 Allowed 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.264 -0.897 . . . . 1.6 109.564 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.662 HD12 ' N ' ' A' ' 58' ' ' LEU . 7.6 mp -65.85 -40.1 91.39 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.102 -0.999 . . . . 1.38 109.772 -179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -69.43 127.95 34.82 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.125 -0.984 . . . . 1.42 108.797 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.96 -1.71 58.02 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.511 -0.743 . . . . 2.17 109.373 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.8 m -64.81 -39.91 94.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.353 -0.842 . . . . 1.56 109.195 179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -84.18 134.0 34.58 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.326 -0.859 . . . . 1.32 109.264 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 58.0 t -114.82 129.11 71.52 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 O-C-N 121.445 -0.784 . . . . 0.91 109.175 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -67.0 139.56 57.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 1.81 109.041 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 59.3 t -115.69 123.42 31.3 Favored Pre-proline 0 N--CA 1.498 1.97 0 N-CA-C 108.638 -0.875 . . . . 1.28 108.638 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -71.12 -168.84 0.35 Allowed 'Trans proline' 0 N--CA 1.491 1.353 0 C-N-CA 121.07 1.18 . . . . 1.65 111.873 -179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.6 ' NH1' ' CE1' ' A' ' 77' ' ' TYR . 24.2 mtt-85 -128.51 149.99 50.36 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.436 -0.79 . . . . 4.09 109.686 -178.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 8.5 t70 -86.41 169.05 13.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.215 -0.928 . . . . 2.84 109.218 179.358 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.494 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 83.1 m-20 -72.44 -22.66 61.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.502 -0.749 . . . . 3.46 110.001 -179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -60.0 -46.37 89.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.025 -1.047 . . . . 4.5 110.425 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.7 ttpp -137.65 112.15 9.05 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.365 -0.834 . . . . 5.12 108.943 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -85.75 173.11 7.43 Favored 'Trans proline' 0 N--CA 1.49 1.308 0 C-N-CA 122.045 1.83 . . . . 3.63 112.094 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -160.5 -166.87 20.17 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.424 -1.47 . . . . 3.15 109.424 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.587 ' O ' ' NH2' ' A' ' 67' ' ' ARG . 97.8 mttt -99.38 123.82 43.99 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.344 -1.092 . . . . 4.36 110.844 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.502 ' C ' ' NH2' ' A' ' 67' ' ' ARG . . . 65.27 -125.27 29.18 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.096 -1.202 . . . . 2.03 110.096 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.545 ' N ' ' NH2' ' A' ' 67' ' ' ARG . 7.9 p -139.92 149.58 43.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.46 -1.023 . . . . 1.8 109.027 -179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.6 ' CE1' ' NH1' ' A' ' 67' ' ' ARG . 32.7 m-85 -76.28 161.71 28.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.912 -1.117 . . . . 1.39 108.485 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 74.1 m95 -118.73 140.27 50.2 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 121.663 0.745 . . . . 0.46 110.518 -178.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.7 t -148.17 155.5 41.47 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.257 -1.016 . . . . 0.56 108.257 179.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.78 -39.98 90.84 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.894 -1.129 . . . . 1.42 109.662 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -167.21 143.49 3.61 Favored Pre-proline 0 C--N 1.296 -1.753 0 O-C-N 121.631 -0.668 . . . . 3.72 109.219 179.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -53.25 -79.72 0.02 OUTLIER 'Trans proline' 0 N--CA 1.495 1.581 0 C-N-CA 121.262 1.308 . . . . 3.55 112.194 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.499 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 48.2 t0 -162.08 42.62 0.14 Allowed 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.536 -1.283 . . . . 6.82 107.536 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 59.1 m -45.37 110.0 0.21 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.67 -0.644 . . . . 6.0 109.854 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.499 ' CD1' ' O ' ' A' ' 83' ' ' ASP . 0.0 OUTLIER -89.95 -76.67 0.42 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.304 -0.872 . . . . 11.0 108.961 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 47.6 t30 -99.25 2.18 45.37 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.438 -0.789 . . . . 10.0 110.441 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 73.1 mtm -90.93 115.35 27.89 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.169 -0.957 . . . . 8.47 109.235 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -68.9 -36.07 77.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.208 -0.932 . . . . 11.97 108.717 179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -69.71 160.11 32.26 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.463 -0.773 . . . . 11.95 109.479 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -80.96 44.68 0.77 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.38 -0.825 . . . . 12.32 110.781 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 87.39 -2.65 86.58 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 110.201 -1.159 . . . . 11.16 110.201 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.0 p -59.96 -38.65 83.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.971 -1.311 . . . . 11.8 108.749 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -84.26 126.25 32.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.387 -0.821 . . . . 10.78 109.372 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 71.2 mt . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.345 -0.983 . . . . 13.12 108.345 179.502 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.433 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.259 0.552 . . . . 4.81 109.6 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 86.9 mt -74.84 145.2 43.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.4 -0.813 . . . . 1.71 109.619 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.0 m -129.99 160.04 41.44 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.595 -0.691 . . . . 1.79 109.459 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.527 ' N ' ' CD ' ' A' ' 4' ' ' LYS . 10.1 mptt -76.53 149.88 81.64 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.203 -0.936 . . . . 3.69 109.551 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.18 161.25 45.12 Favored 'Trans proline' 0 N--CA 1.494 1.539 0 C-N-CA 122.658 2.239 . . . . 0.73 111.589 179.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -74.67 27.66 0.35 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.388 2.059 . . . . 0.84 113.299 -179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -100.42 133.59 44.63 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.878 -1.139 . . . . 1.15 108.839 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -70.31 161.83 29.65 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.148 -0.97 . . . . 1.39 108.914 179.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -59.23 -43.05 92.38 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.98 -1.075 . . . . 1.32 108.307 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.462 ' HA ' HD12 ' A' ' 13' ' ' ILE . 81.9 mt -65.15 -40.02 87.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 N-CA-C 108.606 -0.887 . . . . 0.96 108.606 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.98 -43.97 98.06 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.186 -0.946 . . . . 0.38 109.862 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 90.7 mt -60.01 -40.14 88.22 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 120.913 -1.117 . . . . 0.37 108.432 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.691 HD11 HG23 ' A' ' 52' ' ' ILE . 96.4 mt -62.91 -42.14 95.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.44 -0.787 . . . . 0.49 108.886 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -60.79 -43.21 98.43 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.722 -0.611 . . . . 0.39 110.553 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.558 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.8 mtm -70.1 -39.96 75.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.915 -1.116 . . . . 1.14 109.426 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.456 ' HA ' HD21 ' A' ' 19' ' ' ASN . . . -50.37 -52.34 38.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.538 -0.726 . . . . 0.32 109.898 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 43.6 mt -60.02 -44.29 94.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.392 -0.817 . . . . 0.33 109.368 -179.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 -60.1 -46.14 90.58 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.651 -0.656 . . . . 1.82 111.187 -178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.558 ' ND2' ' O ' ' A' ' 15' ' ' MET . 18.9 p30 -90.04 11.05 21.83 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.991 -1.068 . . . . 1.67 110.474 -178.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.29 120.39 80.94 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 0.63 108.83 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -41.77 -38.22 4.42 Favored 'Trans proline' 0 N--CA 1.49 1.306 0 C-N-CA 121.443 1.429 . . . . 1.29 110.993 179.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.9 tp10 -112.93 137.23 51.63 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 107.817 -1.179 . . . . 2.63 107.817 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.5 tptm -60.02 -39.97 87.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.967 -1.083 . . . . 2.02 108.502 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -82.15 129.15 34.75 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.163 -1.051 . . . . 1.55 108.163 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.12 146.17 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.206 -0.934 . . . . 0.47 110.158 -178.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -79.77 160.0 26.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.519 -0.738 . . . . 0.81 110.278 -179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.3 tp -60.07 -48.41 81.85 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.636 -0.875 . . . . 0.7 108.636 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -60.78 -39.91 90.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.58 -0.7 . . . . 1.25 109.89 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.52 -39.89 95.56 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 110.456 -1.058 . . . . 0.29 110.456 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.0 mt -60.12 -42.54 90.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 120.953 -1.322 . . . . 0.35 109.74 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 39.3 m-85 -62.1 -40.1 94.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.161 -0.962 . . . . 1.4 110.736 -179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -60.4 -40.17 90.0 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.953 -1.092 . . . . 2.51 109.614 -179.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.524 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 65.6 t80 -60.09 -46.85 88.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.341 -0.849 . . . . 1.37 111.168 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 83.3 mt -60.04 -49.83 82.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.046 -1.034 . . . . 0.59 110.826 -178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtm -61.86 -40.0 93.85 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.854 -1.153 . . . . 0.69 110.105 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -61.65 -39.92 93.06 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.165 -0.959 . . . . 1.17 110.921 -179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.458 HH11 ' HG2' ' A' ' 37' ' ' ARG . 0.1 OUTLIER -79.99 -67.69 0.74 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.885 -1.134 . . . . 3.0 110.103 -178.774 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 38' ' ' PHE . 23.7 m-85 -92.09 115.69 65.11 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.156 -0.965 . . . . 1.54 109.004 -179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -79.72 -7.81 14.6 Favored 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.176 1.918 . . . . 1.21 113.278 -178.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 1.1 m-85 -59.94 -40.03 87.56 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.904 -1.122 . . . . 3.74 109.341 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -67.83 -26.78 66.23 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.574 -0.704 . . . . 1.12 110.848 -178.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.7 mtp180 -60.02 -40.01 87.8 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.004 . . . . 2.51 109.477 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.9 tp10 -71.41 -9.31 57.96 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.281 -0.887 . . . . 2.34 109.214 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.465 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 57.5 t-20 -141.51 99.53 3.58 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 109.049 -0.723 . . . . 2.01 109.049 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.539 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 65.0 mttm -96.66 -21.48 17.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 1.68 110.911 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.8 mp0 -90.66 136.36 33.11 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.765 -1.209 . . . . 3.98 110.86 -179.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -75.15 0.23 Allowed Glycine 0 N--CA 1.496 2.656 0 N-CA-C 110.594 -1.003 . . . . 0.78 110.594 178.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.539 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.6 p-90 -62.42 -37.46 85.94 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.265 -1.138 . . . . 0.44 110.898 -178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.416 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 56.9 tt0 -59.83 -50.33 74.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.227 -0.92 . . . . 1.96 111.661 -178.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -71.2 -38.03 72.08 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.912 -1.118 . . . . 1.28 112.272 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 70.7 m -59.95 -40.09 87.82 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.863 -1.148 . . . . 1.49 112.217 -176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.691 HG23 HD11 ' A' ' 13' ' ' ILE . 11.1 mt -61.89 -50.0 81.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.629 -1.294 . . . . 0.64 110.691 -178.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 32.8 ptt180 -69.18 -29.26 67.21 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 120.401 -1.437 . . . . 2.76 109.199 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -69.59 -37.2 76.82 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.044 -1.465 . . . . 2.48 107.044 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -60.59 -36.35 78.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.688 -0.632 . . . . 2.07 109.317 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.404 HD23 ' HA ' ' A' ' 56' ' ' LEU . 82.4 mt -59.99 -42.01 93.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.182 -0.949 . . . . 0.78 110.558 -179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 23.2 t -60.04 -46.86 88.15 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.962 -1.086 . . . . 1.6 109.87 -179.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.536 HD12 ' N ' ' A' ' 58' ' ' LEU . 10.1 mp -69.98 -37.86 75.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.065 -1.022 . . . . 1.38 109.439 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.425 HD21 HD11 ' A' ' 10' ' ' ILE . 92.6 m-20 -75.8 111.99 11.72 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.19 -0.944 . . . . 1.42 109.269 -179.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 61.6 mm-40 -88.03 -9.8 52.29 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.424 -0.797 . . . . 2.17 109.626 -179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.413 ' SG ' ' N ' ' A' ' 62' ' ' PHE . 30.1 p -60.06 -35.9 76.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 1.56 109.412 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.413 ' N ' ' SG ' ' A' ' 61' ' ' CYS . 74.8 m-85 -78.1 147.42 34.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.218 -0.926 . . . . 1.32 108.914 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 92.2 t -118.47 130.64 73.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 121.466 -0.771 . . . . 0.91 110.826 -178.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -76.25 158.67 31.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.523 -0.735 . . . . 1.81 109.176 179.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 93.8 t -134.64 84.26 39.86 Favored Pre-proline 0 N--CA 1.497 1.894 0 O-C-N 121.389 -0.82 . . . . 1.28 108.994 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -48.5 136.19 26.39 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.655 2.237 . . . . 1.65 112.685 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' NH1' ' O ' ' A' ' 73' ' ' GLY . 34.4 ptt180 -87.34 149.8 24.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.365 -0.834 . . . . 4.09 109.058 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -62.15 139.26 58.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.948 -1.095 . . . . 2.84 109.409 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -65.42 -39.98 92.78 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.873 . . . . 3.46 110.276 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 42.9 mtmt -63.66 -40.11 96.03 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.922 -1.111 . . . . 4.5 110.424 -179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -88.8 115.93 64.88 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 120.801 -1.187 . . . . 5.12 108.471 179.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -77.12 105.78 2.13 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 C-N-CA 121.502 1.468 . . . . 3.63 111.912 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.518 ' O ' ' NH1' ' A' ' 67' ' ' ARG . . . -100.55 -158.99 27.87 Favored Glycine 0 N--CA 1.494 2.511 0 N-CA-C 109.543 -1.423 . . . . 3.15 109.543 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt -104.46 19.77 19.72 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.465 -1.02 . . . . 4.36 109.559 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' H ' HH11 ' A' ' 67' ' ' ARG . . . 116.53 -166.11 12.35 Favored Glycine 0 N--CA 1.498 2.79 0 N-CA-C 110.115 -1.194 . . . . 2.03 110.115 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 41.0 t -78.58 145.56 34.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.391 -1.064 . . . . 1.8 109.551 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -104.3 162.15 13.45 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.954 -0.758 . . . . 1.39 108.954 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -117.96 140.01 50.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.509 -0.744 . . . . 0.46 109.589 -179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -144.09 159.93 41.77 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.318 -0.864 . . . . 0.56 109.507 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 92.6 mt -76.97 161.21 28.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.229 -0.919 . . . . 1.42 109.302 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.549 ' O ' ' O ' ' A' ' 82' ' ' PRO . 6.1 m-20 -62.2 157.19 55.19 Favored Pre-proline 0 N--CA 1.49 1.532 0 N-CA-C 108.596 -0.89 . . . . 3.72 108.596 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.549 ' O ' ' O ' ' A' ' 81' ' ' ASP . 74.6 Cg_exo -49.69 -135.99 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.807 0 C-N-CA 122.258 1.972 . . . . 3.55 112.817 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -59.91 -47.28 86.44 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.435 -1.416 . . . . 6.82 108.888 179.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 84' ' ' SER . 3.5 t -179.97 44.3 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.678 -0.86 . . . . 6.0 108.678 179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -62.15 -39.85 94.02 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.153 -0.967 . . . . 11.0 108.889 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.492 ' C ' ' H ' ' A' ' 88' ' ' PHE . 9.9 t-20 -134.82 27.11 3.63 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.511 -0.743 . . . . 10.0 109.793 -179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 7.7 mmt -73.85 15.81 0.26 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.171 -0.956 . . . . 8.47 109.146 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.492 ' H ' ' C ' ' A' ' 86' ' ' ASN . 73.2 m-85 -89.49 35.87 0.83 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 108.982 -0.747 . . . . 11.97 108.982 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.437 ' C ' ' H ' ' A' ' 91' ' ' GLY . 10.0 pt-20 -69.86 169.99 12.01 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.934 . . . . 11.95 109.37 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.0 p30 -65.96 1.5 1.4 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.294 -0.878 . . . . 12.32 109.691 -179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.437 ' H ' ' C ' ' A' ' 89' ' ' GLU . . . -92.26 -146.75 19.39 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.972 -1.651 . . . . 11.16 108.972 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.5 m -173.47 120.36 0.32 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.469 -1.018 . . . . 11.8 109.671 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.423 ' CE2' ' O ' ' A' ' 94' ' ' LEU . 72.7 t80 -82.06 130.03 34.97 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.121 -0.987 . . . . 10.78 109.151 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' O ' ' CE2' ' A' ' 93' ' ' PHE . 58.8 tp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 13.12 109.212 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 99.0 mtp . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.599 0.714 . . . . 4.81 109.19 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.5 mt -69.8 143.16 53.02 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.5 -0.75 . . . . 1.71 109.321 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 m -129.98 159.95 41.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 108.648 -0.871 . . . . 1.79 108.648 179.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -56.25 114.57 7.9 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.082 -1.011 . . . . 3.69 109.013 -179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -40.93 154.26 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.376 0 C-N-CA 122.006 1.804 . . . . 0.73 112.577 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -75.72 30.22 0.38 Allowed 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 122.507 2.138 . . . . 0.84 111.981 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 44.7 m-85 -111.31 133.94 53.26 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.429 -0.794 . . . . 1.15 108.871 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 28.3 t -65.67 160.79 21.96 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.279 -1.008 . . . . 1.39 108.279 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -59.95 -40.03 87.6 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 120.886 -1.134 . . . . 1.32 108.221 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 93.3 mt -63.17 -41.36 92.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.273 -0.892 . . . . 0.96 109.154 179.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.7 -44.72 96.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.38 109.579 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -59.96 -41.4 91.81 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.115 -0.99 . . . . 0.37 108.403 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 91.3 mt -70.01 -41.9 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.379 -0.826 . . . . 0.49 109.453 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -60.2 -40.02 88.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.247 -0.908 . . . . 0.39 110.139 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 77.5 mtm -70.02 -37.48 75.64 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 1.14 110.028 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.9 -46.17 90.21 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.32 110.185 -179.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.1 mt -59.93 -49.98 81.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.139 -0.976 . . . . 0.33 109.071 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -66.79 -38.57 86.77 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 121.473 0.654 . . . . 1.82 109.71 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -77.12 1.04 19.36 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 1.67 109.49 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.35 149.9 76.22 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.187 -0.946 . . . . 0.63 108.705 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -37.33 -73.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 122.193 1.929 . . . . 1.29 112.59 -179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -90.1 -79.97 0.33 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.032 -1.042 . . . . 2.63 110.187 -179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 49.6 tptt -165.5 -34.65 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.876 . . . . 2.02 108.997 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' NZ ' ' OD2' ' A' ' 83' ' ' ASP . 63.1 mttp -88.53 138.38 31.48 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.276 -0.89 . . . . 1.55 109.805 -179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.5 tt -140.81 153.8 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 121.19 -0.944 . . . . 0.47 109.913 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 76.7 p -86.01 166.08 16.17 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.332 -0.855 . . . . 0.81 110.474 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 27' ' ' LEU . 20.2 tp -60.15 -51.59 68.95 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 107.872 -1.159 . . . . 0.7 107.872 179.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -60.85 -40.01 91.3 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.782 -0.574 . . . . 1.25 110.445 178.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -40.02 95.39 Favored Glycine 0 N--CA 1.493 2.439 0 C-N-CA 120.122 -1.037 . . . . 0.29 110.543 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.51 -43.85 95.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.02 -1.282 . . . . 0.35 110.363 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.561 ' O ' ' SD ' ' A' ' 35' ' ' MET . 39.9 m-85 -60.01 -46.64 88.82 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.123 -0.986 . . . . 1.4 111.989 -178.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -59.93 -39.29 84.96 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 120.771 -1.205 . . . . 2.51 110.076 -178.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -60.01 -40.01 87.79 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.309 -0.87 . . . . 1.37 110.427 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.49 -48.54 80.28 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.99 -1.068 . . . . 0.59 111.911 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . 0.561 ' SD ' ' O ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -60.05 -39.96 87.77 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.559 -1.338 . . . . 0.69 110.231 -178.304 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.525 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 88.2 m-20 -68.43 -40.06 81.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.935 -1.103 . . . . 1.17 110.429 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.5 mmm180 -67.69 -40.01 84.39 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.124 -0.985 . . . . 3.0 110.27 -178.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -129.38 122.59 21.02 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.347 -0.845 . . . . 1.54 109.011 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.32 -6.07 16.8 Favored 'Trans proline' 0 N--CA 1.492 1.438 0 C-N-CA 121.55 1.5 . . . . 1.21 111.11 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -60.07 -44.74 94.53 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.809 -0.557 . . . . 3.74 110.733 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -68.38 -23.81 64.71 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.983 -1.073 . . . . 1.12 111.012 -178.078 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.525 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 64.3 mtt-85 -60.07 -40.05 88.18 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.84 -1.163 . . . . 2.51 109.393 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -62.15 -40.01 94.53 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.288 -0.883 . . . . 2.34 110.6 -179.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -116.33 112.69 21.9 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 109.118 -0.697 . . . . 2.01 109.118 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.2 mttt -95.55 -66.39 0.91 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.184 -0.948 . . . . 1.68 110.438 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -65.33 144.25 57.24 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.228 -0.92 . . . . 3.98 109.946 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.15 -62.72 0.32 Allowed Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.582 -1.007 . . . . 0.78 110.582 178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.442 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 41.9 p-90 -80.86 -12.79 59.36 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.899 -1.353 . . . . 0.44 110.469 -178.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -70.01 -41.47 74.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.245 -0.909 . . . . 1.96 110.848 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -70.08 -38.28 75.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.32 -0.863 . . . . 1.28 111.352 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.8 t -59.97 -41.14 91.31 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.954 -1.091 . . . . 1.49 110.662 -178.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 23.8 mm -59.97 -50.05 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.082 -1.011 . . . . 0.64 110.677 -179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -63.03 -39.32 94.38 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.975 -1.078 . . . . 2.76 109.616 -178.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.537 ' NE2' HD11 ' A' ' 58' ' ' LEU . 19.8 t60 -60.04 -39.98 87.77 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.38 -0.825 . . . . 2.48 108.797 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -66.58 -39.91 88.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.225 -0.922 . . . . 2.07 109.502 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 84.8 mt -60.48 -39.99 89.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.952 . . . . 0.78 110.282 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 14.2 t -71.2 -39.95 71.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.937 -1.102 . . . . 1.6 110.868 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.537 HD11 ' NE2' ' A' ' 54' ' ' HIS . 79.1 mt -68.73 -39.99 80.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.074 -1.017 . . . . 1.38 112.049 -178.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 25.5 m120 -62.02 118.4 7.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.691 -1.255 . . . . 1.42 110.432 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -84.22 -31.61 24.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.567 -0.708 . . . . 2.17 109.622 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 7.9 p -66.24 -9.18 29.84 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.191 -0.943 . . . . 1.56 108.965 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -89.85 138.46 31.47 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 107.907 -1.146 . . . . 1.32 107.907 179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 36.2 t -123.84 129.96 74.15 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.982 0 O-C-N 121.303 -0.873 . . . . 0.91 110.469 -178.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -76.2 147.66 38.25 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.365 -0.834 . . . . 1.81 108.956 179.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.442 ' O ' ' O ' ' A' ' 66' ' ' PRO . 15.5 t -139.98 64.5 27.66 Favored Pre-proline 0 N--CA 1.498 1.944 0 O-C-N 121.059 -1.026 . . . . 1.28 109.556 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' O ' ' O ' ' A' ' 65' ' ' VAL . 54.8 Cg_exo -35.52 162.67 0.01 OUTLIER 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 123.013 2.475 . . . . 1.65 113.375 -179.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 54.2 mtp180 -59.79 -172.36 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.36 -0.837 . . . . 4.09 108.847 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 28.7 t0 -80.0 166.68 21.33 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.205 -0.934 . . . . 2.84 108.999 179.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 85.9 m-20 -79.11 -14.36 59.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.272 -0.893 . . . . 3.46 109.96 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 29.6 mmtp -60.56 -40.3 91.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.118 -0.989 . . . . 4.5 109.443 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.527 ' O ' ' O ' ' A' ' 72' ' ' PRO . 2.3 mppt? -86.56 150.43 51.13 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.235 -0.916 . . . . 5.12 109.177 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' A' ' 71' ' ' LYS . 88.6 Cg_exo -47.89 -131.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.503 2.071 0 C-N-CA 122.689 2.26 . . . . 3.63 113.402 178.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.431 ' O ' ' O ' ' A' ' 72' ' ' PRO . . . -51.38 179.24 0.05 OUTLIER Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.118 -1.593 . . . . 3.15 109.118 -179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 37.5 mttp -136.18 154.61 50.9 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.26 -1.141 . . . . 4.36 109.706 -179.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -84.83 -122.95 1.11 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 108.22 -1.952 . . . . 2.03 108.22 178.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 4.2 p -155.28 100.83 2.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.932 -1.334 . . . . 1.8 109.712 179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 5.0 m-30 -82.56 160.0 22.65 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.413 -0.805 . . . . 1.39 108.828 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -141.89 131.43 23.91 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.052 -1.03 . . . . 0.46 110.903 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 12.5 t -155.04 150.94 27.81 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.897 -0.779 . . . . 0.56 108.897 179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 71.9 mt -60.25 -40.07 88.97 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.97 -1.081 . . . . 1.42 109.332 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -154.13 173.13 4.99 Favored Pre-proline 0 C--N 1.296 -1.741 0 N-CA-C 108.242 -1.022 . . . . 3.72 108.242 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -78.82 173.05 14.12 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 121.784 1.656 . . . . 3.55 111.495 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.533 ' OD2' ' NZ ' ' A' ' 24' ' ' LYS . 97.2 m-20 -84.58 63.81 8.11 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 107.958 -1.127 . . . . 6.82 107.958 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.3 t -51.74 -30.05 21.06 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.662 -0.649 . . . . 6.0 109.592 -179.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -64.65 -20.8 66.5 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.025 -1.047 . . . . 11.0 108.999 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -84.25 -0.91 54.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.494 -0.754 . . . . 10.0 110.863 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 43.3 mtm -70.38 152.4 44.14 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.172 -0.955 . . . . 8.47 109.675 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -60.09 -42.8 95.39 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.642 -0.661 . . . . 11.97 110.728 -178.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.87 142.44 58.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.948 -1.095 . . . . 11.95 109.848 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -148.98 154.08 38.85 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.309 -0.869 . . . . 12.32 110.227 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.57 -55.24 4.99 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.861 -1.296 . . . . 11.16 109.861 179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -167.09 122.17 1.07 Allowed 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.234 -1.156 . . . . 11.8 108.973 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.506 ' CD1' ' N ' ' A' ' 93' ' ' PHE . 7.8 p90 -111.39 94.15 4.83 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.663 -0.648 . . . . 10.78 109.614 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.448 ' N ' HD12 ' A' ' 94' ' ' LEU . 10.7 mp . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.229 -0.919 . . . . 13.12 108.807 179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.3 mtt . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.344 -0.613 . . . . 4.81 109.344 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 35.6 mt -105.33 140.0 39.11 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.459 -0.776 . . . . 1.71 109.419 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.4 m -143.86 148.72 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.411 -0.806 . . . . 1.79 109.911 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 63.2 mmtt -70.92 149.99 95.02 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.208 -0.933 . . . . 3.69 108.908 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.03 160.31 30.22 Favored 'Trans proline' 0 N--CA 1.492 1.419 0 C-N-CA 122.2 1.933 . . . . 0.73 111.669 179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.4 26.61 0.31 Allowed 'Trans proline' 0 N--CA 1.495 1.564 0 C-N-CA 122.418 2.079 . . . . 0.84 113.565 -179.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 42.7 m-85 -100.55 137.92 38.31 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.848 -1.157 . . . . 1.15 108.372 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 42.3 m -77.57 166.41 23.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.131 -0.98 . . . . 1.39 108.947 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.7 m-85 -59.94 -37.87 80.75 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.968 -1.082 . . . . 1.32 108.354 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 55' ' ' ASN . 38.0 mm -61.13 -46.48 96.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.431 -0.793 . . . . 0.96 109.338 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.71 95.13 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.199 -0.938 . . . . 0.38 110.786 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.2 mt -59.93 -40.05 87.59 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.853 -1.154 . . . . 0.37 108.599 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.2 mt -65.41 -44.84 94.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 N-CA-C 108.336 -0.987 . . . . 0.49 108.336 178.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -67.44 -40.06 85.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.602 -0.686 . . . . 0.39 110.738 -179.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.423 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.4 mtt -66.7 -39.91 88.25 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.799 -1.188 . . . . 1.14 109.148 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -50.04 75.27 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.537 -0.727 . . . . 0.32 110.107 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.412 HG21 HD11 ' A' ' 80' ' ' LEU . 80.9 mt -60.46 -50.0 82.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.199 -0.938 . . . . 0.33 109.509 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -65.61 -40.0 92.16 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.664 -0.647 . . . . 1.82 110.576 -178.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.423 ' ND2' ' O ' ' A' ' 15' ' ' MET . 70.3 m-80 -82.05 1.27 36.6 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.095 -1.003 . . . . 1.67 109.87 -179.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.42 149.05 74.86 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.187 -0.945 . . . . 0.63 108.634 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -61.12 -32.22 91.17 Favored 'Trans proline' 0 C--N 1.311 -1.395 0 C-N-CA 121.614 1.543 . . . . 1.29 109.806 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 80.7 mm-40 -124.21 139.99 53.39 Favored 'General case' 0 N--CA 1.491 1.602 0 N-CA-C 107.797 -1.186 . . . . 2.63 107.797 178.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.8 tppt? -60.07 -38.99 84.49 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.02 -1.05 . . . . 2.02 108.585 -179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -77.97 120.18 22.46 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.926 -1.139 . . . . 1.55 107.926 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.9 tt -139.73 148.87 22.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 121.248 -0.907 . . . . 0.47 109.971 -178.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 70.3 p -79.83 160.0 26.27 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.464 -0.772 . . . . 0.81 110.89 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 22.7 tp -66.32 -39.99 89.64 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.756 -0.831 . . . . 0.7 108.756 179.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -65.91 -40.0 91.09 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.49 -0.756 . . . . 1.25 109.672 179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.72 -38.51 96.58 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 110.344 -1.102 . . . . 0.29 110.344 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.8 mt -59.99 -42.27 89.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.248 . . . . 0.35 109.933 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.4 m-85 -60.0 -39.11 84.64 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.959 -1.088 . . . . 1.4 109.588 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -59.99 -41.36 91.9 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.045 -1.035 . . . . 2.51 108.882 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -60.95 -47.59 85.75 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.275 -0.891 . . . . 1.37 110.431 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.446 HG21 ' CZ3' ' A' ' 48' ' ' TRP . 2.1 mp -61.73 -49.66 83.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.024 -1.047 . . . . 0.59 110.276 -179.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 29.6 mtm -60.07 -39.91 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.808 -1.183 . . . . 0.69 109.889 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -72.09 -51.85 19.57 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.951 -1.093 . . . . 1.17 109.431 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.4 tpt180 -60.11 -50.0 75.41 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.325 -0.86 . . . . 3.0 109.312 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.0 m-85 -118.57 110.66 38.66 Favored Pre-proline 0 N--CA 1.498 1.929 0 N-CA-C 108.812 -0.81 . . . . 1.54 108.812 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -81.51 -7.33 12.7 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.982 1.788 . . . . 1.21 112.514 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.441 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.7 OUTLIER -60.57 -40.0 90.05 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.915 . . . . 3.74 109.605 -179.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.7 m-85 -64.06 -17.82 63.76 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.693 -0.629 . . . . 1.12 110.777 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 56.0 mtp180 -59.63 -43.17 93.91 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.026 -1.046 . . . . 2.51 108.46 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -63.17 -43.74 97.43 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.337 -0.852 . . . . 2.34 109.624 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 58.8 t30 -102.58 99.02 8.99 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 109.175 -0.676 . . . . 2.01 109.175 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -94.51 -42.56 8.77 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.103 -0.998 . . . . 1.68 109.476 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -81.29 149.5 28.94 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.227 -0.921 . . . . 3.98 109.494 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.42 -73.34 0.28 Allowed Glycine 0 N--CA 1.493 2.497 0 N-CA-C 110.133 -1.187 . . . . 0.78 110.133 179.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.446 ' CZ3' HG21 ' A' ' 34' ' ' ILE . 20.6 p-90 -69.49 -38.73 77.78 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.207 -1.172 . . . . 0.44 110.664 -178.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.04 -42.07 93.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 1.96 110.721 -179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -70.04 -39.57 75.64 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.168 -0.957 . . . . 1.28 110.826 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 91.8 p -59.98 -40.05 87.8 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.183 -0.948 . . . . 1.49 111.259 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 44.7 mm -60.0 -50.01 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 120.835 -1.166 . . . . 0.64 110.126 -179.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.0 mtm180 -60.35 -49.62 76.87 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.968 -1.082 . . . . 2.76 109.44 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -59.99 -39.98 87.57 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.143 -1.058 . . . . 2.48 108.143 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.585 ' ND2' HD21 ' A' ' 59' ' ' ASN . 23.8 t-20 -62.07 -40.34 95.45 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.473 -0.767 . . . . 2.07 109.097 179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 83.7 mt -64.84 -40.06 94.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 0.78 110.456 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.7 m -69.5 -46.84 65.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.983 -1.073 . . . . 1.6 110.43 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 46.1 mt -66.59 -39.98 88.68 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.167 -0.958 . . . . 1.38 110.245 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.585 HD21 ' ND2' ' A' ' 55' ' ' ASN . 42.7 m-80 -75.29 117.54 17.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.059 -1.025 . . . . 1.42 109.752 -179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -90.59 -2.41 57.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.417 -0.802 . . . . 2.17 109.352 179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.2 m -60.36 -39.94 88.99 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.387 -0.821 . . . . 1.56 109.591 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -79.71 152.8 29.7 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 1.32 109.351 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 11.7 t -112.7 127.46 69.92 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.473 -0.767 . . . . 0.91 109.393 -179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 55.0 mttp -68.98 145.76 53.32 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.28 -1.007 . . . . 1.81 108.28 179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 t -137.39 76.97 42.11 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.144 -0.972 . . . . 1.28 109.715 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -50.64 160.81 1.54 Allowed 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 122.62 2.214 . . . . 1.65 111.881 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -83.48 166.45 18.29 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.215 -0.928 . . . . 4.09 109.012 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.1 p-10 -77.55 166.48 23.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 2.84 109.745 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -61.05 -36.45 79.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.542 -0.724 . . . . 3.46 110.882 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 18.6 mtpp -59.99 -40.66 89.94 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.87 -1.144 . . . . 4.5 110.127 -178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 28.9 mmtp -84.13 149.52 55.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 120.924 -1.11 . . . . 5.12 108.702 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.46 141.16 97.04 Favored 'Trans proline' 0 N--CA 1.492 1.414 0 C-N-CA 121.803 1.668 . . . . 3.63 111.397 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.18 80.58 0.49 Allowed Glycine 0 N--CA 1.49 2.285 0 C-N-CA 120.101 -1.047 . . . . 3.15 110.609 -179.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.432 ' O ' ' C ' ' A' ' 75' ' ' GLY . 66.2 mttm -113.42 130.1 56.39 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.481 -1.011 . . . . 4.36 109.697 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 74' ' ' LYS . . . 36.26 -152.31 0.01 OUTLIER Glycine 0 N--CA 1.495 2.574 0 N-CA-C 111.026 -0.829 . . . . 2.03 111.026 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.2 t -155.76 140.04 16.62 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.539 -0.977 . . . . 1.8 108.445 179.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -77.85 154.89 31.38 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.692 -1.255 . . . . 1.39 108.273 179.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -119.95 140.03 51.54 Favored 'General case' 0 N--CA 1.498 1.972 0 CA-C-O 121.758 0.79 . . . . 0.46 110.716 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 11.7 t -139.62 162.24 35.58 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.769 -0.826 . . . . 0.56 108.769 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.412 HD11 HG21 ' A' ' 17' ' ' ILE . 2.2 mp -99.2 16.06 24.05 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.142 -0.974 . . . . 1.42 110.445 -179.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -149.35 152.58 35.96 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 120.837 -1.164 . . . . 3.72 111.005 -178.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.55 -153.69 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.618 0 C-N-CA 122.525 2.15 . . . . 3.55 111.783 178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.449 ' O ' ' N ' ' A' ' 85' ' ' TYR . 42.7 t0 -79.94 71.4 6.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.958 -1.089 . . . . 6.82 108.46 179.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 84' ' ' SER . 5.7 p -59.3 85.83 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.798 0.809 . . . . 6.0 109.312 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.449 ' N ' ' O ' ' A' ' 83' ' ' ASP . 49.2 t80 -82.96 -39.58 21.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 11.0 110.964 -178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -138.54 29.74 2.38 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.0 -1.063 . . . . 10.0 110.009 -179.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.617 ' SD ' ' N ' ' A' ' 87' ' ' MET . 0.2 OUTLIER -52.91 140.45 24.53 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.272 -0.893 . . . . 8.47 109.179 179.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -59.15 -107.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 11.97 109.752 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.556 ' CD ' ' H ' ' A' ' 89' ' ' GLU . 3.5 pm0 -103.8 20.14 18.63 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.277 -0.889 . . . . 11.95 110.01 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -90.89 31.35 1.08 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.309 -0.869 . . . . 12.32 109.455 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -153.47 -113.91 0.53 Allowed Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.674 -1.371 . . . . 11.16 109.674 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 57.4 p -147.04 117.61 7.5 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.169 -1.195 . . . . 11.8 109.097 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.524 ' O ' ' CD2' ' A' ' 93' ' ' PHE . 25.0 p90 -94.75 115.39 27.46 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.363 -0.835 . . . . 10.78 109.192 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 82.3 mt . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.166 -0.959 . . . . 13.12 109.717 -179.682 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 95.4 mtp . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.55 0.691 . . . . 4.81 109.331 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 67.2 mt -74.25 140.63 45.14 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.368 -0.832 . . . . 1.71 109.689 -179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.2 m -140.05 144.11 28.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 108.791 -0.818 . . . . 1.79 108.791 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.9 pttp -70.01 148.5 96.17 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.854 -1.154 . . . . 3.69 108.539 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 50.2 Cg_endo -83.21 124.76 3.83 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.927 1.751 . . . . 0.73 112.133 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.03 -12.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.578 0 C-N-CA 122.555 2.17 . . . . 0.84 114.142 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 14.4 m-85 -62.43 140.07 58.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.534 -1.354 . . . . 1.15 109.519 -179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 20.8 t -79.63 168.23 19.65 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 107.833 -1.173 . . . . 1.39 107.833 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -60.39 -39.91 89.02 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.902 -1.124 . . . . 1.32 109.095 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.467 ' CD1' ' OD1' ' A' ' 55' ' ' ASN . 38.8 mm -62.18 -41.1 90.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.38 -0.825 . . . . 0.96 109.254 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.18 -41.97 85.02 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.211 -0.931 . . . . 0.38 110.154 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.1 -40.06 88.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.921 -1.112 . . . . 0.37 108.972 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -68.54 -40.05 81.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.415 -0.803 . . . . 0.49 109.132 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.31 -39.96 96.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.573 -0.704 . . . . 0.39 110.488 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.436 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.5 mtt -65.35 -39.95 92.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.295 -0.878 . . . . 1.14 110.078 -178.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.97 -48.65 80.82 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.352 -0.843 . . . . 0.32 109.591 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 70.0 mt -61.23 -50.06 82.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.436 -0.79 . . . . 0.33 109.247 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.7 mt-30 -60.01 -40.14 88.21 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.413 0.625 . . . . 1.82 110.125 -179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 15' ' ' MET . 69.4 m-80 -81.94 -0.12 42.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -0.847 . . . . 1.67 109.613 -179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.77 123.5 85.29 Favored Pre-proline 0 C--N 1.303 -1.443 0 O-C-N 121.276 -0.89 . . . . 0.63 108.894 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -42.27 -48.23 6.71 Favored 'Trans proline' 0 N--CA 1.49 1.283 0 C-N-CA 121.44 1.426 . . . . 1.29 110.674 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -105.29 142.0 35.83 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.601 -1.259 . . . . 2.63 107.601 178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 31.7 mmtp -60.02 -37.85 80.99 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 120.952 -1.092 . . . . 2.02 109.485 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.4 mttp -77.74 127.91 33.19 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 107.811 -1.181 . . . . 1.55 107.811 179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 19.3 tt -138.99 151.53 23.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.343 -0.848 . . . . 0.47 109.532 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 81.2 p -81.38 156.92 25.19 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.246 -0.909 . . . . 0.81 110.005 -179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.2 tp -59.97 -48.3 82.28 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.745 0.783 . . . . 0.7 110.04 -179.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -60.01 -39.99 87.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.883 . . . . 1.25 110.2 -179.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.59 -39.49 91.04 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.403 -1.079 . . . . 0.29 110.403 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -59.95 -42.98 91.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.144 -1.209 . . . . 0.35 110.771 -179.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -60.13 -41.34 92.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.851 -1.156 . . . . 1.4 110.564 -178.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -60.13 -39.26 85.67 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.153 -0.967 . . . . 2.51 110.379 -179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -59.85 -49.3 78.23 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.399 -0.813 . . . . 1.37 110.729 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.3 mt -60.04 -49.92 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.0 -1.063 . . . . 0.59 110.733 -179.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 52.7 mtm -60.03 -40.12 88.25 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.874 -1.141 . . . . 0.69 110.445 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 80.3 m-20 -60.39 -45.22 94.34 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.928 -1.107 . . . . 1.17 110.715 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.408 ' HG2' ' NH1' ' A' ' 37' ' ' ARG . 49.0 mtt-85 -68.02 -48.38 65.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.911 -1.118 . . . . 3.0 111.192 -178.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -123.14 125.28 26.27 Favored Pre-proline 0 N--CA 1.5 2.057 0 O-C-N 121.158 -0.964 . . . . 1.54 110.521 -178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -80.22 -5.0 13.45 Favored 'Trans proline' 0 N--CA 1.493 1.471 0 C-N-CA 121.971 1.781 . . . . 1.21 110.707 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -60.01 -40.1 88.1 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 109.335 -0.617 . . . . 3.74 109.335 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.7 m-85 -70.05 -31.28 68.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.411 -0.806 . . . . 1.12 109.906 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.2 mtp180 -60.06 -39.94 87.75 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.165 -0.959 . . . . 2.51 109.204 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -63.26 -40.08 96.39 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.208 -0.933 . . . . 2.34 110.132 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -110.55 101.37 10.05 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 109.175 -0.676 . . . . 2.01 109.175 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 68.5 mttm -88.53 -40.65 13.25 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.094 -1.004 . . . . 1.68 110.178 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -78.53 141.68 37.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.003 -1.061 . . . . 3.98 110.421 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.18 -60.37 0.33 Allowed Glycine 0 N--CA 1.494 2.559 0 N-CA-C 110.188 -1.165 . . . . 0.78 110.188 179.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.424 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 24.2 p-90 -88.85 -11.93 43.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -1.223 . . . . 0.44 110.239 -179.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -69.85 -56.63 6.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.116 -0.99 . . . . 1.96 111.4 -178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -69.92 -38.75 76.33 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.253 -0.904 . . . . 1.28 112.327 -178.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.5 m -59.99 -39.85 87.17 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.783 -1.198 . . . . 1.49 111.226 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -54.06 -68.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.954 -1.091 . . . . 0.64 111.398 -178.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -69.93 -33.13 71.74 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.081 -1.012 . . . . 2.76 112.375 -177.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 41.8 m170 -59.98 -40.16 88.18 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.342 -1.474 . . . . 2.48 107.676 179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.794 HD21 HD21 ' A' ' 59' ' ' ASN . 21.8 t-20 -60.09 -40.53 89.93 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.614 -0.679 . . . . 2.07 109.25 179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 74.5 mt -62.27 -40.14 95.24 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.997 -1.065 . . . . 0.78 109.704 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 58.1 m -64.52 -49.75 70.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.282 -0.886 . . . . 1.6 110.721 -178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.424 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.0 mp -69.98 -40.04 75.58 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.882 -1.136 . . . . 1.38 110.069 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.794 HD21 HD21 ' A' ' 55' ' ' ASN . 99.5 m-20 -69.28 121.94 17.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.13 -0.981 . . . . 1.42 110.505 -178.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.5 -3.41 57.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.676 -0.861 . . . . 2.17 108.676 179.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.2 m -60.05 -39.97 87.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.638 -0.664 . . . . 1.56 109.524 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -77.3 150.04 35.3 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.198 -0.939 . . . . 1.32 109.068 -179.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 29.5 t -111.05 129.99 65.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.534 -0.729 . . . . 0.91 109.573 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -90.64 120.45 31.72 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.194 -1.039 . . . . 1.81 108.194 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.79 127.22 31.7 Favored Pre-proline 0 N--CA 1.502 2.166 0 O-C-N 120.807 -1.183 . . . . 1.28 109.326 -179.469 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -77.46 151.09 28.91 Favored 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 121.855 1.703 . . . . 1.65 112.008 179.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.503 ' NE ' ' O ' ' A' ' 74' ' ' LYS . 27.0 mtm180 -80.73 152.79 28.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.164 -0.96 . . . . 4.09 109.742 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -80.64 164.91 22.51 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.413 -0.804 . . . . 2.84 109.398 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.446 ' C ' ' N ' ' A' ' 71' ' ' LYS . 96.6 m-20 -60.03 -39.97 87.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.237 -0.915 . . . . 3.46 109.659 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 51.9 mtmt -49.82 -15.21 0.17 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.242 -0.911 . . . . 4.5 109.145 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.446 ' N ' ' C ' ' A' ' 69' ' ' ASP . 57.0 mttp -125.72 79.94 67.32 Favored Pre-proline 0 N--CA 1.495 1.776 0 N-CA-C 108.688 -0.856 . . . . 5.12 108.688 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -76.41 132.95 14.05 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.16 1.907 . . . . 3.63 112.45 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 141.43 -99.59 0.24 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.285 -1.526 . . . . 3.15 109.285 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.503 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 92.5 mttt -72.01 155.83 39.89 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -1.159 . . . . 4.36 109.675 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -136.84 39.4 1.64 Allowed Glycine 0 N--CA 1.496 2.681 0 N-CA-C 109.225 -1.55 . . . . 2.03 109.225 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 88.4 p -157.67 152.23 25.06 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.075 -1.25 . . . . 1.8 110.533 -179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -152.17 169.97 21.14 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 107.473 -1.306 . . . . 1.39 107.473 178.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 96.8 m95 -132.89 124.97 28.88 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.252 -0.905 . . . . 0.46 109.553 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.9 t -152.8 152.42 31.59 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.282 -0.886 . . . . 0.56 109.751 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.44 ' O ' ' O ' ' A' ' 81' ' ' ASP . 86.4 mt -78.17 163.49 25.77 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.395 -0.816 . . . . 1.42 108.949 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.44 ' O ' ' O ' ' A' ' 80' ' ' LEU . 0.1 OUTLIER -50.84 177.97 0.04 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.267 -0.896 . . . . 3.72 108.608 -179.708 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.87 -145.1 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.521 0 C-N-CA 121.939 1.759 . . . . 3.55 111.686 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -80.8 57.95 3.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.116 -0.99 . . . . 6.82 109.364 179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 83.2 p -79.59 85.63 5.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.198 -0.939 . . . . 6.0 108.978 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.411 ' N ' ' SD ' ' A' ' 87' ' ' MET . 0.7 OUTLIER -90.04 -79.41 0.34 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.31 -0.869 . . . . 11.0 108.866 -179.827 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.495 ' O ' ' CE2' ' A' ' 88' ' ' PHE . 81.0 m-20 -96.06 6.14 49.53 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.276 -0.89 . . . . 10.0 109.201 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.512 ' SD ' ' N ' ' A' ' 87' ' ' MET . 0.4 OUTLIER -60.98 140.63 57.75 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.678 -0.639 . . . . 8.47 109.593 -179.988 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.495 ' CE2' ' O ' ' A' ' 86' ' ' ASN . 97.6 m-85 -113.55 106.36 14.45 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.588 -0.893 . . . . 11.97 108.588 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -65.05 -22.96 67.05 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.885 0.85 . . . . 11.95 108.99 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -99.97 19.27 16.53 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 108.629 -0.878 . . . . 12.32 108.629 179.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -155.66 -131.92 1.49 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.129 -1.588 . . . . 11.16 109.129 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.8 m -102.87 -159.6 0.73 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.26 -1.141 . . . . 11.8 108.918 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 32.4 p90 -106.11 -23.04 12.71 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.714 -0.616 . . . . 10.78 110.492 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp . . . . . 0 N--CA 1.493 1.7 0 O-C-N 120.874 -1.141 . . . . 13.12 109.412 -179.528 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ptt? . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.174 0.512 . . . . 4.81 109.655 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.3 mt -98.59 140.98 32.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.313 -0.867 . . . . 1.71 109.273 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.9 m -130.49 157.07 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.921 0 O-C-N 121.463 -0.773 . . . . 1.79 109.868 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 11.5 mptt -79.28 152.22 75.99 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.358 -0.839 . . . . 3.69 108.94 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -72.15 160.0 48.43 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.169 1.913 . . . . 0.73 111.709 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.17 20.93 0.4 Allowed 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.739 2.293 . . . . 0.84 113.773 -179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -96.01 137.73 34.66 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.632 -1.292 . . . . 1.15 109.141 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 97.7 p -73.33 165.61 24.74 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.273 -0.892 . . . . 1.39 108.667 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 86.4 m-85 -60.03 -40.02 87.91 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.164 -0.96 . . . . 1.32 109.18 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.35 -39.9 81.62 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.334 -0.854 . . . . 0.96 109.64 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.61 -42.03 99.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.032 -1.043 . . . . 0.38 109.519 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.7 mt -60.76 -39.96 90.69 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.193 -0.942 . . . . 0.37 108.584 179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.449 HG21 HD21 ' A' ' 56' ' ' LEU . 96.6 mt -70.08 -42.06 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.546 -0.722 . . . . 0.49 109.766 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -65.67 -41.3 92.65 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.118 -0.989 . . . . 0.39 109.744 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.8 mtm -69.95 -33.87 72.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.178 -0.951 . . . . 1.14 109.887 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.577 ' O ' ' ND2' ' A' ' 19' ' ' ASN . . . -60.05 -46.61 88.96 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.434 -0.791 . . . . 0.32 109.783 -179.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 69.5 mt -62.03 -45.35 98.91 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.635 0 O-C-N 121.061 -1.024 . . . . 0.33 109.807 -179.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 80.2 mt-30 -63.15 -43.23 98.89 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.803 -0.561 . . . . 1.82 112.178 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -89.98 10.34 24.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.713 -1.242 . . . . 1.67 110.085 -178.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -76.78 150.46 81.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 0.63 108.901 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -57.68 -24.89 65.3 Favored 'Trans proline' 0 N--CA 1.493 1.478 0 C-N-CA 121.732 1.622 . . . . 1.29 110.196 179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -139.91 146.57 39.39 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 107.754 -1.202 . . . . 2.63 107.754 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -59.97 -39.59 86.17 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 120.96 -1.087 . . . . 2.02 108.885 -179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 66.5 mttm -79.06 129.35 34.36 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.001 -1.062 . . . . 1.55 109.273 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 16.9 tt -147.83 143.1 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 N-CA-C 108.796 -0.816 . . . . 0.47 108.796 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 39.3 p -80.02 163.18 24.42 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -0.931 . . . . 0.81 110.053 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.451 HD13 ' CD1' ' A' ' 56' ' ' LEU . 16.0 tp -59.93 -40.69 89.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.509 -0.744 . . . . 0.7 109.094 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -60.59 -40.25 91.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.431 -0.793 . . . . 1.25 110.141 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.08 -39.99 96.52 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 110.274 -1.131 . . . . 0.29 110.274 -179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 97.2 mt -60.48 -40.37 84.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -1.137 . . . . 0.35 110.517 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.426 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 29.1 m-85 -60.02 -39.98 87.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.938 -1.101 . . . . 1.4 110.593 -179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 24.5 mm100 -59.98 -40.0 87.65 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 120.949 -1.095 . . . . 2.51 109.903 -179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . 0.542 ' CE1' ' OD1' ' A' ' 19' ' ' ASN . 93.8 t80 -60.02 -49.91 75.81 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.366 -0.834 . . . . 1.37 111.662 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.69 -49.95 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 120.96 -1.087 . . . . 0.59 112.154 -177.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 45.7 mtm -60.34 -40.04 89.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.706 -1.246 . . . . 0.69 110.994 -178.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -67.17 -48.65 67.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.868 -1.145 . . . . 1.17 110.914 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.99 -40.0 75.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.289 -0.882 . . . . 3.0 112.189 -178.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -126.55 80.44 69.78 Favored Pre-proline 0 N--CA 1.5 2.03 0 O-C-N 121.088 -1.007 . . . . 1.54 110.2 -178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -49.03 -9.85 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.95 2.433 . . . . 1.21 113.643 179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -60.11 -37.51 80.25 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.633 -1.292 . . . . 3.74 108.996 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -69.15 -28.03 66.07 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.736 -0.603 . . . . 1.12 110.898 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 32.3 mtt-85 -58.84 -39.97 82.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.654 -1.279 . . . . 2.51 108.165 179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -67.29 -40.0 86.06 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.218 -0.926 . . . . 2.34 109.026 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.489 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 94.8 m-20 -99.92 101.02 12.01 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 109.226 -0.657 . . . . 2.01 109.226 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.424 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 92.0 mttt -90.41 -78.65 0.37 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.06 -1.025 . . . . 1.68 110.388 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.5 mm-40 -60.03 140.01 57.08 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.382 -0.824 . . . . 3.98 110.235 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.11 -58.2 0.54 Allowed Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.66 -1.376 . . . . 0.78 109.66 179.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.489 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 33.3 p-90 -89.69 -10.58 45.23 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -1.235 . . . . 0.44 110.807 -179.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.407 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 77.9 mt-30 -68.64 -54.53 15.81 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.883 -1.136 . . . . 1.96 110.916 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.7 m120 -65.35 -34.8 79.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.186 -0.946 . . . . 1.28 110.948 -178.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 92.1 p -59.51 -41.51 90.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.917 -1.114 . . . . 1.49 109.933 -178.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -60.13 -50.03 81.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.64 109.797 179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.426 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 25.4 mtt180 -72.76 -38.84 67.21 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.253 -0.905 . . . . 2.76 109.864 -179.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.508 ' NE2' HD11 ' A' ' 58' ' ' LEU . 68.5 t60 -59.99 -39.99 87.64 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 2.48 108.674 -179.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -65.58 -40.01 92.27 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.389 -0.819 . . . . 2.07 109.696 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.451 ' CD1' HD13 ' A' ' 27' ' ' LEU . 44.7 mt -60.53 -46.65 89.38 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 0.78 111.291 -179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.0 p -64.66 -39.96 94.6 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.836 -1.165 . . . . 1.6 110.704 -178.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.508 HD11 ' NE2' ' A' ' 54' ' ' HIS . 43.9 mt -66.99 -37.38 84.12 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.993 -1.067 . . . . 1.38 109.464 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -79.9 110.54 15.37 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.333 -0.854 . . . . 1.42 109.608 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -89.91 -8.61 51.44 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.472 -0.768 . . . . 2.17 109.194 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 91.6 m -59.98 -40.03 87.73 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.856 -1.165 . . . . 1.56 107.856 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -79.24 127.63 32.3 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 107.845 -1.168 . . . . 1.32 107.845 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 19.4 t -102.54 126.94 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.623 -0.88 . . . . 0.91 108.623 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -97.46 117.84 32.61 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.31 -0.868 . . . . 1.81 110.031 -179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.68 149.48 54.22 Favored Pre-proline 0 N--CA 1.488 1.459 0 N-CA-C 108.127 -1.064 . . . . 1.28 108.127 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -74.45 -154.26 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.016 1.811 . . . . 1.65 111.051 179.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 82.9 mtm180 -105.44 146.02 30.06 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.268 -0.895 . . . . 4.09 109.757 -179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.53 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 30.2 t0 -89.87 -171.14 3.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.566 -0.709 . . . . 2.84 110.249 -179.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.53 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 79.4 m-20 -60.03 -39.98 87.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.457 -0.777 . . . . 3.46 109.976 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -80.69 57.19 2.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.26 -0.9 . . . . 4.5 109.509 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.22 114.64 50.7 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.76 -0.588 . . . . 5.12 109.765 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -86.67 6.57 5.31 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.956 1.771 . . . . 3.63 112.764 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.19 67.14 1.21 Allowed Glycine 0 N--CA 1.494 2.553 0 N-CA-C 109.923 -1.271 . . . . 3.15 109.923 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -141.36 177.97 7.74 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.224 -1.162 . . . . 4.36 109.37 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -71.39 -163.1 5.45 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 110.163 -1.175 . . . . 2.03 110.163 -179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 45.9 m -79.24 159.96 27.07 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.469 -1.018 . . . . 1.8 109.416 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -92.06 135.48 33.93 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 1.39 109.645 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.7 m95 -108.86 133.54 52.76 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.521 -0.737 . . . . 0.46 109.657 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -153.76 163.96 39.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.307 -0.871 . . . . 0.56 110.244 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 63.8 mt -77.22 169.61 18.02 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.24 -1.022 . . . . 1.42 108.24 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -46.07 140.2 5.14 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.0 -1.063 . . . . 3.72 109.15 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -81.49 -163.55 0.23 Allowed 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.114 1.876 . . . . 3.55 112.723 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -90.0 72.62 7.41 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 107.69 -1.226 . . . . 6.82 107.69 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 30.1 t -60.05 -37.0 78.53 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.632 -0.668 . . . . 6.0 109.694 -178.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -59.93 -39.26 84.9 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.225 -0.922 . . . . 11.0 109.987 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -69.39 -7.27 36.04 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.95 . . . . 10.0 110.327 -178.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 5.1 mmt -80.4 93.1 5.92 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.255 -0.903 . . . . 8.47 109.729 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 45.1 p90 -80.17 -9.96 59.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 11.97 109.212 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -73.63 150.27 41.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.442 -0.786 . . . . 11.95 109.78 179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 t-20 -75.79 127.68 33.53 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.195 -0.941 . . . . 12.32 109.454 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 72.95 117.88 0.07 OUTLIER Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.405 -1.478 . . . . 11.16 109.405 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.0 p -63.8 -37.75 88.55 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.324 -1.103 . . . . 11.8 109.008 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 62.3 t80 -142.78 150.49 40.08 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.354 -0.841 . . . . 10.78 109.355 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 13.12 109.678 -179.69 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.0 mtt . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.443 -0.577 . . . . 4.81 109.443 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 45.3 mt -83.51 144.93 29.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.157 -0.965 . . . . 1.71 109.719 -179.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.2 m -130.05 159.99 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 N-CA-C 109.046 -0.724 . . . . 1.79 109.046 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.8 pttm -75.67 118.7 72.86 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 3.69 108.937 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -44.59 150.26 0.84 Allowed 'Trans proline' 0 N--CA 1.491 1.375 0 C-N-CA 121.687 1.591 . . . . 0.73 111.809 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.21 -12.57 32.29 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 C-N-CA 122.257 1.971 . . . . 0.84 111.809 179.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -60.5 134.55 57.18 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.216 -0.927 . . . . 1.15 108.645 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 53.1 p -70.42 162.11 29.27 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.176 -1.046 . . . . 1.39 108.176 179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -58.47 -39.99 81.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.897 -1.127 . . . . 1.32 108.101 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 21.1 mm -61.56 -44.51 98.75 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.411 -0.806 . . . . 0.96 109.155 179.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.49 -46.13 91.25 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.19 -0.944 . . . . 0.38 109.828 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -59.95 -40.01 87.54 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.053 -1.03 . . . . 0.37 108.59 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 94.6 mt -69.97 -39.9 78.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.26 -0.9 . . . . 0.49 109.105 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -63.76 -39.9 95.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.521 -0.737 . . . . 0.39 110.016 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 65.3 mtt -66.48 -38.49 87.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.415 -0.803 . . . . 1.14 109.521 -179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.04 -41.57 92.55 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.439 -0.788 . . . . 0.32 109.849 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.4 mt -64.9 -52.92 47.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.96 . . . . 0.33 109.115 -179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 41.9 mt-30 -63.87 -40.01 95.55 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.731 -0.605 . . . . 1.82 109.539 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -69.96 -21.48 63.25 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.543 -0.723 . . . . 1.67 109.967 -179.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -79.31 147.31 68.42 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.009 -1.057 . . . . 0.63 108.898 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -66.38 -48.18 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 121.866 1.711 . . . . 1.29 110.32 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -102.88 123.15 45.98 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 107.722 -1.214 . . . . 2.63 107.722 178.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -61.1 -28.12 68.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 2.02 110.368 -178.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -78.8 88.29 4.65 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.787 -1.196 . . . . 1.55 108.803 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.1 tt -114.33 151.61 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 N-CA-C 109.098 -0.704 . . . . 0.47 109.098 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 73.2 p -79.91 159.54 26.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.81 110.213 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 27.1 tp -60.59 -41.84 95.51 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.839 -0.8 . . . . 0.7 108.839 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -60.19 -40.06 88.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.542 -0.724 . . . . 1.25 110.194 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.68 -40.02 98.2 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 110.693 -0.963 . . . . 0.29 110.693 -179.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.8 mt -60.77 -39.97 83.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.091 -1.241 . . . . 0.35 110.798 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.471 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 28.0 m-85 -59.97 -43.84 94.84 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.709 -1.244 . . . . 1.4 110.19 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -60.0 -39.99 87.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.245 -0.909 . . . . 2.51 109.096 -179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -59.91 -50.06 75.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.657 -0.652 . . . . 1.37 110.883 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 94.7 mt -62.66 -48.33 88.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 120.95 -1.093 . . . . 0.59 111.49 -178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 32.0 mtm -60.01 -40.04 87.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.742 -1.224 . . . . 0.69 109.938 -178.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.522 ' OD1' ' NH2' ' A' ' 42' ' ' ARG . 83.1 m-20 -66.39 -47.03 74.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.063 -1.023 . . . . 1.17 110.727 -179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.085 -1.009 . . . . 3.0 111.06 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 40' ' ' PHE . 65.9 m-85 -126.1 77.22 71.62 Favored Pre-proline 0 N--CA 1.499 2.015 0 O-C-N 121.226 -0.921 . . . . 1.54 109.85 -179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -45.76 -7.42 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.576 0 C-N-CA 122.988 2.459 . . . . 1.21 112.808 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 38' ' ' PHE . 24.1 t80 -58.59 -40.03 82.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.196 -0.94 . . . . 3.74 109.091 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.425 ' O ' ' O ' ' A' ' 44' ' ' ASN . 96.8 m-85 -69.99 -23.86 63.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 1.12 111.501 -178.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.522 ' NH2' ' OD1' ' A' ' 36' ' ' ASP . 66.0 mtt-85 -60.04 -39.98 87.78 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.559 -1.338 . . . . 2.51 108.724 179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -67.2 -37.03 82.96 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.512 -0.742 . . . . 2.34 110.007 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.526 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 33.0 m120 -108.5 119.18 38.77 Favored 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.494 0.664 . . . . 2.01 111.002 -178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 64.3 mttp -119.11 15.0 13.21 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.033 -1.099 . . . . 1.68 108.033 178.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -59.07 -118.08 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.619 -0.675 . . . . 3.98 112.818 -176.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -88.79 -10.06 67.56 Favored Glycine 0 N--CA 1.495 2.573 0 O-C-N 121.18 -0.95 . . . . 0.78 112.275 -176.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.526 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 12.5 p-90 -60.03 -36.99 78.47 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.222 -1.752 . . . . 0.44 107.578 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.1 tt0 -59.99 -50.03 75.34 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.629 -0.669 . . . . 1.96 109.926 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -69.99 -39.96 75.59 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.049 -1.032 . . . . 1.28 111.047 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 89.9 p -56.86 -34.27 67.63 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.077 -1.014 . . . . 1.49 111.119 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.9 mm -59.99 -46.03 94.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.86 -1.15 . . . . 0.64 109.308 -179.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.471 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 26.6 mtt180 -72.94 -39.36 66.3 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.228 -0.92 . . . . 2.76 110.146 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 36.2 t-80 -59.98 -39.97 87.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.386 -0.821 . . . . 2.48 110.253 -178.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.53 ' OD1' ' N ' ' A' ' 56' ' ' LEU . 30.0 p30 -75.02 -25.0 58.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.901 -1.124 . . . . 2.07 110.615 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.53 ' N ' ' OD1' ' A' ' 55' ' ' ASN . 56.2 mt -64.15 -42.93 96.57 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.698 -1.251 . . . . 0.78 110.014 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.6 p -69.99 -40.56 75.23 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.996 -1.065 . . . . 1.6 110.04 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.8 mt -69.49 -40.0 77.32 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.968 -1.083 . . . . 1.38 109.389 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -75.37 118.7 18.54 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.263 -0.898 . . . . 1.42 108.898 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.77 -5.66 56.74 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.505 -0.747 . . . . 2.17 109.072 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.421 ' O ' ' OD1' ' A' ' 81' ' ' ASP . 89.5 m -60.38 -40.03 89.38 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 1.56 109.351 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -85.71 147.05 26.54 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.325 -0.859 . . . . 1.32 108.762 179.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 24.4 t -115.96 124.6 72.48 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 O-C-N 121.471 -0.768 . . . . 0.91 109.366 -179.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 17.7 ttpp -79.04 129.98 35.03 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.501 -0.926 . . . . 1.81 108.501 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.489 ' C ' ' HG ' ' A' ' 76' ' ' SER . 21.7 t -112.66 100.31 50.14 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.623 -0.673 . . . . 1.28 109.875 -178.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -51.56 167.62 0.38 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 122.149 1.899 . . . . 1.65 112.158 179.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.51 ' NE ' ' OH ' ' A' ' 77' ' ' TYR . 16.7 ttt-85 -112.17 161.5 16.48 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.517 -0.739 . . . . 4.09 109.271 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -69.01 147.39 51.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.049 -1.032 . . . . 2.84 109.675 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 48.7 m-20 -79.17 -16.92 55.9 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.366 -0.834 . . . . 3.46 109.966 -179.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 60.4 mttp -60.06 -40.01 87.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.298 -0.876 . . . . 4.5 109.6 -179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.415 ' HB3' HH12 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -121.18 85.18 41.22 Favored Pre-proline 0 N--CA 1.49 1.553 0 N-CA-C 108.378 -0.971 . . . . 5.12 108.378 179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.99 145.52 12.47 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.301 2.001 . . . . 3.63 112.066 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 167.08 -36.08 0.23 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.285 -1.526 . . . . 3.15 109.285 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 69.0 mttt -114.17 152.16 31.61 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.59 -0.947 . . . . 4.36 108.455 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.96 -77.78 0.48 Allowed Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.909 -1.138 . . . . 2.03 110.319 -179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.489 ' HG ' ' C ' ' A' ' 65' ' ' VAL . 30.7 t -158.1 170.24 22.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.157 -1.202 . . . . 1.8 109.959 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.51 ' OH ' ' NE ' ' A' ' 67' ' ' ARG . 7.2 m-85 -108.09 158.53 17.33 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.478 -0.764 . . . . 1.39 109.269 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.6 m95 -119.9 135.5 54.87 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 108.689 -0.856 . . . . 0.46 108.689 178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.9 t -150.57 160.38 43.84 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.119 -0.988 . . . . 0.56 110.025 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.4 mt -77.87 159.57 28.84 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 109.043 -0.725 . . . . 1.42 109.043 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.421 ' OD1' ' O ' ' A' ' 61' ' ' CYS . 1.4 m-20 -76.72 124.19 87.66 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.054 -1.029 . . . . 3.72 109.045 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -48.31 -72.15 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 121.211 1.274 . . . . 3.55 111.022 179.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 85' ' ' TYR . 39.8 t0 -157.72 39.77 0.28 Allowed 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.644 -1.243 . . . . 6.82 107.644 178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 48.7 m -50.13 89.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 109.18 -0.674 . . . . 6.0 109.18 -179.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.537 ' N ' ' O ' ' A' ' 83' ' ' ASP . 19.4 t80 -70.72 -48.71 53.15 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.296 -0.878 . . . . 11.0 110.067 -179.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -150.22 29.61 0.71 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.29 -0.881 . . . . 10.0 109.165 -179.463 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 66.8 mtt -84.97 132.61 34.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.517 -0.739 . . . . 8.47 110.203 -179.121 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -97.32 -0.01 47.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.367 -0.833 . . . . 11.97 109.475 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -140.15 159.1 42.95 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.386 -0.821 . . . . 11.95 110.096 -179.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 56.4 t30 -125.54 129.96 50.76 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.867 -0.79 . . . . 12.32 108.867 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -174.7 -95.68 0.1 OUTLIER Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.653 -1.379 . . . . 11.16 109.653 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 34.2 t -105.16 89.18 3.05 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.452 -1.028 . . . . 11.8 109.259 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.476 ' O ' ' CD2' ' A' ' 93' ' ' PHE . 32.6 p90 -103.48 130.79 50.92 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.519 -0.738 . . . . 10.78 109.332 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.2 mt . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.456 -0.777 . . . . 13.12 109.067 179.734 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.0 mtm . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.232 -0.655 . . . . 4.81 109.232 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 43.3 mt -86.54 144.24 27.32 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 1.71 109.835 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.4 t -141.39 164.17 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.335 -0.853 . . . . 1.79 109.183 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 9.6 mptt -87.36 148.97 45.83 Favored Pre-proline 0 N--CA 1.494 1.77 0 O-C-N 121.466 -0.771 . . . . 3.69 109.167 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -75.68 160.38 37.96 Favored 'Trans proline' 0 N--CA 1.494 1.544 0 C-N-CA 122.465 2.11 . . . . 0.73 112.203 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.19 -1.26 10.68 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.834 2.356 . . . . 0.84 113.612 -179.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -72.55 143.41 48.32 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.593 -1.317 . . . . 1.15 109.416 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 54.1 p -76.31 163.15 27.29 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.538 -0.912 . . . . 1.39 108.538 179.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -60.09 -39.93 87.85 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.924 -1.11 . . . . 1.32 108.647 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 43.9 mm -65.53 -40.02 86.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.37 -0.831 . . . . 0.96 109.062 179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.65 -40.58 92.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 0.38 110.101 -179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.4 mt -60.0 -40.22 88.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.998 -1.064 . . . . 0.37 109.128 -179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.4 mt -63.81 -44.68 98.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.176 -1.046 . . . . 0.49 108.176 178.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.1 m -60.11 -39.99 88.13 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.708 -0.62 . . . . 0.39 109.478 179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 66.9 mtt -68.2 -39.65 82.4 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.47 -0.769 . . . . 1.14 110.019 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.64 88.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.291 -0.881 . . . . 0.32 110.495 -179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 58.6 mt -60.77 -50.97 78.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.008 -1.058 . . . . 0.33 109.669 -179.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -69.99 -39.92 75.63 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.64 -0.662 . . . . 1.82 110.383 -179.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -64.14 -32.98 74.75 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.194 -0.941 . . . . 1.67 109.216 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.78 116.94 62.49 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.363 -0.836 . . . . 0.63 109.134 -179.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -46.54 -33.46 13.12 Favored 'Trans proline' 0 N--CA 1.49 1.322 0 C-N-CA 121.218 1.279 . . . . 1.29 110.696 179.314 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -100.04 113.72 26.51 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.071 -1.085 . . . . 2.63 108.071 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -69.66 -28.81 66.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.019 . . . . 2.02 110.077 -178.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 90.3 mttt -78.47 75.17 5.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.045 -1.034 . . . . 1.55 108.634 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.0 tt -100.98 147.14 8.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 N-CA-C 109.074 -0.713 . . . . 0.47 109.074 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.3 m -80.04 164.88 23.07 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.422 -0.799 . . . . 0.81 109.679 -179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 54.7 tp -59.99 -47.19 86.84 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.214 -1.032 . . . . 0.7 108.214 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.6 m-20 -60.81 -40.04 91.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.751 -0.593 . . . . 1.25 110.139 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.98 -40.01 96.39 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 110.82 -0.912 . . . . 0.29 110.82 -178.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.01 -43.91 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.941 -1.329 . . . . 0.35 109.594 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.421 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 37.7 m-85 -60.17 -40.81 91.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.141 -0.974 . . . . 1.4 110.896 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' OE1' ' OD2' ' A' ' 36' ' ' ASP . 1.0 OUTLIER -66.85 -39.97 87.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.917 -1.114 . . . . 2.51 109.821 -179.454 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -60.03 -46.62 88.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 1.37 111.014 -179.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.99 -41.11 85.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 121.035 -1.04 . . . . 0.59 110.675 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 30.7 mtt -60.12 -39.98 88.14 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.043 -1.036 . . . . 0.69 110.36 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.409 ' OD2' ' OE1' ' A' ' 32' ' ' GLN . 96.7 m-20 -68.92 -52.86 24.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.316 -0.865 . . . . 1.17 111.646 -178.252 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -69.97 -42.89 72.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.873 -1.142 . . . . 3.0 110.07 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 60.4 m-85 -114.99 101.51 54.57 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 108.318 -0.993 . . . . 1.54 108.318 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -80.46 -6.4 13.64 Favored 'Trans proline' 0 N--CA 1.492 1.411 0 C-N-CA 121.958 1.772 . . . . 1.21 112.717 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.506 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.3 OUTLIER -60.0 -36.74 77.85 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 107.883 -1.154 . . . . 3.74 107.883 179.517 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -64.5 -25.28 67.92 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 115.844 -0.616 . . . . 1.12 110.402 -179.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -60.04 -40.46 89.49 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.927 -1.108 . . . . 2.51 109.523 179.788 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -70.09 -39.98 75.26 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.198 -0.939 . . . . 2.34 109.524 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 12.0 t-20 -103.61 100.8 10.65 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.553 -0.906 . . . . 2.01 108.553 179.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.425 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 99.6 mttt -94.59 -68.33 0.81 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.204 -0.935 . . . . 1.68 110.513 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -64.03 139.99 58.82 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.963 -1.085 . . . . 3.98 110.327 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.55 -60.42 0.41 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 110.611 -0.996 . . . . 0.78 110.611 178.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.425 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 37.1 p-90 -84.85 -27.81 26.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.117 -1.225 . . . . 0.44 110.712 -178.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.421 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 93.1 mt-30 -60.36 -42.56 96.02 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.198 -0.939 . . . . 1.96 112.027 -178.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 97.0 m-20 -76.92 -33.92 57.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.711 -1.243 . . . . 1.28 111.8 -178.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.401 ' O ' ' ND2' ' A' ' 55' ' ' ASN . 29.1 t -59.89 -40.11 87.65 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.858 -1.151 . . . . 1.49 111.406 -178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 47.5 mm -62.95 -59.12 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.04 -1.037 . . . . 0.64 111.711 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.9 ptt180 -70.05 -33.53 72.06 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.846 -1.159 . . . . 2.76 110.667 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -59.97 -40.03 87.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 2.48 109.356 179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.401 ' ND2' ' O ' ' A' ' 51' ' ' SER . 94.4 m-20 -70.03 -21.52 63.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.444 -0.785 . . . . 2.07 111.169 -178.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.4 mt -59.96 -50.02 75.4 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.748 -1.22 . . . . 0.78 110.49 -178.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 53.8 m -60.02 -40.01 87.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.971 -1.081 . . . . 1.6 109.727 -179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.463 ' N ' HD12 ' A' ' 58' ' ' LEU . 11.2 mp -66.28 -39.99 89.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.194 -0.941 . . . . 1.38 109.06 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -77.59 113.97 15.95 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.424 -0.797 . . . . 1.42 109.887 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -89.99 -6.21 55.87 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.619 -0.882 . . . . 2.17 108.619 179.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 27.9 p -62.68 -37.74 87.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.601 -0.687 . . . . 1.56 109.835 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -78.37 156.53 29.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.109 -0.995 . . . . 1.32 108.582 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.2 t -120.16 129.96 74.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.464 -0.772 . . . . 0.91 109.608 -179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.94 142.92 52.84 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.183 -0.948 . . . . 1.81 109.501 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 57.8 t -127.11 88.2 54.82 Favored Pre-proline 0 N--CA 1.494 1.751 0 N-CA-C 108.487 -0.931 . . . . 1.28 108.487 179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 88.0 Cg_exo -45.46 175.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 121.994 1.796 . . . . 1.65 112.032 -179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.773 HH11 ' H ' ' A' ' 74' ' ' LYS . 82.8 mtm180 -98.3 156.83 16.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.437 -0.79 . . . . 4.09 109.795 -179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.3 m-20 -65.89 166.26 11.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.384 -0.823 . . . . 2.84 109.407 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -52.56 -32.87 43.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.913 . . . . 3.46 108.559 179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -84.61 58.16 4.75 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.771 -1.196 . . . . 4.5 107.771 178.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.583 ' HZ3' HH12 ' A' ' 67' ' ' ARG . 0.0 OUTLIER -77.0 130.67 74.89 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.684 -0.635 . . . . 5.12 109.295 -179.084 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -83.9 2.92 7.97 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.007 1.805 . . . . 3.63 113.056 -179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.58 55.64 1.64 Allowed Glycine 0 N--CA 1.494 2.541 0 N-CA-C 109.775 -1.33 . . . . 3.15 109.775 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.773 ' H ' HH11 ' A' ' 67' ' ' ARG . 57.0 mtpt -131.67 170.19 15.13 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.643 -0.916 . . . . 4.36 108.991 179.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -69.7 179.27 26.85 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.554 -1.418 . . . . 2.03 109.554 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 80.2 p -79.12 143.72 35.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.159 -1.201 . . . . 1.8 108.934 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -80.19 156.17 27.06 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.08 -1.013 . . . . 1.39 108.889 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -119.96 140.03 51.55 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.529 -0.732 . . . . 0.46 109.904 -178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 9.6 t -145.04 160.38 41.47 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.288 -0.883 . . . . 0.56 109.782 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 90.4 mt -75.94 169.88 17.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.212 -0.93 . . . . 1.42 108.785 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -58.18 147.88 64.42 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.085 -1.009 . . . . 3.72 108.767 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.508 ' O ' ' N ' ' A' ' 84' ' ' SER . 46.3 Cg_endo -66.82 -154.84 0.03 OUTLIER 'Trans proline' 0 N--CA 1.497 1.719 0 C-N-CA 122.557 2.171 . . . . 3.55 112.422 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -67.69 52.6 0.06 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.247 -0.908 . . . . 6.82 108.939 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.508 ' N ' ' O ' ' A' ' 82' ' ' PRO . 10.0 t -60.28 -37.56 80.88 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.456 -0.778 . . . . 6.0 109.833 -179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.417 ' CD1' ' N ' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -57.02 -46.32 82.44 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.911 -1.118 . . . . 11.0 108.051 -179.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 58.4 t30 -143.36 84.58 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.459 -0.775 . . . . 10.0 108.914 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.5 ' O ' ' SD ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -91.09 115.57 28.12 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.751 -0.593 . . . . 8.47 109.435 -179.604 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -60.9 -40.09 91.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.168 -0.958 . . . . 11.97 108.764 179.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -67.79 159.87 29.4 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.469 -0.769 . . . . 11.95 109.673 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -60.65 149.86 33.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.914 . . . . 12.32 108.994 179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.62 -116.28 0.51 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.838 -1.305 . . . . 11.16 109.838 -179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 84.6 p -60.14 -39.59 86.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.358 -1.084 . . . . 11.8 110.183 -179.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.522 ' C ' HD22 ' A' ' 94' ' ' LEU . 63.0 t80 -86.31 119.65 26.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.923 -1.111 . . . . 10.78 110.104 -179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 93' ' ' PHE . 3.9 mm? . . . . . 0 N--CA 1.497 1.884 0 N-CA-C 108.107 -1.072 . . . . 13.12 108.107 179.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtt . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.416 -0.587 . . . . 4.81 109.416 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 80.2 mt -70.24 139.99 52.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.313 -0.867 . . . . 1.71 109.515 -179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.4 m -140.53 147.72 22.83 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.335 -0.853 . . . . 1.79 109.639 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -82.67 129.51 62.1 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 3.69 108.664 179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -78.95 152.28 24.68 Favored 'Trans proline' 0 N--CA 1.493 1.48 0 C-N-CA 121.649 1.566 . . . . 0.73 112.551 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -76.34 -2.48 12.68 Favored 'Trans proline' 0 N--CA 1.496 1.671 0 C-N-CA 122.63 2.22 . . . . 0.84 113.25 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 21.9 m-85 -64.95 143.65 57.81 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.796 -1.19 . . . . 1.15 109.748 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 45.7 t -79.79 165.93 22.25 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.142 -1.058 . . . . 1.39 108.142 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.4 m-85 -59.92 -40.07 87.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.795 -1.19 . . . . 1.32 109.003 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 88.0 mt -68.12 -40.03 82.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.346 -0.846 . . . . 0.96 109.957 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.51 92.74 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.952 -1.092 . . . . 0.38 109.902 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.08 -45.17 93.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.768 -1.208 . . . . 0.37 108.332 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.452 ' CD1' HD21 ' A' ' 55' ' ' ASN . 98.1 mt -63.91 -45.81 95.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 108.971 -0.751 . . . . 0.49 108.971 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.91 -40.61 98.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.431 -0.793 . . . . 0.39 110.573 -179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.532 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.5 mtm -70.04 -39.12 75.92 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.823 -1.173 . . . . 1.14 109.529 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.34 -45.9 90.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.555 -0.715 . . . . 0.32 110.501 -178.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 77.0 mt -60.54 -49.89 82.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.979 -1.076 . . . . 0.33 108.656 -179.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 23.7 mm100 -61.48 -39.94 92.73 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 121.366 0.603 . . . . 1.82 109.494 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 15' ' ' MET . 76.2 m-20 -78.32 -6.06 53.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.41 -0.806 . . . . 1.67 110.37 -179.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.34 126.47 83.16 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.088 -1.008 . . . . 0.63 109.639 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -41.24 -20.71 0.1 Allowed 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.688 1.592 . . . . 1.29 110.931 179.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.532 ' N ' ' O ' ' A' ' 20' ' ' ALA . 13.4 pt-20 -138.5 141.92 39.36 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.141 -1.059 . . . . 2.63 108.141 178.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 28.3 mmtp -60.59 -34.66 74.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.98 -1.075 . . . . 2.02 109.111 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -78.68 118.42 20.75 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.865 . . . . 1.55 109.42 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 11.7 tt -135.69 158.6 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 O-C-N 121.338 -0.851 . . . . 0.47 109.513 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 25.4 p -86.5 161.8 18.4 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.242 -0.911 . . . . 0.81 111.041 -178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 27' ' ' LEU . 20.1 tp -61.12 -50.26 73.92 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.185 0.993 . . . . 0.7 109.002 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -59.97 -39.84 87.06 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.978 -0.556 . . . . 1.25 110.434 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -56.94 -39.94 89.79 Favored Glycine 0 N--CA 1.492 2.393 0 C-N-CA 120.004 -1.094 . . . . 0.29 110.404 -179.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.7 mt -60.8 -40.87 86.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 120.938 -1.331 . . . . 0.35 110.272 -179.498 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' OH ' ' O ' ' A' ' 49' ' ' GLN . 25.1 m-85 -60.03 -40.18 88.46 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.016 -1.052 . . . . 1.4 111.142 -179.084 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -63.34 -37.59 87.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.976 -1.077 . . . . 2.51 110.963 -179.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 t80 -60.01 -45.17 93.63 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.17 -0.956 . . . . 1.37 110.76 -178.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.8 mt -69.81 -52.87 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.035 -1.041 . . . . 0.59 112.039 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 63.6 mtm -61.45 -39.97 92.77 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 0.69 111.283 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -62.34 -50.49 71.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.967 -1.083 . . . . 1.17 110.847 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 62.1 mtt-85 -69.97 -39.98 75.67 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.068 -1.02 . . . . 3.0 111.382 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.555 ' C ' ' H ' ' A' ' 40' ' ' PHE . 89.7 m-85 -122.32 83.04 46.05 Favored Pre-proline 0 N--CA 1.499 2.018 0 O-C-N 121.364 -0.835 . . . . 1.54 110.34 -179.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -52.11 -3.93 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.248 1.966 . . . . 1.21 110.758 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.555 ' H ' ' C ' ' A' ' 38' ' ' PHE . 24.2 t80 -59.98 -39.99 87.59 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.653 -0.869 . . . . 3.74 108.653 179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -70.0 -29.7 66.84 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.577 -0.702 . . . . 1.12 110.655 -179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -60.07 -39.9 87.67 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.841 -1.162 . . . . 2.51 109.714 -179.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -62.4 -40.34 96.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.977 -1.077 . . . . 2.34 109.847 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -111.19 77.27 1.03 Allowed 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.397 -0.594 . . . . 2.01 109.397 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mttp -69.77 -40.03 76.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 120.945 -1.097 . . . . 1.68 110.04 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 98.4 mt-30 -76.67 148.08 37.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.237 -0.915 . . . . 3.98 110.41 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.83 -61.65 0.35 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.323 -1.111 . . . . 0.78 110.323 179.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -89.98 -10.3 45.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.113 -1.227 . . . . 0.44 110.786 -178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' O ' ' OH ' ' A' ' 31' ' ' TYR . 62.8 tt0 -65.58 -56.79 10.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.931 -1.106 . . . . 1.96 110.754 -178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -70.11 -31.76 69.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.942 -1.099 . . . . 1.28 110.603 -179.13 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 t -58.51 -39.55 80.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.288 -0.882 . . . . 1.49 110.539 -178.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.469 ' O ' ' OD1' ' A' ' 55' ' ' ASN . 5.4 mm -60.09 -49.77 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.137 -0.977 . . . . 0.64 110.236 -178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.7 mtp180 -70.05 -36.01 74.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.705 -1.247 . . . . 2.76 110.426 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -59.92 -40.25 88.23 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.015 -1.053 . . . . 2.48 109.797 -179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.548 ' ND2' ' N ' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -67.77 -39.99 84.07 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.511 -1.276 . . . . 2.07 108.396 179.454 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.548 ' N ' ' ND2' ' A' ' 55' ' ' ASN . 54.2 mt -60.07 -48.66 80.79 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.317 -0.864 . . . . 0.78 110.353 179.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.5 p -70.05 -41.3 74.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.121 -0.987 . . . . 1.6 110.45 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.2 mt -69.09 -40.15 78.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.06 -1.025 . . . . 1.38 109.541 -179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -74.14 119.51 18.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.252 -0.905 . . . . 1.42 108.723 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -84.76 -9.84 57.8 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.454 -0.779 . . . . 2.17 109.651 -179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 92.0 m -60.09 -39.96 87.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.381 -0.824 . . . . 1.56 109.413 179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -78.77 140.67 38.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.189 -0.944 . . . . 1.32 108.824 -179.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.56 130.1 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 O-C-N 121.498 -0.751 . . . . 0.91 109.762 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 8.3 mtpm? -73.64 135.57 43.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.236 -0.915 . . . . 1.81 109.211 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 77' ' ' TYR . 77.2 t -130.18 126.55 22.33 Favored Pre-proline 0 N--CA 1.496 1.86 0 N-CA-C 108.882 -0.785 . . . . 1.28 108.882 -179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo -82.82 170.9 12.26 Favored 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 121.693 1.595 . . . . 1.65 112.263 179.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.534 ' NH1' ' OH ' ' A' ' 77' ' ' TYR . 20.5 mtt-85 -69.39 -107.53 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.352 -0.843 . . . . 4.09 109.383 179.403 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.2 p-10 -148.1 169.91 18.96 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.654 -0.653 . . . . 2.84 109.312 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -66.34 -33.42 75.69 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.308 -0.87 . . . . 3.46 110.492 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -60.02 -39.98 87.73 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.12 -0.988 . . . . 4.5 110.547 -178.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -119.39 118.02 32.68 Favored Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 121.393 -0.817 . . . . 5.12 109.106 179.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -41.59 163.75 0.03 OUTLIER 'Trans proline' 0 N--CA 1.49 1.313 0 C-N-CA 121.641 1.561 . . . . 3.63 112.133 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.04 76.85 0.57 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.737 -1.345 . . . . 3.15 109.737 -179.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 60.3 mttp -60.04 -39.95 87.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.307 -1.114 . . . . 4.36 108.645 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -144.77 160.46 27.98 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 108.654 -1.778 . . . . 2.03 108.654 179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 10.6 t -99.03 119.39 37.71 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.146 -1.208 . . . . 1.8 109.505 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.534 ' OH ' ' NH1' ' A' ' 67' ' ' ARG . 9.5 m-30 -75.37 148.9 38.85 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.333 -0.854 . . . . 1.39 108.944 179.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.4 m95 -119.97 141.99 49.18 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.692 -0.63 . . . . 0.46 109.689 -179.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.6 t -143.03 160.04 41.13 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.21 -0.931 . . . . 0.56 109.37 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 89.0 mt -86.94 136.6 32.88 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.173 -0.954 . . . . 1.42 109.909 -179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -74.27 133.75 77.64 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 3.72 109.043 179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -79.18 -162.46 0.18 Allowed 'Trans proline' 0 N--CA 1.491 1.347 0 C-N-CA 121.622 1.548 . . . . 3.55 111.475 179.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -83.35 45.8 1.07 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.213 -0.93 . . . . 6.82 108.883 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 40.1 t -52.91 -31.16 38.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.411 -0.806 . . . . 6.0 109.852 -179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -60.22 -39.3 86.12 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.248 -0.908 . . . . 11.0 109.462 -179.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -86.91 9.21 20.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.28 -0.887 . . . . 10.0 111.313 -178.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 12.1 mmt -81.28 143.39 32.3 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.807 -1.183 . . . . 8.47 109.661 179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -150.03 -139.07 0.09 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.409 -0.807 . . . . 11.97 108.864 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 53.4 mp0 -91.66 10.56 27.67 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.032 -1.042 . . . . 11.95 110.213 -179.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -127.32 135.83 51.09 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.515 -0.74 . . . . 12.32 109.301 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -164.55 89.23 0.1 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.813 -1.315 . . . . 11.16 109.813 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.9 m -99.61 14.18 30.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.373 -1.075 . . . . 11.8 109.252 179.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 36.2 t80 -60.05 -49.9 75.84 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 10.78 109.56 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 53.3 mt . . . . . 0 N--CA 1.499 1.991 0 N-CA-C 108.406 -0.961 . . . . 13.12 108.406 178.886 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 ptp . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.588 0.708 . . . . 4.81 109.458 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 72.0 mt -118.27 142.26 47.67 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 109.222 -0.658 . . . . 1.71 109.222 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.9 m -137.84 160.01 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.311 -0.868 . . . . 1.79 109.785 179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 52.1 mtpt -86.31 117.29 68.45 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.337 -0.852 . . . . 3.69 109.049 179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_exo -50.33 151.39 9.74 Favored 'Trans proline' 0 N--CA 1.494 1.504 0 C-N-CA 121.249 1.299 . . . . 0.73 111.384 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -76.4 -5.61 16.31 Favored 'Trans proline' 0 N--CA 1.494 1.549 0 C-N-CA 122.313 2.009 . . . . 0.84 112.84 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -69.98 142.06 52.89 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.022 -1.049 . . . . 1.15 109.792 -179.565 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 48.8 m -70.89 160.58 32.55 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.774 -0.825 . . . . 1.39 108.774 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 53.3 m-85 -60.01 -39.97 87.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.046 . . . . 1.32 108.748 -179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.7 mt -69.48 -39.54 78.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.223 -0.923 . . . . 0.96 109.036 179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.96 -42.42 94.05 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.321 -0.862 . . . . 0.38 110.291 -179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.5 mt -60.05 -39.94 87.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.983 -1.073 . . . . 0.37 108.895 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.68 -39.99 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.451 0 O-C-N 121.488 -0.758 . . . . 0.49 108.98 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -65.28 -40.05 93.37 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.509 -0.745 . . . . 0.39 110.499 -179.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.0 mtm -69.96 -37.78 75.9 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.156 -0.965 . . . . 1.14 109.792 -179.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.99 -46.18 90.3 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.341 -0.849 . . . . 0.32 110.048 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.5 mt -59.96 -49.58 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.217 -0.927 . . . . 0.33 108.672 -179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -67.74 -39.63 84.22 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.916 -0.584 . . . . 1.82 110.731 -179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -67.63 -19.46 65.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.158 -0.963 . . . . 1.67 109.844 -178.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.58 150.12 75.77 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.232 -0.917 . . . . 0.63 109.292 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_endo -59.79 -52.14 4.91 Favored 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 121.653 1.568 . . . . 1.29 109.578 179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -100.95 135.99 41.51 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 107.066 -1.457 . . . . 2.63 107.066 177.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -64.53 -19.16 65.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.784 -1.198 . . . . 2.02 109.538 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -79.13 126.13 30.32 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.971 -1.081 . . . . 1.55 108.9 179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 13.8 tt -150.16 152.17 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.229 -0.919 . . . . 0.47 109.532 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 65.9 p -79.97 158.74 26.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.197 -0.939 . . . . 0.81 109.659 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.496 HD21 ' NE ' ' A' ' 53' ' ' ARG . 57.1 tp -60.08 -42.99 95.8 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 107.994 -1.113 . . . . 0.7 107.994 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.3 m120 -62.77 -40.0 95.92 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.643 -0.66 . . . . 1.25 110.544 179.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.29 -37.38 91.8 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.656 -1.378 . . . . 0.29 109.656 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 88.3 mt -60.24 -39.97 82.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -1.137 . . . . 0.35 110.064 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.503 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 27.1 m-85 -64.38 -39.45 93.89 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 120.703 -1.248 . . . . 1.4 110.335 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -59.91 -40.54 89.17 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.866 -1.146 . . . . 2.51 108.972 -178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 64.4 t80 -61.9 -50.05 73.75 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.309 -0.869 . . . . 1.37 110.875 -179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 78.5 mt -60.67 -50.16 81.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.089 -1.007 . . . . 0.59 112.175 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 53.6 mtm -60.64 -40.09 90.71 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 0.69 110.514 -178.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -65.32 -48.49 72.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.022 -1.049 . . . . 1.17 111.38 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 mmt180 -69.75 -43.38 72.39 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.775 -1.203 . . . . 3.0 109.87 -179.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -117.37 111.97 39.72 Favored Pre-proline 0 N--CA 1.497 1.893 0 N-CA-C 108.548 -0.908 . . . . 1.54 108.548 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.97 -5.76 14.72 Favored 'Trans proline' 0 N--CA 1.494 1.548 0 C-N-CA 121.873 1.715 . . . . 1.21 112.345 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -60.01 -38.13 81.75 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.371 -0.831 . . . . 3.74 109.418 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -69.91 -23.29 63.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.107 -0.996 . . . . 1.12 110.612 -178.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 mtp180 -59.97 -40.37 88.82 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.897 -1.127 . . . . 2.51 109.543 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.5 tp10 -62.5 -41.05 98.56 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.228 -0.92 . . . . 2.34 110.146 -179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -115.06 98.54 6.85 Favored 'General case' 0 N--CA 1.497 1.906 0 N-CA-C 109.412 -0.588 . . . . 2.01 109.412 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.492 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 61.4 mttp -85.21 -31.79 23.0 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.211 -0.93 . . . . 1.68 109.657 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.2 mm-40 -90.39 145.01 25.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.339 -0.851 . . . . 3.98 110.733 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 106.34 -63.92 0.29 Allowed Glycine 0 N--CA 1.494 2.551 0 N-CA-C 110.726 -0.95 . . . . 0.78 110.726 178.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.492 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 36.7 p-90 -73.08 -34.84 66.47 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.979 -1.306 . . . . 0.44 111.894 -178.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -60.61 -40.89 93.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.702 -1.249 . . . . 1.96 110.811 -178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -64.27 -40.03 95.14 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.876 -1.14 . . . . 1.28 110.607 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 56.2 m -60.81 -40.02 91.16 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.069 -1.019 . . . . 1.49 111.1 -178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 43.7 mm -60.14 -47.97 89.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.041 -1.037 . . . . 0.64 110.832 -179.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.503 ' CG ' ' OH ' ' A' ' 31' ' ' TYR . 13.3 mtp180 -69.84 -37.7 76.25 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.002 -1.061 . . . . 2.76 109.875 -178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.505 ' NE2' HD11 ' A' ' 58' ' ' LEU . 74.9 t60 -59.99 -41.88 93.01 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.368 -0.832 . . . . 2.48 109.675 -179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -64.18 -40.01 95.2 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.245 -0.909 . . . . 2.07 109.62 179.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 85.9 mt -60.01 -40.86 90.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.208 -0.933 . . . . 0.78 110.483 -178.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 90.6 p -69.07 -44.66 72.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.93 -1.106 . . . . 1.6 110.64 -179.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.505 HD11 ' NE2' ' A' ' 54' ' ' HIS . 82.2 mt -70.06 -40.0 75.32 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.042 -1.036 . . . . 1.38 110.027 -179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -74.66 116.11 14.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.899 -1.126 . . . . 1.42 108.943 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -90.87 -3.52 57.29 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.332 -0.855 . . . . 2.17 110.351 -179.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 26.0 p -70.1 -17.9 63.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.991 -1.068 . . . . 1.56 110.172 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -78.29 153.61 31.64 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.991 -1.068 . . . . 1.32 109.132 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 37.9 t -110.06 128.19 66.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 N-CA-C 108.534 -0.913 . . . . 0.91 108.534 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 61.9 mttt -96.85 115.57 27.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.23 -0.919 . . . . 1.81 108.876 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.76 118.43 44.92 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 107.485 -1.302 . . . . 1.28 107.485 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -78.16 -169.49 0.78 Allowed 'Trans proline' 0 N--CA 1.492 1.429 0 C-N-CA 121.714 1.609 . . . . 1.65 113.043 -178.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.515 HH11 ' HG3' ' A' ' 67' ' ' ARG . 3.7 ptm180 -139.64 -164.76 1.74 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.577 -0.897 . . . . 4.09 108.577 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -69.08 147.09 51.99 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.844 -1.16 . . . . 2.84 109.517 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -70.07 -11.57 60.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.371 -0.831 . . . . 3.46 110.207 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.04 -38.89 84.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.165 -0.959 . . . . 4.5 110.224 -178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.509 ' HZ2' ' HB2' ' A' ' 71' ' ' LYS . 8.7 mtmp? -122.3 81.12 45.32 Favored Pre-proline 0 N--CA 1.498 1.929 0 O-C-N 121.359 -0.838 . . . . 5.12 110.171 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -81.81 -0.57 10.44 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.405 2.07 . . . . 3.63 111.618 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.76 -42.73 95.06 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.499 -1.44 . . . . 3.15 109.499 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -77.19 140.81 40.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -1.159 . . . . 4.36 109.193 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -67.03 -177.59 9.18 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.26 -1.536 . . . . 2.03 109.26 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.4 m -80.33 159.73 25.69 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.175 -1.191 . . . . 1.8 109.682 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -70.92 150.98 45.18 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.37 -0.831 . . . . 1.39 109.653 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 80.1 m95 -121.02 130.7 53.9 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.599 -0.688 . . . . 0.46 109.437 179.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.1 t -159.95 164.28 33.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.432 -0.792 . . . . 0.56 109.193 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 81.5 mt -103.96 65.65 0.82 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.319 -0.863 . . . . 1.42 109.09 179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -152.72 83.5 4.81 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.166 -0.959 . . . . 3.72 110.583 -179.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.428 ' O ' ' OD1' ' A' ' 83' ' ' ASP . 31.4 Cg_exo -57.06 -77.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.572 2.181 . . . . 3.55 112.186 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.428 ' OD1' ' O ' ' A' ' 82' ' ' PRO . 63.8 m-20 -155.64 41.56 0.41 Allowed 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 107.943 -1.132 . . . . 6.82 107.943 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 65.5 m -59.97 -39.8 86.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.703 -0.623 . . . . 6.0 110.632 -178.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -57.49 -29.54 64.36 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.66 -1.275 . . . . 11.0 109.462 -179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 67.6 m-80 -77.7 -7.37 56.39 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.12 -0.987 . . . . 10.0 109.744 -179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 61.3 mtt -90.69 104.24 16.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.512 -0.743 . . . . 8.47 109.041 179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -92.98 -0.06 57.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.128 -0.983 . . . . 11.97 109.911 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -98.47 155.6 17.17 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.198 -0.939 . . . . 11.95 109.777 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 38.4 p-10 -90.58 10.73 24.39 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.365 -0.834 . . . . 12.32 109.948 -179.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 170.52 70.01 0.04 OUTLIER Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.921 -1.672 . . . . 11.16 108.921 -179.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 t -72.37 -69.27 0.41 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.475 -1.015 . . . . 11.8 109.537 -179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 45.4 t80 -72.92 -31.84 64.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.287 -0.883 . . . . 10.78 109.863 -179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 85.8 mt . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.176 -0.953 . . . . 13.12 109.872 -178.668 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.448 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.333 -0.617 . . . . 4.81 109.333 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 65.9 mt -101.31 141.33 34.34 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.36 -0.837 . . . . 1.71 109.878 -179.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.02 160.01 41.49 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.578 -0.701 . . . . 1.79 109.457 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.2 mtmp? -71.19 149.07 94.29 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 3.69 109.435 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.413 ' O ' ' N ' ' A' ' 7' ' ' TYR . 93.1 Cg_endo -78.21 138.45 16.05 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 122.179 1.92 . . . . 0.73 111.833 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -39.79 -23.36 0.11 Allowed 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 122.613 2.209 . . . . 0.84 113.871 -179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.413 ' N ' ' O ' ' A' ' 5' ' ' PRO . 3.6 m-85 -59.96 137.44 58.08 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 1.15 110.139 -178.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 44.2 p -83.1 173.82 11.37 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.506 -0.746 . . . . 1.39 109.014 179.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -62.94 -37.94 89.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.192 -0.943 . . . . 1.32 109.113 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 44.3 mm -68.22 -41.28 83.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 0.96 109.741 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.24 -39.43 86.18 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.201 -0.937 . . . . 0.38 110.533 -179.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 79.8 mt -60.11 -39.86 87.69 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.238 -1.023 . . . . 0.37 108.238 -179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.513 HD13 HD21 ' A' ' 56' ' ' LEU . 97.0 mt -66.44 -45.36 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.355 -0.841 . . . . 0.49 109.184 178.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 93.9 m -62.89 -42.91 99.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.528 -0.732 . . . . 0.39 111.066 -178.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.545 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 76.9 mtm -70.0 -40.01 75.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.94 -1.1 . . . . 1.14 110.862 -179.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.409 ' HA ' HD21 ' A' ' 19' ' ' ASN . . . -54.69 -43.29 72.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.101 -1.0 . . . . 0.32 109.449 -179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 84.9 mt -59.93 -45.97 94.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.492 -0.929 . . . . 0.33 108.492 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -60.0 -45.07 93.94 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.193 0.52 . . . . 1.82 110.501 -179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.545 ' ND2' ' O ' ' A' ' 15' ' ' MET . 15.6 p30 -91.11 15.44 11.69 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.866 -1.146 . . . . 1.67 109.874 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.37 129.5 74.64 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.064 -1.023 . . . . 0.63 108.521 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -40.6 -38.05 2.42 Favored 'Trans proline' 0 N--CA 1.491 1.361 0 C-N-CA 121.544 1.496 . . . . 1.29 110.885 179.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 41.1 mp0 -124.54 154.23 40.91 Favored 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 107.253 -1.388 . . . . 2.63 107.253 177.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.782 -1.199 . . . . 2.02 108.489 -179.539 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -90.64 125.84 35.77 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.14 -0.975 . . . . 1.55 109.031 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 15.8 tt -132.48 158.16 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.441 -0.787 . . . . 0.47 109.491 -179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 27.0 p -81.93 158.51 23.9 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 0.81 110.022 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 17.5 tp -59.97 -49.0 79.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.488 -0.758 . . . . 0.7 109.005 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -59.95 -39.57 86.04 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.541 -0.724 . . . . 1.25 109.843 179.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.58 -40.16 96.0 Favored Glycine 0 N--CA 1.492 2.42 0 C-N-CA 120.285 -0.96 . . . . 0.29 110.946 -178.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 84.3 mt -60.71 -42.45 92.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 120.841 -1.388 . . . . 0.35 109.555 -179.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.1 m-85 -60.94 -40.93 95.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.223 -0.923 . . . . 1.4 110.94 -178.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -59.97 -40.07 87.83 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.244 -0.91 . . . . 2.51 109.5 -179.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 79.5 t80 -59.92 -47.79 84.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.16 -0.962 . . . . 1.37 109.771 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 74.7 mt -59.97 -50.07 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.264 -0.897 . . . . 0.59 110.576 -179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.6 mtm -63.86 -39.9 95.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.879 -1.138 . . . . 0.69 110.216 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -66.11 -40.1 90.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.109 -0.994 . . . . 1.17 109.519 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -69.12 -54.05 17.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.33 -0.856 . . . . 3.0 110.351 -179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -110.71 123.56 35.26 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.463 -0.773 . . . . 1.54 109.912 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -77.84 -6.34 15.93 Favored 'Trans proline' 0 N--CA 1.493 1.474 0 C-N-CA 122.011 1.807 . . . . 1.21 111.197 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -60.03 -44.56 94.54 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-O 121.505 0.669 . . . . 3.74 109.541 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -70.07 -27.17 64.4 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.495 -0.753 . . . . 1.12 110.649 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 52.3 mtp180 -60.03 -39.77 87.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.849 -1.157 . . . . 2.51 108.581 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.32 -2.7 29.54 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.243 -0.911 . . . . 2.34 109.401 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.532 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 21.5 t-20 -144.47 98.54 3.22 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.548 -0.72 . . . . 2.01 109.104 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 56.3 mtpt -98.04 -32.93 11.38 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.192 -0.942 . . . . 1.68 110.626 -179.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 97.9 mt-30 -87.84 143.11 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.876 -1.14 . . . . 3.98 110.398 -179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.61 -72.15 0.27 Allowed Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.096 -1.201 . . . . 0.78 110.096 179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.532 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 18.8 p-90 -69.96 -39.35 76.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.208 -1.172 . . . . 0.44 110.874 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.727 HE21 ' NH2' ' A' ' 53' ' ' ARG . 53.5 tt0 -59.99 -50.07 75.17 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.148 -0.97 . . . . 1.96 110.978 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -73.49 -31.69 63.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.936 -1.103 . . . . 1.28 110.044 -179.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.8 m -59.93 -40.21 88.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 1.49 110.258 -178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.462 HG23 HD11 ' A' ' 13' ' ' ILE . 17.0 mt -69.88 -43.62 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 120.796 -1.19 . . . . 0.64 109.138 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.727 ' NH2' HE21 ' A' ' 49' ' ' GLN . 67.2 mtt180 -59.99 -47.18 86.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.718 -1.239 . . . . 2.76 108.417 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.454 ' NE2' HD11 ' A' ' 58' ' ' LEU . 84.1 t60 -60.8 -40.03 91.13 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.467 -0.938 . . . . 2.48 108.467 179.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -64.07 -39.94 95.18 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 108.861 -0.792 . . . . 2.07 108.861 179.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.513 HD21 HD13 ' A' ' 13' ' ' ILE . 32.5 mt -59.99 -45.87 91.31 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.477 -0.764 . . . . 0.78 110.105 -179.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 69.9 m -62.35 -42.44 99.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.902 -1.124 . . . . 1.6 109.337 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.454 HD11 ' NE2' ' A' ' 54' ' ' HIS . 51.6 mt -70.02 -37.22 75.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.371 -0.83 . . . . 1.38 109.775 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -69.18 117.84 11.32 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 1.42 109.898 -179.145 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -90.7 -10.96 41.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.423 -0.798 . . . . 2.17 108.962 179.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 86.1 m -59.94 -40.04 87.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.425 -0.797 . . . . 1.56 109.673 -179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -79.48 146.19 32.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.297 -0.877 . . . . 1.32 109.119 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.98 125.35 67.18 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 108.175 -1.046 . . . . 0.91 108.175 179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.448 ' NZ ' ' CB ' ' A' ' 64' ' ' LYS . 0.1 OUTLIER -77.42 135.57 38.31 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.201 -0.937 . . . . 1.81 109.903 -178.64 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -134.43 139.02 31.48 Favored Pre-proline 0 N--CA 1.498 1.927 0 N-CA-C 108.642 -0.873 . . . . 1.28 108.642 179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -79.41 -155.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.494 1.547 0 C-N-CA 122.254 1.969 . . . . 1.65 112.36 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.405 ' HG2' ' NH1' ' A' ' 67' ' ' ARG . 20.0 ptt-85 -140.85 169.49 17.52 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.398 -0.814 . . . . 4.09 108.876 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -60.03 145.49 46.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.043 -1.035 . . . . 2.84 109.316 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -70.08 -19.87 63.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.319 -0.863 . . . . 3.46 109.998 -179.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 58.7 mttm -71.17 -9.33 57.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 4.5 110.259 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.2 mtmt -130.07 75.3 79.6 Favored Pre-proline 0 N--CA 1.497 1.922 0 O-C-N 121.301 -0.875 . . . . 5.12 110.218 -179.421 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -86.71 179.59 3.32 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.995 2.463 . . . . 3.63 111.585 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.1 12.7 83.01 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.808 -1.317 . . . . 3.15 109.808 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 24.5 mttp -122.05 157.54 31.17 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.618 -0.93 . . . . 4.36 109.117 -179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -74.0 -178.11 37.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.338 -1.105 . . . . 2.03 110.338 -179.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.4 t -80.0 143.25 34.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.42 -1.047 . . . . 1.8 110.093 -179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 8.7 m-30 -79.98 159.66 26.19 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.397 -0.814 . . . . 1.39 109.509 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -132.15 151.53 51.74 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.366 -0.834 . . . . 0.46 109.492 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.5 t -149.99 169.98 19.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 120.967 -1.083 . . . . 0.56 110.347 -179.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.8 mt -78.44 161.46 27.09 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 1.42 110.551 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -67.35 166.98 16.93 Favored Pre-proline 0 N--CA 1.49 1.562 0 N-CA-C 108.991 -0.744 . . . . 3.72 108.991 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -59.83 -136.75 0.0 OUTLIER 'Trans proline' 0 N--CA 1.497 1.705 0 C-N-CA 121.718 1.612 . . . . 3.55 111.686 -179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' CD1' ' A' ' 85' ' ' TYR . 35.5 p-10 -71.16 -0.7 10.31 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.102 -1.073 . . . . 6.82 108.102 178.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.4 m -81.53 37.78 0.47 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.688 -0.633 . . . . 6.0 110.032 -179.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.535 ' CE2' ' OD1' ' A' ' 86' ' ' ASN . 10.2 p90 -61.55 -51.31 69.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.057 -1.027 . . . . 11.0 111.182 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.535 ' OD1' ' CE2' ' A' ' 85' ' ' TYR . 51.8 p30 -136.48 21.05 3.14 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.13 -0.981 . . . . 10.0 110.3 -179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.462 ' C ' ' SD ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -47.49 173.19 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.749 0 O-C-N 121.555 -0.715 . . . . 8.47 109.907 -179.734 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -91.0 103.97 16.62 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.144 -1.058 . . . . 11.97 108.144 179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -53.64 129.82 34.23 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.361 -0.837 . . . . 11.95 109.611 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 34.1 p-10 -151.24 -163.22 1.71 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.5 -0.75 . . . . 12.32 108.995 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -55.68 -50.6 59.88 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.361 -1.496 . . . . 11.16 109.361 -179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 14.4 p -160.38 114.2 2.15 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.158 -1.201 . . . . 11.8 109.438 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -124.9 8.08 8.08 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.502 -0.749 . . . . 10.78 109.02 179.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 59.0 tp . . . . . 0 N--CA 1.488 1.454 0 O-C-N 121.515 -0.741 . . . . 13.12 109.148 179.839 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.7 mmm . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 108.954 -0.758 . . . . 4.81 108.954 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 40.7 mt -76.18 151.21 36.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.036 -1.04 . . . . 1.71 109.486 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.7 m -119.98 152.76 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.625 -0.672 . . . . 1.79 109.372 -179.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 30.8 pttt -52.5 129.26 43.68 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.194 -0.941 . . . . 3.69 109.033 -179.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_exo -42.52 158.31 0.07 OUTLIER 'Trans proline' 0 N--CA 1.495 1.607 0 C-N-CA 121.985 1.79 . . . . 0.73 112.384 179.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -76.55 -9.25 18.59 Favored 'Trans proline' 0 N--CA 1.494 1.55 0 C-N-CA 122.542 2.161 . . . . 0.84 112.878 -179.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -67.34 143.32 56.44 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.955 -1.091 . . . . 1.15 108.993 -179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 29.9 t -69.65 159.98 32.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.143 -0.973 . . . . 1.39 108.573 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -59.9 -39.97 87.2 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.934 -1.104 . . . . 1.32 108.465 -179.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.6 mt -66.53 -39.95 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.786 . . . . 0.96 109.395 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.12 -44.02 95.2 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.362 -0.836 . . . . 0.38 110.103 -179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 85.5 mt -60.06 -40.07 88.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.198 -0.939 . . . . 0.37 108.588 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -67.66 -41.93 86.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.208 -0.933 . . . . 0.49 108.91 179.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.4 m -60.49 -40.1 90.09 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.435 -0.791 . . . . 0.39 109.676 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.43 -39.94 89.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -0.881 . . . . 1.14 109.175 -179.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -61.1 -47.65 85.31 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.629 -0.67 . . . . 0.32 110.474 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 79.9 mt -60.06 -49.86 82.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.059 -1.026 . . . . 0.33 108.973 -179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -65.57 -40.51 92.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.837 -0.539 . . . . 1.82 110.157 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.5 m120 -70.69 -20.61 62.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.316 -0.865 . . . . 1.67 110.372 -179.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.06 119.85 77.88 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.091 -1.006 . . . . 0.63 109.812 -179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -42.99 -29.55 1.58 Allowed 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 121.409 1.406 . . . . 1.29 110.719 179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -115.09 128.13 56.04 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 107.612 -1.255 . . . . 2.63 107.612 178.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -69.93 -27.31 64.65 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.922 -1.111 . . . . 2.02 110.142 -178.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -78.54 74.28 5.08 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.951 -1.093 . . . . 1.55 109.354 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -88.57 147.46 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 N-CA-C 108.815 -0.809 . . . . 0.47 108.815 179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.5 p -79.04 159.56 27.52 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.224 -0.923 . . . . 0.81 109.851 -179.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 27' ' ' LEU . 33.1 tp -60.42 -50.01 75.3 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.63 0.729 . . . . 0.7 109.839 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -60.07 -40.01 88.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.522 -0.736 . . . . 1.25 109.744 179.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.9 -38.62 94.36 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.495 -1.042 . . . . 0.29 110.495 -179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 87.9 mt -60.02 -43.71 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 120.973 -1.31 . . . . 0.35 109.933 -179.218 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.0 m-85 -59.99 -45.38 92.91 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.953 -1.092 . . . . 1.4 110.366 -179.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 21.1 mm100 -59.98 -40.12 88.0 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.37 -0.831 . . . . 2.51 110.265 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -59.92 -46.55 89.01 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.141 -0.974 . . . . 1.37 109.412 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 90.0 mt -65.78 -49.94 74.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -0.918 . . . . 0.59 111.499 -179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.0 mtm -61.11 -40.0 92.1 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.935 -1.103 . . . . 0.69 110.98 -178.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -66.67 -39.93 88.38 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.959 -1.088 . . . . 1.17 110.555 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 41.0 ttm-85 -76.94 -67.04 0.75 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.117 -0.99 . . . . 3.0 111.129 -178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -85.96 130.44 50.37 Favored Pre-proline 0 N--CA 1.496 1.838 0 O-C-N 120.731 -1.23 . . . . 1.54 109.907 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -79.63 -13.26 13.37 Favored 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 122.186 1.924 . . . . 1.21 113.204 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -59.94 -44.37 94.41 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.998 -1.064 . . . . 3.74 110.288 -179.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -70.2 -29.21 66.0 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.385 -0.822 . . . . 1.12 111.114 -178.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.9 mtp180 -60.03 -40.02 87.89 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.949 -1.094 . . . . 2.51 110.124 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -93.2 0.05 57.0 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.003 -1.061 . . . . 2.34 110.264 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.548 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 59.1 t30 -124.27 129.05 50.08 Favored 'General case' 0 N--CA 1.498 1.967 0 CA-C-O 121.271 0.557 . . . . 2.01 109.547 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.45 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 32.1 mmtp -129.12 17.89 6.06 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.512 -0.742 . . . . 1.68 109.402 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -70.43 -160.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.228 -0.92 . . . . 3.98 111.871 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -50.61 -9.21 0.25 Allowed Glycine 0 N--CA 1.491 2.357 0 CA-C-N 116.112 -0.494 . . . . 0.78 111.917 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.548 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -59.99 -35.99 76.2 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.218 -1.754 . . . . 0.44 107.721 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 90.8 mt-30 -61.38 -44.12 97.69 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.757 -0.589 . . . . 1.96 111.154 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 15.4 m120 -80.32 -26.58 38.7 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.002 -1.061 . . . . 1.28 111.703 -178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 66.5 p -69.39 -23.58 63.75 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.763 -1.211 . . . . 1.49 110.868 -178.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.5 mm -69.99 -61.66 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.006 -1.059 . . . . 0.64 111.394 -178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -70.01 -30.92 68.34 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.159 -0.963 . . . . 2.76 111.216 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 84.9 t60 -60.21 -36.82 78.54 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.912 -1.117 . . . . 2.48 109.648 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.428 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 98.5 m-20 -69.94 -19.24 63.39 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.303 -0.873 . . . . 2.07 111.14 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 93.8 mt -59.91 -45.1 93.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.909 -1.119 . . . . 0.78 110.385 -178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.8 p -69.98 -39.6 75.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.968 -1.082 . . . . 1.6 110.102 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 94.6 mt -60.16 -39.95 88.21 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 1.38 110.028 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 83.2 m-20 -64.52 119.0 9.63 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.156 -0.965 . . . . 1.42 109.601 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -81.97 -37.73 26.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.438 -0.789 . . . . 2.17 110.294 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.5 m -65.31 -11.54 42.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.183 -0.948 . . . . 1.56 109.769 -179.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -79.44 131.17 36.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.188 -0.945 . . . . 1.32 109.122 -179.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 86.3 t -97.19 127.94 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.276 -0.89 . . . . 0.91 109.101 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -103.71 118.0 35.69 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.456 -0.777 . . . . 1.81 110.174 -179.066 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.463 ' O ' ' OG ' ' A' ' 76' ' ' SER . 0.0 OUTLIER -113.24 118.19 44.36 Favored Pre-proline 0 N--CA 1.499 1.99 0 N-CA-C 107.867 -1.161 . . . . 1.28 107.867 179.157 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -74.71 154.34 43.94 Favored 'Trans proline' 0 N--CA 1.492 1.403 0 C-N-CA 121.415 1.41 . . . . 1.65 112.367 -179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 68.8 ttt180 -74.07 157.06 36.74 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.39 -0.819 . . . . 4.09 109.562 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -60.12 140.05 57.13 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.155 -0.966 . . . . 2.84 109.585 -179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -70.0 -19.84 63.31 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.302 -0.874 . . . . 3.46 109.211 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -60.08 -40.54 89.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.36 -0.838 . . . . 4.5 109.401 -179.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -132.67 82.35 56.61 Favored Pre-proline 0 N--CA 1.487 1.404 0 O-C-N 121.443 -0.786 . . . . 5.12 109.252 -179.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -81.4 176.64 8.46 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.221 1.947 . . . . 3.63 111.854 -179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 148.12 -69.72 0.34 Allowed Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.282 -1.527 . . . . 3.15 109.282 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.423 ' O ' ' O ' ' A' ' 75' ' ' GLY . 68.2 mttm -77.41 149.92 35.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -1.136 . . . . 4.36 109.314 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.423 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -45.82 -93.98 0.01 OUTLIER Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.043 -1.223 . . . . 2.03 110.043 -179.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 65' ' ' VAL . 7.0 t -152.4 160.05 43.34 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.313 -1.11 . . . . 1.8 109.612 -179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -77.71 157.69 29.99 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.263 -0.898 . . . . 1.39 109.422 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.6 m95 -130.19 130.7 45.02 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.489 -0.757 . . . . 0.46 109.743 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.2 t -149.82 159.44 44.36 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.26 -0.9 . . . . 0.56 109.542 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' O ' ' O ' ' A' ' 81' ' ' ASP . 91.4 mt -80.71 -161.19 0.36 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 1.42 109.717 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 80' ' ' LEU . 3.0 p-10 -49.98 173.06 0.09 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 N-CA-C 108.698 -0.853 . . . . 3.72 108.698 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -66.51 -146.13 0.02 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 121.794 1.663 . . . . 3.55 112.077 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' A' ' 85' ' ' TYR . 88.6 m-20 -90.96 17.39 7.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.437 -0.789 . . . . 6.82 109.485 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 92.8 p -47.08 99.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.265 -0.897 . . . . 6.0 109.064 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.419 ' N ' ' O ' ' A' ' 83' ' ' ASP . 0.1 OUTLIER -79.93 -70.04 0.54 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.283 -0.886 . . . . 11.0 109.658 -178.887 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 53.5 p-10 -127.6 13.08 6.96 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-O 121.926 0.87 . . . . 10.0 108.972 -179.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 47.4 mtm -88.68 107.79 19.12 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 108.697 -0.853 . . . . 8.47 108.697 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -70.0 -39.39 75.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.374 -0.829 . . . . 11.97 110.411 -178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -65.56 148.18 52.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.34 -0.85 . . . . 11.95 110.435 -178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 97.2 m-20 -98.31 11.86 36.64 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.42 -0.8 . . . . 12.32 110.138 -179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -151.16 75.61 0.25 Allowed Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.032 -1.227 . . . . 11.16 110.032 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -145.19 -39.65 0.25 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.103 -1.234 . . . . 11.8 109.619 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.401 ' CD1' ' O ' ' A' ' 93' ' ' PHE . 62.5 t80 -75.74 -18.91 59.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 10.78 110.682 -179.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.521 ' N ' HD12 ' A' ' 94' ' ' LEU . 9.3 mp . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.776 -1.202 . . . . 13.12 109.005 -179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.5 mtt . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.373 0.606 . . . . 4.81 109.482 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 50.0 mt -74.81 149.3 39.71 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.376 -0.827 . . . . 1.71 109.451 -179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -139.08 171.15 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 108.74 -0.837 . . . . 1.79 108.74 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 56.7 tttp -88.56 113.25 54.75 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.515 -0.741 . . . . 3.69 109.225 -179.864 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 7' ' ' TYR . 83.6 Cg_exo -48.73 122.9 8.74 Favored 'Trans proline' 0 N--CA 1.497 1.697 0 C-N-CA 121.639 1.559 . . . . 0.73 112.218 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -45.11 -8.33 0.03 OUTLIER 'Trans proline' 0 N--CA 1.496 1.67 0 C-N-CA 122.274 1.983 . . . . 0.84 113.65 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.504 ' N ' ' O ' ' A' ' 5' ' ' PRO . 37.8 m-85 -71.96 144.52 48.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.707 -1.246 . . . . 1.15 109.926 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 m -82.31 169.94 15.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.345 -0.847 . . . . 1.39 109.419 179.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 94.9 m-85 -60.09 -39.96 87.95 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.14 -0.975 . . . . 1.32 109.158 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.0 mm -69.81 -39.9 78.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 0.96 109.181 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.51 -47.62 84.78 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.305 -0.872 . . . . 0.38 110.342 -179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.5 mt -60.07 -41.45 92.41 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.789 -1.194 . . . . 0.37 108.436 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -65.32 -42.05 92.83 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.048 -1.093 . . . . 0.49 108.048 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.4 m -62.16 -40.02 94.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.584 -0.697 . . . . 0.39 109.47 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -68.26 -39.92 82.05 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.27 -0.894 . . . . 1.14 109.603 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.89 -48.01 81.11 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.329 -0.857 . . . . 0.32 109.252 -179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.428 ' O ' ' HB3' ' A' ' 20' ' ' ALA . 70.1 mt -61.1 -50.07 82.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.162 -0.961 . . . . 0.33 108.757 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.401 HE21 HD11 ' A' ' 80' ' ' LEU . 99.1 mm-40 -61.23 -40.01 92.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.632 -0.668 . . . . 1.82 109.839 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -78.05 -4.16 45.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 1.67 108.967 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.433 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -80.05 119.3 76.16 Favored Pre-proline 0 N--CA 1.488 1.446 0 N-CA-C 108.589 -0.893 . . . . 0.63 108.589 179.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -40.41 -26.72 0.23 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 C-N-CA 121.675 1.583 . . . . 1.29 111.594 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 20' ' ' ALA . 20.7 pt-20 -134.7 153.93 51.78 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 108.036 -1.098 . . . . 2.63 108.036 179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 29.1 mmtp -67.74 -31.56 71.57 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.01 -1.056 . . . . 2.02 110.825 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.8 mttm -78.87 123.42 27.22 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.686 -1.259 . . . . 1.55 109.704 -179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.3 tt -140.39 153.8 22.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.285 -0.884 . . . . 0.47 109.543 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.1 p -81.91 152.63 26.71 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.107 -0.996 . . . . 0.81 110.197 -179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 51.1 tp -60.0 -49.06 79.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.684 -0.858 . . . . 0.7 108.684 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -59.9 -40.11 87.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.453 -0.78 . . . . 1.25 109.811 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -59.06 -39.77 94.74 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 110.581 -1.008 . . . . 0.29 110.581 -179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.5 mt -60.04 -41.54 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.962 -1.317 . . . . 0.35 110.033 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.423 ' CD1' ' NE2' ' A' ' 49' ' ' GLN . 38.9 m-85 -59.99 -45.37 92.94 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.068 -1.02 . . . . 1.4 110.731 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 91.8 mm-40 -61.94 -37.32 84.27 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.041 -1.037 . . . . 2.51 110.852 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -59.98 -49.04 79.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.124 -0.985 . . . . 1.37 110.68 -178.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.2 mt -60.06 -49.96 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.943 -1.098 . . . . 0.59 110.693 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 76.7 mtm -65.47 -39.93 92.57 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.918 -1.114 . . . . 0.69 110.476 -179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -62.52 -40.01 95.39 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.145 -0.972 . . . . 1.17 109.47 -179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 23.9 mmm180 -79.76 -69.39 0.59 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.428 -0.795 . . . . 3.0 109.483 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -89.47 116.53 66.58 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.126 -0.983 . . . . 1.54 109.019 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -80.52 -3.93 12.72 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 121.88 1.72 . . . . 1.21 111.235 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 23.3 t80 -60.06 -39.75 87.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.594 -0.891 . . . . 3.74 108.594 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.434 ' O ' ' O ' ' A' ' 44' ' ' ASN . 93.3 m-85 -69.87 -27.15 64.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.567 -0.708 . . . . 1.12 110.521 -179.242 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.2 mtp180 -59.2 -39.96 84.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 120.823 -1.173 . . . . 2.51 107.994 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -61.3 -40.77 95.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.31 -0.869 . . . . 2.34 109.631 178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.434 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -111.5 108.5 18.05 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.329 -0.619 . . . . 2.01 109.329 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 66.3 mttm -96.64 -40.74 8.86 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.067 -1.02 . . . . 1.68 110.513 -179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 78.1 mt-30 -88.21 142.97 27.33 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.169 -0.957 . . . . 3.98 110.536 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.77 -55.74 0.49 Allowed Glycine 0 N--CA 1.495 2.604 0 N-CA-C 109.562 -1.415 . . . . 0.78 109.562 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.448 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 25.6 p-90 -89.23 -3.07 58.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.185 -1.185 . . . . 0.44 109.256 -179.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.423 ' NE2' ' CD1' ' A' ' 31' ' ' TYR . 67.3 tp60 -74.08 -61.7 1.76 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.142 -0.974 . . . . 1.96 111.089 -178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -69.55 -39.93 77.15 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.302 -0.873 . . . . 1.28 110.656 -178.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 67.2 m -50.84 -31.09 16.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.246 -0.909 . . . . 1.49 111.008 -178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -70.29 -65.7 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 121.003 -1.06 . . . . 0.64 110.894 -178.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.5 ptt180 -69.94 -30.02 67.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.321 -0.862 . . . . 2.76 110.6 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -59.98 -47.19 86.83 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.769 -1.207 . . . . 2.48 108.491 179.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.427 ' OD1' ' OD1' ' A' ' 59' ' ' ASN . 27.2 t-20 -61.08 -42.86 99.29 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.383 -0.823 . . . . 2.07 110.144 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.3 mt -59.96 -41.66 92.4 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.993 . . . . 0.78 110.239 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.1 p -64.05 -50.64 67.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 1.6 110.625 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.413 ' N ' HD12 ' A' ' 58' ' ' LEU . 8.4 mp -69.94 -40.09 75.68 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.929 -1.107 . . . . 1.38 110.056 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.68 HD22 ' N ' ' A' ' 59' ' ' ASN . 0.8 OUTLIER -66.73 122.11 16.91 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.192 -0.943 . . . . 1.42 109.58 -178.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -86.09 -10.2 55.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.471 -0.768 . . . . 2.17 109.34 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 66.3 m -61.26 -40.02 92.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.288 -0.883 . . . . 1.56 109.061 179.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -82.74 129.29 34.95 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.348 -0.982 . . . . 1.32 108.348 179.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 88.9 t -109.94 119.93 60.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.369 -0.832 . . . . 0.91 109.534 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.88 150.06 24.37 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.298 -1.001 . . . . 1.81 108.298 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.01 91.55 22.94 Favored Pre-proline 0 N--CA 1.499 2.001 0 O-C-N 121.31 -0.869 . . . . 1.28 109.789 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_exo -47.35 133.92 20.06 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 121.712 1.608 . . . . 1.65 111.318 179.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.59 HH11 ' H ' ' A' ' 74' ' ' LYS . 47.2 mtp180 -59.32 152.14 21.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.208 -0.932 . . . . 4.09 109.984 -179.096 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -68.2 153.99 42.63 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.372 -0.973 . . . . 2.84 108.372 179.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -69.48 -20.07 63.74 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.069 -1.019 . . . . 3.46 108.881 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp -62.95 -40.07 96.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.71 . . . . 4.5 109.883 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt -135.53 85.12 32.26 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 5.12 109.393 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -86.66 164.77 9.18 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.752 2.302 . . . . 3.63 112.335 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 168.71 -94.91 0.11 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.764 -1.334 . . . . 3.15 109.764 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.59 ' H ' HH11 ' A' ' 67' ' ' ARG . 61.5 mttp -71.63 157.47 37.9 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.362 -1.081 . . . . 4.36 109.579 -179.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 74' ' ' LYS . . . -44.9 -98.51 0.01 OUTLIER Glycine 0 N--CA 1.493 2.451 0 N-CA-C 110.658 -0.977 . . . . 2.03 110.658 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 12.1 m -144.88 158.58 43.75 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.003 -1.293 . . . . 1.8 110.152 -179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -80.01 162.14 25.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.487 -0.758 . . . . 1.39 109.685 179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 87.8 m95 -122.96 130.98 53.5 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 109.227 -0.657 . . . . 0.46 109.227 179.104 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 1.8 t -147.18 161.67 40.44 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.331 -0.855 . . . . 0.56 109.528 -179.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.401 HD11 HE21 ' A' ' 18' ' ' GLN . 76.5 mt -73.15 169.72 16.44 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.346 -0.846 . . . . 1.42 109.325 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.446 ' O ' ' O ' ' A' ' 82' ' ' PRO . 0.4 OUTLIER -46.73 167.44 0.15 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.186 -0.946 . . . . 3.72 109.19 -179.21 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.446 ' O ' ' O ' ' A' ' 81' ' ' ASP . 51.2 Cg_exo -53.98 -145.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.809 0 C-N-CA 122.195 1.93 . . . . 3.55 113.371 -179.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 85' ' ' TYR . 96.0 m-20 -99.53 24.86 7.65 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.341 -0.85 . . . . 6.82 109.263 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.522 ' C ' ' O ' ' A' ' 83' ' ' ASP . 6.2 m 1.95 61.75 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 112.934 0.716 . . . . 6.0 112.934 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.593 ' N ' ' O ' ' A' ' 83' ' ' ASP . 54.3 t80 -90.07 -28.42 19.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 11.0 109.002 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 34.2 m120 -99.88 13.0 35.34 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.394 -0.816 . . . . 10.0 109.9 -179.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.476 ' O ' ' CD1' ' A' ' 93' ' ' PHE . 65.4 mmm -85.41 119.32 25.64 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.217 -0.927 . . . . 8.47 109.825 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.402 ' C ' ' H ' ' A' ' 90' ' ' ASN . 49.6 p90 -118.71 25.43 10.25 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 108.898 -0.779 . . . . 11.97 108.898 179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -57.41 -9.59 1.11 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.394 -0.816 . . . . 11.95 109.535 -179.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 88' ' ' PHE . 23.8 m120 -132.89 142.02 48.69 Favored 'General case' 0 N--CA 1.495 1.775 0 N-CA-C 109.346 -0.612 . . . . 12.32 109.346 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -59.92 -37.91 93.33 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.177 -1.569 . . . . 11.16 109.177 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 58.8 m -60.01 -39.96 87.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.305 -1.115 . . . . 11.8 109.562 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.476 ' CD1' ' O ' ' A' ' 87' ' ' MET . 1.3 t80 -74.92 55.98 0.72 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.236 -0.915 . . . . 10.78 109.094 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 55.5 tp . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.051 -1.031 . . . . 13.12 109.576 -179.918 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.7 mtt . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.48 -0.563 . . . . 4.81 109.48 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 61.2 mt -70.56 140.86 51.85 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.275 -0.89 . . . . 1.71 109.743 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -140.88 148.1 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.387 -0.821 . . . . 1.79 108.977 179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 26.7 mmtp -74.5 145.3 82.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.018 -1.051 . . . . 3.69 108.811 179.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -72.56 161.21 44.71 Favored 'Trans proline' 0 N--CA 1.495 1.612 0 C-N-CA 122.408 2.072 . . . . 0.73 112.162 -179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -76.64 -2.62 12.86 Favored 'Trans proline' 0 N--CA 1.493 1.442 0 C-N-CA 122.519 2.146 . . . . 0.84 112.685 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 31.0 m-85 -64.93 137.45 57.75 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.814 -1.179 . . . . 1.15 108.735 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 49.4 m -77.83 168.67 19.55 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.285 -1.006 . . . . 1.39 108.285 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -60.0 -37.85 80.9 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.022 -1.049 . . . . 1.32 108.617 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 32.9 mm -60.11 -46.29 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.384 -0.823 . . . . 0.96 109.613 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -41.81 95.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -0.872 . . . . 0.38 110.452 -179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.76 -40.14 91.38 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.925 -1.109 . . . . 0.37 108.64 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 97.1 mt -64.12 -42.2 94.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 108.471 -0.937 . . . . 0.49 108.471 178.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -64.38 -40.01 94.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.722 -0.611 . . . . 0.39 110.358 -179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.2 mtt -66.32 -39.34 89.22 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.277 -0.89 . . . . 1.14 109.658 -179.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 20' ' ' ALA . . . -60.14 -41.4 92.62 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.542 -0.724 . . . . 0.32 110.252 -179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.503 ' CG2' ' HZ3' ' A' ' 23' ' ' LYS . 62.3 mt -69.57 -49.14 61.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.106 -0.997 . . . . 0.33 109.431 -179.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -66.03 -40.03 90.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.618 -0.676 . . . . 1.82 110.612 -178.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 67.1 m-80 -82.16 -10.6 59.11 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.073 -1.017 . . . . 1.67 110.78 -178.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 16' ' ' ALA . . . -79.07 149.17 72.88 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 120.942 -1.099 . . . . 0.63 109.022 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -57.62 -57.03 1.36 Allowed 'Trans proline' 0 C--N 1.313 -1.329 0 C-N-CA 121.441 1.427 . . . . 1.29 110.359 179.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 58.4 mp0 -104.98 127.07 52.68 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 107.94 -1.133 . . . . 2.63 107.94 178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.503 ' HZ3' ' CG2' ' A' ' 17' ' ' ILE . 8.7 mtpm? -60.33 -28.91 68.53 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 120.962 -1.086 . . . . 2.02 108.927 -179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -78.05 82.41 4.39 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 107.956 -1.127 . . . . 1.55 107.956 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.4 tt -111.87 148.55 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 N-CA-C 108.767 -0.827 . . . . 0.47 108.767 -179.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 30.7 p -79.03 161.07 26.85 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.116 -0.99 . . . . 0.81 109.233 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 23.4 tp -60.04 -42.63 94.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -0.886 . . . . 0.7 108.962 -179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -60.76 -40.01 90.91 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.286 -0.884 . . . . 1.25 109.643 179.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.71 -35.99 90.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.84 -1.304 . . . . 0.29 109.84 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 91.1 mt -60.76 -41.16 87.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -1.153 . . . . 0.35 110.293 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -60.0 -40.1 88.07 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.531 -1.355 . . . . 1.4 109.383 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.98 -40.35 88.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.462 -0.774 . . . . 2.51 109.798 -178.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -66.71 -47.22 73.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 1.37 110.701 179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.2 mt -60.2 -49.88 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.258 -0.901 . . . . 0.59 110.678 -178.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.1 mtm -62.13 -39.99 94.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.892 -1.13 . . . . 0.69 109.548 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.01 -49.64 75.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.223 -0.923 . . . . 1.17 110.401 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.3 ttm180 -70.04 -58.85 3.35 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.921 -1.112 . . . . 3.0 109.848 -179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -100.04 112.83 64.73 Favored Pre-proline 0 N--CA 1.495 1.793 0 O-C-N 121.206 -0.934 . . . . 1.54 108.892 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.03 -10.16 14.0 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.028 1.819 . . . . 1.21 112.64 -179.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.5 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -60.07 -38.17 82.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.165 -0.959 . . . . 3.74 108.953 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.413 ' O ' ' O ' ' A' ' 44' ' ' ASN . 69.4 m-85 -63.89 -28.75 70.05 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.666 -0.646 . . . . 1.12 110.952 -178.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.89 -39.93 87.02 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.83 -1.169 . . . . 2.51 109.372 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -61.77 -40.08 93.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 2.34 109.461 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.413 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.1 m-20 -114.45 104.74 12.34 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.498 -0.927 . . . . 2.01 108.498 179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 53.8 mtpt -98.47 -32.58 11.41 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.227 -0.921 . . . . 1.68 110.67 -179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -89.72 137.02 32.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.069 -1.02 . . . . 3.98 110.028 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 114.44 -64.9 0.29 Allowed Glycine 0 N--CA 1.495 2.569 0 N-CA-C 109.96 -1.256 . . . . 0.78 109.96 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.511 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 38.0 p-90 -72.88 -37.06 67.45 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.108 -1.231 . . . . 0.44 110.51 -179.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -60.09 -45.38 93.14 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.189 -0.944 . . . . 1.96 110.369 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.4 ' HA ' HH11 ' A' ' 53' ' ' ARG . 98.5 m-20 -68.86 -37.66 79.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 1.28 110.255 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 60.0 m -59.85 -39.35 84.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.073 -1.017 . . . . 1.49 110.043 -179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 7.3 mm -60.01 -46.81 93.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.162 -0.961 . . . . 0.64 110.224 -178.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.425 ' HG3' HH11 ' A' ' 53' ' ' ARG . 1.0 OUTLIER -64.75 -41.49 95.87 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.839 -1.163 . . . . 2.76 109.708 -179.459 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . 0.483 ' NE2' HD11 ' A' ' 58' ' ' LEU . 13.3 t60 -60.03 -45.25 93.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.355 -0.841 . . . . 2.48 109.832 -179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 72.1 m-20 -65.07 -39.96 94.0 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.236 -0.915 . . . . 2.07 109.666 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 15.7 mt -59.89 -46.87 87.95 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.151 -0.968 . . . . 0.78 110.263 -179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 31.2 t -64.73 -44.46 90.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.884 -1.135 . . . . 1.6 109.453 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.483 HD11 ' NE2' ' A' ' 54' ' ' HIS . 26.9 mt -67.88 -43.26 79.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.156 -0.965 . . . . 1.38 109.678 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -85.07 106.89 16.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.297 -0.877 . . . . 1.42 108.76 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -91.01 10.29 27.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.562 -0.711 . . . . 2.17 109.449 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 90.8 m -65.41 -26.05 67.81 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.358 -0.838 . . . . 1.56 109.927 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -79.76 147.91 31.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.025 -1.047 . . . . 1.32 109.122 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.499 ' CG2' ' H ' ' A' ' 81' ' ' ASP . 22.9 t -90.61 118.52 36.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.3 -0.875 . . . . 0.91 109.08 -179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -92.33 100.23 12.85 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.188 -0.945 . . . . 1.81 109.239 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -100.88 123.78 44.24 Favored Pre-proline 0 N--CA 1.495 1.782 0 N-CA-C 108.494 -0.928 . . . . 1.28 108.494 179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -81.89 172.89 11.63 Favored 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 122.013 1.809 . . . . 1.65 112.604 -179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.541 ' NH2' ' OH ' ' A' ' 77' ' ' TYR . 16.7 mtt-85 -80.01 159.28 26.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.454 -0.779 . . . . 4.09 109.08 178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 7.3 t70 -81.27 167.52 19.47 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.373 -0.83 . . . . 2.84 110.032 -179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 87.2 m-20 -62.27 -36.72 82.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.526 -0.734 . . . . 3.46 109.968 179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -59.77 -39.84 86.21 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.151 -0.968 . . . . 4.5 109.381 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 34.5 mttm -90.62 149.18 40.21 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.191 -0.943 . . . . 5.12 109.249 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.565 ' O ' ' N ' ' A' ' 74' ' ' LYS . 74.1 Cg_endo -74.81 130.56 13.59 Favored 'Trans proline' 0 N--CA 1.493 1.484 0 C-N-CA 122.256 1.971 . . . . 3.63 110.814 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -54.11 78.17 0.01 OUTLIER Glycine 0 N--CA 1.495 2.576 0 C-N-CA 120.376 -0.916 . . . . 3.15 111.413 -178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.565 ' N ' ' O ' ' A' ' 72' ' ' PRO . 16.2 mtpp -70.23 -39.71 74.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.048 -1.266 . . . . 4.36 109.104 178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -179.71 -175.88 46.81 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.362 -1.495 . . . . 2.03 109.362 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.8 p -97.9 139.82 33.18 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.272 -1.134 . . . . 1.8 109.387 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.541 ' OH ' ' NH2' ' A' ' 67' ' ' ARG . 29.6 m-85 -87.47 144.22 26.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.101 -1.0 . . . . 1.39 109.291 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -114.56 130.79 56.8 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.523 -0.735 . . . . 0.46 109.288 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 15.3 t -158.51 153.67 25.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.192 -0.943 . . . . 0.56 109.583 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 38.3 mt -95.08 100.12 11.99 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.089 -1.007 . . . . 1.42 109.316 179.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.499 ' H ' ' CG2' ' A' ' 63' ' ' VAL . 1.5 m-20 -140.04 79.05 23.1 Favored Pre-proline 0 N--CA 1.496 1.836 0 O-C-N 121.359 -0.838 . . . . 3.72 109.447 179.34 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -60.87 -141.35 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.527 0 C-N-CA 122.926 2.417 . . . . 3.55 112.293 -179.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 85' ' ' TYR . 40.9 p-10 -93.08 31.79 1.39 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.363 -0.835 . . . . 6.82 109.242 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 1.6 t -49.57 87.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.429 -0.795 . . . . 6.0 109.644 -179.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.604 ' CD2' ' ND2' ' A' ' 86' ' ' ASN . 55.8 t80 -61.83 -50.06 73.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 11.0 109.956 -179.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.604 ' ND2' ' CD2' ' A' ' 85' ' ' TYR . 2.8 m-80 -146.52 24.11 1.25 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.184 -0.947 . . . . 10.0 108.933 179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 14.4 mmt -69.49 120.34 15.13 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.319 -0.863 . . . . 8.47 109.403 -179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -96.53 -27.72 14.73 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.254 -0.904 . . . . 11.97 109.505 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' ASN . 50.3 mt-10 -141.25 172.74 12.27 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.429 -0.794 . . . . 11.95 109.02 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.506 ' O ' ' N ' ' A' ' 92' ' ' SER . 7.8 m120 -44.16 166.36 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.358 -0.839 . . . . 12.32 109.847 -179.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -65.25 50.35 0.12 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.489 -1.044 . . . . 11.16 110.489 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 90' ' ' ASN . 45.7 t -70.97 -13.77 62.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.148 -1.207 . . . . 11.8 108.727 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -55.57 172.03 0.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.812 0.815 . . . . 10.78 110.105 -179.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.581 HD12 ' N ' ' A' ' 94' ' ' LEU . 7.9 mp . . . . . 0 N--CA 1.488 1.447 0 O-C-N 121.674 -0.641 . . . . 13.12 109.47 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 33.9 ttp . . . . . 0 N--CA 1.489 1.517 0 CA-C-O 121.873 0.844 . . . . 4.81 108.934 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 85.2 mt -81.89 142.83 32.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.922 . . . . 1.71 109.409 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 16.9 m -145.74 152.75 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.245 -0.909 . . . . 1.79 109.391 179.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.4 mtpt -45.98 107.68 0.71 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.407 -0.808 . . . . 3.69 109.331 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_exo -50.79 150.84 11.9 Favored 'Trans proline' 0 N--CA 1.495 1.606 0 C-N-CA 121.922 1.748 . . . . 0.73 112.988 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.1 16.9 0.53 Allowed 'Trans proline' 0 N--CA 1.494 1.506 0 C-N-CA 122.531 2.154 . . . . 0.84 111.691 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -101.22 135.81 42.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.385 -0.822 . . . . 1.15 109.455 -179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 91.8 p -80.21 170.01 17.0 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.435 -0.791 . . . . 1.39 109.281 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -60.06 -39.94 87.73 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.244 -0.91 . . . . 1.32 108.913 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.3 mm -66.05 -40.14 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.222 -0.924 . . . . 0.96 108.542 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.82 -46.82 73.96 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.251 -0.905 . . . . 0.38 109.492 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 93.6 mt -60.06 -40.85 90.9 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.043 -1.035 . . . . 0.37 108.336 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 92.5 mt -69.91 -41.54 79.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.449 -0.782 . . . . 0.49 108.959 179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -62.84 -39.94 95.92 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 0.39 109.268 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.522 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 67.3 mtt -68.06 -40.0 82.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.894 . . . . 1.14 108.829 179.201 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.51 -49.5 77.53 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.567 -0.708 . . . . 0.32 110.073 -179.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 82.2 mt -60.04 -49.9 82.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.078 -1.014 . . . . 0.33 109.255 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 98.3 mt-30 -65.43 -39.66 92.35 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.852 -0.53 . . . . 1.82 110.266 -179.208 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 15' ' ' MET . 69.4 m-80 -80.3 5.0 15.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.124 -0.985 . . . . 1.67 110.112 -179.29 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.1 148.37 74.79 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.971 -1.081 . . . . 0.63 109.76 -179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -33.6 -84.37 0.01 OUTLIER 'Trans proline' 0 N--CA 1.49 1.314 0 C-N-CA 122.912 2.408 . . . . 1.29 112.849 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.5 tp10 -90.02 -80.05 0.33 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.685 -1.259 . . . . 2.63 108.542 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.6 tptm -159.16 -33.69 0.06 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.895 -1.128 . . . . 2.02 110.117 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.1 mttp -81.42 129.85 34.81 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.994 -1.066 . . . . 1.55 110.142 -179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.2 tt -130.75 138.74 52.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 N-CA-C 108.611 -0.885 . . . . 0.47 108.611 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 55.2 p -79.99 162.31 24.97 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.176 -0.952 . . . . 0.81 109.965 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.711 HD21 ' HG2' ' A' ' 53' ' ' ARG . 52.1 tp -60.04 -47.01 87.64 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.671 -0.862 . . . . 0.7 108.671 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.442 ' O ' ' OE1' ' A' ' 32' ' ' GLN . 79.7 m-20 -62.55 -39.93 95.22 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.303 -0.873 . . . . 1.25 109.844 179.401 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -57.51 -40.07 91.75 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 110.536 -1.026 . . . . 0.29 110.536 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.9 mt -59.97 -40.69 83.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.987 -1.302 . . . . 0.35 109.381 -179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 32.9 m-85 -60.07 -48.68 80.71 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.108 -0.995 . . . . 1.4 109.955 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.442 ' OE1' ' O ' ' A' ' 28' ' ' ASN . 4.8 mp0 -59.92 -37.79 80.48 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.278 -0.889 . . . . 2.51 109.488 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -59.99 -49.99 75.48 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.356 -0.84 . . . . 1.37 109.64 -179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.84 -49.97 79.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.002 -1.061 . . . . 0.59 110.824 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 60.5 mtm -65.02 -43.49 92.29 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.89 -1.131 . . . . 0.69 110.781 -179.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.36 -44.86 86.32 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.995 -1.066 . . . . 1.17 110.626 -179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.446 ' HG3' HH11 ' A' ' 37' ' ' ARG . 21.7 mmm-85 -70.03 -40.01 75.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.019 -1.051 . . . . 3.0 110.541 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.505 ' C ' ' H ' ' A' ' 40' ' ' PHE . 70.4 m-85 -124.05 82.53 56.31 Favored Pre-proline 0 N--CA 1.497 1.919 0 O-C-N 121.418 -0.801 . . . . 1.54 109.766 -179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -48.45 -6.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.562 2.174 . . . . 1.21 111.779 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.505 ' H ' ' C ' ' A' ' 38' ' ' PHE . 49.6 t80 -59.94 -42.76 94.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.515 -0.74 . . . . 3.74 109.898 179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.03 -22.15 63.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 1.12 110.937 -178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 55.5 mtp180 -59.95 -39.84 86.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.912 -1.117 . . . . 2.51 109.705 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -85.54 2.85 43.14 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.046 -1.034 . . . . 2.34 109.728 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.501 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 81.3 m-20 -133.92 115.67 14.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.626 -0.672 . . . . 2.01 109.832 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' O ' ' O ' ' A' ' 46' ' ' GLN . 56.0 mttp -110.47 13.74 22.68 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.477 -0.935 . . . . 1.68 108.477 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 48' ' ' TRP . 87.7 mt-30 -47.39 -177.95 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.995 0.902 . . . . 3.98 111.401 -178.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -46.9 -8.89 0.03 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.932 -0.867 . . . . 0.78 110.932 -179.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.545 ' N ' ' O ' ' A' ' 46' ' ' GLN . 3.8 p-90 -59.87 -40.75 89.71 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.575 -1.544 . . . . 0.44 107.939 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.514 ' N ' ' CG ' ' A' ' 48' ' ' TRP . 58.5 tt0 -60.06 -50.3 74.26 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.261 0.553 . . . . 1.96 111.316 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -73.23 -40.07 64.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.824 -1.173 . . . . 1.28 110.759 -178.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 96.3 p -51.94 -30.05 22.86 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.2 -0.937 . . . . 1.49 110.773 -178.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.1 mm -60.76 -52.26 63.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.912 -1.118 . . . . 0.64 110.489 -179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.711 ' HG2' HD21 ' A' ' 27' ' ' LEU . 32.6 mtp180 -69.98 -40.67 75.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.052 . . . . 2.76 110.154 -179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 55.1 m80 -63.34 -39.98 96.02 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.079 -1.013 . . . . 2.48 108.659 179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.96 -40.0 95.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.093 -1.077 . . . . 2.07 108.093 179.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 82.2 mt -68.51 -40.59 80.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.468 -0.77 . . . . 0.78 109.823 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 45.3 t -69.95 -44.24 69.93 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.205 -0.934 . . . . 1.6 109.468 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 56.9 mt -69.62 -39.71 77.03 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.235 -0.915 . . . . 1.38 109.046 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -75.58 105.81 6.81 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.168 -0.957 . . . . 1.42 109.31 -179.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -89.47 -1.08 57.92 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.981 -1.118 . . . . 2.17 107.981 179.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 98.4 m -60.17 -34.09 73.1 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.042 -0.725 . . . . 1.56 109.042 179.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -78.51 155.55 29.73 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.421 -0.8 . . . . 1.32 109.025 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.0 t -112.02 125.73 69.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.517 -0.74 . . . . 0.91 109.209 -179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 87.1 mttt -76.61 154.65 34.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.331 -0.856 . . . . 1.81 109.167 179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.1 t -123.24 91.77 49.53 Favored Pre-proline 0 N--CA 1.498 1.969 0 O-C-N 121.49 -0.756 . . . . 1.28 109.0 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_exo -45.1 151.09 0.82 Allowed 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.097 1.865 . . . . 1.65 112.524 -179.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -114.84 158.98 21.19 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 109.182 -0.673 . . . . 4.09 109.182 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.12 166.87 0.2 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.325 -0.86 . . . . 2.84 110.171 -179.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.421 ' O ' ' N ' ' A' ' 71' ' ' LYS . 95.6 m-20 -69.15 -26.06 64.69 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.513 -0.742 . . . . 3.46 109.881 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.1 mtmt -70.35 47.42 0.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.196 -0.94 . . . . 4.5 109.355 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.421 ' N ' ' O ' ' A' ' 69' ' ' ASP . 4.2 ptmt -98.04 111.95 60.64 Favored Pre-proline 0 N--CA 1.496 1.846 0 O-C-N 121.366 -0.834 . . . . 5.12 109.927 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -83.7 10.45 3.68 Favored 'Trans proline' 0 N--CA 1.49 1.298 0 C-N-CA 121.966 1.777 . . . . 3.63 111.728 178.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 172.58 -77.83 0.09 OUTLIER Glycine 0 N--CA 1.492 2.433 0 N-CA-C 109.395 -1.482 . . . . 3.15 109.395 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -59.99 141.08 56.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -1.187 . . . . 4.36 108.549 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -127.21 -14.29 2.73 Favored Glycine 0 N--CA 1.5 2.93 0 C-N-CA 120.357 -0.925 . . . . 2.03 111.962 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.1 m -158.61 154.73 27.02 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.092 -1.828 . . . . 1.8 111.785 -179.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.442 ' CD1' ' N ' ' A' ' 77' ' ' TYR . 21.6 m-85 -110.57 163.66 13.49 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 108.038 -1.097 . . . . 1.39 108.038 178.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 m95 -110.96 127.16 55.4 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.408 -0.807 . . . . 0.46 109.58 -179.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 13.3 t -141.67 159.19 42.72 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.305 -0.872 . . . . 0.56 109.686 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.452 ' O ' ' O ' ' A' ' 81' ' ' ASP . 75.4 mt -76.27 172.54 12.7 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.452 -0.78 . . . . 1.42 109.973 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.452 ' O ' ' O ' ' A' ' 80' ' ' LEU . 1.1 m-20 -48.56 176.68 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.67 0 N-CA-C 108.894 -0.78 . . . . 3.72 108.894 -179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_exo -66.58 -142.35 0.01 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 C-N-CA 121.796 1.664 . . . . 3.55 111.233 -179.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.578 ' O ' ' N ' ' A' ' 85' ' ' TYR . 74.9 m-20 -88.27 5.47 41.59 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.981 -1.074 . . . . 6.82 108.874 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 12.0 p -54.96 83.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.447 -0.783 . . . . 6.0 108.95 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' A' ' 83' ' ' ASP . 8.7 t80 -80.15 -67.98 0.72 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 11.0 109.73 -178.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.777 HD22 ' H ' ' A' ' 86' ' ' ASN . 0.0 OUTLIER -109.2 18.27 20.71 Favored 'General case' 0 N--CA 1.496 1.851 0 CA-C-O 121.694 0.759 . . . . 10.0 109.448 -179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -84.0 123.97 30.56 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.45 0.643 . . . . 8.47 110.346 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -139.08 -0.62 1.84 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.439 -0.788 . . . . 11.97 109.009 179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 19.2 pt-20 -150.03 170.28 19.24 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.364 -0.835 . . . . 11.95 109.067 -179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.513 ' N ' ' ND2' ' A' ' 90' ' ' ASN . 0.1 OUTLIER -49.37 142.31 7.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.213 -0.93 . . . . 12.32 109.318 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -79.89 2.73 73.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.932 -1.267 . . . . 11.16 109.932 -179.441 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 78.0 p -59.85 -38.63 82.65 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.159 -1.201 . . . . 11.8 108.894 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 80.7 t80 -61.88 132.68 53.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.256 -0.902 . . . . 10.78 108.846 179.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 38.1 tp . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.12 -0.988 . . . . 13.12 109.026 -179.778 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.1 ttm . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.761 -0.459 . . . . 4.81 109.761 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 42.4 mt -111.1 140.12 45.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.623 -0.673 . . . . 1.71 109.541 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 30.8 m -136.1 160.08 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.566 -0.709 . . . . 1.79 109.358 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' CD ' ' N ' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -70.05 150.31 96.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 108.241 -1.022 . . . . 3.69 108.241 179.194 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 7' ' ' TYR . 55.4 Cg_endo -81.57 136.35 9.68 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 C-N-CA 122.091 1.861 . . . . 0.73 112.147 -179.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -39.64 -17.99 0.05 OUTLIER 'Trans proline' 0 N--CA 1.493 1.498 0 C-N-CA 122.546 2.164 . . . . 0.84 113.793 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.503 ' N ' ' O ' ' A' ' 5' ' ' PRO . 6.1 m-85 -67.69 129.04 38.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.766 -1.209 . . . . 1.15 110.171 -178.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 80.1 p -81.94 177.17 9.0 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.486 -0.759 . . . . 1.39 109.059 179.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -59.93 -41.48 91.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.188 -0.945 . . . . 1.32 109.562 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 45.6 mm -61.01 -47.46 93.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.96 109.784 179.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.71 -41.89 87.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.24 -0.913 . . . . 0.38 110.317 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 84.3 mt -60.03 -45.63 92.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.831 -1.168 . . . . 0.37 109.051 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 84.2 mt -62.19 -40.02 86.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 N-CA-C 108.123 -1.065 . . . . 0.49 108.123 178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.33 -39.95 94.77 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.614 -0.679 . . . . 0.39 109.593 179.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 63.0 mtt -65.83 -39.91 91.27 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.35 -0.844 . . . . 1.14 109.76 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.01 -46.31 89.91 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.394 -0.816 . . . . 0.32 109.835 -179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 80.1 mt -60.02 -49.97 81.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.151 -0.968 . . . . 0.33 108.543 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -65.19 -40.04 93.66 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.213 0.53 . . . . 1.82 110.168 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.12 0.7 43.95 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.295 -0.878 . . . . 1.67 110.45 -178.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.08 148.42 74.96 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 120.96 -1.087 . . . . 0.63 108.759 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -62.81 -23.53 74.4 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 121.608 1.539 . . . . 1.29 109.768 179.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -138.35 148.79 44.94 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.964 -1.124 . . . . 2.63 107.964 178.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp -61.64 -36.9 82.09 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.007 -1.058 . . . . 2.02 108.274 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -83.87 119.39 24.81 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.377 -0.971 . . . . 1.55 108.377 179.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 14.7 tt -138.14 152.71 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.368 -0.832 . . . . 0.47 109.048 -179.667 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 72.2 p -80.08 153.8 28.52 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.225 -0.922 . . . . 0.81 109.238 -179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 26.9 tp -59.97 -40.27 88.53 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.446 -0.784 . . . . 0.7 108.889 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -60.17 -40.06 88.61 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.506 -0.746 . . . . 1.25 109.913 179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.92 -38.83 97.22 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.639 -0.985 . . . . 0.29 110.639 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 92.2 mt -60.04 -40.44 83.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.118 -1.225 . . . . 0.35 110.017 -178.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.533 ' CE1' ' OE1' ' A' ' 49' ' ' GLN . 32.1 m-85 -60.03 -41.95 93.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.901 -1.124 . . . . 1.4 110.263 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -60.14 -40.24 89.14 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.297 -0.877 . . . . 2.51 110.078 -178.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -60.94 -49.63 76.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.624 -0.672 . . . . 1.37 111.446 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 86.2 mt -59.93 -49.86 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.106 -0.996 . . . . 0.59 111.631 -178.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 57.8 mtm -60.0 -40.03 87.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.689 -1.257 . . . . 0.69 111.164 -178.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -68.29 -46.18 71.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.649 -1.282 . . . . 1.17 111.019 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.441 ' HA ' ' HE ' ' A' ' 37' ' ' ARG . 0.0 OUTLIER -70.0 -40.06 75.5 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.89 -1.131 . . . . 3.0 109.943 -179.314 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -121.63 110.04 33.97 Favored Pre-proline 0 N--CA 1.497 1.879 0 N-CA-C 108.662 -0.866 . . . . 1.54 108.662 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.471 ' O ' ' OE1' ' A' ' 43' ' ' GLU . 95.8 Cg_endo -79.59 -11.27 14.27 Favored 'Trans proline' 0 N--CA 1.492 1.393 0 C-N-CA 121.927 1.751 . . . . 1.21 113.011 -178.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 40' ' ' PHE . 0.5 OUTLIER -58.47 -35.97 72.99 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.176 -0.952 . . . . 3.74 109.22 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.43 ' O ' ' O ' ' A' ' 44' ' ' ASN . 91.5 m-85 -67.6 -29.5 68.86 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.767 -0.583 . . . . 1.12 110.603 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -59.96 -39.96 87.4 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.027 -1.046 . . . . 2.51 109.582 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' OE1' ' O ' ' A' ' 39' ' ' PRO . 54.7 mp0 -66.62 -39.97 88.56 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.037 -1.039 . . . . 2.34 109.048 179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.43 ' O ' ' O ' ' A' ' 41' ' ' TYR . 94.4 m-20 -106.23 106.49 17.03 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 109.257 -0.645 . . . . 2.01 109.257 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 59.1 mttm -98.38 -42.61 7.27 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.114 -0.991 . . . . 1.68 109.96 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 23.0 mm100 -77.98 140.14 39.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.165 -0.96 . . . . 3.98 109.873 -179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 110.86 -59.98 0.34 Allowed Glycine 0 N--CA 1.496 2.679 0 N-CA-C 110.443 -1.063 . . . . 0.78 110.443 179.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.422 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 26.2 p-90 -89.44 -14.77 34.67 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.025 -1.279 . . . . 0.44 110.497 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.533 ' OE1' ' CE1' ' A' ' 31' ' ' TYR . 3.2 tp-100 -69.92 -60.02 2.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.061 -1.024 . . . . 1.96 110.926 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -72.36 -28.67 63.17 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.906 -1.121 . . . . 1.28 110.942 -178.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 58.6 m -59.95 -38.82 83.58 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.909 -1.119 . . . . 1.49 109.857 -179.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.7 mm -59.95 -44.77 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.938 . . . . 0.64 110.086 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.1 mtm180 -68.97 -44.79 72.21 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.791 -1.193 . . . . 2.76 110.482 -178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 29.5 m80 -60.01 -41.66 92.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.025 -1.047 . . . . 2.48 109.279 -179.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.736 HD21 HD21 ' A' ' 59' ' ' ASN . 21.7 t-20 -61.96 -42.26 98.92 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.213 -0.93 . . . . 2.07 108.753 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 38.0 mt -60.06 -46.83 88.24 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.409 -0.807 . . . . 0.78 109.903 179.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.9 t -70.4 -41.98 72.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.192 -0.943 . . . . 1.6 109.961 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 84.3 mt -66.36 -39.96 89.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -0.954 . . . . 1.38 110.084 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.736 HD21 HD21 ' A' ' 55' ' ' ASN . 93.7 m-20 -74.73 119.75 19.35 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.148 -0.97 . . . . 1.42 108.984 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -89.96 -2.7 58.21 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.175 -0.953 . . . . 2.17 108.667 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.424 ' O ' ' OD2' ' A' ' 81' ' ' ASP . 93.7 m -62.61 -40.04 95.7 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.504 -0.747 . . . . 1.56 109.367 179.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -80.6 152.62 28.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 1.32 109.421 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.6 t -127.42 128.04 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.549 -0.72 . . . . 0.91 109.589 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 42.4 mtmt -83.82 150.02 26.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.253 -0.904 . . . . 1.81 109.415 179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.2 80.03 69.31 Favored Pre-proline 0 N--CA 1.496 1.857 0 N-CA-C 108.111 -1.07 . . . . 1.28 108.111 179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 99.1 Cg_exo -43.63 160.63 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.249 1.966 . . . . 1.65 112.252 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 31.0 mtp180 -76.35 159.29 30.65 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.157 -0.965 . . . . 4.09 108.742 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -66.82 155.4 38.39 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.221 -0.924 . . . . 2.84 108.579 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -61.58 -18.89 61.21 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.092 -1.005 . . . . 3.46 109.281 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -74.67 -9.12 58.26 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.414 -0.804 . . . . 4.5 109.408 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.443 ' O ' ' O ' ' A' ' 72' ' ' PRO . 34.5 mmtm -130.01 79.92 72.1 Favored Pre-proline 0 N--CA 1.497 1.916 0 O-C-N 121.462 -0.774 . . . . 5.12 109.393 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.443 ' O ' ' O ' ' A' ' 71' ' ' LYS . 48.2 Cg_exo -54.83 -145.32 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.907 2.405 . . . . 3.63 112.161 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 62.24 -124.98 34.94 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.237 -1.145 . . . . 3.15 110.237 179.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 30.3 mmtp -61.26 140.19 58.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.375 -1.074 . . . . 4.36 109.822 -179.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -132.9 40.67 1.58 Allowed Glycine 0 N--CA 1.496 2.647 0 N-CA-C 109.646 -1.382 . . . . 2.03 109.646 -179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 68.6 m -154.84 129.11 8.98 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.866 -1.373 . . . . 1.8 111.302 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -132.1 158.57 41.28 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 107.218 -1.401 . . . . 1.39 107.218 177.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -122.75 134.78 54.43 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.27 -0.894 . . . . 0.46 110.23 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.8 t -152.64 161.32 42.73 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.479 -0.763 . . . . 0.56 109.245 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.6 mt -79.57 160.01 26.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.033 -1.042 . . . . 1.42 109.488 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 81' ' ' ASP . 0.0 OUTLIER -53.56 174.33 0.17 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.381 -0.824 . . . . 3.72 108.975 -179.449 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -62.54 -140.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.496 1.634 0 C-N-CA 122.086 1.857 . . . . 3.55 111.709 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.558 ' O ' ' N ' ' A' ' 85' ' ' TYR . 34.3 p-10 -82.19 9.25 9.05 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.286 -0.884 . . . . 6.82 108.698 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 84.7 p -58.09 75.58 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.569 -0.707 . . . . 6.0 109.892 -179.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 83' ' ' ASP . 21.1 p90 -62.51 -48.81 77.91 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.994 -1.066 . . . . 11.0 108.349 179.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.509 ' N ' ' CD2' ' A' ' 85' ' ' TYR . 36.1 m120 -154.03 82.31 1.14 Allowed 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.339 -0.986 . . . . 10.0 108.339 177.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.511 ' O ' ' SD ' ' A' ' 87' ' ' MET . 0.0 OUTLIER -73.47 132.7 43.22 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.461 -0.774 . . . . 8.47 109.14 -179.44 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -80.48 -39.57 27.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.149 -0.969 . . . . 11.97 110.351 -179.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 60.0 mm-40 -119.19 159.88 23.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.569 -0.707 . . . . 11.95 109.812 -178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -82.53 2.28 33.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.452 -0.78 . . . . 12.32 109.03 179.488 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -142.03 -83.35 0.07 OUTLIER Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.267 -1.533 . . . . 11.16 109.267 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.3 t -85.46 78.6 9.67 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.22 -1.165 . . . . 11.8 109.254 179.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 41.2 p90 -89.95 0.27 57.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.175 -0.953 . . . . 10.78 109.656 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 73.7 mt . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.155 -0.966 . . . . 13.12 108.685 179.707 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.1 mtt . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.426 -0.583 . . . . 4.81 109.426 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 47.5 mt -86.93 140.0 30.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.209 -0.932 . . . . 1.71 109.534 -179.786 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 28.5 m -145.86 156.02 12.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.507 -0.746 . . . . 1.79 109.198 -179.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 47.8 mmtt -70.34 147.13 95.03 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.071 -1.018 . . . . 3.69 108.525 179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.425 ' O ' ' N ' ' A' ' 7' ' ' TYR . 68.7 Cg_endo -79.55 143.08 16.76 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 121.974 1.783 . . . . 0.73 111.352 179.499 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -39.74 -24.36 0.12 Allowed 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.249 1.966 . . . . 0.84 113.373 -179.576 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.425 ' N ' ' O ' ' A' ' 5' ' ' PRO . 12.4 m-85 -60.61 131.54 51.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.909 -1.119 . . . . 1.15 109.895 -179.201 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 34.4 t -81.7 169.21 17.24 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.482 -0.933 . . . . 1.39 108.482 179.087 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -60.0 -40.3 88.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.139 -0.976 . . . . 1.32 109.352 -179.487 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 96.4 mt -61.29 -43.45 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.015 -1.053 . . . . 0.96 108.935 179.318 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.42 -41.17 85.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.421 -0.8 . . . . 0.38 109.855 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 88.9 mt -59.98 -40.21 88.38 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.039 -1.038 . . . . 0.37 109.059 179.929 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.7 mt -63.92 -44.2 97.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.04 -1.038 . . . . 0.49 108.247 178.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.6 m -60.56 -40.04 90.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 0.39 110.376 -179.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.6 mtt -66.97 -39.96 87.33 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.307 -0.87 . . . . 1.14 109.811 -179.081 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.11 -45.11 94.06 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.367 -0.833 . . . . 0.32 109.961 -179.908 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 73.6 mt -62.33 -46.3 96.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.244 -0.91 . . . . 0.33 109.03 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 26.2 mm100 -59.94 -40.04 87.58 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.71 -0.619 . . . . 1.82 109.462 -179.475 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -83.25 -3.06 57.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.206 -0.933 . . . . 1.67 109.462 -179.799 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -80.01 124.84 82.82 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.133 -0.98 . . . . 0.63 109.493 -179.898 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -42.93 -57.09 1.87 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 C-N-CA 121.397 1.398 . . . . 1.29 110.92 179.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -97.52 140.82 31.37 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.852 -1.166 . . . . 2.63 107.852 178.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 65.8 mmtt -59.9 -35.53 75.06 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.068 -1.02 . . . . 2.02 110.087 -178.969 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -76.97 129.95 36.83 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.604 -1.31 . . . . 1.55 108.533 179.854 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 21.0 tt -139.9 147.68 23.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.423 -0.798 . . . . 0.47 109.694 -179.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.5 p -82.66 150.22 26.92 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.479 -0.763 . . . . 0.81 109.295 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.463 HD13 ' CD1' ' A' ' 56' ' ' LEU . 51.4 tp -59.97 -41.59 92.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.171 -0.956 . . . . 0.7 108.627 -179.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -60.33 -41.75 94.18 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.547 -0.72 . . . . 1.25 110.106 179.43 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -61.13 -39.51 97.23 Favored Glycine 0 N--CA 1.493 2.49 0 N-CA-C 110.492 -1.043 . . . . 0.29 110.492 -179.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 83.0 mt -59.99 -39.98 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.18 -1.188 . . . . 0.35 110.284 -178.998 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -59.97 -42.0 93.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.636 -1.29 . . . . 1.4 109.569 -178.964 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -61.56 -40.67 95.58 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.127 -0.983 . . . . 2.51 109.789 -179.793 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -61.26 -49.88 75.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.481 -0.762 . . . . 1.37 111.377 -179.061 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 81.9 mt -60.07 -44.72 95.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.053 -1.029 . . . . 0.59 110.738 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 18.7 mtm -60.01 -41.79 92.89 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.919 -1.113 . . . . 0.69 109.416 -179.074 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -70.02 -40.0 75.46 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.224 -0.923 . . . . 1.17 110.417 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 tpm_? -68.05 -60.03 2.8 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.188 -0.945 . . . . 3.0 110.654 -178.493 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -105.08 126.31 31.37 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.316 -0.865 . . . . 1.54 109.257 -179.297 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -80.64 -16.54 10.37 Favored 'Trans proline' 0 N--CA 1.495 1.609 0 C-N-CA 122.161 1.907 . . . . 1.21 113.555 -179.135 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.409 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.6 OUTLIER -60.03 -40.01 87.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.826 -1.171 . . . . 3.74 110.181 -178.922 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -67.09 -17.59 64.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.428 -0.795 . . . . 1.12 110.908 -178.554 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 23.4 mmm180 -60.06 -48.66 80.81 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.999 -1.063 . . . . 2.51 109.141 -179.51 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -70.0 -39.96 75.55 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.728 0.775 . . . . 2.34 110.326 -179.832 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.453 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 14.6 t-20 -93.96 99.98 12.21 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.638 -0.664 . . . . 2.01 109.372 -179.406 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.449 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 62.0 mttp -97.77 -39.26 9.12 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.2 -0.938 . . . . 1.68 110.189 -179.63 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.7 mt-30 -87.66 139.79 30.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.305 -0.872 . . . . 3.98 110.107 -178.429 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.72 -59.22 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 N-CA-C 110.403 -1.079 . . . . 0.78 110.403 179.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.453 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 31.7 p-90 -82.48 -12.5 57.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.964 -1.315 . . . . 0.44 110.479 -178.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -70.0 -54.23 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.92 -1.113 . . . . 1.96 110.739 -179.099 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -70.03 -25.93 63.8 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.904 -1.123 . . . . 1.28 110.841 -178.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 86.3 p -60.11 -39.92 87.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.913 -1.117 . . . . 1.49 110.139 -178.955 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 45.2 mm -60.49 -47.94 90.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.415 -0.803 . . . . 0.64 110.604 -179.657 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' CZ ' ' CB ' ' A' ' 53' ' ' ARG . 0.5 OUTLIER -69.95 -42.53 73.08 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.882 -1.136 . . . . 2.76 110.535 -178.83 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -44.8 94.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.124 -0.985 . . . . 2.48 108.961 -178.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 94.0 m-20 -59.98 -40.14 88.07 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.204 -0.935 . . . . 2.07 109.459 -179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.463 ' CD1' HD13 ' A' ' 27' ' ' LEU . 86.6 mt -61.2 -42.18 98.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.114 -0.991 . . . . 0.78 110.446 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.7 p -66.73 -46.53 75.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.109 -0.994 . . . . 1.6 110.753 -179.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 mp -70.28 -39.91 74.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.862 -1.149 . . . . 1.38 110.249 -179.448 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.499 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 77.1 m-20 -77.7 118.01 19.65 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.136 -0.977 . . . . 1.42 109.351 -179.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -90.65 -2.96 57.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.393 -0.817 . . . . 2.17 110.017 -179.606 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.582 ' SG ' ' CD2' ' A' ' 62' ' ' PHE . 12.2 p -61.41 -32.44 72.39 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 1.56 108.868 179.545 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.582 ' CD2' ' SG ' ' A' ' 61' ' ' CYS . 90.8 m-85 -79.06 150.06 31.96 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.438 -0.789 . . . . 1.32 109.194 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.2 t -109.33 122.04 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 N-CA-C 108.777 -0.823 . . . . 0.91 108.777 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -80.78 111.55 17.34 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.379 -0.826 . . . . 1.81 110.142 -179.095 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 92.5 t -103.75 113.68 65.29 Favored Pre-proline 0 N--CA 1.495 1.777 0 N-CA-C 107.938 -1.134 . . . . 1.28 107.938 178.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.58 143.19 16.8 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.816 1.677 . . . . 1.65 112.711 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.451 ' NH1' ' O ' ' A' ' 73' ' ' GLY . 32.2 ptt180 -71.87 142.47 49.56 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.383 -0.823 . . . . 4.09 108.966 179.529 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -83.13 149.22 27.02 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.226 -0.921 . . . . 2.84 109.143 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -60.04 -39.88 87.46 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.138 -0.976 . . . . 3.46 109.679 -179.653 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -64.68 -25.42 67.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.128 -0.982 . . . . 4.5 109.32 -179.966 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 39.6 tttp -118.21 90.48 38.09 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.547 -0.721 . . . . 5.12 109.233 -179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.44 138.94 87.13 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.996 1.797 . . . . 3.63 110.853 178.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.451 ' O ' ' NH1' ' A' ' 67' ' ' ARG . . . -148.33 -178.57 23.57 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.5 -1.44 . . . . 3.15 109.5 -179.642 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.407 ' O ' ' C ' ' A' ' 75' ' ' GLY . 16.7 mtpp -96.97 138.67 34.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.246 -1.149 . . . . 4.36 109.552 -179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 74' ' ' LYS . . . 42.27 -125.94 4.14 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.814 -1.314 . . . . 2.03 109.814 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.4 p -130.06 138.72 50.89 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.666 -0.902 . . . . 1.8 108.573 179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -67.37 137.68 56.16 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.054 -1.029 . . . . 1.39 108.91 179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -120.05 139.98 51.7 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.403 -0.811 . . . . 0.46 109.843 -179.003 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 14.3 t -153.23 153.12 32.07 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.926 . . . . 0.56 109.895 179.484 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 70.0 mt -74.98 -133.81 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.561 -0.903 . . . . 1.42 108.561 179.175 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -139.8 70.69 36.67 Favored Pre-proline 0 N--CA 1.496 1.832 0 O-C-N 121.333 -0.854 . . . . 3.72 108.869 178.919 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -75.17 -145.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.895 2.396 . . . . 3.55 112.163 -179.496 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.485 ' O ' ' N ' ' A' ' 85' ' ' TYR . 28.3 p-10 -72.95 74.42 1.17 Allowed 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.088 -1.079 . . . . 6.82 108.088 179.276 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 5.1 p -50.48 -7.58 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.855 -0.528 . . . . 6.0 110.357 -179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 83' ' ' ASP . 65.6 t80 -61.13 -38.05 84.99 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.752 -1.218 . . . . 11.0 109.629 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.446 ' OD1' ' OD2' ' A' ' 83' ' ' ASP . 23.2 m120 -70.04 -17.61 63.26 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 10.0 110.702 -178.657 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.43 ' O ' ' O ' ' A' ' 86' ' ' ASN . 64.4 mtt -60.7 -155.77 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 119.42 -0.912 . . . . 8.47 108.965 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -70.39 -149.95 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.347 0 O-C-N 120.793 -1.192 . . . . 11.97 109.51 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -109.71 15.29 22.89 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.246 0.546 . . . . 11.95 109.818 -179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -153.36 152.13 30.74 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.28 -0.887 . . . . 12.32 109.611 -179.699 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 76.38 21.85 74.45 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.563 -1.415 . . . . 11.16 109.563 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.3 t -87.06 104.11 16.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.331 -1.099 . . . . 11.8 108.79 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -58.61 132.65 54.44 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 109.099 -0.704 . . . . 10.78 109.099 -179.804 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.496 1.866 0 O-C-N 121.544 -0.723 . . . . 13.12 109.748 -179.562 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.1 mtp . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.381 -0.6 . . . . 4.81 109.381 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 56.7 mt -102.31 140.1 37.04 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.433 -0.792 . . . . 1.71 109.511 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 18.1 m -135.13 148.87 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.53 -0.731 . . . . 1.79 109.38 -179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 6.3 mtmp? -70.17 128.22 91.67 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.329 -0.857 . . . . 3.69 108.789 179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -85.01 151.95 11.04 Favored 'Trans proline' 0 N--CA 1.491 1.36 0 C-N-CA 121.839 1.692 . . . . 0.73 112.635 -179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -82.25 2.52 8.47 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 122.633 2.222 . . . . 0.84 113.83 179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -63.59 140.21 58.85 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.514 -1.367 . . . . 1.15 109.48 -179.45 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 72.0 m -74.54 164.33 26.72 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.272 -0.893 . . . . 1.39 109.073 179.502 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -59.9 -40.07 87.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.166 -0.959 . . . . 1.32 108.622 179.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.633 HD11 HD21 ' A' ' 55' ' ' ASN . 32.2 mm -69.62 -40.0 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.204 -0.935 . . . . 0.96 108.973 179.591 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.02 -42.92 95.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.346 -0.846 . . . . 0.38 109.692 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 91.9 mt -59.99 -42.84 95.08 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.062 -1.024 . . . . 0.37 108.436 179.687 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.6 mt -63.49 -45.74 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.377 -0.827 . . . . 0.49 108.807 179.003 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.3 m -60.73 -40.03 90.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.411 -0.805 . . . . 0.39 109.876 -179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 67.2 mtt -67.43 -39.88 85.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.085 -1.009 . . . . 1.14 109.009 179.956 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -60.09 -49.33 78.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.43 -0.794 . . . . 0.32 109.802 -179.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 81.4 mt -59.98 -50.02 81.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.195 -1.039 . . . . 0.33 108.195 179.872 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -60.02 -39.98 87.71 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.393 0.616 . . . . 1.82 109.348 179.373 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -84.01 -0.51 51.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.369 -0.832 . . . . 1.67 109.759 -179.382 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 22' ' ' GLU . . . -78.92 126.48 82.14 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.057 -1.027 . . . . 0.63 108.836 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -38.79 -28.12 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.294 0 C-N-CA 121.785 1.657 . . . . 1.29 111.328 179.583 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 20' ' ' ALA . 12.8 pt-20 -145.69 155.28 42.88 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 108.174 -1.047 . . . . 2.63 108.174 178.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -60.05 -38.03 81.59 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.174 -0.953 . . . . 2.02 109.687 -179.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -79.07 108.25 12.41 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.082 -1.011 . . . . 1.55 109.751 -179.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 17.1 tt -133.58 154.39 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 N-CA-C 108.941 -0.763 . . . . 0.47 108.941 179.414 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 68.4 p -80.45 155.37 27.1 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.217 -0.927 . . . . 0.81 110.306 -179.597 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 25.8 tp -59.98 -43.39 95.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.584 -0.895 . . . . 0.7 108.584 179.377 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.1 -39.93 91.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.805 . . . . 1.25 109.748 178.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.36 -40.05 96.99 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 110.554 -1.018 . . . . 0.29 110.554 -179.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 81.4 mt -60.02 -41.11 85.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.08 -1.247 . . . . 0.35 110.123 -178.746 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -62.48 -38.07 88.42 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.842 -1.161 . . . . 1.4 110.012 -179.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -57.37 -44.27 84.24 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.097 -1.002 . . . . 2.51 108.872 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.5 t80 -60.16 -47.59 85.29 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.251 -0.905 . . . . 1.37 110.198 179.221 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 85.3 mt -59.93 -49.98 81.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.08 -1.012 . . . . 0.59 110.94 -178.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtm -66.78 -40.03 88.02 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 120.767 -1.208 . . . . 0.69 109.771 -179.462 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -70.32 -43.05 71.09 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.971 -1.08 . . . . 1.17 110.677 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.535 ' NH1' ' CE1' ' A' ' 38' ' ' PHE . 0.3 OUTLIER -69.96 -40.0 75.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.863 -1.148 . . . . 3.0 109.516 -179.651 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.535 ' CE1' ' NH1' ' A' ' 37' ' ' ARG . 62.7 m-85 -127.81 78.17 75.39 Favored Pre-proline 0 N--CA 1.499 1.979 0 O-C-N 121.307 -0.87 . . . . 1.54 109.44 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_exo -46.68 -7.22 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 122.754 2.303 . . . . 1.21 112.434 179.694 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.513 ' N ' ' O ' ' A' ' 38' ' ' PHE . 40.3 t80 -59.92 -39.3 85.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.207 -0.933 . . . . 3.74 109.4 179.497 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.441 ' O ' ' O ' ' A' ' 44' ' ' ASN . 78.6 m-85 -69.81 -20.96 63.43 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.503 -0.748 . . . . 1.12 110.943 -178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -59.99 -39.76 86.83 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.593 -1.317 . . . . 2.51 108.758 179.034 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 55.3 mp0 -77.91 -9.46 59.09 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.286 -0.884 . . . . 2.34 109.95 -179.674 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.504 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 82.9 m-20 -129.27 116.9 19.83 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.608 -0.683 . . . . 2.01 110.237 -179.85 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 67.0 mttm -109.99 11.73 23.93 Favored 'General case' 0 N--CA 1.496 1.854 0 N-CA-C 108.717 -0.845 . . . . 1.68 108.717 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.538 ' O ' ' N ' ' A' ' 48' ' ' TRP . 95.8 mm-40 -48.24 177.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 122.001 0.905 . . . . 3.98 111.857 -178.315 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.431 ' C ' ' N ' ' A' ' 49' ' ' GLN . . . -42.28 -15.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.338 0 CA-C-N 115.779 -0.646 . . . . 0.78 111.509 -178.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.538 ' N ' ' O ' ' A' ' 46' ' ' GLN . 9.2 p-90 -51.18 -20.78 1.67 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.514 -1.58 . . . . 0.44 107.893 179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.431 ' N ' ' C ' ' A' ' 47' ' ' GLY . 30.1 tt0 -86.37 -57.13 3.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.28 -0.637 . . . . 1.96 109.28 179.764 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.9 -33.96 72.89 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.381 -0.824 . . . . 1.28 109.589 -179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 74.1 m -60.04 -39.95 87.73 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 1.49 108.929 -179.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 10.5 mm -60.13 -49.88 82.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.539 -0.725 . . . . 0.64 109.65 179.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 45.0 mtt180 -61.9 -44.54 96.6 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.968 -1.083 . . . . 2.76 108.768 -179.752 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 58.2 t60 -60.01 -41.48 92.23 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.295 -0.878 . . . . 2.48 108.88 179.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.633 HD21 HD11 ' A' ' 10' ' ' ILE . 37.7 t-20 -63.89 -40.1 95.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.567 -0.708 . . . . 2.07 109.341 -179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 77.0 mt -59.99 -47.81 84.27 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.12 -0.987 . . . . 0.78 109.691 179.93 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.4 m -62.6 -40.13 95.95 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.117 -0.989 . . . . 1.6 109.164 179.397 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.458 ' O ' HD23 ' A' ' 58' ' ' LEU . 3.3 tt -65.84 -50.39 64.76 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.859 -0.525 . . . . 1.38 110.16 -178.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -69.98 117.47 11.6 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 118.844 -1.142 . . . . 1.42 108.724 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -90.1 -2.47 58.1 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 108.476 -0.935 . . . . 2.17 108.476 -179.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 96.1 m -60.08 -39.12 84.98 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 109.254 -0.647 . . . . 1.56 109.254 179.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -78.29 150.31 33.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.358 -0.839 . . . . 1.32 109.418 -179.606 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 94.0 t -110.7 125.87 68.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.447 -0.783 . . . . 0.91 109.464 179.94 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.49 139.83 51.74 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 107.957 -1.127 . . . . 1.81 107.957 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.09 77.36 61.81 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 121.201 -0.937 . . . . 1.28 109.366 179.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.5 169.23 0.8 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.459 2.106 . . . . 1.65 111.557 179.276 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.572 ' CZ ' ' H ' ' A' ' 74' ' ' LYS . 32.2 mtm180 -83.01 174.94 10.43 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.165 -0.959 . . . . 4.09 108.758 179.434 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -58.97 150.69 23.81 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.307 -0.87 . . . . 2.84 108.721 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -68.9 -18.62 64.14 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.187 -0.946 . . . . 3.46 109.331 -179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 66.2 mmtt -62.01 -40.0 94.16 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 4.5 108.766 179.803 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.504 ' C ' ' H ' ' A' ' 73' ' ' GLY . 21.8 mmtp -81.62 150.53 66.68 Favored Pre-proline 0 C--N 1.303 -1.427 0 N-CA-C 108.354 -0.98 . . . . 5.12 108.354 179.648 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.71 13.72 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.81 1.673 . . . . 3.63 112.238 -179.399 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.504 ' H ' ' C ' ' A' ' 71' ' ' LYS . . . 56.78 78.98 0.1 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.918 -1.273 . . . . 3.15 109.918 179.407 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.572 ' H ' ' CZ ' ' A' ' 67' ' ' ARG . 68.1 mttm -67.64 -32.52 73.28 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.221 -1.164 . . . . 4.36 109.937 179.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -168.35 -161.51 18.43 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.496 -1.442 . . . . 2.03 109.496 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 26.8 t -133.41 122.57 23.92 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.543 -0.975 . . . . 1.8 109.437 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -75.4 176.73 7.21 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 1.39 108.551 179.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -138.37 149.96 46.09 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.281 -0.887 . . . . 0.46 109.511 179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 8.8 t -157.23 159.34 37.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.091 -1.005 . . . . 0.56 110.003 179.753 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.464 ' O ' ' O ' ' A' ' 81' ' ' ASP . 77.4 mt -74.82 171.21 14.39 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.502 -0.925 . . . . 1.42 108.502 179.225 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.464 ' O ' ' O ' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -49.24 175.73 0.05 OUTLIER Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.231 -0.918 . . . . 3.72 108.717 -179.893 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -64.88 -143.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 121.874 1.716 . . . . 3.55 111.897 -178.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.563 ' O ' ' N ' ' A' ' 85' ' ' TYR . 74.2 m-20 -95.49 32.03 1.88 Allowed 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.723 -0.843 . . . . 6.82 108.723 179.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.1 t -63.47 67.88 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.112 -0.699 . . . . 6.0 109.112 -179.649 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.563 ' N ' ' O ' ' A' ' 83' ' ' ASP . 14.4 t80 -80.02 -69.76 0.57 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.291 -0.88 . . . . 11.0 109.304 -179.449 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -118.6 20.67 12.88 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.62 -0.675 . . . . 10.0 109.735 179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . . . . . . . . . 1.8 mpt? -83.5 96.3 8.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 8.47 109.186 179.648 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 55.7 m-85 -106.07 -0.95 24.38 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 108.964 -0.754 . . . . 11.97 108.964 179.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -77.32 -160.71 0.18 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.47 -0.769 . . . . 11.95 109.138 179.831 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -66.95 -14.22 62.61 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.043 -1.036 . . . . 12.32 109.538 -179.769 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 110.64 77.07 0.89 Allowed Glycine 0 N--CA 1.496 2.653 0 N-CA-C 109.561 -1.416 . . . . 11.16 109.561 179.793 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.4 t -101.13 85.46 2.83 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.409 -1.054 . . . . 11.8 108.877 179.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -60.07 -49.95 75.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 10.78 109.551 -179.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.1 mt . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 13.12 109.346 179.858 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 tpp . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.143 -0.688 . . . . 4.81 109.143 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 81.5 mt -113.25 139.4 48.84 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.349 -0.611 . . . . 1.71 109.349 -179.744 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.1 m -130.03 160.01 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.625 -0.672 . . . . 1.79 109.312 179.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 38.4 mtmt -66.74 149.74 98.08 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.094 -1.004 . . . . 3.69 110.035 -179.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.92 160.59 33.73 Favored 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.624 2.216 . . . . 0.73 111.618 178.952 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -73.26 4.37 3.9 Favored 'Trans proline' 0 N--CA 1.495 1.57 0 C-N-CA 122.481 2.121 . . . . 0.84 113.285 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -82.17 135.89 35.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.718 -1.239 . . . . 1.15 109.136 179.975 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 43.5 t -71.72 162.54 29.29 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.215 -0.928 . . . . 1.39 108.634 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -59.67 -39.9 85.99 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.93 -1.106 . . . . 1.32 108.629 -179.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 92.4 mt -65.43 -39.98 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.337 -0.852 . . . . 0.96 108.981 179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.15 87.47 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.341 -0.85 . . . . 0.38 109.884 179.913 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 94.9 mt -60.05 -41.68 92.85 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.884 -1.135 . . . . 0.37 108.792 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.516 HG21 HD21 ' A' ' 56' ' ' LEU . 92.2 mt -70.0 -41.98 79.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.372 -0.83 . . . . 0.49 109.663 179.631 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 90.7 m -60.41 -42.53 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.147 -0.971 . . . . 0.39 109.448 -179.197 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 74.5 mtm -69.92 -36.83 75.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.402 -0.811 . . . . 1.14 109.839 179.761 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.15 -45.5 90.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.343 -0.848 . . . . 0.32 109.494 -179.596 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 83.4 mt -59.98 -49.94 82.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 N-CA-C 108.39 -0.967 . . . . 0.33 108.39 179.651 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -61.68 -39.95 93.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.447 -0.783 . . . . 1.82 109.324 179.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -80.48 3.82 20.27 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.41 -0.806 . . . . 1.67 109.748 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.7 147.58 71.34 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.105 -0.997 . . . . 0.63 109.356 -179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -65.98 -20.68 57.46 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 C-N-CA 121.851 1.701 . . . . 1.29 110.041 179.15 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -144.25 149.6 36.59 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 107.843 -1.169 . . . . 2.63 107.843 178.24 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm -60.6 -39.89 89.76 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.15 -0.969 . . . . 2.02 110.297 -178.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -77.86 124.78 28.41 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.923 -1.111 . . . . 1.55 109.017 -179.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.8 tt -138.83 142.72 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.382 -0.824 . . . . 0.47 109.394 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 26.4 p -79.89 157.92 26.82 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.362 -0.836 . . . . 0.81 109.223 -179.895 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 12.5 tp -60.01 -40.23 88.52 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.313 -0.867 . . . . 0.7 109.392 -179.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.6 m120 -60.03 -41.94 93.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.359 -0.838 . . . . 1.25 110.57 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -62.09 -38.56 96.31 Favored Glycine 0 N--CA 1.494 2.516 0 O-C-N 121.193 -0.942 . . . . 0.29 111.203 -178.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.7 mt -59.97 -40.02 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.065 -1.256 . . . . 0.35 109.79 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.403 ' OH ' ' CG ' ' A' ' 53' ' ' ARG . 33.3 m-85 -59.96 -39.95 87.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.11 -0.994 . . . . 1.4 110.029 179.629 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -59.68 -40.01 86.43 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.367 -0.833 . . . . 2.51 110.137 -178.251 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 52.3 t80 -60.52 -40.36 91.15 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 1.37 109.896 -179.91 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 26.0 mm -61.44 -61.65 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 O-C-N 121.107 -0.996 . . . . 0.59 110.624 -179.192 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.5 mtm -59.98 -40.03 87.72 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.388 -0.82 . . . . 0.69 110.446 -178.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -61.14 -40.12 92.63 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 1.17 110.471 -179.105 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -89.17 -55.77 3.54 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.021 -1.049 . . . . 3.0 110.063 -179.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.9 m-85 -96.05 112.47 59.63 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 120.973 -1.079 . . . . 1.54 108.688 179.792 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -79.96 -7.44 14.32 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 121.815 1.677 . . . . 1.21 111.884 -179.472 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 36.7 t80 -60.01 -40.06 87.96 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.464 -0.773 . . . . 3.74 110.229 -179.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -70.98 -13.13 61.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.284 -0.885 . . . . 1.12 110.874 -178.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.479 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 21.1 mmm180 -59.99 -40.03 87.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.096 -1.002 . . . . 2.51 110.735 -179.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -87.32 0.08 55.98 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.955 -1.091 . . . . 2.34 110.339 -178.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.514 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 68.7 m-80 -133.96 108.55 8.46 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.763 -0.829 . . . . 2.01 108.763 179.144 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.479 ' NZ ' ' O ' ' A' ' 42' ' ' ARG . 61.1 mttp -111.97 -29.97 7.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.681 -0.637 . . . . 1.68 110.051 -179.13 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -90.66 139.42 30.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.185 -0.947 . . . . 3.98 109.781 -179.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.27 -64.19 0.31 Allowed Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.435 -1.066 . . . . 0.78 110.435 179.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.514 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 23.1 p-90 -77.05 -20.06 56.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.962 -1.316 . . . . 0.44 110.478 -178.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.623 ' NE2' ' NH2' ' A' ' 53' ' ' ARG . 66.7 tt0 -62.29 -52.3 64.24 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.047 -1.033 . . . . 1.96 110.628 -179.715 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -68.97 -35.06 76.3 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.238 -0.914 . . . . 1.28 110.194 -178.896 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 73.2 m -59.97 -40.07 87.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 1.49 109.746 -179.001 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.4 mm -60.91 -45.99 97.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.64 110.25 179.742 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.623 ' NH2' ' NE2' ' A' ' 49' ' ' GLN . 41.7 mtt180 -69.52 -40.12 77.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.951 -1.093 . . . . 2.76 109.888 -178.83 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 32.1 m170 -60.14 -40.15 88.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.051 -1.03 . . . . 2.48 108.765 179.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.422 ' O ' ' ND2' ' A' ' 59' ' ' ASN . 95.2 m-20 -61.85 -39.95 93.63 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.54 -0.911 . . . . 2.07 108.54 179.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.516 HD21 HG21 ' A' ' 13' ' ' ILE . 78.1 mt -70.0 -40.02 75.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.374 -0.829 . . . . 0.78 110.267 179.805 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.5 p -74.56 -44.88 48.84 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.21 -0.931 . . . . 1.6 110.495 -179.28 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 81.6 mt -68.65 -39.9 80.5 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.169 -0.957 . . . . 1.38 110.214 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.422 ' ND2' ' O ' ' A' ' 55' ' ' ASN . 96.1 m-20 -66.19 120.3 12.99 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.297 -1.001 . . . . 1.42 108.297 -179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.433 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 25.7 mp0 -87.81 -10.97 49.34 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 121.272 -0.893 . . . . 2.17 109.361 -179.062 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.9 m -64.14 -40.01 95.24 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.451 -0.78 . . . . 1.56 109.926 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 59.7 m-85 -79.6 127.93 32.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.062 -1.024 . . . . 1.32 109.736 -179.413 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.4 t -115.37 124.72 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 N-CA-C 108.454 -0.943 . . . . 0.91 108.454 179.408 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 16.2 pttp -94.15 150.66 20.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.081 -1.012 . . . . 1.81 110.511 -179.438 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.97 86.62 25.96 Favored Pre-proline 0 N--CA 1.496 1.863 0 N-CA-C 107.722 -1.214 . . . . 1.28 107.722 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_exo -42.87 167.61 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.485 0 C-N-CA 122.618 2.212 . . . . 1.65 113.694 -178.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.687 HH22 ' N ' ' A' ' 73' ' ' GLY . 84.9 mtm180 -86.11 -179.38 6.73 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.944 -0.762 . . . . 4.09 108.944 179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -64.51 151.37 44.63 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 108.313 -0.995 . . . . 2.84 108.313 178.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -66.0 -19.97 66.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.025 -1.047 . . . . 3.46 109.612 -179.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -94.91 2.52 55.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.192 -0.942 . . . . 4.5 110.681 -179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 37.7 tttp -129.96 80.03 71.97 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.123 -0.986 . . . . 5.12 110.084 -179.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.524 ' C ' HH12 ' A' ' 67' ' ' ARG . 66.9 Cg_endo -90.44 -165.91 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 123.414 2.743 . . . . 3.63 112.005 179.273 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.687 ' N ' HH22 ' A' ' 67' ' ' ARG . . . 107.46 -85.06 0.4 Allowed Glycine 0 N--CA 1.498 2.824 0 O-C-N 121.191 -0.943 . . . . 3.15 111.502 178.842 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.541 ' N ' ' NH1' ' A' ' 67' ' ' ARG . 24.5 mtpp -66.59 166.94 11.81 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -1.153 . . . . 4.36 111.39 -178.087 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -70.14 178.84 29.41 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.85 -1.3 . . . . 2.03 109.85 -179.674 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 84.4 p -80.17 169.34 17.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.354 -1.086 . . . . 1.8 110.047 -179.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 50.0 m-85 -90.38 144.91 25.37 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 1.39 109.418 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 88.0 m95 -120.05 139.36 52.65 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.536 -0.727 . . . . 0.46 109.458 179.304 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 6.2 t -150.65 167.52 27.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.49 -0.756 . . . . 0.56 109.168 -179.759 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 98.1 mt -70.96 168.41 17.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.215 -0.928 . . . . 1.42 109.495 179.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -60.13 128.71 87.76 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.383 -0.823 . . . . 3.72 109.605 -178.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -83.76 -152.73 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.5 0 C-N-CA 122.302 2.002 . . . . 3.55 111.617 179.621 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -76.18 71.67 2.93 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 107.747 -1.205 . . . . 6.82 107.747 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.9 p -69.99 -17.25 63.28 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.653 -0.654 . . . . 6.0 110.64 -178.496 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -63.04 -32.88 74.35 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.835 -1.166 . . . . 11.0 108.809 -179.603 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.419 ' O ' ' O ' ' A' ' 87' ' ' MET . 28.0 m120 -97.97 19.41 13.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.281 -0.887 . . . . 10.0 109.662 -179.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.419 ' O ' ' O ' ' A' ' 86' ' ' ASN . 0.1 OUTLIER -48.11 175.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.447 -0.783 . . . . 8.47 109.692 179.926 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -81.75 73.32 8.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.209 -0.932 . . . . 11.97 108.559 179.379 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . 0.407 ' OE1' ' O ' ' A' ' 91' ' ' GLY . 10.6 pt-20 -65.26 143.47 57.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 11.95 109.721 -179.414 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -94.98 13.5 24.8 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.416 -0.803 . . . . 12.32 109.698 -179.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.407 ' O ' ' OE1' ' A' ' 89' ' ' GLU . . . -169.66 -125.77 0.82 Allowed Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.874 -1.155 . . . . 11.16 110.228 -179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 52.3 p -135.12 46.38 2.42 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -1.001 . . . . 11.8 109.416 -179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -59.97 -40.57 89.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 10.78 111.347 -179.432 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 62.3 tp . . . . . 0 N--CA 1.492 1.654 0 O-C-N 120.674 -1.266 . . . . 13.12 109.337 -178.983 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.4 tpt . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.03 -0.73 . . . . 4.81 109.03 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 64.6 mt -85.95 147.73 26.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.514 -0.742 . . . . 1.71 109.095 179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.6 m -144.54 142.51 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.166 -0.959 . . . . 1.79 109.754 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 35.0 mmtm -78.17 140.7 61.64 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.364 -0.835 . . . . 3.69 108.749 179.735 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.37 159.61 39.82 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.024 1.816 . . . . 0.73 111.967 -179.849 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -76.7 -6.42 16.88 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.486 2.124 . . . . 0.84 112.51 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 -66.9 131.78 46.6 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.882 -1.136 . . . . 1.15 108.944 -179.791 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 23.0 t -72.08 162.99 28.67 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.227 -0.921 . . . . 1.39 108.906 179.739 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -60.01 -33.93 72.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.114 -0.991 . . . . 1.32 108.561 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.5 mm -68.8 -40.03 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.401 -0.962 . . . . 0.96 108.401 179.229 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.16 90.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.42 -0.8 . . . . 0.38 110.105 -179.763 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 83.1 mt -59.99 -39.99 87.61 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.071 -1.018 . . . . 0.37 108.368 179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 95.4 mt -69.08 -40.11 80.33 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.377 -0.827 . . . . 0.49 108.867 179.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.8 m -67.92 -40.33 83.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.877 . . . . 0.39 110.641 -179.631 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 76.5 mtm -70.02 -37.43 75.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.962 -1.086 . . . . 1.14 109.985 -179.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -57.68 -43.34 85.0 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.433 -0.792 . . . . 0.32 109.761 -179.333 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 85.3 mt -60.01 -47.38 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.205 -0.934 . . . . 0.33 108.867 179.874 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.459 ' NE2' ' NZ ' ' A' ' 23' ' ' LYS . 98.7 mm-40 -68.43 -40.04 81.33 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.624 -0.672 . . . . 1.82 110.004 -179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -74.71 -13.26 60.59 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.328 -0.858 . . . . 1.67 110.387 -179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.9 150.21 74.88 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.107 -0.996 . . . . 0.63 109.665 -179.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -65.4 -41.6 15.26 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.019 1.812 . . . . 1.29 110.414 179.164 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -118.03 132.57 56.36 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 107.445 -1.317 . . . . 2.63 107.445 178.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' NE2' ' A' ' 18' ' ' GLN . 68.5 mttm -69.0 -21.57 64.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.137 -0.977 . . . . 2.02 109.981 -178.455 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -79.86 33.13 0.26 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 1.55 109.226 179.645 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.401 ' H ' ' C ' ' A' ' 23' ' ' LYS . 16.0 tt -56.87 154.54 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.47 109.469 -179.976 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 69.3 p -79.97 162.43 24.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.274 -0.891 . . . . 0.81 110.152 -179.366 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.6 tp -59.99 -50.01 75.42 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 108.481 -0.933 . . . . 0.7 108.481 -179.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.6 m120 -60.51 -39.98 89.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.579 -0.701 . . . . 1.25 110.306 179.686 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -54.14 -38.55 61.49 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.389 -1.484 . . . . 0.29 109.389 -179.411 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 96.9 mt -60.24 -41.54 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.207 -1.172 . . . . 0.35 109.741 -179.976 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 23.9 m-85 -60.0 -43.35 95.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.12 -0.987 . . . . 1.4 109.952 -179.54 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -59.99 -40.01 87.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.375 -0.828 . . . . 2.51 109.743 -179.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -60.03 -45.54 92.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.429 -0.794 . . . . 1.37 110.001 -179.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 71.5 mt -64.66 -49.95 77.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.09 -1.006 . . . . 0.59 110.711 -179.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 77.6 mtm -63.04 -42.86 99.86 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 0.69 111.03 -178.466 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -70.1 -40.13 75.11 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.855 -1.153 . . . . 1.17 111.148 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 29.8 mmt180 -70.08 -40.23 75.13 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.908 -1.12 . . . . 3.0 109.88 -179.222 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.13 117.49 31.99 Favored Pre-proline 0 N--CA 1.496 1.859 0 N-CA-C 107.986 -1.116 . . . . 1.54 107.986 179.595 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.76 -9.48 17.02 Favored 'Trans proline' 0 N--CA 1.494 1.545 0 C-N-CA 121.838 1.692 . . . . 1.21 112.463 -178.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.523 ' CD1' ' N ' ' A' ' 40' ' ' PHE . 0.4 OUTLIER -59.97 -39.56 86.07 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.276 -0.89 . . . . 3.74 108.999 179.936 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 88.0 m-85 -70.08 -26.54 64.05 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.569 -0.707 . . . . 1.12 110.559 -179.064 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 50.7 mtp180 -59.99 -33.59 72.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.927 -1.108 . . . . 2.51 108.796 179.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -93.01 9.98 33.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.21 -0.931 . . . . 2.34 109.532 179.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.503 ' O ' ' NE1' ' A' ' 48' ' ' TRP . 60.3 t30 -139.04 125.6 20.59 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.357 -0.84 . . . . 2.01 109.813 -179.941 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -124.48 15.14 8.89 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.739 -0.838 . . . . 1.68 108.739 -179.857 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 48' ' ' TRP . 91.7 mm-40 -61.18 -169.18 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 CA-C-O 122.142 0.972 . . . . 3.98 112.085 -177.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.05 -8.48 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 CA-C-N 115.669 -0.696 . . . . 0.78 111.633 -178.469 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.503 ' NE1' ' O ' ' A' ' 44' ' ' ASN . 7.0 p-90 -60.02 -27.7 67.12 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.476 -1.602 . . . . 0.44 107.947 179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -70.04 -58.45 3.82 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.534 -0.729 . . . . 1.96 110.947 179.577 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -61.79 -39.97 93.58 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.836 -1.165 . . . . 1.28 110.97 -178.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 28.0 t -56.95 -32.08 65.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.199 -0.938 . . . . 1.49 110.833 -178.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 4.8 mm -62.09 -57.32 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.93 -1.106 . . . . 0.64 111.342 -178.505 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 14.1 ptm180 -83.59 -29.07 28.07 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.736 -1.227 . . . . 2.76 110.359 -178.84 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -60.05 -40.02 87.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.041 -1.037 . . . . 2.48 109.633 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -69.42 -24.11 63.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.251 -0.906 . . . . 2.07 110.525 -178.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 86.4 mt -60.96 -40.03 91.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.806 -1.184 . . . . 0.78 109.494 -179.884 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 48.1 t -60.9 -48.07 83.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.246 -0.909 . . . . 1.6 110.142 -179.743 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.599 HD12 ' N ' ' A' ' 58' ' ' LEU . 8.7 mp -68.29 -40.09 81.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.055 -1.028 . . . . 1.38 109.348 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -79.91 113.58 18.18 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.185 -0.947 . . . . 1.42 109.022 179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -89.88 1.17 56.52 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.602 -0.888 . . . . 2.17 108.602 -179.787 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 93.2 m -60.04 -36.91 78.31 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.681 -0.637 . . . . 1.56 109.4 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -78.51 161.44 27.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.232 -0.918 . . . . 1.32 109.583 -179.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 48.2 t -117.63 130.06 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.543 -0.723 . . . . 0.91 109.636 -179.352 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -86.96 127.02 35.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.259 -0.901 . . . . 1.81 109.967 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.418 ' O ' ' O ' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -132.38 71.74 79.0 Favored Pre-proline 0 N--CA 1.497 1.892 0 N-CA-C 108.581 -0.896 . . . . 1.28 108.581 178.686 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.418 ' O ' ' O ' ' A' ' 65' ' ' VAL . 81.1 Cg_exo -44.63 177.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.65 2.233 . . . . 1.65 112.272 -179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . . . . . . . . . 64.6 mtt180 -75.18 160.73 30.08 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.199 -0.938 . . . . 4.09 108.67 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 6.9 t0 -58.04 166.69 1.46 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.043 -1.036 . . . . 2.84 109.114 -179.703 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 99.0 m-20 -68.08 -25.79 65.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 3.46 109.548 -179.735 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -60.11 -40.01 88.17 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 4.5 109.648 179.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.548 ' O ' ' N ' ' A' ' 73' ' ' GLY . 24.7 mmtm -79.63 139.29 54.64 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.081 -1.012 . . . . 5.12 109.253 -179.862 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -43.96 -10.62 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.585 0 C-N-CA 122.06 1.84 . . . . 3.63 113.009 179.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 71' ' ' LYS . . . 86.65 50.24 3.84 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 109.87 -1.292 . . . . 3.15 109.87 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -85.42 144.18 28.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.204 -1.174 . . . . 4.36 109.721 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 47.18 -162.18 0.25 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.661 -1.376 . . . . 2.03 109.661 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.9 p -157.08 130.75 8.11 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -1.105 . . . . 1.8 108.911 179.695 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 77' ' ' TYR . 5.7 m-30 -80.36 160.01 25.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.29 -0.881 . . . . 1.39 109.001 179.633 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -134.51 143.13 47.27 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.458 -0.776 . . . . 0.46 109.67 -179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . . . . . . . . . 10.6 t -149.54 166.19 29.95 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.132 -0.98 . . . . 0.56 109.208 179.721 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 50.3 mt -101.84 119.72 39.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.181 -0.949 . . . . 1.42 109.971 -179.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -171.71 73.76 0.49 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.264 -0.898 . . . . 3.72 110.116 179.215 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -60.91 -143.33 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 122.697 2.264 . . . . 3.55 111.82 -179.795 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.555 ' O ' ' N ' ' A' ' 85' ' ' TYR . 40.5 m-20 -88.62 44.59 1.22 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.187 -0.946 . . . . 6.82 108.853 179.532 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.0 m -62.62 71.43 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.561 -0.712 . . . . 6.0 109.277 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.555 ' N ' ' O ' ' A' ' 83' ' ' ASP . 83.0 t80 -61.64 -44.87 96.17 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.463 -0.773 . . . . 11.0 109.941 -179.804 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . 0.419 ' OD1' ' CE1' ' A' ' 88' ' ' PHE . 50.1 t-20 -140.44 31.1 1.91 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.277 -0.889 . . . . 10.0 109.011 -179.984 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.405 ' O ' ' O ' ' A' ' 90' ' ' ASN . 15.0 mmt -89.58 2.37 54.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.48 -0.763 . . . . 8.47 109.912 -179.103 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.419 ' CE1' ' OD1' ' A' ' 86' ' ' ASN . 49.6 p90 -70.04 -20.09 63.27 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.305 -0.872 . . . . 11.97 109.385 179.846 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -61.23 -40.02 92.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.241 -0.912 . . . . 11.95 109.684 179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.405 ' O ' ' O ' ' A' ' 87' ' ' MET . 28.9 m120 -140.05 148.13 41.35 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.159 -0.682 . . . . 12.32 109.159 179.513 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -99.95 10.17 60.24 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 109.968 -1.253 . . . . 11.16 109.968 -179.716 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.2 m -130.27 78.38 1.84 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.442 -1.034 . . . . 11.8 109.895 -179.532 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.536 ' O ' ' CD2' ' A' ' 93' ' ' PHE . 13.7 p90 -108.39 97.88 7.49 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.782 -0.821 . . . . 10.78 108.782 179.242 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.679 HD23 ' O ' ' A' ' 94' ' ' LEU . 3.7 tt . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.159 -0.963 . . . . 13.12 110.121 -179.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.9 ttm . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.152 -0.685 . . . . 4.81 109.152 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 87.9 mt -109.92 143.45 39.84 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.475 -0.765 . . . . 1.71 109.196 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -139.62 158.62 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.306 -0.871 . . . . 1.79 109.032 179.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.444 ' H ' ' HD3' ' A' ' 4' ' ' LYS . 0.0 OUTLIER -70.27 146.84 94.93 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.047 -1.033 . . . . 3.69 108.928 179.784 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -77.2 159.23 33.45 Favored 'Trans proline' 0 N--CA 1.492 1.408 0 C-N-CA 122.099 1.866 . . . . 0.73 112.078 179.882 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -80.69 10.06 3.48 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.472 2.115 . . . . 0.84 112.7 179.724 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -85.16 140.26 31.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.888 -1.133 . . . . 1.15 109.572 -179.342 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 85.7 p -80.04 170.38 16.54 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.395 -0.815 . . . . 1.39 108.872 179.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -60.0 -40.15 88.2 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.109 -0.994 . . . . 1.32 109.154 -179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 40.8 mm -61.09 -48.07 90.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.402 -0.812 . . . . 0.96 109.002 179.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -43.47 98.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 0.38 110.295 -179.555 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 89.5 mt -59.93 -44.01 94.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.939 -1.101 . . . . 0.37 109.189 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . . . . . . . . . 96.2 mt -70.01 -39.98 78.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.186 -0.946 . . . . 0.49 109.264 179.415 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 94.2 m -62.93 -40.54 97.95 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.39 109.821 -179.558 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 78.6 mtm -70.04 -36.57 75.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.306 -0.872 . . . . 1.14 109.335 179.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -59.18 -45.97 89.62 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.326 -0.859 . . . . 0.32 109.658 -179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 86.9 mt -60.0 -50.08 81.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.078 -1.014 . . . . 0.33 109.983 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -69.95 -37.96 76.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.717 -0.614 . . . . 1.82 110.46 -179.27 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -75.83 -1.5 25.51 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.177 -0.952 . . . . 1.67 110.085 -179.062 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -78.19 147.91 73.71 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.079 -1.013 . . . . 0.63 109.528 -179.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -66.02 -19.57 57.62 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 121.8 1.667 . . . . 1.29 109.9 178.935 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -130.71 138.26 49.91 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 107.143 -1.428 . . . . 2.63 107.143 178.517 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -60.0 -39.97 87.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 120.943 -1.098 . . . . 2.02 109.156 -178.585 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 59.8 mttp -79.3 130.79 35.8 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.181 -0.949 . . . . 1.55 108.719 179.693 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 20.6 tt -140.06 148.64 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 0.47 109.473 -179.169 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 82.7 p -83.62 167.05 17.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.81 110.148 -179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 19.4 tp -59.94 -49.72 76.57 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.077 -1.083 . . . . 0.7 108.077 179.564 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -60.08 -40.02 88.11 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 115.986 -0.552 . . . . 1.25 110.392 179.098 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -58.86 -39.91 94.52 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 110.384 -1.086 . . . . 0.29 110.384 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 94.9 mt -60.11 -43.39 92.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.043 -1.269 . . . . 0.35 109.645 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.6 m-85 -60.02 -40.0 87.79 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.963 -1.086 . . . . 1.4 110.821 179.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -59.95 -42.72 94.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.899 -1.126 . . . . 2.51 110.74 -178.237 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -59.98 -48.56 81.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -0.934 . . . . 1.37 111.414 -179.16 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 97.1 mt -59.93 -49.98 81.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.944 -1.097 . . . . 0.59 111.401 -177.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 21.5 mtm -59.99 -46.14 90.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.849 -1.157 . . . . 0.69 110.673 -178.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -70.09 -39.89 75.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.885 -1.134 . . . . 1.17 110.064 -179.816 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -69.09 -39.97 78.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.371 -0.831 . . . . 3.0 110.378 -178.679 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.528 ' O ' ' N ' ' A' ' 40' ' ' PHE . 67.3 m-85 -131.34 80.04 68.7 Favored Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 121.309 -0.869 . . . . 1.54 110.148 -179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -45.72 -9.44 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.698 2.265 . . . . 1.21 112.02 179.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.528 ' N ' ' O ' ' A' ' 38' ' ' PHE . 31.5 t80 -60.06 -39.93 87.74 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.464 -0.773 . . . . 3.74 109.833 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -68.2 -20.76 64.88 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.123 -0.986 . . . . 1.12 110.904 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.415 ' HG2' ' NH1' ' A' ' 42' ' ' ARG . 61.5 mtt-85 -60.03 -40.08 88.11 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.817 -1.177 . . . . 2.51 109.532 -179.838 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -63.38 -40.12 96.38 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.142 -0.974 . . . . 2.34 110.132 -179.611 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -105.82 106.08 16.42 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.813 -0.554 . . . . 2.01 109.795 -179.896 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HA ' ' HE1' ' A' ' 48' ' ' TRP . 66.8 mttm -97.38 -39.69 9.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.245 -0.909 . . . . 1.68 110.533 179.855 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.81 145.8 31.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.003 -1.061 . . . . 3.98 109.894 -179.54 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.2 -72.64 0.28 Allowed Glycine 0 N--CA 1.493 2.496 0 N-CA-C 110.748 -0.941 . . . . 0.78 110.748 179.121 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TRP . . . . . 0.474 ' HE1' ' HA ' ' A' ' 45' ' ' LYS . 20.2 p-90 -69.99 -23.94 63.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.016 -1.285 . . . . 0.44 111.438 -178.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -60.08 -50.47 73.6 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.668 -1.27 . . . . 1.96 111.407 -178.516 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -73.84 -33.56 64.18 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.778 -1.201 . . . . 1.28 111.32 -178.929 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 81.3 p -59.9 -36.37 76.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.069 -1.02 . . . . 1.49 110.757 -178.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.2 mm -60.04 -49.85 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.938 -1.101 . . . . 0.64 110.314 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 -70.08 -39.38 75.63 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.222 -0.924 . . . . 2.76 110.622 -179.572 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' HIS . . . . . . . . . . . . . 64.7 m170 -60.02 -39.86 87.29 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.029 -1.044 . . . . 2.48 108.514 -179.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -60.01 -40.01 87.8 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.051 -1.092 . . . . 2.07 108.051 179.243 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 56' ' ' LEU . 91.6 mt -66.72 -40.05 88.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.49 -0.757 . . . . 0.78 109.646 179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 88.8 p -75.01 -49.3 20.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.091 -1.005 . . . . 1.6 109.99 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 33.3 mt -64.17 -40.19 95.6 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.054 -1.029 . . . . 1.38 109.274 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . 0.448 ' OD1' ' SG ' ' A' ' 61' ' ' CYS . 8.9 t-20 -83.95 116.93 23.04 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.402 -0.962 . . . . 1.42 108.402 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -88.94 1.75 54.95 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.39 -0.819 . . . . 2.17 109.94 -178.634 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.448 ' SG ' ' OD1' ' A' ' 59' ' ' ASN . 96.8 m -59.97 -39.96 87.46 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.173 -0.954 . . . . 1.56 108.638 179.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -78.95 146.14 33.62 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.475 -0.766 . . . . 1.32 108.976 -179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 56.8 t -121.15 129.96 75.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 108.419 -0.956 . . . . 0.91 108.419 179.745 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -67.25 139.08 57.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.006 -1.059 . . . . 1.81 109.905 -179.579 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 66.8 t -112.4 119.98 42.41 Favored Pre-proline 0 N--CA 1.495 1.791 0 N-CA-C 108.556 -0.905 . . . . 1.28 108.556 179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.86 178.84 6.91 Favored 'Trans proline' 0 C--N 1.313 -1.338 0 C-N-CA 121.531 1.488 . . . . 1.65 112.268 -179.287 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.48 ' NE ' ' O ' ' A' ' 74' ' ' LYS . 20.0 ptt-85 -138.1 159.02 43.13 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.535 -0.728 . . . . 4.09 109.112 -179.886 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 69' ' ' ASP . 36.2 t0 -64.99 169.33 5.41 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.115 -0.991 . . . . 2.84 108.497 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.431 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 72.5 m-20 -89.68 -3.34 58.27 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.135 -0.978 . . . . 3.46 109.97 -179.393 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -93.09 5.42 51.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.101 -0.999 . . . . 4.5 109.234 179.74 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 58.0 mmtt -129.98 78.65 74.53 Favored Pre-proline 0 N--CA 1.499 2.011 0 O-C-N 121.504 -0.747 . . . . 5.12 109.429 179.799 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' O ' ' N ' ' A' ' 74' ' ' LYS . 2.9 Cg_exo -73.25 -166.82 0.32 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.723 2.282 . . . . 3.63 112.163 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 68.24 -62.87 0.39 Allowed Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.898 -1.281 . . . . 3.15 109.898 179.677 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.48 ' O ' ' NE ' ' A' ' 67' ' ' ARG . 0.6 OUTLIER -68.6 137.62 54.4 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.212 -1.17 . . . . 4.36 108.942 179.949 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -94.66 -155.98 31.89 Favored Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.141 -1.584 . . . . 2.03 109.141 179.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 48.3 m -78.59 131.51 36.76 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.27 -1.136 . . . . 1.8 108.249 179.308 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 29.9 m-85 -78.4 159.98 28.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.036 -1.04 . . . . 1.39 109.411 -178.96 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 75.7 m95 -113.18 139.93 48.35 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 109.055 -0.72 . . . . 0.46 109.055 179.712 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' THR . . . . . 0.446 ' O ' ' O ' ' A' ' 80' ' ' LEU . 15.2 t -143.1 160.69 39.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.189 -0.944 . . . . 0.56 109.862 -179.124 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' O ' ' O ' ' A' ' 79' ' ' THR . 81.7 mt -59.69 -121.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.401 -0.812 . . . . 1.42 109.575 179.795 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ASP . . . . . 0.454 ' O ' ' O ' ' A' ' 82' ' ' PRO . 23.3 t0 -137.23 72.53 52.45 Favored Pre-proline 0 N--CA 1.494 1.729 0 N-CA-C 108.383 -0.969 . . . . 3.72 108.383 179.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.454 ' O ' ' O ' ' A' ' 81' ' ' ASP . 62.8 Cg_exo -52.4 -130.11 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 123.275 2.65 . . . . 3.55 112.89 -179.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 76.4 m-20 -89.89 78.92 6.72 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 107.901 -1.148 . . . . 6.82 107.901 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 82.7 p -61.73 -12.46 16.81 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.49 0.662 . . . . 6.0 109.276 -179.246 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -58.15 -26.16 62.35 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.551 -0.907 . . . . 11.0 108.551 178.859 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' ASN . . . . . . . . . . . . . 18.5 m120 -69.96 -20.06 63.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.214 -0.929 . . . . 10.0 109.532 179.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' MET . . . . . 0.433 ' O ' ' O ' ' A' ' 88' ' ' PHE . 68.6 mtm -79.98 -172.95 3.65 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.785 -0.821 . . . . 8.47 108.785 179.19 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.433 ' O ' ' O ' ' A' ' 87' ' ' MET . 63.9 m-85 -62.2 -136.89 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.127 -0.983 . . . . 11.97 109.7 -179.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -130.19 21.55 5.28 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.598 -0.689 . . . . 11.95 109.815 -179.6 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -125.88 130.41 51.27 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.494 -0.754 . . . . 12.32 109.72 -179.823 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 168.43 -136.83 4.26 Favored Glycine 0 N--CA 1.486 1.967 0 N-CA-C 108.875 -1.69 . . . . 11.16 108.875 179.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 88.4 p -113.71 5.74 16.55 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.692 -0.887 . . . . 11.8 109.896 179.926 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' PHE . . . . . 0.42 ' C ' HD12 ' A' ' 94' ' ' LEU . 47.6 t80 -82.86 124.41 30.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.027 -1.045 . . . . 10.78 109.283 -179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.445 ' N ' HD12 ' A' ' 94' ' ' LEU . 10.9 mp . . . . . 0 N--CA 1.495 1.79 0 O-C-N 121.402 -0.811 . . . . 13.12 109.147 -179.968 . . . . . . . . 1 1 . 1 stop_ save_